data_1yka_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yka _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.651 ' CG2' HE21 ' A' ' 9' ' ' GLN . 48.2 mt . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.37 -44.3 84.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.27 -47.34 77.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.162 174.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.78 HD11 ' HB2' ' A' ' 62' ' ' LEU . 84.4 mt -57.8 -44.63 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.249 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.651 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.9 mt-30 -61.87 -40.38 95.16 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.594 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.2 mmp_? -60.86 -36.47 79.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 73.5 mt-30 -71.79 -45.12 62.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.415 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.834 HG21 ' HA2' ' A' ' 78' ' ' GLY . 27.2 mt -63.4 -44.28 98.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.095 0.474 . . . . 0.0 110.107 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.14 96.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 11.9 pt-20 -69.23 -37.48 78.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.694 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.33 126.42 86.45 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 121.315 0.579 . . . . 0.0 110.615 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 52.5 Cg_exo -62.1 -42.22 31.0 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 112.82 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.3 mm -136.75 119.48 20.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 18.0 tp -132.8 139.95 47.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.345 -170.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.4 tp -136.39 122.98 20.95 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.02 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.642 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.0 m-85 -98.95 118.06 34.87 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.491 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.9 ptt? -145.99 -166.18 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.662 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.068 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.9 tttt -99.61 118.48 36.24 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.467 -0.771 . . . . 0.0 110.079 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.93 68.46 1.02 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.096 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.4 m -77.71 139.24 62.47 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -53.68 -41.28 75.32 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.086 1.857 . . . . 0.0 111.724 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.87 -35.67 81.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.881 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -154.93 111.38 2.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.408 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 39.0 Cg_endo -74.41 32.29 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.654 2.236 . . . . 0.0 113.868 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -165.07 46.52 0.09 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.163 0.506 . . . . 0.0 110.132 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.77 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 37.5 t -71.65 66.97 0.54 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.158 -173.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.91 -140.81 3.08 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -76.91 -33.79 57.75 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.145 0.498 . . . . 0.0 110.699 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.831 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 15.1 p -49.88 -21.06 1.03 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.592 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.18 -42.73 30.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' A' ' 36' ' ' ALA . 1.7 pm0 -80.47 -34.94 35.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.233 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . . . -69.46 -43.08 73.98 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.526 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 7.9 p -53.38 -37.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.108 0.48 . . . . 0.0 110.729 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.516 ' HA ' HE21 ' A' ' 38' ' ' GLN . 0.9 OUTLIER -63.13 -46.18 88.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.842 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . . . -60.9 -44.41 97.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.876 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -60.65 -55.48 32.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 109.675 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.75 70.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.476 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 38' ' ' GLN . . . -71.93 -48.34 46.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.727 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.83 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.3 m -68.62 -57.42 5.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.83 -147.59 20.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.452 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 50.0 mm-40 -100.36 -153.58 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.53 0.681 . . . . 0.0 111.184 174.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.05 154.16 42.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.872 177.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CE1' HD22 ' A' ' 19' ' ' LEU . 17.4 p90 -145.97 158.89 43.86 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.006 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.57 146.34 25.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -137.72 149.16 46.26 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -122.63 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' MET . 10.5 p-10 -74.11 130.33 39.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.081 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.642 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -146.68 -34.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.651 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 1.068 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -63.4 -13.2 37.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.518 171.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.47 -45.44 6.76 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.347 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -76.31 116.02 52.38 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.953 0.342 . . . . 0.0 110.742 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.74 -45.18 26.4 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.0 2.467 . . . . 0.0 113.608 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.41 -54.33 14.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.507 0.67 . . . . 0.0 111.126 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.652 HG21 HD12 ' A' ' 8' ' ' ILE . 36.2 mt -63.6 -35.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.2 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.702 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 61.9 ttt-85 -57.61 -33.36 68.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.095 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.563 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -90.62 -52.68 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.62 -54.63 5.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -168.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.792 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -55.22 -44.39 99.6 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.702 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 22.1 Cg_endo -58.13 -41.74 64.4 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 121.465 1.444 . . . . 0.0 111.447 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.606 ' HZ2' ' HB2' ' A' ' 64' ' ' LYS . 10.6 mtmp? -61.1 -32.37 72.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.751 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.523 ' CD2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -63.15 -43.2 99.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.574 ' HB3' HD22 ' A' ' 80' ' ' LEU . . . -78.16 -57.66 3.67 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.404 -0.918 . . . . 0.0 112.389 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.506 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 41.5 t30 -174.73 -54.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.784 0.802 . . . . 0.0 110.323 168.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.558 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -55.6 148.58 34.3 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.835 -1.53 . . . . 0.0 113.274 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -61.62 -38.96 57.84 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.461 2.107 . . . . 0.0 110.459 172.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -143.06 -127.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.253 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.876 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 47.8 m-85 -138.15 -170.99 0.25 Allowed Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.876 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.6 Cg_endo -67.17 155.57 84.83 Favored 'Cis proline' 0 C--N 1.352 0.757 0 CA-C-N 121.132 1.44 . . . . 0.0 114.613 -0.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.476 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 59.3 mt-30 -147.51 132.66 18.33 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.429 173.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -95.85 138.56 33.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.987 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.559 ' CZ2' ' HB1' ' A' ' 66' ' ' ALA . 55.9 m95 -125.06 127.47 46.99 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.18 0.514 . . . . 0.0 110.73 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.901 HG22 HD12 ' A' ' 100' ' ' ILE . 65.4 t -111.61 121.16 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 176.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' CG ' ' HH ' ' A' ' 107' ' ' TYR . 10.2 t70 57.15 29.12 16.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.507 1.622 . . . . 0.0 108.691 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.834 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 73.41 29.11 64.52 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 113.6 -1.637 . . . . 0.0 113.152 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.57 132.15 51.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 110.807 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 66' ' ' ALA . 54.0 tp -65.71 132.42 48.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.801 -172.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.1 t -110.49 -53.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.199 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 142.19 135.11 3.05 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.36 -62.25 1.66 Allowed Glycine 0 C--O 1.223 -0.584 0 C-N-CA 119.525 -1.322 . . . . 0.0 116.232 -168.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -78.01 -70.76 0.46 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -168.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -80.19 -40.59 26.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.447 HG13 ' HA3' ' A' ' 82' ' ' GLY . 48.3 mm -55.9 -45.64 79.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.265 -174.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 82' ' ' GLY . 86.0 t -59.26 -49.24 84.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.206 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' A' ' 91' ' ' TYR . 39.6 mm -60.28 -48.79 86.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.456 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.743 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 40.0 tt0 -61.63 -53.28 58.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.69 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.553 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 80.8 mtp -62.64 -30.61 71.49 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.783 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 14.1 t80 -57.34 -52.24 66.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.69 170.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -63.55 -40.59 97.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.101 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 46.3 mmm-85 -59.62 -33.95 72.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.363 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 90.28 -24.66 15.31 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.286 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.655 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 91.0 mt-10 -60.07 -29.78 68.79 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 6.5 tt -61.74 -54.5 41.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.071 0.463 . . . . 0.0 110.208 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.83 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.1 pt20 -63.86 -26.58 68.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.775 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 90.9 mm-40 -62.9 -44.82 95.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 24.5 mt -69.9 -46.83 64.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.178 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.901 HD12 HG22 ' A' ' 76' ' ' VAL . 47.7 mm -60.62 -46.31 95.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.679 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 38.7 ttpt -55.54 -53.59 54.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.193 0.308 . . . . 0.0 111.424 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.85 -44.48 93.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.119 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 77' ' ' ASP . 61.9 m -63.29 -47.14 83.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.645 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.612 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.11 -45.15 94.74 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.389 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.2 95.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.551 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -33.19 71.23 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.841 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.578 ' HH ' ' CG ' ' A' ' 77' ' ' ASP . 58.0 m-85 -78.68 -47.29 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.612 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -100.38 -147.32 0.35 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 51.6 p -74.45 -155.62 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.969 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 110' ' ' GLU . 4.1 mm-40 -75.3 57.16 0.87 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.809 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.31 114.18 6.77 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.158 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -95.59 47.31 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 122.699 2.266 . . . . 0.0 112.919 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.487 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 7.6 m-20 . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.143 -168.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.673 ' CG2' HE21 ' A' ' 9' ' ' GLN . 33.5 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.591 0.234 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.3 -44.51 68.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.336 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -76.05 -38.41 57.17 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.498 HG23 HD13 ' A' ' 62' ' ' LEU . 75.1 mt -58.63 -46.9 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.914 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.673 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.0 mt-30 -62.3 -40.48 96.44 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.76 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -60.39 -35.56 76.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.79 0.329 . . . . 0.0 110.668 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.94 -44.35 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.774 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.603 HG21 HD23 ' A' ' 18' ' ' LEU . 28.9 mt -67.23 -47.34 81.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.529 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -59.42 -39.35 83.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.85 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.79 -30.63 70.12 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.946 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.31 126.77 86.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.069 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.46 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 52.7 Cg_exo -61.92 -42.95 27.68 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.849 2.366 . . . . 0.0 112.431 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.2 mm -137.37 121.1 22.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.603 HD23 HG21 ' A' ' 12' ' ' ILE . 24.5 tp -133.04 141.21 48.12 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.64 -170.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.546 HD23 ' CE1' ' A' ' 47' ' ' PHE . 12.8 tp -137.39 119.0 14.93 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.986 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.584 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.8 m-85 -96.51 119.6 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.036 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 23.2 ptt? -145.92 -166.99 2.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.417 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 86.9 tttt -95.76 90.04 5.52 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -91.84 67.69 2.1 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.463 -170.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -77.87 146.55 72.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.366 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.76 -39.78 89.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.995 1.797 . . . . 0.0 111.066 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.57 -34.36 77.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.617 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 30' ' ' CYS . 1.8 tt -161.42 112.59 1.24 Allowed Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.462 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -69.56 14.3 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.807 2.338 . . . . 0.0 114.11 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.667 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 24.8 p -163.21 47.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.31 0.576 . . . . 0.0 110.613 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.684 ' HA ' HD12 ' A' ' 27' ' ' LEU . 48.0 t -56.46 -40.63 75.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.658 -173.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.59 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.33 -134.48 0.13 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.237 -0.506 . . . . 0.0 114.275 -175.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 41.6 m-85 -74.23 -18.01 60.81 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 121.057 0.456 . . . . 0.0 111.872 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.474 ' HG ' ' HB2' ' A' ' 29' ' ' SER . 8.4 p -63.78 -19.5 65.04 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.9 -42.84 13.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.58 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.85 -38.88 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.299 0.571 . . . . 0.0 110.198 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . . . -63.32 -46.03 88.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.909 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.479 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 9.3 p -55.23 -39.18 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.523 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 1.7 mm100 -67.02 -48.71 67.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . . . -58.29 -45.12 88.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.89 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.497 HD13 ' CD2' ' A' ' 74' ' ' LEU . 1.3 tt -61.18 -55.38 32.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.232 0.539 . . . . 0.0 110.197 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.02 -32.35 71.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.175 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 38' ' ' GLN . . . -70.62 -47.52 59.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.664 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.3 p -77.16 -51.44 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.846 0.355 . . . . 0.0 111.098 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.78 -134.68 8.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.831 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 108' ' ' LYS . 10.4 pt-20 -128.25 -152.12 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.561 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 36.8 mmt180 -64.8 150.42 47.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.543 0.687 . . . . 0.0 112.777 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.546 ' CE1' HD23 ' A' ' 19' ' ' LEU . 16.5 p90 -149.4 157.35 43.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.732 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.25 146.94 25.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -137.7 153.36 49.79 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.4 t -130.18 129.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.528 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -74.62 135.2 42.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 21' ' ' MET . 1.1 pp -151.63 -37.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.522 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.729 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -64.39 -11.44 32.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.726 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.57 -41.77 8.76 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.504 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 74.7 m-20 -76.76 131.64 73.32 Favored Pre-proline 0 N--CA 1.473 0.712 0 O-C-N 122.241 -0.287 . . . . 0.0 110.376 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 16.6 Cg_exo -68.3 -44.45 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.468 2.112 . . . . 0.0 112.421 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.571 ' OD1' HG13 ' A' ' 58' ' ' ILE . 1.3 p30 -77.78 -56.0 4.87 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.571 HG13 ' OD1' ' A' ' 57' ' ' ASP . 48.7 mt -60.42 -32.88 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.45 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.554 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 80.0 ttt180 -51.63 -36.25 45.17 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.222 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.39 -44.64 11.89 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -77.32 -60.23 2.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -160.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.691 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 2.0 pt? -69.14 -31.81 2.95 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 14.1 Cg_endo -54.93 -41.36 79.37 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.533 1.489 . . . . 0.0 110.509 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.64 -39.4 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.494 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.531 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -70.83 -42.48 70.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.038 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.69 -57.99 3.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.484 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.713 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.9 t-20 -175.89 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 122.102 0.953 . . . . 0.0 109.407 169.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.713 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -57.32 148.53 52.95 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.209 -1.814 . . . . 0.0 113.328 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -62.85 -35.98 64.27 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.279 1.986 . . . . 0.0 110.314 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 p -143.19 -128.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.036 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.844 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.8 m-85 -139.09 -167.85 0.17 Allowed Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 48.4 Cg_endo -67.42 151.12 84.17 Favored 'Cis proline' 0 C--N 1.359 1.091 0 CA-C-N 121.318 1.507 . . . . 0.0 114.006 -1.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.697 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 19.3 mt-30 -139.15 132.57 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.188 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.497 ' CD2' HD13 ' A' ' 40' ' ' LEU . 3.3 tm? -95.75 137.23 35.11 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 67.9 m95 -122.99 132.48 54.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 110.92 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.736 HG21 HD11 ' A' ' 99' ' ' LEU . 58.0 t -118.54 119.73 62.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.483 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' HB2' HG22 ' A' ' 103' ' ' THR . 33.3 t70 56.68 25.53 10.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.857 1.313 . . . . 0.0 110.02 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.531 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 80.49 28.4 47.99 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.135 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.11 135.58 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.996 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.614 HD23 ' CZ3' ' A' ' 68' ' ' TRP . 53.1 tp -70.97 129.16 38.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.261 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 86' ' ' ILE . 98.5 t -105.62 -54.74 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.824 170.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.493 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 141.01 133.4 2.93 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -86.11 -64.84 1.45 Allowed Glycine 0 C--O 1.217 -0.907 0 C-N-CA 119.046 -1.549 . . . . 0.0 116.436 -167.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 18.4 p -78.94 -59.61 2.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.21 1.005 . . . . 0.0 113.031 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.3 -46.11 21.0 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 120.886 0.374 . . . . 0.0 111.0 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.493 HG13 ' HA3' ' A' ' 82' ' ' GLY . 46.0 mm -63.4 -42.69 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.73 -171.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 83' ' ' GLY . 71.6 t -59.5 -48.35 87.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.141 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.1 mm -59.03 -49.01 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.75 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 39.7 tt0 -61.61 -54.49 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.679 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.592 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -56.21 -36.27 68.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.536 0.208 . . . . 0.0 111.412 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.0 t80 -59.6 -50.85 72.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.062 174.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.6 mt-30 -66.01 -44.02 85.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.75 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.9 mmm-85 -58.93 -33.71 70.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.23 21.67 64.54 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.567 -1.197 . . . . 0.0 112.152 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.3 mt-10 -88.35 -29.4 20.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.379 0.609 . . . . 0.0 110.851 173.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 60.3 tp -62.16 -55.0 33.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.048 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.722 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 16.3 pt20 -59.22 -26.26 64.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.632 174.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.1 mm-40 -68.81 -55.14 12.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.801 0.334 . . . . 0.0 111.404 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.736 HD11 HG21 ' A' ' 76' ' ' VAL . 2.3 pp -71.19 -36.09 71.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.044 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 76' ' ' VAL . 46.2 mm -62.31 -44.67 99.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 113' ' ' ASP . 21.9 ttmt -49.29 -57.6 6.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.51 0.672 . . . . 0.0 111.793 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 88.2 tt0 -62.15 -46.09 90.55 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.528 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.539 HG22 ' HB2' ' A' ' 77' ' ' ASP . 86.6 m -67.22 -49.73 63.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 100' ' ' ILE . . . -58.93 -45.97 89.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.581 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.73 91.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -67.3 -26.79 66.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.79 -177.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.518 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 37.8 m-85 -79.19 -46.61 17.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.204 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 45' ' ' GLU . 48.0 mtmt -91.94 -158.27 0.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.308 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 p -84.84 55.25 3.37 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.353 1.073 . . . . 0.0 112.015 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 53.86 47.23 24.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.319 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 40.0 mm-40 -62.44 136.34 95.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.585 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.39 132.25 20.41 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.084 2.523 . . . . 0.0 112.401 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.672 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 10.9 t70 . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.672 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.696 ' CG2' HE21 ' A' ' 9' ' ' GLN . 65.1 mt . . . . . 0 C--O 1.232 0.139 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 52.6 mm-40 -53.96 -47.62 71.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -67.12 -43.93 81.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.283 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 62' ' ' LEU . 81.4 mt -59.23 -44.48 92.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.696 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.3 mt-30 -61.34 -43.46 98.83 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.486 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.566 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.3 mmp_? -61.15 -35.84 78.17 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -68.08 -45.75 72.92 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.538 HG23 HD22 ' A' ' 18' ' ' LEU . 41.3 mt -63.55 -41.14 91.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.918 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -34.27 71.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.347 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 72.8 mt-10 -59.84 -50.42 73.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.898 0.38 . . . . 0.0 111.07 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -79.33 128.81 74.3 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.111 -171.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.8 Cg_exo -59.05 -42.6 49.86 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 123.144 2.563 . . . . 0.0 112.03 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.6 mm -133.88 122.64 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.591 ' CD2' ' HE1' ' A' ' 20' ' ' TYR . 20.8 tp -133.87 141.7 47.49 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.2 -171.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.4 tp -136.61 119.87 16.75 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.096 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.591 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 6.2 m-85 -98.26 119.33 36.74 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.795 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.628 ' O ' HD12 ' A' ' 52' ' ' ILE . 23.0 ptt? -146.19 -166.81 2.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.206 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.857 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 84.4 tttt -96.57 144.74 26.35 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.66 121.2 3.55 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.508 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.554 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 41.5 t -132.93 144.87 54.66 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.59 -39.89 86.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.475 2.117 . . . . 0.0 111.277 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -68.43 -34.34 75.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.496 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 29' ' ' SER . 2.7 tt -158.09 117.56 1.87 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -74.99 26.3 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.5 2.134 . . . . 0.0 114.434 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.1 p -164.33 49.86 0.12 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.529 0.681 . . . . 0.0 111.448 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.731 ' HG ' ' HG2' ' A' ' 22' ' ' LYS . 1.6 p -67.06 61.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.426 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.81 -138.69 2.57 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.504 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 42.9 m-85 -76.9 -19.86 56.92 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.522 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 25.8 p -69.52 -15.2 63.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -46.95 -42.12 17.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.586 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.74 -40.87 32.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.085 0.469 . . . . 0.0 110.438 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -61.96 -43.84 97.99 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.922 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 47' ' ' PHE . 11.4 p -55.8 -38.49 51.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.583 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.567 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 1.7 mm100 -68.13 -46.01 72.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.367 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 88' ' ' ILE . . . -58.36 -45.41 88.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.548 HD11 ' CD2' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -63.42 -55.43 24.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.164 0.507 . . . . 0.0 110.364 -175.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.34 70.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 38' ' ' GLN . . . -70.05 -48.63 57.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.312 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -73.3 -58.17 3.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.05 -143.31 13.79 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.465 -0.874 . . . . 0.0 114.164 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.668 ' OE2' ' HB3' ' A' ' 111' ' ' GLU . 51.8 mt-10 -97.37 -154.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.437 0.637 . . . . 0.0 111.337 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 40.6 mmt180 -66.88 153.3 43.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.164 170.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 24.4 p90 -147.67 153.43 39.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.3 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.21 144.85 27.22 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -132.67 153.27 51.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.35 129.73 69.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.576 ' HA ' ' O ' ' A' ' 21' ' ' MET . 43.2 p-10 -75.34 135.64 40.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.63 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 1.03 HG22 HD22 ' A' ' 55' ' ' ASN . 1.1 pp -149.68 -37.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.857 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.76 -11.05 23.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.613 170.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 -40.56 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.073 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 1.03 HD22 HG22 ' A' ' 52' ' ' ILE . 19.8 p30 -80.23 140.85 53.14 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 121.389 0.614 . . . . 0.0 111.428 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.23 -41.79 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.995 1.797 . . . . 0.0 112.524 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -78.74 -55.84 4.86 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -170.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.668 HG21 HD13 ' A' ' 8' ' ' ILE . 51.3 mt -62.9 -39.1 83.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.392 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.1 ttt180 -53.93 -34.72 60.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.048 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.17 -54.16 5.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 64' ' ' LYS . 42.1 mt-10 -79.84 -51.36 9.24 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.846 ' HB2' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -58.07 -43.29 98.29 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -171.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.605 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 21.2 Cg_endo -57.76 -38.71 92.0 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 121.631 1.554 . . . . 0.0 111.197 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 61' ' ' GLU . 5.0 mtpm? -55.09 -39.48 69.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.04 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.523 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.79 -41.62 91.76 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.133 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.72 -56.93 3.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.97 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -174.99 -55.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.319 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.27 151.36 58.89 Favored Pre-proline 0 C--O 1.222 -0.365 0 CA-C-N 113.646 -1.615 . . . . 0.0 113.72 -175.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.21 -39.21 39.84 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.318 2.012 . . . . 0.0 110.336 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.549 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 67.9 p -142.44 -124.38 0.09 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.66 172.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.851 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 24.1 m-85 -138.67 -168.26 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.851 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 41.6 Cg_endo -67.4 155.34 85.75 Favored 'Cis proline' 0 C--N 1.361 1.228 0 CA-C-N 121.235 1.477 . . . . 0.0 114.466 -1.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.718 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 18.8 mt-30 -143.6 133.07 23.44 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.507 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.548 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -95.8 137.42 34.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.998 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 61.4 m95 -122.66 129.3 51.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.283 0.563 . . . . 0.0 110.805 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.907 HG22 HD11 ' A' ' 100' ' ' ILE . 48.7 t -115.16 119.96 63.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 103' ' ' THR . 10.3 t70 56.22 30.33 16.39 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 123.563 1.649 . . . . 0.0 108.812 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 74.53 29.06 62.28 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.381 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 49.5 mt-10 -125.37 133.71 52.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.383 . . . . 0.0 110.782 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.668 HD22 ' CZ3' ' A' ' 68' ' ' TRP . 55.4 tp -71.05 130.95 42.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.609 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.533 HG11 HG21 ' A' ' 86' ' ' ILE . 99.3 t -110.37 -52.05 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.199 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.64 134.92 2.75 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.47 -64.63 1.56 Allowed Glycine 0 C--O 1.218 -0.897 0 C-N-CA 118.751 -1.69 . . . . 0.0 116.526 -166.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.504 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 25.1 p -80.62 -69.04 0.63 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.285 1.042 . . . . 0.0 112.824 -170.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -74.42 -43.7 55.12 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.263 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.533 HG21 HG11 ' A' ' 81' ' ' VAL . 50.7 mm -58.54 -45.31 90.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.937 -174.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 82' ' ' GLY . 74.5 t -57.44 -48.01 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.185 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.499 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 44.0 mm -60.29 -51.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.973 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.726 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.7 tt0 -62.19 -50.17 72.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.795 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.4 mmt -57.81 -39.73 78.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.843 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.487 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 13.3 t80 -60.15 -49.14 78.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.805 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.3 mt-30 -65.5 -40.09 92.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.83 0.348 . . . . 0.0 110.168 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.7 mmm-85 -57.82 -33.24 68.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.143 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.22 21.64 64.62 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.602 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 93.0 mt-10 -99.06 -13.85 19.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 0.0 111.543 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.514 HD11 HD11 ' A' ' 99' ' ' LEU . 55.7 tp -72.12 -53.06 13.89 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.733 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.2 pm0 -56.31 -25.66 49.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.703 170.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 11.7 mm-40 -71.17 -50.52 32.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.845 0.355 . . . . 0.0 111.58 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.514 HD11 HD11 ' A' ' 96' ' ' LEU . 2.6 pp -74.59 -36.22 63.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.907 HD11 HG22 ' A' ' 76' ' ' VAL . 42.6 mm -63.63 -42.11 94.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 173.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 21.8 ttmm -52.42 -56.24 16.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.303 0.573 . . . . 0.0 111.25 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -57.3 -48.61 78.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.924 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.605 HG22 ' HB2' ' A' ' 77' ' ' ASP . 94.8 m -69.4 -47.95 62.58 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.581 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -61.22 -47.93 83.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.005 0.431 . . . . 0.0 110.307 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.69 95.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -68.92 -29.76 68.09 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.11 -0.369 . . . . 0.0 111.863 -178.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.499 ' HH ' ' CG ' ' A' ' 77' ' ' ASP . 52.8 m-85 -78.78 -46.6 18.46 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.245 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.581 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.68 -160.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.681 174.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.414 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 66.7 p -84.73 -140.1 0.07 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.953 174.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.77 45.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.959 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.668 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . 5.0 mm-40 -70.81 130.58 88.4 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.996 0.427 . . . . 0.0 111.373 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 1.5 Cg_endo -82.98 116.42 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.837 2.358 . . . . 0.0 112.318 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.431 ' CG ' ' HA ' ' A' ' 101' ' ' LYS . 12.9 t70 . . . . . 0 C--N 1.322 -0.596 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.93 HG21 ' HG3' ' A' ' 9' ' ' GLN . 22.4 mm . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.471 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 70.6 mm-40 -44.69 -45.79 9.94 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -62.16 -43.76 98.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.074 0.464 . . . . 0.0 110.93 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.938 HD12 ' HB2' ' A' ' 62' ' ' LEU . 73.0 mt -68.3 -40.55 82.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.626 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.93 ' HG3' HG21 ' A' ' 5' ' ' ILE . 62.7 mt-30 -58.54 -44.2 89.51 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -55.54 -34.73 64.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.268 175.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.621 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 38.6 tt0 -68.44 -48.41 64.66 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.431 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.498 HG12 ' HH ' ' A' ' 20' ' ' TYR . 21.0 mt -68.32 -39.24 80.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.77 0.795 . . . . 0.0 110.472 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.46 81.0 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.839 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.1 pt-20 -70.03 -39.28 75.86 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -173.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.588 ' OD1' HD23 ' A' ' 18' ' ' LEU . 2.7 p30 -79.22 134.96 58.35 Favored Pre-proline 0 CA--C 1.518 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 112.737 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HG2' ' HE3' ' A' ' 108' ' ' LYS . 32.7 Cg_exo -64.24 -41.73 20.5 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 123.165 2.576 . . . . 0.0 111.648 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -138.52 121.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 75' ' ' TRP . 25.6 tp -132.43 141.25 48.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.232 0.539 . . . . 0.0 111.959 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.5 tp -132.34 120.67 22.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.791 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.671 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.5 m-85 -99.53 120.99 40.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.703 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.725 ' HE2' ' HD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.1 -154.05 0.53 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.768 ' HD3' ' HB3' ' A' ' 30' ' ' CYS . 64.6 tttm -100.7 112.01 24.34 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.59 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.43 69.5 1.06 Allowed Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.674 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -78.85 143.97 63.26 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.198 . . . . 0.0 111.068 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.04 -40.23 85.38 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.119 1.879 . . . . 0.0 110.94 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -65.27 -33.09 75.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.765 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -160.46 116.67 1.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.511 ' O ' ' SD ' ' A' ' 21' ' ' MET . 9.3 Cg_exo -72.94 31.43 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.738 2.292 . . . . 0.0 113.984 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -169.61 51.82 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.454 0.702 . . . . 0.0 110.241 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.768 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.8 t -56.37 -37.07 69.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.551 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -70.5 -135.82 0.11 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.5 -36.4 57.81 Favored 'General case' 0 C--O 1.219 -0.529 0 O-C-N 122.353 -0.498 . . . . 0.0 111.943 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.48 ' CB ' ' HB3' ' A' ' 21' ' ' MET . 34.6 t -54.01 -10.39 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.41 -42.32 42.2 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.083 0.24 . . . . 0.0 111.325 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.431 HE21 ' HB1' ' A' ' 36' ' ' ALA . 1.5 pm0 -80.56 -34.85 35.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.234 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB1' HE21 ' A' ' 35' ' ' GLN . . . -67.26 -42.75 83.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.304 -175.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.577 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.54 -37.41 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.305 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.8 mm100 -64.81 -46.08 83.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.306 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . . . -59.65 -43.95 93.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.618 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.531 HD13 ' CD2' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -64.12 -57.88 8.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.618 -174.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.41 72.65 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.271 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.52 -48.84 59.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.681 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.5 p -72.81 -54.25 9.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.795 -173.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.754 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.38 -142.45 12.75 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.451 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 17.1 pt-20 -99.95 -154.68 0.48 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.52 . . . . 0.0 111.082 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.79 158.68 33.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.991 170.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.577 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 15.5 p90 -152.96 159.73 42.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.297 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -97.54 151.98 19.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.725 ' HD1' ' HE2' ' A' ' 21' ' ' MET . 2.0 p90 -138.05 151.59 48.0 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 18' ' ' LEU . 46.2 t -132.3 126.78 56.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.59 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.8 p30 -76.59 131.39 38.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.277 0.56 . . . . 0.0 110.73 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.671 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -143.5 -33.93 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.709 -174.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.6 mm? -65.74 -9.47 28.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.142 166.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -46.82 6.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.236 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -83.44 116.57 65.16 Favored Pre-proline 0 N--CA 1.476 0.842 0 O-C-N 122.059 -0.401 . . . . 0.0 111.025 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.93 -44.81 18.78 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.792 2.328 . . . . 0.0 113.248 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -61.5 -55.07 35.16 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.443 0.64 . . . . 0.0 111.341 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.9 mt -67.34 -36.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.365 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.3 ttt180 -56.98 -33.68 67.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.72 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.51 7.33 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.718 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 55.3 mm-40 -84.7 -51.05 7.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -167.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.938 ' HB2' HD12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -60.09 -41.67 85.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -172.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.611 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 32.4 Cg_endo -59.52 -39.28 76.95 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 C-N-CA 121.282 1.321 . . . . 0.0 111.168 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 37.9 mtmt -55.55 -41.75 73.68 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.219 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.632 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -63.32 -44.89 93.64 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.111 -176.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.717 ' HB1' ' CZ2' ' A' ' 75' ' ' TRP . . . -74.1 -56.11 5.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.462 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.745 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.5 t-20 -174.82 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.188 0.994 . . . . 0.0 110.006 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.745 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.12 148.25 62.31 Favored Pre-proline 0 C--O 1.219 -0.542 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.365 -175.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.77 -37.36 68.1 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 121.912 1.741 . . . . 0.0 110.437 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.44 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 37.2 p -143.07 -128.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.58 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.863 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.6 m-85 -137.11 -169.7 0.22 Allowed Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.863 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.55 153.39 82.59 Favored 'Cis proline' 0 C--N 1.361 1.22 0 CA-C-N 121.374 1.527 . . . . 0.0 114.14 -0.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.704 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.6 mt-30 -142.28 135.45 28.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.298 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.531 ' CD2' HD13 ' A' ' 40' ' ' LEU . 3.2 tm? -99.3 133.71 43.2 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.717 ' CZ2' ' HB1' ' A' ' 66' ' ' ALA . 59.4 m95 -116.9 131.33 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.314 0.578 . . . . 0.0 110.863 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 99' ' ' LEU . 86.4 t -121.67 122.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 37.3 t70 58.22 30.12 18.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.811 1.291 . . . . 0.0 109.332 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 72.68 28.77 66.62 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.16 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -137.04 137.56 39.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 111.479 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.542 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 46.3 tp -66.96 132.48 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.229 -172.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.969 HG11 HG23 ' A' ' 86' ' ' ILE . 76.1 t -110.32 -54.65 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.921 171.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.604 ' O ' HG21 ' A' ' 87' ' ' VAL . . . 145.63 134.49 2.7 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.87 -62.39 1.69 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -168.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.1 p -78.67 -68.12 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.701 -0.882 . . . . 0.0 112.992 -170.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.94 -47.65 43.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.031 0.444 . . . . 0.0 111.008 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.969 HG23 HG11 ' A' ' 81' ' ' VAL . 44.4 mm -59.95 -46.82 93.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.754 -170.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.604 HG21 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -56.11 -50.33 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.361 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.467 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.7 mm -61.94 -50.66 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.631 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.773 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.3 tt0 -63.25 -50.48 70.02 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.422 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.457 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.3 mmt -57.54 -38.02 74.02 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.525 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.0 t80 -58.02 -51.64 68.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.149 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.0 mt-30 -63.93 -39.85 95.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.649 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.773 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 25.9 mmm180 -63.6 -33.89 76.6 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.821 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 99.59 -24.09 33.58 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.34 -170.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.548 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 5.1 mm-40 -52.14 -36.14 50.52 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 99' ' ' LEU . 53.3 tp -64.77 -54.99 22.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.68 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.763 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.5 pt20 -61.18 -26.47 67.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.405 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 10.4 mm100 -66.81 -54.54 21.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.633 0.254 . . . . 0.0 111.407 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.828 HD12 HG22 ' A' ' 76' ' ' VAL . 3.0 pp -70.28 -35.26 73.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.558 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.823 HD12 HG23 ' A' ' 76' ' ' VAL . 35.7 mm -62.97 -48.6 87.22 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -55.62 -52.22 64.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 111.753 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -57.1 -45.32 83.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.949 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 ' HE2' ' A' ' 107' ' ' TYR . 91.1 m -68.0 -47.97 67.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.417 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.06 99.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.025 0.441 . . . . 0.0 110.06 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.65 99.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -72.14 -33.6 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.643 -178.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.471 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 80.0 m-85 -79.57 -46.69 16.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.767 173.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -89.58 -149.91 0.2 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.184 -177.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.448 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 25.3 t -82.84 -148.36 0.08 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.331 170.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -75.11 54.3 0.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.877 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 38.5 mm-40 -66.11 117.56 44.07 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 121.178 0.514 . . . . 0.0 110.398 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -99.7 49.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.598 2.865 . . . . 0.0 113.233 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.754 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 36.4 m-20 . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.711 ' CG2' HE21 ' A' ' 9' ' ' GLN . 73.3 mt . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -53.38 -47.29 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.982 0.42 . . . . 0.0 110.725 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.943 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -68.43 -45.35 72.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.56 175.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.886 HD13 ' HB2' ' A' ' 62' ' ' LEU . 82.6 mt -56.69 -44.2 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.711 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.7 mt-30 -60.35 -35.84 76.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.831 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -60.23 -35.68 76.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.494 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -72.36 -42.11 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.542 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.547 HD11 ' OH ' ' A' ' 65' ' ' TYR . 19.6 mt -68.39 -45.66 81.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.119 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -37.81 78.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.169 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.2 pt-20 -68.57 -34.8 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -78.55 127.57 80.15 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-O 120.901 0.381 . . . . 0.0 111.273 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.7 Cg_exo -61.8 -42.84 29.05 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.019 2.48 . . . . 0.0 112.333 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.1 mm -137.47 120.95 21.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.605 ' CD2' ' HE1' ' A' ' 20' ' ' TYR . 21.5 tp -133.41 142.43 48.34 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.466 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.3 tp -136.32 120.28 17.55 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.12 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.635 ' CE2' HD22 ' A' ' 62' ' ' LEU . 5.5 m-85 -97.35 117.92 32.66 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.848 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 21.6 ptt? -146.84 -164.89 2.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.4 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.93 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 61.9 tttm -98.34 103.16 15.08 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.24 67.0 1.76 Allowed Glycine 0 C--N 1.309 -0.926 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.437 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 t -76.07 141.3 70.85 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.6 -41.42 45.11 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.253 1.969 . . . . 0.0 112.188 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -65.14 -35.62 81.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.844 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.57 HD21 ' H ' ' A' ' 29' ' ' SER . 3.0 tt -158.57 118.99 1.84 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -172.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.1 Cg_exo -71.99 20.37 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.798 2.332 . . . . 0.0 114.303 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.57 ' H ' HD21 ' A' ' 27' ' ' LEU . 21.7 p -161.97 52.35 0.23 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.517 0.675 . . . . 0.0 111.037 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 43.4 t -71.54 56.24 0.25 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.126 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.23 -136.53 2.02 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.689 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 28.2 m-85 -76.25 -38.28 56.48 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 117.481 0.64 . . . . 0.0 109.518 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.504 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 35.1 p -46.4 -24.58 0.52 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.195 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.99 -42.2 48.6 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.555 0.216 . . . . 0.0 111.097 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.689 ' HG3' ' O ' ' A' ' 32' ' ' PHE . 1.8 pp0? -77.41 -37.94 50.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB3' ' NE2' ' A' ' 35' ' ' GLN . . . -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.629 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 10.6 p -57.53 -38.98 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 1.8 mm100 -65.42 -41.92 93.07 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.924 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.496 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.1 -43.33 95.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.604 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 74' ' ' LEU . 1.2 tt -63.08 -56.0 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 0.0 109.908 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.35 72.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.899 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.6 m -70.41 -60.36 2.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.33 -138.91 9.57 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -115.09 -151.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.621 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -59.38 152.68 20.73 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.628 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.629 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 26.1 p90 -155.64 154.16 31.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.057 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 151.71 20.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.947 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.3 p90 -135.72 153.91 51.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG21 HD13 ' A' ' 18' ' ' LEU . 61.6 t -131.43 134.51 60.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.652 ' OD1' ' HB3' ' A' ' 54' ' ' GLN . 7.9 t70 -73.13 138.89 46.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.185 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.663 HD13 ' CB ' ' A' ' 71' ' ' PHE . 1.1 pp -152.0 -35.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.387 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.93 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -65.25 -18.0 64.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.387 174.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.652 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -94.94 -43.23 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.616 176.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -71.51 118.55 67.27 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 117.797 0.271 . . . . 0.0 110.503 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.81 -43.98 8.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.313 2.009 . . . . 0.0 113.029 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -69.25 -52.79 24.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.85 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.8 mt -65.12 -36.53 78.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.391 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.2 tmm_? -56.32 -37.93 70.61 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.73 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.608 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -80.43 -50.99 9.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.537 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 4.9 mm-40 -79.18 -53.51 6.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -167.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.886 ' HB2' HD13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -62.53 -40.69 67.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.641 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 27.5 Cg_endo -59.44 -40.74 64.25 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 121.378 1.385 . . . . 0.0 111.468 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.608 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 51.6 mtmt -56.28 -36.06 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.556 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.547 ' OH ' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.81 -43.23 80.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.534 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.628 ' HB1' ' CZ2' ' A' ' 75' ' ' TRP . . . -75.81 -56.26 4.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.434 -174.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.757 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -175.47 -53.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.253 1.025 . . . . 0.0 109.362 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.757 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.73 150.64 57.18 Favored Pre-proline 0 C--O 1.218 -0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 113.484 -176.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 68' ' ' TRP . 10.3 Cg_exo -64.1 -39.12 32.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.211 1.941 . . . . 0.0 110.113 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 47.6 p -143.12 -129.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.728 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.889 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.4 m-85 -137.86 -171.85 0.29 Allowed Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.528 -0.733 . . . . 0.0 109.141 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.889 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.57 156.07 82.31 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 120.933 1.369 . . . . 0.0 114.469 -0.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.668 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.9 mt-30 -142.08 133.58 26.67 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.264 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.512 ' CD2' HD13 ' A' ' 40' ' ' LEU . 3.3 tm? -94.06 138.13 32.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.628 ' CZ2' ' HB1' ' A' ' 66' ' ' ALA . 58.9 m95 -124.28 128.03 48.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.257 0.551 . . . . 0.0 110.828 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.793 HG22 HD13 ' A' ' 100' ' ' ILE . 66.8 t -110.54 120.96 62.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.588 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 32.6 t70 56.39 27.44 12.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.917 1.341 . . . . 0.0 110.01 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.524 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 77.38 29.34 56.15 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.905 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -125.83 132.62 52.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 56.3 tp -69.81 130.29 41.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 86' ' ' ILE . 88.3 t -108.35 -55.75 5.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.346 172.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.488 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 144.29 131.41 2.43 Favored Glycine 0 C--O 1.22 -0.768 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -85.36 -62.33 1.65 Allowed Glycine 0 C--O 1.222 -0.641 0 C-N-CA 119.593 -1.289 . . . . 0.0 116.1 -168.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 p -77.52 -67.85 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.759 -0.848 . . . . 0.0 112.934 -170.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -79.04 -45.0 21.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.023 -173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' HA3' ' A' ' 82' ' ' GLY . 48.0 mm -58.01 -47.01 87.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.505 HG11 HD22 ' A' ' 96' ' ' LEU . 60.5 t -57.29 -51.86 64.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.568 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 45.6 mm -59.83 -50.39 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.686 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 42.7 tt0 -61.04 -51.51 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.694 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.667 ' HG2' ' N ' ' A' ' 96' ' ' LEU . 46.5 ttm -63.88 -32.59 74.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.098 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.899 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 7.8 t80 -57.35 -52.05 66.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.657 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.1 mt-30 -62.83 -38.28 90.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.14 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.686 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -59.12 -32.84 70.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.062 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.04 17.64 79.54 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.571 -171.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.641 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 88.9 mt-10 -90.87 -27.17 18.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.525 177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.667 ' N ' ' HG2' ' A' ' 90' ' ' MET . 61.7 tp -60.1 -53.66 55.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.579 0.704 . . . . 0.0 109.462 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.796 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 14.1 pt20 -64.31 -26.62 68.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.28 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.63 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.59 -44.16 91.52 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.175 0.512 . . . . 0.0 109.713 175.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 25.4 mt -69.95 -46.46 65.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.57 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.793 HD13 HG22 ' A' ' 76' ' ' VAL . 50.4 mm -61.08 -45.23 98.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.148 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 113' ' ' ASP . 36.4 ttpt -55.96 -48.78 75.18 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.49 -44.03 96.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.13 0.49 . . . . 0.0 110.373 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.588 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 42.1 m -75.33 -52.2 11.39 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.58 94.12 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.261 -0.274 . . . . 0.0 111.154 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.3 80.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.635 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -75.04 -27.03 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.153 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.608 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 44.4 m-85 -80.73 -45.77 16.54 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.063 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.556 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -76.64 -156.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.4 p -82.45 -147.75 0.08 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -76.81 46.51 0.46 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.916 0.389 . . . . 0.0 110.925 171.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -68.34 129.06 93.02 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.894 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.15 111.38 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.399 2.066 . . . . 0.0 112.721 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.58 ' CB ' ' HA ' ' A' ' 101' ' ' LYS . 31.1 t70 . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.692 ' CG2' HE21 ' A' ' 9' ' ' GLN . 91.5 mt . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.566 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 33.8 mm-40 -51.28 -53.71 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 111.429 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.78 -40.19 88.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.304 0.573 . . . . 0.0 110.674 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.926 HG21 ' HG ' ' A' ' 62' ' ' LEU . 83.4 mt -59.76 -46.14 93.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.616 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.692 HE21 ' CG2' ' A' ' 5' ' ' ILE . 69.3 mt-30 -61.77 -35.24 77.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.662 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -60.82 -38.54 85.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.172 175.086 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.533 ' HG2' ' HA ' ' A' ' 8' ' ' ILE . 17.2 pt20 -79.68 -39.81 30.47 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.009 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.465 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 22.3 mt -61.88 -45.22 99.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.218 0.533 . . . . 0.0 110.429 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.6 91.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.1 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.0 pt-20 -70.43 -30.15 66.93 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.828 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.462 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.74 126.87 85.32 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.275 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' ASN . 51.0 Cg_exo -60.29 -43.56 33.93 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.911 2.407 . . . . 0.0 112.56 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.2 mm -139.92 120.61 14.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.578 HD11 HG21 ' A' ' 50' ' ' VAL . 20.0 tp -133.76 142.26 47.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.375 -169.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 14.5 tp -137.52 116.62 12.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.17 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.559 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 6.6 m-85 -96.35 118.83 33.69 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.305 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.831 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 24.2 ptt? -147.44 -167.44 2.79 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.618 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 65.9 tttm -97.11 108.68 21.46 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -94.63 71.15 1.13 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.328 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.9 m -78.67 146.71 69.73 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.92 -41.69 74.62 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.479 2.119 . . . . 0.0 112.288 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.88 -31.45 71.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.545 HD23 ' H ' ' A' ' 29' ' ' SER . 2.5 tt -157.58 115.22 1.88 Allowed Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.84 22.12 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.674 2.25 . . . . 0.0 113.713 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.831 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 15.7 p -163.14 50.48 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.014 0.526 . . . . 0.0 109.903 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.618 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 37.6 t -71.93 53.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.288 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.12 -134.38 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.152 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 1.034 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 63.3 m-85 -76.43 -23.16 53.95 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -74.82 -11.54 60.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.664 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -50.76 -43.4 58.29 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.534 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -77.42 -39.13 48.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.068 0.461 . . . . 0.0 110.107 176.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.34 89.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.102 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 38' ' ' GLN . 11.6 p -56.8 -39.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.321 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.519 ' N ' HG11 ' A' ' 37' ' ' VAL . 1.7 mm100 -66.89 -47.35 72.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.858 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . . . -59.36 -42.86 92.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.984 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.531 HD11 ' CD2' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -62.37 -57.08 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 110.036 -175.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.03 69.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.204 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 38' ' ' GLN . . . -72.82 -50.62 23.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.557 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -76.5 -52.99 8.73 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.246 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.64 -135.59 8.99 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.486 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 26.3 mt-10 -141.95 -147.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.101 -0.549 . . . . 0.0 111.348 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 34.3 mmt-85 -48.02 146.96 2.28 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.359 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 21.6 p90 -159.38 150.86 20.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.876 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.99 144.06 28.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.557 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.518 ' CG ' ' HE2' ' A' ' 21' ' ' MET . 2.7 p90 -130.78 149.74 52.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 18' ' ' LEU . 44.0 t -124.31 128.04 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.0 p30 -78.46 132.2 37.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.393 0.616 . . . . 0.0 110.166 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.658 HD13 ' CB ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -142.53 -34.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.342 -173.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.593 ' HB2' ' CB ' ' A' ' 22' ' ' LYS . 1.8 mm? -67.19 -8.68 33.2 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.116 167.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.25 -47.12 5.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.698 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.656 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.1 m-20 -73.78 131.35 81.96 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 121.958 -0.464 . . . . 0.0 111.419 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.76 -43.63 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.364 2.043 . . . . 0.0 112.924 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -76.1 -55.5 5.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.78 -33.38 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.656 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 28.1 ttm180 -49.73 -40.4 40.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.612 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.39 18.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.425 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 56.7 mm-40 -78.86 -60.08 2.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -161.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.92 -25.18 0.49 Allowed Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -170.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.701 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 14.1 Cg_endo -55.24 -41.82 74.66 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 121.682 1.637 . . . . 0.0 110.682 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -48.38 -41.93 30.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.777 175.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.55 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -71.97 -41.7 67.39 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.149 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.702 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . . . -72.53 -57.56 4.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.64 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.686 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 50.3 t30 -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.256 1.027 . . . . 0.0 109.861 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.686 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -60.78 148.07 83.39 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 113.12 -1.854 . . . . 0.0 112.738 -176.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -61.95 -33.94 82.45 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.194 1.93 . . . . 0.0 110.145 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -143.0 -126.64 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.917 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.906 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.3 m-85 -142.28 -164.49 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.906 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 2.1 Cg_endo -74.32 154.9 99.88 Favored 'Cis proline' 0 C--N 1.362 1.278 0 CA-C-N 121.503 1.572 . . . . 0.0 113.282 -2.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.632 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 61.8 mt-30 -144.02 135.4 25.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.704 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.531 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -93.55 137.04 33.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.702 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 59.1 m95 -121.26 132.56 54.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.236 0.541 . . . . 0.0 111.083 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 100' ' ' ILE . 85.0 t -117.06 120.88 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.59 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 30.6 t70 56.38 28.35 13.38 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.799 1.285 . . . . 0.0 110.43 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.51 28.21 55.77 Favored Glycine 0 C--N 1.311 -0.821 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.887 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -127.76 133.84 49.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.501 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 52.0 tp -69.44 130.25 41.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.771 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.995 HG11 HG22 ' A' ' 86' ' ' ILE . 81.6 t -107.35 -54.4 5.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.902 173.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 144.59 140.78 3.64 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.16 -67.66 1.4 Allowed Glycine 0 C--O 1.217 -0.951 0 C-N-CA 118.549 -1.786 . . . . 0.0 116.1 -167.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 1.034 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 42.0 t -81.76 -68.03 0.73 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.767 1.283 . . . . 0.0 112.657 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 86' ' ' ILE . 1.5 m-20 -65.53 -49.62 68.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.6 -169.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.995 HG22 HG11 ' A' ' 81' ' ' VAL . 2.6 mp -63.58 -43.15 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.992 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.572 ' HA ' HD13 ' A' ' 96' ' ' LEU . 53.1 t -59.84 -51.39 73.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.441 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.56 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.1 mm -59.02 -48.77 85.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.928 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.735 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.2 tt0 -62.28 -52.11 64.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.096 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.664 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.9 mmt -60.43 -34.78 74.47 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.605 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 7.6 t80 -58.2 -50.04 74.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.772 172.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.4 mt-30 -64.31 -40.81 96.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.11 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -61.96 -34.53 76.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.584 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.77 -23.53 32.33 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.824 -171.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.749 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 4.7 mm-40 -56.4 -39.69 73.41 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.824 0.45 . . . . 0.0 112.179 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.8 tt -60.31 -52.7 64.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.186 -176.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.712 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -64.68 -26.75 68.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -68.61 -46.83 68.23 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.108 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 53.5 mt -63.44 -46.19 87.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.06 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 76' ' ' VAL . 48.8 mm -62.1 -45.17 99.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.145 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HA ' ' OD2' ' A' ' 113' ' ' ASP . 26.0 ttpp -53.03 -52.7 57.61 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.234 0.54 . . . . 0.0 111.375 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 87.7 tt0 -65.2 -46.6 80.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.547 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.949 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 91.4 m -66.87 -46.99 73.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.368 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 100' ' ' ILE . . . -62.93 -42.29 99.75 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.58 78.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' A' ' 103' ' ' THR 0.255 0.0 OUTLIER -77.79 -26.97 50.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.349 178.631 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.689 ' CE2' ' HE3' ' A' ' 106' ' ' LYS . 93.8 m-85 -87.95 -49.55 6.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.521 171.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -101.82 135.9 42.57 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 p -58.17 115.84 3.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 49.47 43.23 23.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.396 -1.729 . . . . 0.0 114.143 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -78.33 117.69 67.73 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.38 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.18 59.03 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.697 2.931 . . . . 0.0 114.431 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.505 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 55.1 m-20 . . . . . 0 C--N 1.314 -0.947 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.69 ' CG2' HE21 ' A' ' 9' ' ' GLN . 62.2 mt . . . . . 0 C--O 1.225 -0.229 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -54.42 -45.67 73.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.002 0.43 . . . . 0.0 110.331 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -71.64 -40.19 69.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.051 174.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.847 HD13 ' HB3' ' A' ' 62' ' ' LEU . 72.3 mt -57.51 -43.66 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.56 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.69 HE21 ' CG2' ' A' ' 5' ' ' ILE . 73.1 mt-30 -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.587 HH21 ' HB3' ' A' ' 13' ' ' ALA . 5.7 tpm_? -60.01 -38.24 82.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.383 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 53.0 tt0 -68.0 -45.8 73.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.124 0.487 . . . . 0.0 110.948 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.709 HG22 ' HA2' ' A' ' 78' ' ' GLY . 29.3 mt -66.56 -46.64 85.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.009 0.433 . . . . 0.0 110.722 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.587 ' HB3' HH21 ' A' ' 10' ' ' ARG . . . -61.49 -38.69 88.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.4 pt-20 -66.93 -34.39 77.68 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.353 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 70.2 m-80 -77.34 128.38 80.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.582 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.4 Cg_exo -60.22 -42.93 38.54 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 123.063 2.509 . . . . 0.0 112.075 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 100' ' ' ILE . 36.0 mm -139.4 125.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.611 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 27.5 tp -133.44 141.21 47.72 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.386 -170.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.3 tp -136.43 119.06 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.602 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -96.98 119.36 35.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.972 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.4 ptt? -146.19 -169.38 3.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.299 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.041 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.8 tttt -97.68 115.04 27.16 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.665 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.62 70.21 1.0 Allowed Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.399 -175.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.4 p -79.05 143.37 61.21 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.777 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.3 -41.51 65.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.389 2.059 . . . . 0.0 112.278 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -65.0 -32.29 73.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.418 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 29' ' ' SER . 51.3 tp -158.72 116.92 1.72 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.532 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 11.3 Cg_exo -71.86 27.97 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.3 2.0 . . . . 0.0 112.736 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 27' ' ' LEU . 40.6 p -162.84 51.56 0.18 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.179 0.514 . . . . 0.0 111.889 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.628 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 40.4 t -72.84 59.19 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.225 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.07 -139.81 2.97 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.82 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.488 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 55.1 m-85 -74.88 -17.7 60.54 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 120.994 0.426 . . . . 0.0 111.632 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 30.2 p -69.92 -18.45 63.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -48.65 -42.23 33.81 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.581 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.71 -38.97 58.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.141 0.496 . . . . 0.0 109.853 178.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.49 92.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.048 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.538 HG11 ' N ' ' A' ' 38' ' ' GLN . 10.1 p -57.98 -39.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.028 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 1.8 mm100 -67.11 -44.28 80.33 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -58.91 -47.35 85.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.991 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.572 HD12 HD21 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -61.37 -51.83 67.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.9 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.75 67.98 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.883 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -71.65 -48.66 46.22 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.15 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.926 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -70.45 -9.18 55.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.811 170.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 40' ' ' LEU . . . -10.59 120.48 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.967 0 CA-C-N 110.684 -2.962 . . . . 0.0 119.056 -160.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.761 ' OE2' ' HA ' ' A' ' 97' ' ' GLN . 3.6 mp0 -133.43 138.19 46.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 109.95 -3.125 . . . . 0.0 103.887 164.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -56.39 129.41 40.45 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.643 -170.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 14.7 p90 -140.47 148.08 40.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.04 -166.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.36 152.94 21.0 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.929 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.5 p90 -136.38 153.18 51.18 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.441 ' CG2' HD13 ' A' ' 18' ' ' LEU . 61.4 t -128.95 131.45 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.5 p30 -76.51 132.37 39.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 110.368 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.602 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.2 pp -147.64 -37.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 1.041 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -65.56 -7.66 15.86 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.22 173.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -42.84 7.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.433 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.4 m-20 -77.09 123.26 87.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.5 -45.23 11.99 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.121 1.881 . . . . 0.0 112.763 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.04 -56.72 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.993 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HD21 ' A' ' 62' ' ' LEU . 33.2 mt -61.73 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.473 -175.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 78.9 ttt180 -52.8 -31.93 41.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.7 -47.36 8.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.4 -60.61 2.26 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -163.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HD13 ' A' ' 8' ' ' ILE . 1.8 pt? -68.36 -33.49 4.78 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.5 Cg_endo -53.94 -42.11 69.4 Favored 'Trans proline' 0 C--N 1.353 0.81 0 CA-C-N 120.939 1.371 . . . . 0.0 110.785 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.13 -40.53 61.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.28 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.502 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.3 -43.98 76.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.6 -57.59 3.77 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.816 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.744 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.3 t-20 -174.99 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.109 0.957 . . . . 0.0 109.972 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.744 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -57.67 149.18 53.44 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 113.303 -1.772 . . . . 0.0 113.351 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -62.18 -37.11 65.17 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.426 2.084 . . . . 0.0 110.194 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 57.8 p -141.86 -124.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.278 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.917 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 46.0 m-85 -141.43 -170.58 0.24 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.917 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 58.5 Cg_endo -69.71 154.2 93.06 Favored 'Cis proline' 0 C--N 1.357 1.004 0 CA-C-N 121.27 1.489 . . . . 0.0 114.349 -1.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.58 HE22 ' HA ' ' A' ' 63' ' ' PRO . 61.2 mt-30 -144.96 134.92 23.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.655 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 40' ' ' LEU . 3.3 tm? -98.63 137.52 37.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.029 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 60.3 m95 -123.81 132.19 53.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.276 0.56 . . . . 0.0 111.222 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.756 HG21 HD12 ' A' ' 99' ' ' LEU . 38.9 t -114.31 118.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.2 t70 55.61 26.9 9.74 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.388 1.566 . . . . 0.0 108.72 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.709 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.82 28.54 46.02 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.607 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.47 133.33 47.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.973 0.416 . . . . 0.0 111.077 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 55.5 tp -68.81 133.44 48.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 76' ' ' VAL . 90.1 t -110.41 -54.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.069 170.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 147.48 135.03 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.54 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -85.1 -63.56 1.58 Allowed Glycine 0 C--O 1.219 -0.803 0 C-N-CA 119.291 -1.433 . . . . 0.0 116.589 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.9 p -78.89 -67.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.427 -1.043 . . . . 0.0 113.373 -168.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.21 -43.34 28.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.689 HG22 HG12 ' A' ' 81' ' ' VAL . 48.4 mm -57.18 -45.61 84.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.157 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 83' ' ' GLY . 71.8 t -58.67 -48.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.44 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.691 HD12 ' HB1' ' A' ' 39' ' ' ALA . 36.9 mm -58.59 -53.42 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.09 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.719 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.4 tt0 -63.2 -49.36 74.53 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.246 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -61.09 -37.64 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 2.3 t80 -57.86 -49.39 76.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.553 173.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.5 mt-30 -64.16 -39.64 94.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.719 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.1 mmm180 -57.49 -33.55 68.13 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.639 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 89.82 -24.05 17.16 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.211 -170.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.1 mt-10 -60.92 -26.44 67.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 7.9 tt -73.08 -53.96 9.74 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.926 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 17.5 pt20 -57.89 -25.92 61.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.181 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.3 mm100 -69.23 -53.27 20.75 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.667 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 76' ' ' VAL . 2.8 pp -71.58 -35.39 70.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.746 HG13 HD22 ' A' ' 96' ' ' LEU . 29.4 mm -66.1 -48.38 81.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.173 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -56.31 -51.07 69.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.683 0.278 . . . . 0.0 110.953 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -55.96 -48.02 76.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.876 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 63.7 m -63.15 -48.31 78.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.512 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.64 ' HB1' ' HZ3' ' A' ' 108' ' ' LYS . . . -60.15 -46.44 89.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.94 88.48 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.132 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -20.8 61.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.771 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.582 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 33.0 m-85 -81.83 -46.77 13.7 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.64 ' HZ3' ' HB1' ' A' ' 104' ' ' ALA . 1.0 OUTLIER -87.09 -151.65 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.311 170.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -86.55 -153.82 0.21 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.7 51.43 0.11 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.471 0.309 . . . . 0.0 111.771 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.462 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 56.7 mm-40 -70.58 122.81 87.72 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.152 0.501 . . . . 0.0 112.021 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.67 65.35 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.337 2.692 . . . . 0.0 113.271 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.625 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 31.4 m-20 . . . . . 0 C--N 1.314 -0.943 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.482 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.641 ' CG2' HE21 ' A' ' 9' ' ' GLN . 63.7 mt . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -54.73 -44.12 73.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.636 0.255 . . . . 0.0 110.787 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.4 -45.11 73.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 62' ' ' LEU . 69.0 mt -59.53 -45.06 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.641 HE21 ' CG2' ' A' ' 5' ' ' ILE . 69.9 mt-30 -64.3 -38.36 90.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.474 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.444 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 13.3 mmp_? -62.61 -37.01 84.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 109.868 172.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.69 -46.0 70.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.6 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.714 HG22 ' HA2' ' A' ' 78' ' ' GLY . 35.7 mt -65.72 -44.43 93.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.094 0.473 . . . . 0.0 110.53 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.01 95.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.089 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 23.5 pt-20 -66.55 -32.75 74.29 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.33 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -77.16 127.24 83.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.595 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 15' ' ' ASN . 52.1 Cg_exo -59.68 -43.44 38.57 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.752 2.301 . . . . 0.0 112.576 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 100' ' ' ILE . 31.6 mm -140.27 124.2 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.618 HD21 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -134.32 142.15 47.16 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.625 -169.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.5 tp -135.15 116.95 15.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.525 ' HE1' HD22 ' A' ' 18' ' ' LEU . 10.8 m-85 -96.83 117.94 32.18 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.795 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.669 ' O ' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -147.12 -158.15 0.88 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 64.9 tttm -98.85 107.95 20.51 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.648 -0.657 . . . . 0.0 109.756 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.65 126.19 8.68 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.062 -1.065 . . . . 0.0 111.79 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 37.2 t -146.4 145.16 22.81 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -41.13 79.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.204 1.936 . . . . 0.0 111.18 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.4 pttt -65.72 -32.36 73.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.667 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 29' ' ' SER . 0.4 OUTLIER -160.49 119.98 1.59 Allowed Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.463 ' O ' ' SD ' ' A' ' 21' ' ' MET . 44.0 Cg_endo -73.34 20.69 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.382 0 C-N-CA 122.41 2.073 . . . . 0.0 114.121 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.583 ' H ' HD13 ' A' ' 27' ' ' LEU . 22.1 p -169.51 52.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.532 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.9 t -55.8 -37.7 68.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -168.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.707 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -68.83 -135.65 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.924 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -74.18 -32.61 63.15 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 122.204 -0.586 . . . . 0.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.499 ' HG ' ' HB2' ' A' ' 29' ' ' SER . 20.7 p -46.54 -22.09 0.24 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.271 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.96 32.14 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.231 0.332 . . . . 0.0 111.867 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 36' ' ' ALA . 1.3 pm0 -80.69 -35.5 33.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.266 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' HE21 ' A' ' 35' ' ' GLN . . . -68.97 -44.3 73.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -175.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.561 HG21 ' HZ ' ' A' ' 47' ' ' PHE . 8.0 p -53.4 -38.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.484 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.2 mm100 -63.74 -46.82 83.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.077 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.624 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.15 -42.04 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.839 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -61.95 -56.23 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.511 . . . . 0.0 109.895 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.31 71.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.294 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -71.39 -47.43 56.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.776 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.6 m -72.23 -57.98 3.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -103.87 -148.62 19.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.314 -0.946 . . . . 0.0 114.421 -175.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.8 mm-40 -105.98 -154.4 0.52 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 37.1 mmt-85 -62.2 152.7 32.53 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.558 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.561 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 24.4 p90 -151.87 156.14 39.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.142 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.51 149.67 22.49 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.2 p90 -136.63 151.74 49.65 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 18' ' ' LEU . 54.0 t -130.98 129.5 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.377 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 2.7 p30 -75.01 134.19 41.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.503 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.669 HD11 ' O ' ' A' ' 21' ' ' MET . 1.3 pp -149.28 -34.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.6 mm? -67.87 -7.57 29.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.583 169.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.43 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.59 -38.42 10.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.861 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.2 m-20 -79.39 128.03 76.71 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 120.642 0.258 . . . . 0.0 111.009 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.86 -45.0 6.86 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.333 2.022 . . . . 0.0 112.928 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -84.52 -49.73 8.35 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.495 HG22 HG22 ' A' ' 52' ' ' ILE . 40.9 mt -58.39 -33.32 47.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.35 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.676 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -50.53 -38.7 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.976 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.632 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -91.42 -35.34 14.42 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.65 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 51.7 mt-10 -76.18 -61.62 1.88 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -162.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.676 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 2.0 pt? -70.71 -32.49 2.57 Favored Pre-proline 0 N--CA 1.468 0.433 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 18.9 Cg_endo -56.09 -40.04 87.43 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 120.925 1.366 . . . . 0.0 110.85 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.65 ' NZ ' ' HA ' ' A' ' 61' ' ' GLU . 31.6 mtmm -56.25 -38.34 70.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.519 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -66.48 -43.12 86.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.136 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.585 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . . . -75.4 -57.1 4.1 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.104 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.673 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.2 t30 -175.87 -53.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.167 0.984 . . . . 0.0 109.47 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.673 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -54.9 149.24 24.1 Favored Pre-proline 0 C--O 1.217 -0.623 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.388 -176.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -62.77 -37.75 53.8 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.242 1.961 . . . . 0.0 110.191 171.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 59' ' ' ARG . 60.9 p -142.01 -130.43 0.1 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.635 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.817 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 17.1 m-85 -137.67 -166.15 0.11 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.817 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.1 Cg_endo -65.87 153.28 80.0 Favored 'Cis proline' 0 C--N 1.362 1.274 0 CA-C-N 121.586 1.602 . . . . 0.0 113.744 -1.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.623 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.1 mt-30 -141.74 133.11 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.53 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.489 ' CD2' HD12 ' A' ' 40' ' ' LEU . 3.3 tm? -93.96 138.4 32.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.585 ' CH2' ' HB3' ' A' ' 66' ' ' ALA . 59.6 m95 -126.77 130.19 49.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.799 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' HB ' HD12 ' A' ' 100' ' ' ILE . 2.4 p -125.63 123.79 65.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.594 ' HB2' HG22 ' A' ' 103' ' ' THR . 10.5 t70 61.28 28.25 17.81 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.468 1.604 . . . . 0.0 108.091 -171.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.714 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 68.2 25.67 74.46 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 113.029 -1.896 . . . . 0.0 112.95 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 37.0 mm-40 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.805 0.442 . . . . 0.0 110.559 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 66' ' ' ALA . 44.6 tp -71.93 125.13 26.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.764 0.316 . . . . 0.0 111.567 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 86' ' ' ILE . 71.8 t -106.27 -53.04 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.934 172.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.487 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 141.46 134.45 3.02 Favored Glycine 0 C--O 1.221 -0.693 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -85.23 -62.63 1.64 Allowed Glycine 0 C--O 1.22 -0.742 0 C-N-CA 119.498 -1.334 . . . . 0.0 116.292 -168.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.4 p -77.24 -68.25 0.63 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.683 -0.892 . . . . 0.0 112.903 -170.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.4 -44.59 28.69 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 111.289 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.487 HG13 ' HA3' ' A' ' 82' ' ' GLY . 45.0 mm -59.33 -44.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.258 -172.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 83' ' ' GLY . 69.1 t -58.02 -49.51 81.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 91' ' ' TYR . 37.9 mm -60.58 -48.56 88.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.497 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.818 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -62.24 -52.88 61.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.593 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.569 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.4 mmt -57.35 -36.52 71.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.581 0.229 . . . . 0.0 111.35 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.771 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 19.6 t80 -56.23 -51.27 68.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.995 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -65.59 -44.85 85.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.691 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 2.1 mmp_? -60.64 -33.94 73.53 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.978 0.418 . . . . 0.0 111.281 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 98.6 -25.24 28.74 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.716 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.2 mt-10 -56.0 -32.33 63.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 61.7 tp -57.41 -55.71 31.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.181 0.515 . . . . 0.0 110.703 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.776 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.3 pt20 -65.61 -26.22 67.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.627 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.8 mm100 -63.83 -46.42 85.12 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.0 mt -67.76 -46.49 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.149 177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.533 HD11 HG22 ' A' ' 17' ' ' ILE . 32.8 mm -63.7 -42.47 96.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.847 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' CA ' ' HB2' ' A' ' 113' ' ' ASP . 28.2 ttpt -54.72 -56.09 22.96 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.505 0.669 . . . . 0.0 110.863 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -58.75 -45.95 88.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.567 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 77' ' ' ASP . 88.5 m -69.85 -49.07 56.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.26 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -59.27 -44.36 92.45 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.267 -0.271 . . . . 0.0 110.314 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.48 93.68 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.598 0.561 . . . . 0.0 111.798 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -18.57 62.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.45 ' HE2' HG22 ' A' ' 103' ' ' THR . 57.1 m-85 -92.08 -47.52 7.21 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.261 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.418 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 46.2 mtmt -101.03 -147.18 0.35 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.952 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -64.92 155.53 34.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.884 164.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.49 55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -174.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -65.08 121.26 73.21 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.23 60.21 1.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.697 2.932 . . . . 0.0 113.434 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.431 ' HB2' ' CA ' ' A' ' 101' ' ' LYS . 1.2 m-20 . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 0.0 112.01 -174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.651 ' CG2' HE21 ' A' ' 9' ' ' GLN . 52.9 mt . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -57.02 -47.0 81.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -67.16 -43.89 81.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.805 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.676 HD13 ' HB3' ' A' ' 62' ' ' LEU . 69.7 mt -59.6 -48.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.651 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.1 mt-30 -61.55 -39.74 92.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.396 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.748 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mmp_? -59.49 -40.4 86.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -71.92 -43.13 65.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 78' ' ' GLY . 39.8 mt -60.08 -42.09 88.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.208 0.528 . . . . 0.0 109.577 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -36.68 78.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.718 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.748 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 83.0 mt-10 -58.68 -46.46 87.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.598 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.0 m-80 -79.31 124.27 84.28 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.254 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 32.1 Cg_exo -62.9 -43.45 19.92 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 C-N-CA 122.355 2.037 . . . . 0.0 111.77 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mm -128.9 120.89 53.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 12' ' ' ILE . 20.8 tp -133.54 140.56 47.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.452 -169.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.465 HD23 ' CE1' ' A' ' 47' ' ' PHE . 11.6 tp -134.69 116.93 15.48 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.351 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.636 ' HB3' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -97.93 115.94 29.15 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.011 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.58 ' HE2' ' HB2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.72 -154.36 0.55 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.917 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 2.2 tmtp? -98.04 97.1 8.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -170.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.668 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.23 71.73 1.39 Allowed Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.499 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.527 ' HB2' ' HE2' ' A' ' 22' ' ' LYS . 38.5 t -78.59 145.14 66.64 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.95 -40.07 87.5 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.058 1.838 . . . . 0.0 111.475 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -70.01 -30.74 68.12 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.605 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD11 ' HD2' ' A' ' 28' ' ' PRO . 54.2 tp -157.88 118.38 1.94 Allowed Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HD2' HD11 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -70.73 22.28 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.509 2.139 . . . . 0.0 113.647 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 27' ' ' LEU . 10.9 p -164.95 48.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 110.883 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.917 ' HB3' ' HD2' ' A' ' 22' ' ' LYS . 42.6 t -70.42 58.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.442 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.25 -139.4 2.63 Favored Glycine 0 C--N 1.314 -0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' A' ' 34' ' ' ALA . 40.3 m-85 -78.05 -45.73 22.79 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 117.63 0.715 . . . . 0.0 111.582 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.48 ' O ' HG13 ' A' ' 37' ' ' VAL . 35.5 t -52.21 -10.26 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 32' ' ' PHE . . . -49.52 -41.87 42.25 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 119.265 -0.397 . . . . 0.0 110.401 170.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.553 HE21 ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -81.29 -30.48 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 172.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.553 ' N ' HE21 ' A' ' 35' ' ' GLN . . . -67.27 -42.69 83.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 33' ' ' SER . 26.9 m -54.67 -41.59 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.879 ' H ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -56.92 -47.9 79.53 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 122.443 0.297 . . . . 0.0 110.29 178.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.4 88.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.859 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.533 HD13 ' CG ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -64.55 -55.09 22.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -177.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.32 74.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.959 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.51 -45.5 68.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.649 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 27.2 p -76.81 -56.11 4.89 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -173.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.663 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.16 -144.85 16.66 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.066 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.29 -153.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 155.39 40.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.627 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CG ' HD13 ' A' ' 40' ' ' LEU . 17.6 p90 -145.01 158.41 43.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 -169.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 152.05 19.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.58 ' HB2' ' HE2' ' A' ' 21' ' ' MET . 1.5 p90 -138.67 154.41 48.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.582 HG23 HD13 ' A' ' 18' ' ' LEU . 48.4 t -131.45 129.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.668 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.2 p30 -78.97 133.33 36.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 110.523 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.711 HD11 ' CG ' ' A' ' 71' ' ' PHE . 1.3 pp -147.47 -35.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 -173.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.622 ' N ' HD13 ' A' ' 52' ' ' ILE . 1.4 mm? -66.21 -9.6 33.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.304 169.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 -42.94 8.02 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.674 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -78.84 123.26 85.27 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.322 -0.237 . . . . 0.0 110.707 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.81 -45.06 9.05 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.099 1.866 . . . . 0.0 112.802 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.17 -52.95 12.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.441 ' O ' HD23 ' A' ' 62' ' ' LEU . 37.6 mt -61.77 -36.97 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.522 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.593 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 54.6 ttp85 -51.24 -35.19 35.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.459 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -85.0 -47.12 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -170.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -78.87 -59.52 2.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -161.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.676 ' HB3' HD13 ' A' ' 8' ' ' ILE . 2.2 pt? -67.48 -33.37 5.43 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -173.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 12.3 Cg_endo -55.1 -41.15 81.48 Favored 'Trans proline' 0 C--N 1.352 0.714 0 CA-C-N 121.167 1.452 . . . . 0.0 111.125 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.1 mtmp? -58.58 -34.01 70.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.682 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -66.6 -44.17 82.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.935 176.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB1' ' CZ2' ' A' ' 75' ' ' TRP . . . -75.66 -57.33 3.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.592 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.73 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.1 t-20 -175.67 -56.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.158 0.98 . . . . 0.0 109.636 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.73 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -56.58 151.27 31.0 Favored Pre-proline 0 C--O 1.22 -0.458 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.257 -176.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -64.13 -36.96 44.62 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.312 2.008 . . . . 0.0 110.024 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.3 p -142.1 -125.09 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.765 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.831 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 22.0 m-85 -141.53 -164.8 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.831 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.44 153.46 82.21 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 121.849 1.696 . . . . 0.0 113.699 -1.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.727 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.2 mt-30 -142.5 132.04 23.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.495 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.493 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -94.81 135.11 36.7 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.64 ' CZ2' ' HB1' ' A' ' 66' ' ' ALA . 62.2 m95 -119.02 128.87 54.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.43 0.634 . . . . 0.0 110.789 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.602 HG22 HD12 ' A' ' 100' ' ' ILE . 92.5 t -115.53 120.49 64.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.222 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 103' ' ' THR . 32.4 t70 57.73 28.55 16.02 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.034 1.397 . . . . 0.0 109.889 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 76.01 28.29 60.81 Favored Glycine 0 C--N 1.312 -0.781 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.047 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.4 135.09 46.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.498 . . . . 0.0 111.305 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.572 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 54.9 tp -69.22 131.13 44.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.377 -174.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.404 HG11 HG23 ' A' ' 86' ' ' ILE . 96.8 t -110.57 -51.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.028 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.459 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 144.64 133.6 2.67 Favored Glycine 0 C--O 1.222 -0.615 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -84.56 -62.44 1.71 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.492 -1.337 . . . . 0.0 116.064 -168.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 20.5 p -78.99 -67.55 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.689 -0.889 . . . . 0.0 112.955 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -78.59 -43.8 25.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.66 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.459 HG13 ' HA3' ' A' ' 82' ' ' GLY . 49.9 mm -59.86 -44.51 94.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.772 -173.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 83' ' ' GLY . 96.0 t -57.69 -48.91 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.661 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 35.6 mm -60.11 -51.59 71.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.758 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 84.2 tt0 -59.37 -54.74 43.23 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.38 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.669 ' HB2' HD22 ' A' ' 96' ' ' LEU . 26.4 mmt -58.15 -37.95 75.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.534 0.207 . . . . 0.0 110.743 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.493 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.0 t80 -57.16 -49.81 74.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.391 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -64.79 -38.56 91.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.113 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 1.2 mmm180 -62.34 -32.0 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.767 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 21.24 58.45 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.555 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.728 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.9 mm-40 -90.39 -32.41 16.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.404 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -60.47 -53.43 57.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.54 -172.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.733 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.0 pm0 -62.57 -28.88 70.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.58 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.0 mm100 -66.12 -45.98 79.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.4 mt -67.4 -45.14 77.05 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.03 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.602 HD12 HG22 ' A' ' 76' ' ' VAL . 51.0 mm -64.97 -42.5 94.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.465 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 31.9 ttmt -52.0 -56.66 12.91 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.453 0.644 . . . . 0.0 111.225 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.58 -43.99 89.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.255 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 77' ' ' ASP . 73.1 m -72.41 -44.05 63.01 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.783 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.532 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -65.98 -44.11 85.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.481 -0.762 . . . . 0.0 110.167 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.11 95.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.808 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.564 ' HG3' ' N ' ' A' ' 107' ' ' TYR . 17.1 ptpt -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.014 -0.429 . . . . 0.0 110.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.601 ' HD2' ' O ' ' A' ' 103' ' ' THR . 81.1 m-85 -77.99 -45.73 23.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -97.55 -150.33 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.733 177.485 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.467 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 11.1 p -67.93 169.66 9.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 166.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.72 60.39 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 65.8 mm-40 -58.44 126.36 78.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.778 0.799 . . . . 0.0 111.73 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 73.9 Cg_endo -94.15 56.75 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 123.416 2.744 . . . . 0.0 113.039 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.663 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.5 m-20 . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.05 -169.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.629 ' CG2' HE21 ' A' ' 9' ' ' GLN . 95.1 mt . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.73 -49.33 68.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.7 mptt -72.54 -39.62 67.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.034 175.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.942 HD13 ' HB3' ' A' ' 62' ' ' LEU . 71.8 mt -58.21 -47.65 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.011 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.629 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.9 mt-30 -61.03 -32.79 72.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.483 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 17.2 mmt180 -60.06 -37.54 80.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.419 . . . . 0.0 110.51 173.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 45.4 tt0 -72.97 -45.46 57.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.378 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.644 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 21.8 mt -63.78 -42.8 97.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.228 0.537 . . . . 0.0 110.111 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.28 98.3 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.788 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.4 pt-20 -65.07 -38.56 91.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.264 -175.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -78.74 127.15 81.1 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 31.8 Cg_endo -64.25 -41.24 22.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.011 2.474 . . . . 0.0 112.384 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 100' ' ' ILE . 34.2 mm -132.87 123.59 48.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.644 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 33.2 tp -133.8 143.45 48.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.436 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.43 118.5 15.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.345 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.549 ' HE1' HD21 ' A' ' 18' ' ' LEU . 7.6 m-85 -96.46 119.13 34.38 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.273 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 22.8 ptt? -146.5 -168.08 2.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.896 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.049 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 40.1 ttmt -96.75 138.15 34.75 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -140.49 135.15 6.86 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 118.287 -1.911 . . . . 0.0 112.975 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 t -121.29 150.61 54.47 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.626 -1.287 . . . . 0.0 108.466 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.03 -38.14 58.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.023 1.815 . . . . 0.0 111.664 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -70.49 -35.09 73.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.773 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 29' ' ' SER . 59.0 tp -159.43 114.62 1.55 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.557 ' O ' ' HE1' ' A' ' 21' ' ' MET . 52.2 Cg_endo -73.38 32.51 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.081 2.521 . . . . 0.0 113.891 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.815 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 11.3 p -165.47 47.3 0.09 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.01 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 49.1 t -74.39 53.07 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.885 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.31 -141.22 3.14 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -76.4 -36.04 58.29 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.299 0.571 . . . . 0.0 109.847 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.573 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 48.7 p -52.35 -22.87 5.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.748 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.75 -44.43 28.14 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.473 0.483 . . . . 0.0 111.656 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.627 ' HG2' HD12 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -80.92 -35.34 32.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.582 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.608 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.571 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -54.47 -37.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.1 mm100 -65.76 -45.4 82.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.77 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.489 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -57.69 -44.73 86.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.509 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.613 HD12 ' CD1' ' A' ' 74' ' ' LEU . 1.2 tt -62.24 -57.13 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.481 . . . . 0.0 110.362 -175.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.49 71.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.123 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.21 -49.53 42.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.629 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.731 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.7 p -76.4 -49.97 15.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.344 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.47 -131.47 7.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.064 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.589 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 4.6 mm-40 -140.39 -152.56 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.149 0.579 . . . . 0.0 111.04 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.451 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 42.2 mmm-85 -55.68 148.02 17.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.832 0.825 . . . . 0.0 112.387 -173.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.571 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 21.9 p90 -156.65 155.36 31.65 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.292 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.01 159.25 15.09 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.687 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -143.7 154.32 43.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.43 127.81 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' MET . 12.1 p-10 -81.25 131.5 35.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.573 . . . . 0.0 110.585 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 21' ' ' MET . 1.2 pp -146.69 -32.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.287 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 1.049 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -67.32 -8.49 32.77 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.545 171.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.425 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -97.42 -48.55 5.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.33 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.609 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.3 m-20 -79.66 116.03 57.89 Favored Pre-proline 0 N--CA 1.472 0.647 0 O-C-N 122.118 -0.364 . . . . 0.0 110.784 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 24.7 Cg_exo -64.14 -44.34 12.63 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.981 2.454 . . . . 0.0 113.402 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -66.42 -54.64 21.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -62.28 -34.76 65.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 29.2 ttm180 -53.16 -40.91 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.031 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.463 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -79.61 -38.6 33.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -167.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.88 -59.21 2.87 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -161.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.942 ' HB3' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.17 -26.94 0.57 Allowed Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -170.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.734 ' HD3' HD11 ' A' ' 62' ' ' LEU . 18.4 Cg_endo -57.08 -41.61 72.76 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.603 1.608 . . . . 0.0 111.521 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 53.6 mtmt -59.58 -34.24 72.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.701 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.578 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -66.15 -42.2 89.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . . . -75.95 -56.86 4.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.446 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.701 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 22.6 t-20 -175.71 -55.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 122.159 0.981 . . . . 0.0 109.613 170.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.701 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.8 OUTLIER -56.82 150.37 38.04 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.645 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -63.79 -38.83 37.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.419 2.079 . . . . 0.0 110.283 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.9 p -141.4 -125.97 0.1 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.388 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.76 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.4 m-85 -141.13 -166.1 0.11 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.76 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 39.1 Cg_endo -65.65 156.7 78.42 Favored 'Cis proline' 0 C--N 1.362 1.244 0 CA-C-N 121.597 1.606 . . . . 0.0 113.836 -2.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.681 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 70.9 mt-30 -146.52 131.39 18.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.805 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.613 ' CD1' HD12 ' A' ' 40' ' ' LEU . 61.1 tp -91.32 137.84 32.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.625 174.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.61 ' CZ2' ' HB3' ' A' ' 66' ' ' ALA . 58.2 m95 -121.9 125.21 45.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.284 0.564 . . . . 0.0 109.921 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.491 HG22 HD13 ' A' ' 100' ' ' ILE . 66.4 t -110.04 119.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.197 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 58.24 28.85 17.17 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 123.403 1.573 . . . . 0.0 108.589 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.494 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 75.62 29.8 59.07 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.726 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 48.9 mt-10 -126.97 131.0 51.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.661 0.267 . . . . 0.0 110.359 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.57 HD23 ' CZ3' ' A' ' 68' ' ' TRP . 47.6 tp -67.66 130.9 44.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -173.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 86' ' ' ILE . 94.4 t -112.29 -52.52 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.123 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 145.85 136.0 2.88 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.511 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -86.88 -64.09 1.43 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.377 -1.392 . . . . 0.0 116.471 -169.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.0 p -80.13 -66.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.692 -0.887 . . . . 0.0 112.831 -171.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -74.03 -46.36 43.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.026 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 81' ' ' VAL . 2.0 mp -60.98 -46.79 95.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.21 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.608 ' HB ' ' HB1' ' A' ' 36' ' ' ALA . 70.9 t -55.76 -49.4 74.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.258 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.627 HD12 ' HG2' ' A' ' 35' ' ' GLN . 36.9 mm -62.12 -50.71 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.947 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.6 tt0 -62.46 -51.93 65.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.679 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.602 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -58.95 -33.63 70.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.308 0.243 . . . . 0.0 111.543 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.668 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.2 t80 -59.06 -52.48 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.129 172.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.0 mt-30 -62.88 -42.88 99.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.418 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 38.5 mmm-85 -62.58 -34.55 77.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.248 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 102.58 -23.79 32.91 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.945 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.779 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.3 mt-10 -56.11 -33.27 64.95 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.6 tt -69.77 -50.04 47.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.184 0.516 . . . . 0.0 109.669 -174.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.731 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.2 pt20 -61.55 -25.22 67.16 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.058 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.5 mm100 -69.79 -48.08 60.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.53 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 54.1 mt -63.9 -46.11 86.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.201 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.491 HD13 HG22 ' A' ' 76' ' ' VAL . 50.5 mm -64.43 -44.48 97.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.818 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -48.74 -52.14 25.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.352 0.596 . . . . 0.0 111.144 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -62.24 -50.82 70.22 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.432 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.578 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 95.3 m -71.18 -48.94 48.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.514 ' HB2' ' OD2' ' A' ' 113' ' ' ASP . . . -61.67 -46.37 90.0 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.141 -0.349 . . . . 0.0 110.55 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . . . -61.77 -32.85 73.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.911 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.663 ' HZ3' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -80.44 -17.86 50.51 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.654 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 53.9 m-85 -90.5 -50.52 5.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.858 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.588 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 2.1 mppt? -103.06 121.23 42.15 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 165.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 p -46.26 113.19 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 105' ' ' ALA . 53.5 mt-10 49.66 44.56 24.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.317 -1.765 . . . . 0.0 113.355 172.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.588 ' OE1' ' HB2' ' A' ' 108' ' ' LYS . 8.9 pt-20 -75.67 130.16 79.8 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.521 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 3.7 Cg_exo -79.56 121.62 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.743 2.295 . . . . 0.0 111.611 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.589 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 43.7 m-20 . . . . . 0 CA--C 1.513 -0.461 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.691 ' CG2' HE21 ' A' ' 9' ' ' GLN . 59.9 mt . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.92 -43.54 94.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 0.0 110.065 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -63.75 -45.22 90.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.038 172.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.892 HD13 ' HB3' ' A' ' 62' ' ' LEU . 74.4 mt -60.94 -43.86 96.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.659 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.691 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.8 mt-30 -63.24 -38.71 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.299 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -60.75 -37.01 80.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.32 0.581 . . . . 0.0 109.766 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 38.2 tt0 -68.09 -45.45 73.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.001 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.432 HG21 ' HA2' ' A' ' 78' ' ' GLY . 36.4 mt -70.43 -44.59 77.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 110.661 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.26 77.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.2 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.34 -34.04 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.829 -176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 76.9 m-20 -77.61 128.63 79.26 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-O 121.166 0.508 . . . . 0.0 111.112 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 15' ' ' ASN . 44.5 Cg_exo -61.78 -42.92 28.68 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 123.008 2.472 . . . . 0.0 112.679 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mm -139.61 122.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.542 ' CD2' ' HE1' ' A' ' 20' ' ' TYR . 23.2 tp -134.15 141.34 47.06 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.505 -169.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.493 ' HG ' ' HG3' ' A' ' 21' ' ' MET . 12.1 tp -135.45 117.21 15.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.525 -176.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.542 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 8.7 m-85 -97.33 117.99 32.8 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.938 174.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.575 ' HE2' ' CD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.09 -159.48 1.04 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.727 177.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.047 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 34.7 ttpt -99.65 117.75 34.68 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.374 -0.829 . . . . 0.0 110.562 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.579 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.84 70.6 0.95 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.512 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -78.21 140.68 61.41 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.45 -41.3 74.29 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.054 1.836 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -69.46 -30.35 68.23 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.041 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tt -156.57 105.91 2.0 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.44 ' O ' ' SD ' ' A' ' 21' ' ' MET . 15.0 Cg_exo -73.66 28.57 0.31 Allowed 'Trans proline' 0 C--O 1.223 -0.225 0 C-N-CA 122.642 2.228 . . . . 0.0 114.052 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -166.09 52.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.836 0.351 . . . . 0.0 111.484 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.655 ' HB3' ' HE3' ' A' ' 22' ' ' LYS . 46.3 t -71.32 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.08 -139.29 47.8 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.203 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.472 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 37.9 m-85 -79.29 -20.88 46.92 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 21' ' ' MET . 30.6 p -70.2 -11.71 61.08 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -170.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.24 -43.89 22.32 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.352 0.407 . . . . 0.0 111.864 -175.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.566 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.02 -40.02 40.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.617 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . . . -64.16 -44.96 90.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.154 -173.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p -55.75 -38.8 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.559 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.502 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -67.24 -46.66 73.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.891 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . . . -59.87 -42.31 93.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.862 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.522 HD12 ' CD2' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -62.09 -56.74 15.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.374 0.607 . . . . 0.0 109.704 -175.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.06 72.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.486 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -46.34 64.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.901 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.4 m -71.91 -59.36 2.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.04 -145.01 13.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.371 -0.918 . . . . 0.0 114.499 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.813 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 32.2 mm-40 -120.37 -150.41 0.45 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.857 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 43.2 mmm-85 -55.54 144.98 24.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.058 0.933 . . . . 0.0 113.262 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -150.83 152.56 33.93 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.386 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.7 152.71 19.35 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.479 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.575 ' CD1' ' HE2' ' A' ' 21' ' ' MET . 2.9 p90 -137.36 150.58 47.81 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.56 126.56 63.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.579 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.4 p30 -76.23 129.55 36.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.3 pp -145.59 -36.41 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 1.047 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.99 -11.58 30.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.423 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.43 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.51 -41.78 8.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.405 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -87.93 116.14 65.26 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 122.198 -0.313 . . . . 0.0 110.667 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.16 -43.83 13.94 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.167 1.912 . . . . 0.0 113.28 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.16 -50.67 67.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.029 0.443 . . . . 0.0 111.8 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.0 -40.67 81.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.63 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 78.9 ttt180 -52.1 -37.69 54.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.89 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.41 -49.16 44.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.2 -59.17 2.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -163.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.892 ' HB3' HD13 ' A' ' 8' ' ' ILE . 2.1 pt? -66.1 -33.21 6.58 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -168.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.706 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 12.8 Cg_endo -55.16 -40.13 87.38 Favored 'Trans proline' 0 C--N 1.348 0.501 0 CA-C-N 121.182 1.458 . . . . 0.0 110.573 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -51.71 -41.02 61.16 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.759 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.537 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -70.68 -42.94 70.07 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.446 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.79 -59.92 2.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.703 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.72 ' HB2' ' HE3' ' A' ' 68' ' ' TRP . 8.4 m120 -168.61 -59.42 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.971 0.908 . . . . 0.0 109.172 168.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.72 ' HE3' ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -53.46 149.84 13.83 Favored Pre-proline 0 C--O 1.217 -0.61 0 CA-C-N 113.118 -1.855 . . . . 0.0 113.697 -174.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.99 -37.36 43.83 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 121.873 1.716 . . . . 0.0 110.229 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 74.5 p -142.12 -123.41 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.279 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.841 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.6 m-85 -141.03 -168.04 0.17 Allowed Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.841 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.3 Cg_endo -67.8 153.41 87.0 Favored 'Cis proline' 0 C--N 1.362 1.261 0 CA-C-N 121.309 1.503 . . . . 0.0 114.286 -1.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.622 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.7 mt-30 -141.41 134.77 29.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.661 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.522 ' CD2' HD12 ' A' ' 40' ' ' LEU . 3.3 tm? -99.22 135.17 41.02 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -119.63 131.11 55.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.795 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.701 HG21 HD12 ' A' ' 100' ' ' ILE . 89.2 t -116.66 120.6 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t0 54.8 37.74 29.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 123.242 1.496 . . . . 0.0 108.595 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.432 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 67.19 29.09 73.97 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.957 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -132.5 134.85 45.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.382 0.611 . . . . 0.0 111.366 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.602 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 60.8 tp -67.36 130.35 42.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.818 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 86' ' ' ILE . 99.3 t -106.03 -54.28 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.772 170.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.32 134.16 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.71 -63.98 1.58 Allowed Glycine 0 C--O 1.219 -0.829 0 C-N-CA 119.047 -1.549 . . . . 0.0 116.316 -167.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 22.4 p -80.21 -67.45 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.429 1.115 . . . . 0.0 112.956 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.33 -45.29 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.316 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.739 HG23 HG12 ' A' ' 81' ' ' VAL . 50.4 mm -57.8 -44.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.338 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.606 HG11 HD23 ' A' ' 96' ' ' LEU . 79.4 t -58.02 -48.51 84.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.99 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 38.1 mm -59.78 -49.91 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.388 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.758 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 35.5 tt0 -60.79 -52.95 62.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.291 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.511 ' HG3' ' CA ' ' A' ' 96' ' ' LEU . 41.7 tpp -60.88 -34.81 75.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.901 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 16.8 t80 -58.81 -51.45 69.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.014 171.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.6 mt-30 -62.38 -39.29 92.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.991 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.758 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 45.6 mmm-85 -60.75 -30.72 70.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.73 175.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.02 -23.69 10.45 Favored Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.725 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.9 mt-10 -62.51 -21.32 65.42 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.606 HD23 HG11 ' A' ' 87' ' ' VAL . 62.5 tp -61.35 -54.86 38.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.343 0.592 . . . . 0.0 110.669 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 11.8 pt20 -64.03 -25.53 68.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.374 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 13.3 mm100 -64.2 -48.08 77.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.272 0.558 . . . . 0.0 109.599 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 38.5 mt -65.74 -45.88 80.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.155 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.701 HD12 HG21 ' A' ' 76' ' ' VAL . 50.8 mm -63.82 -44.35 98.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.144 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 28.7 ttmt -51.89 -57.69 8.66 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 111.2 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.5 -45.79 92.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.165 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 80.7 m -68.99 -46.85 67.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.426 ' HA ' ' HZ2' ' A' ' 108' ' ' LYS . . . -60.75 -45.93 92.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.37 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.09 82.01 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.754 0.659 . . . . 0.0 112.323 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.06 -33.39 63.66 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.747 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.497 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 80.1 m-85 -80.19 -51.55 8.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.641 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.426 ' HZ2' ' HA ' ' A' ' 104' ' ' ALA . 1.1 mppt? -106.29 131.34 53.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m -51.82 125.44 15.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.471 0.653 . . . . 0.0 112.267 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 35.13 52.0 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.293 -1.776 . . . . 0.0 114.969 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 27.4 tt0 -77.37 120.49 81.73 Favored Pre-proline 0 N--CA 1.427 -1.592 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 6.1 Cg_exo -86.73 60.75 4.27 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.55 2.833 . . . . 0.0 114.563 -170.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.813 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.8 m-20 . . . . . 0 C--N 1.317 -0.806 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.651 ' CG2' HE21 ' A' ' 9' ' ' GLN . 41.2 mt . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 120.352 0.12 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.62 -51.15 64.01 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.484 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 20.4 ptmt -67.53 -40.37 85.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.44 0.638 . . . . 0.0 109.599 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 62' ' ' LEU . 73.9 mt -57.54 -49.09 81.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.941 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.651 HE21 ' CG2' ' A' ' 5' ' ' ILE . 68.3 mt-30 -61.71 -40.75 96.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.597 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -57.75 -37.07 72.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.296 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.544 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.01 -47.19 69.13 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.122 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.735 HG21 ' HA2' ' A' ' 78' ' ' GLY . 22.2 mt -67.52 -39.15 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.789 0.804 . . . . 0.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.71 88.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.512 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.6 pt-20 -70.33 -38.49 74.88 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 18' ' ' LEU . 1.6 p30 -77.17 135.44 66.38 Favored Pre-proline 0 CA--C 1.512 -0.514 0 CA-C-O 121.652 0.739 . . . . 0.0 111.877 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 33.7 Cg_exo -62.75 -42.17 26.91 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 122.801 2.334 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.5 mm -139.38 120.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.599 ' CD2' ' HE1' ' A' ' 20' ' ' TYR . 27.7 tp -131.66 142.89 49.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.483 0.659 . . . . 0.0 111.855 -171.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.9 tp -136.94 123.85 21.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.442 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.604 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.2 m-85 -98.86 119.99 38.55 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.801 -0.562 . . . . 0.0 111.702 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.591 ' O ' HD13 ' A' ' 52' ' ' ILE . 18.5 ptt? -146.23 -165.77 2.3 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.852 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 63.8 tttm -99.08 121.45 41.01 Favored 'General case' 0 C--O 1.208 -1.122 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.69 69.19 1.03 Allowed Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.332 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -79.94 148.54 68.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.818 -0.225 . . . . 0.0 111.233 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.85 -41.5 68.67 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.19 1.927 . . . . 0.0 111.121 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.596 ' HE3' ' SG ' ' A' ' 30' ' ' CYS . 60.8 pttt -66.7 -31.31 71.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.66 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 29' ' ' SER . 49.6 tp -160.43 122.84 1.82 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 2.8 Cg_exo -73.9 29.36 0.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 27' ' ' LEU . 8.3 t -165.35 47.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.48 173.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.596 ' SG ' ' HE3' ' A' ' 26' ' ' LYS . 34.6 t -71.24 57.08 0.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.86 -136.4 2.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -76.71 -38.65 53.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 117.607 0.703 . . . . 0.0 110.992 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.831 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 33.1 t -55.13 -10.15 0.5 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.54 -40.74 60.26 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.194 0.198 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.519 ' HG2' HD12 ' A' ' 88' ' ' ILE . 1.2 pm0 -80.49 -35.72 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.922 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 87' ' ' VAL . . . -64.24 -43.64 94.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.142 0.577 . . . . 0.0 112.518 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 38' ' ' GLN . 11.2 p -56.23 -36.13 44.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.337 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.528 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.3 mm100 -66.12 -43.8 86.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.102 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.626 ' HB1' HD11 ' A' ' 88' ' ' ILE . . . -57.08 -45.21 83.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.456 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.548 HD12 HD22 ' A' ' 74' ' ' LEU . 1.8 mt -61.84 -59.41 5.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.01 67.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -73.38 -49.13 28.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.402 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.818 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.1 p -75.55 -57.23 4.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.199 -171.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.25 -142.15 12.21 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.439 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 90.7 mt-10 -100.2 -151.46 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.943 0.878 . . . . 0.0 111.248 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.94 158.29 35.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.57 174.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.466 ' CE1' HD21 ' A' ' 19' ' ' LEU . 13.5 p90 -151.82 160.83 43.42 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.688 -171.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.19 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.6 p90 -140.3 152.56 45.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.557 HG22 HD11 ' A' ' 18' ' ' LEU . 51.5 t -129.37 132.19 66.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.804 0.335 . . . . 0.0 110.339 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 21' ' ' MET . 32.3 p-10 -76.64 129.32 36.22 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.543 0.687 . . . . 0.0 110.686 173.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.663 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.2 pp -144.4 -36.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.903 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.852 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -65.6 -10.42 35.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.814 168.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -43.8 7.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.603 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -83.86 113.94 50.81 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 122.137 -0.352 . . . . 0.0 110.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.9 -45.54 28.12 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.966 2.444 . . . . 0.0 113.381 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.504 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.89 -38.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.138 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 58.3 ttt-85 -49.81 -35.78 24.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.425 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.77 -41.28 14.24 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -174.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -79.57 -60.94 2.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -162.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.878 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -73.09 -27.66 0.88 Allowed Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -172.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.759 ' HD3' HD11 ' A' ' 62' ' ' LEU . 17.9 Cg_endo -57.2 -41.17 76.7 Favored 'Trans proline' 0 C--N 1.357 1.006 0 CA-C-N 121.368 1.524 . . . . 0.0 110.853 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 39.1 mtmt -54.86 -39.37 68.56 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.733 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -68.43 -41.52 80.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.871 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.564 ' HB1' ' CH2' ' A' ' 75' ' ' TRP . . . -74.91 -57.7 3.74 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.562 -176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.648 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 48.6 t30 -175.0 -53.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.947 0.88 . . . . 0.0 109.987 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.648 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.93 146.62 81.65 Favored Pre-proline 0 C--O 1.218 -0.6 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.208 -176.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.01 -35.99 84.81 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.127 1.885 . . . . 0.0 110.667 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.1 p -141.79 -128.58 0.1 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.568 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.854 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 30.5 m-85 -142.23 -173.75 0.38 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.854 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.6 Cg_endo -66.99 160.16 78.87 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 120.848 1.339 . . . . 0.0 114.36 -0.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.64 ' HA ' ' CA ' ' A' ' 83' ' ' GLY . 56.0 mt-30 -150.78 129.45 12.3 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.179 172.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.548 HD22 HD12 ' A' ' 40' ' ' LEU . 3.1 tm? -89.58 137.38 32.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.024 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.564 ' CH2' ' HB1' ' A' ' 66' ' ' ALA . 58.6 m95 -121.64 131.34 54.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.206 0.526 . . . . 0.0 110.87 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.957 HG23 HD12 ' A' ' 100' ' ' ILE . 67.2 t -116.6 119.52 62.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.617 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t70 54.75 41.5 31.87 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.993 1.378 . . . . 0.0 108.933 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.735 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 62.76 28.28 71.41 Favored Glycine 0 C--N 1.31 -0.897 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.696 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -129.04 134.8 48.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 111.107 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 54.3 tp -66.64 136.96 56.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.618 -173.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 86' ' ' ILE . 96.2 t -115.08 -56.26 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.813 170.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.754 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 155.73 133.74 1.73 Allowed Glycine 0 C--O 1.225 -0.431 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.64 ' CA ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.67 -61.37 1.7 Allowed Glycine 0 C--O 1.218 -0.886 0 C-N-CA 119.999 -1.096 . . . . 0.0 115.625 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.58 -67.9 0.73 Allowed 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.705 -0.88 . . . . 0.0 112.262 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -80.72 -51.32 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.9 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.754 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 50.1 mm -55.8 -53.5 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.459 -171.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.668 HG13 ' HB2' ' A' ' 36' ' ' ALA . 10.4 p -59.8 -43.12 91.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.34 -173.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.626 HD11 ' HB1' ' A' ' 39' ' ' ALA . 34.8 mm -59.14 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.489 175.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.722 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.9 tt0 -62.54 -48.94 77.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.483 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 25.6 mmt -54.62 -39.79 68.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.922 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.789 ' HB2' HD13 ' A' ' 96' ' ' LEU . 6.8 t80 -59.01 -52.68 64.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 174.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.1 -38.66 91.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.742 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 23.1 mmm180 -61.64 -32.07 72.2 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.402 0.62 . . . . 0.0 109.824 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 83.61 21.43 58.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.611 -174.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 62.8 mm-40 -90.34 -31.36 16.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 110.737 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 91' ' ' TYR . 1.4 tt -57.77 -54.75 43.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.204 -175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.818 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.1 pt20 -62.18 -27.43 68.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.394 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 9.4 mm-40 -68.83 -44.26 73.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.295 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 40.6 mt -65.84 -48.08 72.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.686 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.957 HD12 HG23 ' A' ' 76' ' ' VAL . 42.5 mm -60.86 -48.28 89.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.102 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 39.7 ttpt -58.17 -47.26 83.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.643 0.259 . . . . 0.0 111.676 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -59.49 -48.32 82.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.018 0.437 . . . . 0.0 110.046 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.617 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 60.2 m -69.74 -46.25 66.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.372 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.7 ' HB2' ' HE2' ' A' ' 108' ' ' LYS . . . -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.56 86.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.8 -26.57 64.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.877 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.592 ' HH ' ' CG ' ' A' ' 77' ' ' ASP . 92.3 m-85 -91.48 -48.9 6.61 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.531 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.7 ' HE2' ' HB2' ' A' ' 104' ' ' ALA . 39.4 mtmt -91.72 110.22 21.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -61.64 125.76 24.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.098 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 55.87 45.28 24.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.371 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 5.5 mm-40 -121.87 67.13 22.36 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.214 176.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.08 115.98 3.44 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.797 1.665 . . . . 0.0 112.431 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.663 ' CG2' HE21 ' A' ' 9' ' ' GLN . 57.7 mt . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.507 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 97.3 mt-10 -56.55 -46.01 80.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.342 . . . . 0.0 110.43 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.806 ' HZ3' ' HB3' ' A' ' 7' ' ' LYS . 3.7 mmmp? -65.21 -44.09 89.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 172.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 1.078 HG21 HD22 ' A' ' 62' ' ' LEU . 91.1 mt -60.31 -46.96 94.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.599 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.663 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.6 mt-30 -62.55 -43.6 98.41 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.803 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -59.09 -33.9 71.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.591 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.4 tt0 -72.35 -44.77 62.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.077 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.785 HG23 HD22 ' A' ' 18' ' ' LEU . 38.1 mt -67.31 -43.11 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.173 0.511 . . . . 0.0 110.184 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.41 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.211 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -66.8 -32.71 74.17 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.613 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -78.43 127.04 82.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.84 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 69.3 Cg_exo -58.47 -42.61 53.36 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.992 2.462 . . . . 0.0 111.973 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.3 mm -138.28 123.23 22.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD22 HG23 ' A' ' 12' ' ' ILE . 21.2 tp -133.92 141.24 47.25 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -171.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' CD2' ' HE1' ' A' ' 21' ' ' MET . 13.5 tp -138.98 118.87 13.24 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.749 -173.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.644 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 m-85 -97.69 124.75 42.14 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.332 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 13.3 ptp -145.03 -168.21 2.88 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.241 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.881 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 64.2 tttm -97.68 111.87 23.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.57 127.78 9.31 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 119.619 -1.276 . . . . 0.0 112.628 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 m -142.73 141.54 20.49 Favored Pre-proline 0 N--CA 1.442 -0.844 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -52.98 -41.16 73.42 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.331 2.021 . . . . 0.0 111.981 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.14 -27.24 62.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.164 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.453 HD21 ' H ' ' A' ' 29' ' ' SER . 1.4 tt -158.71 113.22 1.65 Allowed Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' O ' ' SD ' ' A' ' 21' ' ' MET . 39.3 Cg_endo -71.63 15.86 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.566 2.178 . . . . 0.0 114.156 -176.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.769 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.8 p -161.69 51.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 39.0 t -68.71 51.58 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.465 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.0 -137.02 2.11 Favored Glycine 0 C--N 1.316 -0.564 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.176 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.27 -39.79 53.46 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 117.11 0.455 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.799 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 19.2 t -57.64 -11.21 1.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.455 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' O ' HG11 ' A' ' 37' ' ' VAL . . . -53.31 -43.67 67.76 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.35 0.406 . . . . 0.0 111.521 176.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HG2' HD13 ' A' ' 88' ' ' ILE . 1.2 pm0 -80.25 -31.94 38.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.746 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.58 85.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.216 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.726 ' HB ' ' HE2' ' A' ' 21' ' ' MET . 9.5 p -54.46 -37.09 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.219 0.533 . . . . 0.0 110.447 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.512 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -64.56 -46.3 83.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -58.62 -44.08 89.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.577 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.53 HD13 HD23 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -62.73 -55.83 23.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.437 . . . . 0.0 110.376 -175.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.88 70.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.182 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.97 -48.6 43.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.509 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.7 p -75.69 -50.54 15.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.43 -130.51 7.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.092 -0.575 . . . . 0.0 114.419 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.616 ' OE2' ' HB1' ' A' ' 104' ' ' ALA . 2.4 pp20? -128.89 -152.74 0.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.457 -0.872 . . . . 0.0 109.65 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 -64.17 152.96 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.608 0.718 . . . . 0.0 111.421 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.49 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 20.8 p90 -158.78 150.01 20.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.866 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.05 144.24 28.42 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.193 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.2 p90 -124.87 154.61 40.79 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.4 t -130.66 130.14 64.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' MET . 11.3 p-10 -74.94 132.29 41.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.228 175.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -149.21 -31.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.965 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.881 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -68.34 -9.34 47.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.269 167.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.82 -47.68 6.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.984 176.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.4 m-20 -73.8 126.27 89.7 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 120.502 0.191 . . . . 0.0 110.653 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.98 -42.89 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.246 1.964 . . . . 0.0 113.16 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.86 -53.31 8.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.945 0.402 . . . . 0.0 112.021 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.525 HG21 HD23 ' A' ' 62' ' ' LEU . 37.3 mt -60.8 -32.34 51.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.49 0.662 . . . . 0.0 110.33 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.711 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 29.8 ttm180 -53.16 -34.91 58.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.167 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.4 6.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 61' ' ' GLU . 4.7 mm-40 -76.64 -55.0 5.9 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -163.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 1.078 HD22 HG21 ' A' ' 8' ' ' ILE . 3.6 pp -68.39 -35.89 7.78 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.711 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 25.6 Cg_endo -58.21 -42.43 56.76 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.393 1.396 . . . . 0.0 111.394 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -58.31 -34.17 70.29 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.073 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -65.65 -39.99 91.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.937 177.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.58 -53.53 11.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.575 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.897 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.5 t-20 -171.55 -47.83 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.022 174.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.897 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 33.5 p90 -124.8 146.33 52.68 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -40.19 -36.8 1.64 Allowed 'Trans proline' 0 C--N 1.352 0.715 1 C-N-CA 125.4 4.067 . . . . 0.0 117.152 -169.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 p -140.5 -135.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 119.076 0.853 . . . . 0.0 111.951 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.869 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 49.2 m-85 -145.15 -172.43 0.31 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.869 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 21.1 Cg_endo -62.91 154.53 69.04 Favored 'Cis proline' 0 C--N 1.36 1.184 0 CA-C-N 120.6 1.25 . . . . 0.0 114.33 -0.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.704 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 25.2 mt-30 -139.97 131.7 27.39 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.352 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.67 HD11 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -95.94 139.35 32.26 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.339 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.67 ' N ' HD11 ' A' ' 74' ' ' LEU . 57.7 m95 -127.73 127.79 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.384 0.611 . . . . 0.0 110.739 177.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 99' ' ' LEU . 57.3 t -113.2 118.33 57.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.273 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.587 ' HB2' HG21 ' A' ' 103' ' ' THR . 10.6 t70 57.03 32.26 21.37 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 123.757 1.741 . . . . 0.0 108.711 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.773 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.33 28.43 67.96 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 113.488 -1.687 . . . . 0.0 113.04 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 40.5 mt-10 -119.44 133.37 55.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.668 HD22 ' CZ3' ' A' ' 68' ' ' TRP . 18.9 tp -65.57 131.44 46.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.781 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.581 ' O ' HD11 ' A' ' 86' ' ' ILE . 84.6 t -117.76 -52.84 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.931 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.744 ' HA2' ' HH2' ' A' ' 68' ' ' TRP . . . 134.08 133.24 3.3 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.421 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.37 -60.82 1.87 Allowed Glycine 0 C--O 1.222 -0.634 0 N-CA-C 116.367 1.307 . . . . 0.0 116.367 -166.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -75.24 -68.95 0.51 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.439 -1.036 . . . . 0.0 113.378 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -78.71 -43.9 24.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.443 0.639 . . . . 0.0 110.629 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.581 HD11 ' O ' ' A' ' 81' ' ' VAL . 43.7 mt -60.34 -42.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.456 -171.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -59.93 -50.38 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.055 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.512 HD12 ' HB1' ' A' ' 39' ' ' ALA . 37.7 mm -60.73 -49.04 86.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.447 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.776 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.9 tt0 -61.89 -54.35 43.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.918 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.406 ' HA ' ' HB2' ' A' ' 93' ' ' ARG . 55.1 mtt -58.43 -32.46 68.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.586 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.2 t80 -58.57 -53.19 61.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.73 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.1 mt-30 -65.12 -39.45 93.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.48 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.776 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.0 mmt180 -59.37 -33.6 71.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.657 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.608 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 94.8 -24.37 28.51 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -169.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.664 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.8 mt-10 -57.57 -31.22 65.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.601 HD11 HD12 ' A' ' 99' ' ' LEU . 56.3 tp -68.91 -55.42 11.08 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.585 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 10.2 pt20 -57.56 -24.71 57.66 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.15 171.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.3 mm100 -71.01 -56.75 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 76' ' ' VAL . 2.2 pp -70.67 -34.72 72.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.668 ' N ' HD13 ' A' ' 99' ' ' LEU . 38.1 mm -62.03 -42.32 94.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 39.5 ttmt -52.32 -56.8 12.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.183 0.516 . . . . 0.0 112.072 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.38 -45.9 90.17 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.582 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.587 HG21 ' HB2' ' A' ' 77' ' ' ASP . 58.8 m -66.45 -51.09 60.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.351 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.616 ' HB1' ' OE2' ' A' ' 45' ' ' GLU . . . -60.94 -51.66 68.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.87 -175.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.61 73.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.515 -176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.578 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.58 -25.73 50.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.042 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 54.4 m-85 -84.93 -48.59 9.14 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.09 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.428 ' HZ2' ' CD ' ' A' ' 45' ' ' GLU . 2.5 mppt? -102.66 108.41 19.67 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 163.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 m -53.46 122.76 10.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.416 0.627 . . . . 0.0 110.787 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 49.31 38.98 14.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.736 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 45' ' ' GLU . 38.7 tt0 -77.49 133.32 67.52 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.05 128.26 23.61 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.865 1.71 . . . . 0.0 112.65 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 N--CA 1.445 -0.7 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.694 -177.79 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.664 ' CG2' HE21 ' A' ' 9' ' ' GLN . 77.8 mt . . . . . 0 N--CA 1.461 0.113 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.97 -44.03 82.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.144 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.651 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -70.79 -45.45 64.66 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.956 0.408 . . . . 0.0 110.175 171.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.618 HD11 HD23 ' A' ' 62' ' ' LEU . 79.4 mt -54.35 -47.09 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.664 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.7 mt-30 -63.62 -39.74 95.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.596 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 12.1 mmp_? -61.09 -34.22 74.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.343 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -74.63 -41.27 60.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.469 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.768 HG22 ' HA2' ' A' ' 78' ' ' GLY . 30.5 mt -66.5 -46.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.712 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.468 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.13 -39.96 94.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.862 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' OE2' ' HA ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -65.5 -32.5 74.13 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.113 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -76.68 125.44 87.25 Favored Pre-proline 0 CA--C 1.517 -0.312 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.846 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HA ' ' CE2' ' A' ' 107' ' ' TYR . 45.7 Cg_exo -62.26 -42.91 25.84 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 122.462 2.108 . . . . 0.0 112.225 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.7 mm -136.27 121.71 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.582 HD13 HG22 ' A' ' 50' ' ' VAL . 22.0 tp -133.05 142.08 48.58 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.327 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.1 tp -137.21 119.9 16.16 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.151 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.66 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -97.36 120.03 36.99 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.986 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.68 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 21.1 ptt? -146.29 -170.92 3.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.126 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.026 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.2 119.87 35.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.387 -0.821 . . . . 0.0 109.576 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.77 71.62 1.29 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.077 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.403 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 36.6 t -78.54 142.56 62.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.85 -40.9 82.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.019 1.812 . . . . 0.0 111.459 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.7 pttt -67.99 -30.36 69.61 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.805 177.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 29' ' ' SER . 49.1 tp -160.62 115.97 1.4 Allowed Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.479 ' O ' ' HE1' ' A' ' 21' ' ' MET . 12.2 Cg_exo -71.19 29.73 0.22 Allowed 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 123.145 2.563 . . . . 0.0 112.985 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.68 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 11.9 p -162.58 46.61 0.15 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 42.6 t -64.64 147.57 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.678 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.55 -141.35 15.27 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.799 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -78.2 -38.27 43.69 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.0 p -46.77 -19.61 0.1 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.35 -42.99 53.94 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.985 0.178 . . . . 0.0 111.095 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.602 HE21 ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.35 -37.11 38.26 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' N ' HE21 ' A' ' 35' ' ' GLN . . . -66.6 -45.79 78.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.556 HG12 HE21 ' A' ' 38' ' ' GLN . 13.1 p -56.36 -36.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.73 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.556 HE21 HG12 ' A' ' 37' ' ' VAL . 32.3 mm-40 -66.78 -46.85 73.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.285 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 91' ' ' TYR . . . -59.05 -40.09 84.02 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.15 0.281 . . . . 0.0 111.609 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.56 HD11 HD21 ' A' ' 74' ' ' LEU . 1.3 tt -62.43 -57.26 11.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.938 -175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 -35.19 79.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.386 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.12 -47.67 76.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.016 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.717 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.3 m -73.08 -55.57 6.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.2 -133.14 8.01 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.308 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 113' ' ' ASP . 64.5 mm-40 -137.36 -150.64 0.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.708 -0.746 . . . . 0.0 110.241 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.585 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -60.07 150.72 28.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.476 0.655 . . . . 0.0 112.487 -172.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.421 ' CE1' HD23 ' A' ' 19' ' ' LEU . 20.3 p90 -157.93 156.72 31.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.359 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -98.34 152.94 18.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.621 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.5 p90 -138.1 152.63 48.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.582 HG22 HD13 ' A' ' 18' ' ' LEU . 58.6 t -129.66 130.91 67.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 110.27 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' MET . 9.5 p-10 -76.53 128.12 34.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.58 175.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.66 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -145.22 -38.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 1.026 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -60.46 -17.81 47.2 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.003 0.82 . . . . 0.0 110.822 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.677 HE22 ' ND2' ' A' ' 55' ' ' ASN . 3.1 pp0? -95.34 -33.97 12.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.677 ' ND2' HE22 ' A' ' 54' ' ' GLN . 77.9 m-20 -74.72 131.22 79.91 Favored Pre-proline 0 N--CA 1.477 0.88 0 O-C-N 122.178 -0.326 . . . . 0.0 110.709 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.79 -43.99 4.68 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.467 2.111 . . . . 0.0 112.943 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.58 -57.95 3.56 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.63 HG22 ' CG2' ' A' ' 52' ' ' ILE . 37.5 mt -59.71 -35.28 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.688 -173.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.565 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -55.72 -27.99 53.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.95 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.51 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -89.14 -48.08 7.64 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -171.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.646 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 52.7 mt-10 -78.93 -60.05 2.53 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.294 1.591 . . . . 0.0 115.294 -162.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.678 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 1.8 pt? -67.47 -34.64 7.05 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 19.1 Cg_endo -56.11 -38.22 95.2 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.405 1.403 . . . . 0.0 110.997 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 42.8 mtmt -55.23 -41.99 72.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.439 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.535 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.63 -38.86 84.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.093 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . . . -68.75 -53.54 21.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.158 -175.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.934 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.6 t-20 -172.35 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.658 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.934 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 31.2 p90 -126.49 149.42 67.68 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.736 -167.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.62 -37.48 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 125.256 3.971 . . . . 0.0 117.05 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.9 p -140.78 -137.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.202 0.91 . . . . 0.0 111.961 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.864 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 42.6 m-85 -140.57 -170.71 0.25 Allowed Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -173.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.864 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.0 Cg_endo -64.41 148.62 70.15 Favored 'Cis proline' 0 C--N 1.36 1.149 0 CA-C-N 120.864 1.344 . . . . 0.0 113.495 -2.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.624 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 68.2 mt-30 -133.5 130.59 38.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.758 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.56 HD21 HD11 ' A' ' 40' ' ' LEU . 3.3 tm? -92.31 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.539 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 67.3 m95 -125.03 129.4 50.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.69 0.757 . . . . 0.0 111.323 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.547 HG23 HD12 ' A' ' 100' ' ' ILE . 86.5 t -115.91 120.08 63.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.1 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.493 ' N ' HG21 ' A' ' 103' ' ' THR . 10.1 t70 56.93 32.08 20.9 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 123.078 1.418 . . . . 0.0 109.145 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.768 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.17 28.19 70.59 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 114.044 -1.435 . . . . 0.0 113.264 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -127.95 135.14 49.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 111.126 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.763 HD22 ' CZ3' ' A' ' 68' ' ' TRP . 19.4 tp -64.65 136.13 56.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.67 -172.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.3 t -120.8 -53.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.358 170.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.862 ' HA2' ' HH2' ' A' ' 68' ' ' TRP . . . 129.7 133.32 3.58 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.567 ' HA2' HG23 ' A' ' 87' ' ' VAL . . . -85.73 -61.37 1.7 Allowed Glycine 0 C--O 1.221 -0.69 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -167.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.18 -68.91 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.632 -0.922 . . . . 0.0 113.431 -166.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -80.72 -41.91 22.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.077 0.465 . . . . 0.0 110.469 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.445 ' CD1' ' H ' ' A' ' 86' ' ' ILE . 2.5 mp -60.41 -45.7 96.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.58 -171.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.708 HG12 HD23 ' A' ' 96' ' ' LEU . 71.0 t -58.83 -47.67 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.715 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.525 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 32.8 mm -60.15 -46.61 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.02 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.715 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 85.2 tt0 -61.11 -54.66 41.82 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.932 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.578 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.3 mmt -57.97 -36.32 72.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.712 0.292 . . . . 0.0 111.512 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.703 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 18.7 t80 -56.36 -51.43 68.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.781 172.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 77.2 mt-30 -65.32 -38.46 90.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.715 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.9 mmm180 -58.94 -34.37 71.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.072 176.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 86.88 -23.93 9.78 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -168.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.78 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.6 mt-10 -58.01 -29.39 65.27 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 87' ' ' VAL . 63.7 tp -60.14 -56.63 19.19 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.201 0.524 . . . . 0.0 111.063 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.717 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.2 pt20 -63.12 -28.99 70.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.917 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.6 mm100 -62.27 -47.15 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.038 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 37.0 mt -66.19 -45.36 81.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 96' ' ' LEU . 49.5 mm -61.38 -47.88 91.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.721 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 39.7 ttpt -62.01 -49.46 75.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.553 0.216 . . . . 0.0 111.339 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -55.42 -44.95 76.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.614 0.721 . . . . 0.0 109.957 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.493 HG21 ' N ' ' A' ' 77' ' ' ASP . 92.9 m -70.53 -45.86 64.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.472 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.509 ' HA ' ' HZ3' ' A' ' 108' ' ' LYS . . . -59.65 -44.23 93.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 109' ' ' SER . . . -61.01 -41.84 97.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.478 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -72.87 -31.78 64.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.333 -178.494 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.561 ' CE2' ' HA ' ' A' ' 16' ' ' PRO . 60.0 m-85 -78.47 -47.09 18.15 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.533 ' CE ' ' HG3' ' A' ' 111' ' ' GLU . 3.1 mppt? -98.82 -145.47 0.32 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.496 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 105' ' ' ALA . 50.4 m -83.57 -155.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -70.08 59.91 0.18 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.533 ' HG3' ' CE ' ' A' ' 108' ' ' LYS . 58.5 mm-40 -59.48 121.94 60.61 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -92.7 48.14 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.656 2.237 . . . . 0.0 113.924 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.1 m-20 . . . . . 0 C--N 1.309 -1.179 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.113 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.665 ' CG2' HE21 ' A' ' 9' ' ' GLN . 61.1 mt . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -55.61 -47.1 77.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.21 -43.5 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.48 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.867 HD11 ' HB2' ' A' ' 62' ' ' LEU . 85.2 mt -62.32 -47.83 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.435 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.665 HE21 ' CG2' ' A' ' 5' ' ' ILE . 73.0 mt-30 -62.91 -39.35 94.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.224 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -58.86 -34.5 71.66 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 8.2 tt0 -73.14 -50.35 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.64 HG21 ' HA2' ' A' ' 78' ' ' GLY . 26.5 mt -63.4 -38.13 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.873 0.845 . . . . 0.0 111.042 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.4 83.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.269 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -73.78 -35.82 65.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.861 -171.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.652 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -77.21 131.28 72.69 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 121.494 0.664 . . . . 0.0 111.323 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 50.2 Cg_exo -59.44 -42.06 52.05 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.24 2.626 . . . . 0.0 112.492 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.463 HG23 HD11 ' A' ' 100' ' ' ILE . 33.9 mm -141.9 121.33 10.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.652 HD22 ' OD1' ' A' ' 15' ' ' ASN . 22.8 tp -131.83 142.67 49.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 0.0 111.313 -170.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.663 HD23 ' SD ' ' A' ' 21' ' ' MET . 11.8 tp -137.22 121.45 18.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.359 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.651 ' HB3' HG12 ' A' ' 52' ' ' ILE . 8.0 m-85 -97.92 115.69 28.62 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.901 ' HE1' ' HB3' ' A' ' 33' ' ' SER . 14.2 ptm -148.06 -157.18 0.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.016 173.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 tttt -98.28 125.98 43.59 Favored 'General case' 0 C--O 1.213 -0.857 0 O-C-N 121.232 -0.917 . . . . 0.0 112.154 -169.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 67.91 0.94 Allowed Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.442 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 p -77.09 145.04 72.75 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -51.62 -41.48 60.97 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.616 2.211 . . . . 0.0 112.127 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.75 -29.08 68.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.131 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 29' ' ' SER . 2.8 tt -159.96 118.0 1.57 Allowed Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -173.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.66 17.84 0.13 Allowed 'Trans proline' 0 N--CA 1.47 0.141 0 C-N-CA 122.801 2.334 . . . . 0.0 114.471 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.82 ' HB2' ' HE3' ' A' ' 21' ' ' MET . 11.2 p -164.12 61.11 0.15 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.42 0.629 . . . . 0.0 112.605 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 39.1 t -80.67 -143.3 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.946 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 65.42 -152.89 51.27 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 122.409 -0.182 . . . . 0.0 113.432 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 17.6 m-85 -78.19 -35.95 48.0 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.901 ' HB3' ' HE1' ' A' ' 21' ' ' MET . 32.4 t -59.72 -7.3 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.036 -0.415 . . . . 0.0 112.091 -172.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' HG13 ' A' ' 37' ' ' VAL . . . -45.28 -42.05 9.27 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.527 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.01 -38.86 61.43 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.244 0.545 . . . . 0.0 109.708 177.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -65.72 -43.97 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.383 -175.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 34' ' ' ALA . 11.1 p -55.87 -37.6 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.449 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.531 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 1.5 mm100 -67.78 -45.44 74.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.783 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HB3' ' CG ' ' A' ' 91' ' ' TYR . . . -58.0 -44.69 87.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.644 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -61.25 -57.49 12.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.955 0.407 . . . . 0.0 110.271 -175.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.05 -32.17 70.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.567 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 38' ' ' GLN . . . -69.35 -48.6 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.2 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.3 p -74.47 -54.58 7.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.18 -130.2 6.93 Favored Glycine 0 N--CA 1.454 -0.151 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.933 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.674 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 49.5 mt-10 -140.84 -149.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.168 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -48.1 146.64 2.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.47 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 20.0 p90 -158.5 153.15 24.66 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.35 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.61 152.77 19.24 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.682 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -132.12 148.44 52.48 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.602 HG21 HD12 ' A' ' 18' ' ' LEU . 43.3 t -123.2 131.12 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.6 p30 -81.63 131.23 35.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.365 0.602 . . . . 0.0 109.957 176.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.651 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.2 pp -147.49 -28.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.741 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.9 mm? -65.87 -14.5 61.58 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 -46.12 6.58 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.858 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.8 m-20 -77.28 121.33 84.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.615 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 18.5 Cg_exo -66.89 -43.66 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.974 2.449 . . . . 0.0 112.939 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.78 -51.08 29.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mt -63.52 -34.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.172 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.621 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 47.9 ttt85 -50.88 -35.32 32.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.195 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.606 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -90.89 -51.87 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.429 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 56.6 mm-40 -76.93 -55.46 5.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -167.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.867 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -61.55 -43.57 89.12 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -172.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.621 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 20.4 Cg_endo -57.81 -41.54 68.62 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 121.334 1.356 . . . . 0.0 111.217 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 52.4 mtmt -57.04 -35.27 69.1 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.766 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -67.0 -43.22 83.48 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.943 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.493 ' HB1' ' CZ2' ' A' ' 75' ' ' TRP . . . -75.08 -56.88 4.29 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.799 -175.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.703 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 25.8 t-20 -174.85 -55.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.34 1.067 . . . . 0.0 109.507 172.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.703 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.3 m-90 -58.79 147.28 72.58 Favored Pre-proline 0 C--O 1.216 -0.687 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.339 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.71 -38.27 72.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.345 2.03 . . . . 0.0 110.306 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.9 p -142.66 -124.73 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.462 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.918 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 53.6 m-85 -139.61 -172.27 0.31 Allowed Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.918 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 64.3 Cg_endo -71.37 165.05 81.99 Favored 'Cis proline' 0 C--N 1.357 1.014 0 CA-C-N 120.777 1.313 . . . . 0.0 114.611 -1.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.778 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.6 pt20 -156.74 133.67 10.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.038 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.586 ' CD1' HD11 ' A' ' 40' ' ' LEU . 61.4 tp -90.72 141.91 28.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.734 178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.644 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 52.1 m95 -129.16 125.13 36.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 110.329 175.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 100' ' ' ILE . 60.6 t -106.04 117.37 51.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.653 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 60.6 t0 57.09 33.99 24.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 123.117 1.437 . . . . 0.0 109.465 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.64 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 71.41 29.24 68.42 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.071 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -127.31 129.04 46.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.312 . . . . 0.0 110.492 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.492 HD23 ' CZ3' ' A' ' 68' ' ' TRP . 59.2 tp -67.95 135.56 52.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.806 -170.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 86' ' ' ILE . 97.9 t -117.48 -53.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.194 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' O ' HG22 ' A' ' 87' ' ' VAL . . . 146.54 140.03 3.4 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.02 -67.35 1.41 Allowed Glycine 0 C--O 1.216 -0.994 0 C-N-CA 118.226 -1.94 . . . . 0.0 116.258 -167.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 41.8 t -81.61 -68.72 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.728 1.264 . . . . 0.0 113.088 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.88 -47.13 60.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.404 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 81' ' ' VAL . 45.7 mm -58.36 -43.78 87.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.388 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 69.3 t -59.46 -49.23 84.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.974 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.514 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.3 mm -58.22 -49.68 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.36 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.72 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.2 tt0 -61.25 -54.28 46.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.693 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.753 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 24.9 mmt -58.58 -35.03 71.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.5 t80 -58.62 -50.63 73.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.767 173.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.2 mt-30 -62.69 -41.32 99.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.72 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 28.8 mmm180 -58.74 -33.88 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.699 178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.9 17.37 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.65 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.808 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 41.0 mt-10 -57.49 -36.92 72.12 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 122.96 0.504 . . . . 0.0 111.728 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.753 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.9 tt -61.29 -54.63 41.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.128 0.49 . . . . 0.0 109.92 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.758 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 18.9 pt20 -64.91 -28.96 69.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.889 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 2.0 tp-100 -63.93 -44.13 93.81 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.239 0.616 . . . . 0.0 110.032 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.808 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 43.0 mt -68.78 -47.53 65.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.907 174.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.709 HD12 HG21 ' A' ' 76' ' ' VAL . 46.3 mm -57.56 -47.65 84.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.432 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 26.7 ttpp -55.26 -50.73 68.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.664 0.269 . . . . 0.0 111.692 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -48.77 80.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.653 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.0 m -65.17 -53.24 47.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.399 0.619 . . . . 0.0 111.694 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.633 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.71 -44.14 97.0 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.822 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.62 75.92 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.399 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.46 -29.34 67.0 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.131 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.584 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 46.9 m-85 -79.56 -46.06 18.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.633 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -77.77 -163.73 0.43 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.097 0.475 . . . . 0.0 110.395 170.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 17.0 p -87.45 59.63 5.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.156 0.979 . . . . 0.0 111.964 175.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 57.07 47.47 17.35 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.777 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 108' ' ' LYS . 43.1 mm-40 -67.78 135.89 92.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.858 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.8 Cg_exo -80.43 51.37 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 124.589 3.526 . . . . 0.0 113.017 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.676 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.4 m-20 . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.67 ' CG2' HE21 ' A' ' 9' ' ' GLN . 74.7 mt . . . . . 0 C--O 1.232 0.171 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 9.7 pt-20 -52.06 -46.57 65.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.023 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 47.5 mmtm -73.54 -43.69 59.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.015 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.775 HD13 ' HB3' ' A' ' 62' ' ' LEU . 66.9 mt -53.23 -44.45 53.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.67 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.1 mt-30 -63.14 -33.57 75.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.937 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -58.08 -40.26 80.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.359 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.686 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.8 mp0 -73.69 -46.41 46.46 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.504 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 18.4 mt -59.94 -44.61 94.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.39 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.58 95.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.955 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.4 pt-20 -66.44 -31.38 72.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.269 -176.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -76.63 125.87 86.75 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.927 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.515 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 51.5 Cg_exo -60.38 -42.98 37.01 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 123.058 2.505 . . . . 0.0 112.437 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.8 mm -141.13 123.26 14.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.654 ' HB3' ' HB2' ' A' ' 75' ' ' TRP . 20.0 tp -133.51 142.09 48.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.16 -167.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.2 tp -136.37 117.99 14.94 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.326 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.763 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.9 m-85 -97.25 121.76 39.51 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.993 -0.442 . . . . 0.0 112.012 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.989 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 45.3 mmm -147.16 -158.49 0.92 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.987 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.93 112.82 24.41 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.777 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.9 68.04 1.5 Allowed Glycine 0 C--N 1.306 -1.118 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.095 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 p -77.71 144.57 69.3 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -52.74 -40.25 74.58 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.267 1.978 . . . . 0.0 111.529 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -66.7 -32.56 73.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.153 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 27' ' ' LEU . 2.8 tt -156.17 115.91 2.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -176.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.34 15.6 0.2 Allowed 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.895 2.397 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.49 ' H ' HD23 ' A' ' 27' ' ' LEU . 31.4 p -164.83 47.08 0.1 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.141 0.496 . . . . 0.0 111.177 177.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 45.2 t -65.81 124.12 21.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.306 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.84 -134.71 6.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.424 -175.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.32 -42.14 31.58 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.672 ' CB ' ' HG3' ' A' ' 21' ' ' MET . 29.6 t -55.0 -10.12 0.46 Allowed 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.61 11.29 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.653 0.206 . . . . 0.0 110.893 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.499 HE21 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pm0 -81.53 -36.99 28.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.008 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB3' HE21 ' A' ' 35' ' ' GLN . . . -67.36 -44.74 78.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.483 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.38 -37.95 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.716 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 1.3 mm100 -62.29 -45.1 94.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.113 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . . . -60.3 -45.9 91.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.42 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD12 ' CD2' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -62.77 -56.59 16.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.526 -174.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.49 -32.14 69.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -71.24 -48.56 50.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.042 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.854 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 31.7 p -71.73 -56.29 6.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.327 -171.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.809 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -102.51 -146.09 17.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.456 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -102.39 -153.55 0.47 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.283 -0.458 . . . . 0.0 111.337 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HD2' ' C ' ' A' ' 46' ' ' ARG . 6.5 ppt_? -71.56 150.35 44.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -176.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.483 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 12.9 p90 -141.35 156.31 45.84 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.541 -170.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 18' ' ' LEU . . . -97.43 152.47 18.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.888 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.9 p90 -136.77 153.97 50.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.71 130.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.777 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -78.64 134.9 37.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.48 0.657 . . . . 0.0 110.907 175.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.763 HG12 ' HD2' ' A' ' 20' ' ' TYR . 1.3 pp -153.08 -34.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.616 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.987 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.2 mm? -69.8 -5.84 28.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.368 168.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.85 -43.21 7.59 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.256 176.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 75.2 m-80 -82.21 124.9 78.05 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.029 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.18 -44.22 9.79 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 121.992 1.795 . . . . 0.0 112.524 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -56.3 6.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.036 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.408 ' O ' HD21 ' A' ' 62' ' ' LEU . 28.9 mt -61.72 -33.92 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.39 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.607 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 59.8 ttp180 -51.93 -34.0 39.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.982 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -87.15 -41.59 13.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.57 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -77.96 -61.65 1.93 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -164.37 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.775 ' HB3' HD13 ' A' ' 8' ' ' ILE . 2.2 pt? -71.46 -34.0 2.99 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -171.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.74 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 19.8 Cg_endo -56.04 -38.72 94.34 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.348 1.365 . . . . 0.0 110.772 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 61' ' ' GLU . 8.8 mtmp? -54.11 -39.1 66.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.776 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.601 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -70.6 -38.28 73.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.643 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.505 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . . . -70.76 -54.31 12.21 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.562 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.838 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.5 t-20 -171.94 -54.22 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.347 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.838 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 32.8 p90 -105.55 144.71 29.38 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.096 -1.411 . . . . 0.0 114.511 -167.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -40.84 -37.0 2.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 125.07 3.847 . . . . 0.0 115.919 -172.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -140.41 -133.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.223 0.465 . . . . 0.0 111.409 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.884 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 45.5 m-85 -141.81 -174.17 0.4 Allowed Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -170.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.989 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 42.6 Cg_endo -65.99 172.58 32.22 Favored 'Cis proline' 0 C--N 1.357 0.989 0 CA-C-N 120.1 1.072 . . . . 0.0 114.032 -0.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.86 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.9 pt20 -160.58 132.43 5.95 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.395 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.538 HD21 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -96.6 137.68 35.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.217 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.663 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 55.5 m95 -126.36 125.8 42.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.438 0.637 . . . . 0.0 110.637 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.845 HG22 HD13 ' A' ' 100' ' ' ILE . 64.8 t -106.77 119.72 56.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.907 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.556 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 35.1 t70 55.79 28.72 12.73 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.764 1.269 . . . . 0.0 110.268 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 77.82 29.89 53.54 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.048 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 46.9 mt-10 -126.33 133.83 51.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.706 0.289 . . . . 0.0 111.172 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.68 HD23 ' CZ3' ' A' ' 68' ' ' TRP . 24.6 tp -63.76 135.6 56.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.193 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.496 ' O ' HG21 ' A' ' 86' ' ' ILE . 98.4 t -124.33 -51.95 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.765 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.698 ' HA2' ' CH2' ' A' ' 68' ' ' TRP . . . 135.29 135.88 3.53 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 87' ' ' VAL . . . -84.35 -61.8 1.78 Allowed Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.682 -1.247 . . . . 0.0 116.208 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 17.6 p -79.86 -67.83 0.73 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 -44.92 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.673 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.511 HG13 ' HA3' ' A' ' 82' ' ' GLY . 50.8 mm -56.27 -45.94 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.045 -174.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 HD22 ' A' ' 96' ' ' LEU . 79.5 t -58.34 -49.1 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 91' ' ' TYR . 37.6 mm -60.7 -50.64 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.606 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.4 tt0 -61.19 -52.36 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.071 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 59.9 mtt -61.7 -31.14 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.9 t80 -58.35 -51.86 68.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 171.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.1 mt-30 -64.96 -40.3 94.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.231 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 42.7 mmm-85 -57.81 -33.29 68.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.464 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.695 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.38 -25.81 18.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.903 -173.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.772 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 55.6 mt-10 -53.57 -37.27 62.75 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.631 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.9 tp -59.68 -54.69 43.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 110.575 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.854 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 12.3 pt20 -65.32 -26.01 67.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.663 175.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.695 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 97.3 mm-40 -65.71 -44.57 85.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.266 0.555 . . . . 0.0 109.611 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 44.1 mt -69.65 -47.14 64.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.144 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.845 HD13 HG22 ' A' ' 76' ' ' VAL . 45.7 mm -61.98 -42.26 94.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.789 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 29.7 ttmt -51.34 -59.14 4.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.37 0.605 . . . . 0.0 111.584 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.41 -42.74 99.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.484 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.556 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 74.8 m -69.03 -48.58 62.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.752 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.638 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -60.39 -45.96 91.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.601 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.42 81.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.53 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -73.59 -26.38 60.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.242 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 54.3 m-85 -83.68 -47.23 11.43 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.638 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -83.41 -154.81 0.15 Allowed 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 36.6 m -75.37 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.78 46.93 0.23 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.868 0.366 . . . . 0.0 111.774 174.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -76.86 110.17 11.06 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.347 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -90.8 120.93 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.432 . . . . 0.0 111.81 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.809 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 21.0 m-20 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.019 0.437 . . . . 0.0 111.627 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 1.001 HG22 ' HG3' ' A' ' 9' ' ' GLN . 30.2 mm . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 13.6 pt-20 -40.68 -48.32 2.93 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 75.3 mmtt -62.76 -43.8 97.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 110.303 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 1.007 HD11 ' HB3' ' A' ' 62' ' ' LEU . 71.9 mt -65.53 -50.05 74.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.631 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 1.001 ' HG3' HG22 ' A' ' 5' ' ' ILE . 64.9 mt-30 -56.01 -40.48 73.44 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.9 mmp_? -60.93 -33.88 73.84 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.977 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.4 tt0 -72.21 -42.98 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.439 174.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.693 ' HA ' HD13 ' A' ' 18' ' ' LEU . 18.8 mt -64.16 -45.27 96.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.04 0.448 . . . . 0.0 110.376 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -41.01 96.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.936 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 14.0 pt-20 -64.26 -37.42 87.43 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.64 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.453 ' CB ' ' HG ' ' A' ' 18' ' ' LEU . 77.5 m-20 -77.2 120.56 82.09 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 49.2 Cg_exo -62.17 -42.05 31.56 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.541 2.161 . . . . 0.0 111.829 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 100' ' ' ILE . 31.4 mm -131.93 125.32 54.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.693 HD13 ' HA ' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -131.69 143.4 50.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.276 -169.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 17.0 tp -136.67 113.24 10.12 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.394 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.513 ' HB3' HG12 ' A' ' 52' ' ' ILE . 8.0 m-85 -96.01 115.06 26.85 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.815 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.619 ' HE1' ' O ' ' A' ' 28' ' ' PRO . 24.5 ptt? -145.97 -157.31 0.79 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.113 -176.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.735 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 79.6 tttt -98.42 143.38 28.92 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -142.75 130.18 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.204 -171.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 27.9 t -146.56 143.68 19.29 Favored Pre-proline 0 C--N 1.312 -1.029 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.71 -36.54 82.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.143 1.895 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.434 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 18.4 ptpt -64.65 -35.15 80.08 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.178 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.466 ' C ' HD22 ' A' ' 27' ' ' LEU . 3.2 tt -159.52 113.27 1.52 Allowed Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.619 ' O ' ' HE1' ' A' ' 21' ' ' MET . 36.5 Cg_endo -72.85 19.63 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 114.649 -174.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.3 p -164.14 49.69 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.468 0.651 . . . . 0.0 111.295 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.735 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 2.2 p -69.44 49.67 0.09 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.32 -136.15 2.15 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.704 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.627 ' HB3' ' SG ' ' A' ' 84' ' ' CYS . 4.2 m-85 -74.63 -40.31 61.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.869 0.843 . . . . 0.0 109.466 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.584 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 51.2 p -54.17 -18.07 3.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.548 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.65 -39.47 36.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 110.401 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.857 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -79.89 -38.88 31.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 175.637 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 33' ' ' SER . . . -67.75 -44.28 77.91 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.541 HG11 ' N ' ' A' ' 38' ' ' GLN . 10.5 p -54.38 -39.38 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.119 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.541 ' N ' HG11 ' A' ' 37' ' ' VAL . 1.6 mm100 -64.42 -43.87 92.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.329 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.613 ' HB2' ' CG ' ' A' ' 91' ' ' TYR . . . -58.38 -42.09 86.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.743 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.538 HD13 HD22 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -63.18 -55.97 20.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.146 0.498 . . . . 0.0 110.023 -175.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.08 70.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.468 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -72.04 -46.26 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.47 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.698 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -77.71 -55.25 5.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.52 -135.33 8.82 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.064 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 30.8 mt-10 -134.9 -148.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.957 0.503 . . . . 0.0 110.909 177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 26.0 mmm180 -50.6 146.42 5.62 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.498 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.533 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 26.6 p90 -158.22 153.77 26.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.962 -175.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.38 143.5 29.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.3 p90 -124.86 148.36 48.29 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.556 HG21 HD21 ' A' ' 18' ' ' LEU . 57.7 t -124.81 130.8 73.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.198 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.409 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 41.6 p-10 -78.27 132.07 37.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.604 0.716 . . . . 0.0 110.22 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.966 HD13 ' HG ' ' A' ' 53' ' ' LEU . 1.4 pp -148.68 -34.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.124 -172.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.966 ' HG ' HD13 ' A' ' 52' ' ' ILE . 36.4 mt -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.779 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -46.21 6.25 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.5 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 m-20 -76.42 120.36 81.32 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 120.579 0.228 . . . . 0.0 110.729 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.19 -44.77 11.36 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.261 1.974 . . . . 0.0 113.039 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.05 -54.13 14.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.0 -36.02 71.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 110.279 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.63 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 60.5 ttp180 -51.5 -32.44 27.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.801 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -90.7 -39.14 12.61 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 14.8 tp10 -79.64 -62.09 1.8 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -163.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 1.007 ' HB3' HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -74.28 -26.36 0.69 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -173.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.694 ' HD3' HD11 ' A' ' 62' ' ' LEU . 31.9 Cg_endo -59.73 -40.76 61.36 Favored 'Trans proline' 0 C--N 1.358 1.069 0 CA-C-N 121.352 1.519 . . . . 0.0 110.683 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 8.6 mtmp? -56.54 -39.25 73.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.352 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.618 ' CD2' HG21 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -64.38 -44.03 92.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . . . -77.88 -57.23 3.91 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.504 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.653 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.3 t30 -174.68 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.026 0.917 . . . . 0.0 110.45 169.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.684 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.49 147.11 51.22 Favored Pre-proline 0 C--O 1.222 -0.38 0 CA-C-N 113.358 -1.747 . . . . 0.0 113.311 -174.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.5 -36.52 76.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.232 1.955 . . . . 0.0 110.045 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.482 HG23 ' HG2' ' A' ' 59' ' ' ARG . 41.6 p -142.69 -126.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.181 176.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.782 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 10.9 m-85 -143.47 -164.26 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.782 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.2 Cg_endo -67.09 154.92 84.86 Favored 'Cis proline' 0 C--N 1.364 1.385 0 CA-C-N 121.993 1.747 . . . . 0.0 114.057 -1.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.684 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 21.0 mt-30 -142.62 134.13 26.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.641 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 40' ' ' LEU . 3.0 tm? -91.09 137.91 32.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.597 ' CH2' ' HB3' ' A' ' 66' ' ' ALA . 69.5 m95 -125.19 128.7 48.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 0.0 110.935 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.605 HG21 HD11 ' A' ' 100' ' ' ILE . 96.4 t -112.9 115.23 49.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.57 ' HB2' HG23 ' A' ' 103' ' ' THR . 11.7 t70 57.58 30.56 18.96 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.633 1.682 . . . . 0.0 108.809 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.614 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 73.14 29.01 65.23 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 113.485 -1.688 . . . . 0.0 113.05 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 91.4 mt-10 -115.94 130.57 56.88 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.568 HD23 ' HB2' ' A' ' 66' ' ' ALA . 47.0 tp -69.32 134.56 49.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 111.756 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.45 ' O ' HG21 ' A' ' 86' ' ' ILE . 93.9 t -119.32 -50.33 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.145 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.28 132.88 2.91 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.615 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -84.77 -64.12 1.57 Allowed Glycine 0 C--O 1.222 -0.631 0 C-N-CA 118.895 -1.621 . . . . 0.0 116.644 -166.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 32' ' ' PHE . 42.2 t -80.3 -68.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.428 1.114 . . . . 0.0 112.3 -170.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.22 -43.98 66.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.498 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 81' ' ' VAL . 2.4 mp -62.16 -44.1 98.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.151 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 83' ' ' GLY . 73.4 t -57.21 -49.2 80.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.244 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.857 HD11 ' HG2' ' A' ' 35' ' ' GLN . 35.7 mm -60.1 -49.92 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.043 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.733 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.2 tt0 -62.16 -51.62 67.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.845 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.572 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.0 mmt -58.77 -35.12 72.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.505 0.193 . . . . 0.0 111.307 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.613 ' CG ' ' HB2' ' A' ' 39' ' ' ALA . 9.7 t80 -58.58 -51.23 70.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.205 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.0 mt-30 -64.77 -41.01 96.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.089 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.733 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.3 mmm-85 -60.43 -34.66 74.3 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.654 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.676 ' O ' ' HG3' ' A' ' 98' ' ' GLN . . . 95.36 -24.79 27.51 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.27 -174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.704 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -58.7 -30.03 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.3 tp -59.3 -54.57 45.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.645 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.698 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 15.9 pt20 -63.45 -28.08 69.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.002 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.676 ' HG3' ' O ' ' A' ' 94' ' ' GLY . 75.2 mt-30 -62.79 -46.04 89.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 49.1 mt -65.39 -44.58 87.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.856 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.27 -46.77 95.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.492 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 113' ' ' ASP . 38.7 ttpt -59.17 -50.73 72.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.882 0.373 . . . . 0.0 110.989 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -52.15 -45.53 65.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.32 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.57 HG23 ' HB2' ' A' ' 77' ' ' ASP . 86.0 m -77.06 -48.6 17.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.971 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 108' ' ' LYS . . . -59.54 -43.69 93.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.37 96.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.549 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.06 -32.34 64.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.281 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.502 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 65.7 m-85 -79.1 -47.47 16.06 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.72 -150.73 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 21.1 p -88.15 -150.54 0.18 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.935 169.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -70.6 54.47 0.16 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -69.44 114.9 27.44 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 110.411 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -93.2 52.59 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.335 2.69 . . . . 0.0 113.795 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.3 m-20 . . . . . 0 C--N 1.315 -0.925 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -172.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.523 HG12 ' CB ' ' A' ' 65' ' ' TYR . 2.0 mp . . . . . 0 C--O 1.225 -0.237 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 24.8 pt-20 -55.25 -40.4 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.607 0.639 . . . . 0.0 110.246 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.32 -43.38 88.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.521 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.822 HD11 ' HB3' ' A' ' 62' ' ' LEU . 77.9 mt -65.71 -47.47 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.876 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.727 ' NE2' ' HE2' ' A' ' 65' ' ' TYR . 59.5 mm-40 -62.16 -25.97 68.07 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.278 -173.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 3.4 mmp_? -50.85 -41.28 57.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 94.4 mm-40 -75.06 -49.35 20.01 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.296 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.562 HG22 ' HA2' ' A' ' 78' ' ' GLY . 4.6 mt -61.44 -43.11 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.601 0.715 . . . . 0.0 111.016 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.83 79.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.759 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 10.5 pt-20 -73.33 -36.26 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -173.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.628 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 3.6 p30 -77.63 134.12 65.96 Favored Pre-proline 0 CA--C 1.517 -0.307 0 CA-C-O 121.793 0.806 . . . . 0.0 112.092 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 31.3 Cg_exo -63.33 -42.09 23.89 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.047 2.498 . . . . 0.0 111.723 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.5 mm -139.59 119.16 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.628 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . 31.1 tp -128.6 142.39 51.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -171.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.16 120.29 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.658 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.626 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 8.9 m-85 -98.87 122.1 41.67 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.848 -0.533 . . . . 0.0 111.396 173.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.783 ' HE1' ' HD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -147.84 -155.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.748 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 57.1 tttp -99.31 121.37 40.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.618 -0.676 . . . . 0.0 109.321 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.36 121.51 7.01 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.246 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 37.9 t -125.77 140.65 37.14 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.38 -41.3 79.55 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.167 1.911 . . . . 0.0 111.665 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -74.44 -28.39 61.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.535 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.516 ' C ' HD21 ' A' ' 27' ' ' LEU . 3.5 tt -154.66 104.95 2.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.471 ' O ' ' SD ' ' A' ' 21' ' ' MET . 16.8 Cg_exo -72.29 35.47 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 114.476 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.464 ' H ' HD21 ' A' ' 27' ' ' LEU . 7.0 p -169.74 49.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.095 0.558 . . . . 0.0 111.187 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.697 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 51.3 t -54.76 -36.65 65.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.15 -137.69 0.17 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.166 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.457 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.1 m-85 -75.95 -18.61 59.27 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.504 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 35.8 t -64.75 -12.16 44.27 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.003 -0.436 . . . . 0.0 111.891 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.86 -42.4 26.53 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.559 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -80.24 -41.68 24.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.07 0.462 . . . . 0.0 110.263 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.62 96.65 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.682 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.726 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 13.9 p -56.66 -39.48 63.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.348 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.548 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.8 mm100 -68.91 -46.15 69.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB3' ' CG ' ' A' ' 91' ' ' TYR . . . -59.95 -42.8 94.86 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.294 0.371 . . . . 0.0 111.505 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD13 HD21 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -63.15 -55.11 27.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.412 0.625 . . . . 0.0 109.681 -176.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.16 69.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.478 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 -49.13 19.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.506 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.761 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.6 p -74.52 -53.36 9.62 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.457 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.5 -141.0 11.51 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.87 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 69.8 mm-40 -117.87 -152.15 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.832 0.453 . . . . 0.0 111.144 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' HE ' ' N ' ' A' ' 46' ' ' ARG . 3.4 mmp_? -65.44 158.23 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.46 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.726 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 17.0 p90 -154.35 159.07 40.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.551 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.86 154.09 17.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.805 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.783 ' HD1' ' HE1' ' A' ' 21' ' ' MET . 1.8 p90 -143.6 153.89 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -174.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.603 HG22 HD12 ' A' ' 18' ' ' LEU . 57.6 t -133.79 130.29 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.504 0.193 . . . . 0.0 110.56 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -74.49 131.9 41.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.485 0.659 . . . . 0.0 110.924 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 21' ' ' MET . 1.4 pp -147.85 -35.63 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.861 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.748 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -65.35 -11.62 43.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.412 167.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -97.52 -44.94 6.61 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.465 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.9 m-20 -82.25 118.12 70.83 Favored Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 122.192 -0.318 . . . . 0.0 110.437 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.69 -44.09 14.8 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.434 2.089 . . . . 0.0 113.756 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -72.53 -52.71 14.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.078 0.466 . . . . 0.0 111.573 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -62.46 -35.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.268 0.556 . . . . 0.0 110.424 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 62.4 ttp180 -52.89 -32.43 45.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.202 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.644 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -88.19 -41.53 12.91 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.576 -166.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 32.0 tp10 -78.79 -59.67 2.69 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -158.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 8' ' ' ILE . 1.9 pt? -68.11 -31.39 3.25 Favored Pre-proline 0 N--CA 1.474 0.726 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.705 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 18.5 Cg_endo -57.82 -43.44 49.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 121.103 1.43 . . . . 0.0 111.138 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 48.6 mtmt -55.68 -37.88 68.9 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.035 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.727 ' HE2' ' NE2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -65.21 -50.83 64.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.477 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB3' HD23 ' A' ' 80' ' ' LEU . . . -73.3 -55.7 6.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.379 -0.929 . . . . 0.0 112.935 -170.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.635 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 46.8 t30 -175.41 -52.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.211 1.005 . . . . 0.0 110.237 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.635 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -59.75 150.33 68.15 Favored Pre-proline 0 C--O 1.215 -0.743 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.936 -177.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -63.54 -36.76 52.05 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 121.954 1.769 . . . . 0.0 109.912 171.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -141.79 -124.28 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.003 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.819 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 25.7 m-85 -140.72 -165.61 0.1 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.819 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.1 Cg_endo -67.09 153.51 84.62 Favored 'Cis proline' 0 C--N 1.361 1.216 0 CA-C-N 121.691 1.64 . . . . 0.0 113.885 -1.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.581 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 70.6 mt-30 -143.21 135.19 26.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.706 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 40' ' ' LEU . 3.3 tm? -100.08 135.17 41.91 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.588 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.585 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 49.4 m95 -121.91 125.77 47.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.242 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 100' ' ' ILE . 58.5 t -105.91 119.04 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.554 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.1 t70 56.74 27.95 13.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 123.722 1.725 . . . . 0.0 108.622 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.07 29.3 54.38 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.375 -1.739 . . . . 0.0 113.044 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -124.68 130.97 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.322 . . . . 0.0 110.472 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.581 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 40.6 tp -68.95 127.31 32.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.406 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.764 HG13 HG23 ' A' ' 86' ' ' ILE . 87.3 t -105.28 -55.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.759 170.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.463 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 147.39 135.23 2.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.29 -65.52 1.52 Allowed Glycine 0 C--O 1.217 -0.943 0 C-N-CA 118.584 -1.77 . . . . 0.0 116.482 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 21.8 p -80.56 -68.05 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.76 1.28 . . . . 0.0 113.231 -171.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.26 -46.82 63.62 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.939 0.399 . . . . 0.0 111.244 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.764 HG23 HG13 ' A' ' 81' ' ' VAL . 46.1 mm -59.99 -44.79 95.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.013 -172.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 91' ' ' TYR . 56.0 t -58.27 -49.03 83.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.289 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.482 ' O ' ' HD2' ' A' ' 91' ' ' TYR . 39.4 mm -58.1 -53.21 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.41 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.722 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 87.8 tt0 -65.97 -47.43 74.64 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.882 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.733 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.2 mmt -58.62 -36.55 74.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.633 0.254 . . . . 0.0 111.057 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.587 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -58.03 -48.81 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 172.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.537 ' HG2' ' CD2' ' A' ' 91' ' ' TYR . 15.2 mm-40 -62.58 -43.75 98.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.013 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 44.4 mmm-85 -62.93 -33.99 76.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.777 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 96.13 -25.29 26.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.744 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.5 mt-10 -55.54 -35.53 65.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 63.6 tp -62.37 -54.66 37.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.761 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -63.49 -26.78 68.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.024 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.6 mm-40 -64.0 -46.63 83.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.132 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 46.4 mt -67.6 -44.75 77.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.903 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.594 HD12 HG21 ' A' ' 76' ' ' VAL . 50.0 mm -60.62 -46.26 96.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.482 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 113' ' ' ASP . 39.4 ttpt -59.06 -52.86 63.91 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.3 -43.14 82.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.259 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 46.7 m -72.07 -50.17 30.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.076 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.05 92.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.565 -177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.31 72.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.589 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.77 -29.58 51.03 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.959 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 62.9 m-85 -86.83 -49.54 7.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.005 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.813 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -96.03 119.82 35.21 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.148 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -54.32 117.04 2.96 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 52.07 37.49 21.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.245 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 60.6 mm-40 -80.46 123.65 82.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.634 174.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.1 Cg_endo -83.94 109.41 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.696 2.264 . . . . 0.0 112.45 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.63 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.2 m-20 . . . . . 0 C--N 1.321 -0.66 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.394 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.731 HG22 HE21 ' A' ' 9' ' ' GLN . 37.5 mt . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 96.1 mt-10 -49.27 -47.55 46.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.545 0.212 . . . . 0.0 111.556 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 19.2 ptpt -61.79 -43.42 98.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.612 0.72 . . . . 0.0 110.116 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.647 HD12 HD21 ' A' ' 62' ' ' LEU . 72.2 mt -66.26 -46.84 86.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.936 -174.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.731 HE21 HG22 ' A' ' 5' ' ' ILE . 72.1 mt-30 -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.549 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.532 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.0 mmp_? -59.89 -37.55 79.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.851 0.358 . . . . 0.0 110.361 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 51.7 tt0 -71.03 -49.21 47.41 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.15 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.805 HG23 ' HA2' ' A' ' 78' ' ' GLY . 17.3 mt -65.88 -39.52 84.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.667 0.746 . . . . 0.0 110.835 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 9' ' ' GLN . . . -62.7 -36.12 81.94 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.637 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 24.0 pt-20 -72.81 -39.24 66.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.661 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -76.58 134.18 69.8 Favored Pre-proline 0 CA--C 1.515 -0.384 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -176.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 20.1 Cg_endo -61.94 -40.84 40.89 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.158 2.572 . . . . 0.0 112.056 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.7 mm -139.27 120.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.661 HD22 ' OD1' ' A' ' 15' ' ' ASN . 28.1 tp -132.02 143.14 49.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.376 0.608 . . . . 0.0 111.414 -173.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.86 HD23 ' HE3' ' A' ' 21' ' ' MET . 16.1 tp -138.95 120.6 15.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.362 -176.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.653 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -96.66 124.5 40.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.752 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.861 ' HE2' ' HB2' ' A' ' 33' ' ' SER . 8.0 ptp -145.26 -171.09 3.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.524 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.809 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.3 tttm -95.97 140.62 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -138.67 129.5 4.52 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 118.941 -1.6 . . . . 0.0 113.696 -165.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.409 ' HB3' ' HG ' ' A' ' 30' ' ' CYS . 80.1 p -150.43 142.72 15.82 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.0 -38.99 60.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.598 2.199 . . . . 0.0 112.025 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -62.99 -33.08 74.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.325 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' SER . 2.9 tt -160.02 108.7 1.42 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.85 19.97 0.18 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.239 1.959 . . . . 0.0 114.34 -174.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.809 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 13.5 p -164.22 49.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.287 0.565 . . . . 0.0 111.532 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.749 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 3.6 p -65.83 54.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.65 -137.58 2.24 Favored Glycine 0 C--N 1.321 -0.267 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.8 -39.67 61.57 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.761 0.791 . . . . 0.0 108.952 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.861 ' HB2' ' HE2' ' A' ' 21' ' ' MET . 20.6 p -48.1 -24.14 1.03 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.695 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -51.52 -41.76 61.25 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.286 0.366 . . . . 0.0 111.652 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -33.24 43.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.352 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.17 66.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.132 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.807 ' HB ' ' HE1' ' A' ' 21' ' ' MET . 8.5 p -52.25 -38.12 24.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.7 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.576 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 1.1 mm100 -62.25 -46.94 86.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.819 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 91' ' ' TYR . . . -60.61 -43.84 97.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.087 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.546 HD22 ' C ' ' A' ' 40' ' ' LEU . 1.5 tt -61.85 -55.15 32.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -176.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.36 76.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.441 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 38' ' ' GLN . . . -67.77 -49.59 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.37 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.744 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.5 m -72.84 -56.02 5.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.49 -134.85 8.63 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.153 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.4 mm-40 -140.88 -152.17 0.4 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.822 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.494 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 28.8 mmm180 -58.15 143.67 43.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.823 0.82 . . . . 0.0 112.636 -169.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.649 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 16.6 p90 -152.93 156.42 38.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.878 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.45 146.87 25.31 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.1 p90 -136.83 150.21 48.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.588 HG22 HD12 ' A' ' 18' ' ' LEU . 48.3 t -127.6 127.66 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.631 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.8 p30 -77.9 133.9 38.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.293 0.568 . . . . 0.0 109.83 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.653 HG12 ' HD2' ' A' ' 20' ' ' TYR . 1.1 pp -148.1 -32.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.264 -171.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.757 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -66.54 -11.09 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.098 167.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.38 -43.27 8.46 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.07 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -77.63 123.99 86.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 121.026 0.441 . . . . 0.0 110.925 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.32 -42.94 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.373 2.049 . . . . 0.0 113.523 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -82.94 -50.89 8.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.672 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.473 HG21 ' CG2' ' A' ' 52' ' ' ILE . 36.0 mt -56.8 -37.11 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.249 0.547 . . . . 0.0 110.635 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.611 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 58.7 ttp180 -53.16 -31.24 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.158 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.35 -35.98 19.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -78.27 -61.14 2.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -162.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.669 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 1.9 pt? -76.8 -31.88 0.96 Allowed Pre-proline 0 N--CA 1.472 0.626 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.818 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 11.7 Cg_endo -55.21 -39.7 89.59 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 CA-C-N 120.917 1.363 . . . . 0.0 110.53 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -53.91 -41.36 67.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.543 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.602 ' HH ' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -68.56 -41.9 79.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.461 -178.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.6 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . . . -73.49 -58.32 3.39 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.988 -176.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.439 ' HB2' ' CE3' ' A' ' 68' ' ' TRP . 24.4 m-20 -173.27 -57.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.052 0.93 . . . . 0.0 109.539 168.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 63' ' ' PRO . 1.2 m-90 -53.88 147.8 22.62 Favored Pre-proline 0 C--O 1.215 -0.713 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.381 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.7 -36.21 53.47 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.289 1.993 . . . . 0.0 110.096 171.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -142.04 -127.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.372 -1.286 . . . . 0.0 109.698 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.93 ' HD2' ' HG2' ' A' ' 73' ' ' GLN . 36.0 m-85 -142.78 -170.63 0.24 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.9 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 38.4 Cg_endo -68.34 157.76 87.22 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 120.981 1.386 . . . . 0.0 114.525 -1.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.93 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.7 pt20 -148.57 133.72 18.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.741 174.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.506 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -95.38 138.37 33.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.999 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.764 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 56.1 m95 -127.07 126.93 43.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.497 0.665 . . . . 0.0 110.894 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.897 HG22 HD13 ' A' ' 100' ' ' ILE . 50.2 t -106.28 114.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.483 -0.781 . . . . 0.0 108.919 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.528 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 25.1 t70 54.42 32.08 15.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 123.108 1.432 . . . . 0.0 110.364 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 79.7 28.74 50.41 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 113.789 -1.551 . . . . 0.0 113.565 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -127.29 131.3 50.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.904 173.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.558 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.5 tp -68.95 130.2 42.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.607 -174.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.443 ' O ' HG21 ' A' ' 86' ' ' ILE . 91.7 t -107.09 -54.11 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.447 168.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 87' ' ' VAL . . . 144.88 132.82 2.55 Favored Glycine 0 C--O 1.22 -0.761 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.56 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.13 -62.43 1.66 Allowed Glycine 0 C--O 1.221 -0.678 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.863 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.2 p -77.18 -67.6 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.798 -0.825 . . . . 0.0 112.557 -171.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -73.6 -48.77 30.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.488 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 43.1 mm -61.92 -42.27 94.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.382 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 82' ' ' GLY . 65.6 t -58.74 -48.22 86.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.792 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.554 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.0 mm -60.9 -47.31 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.595 0.236 . . . . 0.0 110.831 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.75 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.9 tt0 -59.79 -55.21 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.651 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.584 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -60.07 -35.67 75.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.35 0.26 . . . . 0.0 111.276 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.744 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 17.7 t80 -56.79 -50.96 70.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.848 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -63.76 -40.68 97.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.75 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.1 mmm-85 -63.63 -33.94 76.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.15 -24.39 25.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.169 -171.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.564 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.7 mt-10 -58.22 -27.23 63.74 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.584 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 6.2 tt -60.44 -58.95 6.33 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.707 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.5 pt20 -60.27 -27.04 66.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.35 176.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.2 mm100 -65.07 -55.66 17.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 96' ' ' LEU . 2.5 pp -70.76 -32.34 69.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.665 177.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.897 HD13 HG22 ' A' ' 76' ' ' VAL . 34.3 mm -64.57 -48.23 85.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.254 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' O ' ' HB1' ' A' ' 105' ' ' ALA . 39.1 ttpt -56.81 -52.05 66.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.369 -176.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.91 -44.58 78.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 32.6 m -71.0 -50.55 32.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.613 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.48 93.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.537 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 101' ' ' LYS . . . -60.18 -41.72 93.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -176.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.885 ' HZ2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -73.46 -26.86 61.11 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.985 -178.33 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.479 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 43.0 m-85 -87.68 -47.21 8.84 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.092 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.624 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -75.71 -158.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 6.2 p -76.18 -167.36 0.74 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.674 165.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.71 57.34 0.13 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -73.12 124.63 90.84 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.359 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -96.44 53.03 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.962 3.108 . . . . 0.0 113.991 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.517 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 28.6 m-20 . . . . . 0 C--N 1.313 -1.007 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -171.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.638 ' CG2' HE21 ' A' ' 9' ' ' GLN . 44.4 mt . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 54.3 mt-10 -55.55 -47.42 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.582 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -62.68 -43.51 98.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 110.648 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 62' ' ' LEU . 75.5 mt -60.95 -45.77 97.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.929 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.638 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.6 mt-30 -64.92 -33.26 75.6 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.365 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 4.3 mmp_? -55.94 -42.26 75.9 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -69.14 -44.35 72.51 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.953 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.417 HG22 ' HA2' ' A' ' 78' ' ' GLY . 19.9 mt -65.56 -43.34 94.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.442 0.639 . . . . 0.0 110.171 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.47 68.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.481 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 32.0 mt-10 -62.18 -46.65 87.99 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.077 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -78.45 125.17 85.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.231 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 37.3 Cg_endo -66.25 -42.0 11.39 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.467 2.111 . . . . 0.0 112.21 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.423 HG21 ' HB2' ' A' ' 47' ' ' PHE . 27.5 mm -127.12 119.82 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 50' ' ' VAL . 21.5 tp -133.59 141.34 47.63 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.98 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.3 tp -138.27 120.1 15.32 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.306 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.642 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.8 m-85 -97.28 120.53 37.81 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.582 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.577 ' O ' HD11 ' A' ' 52' ' ' ILE . 20.0 ptt? -146.6 -163.77 1.83 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 29.2 tptp -96.73 127.63 42.91 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.144 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.37 125.46 8.38 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.618 -1.753 . . . . 0.0 111.74 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 46.4 t -138.5 141.22 30.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -54.01 -41.09 78.14 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.246 1.964 . . . . 0.0 111.453 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -71.71 -28.48 63.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.894 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 24' ' ' SER . 2.2 tt -161.5 121.72 1.55 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.42 ' N ' HD22 ' A' ' 27' ' ' LEU . 50.1 Cg_endo -71.71 29.38 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.277 1.984 . . . . 0.0 113.307 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.62 ' OG ' ' HB3' ' A' ' 33' ' ' SER . 11.8 t -165.78 54.69 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 42.7 t -55.59 -36.88 67.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.698 -173.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.626 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -73.42 -138.68 0.37 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 36.4 m-85 -77.58 -20.87 53.31 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.635 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 32.8 t -69.02 -10.21 56.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.423 -0.798 . . . . 0.0 111.083 -174.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.26 -40.84 17.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.542 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.94 -38.04 38.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 178.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.86 91.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.931 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 8.7 p -56.19 -36.47 45.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.887 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 2.1 mm100 -67.73 -42.07 82.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.719 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 87' ' ' VAL . . . -57.27 -48.08 79.81 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.07 0.231 . . . . 0.0 111.183 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.533 HD12 HD23 ' A' ' 74' ' ' LEU . 9.9 mt -58.97 -62.29 1.99 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.952 0.882 . . . . 0.0 112.567 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.19 -28.51 58.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.134 -176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 38' ' ' GLN . . . -74.51 -56.32 4.96 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.319 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.955 ' SG ' ' HB3' ' A' ' 97' ' ' GLN . 42.6 t -72.21 -59.13 2.89 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.815 -167.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -103.12 -125.59 5.68 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.354 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.11 -148.34 0.24 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.483 -0.859 . . . . 0.0 111.49 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -61.46 143.24 56.21 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.992 0.901 . . . . 0.0 112.119 -165.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 14.6 p90 -154.21 152.45 30.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.963 -1.472 . . . . 0.0 109.039 -173.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.59 149.66 23.04 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.372 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -134.34 151.12 51.05 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.593 HG22 HD12 ' A' ' 18' ' ' LEU . 61.9 t -127.16 128.19 70.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.869 0.366 . . . . 0.0 110.099 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.1 p30 -75.65 130.61 39.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.739 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.642 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.2 pp -146.1 -34.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.751 -173.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -63.05 -14.5 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.906 167.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -95.15 -42.9 8.35 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.778 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.6 m-20 -79.2 122.34 84.12 Favored Pre-proline 0 N--CA 1.472 0.635 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.91 -44.72 9.5 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.147 1.898 . . . . 0.0 113.118 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -75.74 -47.68 24.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.2 -38.25 81.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.176 0.512 . . . . 0.0 110.487 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.581 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 77.4 ttt180 -50.88 -36.3 37.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.212 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.559 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -83.84 -42.19 16.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 50.3 mm-40 -78.0 -59.31 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -161.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.806 ' HB3' HD12 ' A' ' 8' ' ' ILE . 2.2 pt? -70.45 -32.59 2.74 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.3 Cg_endo -53.68 -42.25 67.61 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.324 1.349 . . . . 0.0 111.415 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 46.2 mtmt -54.57 -38.87 67.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.709 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -69.26 -41.09 77.37 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.144 -179.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . . . -78.74 -57.35 3.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.583 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.6 t30 -175.0 -53.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 0.0 110.084 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.679 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -59.62 150.48 66.32 Favored Pre-proline 0 C--O 1.215 -0.746 0 CA-C-N 113.347 -1.752 . . . . 0.0 113.058 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.77 -33.81 42.62 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 121.828 1.685 . . . . 0.0 110.235 171.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 50.7 p -142.47 -124.2 0.09 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.083 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.895 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 55.0 m-85 -141.8 -167.51 0.15 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.895 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 56.9 Cg_endo -68.77 153.42 90.27 Favored 'Cis proline' 0 C--N 1.36 1.179 0 CA-C-N 121.631 1.618 . . . . 0.0 114.107 -1.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.618 HE22 ' HA ' ' A' ' 63' ' ' PRO . 58.2 mt-30 -145.27 133.32 21.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 40' ' ' LEU . 3.2 tm? -95.56 137.46 34.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.806 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 61.2 m95 -122.4 127.42 49.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 1.027 HG22 HD11 ' A' ' 100' ' ' ILE . 46.4 t -106.02 115.2 47.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.602 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 28.5 t70 55.9 32.65 20.14 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 123.251 1.5 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.69 28.54 60.97 Favored Glycine 0 C--N 1.308 -0.988 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.989 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -124.69 129.75 51.1 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.175 0.19 . . . . 0.0 110.778 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 51.8 tp -69.94 136.59 50.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 86' ' ' ILE . 92.5 t -119.31 -53.8 3.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.94 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 147.12 137.0 2.91 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 87' ' ' VAL . . . -84.62 -65.82 1.49 Allowed Glycine 0 C--O 1.216 -0.98 0 C-N-CA 118.929 -1.605 . . . . 0.0 116.338 -168.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 1.9 p -79.33 -69.29 0.59 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.744 1.272 . . . . 0.0 113.388 -173.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.56 -48.4 64.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.415 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.598 HG22 HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.81 -46.8 93.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.642 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 83' ' ' GLY . 77.3 t -58.23 -50.48 78.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.082 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 39.0 mm -56.04 -51.24 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.221 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.702 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.2 tt0 -62.59 -49.79 73.83 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.317 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.899 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 96.3 mmm -59.86 -38.36 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.636 ' HD1' ' HB2' ' A' ' 43' ' ' CYS . 3.0 t80 -60.05 -46.35 89.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.158 0.583 . . . . 0.0 110.475 173.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.2 mt-30 -64.59 -40.16 95.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.779 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 29.0 mmm180 -59.01 -33.87 71.21 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.053 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.25 20.16 79.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.313 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.626 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 53.7 mt-10 -98.8 -24.58 14.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.106 0.479 . . . . 0.0 111.28 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.899 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 23.5 tp -75.2 -43.23 53.17 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.955 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 5.2 pt20 -57.99 -26.9 62.97 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.266 170.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 3.3 mm100 -72.95 -48.03 40.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 39.7 mt -66.33 -48.0 71.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.741 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 1.027 HD11 HG22 ' A' ' 76' ' ' VAL . 26.5 mm -62.04 -47.14 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.162 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -55.67 -47.25 77.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 123.253 0.345 . . . . 0.0 111.795 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.07 -46.81 78.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.008 0.432 . . . . 0.0 109.922 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.602 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 89.7 m -68.45 -54.69 15.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.164 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.567 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.66 -49.93 74.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.992 -174.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.86 -41.24 82.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.43 -24.5 61.23 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.423 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.462 ' HE2' HG23 ' A' ' 103' ' ' THR . 35.5 m-85 -88.53 -41.7 12.55 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.688 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 108' ' ' LYS . 9.5 mmpt? -72.99 -156.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.56 0.695 . . . . 0.0 109.849 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 111' ' ' GLU . 35.7 t -82.22 -146.27 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.722 170.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -79.93 44.68 0.67 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.33 0.586 . . . . 0.0 109.467 169.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 50.5 mm-40 -73.63 135.02 78.49 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.311 -172.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.95 42.86 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.69 2.927 . . . . 0.0 114.188 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 123.672 0.789 . . . . 0.0 112.935 179.465 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 m -62.63 123.74 19.16 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.6 t -72.97 46.4 0.17 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.44 0.638 . . . . 0.0 111.918 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 8' ' ' ILE . 10.2 t -168.03 -46.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.855 -0.528 . . . . 0.0 111.088 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.651 ' CG2' HE21 ' A' ' 9' ' ' GLN . 48.2 mt -58.02 -40.27 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 118.005 0.366 . . . . 0.0 111.647 176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.37 -44.3 84.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.27 -47.34 77.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.162 174.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.78 HD11 ' HB2' ' A' ' 62' ' ' LEU . 84.4 mt -57.8 -44.63 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.249 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.651 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.9 mt-30 -61.87 -40.38 95.16 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.594 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.2 mmp_? -60.86 -36.47 79.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 73.5 mt-30 -71.79 -45.12 62.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.415 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.834 HG21 ' HA2' ' A' ' 78' ' ' GLY . 27.2 mt -63.4 -44.28 98.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.095 0.474 . . . . 0.0 110.107 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.14 96.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 11.9 pt-20 -69.23 -37.48 78.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.694 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.33 126.42 86.45 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 121.315 0.579 . . . . 0.0 110.615 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 52.5 Cg_exo -62.1 -42.22 31.0 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 112.82 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.3 mm -136.75 119.48 20.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 18.0 tp -132.8 139.95 47.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.345 -170.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.4 tp -136.39 122.98 20.95 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.02 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.642 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.0 m-85 -98.95 118.06 34.87 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.491 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.9 ptt? -145.99 -166.18 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.662 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.068 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.9 tttt -99.61 118.48 36.24 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.467 -0.771 . . . . 0.0 110.079 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.93 68.46 1.02 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.096 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.4 m -77.71 139.24 62.47 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -53.68 -41.28 75.32 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.086 1.857 . . . . 0.0 111.724 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.87 -35.67 81.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.881 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -154.93 111.38 2.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.408 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 39.0 Cg_endo -74.41 32.29 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.654 2.236 . . . . 0.0 113.868 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -165.07 46.52 0.09 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.163 0.506 . . . . 0.0 110.132 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.77 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 37.5 t -71.65 66.97 0.54 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.158 -173.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.91 -140.81 3.08 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -76.91 -33.79 57.75 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.145 0.498 . . . . 0.0 110.699 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.831 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 15.1 p -49.88 -21.06 1.03 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.592 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.18 -42.73 30.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' A' ' 36' ' ' ALA . 1.7 pm0 -80.47 -34.94 35.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.233 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . . . -69.46 -43.08 73.98 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.526 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 7.9 p -53.38 -37.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.108 0.48 . . . . 0.0 110.729 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.516 ' HA ' HE21 ' A' ' 38' ' ' GLN . 0.9 OUTLIER -63.13 -46.18 88.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.842 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . . . -60.9 -44.41 97.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.876 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -60.65 -55.48 32.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 109.675 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.75 70.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.476 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 38' ' ' GLN . . . -71.93 -48.34 46.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.727 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.83 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.3 m -68.62 -57.42 5.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.83 -147.59 20.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.452 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 50.0 mm-40 -100.36 -153.58 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.53 0.681 . . . . 0.0 111.184 174.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.05 154.16 42.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.872 177.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CE1' HD22 ' A' ' 19' ' ' LEU . 17.4 p90 -145.97 158.89 43.86 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.006 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.57 146.34 25.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -137.72 149.16 46.26 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -122.63 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' MET . 10.5 p-10 -74.11 130.33 39.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.081 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.642 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -146.68 -34.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.651 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 1.068 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -63.4 -13.2 37.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.518 171.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.47 -45.44 6.76 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.347 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -76.31 116.02 52.38 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.953 0.342 . . . . 0.0 110.742 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.74 -45.18 26.4 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.0 2.467 . . . . 0.0 113.608 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.41 -54.33 14.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.507 0.67 . . . . 0.0 111.126 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.652 HG21 HD12 ' A' ' 8' ' ' ILE . 36.2 mt -63.6 -35.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.2 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.702 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 61.9 ttt-85 -57.61 -33.36 68.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.095 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -90.62 -52.68 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.62 -54.63 5.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -168.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.792 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -55.22 -44.39 99.6 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.702 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 22.1 Cg_endo -58.13 -41.74 64.4 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 121.465 1.444 . . . . 0.0 111.447 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.606 ' HZ2' ' HB2' ' A' ' 64' ' ' LYS . 10.6 mtmp? -61.1 -32.37 72.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.751 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.523 ' CD2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -63.15 -43.2 99.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.574 ' HB3' HD22 ' A' ' 80' ' ' LEU . . . -78.16 -57.66 3.67 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.404 -0.918 . . . . 0.0 112.389 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.506 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 41.5 t30 -174.73 -54.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.784 0.802 . . . . 0.0 110.323 168.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.558 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -55.6 148.58 34.3 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.835 -1.53 . . . . 0.0 113.274 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -61.62 -38.96 57.84 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.461 2.107 . . . . 0.0 110.459 172.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -143.06 -127.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.253 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.876 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 47.8 m-85 -138.15 -170.99 0.25 Allowed Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.876 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.6 Cg_endo -67.17 155.57 84.83 Favored 'Cis proline' 0 C--N 1.352 0.757 0 CA-C-N 121.132 1.44 . . . . 0.0 114.613 -0.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.476 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 59.3 mt-30 -147.51 132.66 18.33 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.429 173.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.528 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -95.85 138.56 33.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.987 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.559 ' CZ2' ' HB1' ' A' ' 66' ' ' ALA . 55.9 m95 -125.06 127.47 46.99 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.18 0.514 . . . . 0.0 110.73 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.901 HG22 HD12 ' A' ' 100' ' ' ILE . 65.4 t -111.61 121.16 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 176.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' CG ' ' HH ' ' A' ' 107' ' ' TYR . 10.2 t70 57.15 29.12 16.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.507 1.622 . . . . 0.0 108.691 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.834 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 73.41 29.11 64.52 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 113.6 -1.637 . . . . 0.0 113.152 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.57 132.15 51.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 110.807 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 66' ' ' ALA . 54.0 tp -65.71 132.42 48.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.801 -172.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.1 t -110.49 -53.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.199 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 142.19 135.11 3.05 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.36 -62.25 1.66 Allowed Glycine 0 C--O 1.223 -0.584 0 C-N-CA 119.525 -1.322 . . . . 0.0 116.232 -168.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -78.01 -70.76 0.46 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -168.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -80.19 -40.59 26.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.447 HG13 ' HA3' ' A' ' 82' ' ' GLY . 48.3 mm -55.9 -45.64 79.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.265 -174.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 82' ' ' GLY . 86.0 t -59.26 -49.24 84.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.206 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' A' ' 91' ' ' TYR . 39.6 mm -60.28 -48.79 86.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.456 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.743 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 40.0 tt0 -61.63 -53.28 58.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.69 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.553 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 80.8 mtp -62.64 -30.61 71.49 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.783 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 14.1 t80 -57.34 -52.24 66.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.69 170.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -63.55 -40.59 97.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.101 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 46.3 mmm-85 -59.62 -33.95 72.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.363 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 90.28 -24.66 15.31 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.286 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.655 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 91.0 mt-10 -60.07 -29.78 68.79 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 6.5 tt -61.74 -54.5 41.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.071 0.463 . . . . 0.0 110.208 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.83 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.1 pt20 -63.86 -26.58 68.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.775 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 90.9 mm-40 -62.9 -44.82 95.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 24.5 mt -69.9 -46.83 64.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.178 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.901 HD12 HG22 ' A' ' 76' ' ' VAL . 47.7 mm -60.62 -46.31 95.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.679 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.882 ' HD3' ' H ' ' A' ' 115' ' ' GLU . 38.7 ttpt -55.54 -53.59 54.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.193 0.308 . . . . 0.0 111.424 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.85 -44.48 93.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.119 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 77' ' ' ASP . 61.9 m -63.29 -47.14 83.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.645 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.612 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.11 -45.15 94.74 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.389 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.2 95.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.551 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -33.19 71.23 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.841 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.578 ' HH ' ' CG ' ' A' ' 77' ' ' ASP . 58.0 m-85 -78.68 -47.29 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.612 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -100.38 -147.32 0.35 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 51.6 p -74.45 -155.62 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.969 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 110' ' ' GLU . 4.1 mm-40 -75.3 57.16 0.87 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.809 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.31 114.18 6.77 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.158 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -95.59 47.31 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 122.699 2.266 . . . . 0.0 112.919 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.487 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 7.6 m-20 -52.35 -66.64 0.35 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.143 -168.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.634 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -77.97 -52.19 9.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.305 0.574 . . . . 0.0 110.682 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.882 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 39.6 tt0 . . . . . 0 C--O 1.253 1.289 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.971 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtm . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p -168.01 138.37 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.945 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -72.4 125.05 26.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.787 ' HB ' ' HG2' ' A' ' 6' ' ' GLU . 41.0 p -73.3 131.0 41.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.068 0.461 . . . . 0.0 111.134 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.673 ' CG2' HE21 ' A' ' 9' ' ' GLN . 33.5 mt -60.11 -32.16 49.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.249 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.787 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 10.8 pt-20 -53.3 -44.51 68.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.336 176.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.719 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.1 ptmt -76.05 -38.41 57.17 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.498 HG23 HD13 ' A' ' 62' ' ' LEU . 75.1 mt -58.63 -46.9 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.914 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.673 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.0 mt-30 -62.3 -40.48 96.44 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.76 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -60.39 -35.56 76.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.79 0.329 . . . . 0.0 110.668 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.94 -44.35 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.774 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.603 HG21 HD23 ' A' ' 18' ' ' LEU . 28.9 mt -67.23 -47.34 81.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.529 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -59.42 -39.35 83.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.85 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.79 -30.63 70.12 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.946 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.31 126.77 86.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.069 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.46 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 52.7 Cg_exo -61.92 -42.95 27.68 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.849 2.366 . . . . 0.0 112.431 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.2 mm -137.37 121.1 22.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.603 HD23 HG21 ' A' ' 12' ' ' ILE . 24.5 tp -133.04 141.21 48.12 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.64 -170.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.546 HD23 ' CE1' ' A' ' 47' ' ' PHE . 12.8 tp -137.39 119.0 14.93 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.986 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.584 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.8 m-85 -96.51 119.6 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.036 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 23.2 ptt? -145.92 -166.99 2.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.417 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 86.9 tttt -95.76 90.04 5.52 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -91.84 67.69 2.1 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.463 -170.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -77.87 146.55 72.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.366 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.76 -39.78 89.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.995 1.797 . . . . 0.0 111.066 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.57 -34.36 77.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.617 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 30' ' ' CYS . 1.8 tt -161.42 112.59 1.24 Allowed Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.462 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -69.56 14.3 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.807 2.338 . . . . 0.0 114.11 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.667 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 24.8 p -163.21 47.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.31 0.576 . . . . 0.0 110.613 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.684 ' HA ' HD12 ' A' ' 27' ' ' LEU . 48.0 t -56.46 -40.63 75.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.658 -173.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.59 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.33 -134.48 0.13 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.237 -0.506 . . . . 0.0 114.275 -175.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 41.6 m-85 -74.23 -18.01 60.81 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 121.057 0.456 . . . . 0.0 111.872 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.474 ' HG ' ' HB2' ' A' ' 29' ' ' SER . 8.4 p -63.78 -19.5 65.04 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.9 -42.84 13.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.58 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.85 -38.88 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.299 0.571 . . . . 0.0 110.198 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . . . -63.32 -46.03 88.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.909 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.479 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 9.3 p -55.23 -39.18 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.523 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 1.7 mm100 -67.02 -48.71 67.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . . . -58.29 -45.12 88.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.89 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.497 HD13 ' CD2' ' A' ' 74' ' ' LEU . 1.3 tt -61.18 -55.38 32.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.232 0.539 . . . . 0.0 110.197 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.02 -32.35 71.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.175 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 38' ' ' GLN . . . -70.62 -47.52 59.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.664 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.3 p -77.16 -51.44 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.846 0.355 . . . . 0.0 111.098 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.78 -134.68 8.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.831 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 108' ' ' LYS . 10.4 pt-20 -128.25 -152.12 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.561 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 36.8 mmt180 -64.8 150.42 47.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.543 0.687 . . . . 0.0 112.777 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.546 ' CE1' HD23 ' A' ' 19' ' ' LEU . 16.5 p90 -149.4 157.35 43.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.732 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.25 146.94 25.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -137.7 153.36 49.79 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.4 t -130.18 129.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.528 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -74.62 135.2 42.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 21' ' ' MET . 1.1 pp -151.63 -37.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.522 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.729 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -64.39 -11.44 32.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.726 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.57 -41.77 8.76 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.504 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 74.7 m-20 -76.76 131.64 73.32 Favored Pre-proline 0 N--CA 1.473 0.712 0 O-C-N 122.241 -0.287 . . . . 0.0 110.376 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 16.6 Cg_exo -68.3 -44.45 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.468 2.112 . . . . 0.0 112.421 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.571 ' OD1' HG13 ' A' ' 58' ' ' ILE . 1.3 p30 -77.78 -56.0 4.87 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.571 HG13 ' OD1' ' A' ' 57' ' ' ASP . 48.7 mt -60.42 -32.88 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.45 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.554 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 80.0 ttt180 -51.63 -36.25 45.17 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.222 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.39 -44.64 11.89 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -77.32 -60.23 2.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -160.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.691 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 2.0 pt? -69.14 -31.81 2.95 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 14.1 Cg_endo -54.93 -41.36 79.37 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.533 1.489 . . . . 0.0 110.509 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.64 -39.4 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.494 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.531 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -70.83 -42.48 70.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.038 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.69 -57.99 3.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.484 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.713 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.9 t-20 -175.89 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 122.102 0.953 . . . . 0.0 109.407 169.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.713 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -57.32 148.53 52.95 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.209 -1.814 . . . . 0.0 113.328 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -62.85 -35.98 64.27 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.279 1.986 . . . . 0.0 110.314 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 p -143.19 -128.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.036 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.844 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.8 m-85 -139.09 -167.85 0.17 Allowed Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 48.4 Cg_endo -67.42 151.12 84.17 Favored 'Cis proline' 0 C--N 1.359 1.091 0 CA-C-N 121.318 1.507 . . . . 0.0 114.006 -1.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.697 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 19.3 mt-30 -139.15 132.57 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.188 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.497 ' CD2' HD13 ' A' ' 40' ' ' LEU . 3.3 tm? -95.75 137.23 35.11 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 67.9 m95 -122.99 132.48 54.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 110.92 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.736 HG21 HD11 ' A' ' 99' ' ' LEU . 58.0 t -118.54 119.73 62.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.483 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' HB2' HG22 ' A' ' 103' ' ' THR . 33.3 t70 56.68 25.53 10.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.857 1.313 . . . . 0.0 110.02 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.531 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 80.49 28.4 47.99 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.135 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.11 135.58 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.996 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.614 HD23 ' CZ3' ' A' ' 68' ' ' TRP . 53.1 tp -70.97 129.16 38.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.261 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 86' ' ' ILE . 98.5 t -105.62 -54.74 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.824 170.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.493 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 141.01 133.4 2.93 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -86.11 -64.84 1.45 Allowed Glycine 0 C--O 1.217 -0.907 0 C-N-CA 119.046 -1.549 . . . . 0.0 116.436 -167.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 18.4 p -78.94 -59.61 2.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.21 1.005 . . . . 0.0 113.031 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.3 -46.11 21.0 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 120.886 0.374 . . . . 0.0 111.0 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.493 HG13 ' HA3' ' A' ' 82' ' ' GLY . 46.0 mm -63.4 -42.69 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.73 -171.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 83' ' ' GLY . 71.6 t -59.5 -48.35 87.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.141 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.1 mm -59.03 -49.01 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.75 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 39.7 tt0 -61.61 -54.49 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.679 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.592 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -56.21 -36.27 68.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.536 0.208 . . . . 0.0 111.412 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.0 t80 -59.6 -50.85 72.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.062 174.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.6 mt-30 -66.01 -44.02 85.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.75 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.9 mmm-85 -58.93 -33.71 70.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.23 21.67 64.54 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.567 -1.197 . . . . 0.0 112.152 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.3 mt-10 -88.35 -29.4 20.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.379 0.609 . . . . 0.0 110.851 173.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 60.3 tp -62.16 -55.0 33.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.048 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.791 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 16.3 pt20 -59.22 -26.26 64.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.632 174.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.1 mm-40 -68.81 -55.14 12.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.801 0.334 . . . . 0.0 111.404 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.736 HD11 HG21 ' A' ' 76' ' ' VAL . 2.3 pp -71.19 -36.09 71.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.044 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 76' ' ' VAL . 46.2 mm -62.31 -44.67 99.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 113' ' ' ASP . 21.9 ttmt -49.29 -57.6 6.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.51 0.672 . . . . 0.0 111.793 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 88.2 tt0 -62.15 -46.09 90.55 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.528 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.539 HG22 ' HB2' ' A' ' 77' ' ' ASP . 86.6 m -67.22 -49.73 63.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 100' ' ' ILE . . . -58.93 -45.97 89.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.581 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.73 91.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -67.3 -26.79 66.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.79 -177.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.518 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 37.8 m-85 -79.19 -46.61 17.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.204 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 45' ' ' GLU . 48.0 mtmt -91.94 -158.27 0.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.308 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 p -84.84 55.25 3.37 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.353 1.073 . . . . 0.0 112.015 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 53.86 47.23 24.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.319 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 40.0 mm-40 -62.44 136.34 95.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.585 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.39 132.25 20.41 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.084 2.523 . . . . 0.0 112.401 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.672 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 10.9 t70 -120.69 -104.96 0.39 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.672 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.791 ' HB1' ' HB2' ' A' ' 97' ' ' GLN . . . -64.25 -33.03 74.87 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.481 0.658 . . . . 0.0 110.182 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.861 -172.798 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ppp? . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 4' ' ' THR . 32.7 p -79.12 -125.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.614 171.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 3' ' ' THR . 31.0 m 74.17 -24.18 0.21 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.772 0.429 . . . . 0.0 112.062 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.721 HG23 HD11 ' A' ' 8' ' ' ILE . 31.7 m -51.57 -49.6 61.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.542 0.337 . . . . 0.0 111.32 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.696 ' CG2' HE21 ' A' ' 9' ' ' GLN . 65.1 mt -60.43 -37.46 74.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 52.6 mm-40 -53.96 -47.62 71.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -67.12 -43.93 81.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.283 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 62' ' ' LEU . 81.4 mt -59.23 -44.48 92.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.696 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.3 mt-30 -61.34 -43.46 98.83 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.486 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.566 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.3 mmp_? -61.15 -35.84 78.17 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -68.08 -45.75 72.92 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.538 HG23 HD22 ' A' ' 18' ' ' LEU . 41.3 mt -63.55 -41.14 91.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.918 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -34.27 71.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.347 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 72.8 mt-10 -59.84 -50.42 73.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.898 0.38 . . . . 0.0 111.07 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -79.33 128.81 74.3 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.111 -171.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.8 Cg_exo -59.05 -42.6 49.86 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 123.144 2.563 . . . . 0.0 112.03 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.6 mm -133.88 122.64 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.591 ' CD2' ' HE1' ' A' ' 20' ' ' TYR . 20.8 tp -133.87 141.7 47.49 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.2 -171.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.4 tp -136.61 119.87 16.75 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.096 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.591 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 6.2 m-85 -98.26 119.33 36.74 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.795 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.628 ' O ' HD12 ' A' ' 52' ' ' ILE . 23.0 ptt? -146.19 -166.81 2.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.206 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.857 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 84.4 tttt -96.57 144.74 26.35 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.66 121.2 3.55 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.508 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.554 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 41.5 t -132.93 144.87 54.66 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.59 -39.89 86.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.475 2.117 . . . . 0.0 111.277 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -68.43 -34.34 75.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.496 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 29' ' ' SER . 2.7 tt -158.09 117.56 1.87 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -74.99 26.3 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.5 2.134 . . . . 0.0 114.434 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.1 p -164.33 49.86 0.12 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.529 0.681 . . . . 0.0 111.448 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.731 ' HG ' ' HG2' ' A' ' 22' ' ' LYS . 1.6 p -67.06 61.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.426 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.81 -138.69 2.57 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.504 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 42.9 m-85 -76.9 -19.86 56.92 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.522 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 25.8 p -69.52 -15.2 63.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -46.95 -42.12 17.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.586 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.74 -40.87 32.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.085 0.469 . . . . 0.0 110.438 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -61.96 -43.84 97.99 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.922 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 47' ' ' PHE . 11.4 p -55.8 -38.49 51.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.583 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.567 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 1.7 mm100 -68.13 -46.01 72.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.367 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 88' ' ' ILE . . . -58.36 -45.41 88.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.548 HD11 ' CD2' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -63.42 -55.43 24.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.164 0.507 . . . . 0.0 110.364 -175.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.34 70.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 38' ' ' GLN . . . -70.05 -48.63 57.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.312 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -73.3 -58.17 3.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.05 -143.31 13.79 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.465 -0.874 . . . . 0.0 114.164 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.668 ' OE2' ' HB3' ' A' ' 111' ' ' GLU . 51.8 mt-10 -97.37 -154.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.437 0.637 . . . . 0.0 111.337 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 40.6 mmt180 -66.88 153.3 43.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.164 170.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 24.4 p90 -147.67 153.43 39.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.3 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.21 144.85 27.22 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -132.67 153.27 51.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.35 129.73 69.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.576 ' HA ' ' O ' ' A' ' 21' ' ' MET . 43.2 p-10 -75.34 135.64 40.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.63 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 1.03 HG22 HD22 ' A' ' 55' ' ' ASN . 1.1 pp -149.68 -37.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.857 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.76 -11.05 23.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.613 170.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 -40.56 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.073 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 1.03 HD22 HG22 ' A' ' 52' ' ' ILE . 19.8 p30 -80.23 140.85 53.14 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 121.389 0.614 . . . . 0.0 111.428 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.23 -41.79 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.995 1.797 . . . . 0.0 112.524 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -78.74 -55.84 4.86 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -170.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.668 HG21 HD13 ' A' ' 8' ' ' ILE . 51.3 mt -62.9 -39.1 83.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.392 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.1 ttt180 -53.93 -34.72 60.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.048 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.17 -54.16 5.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 64' ' ' LYS . 42.1 mt-10 -79.84 -51.36 9.24 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.846 ' HB2' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -58.07 -43.29 98.29 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -171.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.605 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 21.2 Cg_endo -57.76 -38.71 92.0 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 121.631 1.554 . . . . 0.0 111.197 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 61' ' ' GLU . 5.0 mtpm? -55.09 -39.48 69.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.04 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.523 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.79 -41.62 91.76 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.133 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.72 -56.93 3.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.97 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -174.99 -55.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.319 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.27 151.36 58.89 Favored Pre-proline 0 C--O 1.222 -0.365 0 CA-C-N 113.646 -1.615 . . . . 0.0 113.72 -175.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.21 -39.21 39.84 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.318 2.012 . . . . 0.0 110.336 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.549 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 67.9 p -142.44 -124.38 0.09 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.66 172.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.851 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 24.1 m-85 -138.67 -168.26 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.851 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 41.6 Cg_endo -67.4 155.34 85.75 Favored 'Cis proline' 0 C--N 1.361 1.228 0 CA-C-N 121.235 1.477 . . . . 0.0 114.466 -1.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.718 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 18.8 mt-30 -143.6 133.07 23.44 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.507 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.548 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -95.8 137.42 34.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.998 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 61.4 m95 -122.66 129.3 51.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.283 0.563 . . . . 0.0 110.805 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.907 HG22 HD11 ' A' ' 100' ' ' ILE . 48.7 t -115.16 119.96 63.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 103' ' ' THR . 10.3 t70 56.22 30.33 16.39 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 123.563 1.649 . . . . 0.0 108.812 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 74.53 29.06 62.28 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.381 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 49.5 mt-10 -125.37 133.71 52.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.383 . . . . 0.0 110.782 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.668 HD22 ' CZ3' ' A' ' 68' ' ' TRP . 55.4 tp -71.05 130.95 42.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.609 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.533 HG11 HG21 ' A' ' 86' ' ' ILE . 99.3 t -110.37 -52.05 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.199 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.64 134.92 2.75 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.47 -64.63 1.56 Allowed Glycine 0 C--O 1.218 -0.897 0 C-N-CA 118.751 -1.69 . . . . 0.0 116.526 -166.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.504 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 25.1 p -80.62 -69.04 0.63 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.285 1.042 . . . . 0.0 112.824 -170.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -74.42 -43.7 55.12 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.263 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.533 HG21 HG11 ' A' ' 81' ' ' VAL . 50.7 mm -58.54 -45.31 90.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.937 -174.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 82' ' ' GLY . 74.5 t -57.44 -48.01 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.185 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.499 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 44.0 mm -60.29 -51.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.973 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.726 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.7 tt0 -62.19 -50.17 72.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.795 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.4 mmt -57.81 -39.73 78.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.843 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.487 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 13.3 t80 -60.15 -49.14 78.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.805 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.3 mt-30 -65.5 -40.09 92.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.83 0.348 . . . . 0.0 110.168 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.7 mmm-85 -57.82 -33.24 68.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.143 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.22 21.64 64.62 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.602 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 93.0 mt-10 -99.06 -13.85 19.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 0.0 111.543 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.514 HD11 HD11 ' A' ' 99' ' ' LEU . 55.7 tp -72.12 -53.06 13.89 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.733 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.2 pm0 -56.31 -25.66 49.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.703 170.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 11.7 mm-40 -71.17 -50.52 32.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.845 0.355 . . . . 0.0 111.58 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.514 HD11 HD11 ' A' ' 96' ' ' LEU . 2.6 pp -74.59 -36.22 63.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.907 HD11 HG22 ' A' ' 76' ' ' VAL . 42.6 mm -63.63 -42.11 94.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 173.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 21.8 ttmm -52.42 -56.24 16.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.303 0.573 . . . . 0.0 111.25 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -57.3 -48.61 78.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.924 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.605 HG22 ' HB2' ' A' ' 77' ' ' ASP . 94.8 m -69.4 -47.95 62.58 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.581 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -61.22 -47.93 83.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.005 0.431 . . . . 0.0 110.307 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.69 95.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -68.92 -29.76 68.09 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.11 -0.369 . . . . 0.0 111.863 -178.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.499 ' HH ' ' CG ' ' A' ' 77' ' ' ASP . 52.8 m-85 -78.78 -46.6 18.46 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.245 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.581 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.68 -160.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.681 174.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.414 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 66.7 p -84.73 -140.1 0.07 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.953 174.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.77 45.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.959 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.668 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . 5.0 mm-40 -70.81 130.58 88.4 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.996 0.427 . . . . 0.0 111.373 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 1.5 Cg_endo -82.98 116.42 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.837 2.358 . . . . 0.0 112.318 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.431 ' CG ' ' HA ' ' A' ' 101' ' ' LYS . 12.9 t70 -84.01 -124.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 97' ' ' GLN . . . -61.18 -42.7 99.04 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.362 0.601 . . . . 0.0 110.299 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 117.539 -1.22 . . . . 0.0 108.046 175.738 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' C ' ' H ' ' A' ' 3' ' ' THR . 26.0 ttt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.176 0.036 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 m 70.82 -41.42 0.5 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.565 0.746 . . . . 0.0 112.042 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 1' ' ' MET . 24.9 p -57.09 135.73 56.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.341 0.591 . . . . 0.0 112.456 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.4 m -62.48 -25.55 68.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.212 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.93 HG21 ' HG3' ' A' ' 9' ' ' GLN . 22.4 mm -53.88 -34.77 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.878 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 70.6 mm-40 -44.69 -45.79 9.94 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -62.16 -43.76 98.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.074 0.464 . . . . 0.0 110.93 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.938 HD12 ' HB2' ' A' ' 62' ' ' LEU . 73.0 mt -68.3 -40.55 82.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.626 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.93 ' HG3' HG21 ' A' ' 5' ' ' ILE . 62.7 mt-30 -58.54 -44.2 89.51 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -55.54 -34.73 64.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.268 175.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.621 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 38.6 tt0 -68.44 -48.41 64.66 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.431 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.498 HG12 ' HH ' ' A' ' 20' ' ' TYR . 21.0 mt -68.32 -39.24 80.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.77 0.795 . . . . 0.0 110.472 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.46 81.0 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.839 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.1 pt-20 -70.03 -39.28 75.86 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -173.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.588 ' OD1' HD23 ' A' ' 18' ' ' LEU . 2.7 p30 -79.22 134.96 58.35 Favored Pre-proline 0 CA--C 1.518 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 112.737 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HG2' ' HE3' ' A' ' 108' ' ' LYS . 32.7 Cg_exo -64.24 -41.73 20.5 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 123.165 2.576 . . . . 0.0 111.648 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -138.52 121.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 75' ' ' TRP . 25.6 tp -132.43 141.25 48.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.232 0.539 . . . . 0.0 111.959 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.5 tp -132.34 120.67 22.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.791 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.671 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.5 m-85 -99.53 120.99 40.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.703 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.725 ' HE2' ' HD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.1 -154.05 0.53 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.768 ' HD3' ' HB3' ' A' ' 30' ' ' CYS . 64.6 tttm -100.7 112.01 24.34 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.59 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.43 69.5 1.06 Allowed Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.674 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -78.85 143.97 63.26 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.198 . . . . 0.0 111.068 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.04 -40.23 85.38 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.119 1.879 . . . . 0.0 110.94 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -65.27 -33.09 75.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.765 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -160.46 116.67 1.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.511 ' O ' ' SD ' ' A' ' 21' ' ' MET . 9.3 Cg_exo -72.94 31.43 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.738 2.292 . . . . 0.0 113.984 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -169.61 51.82 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.454 0.702 . . . . 0.0 110.241 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.768 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.8 t -56.37 -37.07 69.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.551 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -70.5 -135.82 0.11 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.5 -36.4 57.81 Favored 'General case' 0 C--O 1.219 -0.529 0 O-C-N 122.353 -0.498 . . . . 0.0 111.943 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.48 ' CB ' ' HB3' ' A' ' 21' ' ' MET . 34.6 t -54.01 -10.39 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.41 -42.32 42.2 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.083 0.24 . . . . 0.0 111.325 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.431 HE21 ' HB1' ' A' ' 36' ' ' ALA . 1.5 pm0 -80.56 -34.85 35.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.234 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB1' HE21 ' A' ' 35' ' ' GLN . . . -67.26 -42.75 83.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.304 -175.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.577 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.54 -37.41 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.305 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.8 mm100 -64.81 -46.08 83.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.306 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . . . -59.65 -43.95 93.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.618 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.531 HD13 ' CD2' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -64.12 -57.88 8.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.618 -174.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.41 72.65 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.271 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.52 -48.84 59.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.681 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.5 p -72.81 -54.25 9.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.795 -173.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.754 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.38 -142.45 12.75 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.451 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 17.1 pt-20 -99.95 -154.68 0.48 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.52 . . . . 0.0 111.082 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.79 158.68 33.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.991 170.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.577 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 15.5 p90 -152.96 159.73 42.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.297 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -97.54 151.98 19.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.725 ' HD1' ' HE2' ' A' ' 21' ' ' MET . 2.0 p90 -138.05 151.59 48.0 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 18' ' ' LEU . 46.2 t -132.3 126.78 56.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.59 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.8 p30 -76.59 131.39 38.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.277 0.56 . . . . 0.0 110.73 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.671 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -143.5 -33.93 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.709 -174.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.6 mm? -65.74 -9.47 28.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.142 166.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -46.82 6.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.236 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -83.44 116.57 65.16 Favored Pre-proline 0 N--CA 1.476 0.842 0 O-C-N 122.059 -0.401 . . . . 0.0 111.025 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.93 -44.81 18.78 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.792 2.328 . . . . 0.0 113.248 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -61.5 -55.07 35.16 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.443 0.64 . . . . 0.0 111.341 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.9 mt -67.34 -36.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.365 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.3 ttt180 -56.98 -33.68 67.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.72 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.51 7.33 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.718 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 55.3 mm-40 -84.7 -51.05 7.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -167.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.938 ' HB2' HD12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -60.09 -41.67 85.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -172.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.611 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 32.4 Cg_endo -59.52 -39.28 76.95 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 C-N-CA 121.282 1.321 . . . . 0.0 111.168 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 37.9 mtmt -55.55 -41.75 73.68 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.219 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.632 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -63.32 -44.89 93.64 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.111 -176.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.717 ' HB1' ' CZ2' ' A' ' 75' ' ' TRP . . . -74.1 -56.11 5.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.462 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.745 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.5 t-20 -174.82 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.188 0.994 . . . . 0.0 110.006 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.745 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.12 148.25 62.31 Favored Pre-proline 0 C--O 1.219 -0.542 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.365 -175.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.77 -37.36 68.1 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 121.912 1.741 . . . . 0.0 110.437 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.44 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 37.2 p -143.07 -128.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.58 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.863 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.6 m-85 -137.11 -169.7 0.22 Allowed Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.863 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.55 153.39 82.59 Favored 'Cis proline' 0 C--N 1.361 1.22 0 CA-C-N 121.374 1.527 . . . . 0.0 114.14 -0.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.704 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.6 mt-30 -142.28 135.45 28.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.298 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.531 ' CD2' HD13 ' A' ' 40' ' ' LEU . 3.2 tm? -99.3 133.71 43.2 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.717 ' CZ2' ' HB1' ' A' ' 66' ' ' ALA . 59.4 m95 -116.9 131.33 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.314 0.578 . . . . 0.0 110.863 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 99' ' ' LEU . 86.4 t -121.67 122.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 37.3 t70 58.22 30.12 18.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.811 1.291 . . . . 0.0 109.332 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 72.68 28.77 66.62 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.16 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -137.04 137.56 39.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 111.479 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.542 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 46.3 tp -66.96 132.48 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.229 -172.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.969 HG11 HG23 ' A' ' 86' ' ' ILE . 76.1 t -110.32 -54.65 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.921 171.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.604 ' O ' HG21 ' A' ' 87' ' ' VAL . . . 145.63 134.49 2.7 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.87 -62.39 1.69 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -168.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.1 p -78.67 -68.12 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.701 -0.882 . . . . 0.0 112.992 -170.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.94 -47.65 43.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.031 0.444 . . . . 0.0 111.008 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.969 HG23 HG11 ' A' ' 81' ' ' VAL . 44.4 mm -59.95 -46.82 93.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.754 -170.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.604 HG21 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -56.11 -50.33 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.361 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.467 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.7 mm -61.94 -50.66 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.631 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.773 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.3 tt0 -63.25 -50.48 70.02 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.422 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.457 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.3 mmt -57.54 -38.02 74.02 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.525 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.0 t80 -58.02 -51.64 68.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.149 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.0 mt-30 -63.93 -39.85 95.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.649 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.773 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 25.9 mmm180 -63.6 -33.89 76.6 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.821 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 99.59 -24.09 33.58 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.34 -170.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.548 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 5.1 mm-40 -52.14 -36.14 50.52 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 99' ' ' LEU . 53.3 tp -64.77 -54.99 22.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.68 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.763 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.5 pt20 -61.18 -26.47 67.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.405 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 10.4 mm100 -66.81 -54.54 21.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.633 0.254 . . . . 0.0 111.407 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.828 HD12 HG22 ' A' ' 76' ' ' VAL . 3.0 pp -70.28 -35.26 73.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.558 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.823 HD12 HG23 ' A' ' 76' ' ' VAL . 35.7 mm -62.97 -48.6 87.22 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -55.62 -52.22 64.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 111.753 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -57.1 -45.32 83.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.949 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 ' HE2' ' A' ' 107' ' ' TYR . 91.1 m -68.0 -47.97 67.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.417 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.06 99.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.025 0.441 . . . . 0.0 110.06 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.65 99.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -72.14 -33.6 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.643 -178.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.471 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 80.0 m-85 -79.57 -46.69 16.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.767 173.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -89.58 -149.91 0.2 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.184 -177.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.448 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 25.3 t -82.84 -148.36 0.08 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.331 170.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -75.11 54.3 0.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.877 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 38.5 mm-40 -66.11 117.56 44.07 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 121.178 0.514 . . . . 0.0 110.398 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -99.7 49.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.598 2.865 . . . . 0.0 113.233 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.754 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 36.4 m-20 -50.31 -61.23 2.29 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 97' ' ' GLN . . . -79.62 -53.62 6.67 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.016 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.136 -175.236 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HB3' ' HE3' ' A' ' 1' ' ' MET . 95.4 mmm . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 111.482 0.178 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -59.31 136.65 58.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.101 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.584 HG21 HG12 ' A' ' 58' ' ' ILE . 68.5 p 53.09 -121.48 1.88 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.166 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 3' ' ' THR . 58.5 m 75.18 132.5 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.4 0.619 . . . . 0.0 110.82 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.711 ' CG2' HE21 ' A' ' 9' ' ' GLN . 73.3 mt -53.75 -37.48 32.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.6 -175.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -53.38 -47.29 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.982 0.42 . . . . 0.0 110.725 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.943 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -68.43 -45.35 72.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.56 175.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.886 HD13 ' HB2' ' A' ' 62' ' ' LEU . 82.6 mt -56.69 -44.2 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.711 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.7 mt-30 -60.35 -35.84 76.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.831 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -60.23 -35.68 76.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.494 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -72.36 -42.11 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.542 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.547 HD11 ' OH ' ' A' ' 65' ' ' TYR . 19.6 mt -68.39 -45.66 81.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.119 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -37.81 78.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.169 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.2 pt-20 -68.57 -34.8 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -78.55 127.57 80.15 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-O 120.901 0.381 . . . . 0.0 111.273 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.7 Cg_exo -61.8 -42.84 29.05 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.019 2.48 . . . . 0.0 112.333 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.1 mm -137.47 120.95 21.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.605 ' CD2' ' HE1' ' A' ' 20' ' ' TYR . 21.5 tp -133.41 142.43 48.34 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.466 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.3 tp -136.32 120.28 17.55 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.12 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.635 ' CE2' HD22 ' A' ' 62' ' ' LEU . 5.5 m-85 -97.35 117.92 32.66 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.848 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 21.6 ptt? -146.84 -164.89 2.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.4 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.93 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 61.9 tttm -98.34 103.16 15.08 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.24 67.0 1.76 Allowed Glycine 0 C--N 1.309 -0.926 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.437 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 t -76.07 141.3 70.85 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.6 -41.42 45.11 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.253 1.969 . . . . 0.0 112.188 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -65.14 -35.62 81.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.844 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.57 HD21 ' H ' ' A' ' 29' ' ' SER . 3.0 tt -158.57 118.99 1.84 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -172.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.1 Cg_exo -71.99 20.37 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.798 2.332 . . . . 0.0 114.303 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.57 ' H ' HD21 ' A' ' 27' ' ' LEU . 21.7 p -161.97 52.35 0.23 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.517 0.675 . . . . 0.0 111.037 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 43.4 t -71.54 56.24 0.25 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.126 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.23 -136.53 2.02 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.689 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 28.2 m-85 -76.25 -38.28 56.48 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 117.481 0.64 . . . . 0.0 109.518 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.504 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 35.1 p -46.4 -24.58 0.52 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.195 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.99 -42.2 48.6 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.555 0.216 . . . . 0.0 111.097 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.689 ' HG3' ' O ' ' A' ' 32' ' ' PHE . 1.8 pp0? -77.41 -37.94 50.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB3' ' NE2' ' A' ' 35' ' ' GLN . . . -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.629 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 10.6 p -57.53 -38.98 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 1.8 mm100 -65.42 -41.92 93.07 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.924 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.496 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.1 -43.33 95.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.604 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 74' ' ' LEU . 1.2 tt -63.08 -56.0 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 0.0 109.908 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.35 72.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.899 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.6 m -70.41 -60.36 2.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.33 -138.91 9.57 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -115.09 -151.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.621 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -59.38 152.68 20.73 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.628 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.629 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 26.1 p90 -155.64 154.16 31.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.057 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 151.71 20.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.947 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.3 p90 -135.72 153.91 51.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG21 HD13 ' A' ' 18' ' ' LEU . 61.6 t -131.43 134.51 60.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.652 ' OD1' ' HB3' ' A' ' 54' ' ' GLN . 7.9 t70 -73.13 138.89 46.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.185 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.663 HD13 ' CB ' ' A' ' 71' ' ' PHE . 1.1 pp -152.0 -35.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.387 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.93 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -65.25 -18.0 64.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.387 174.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.652 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -94.94 -43.23 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.616 176.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -71.51 118.55 67.27 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 117.797 0.271 . . . . 0.0 110.503 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.81 -43.98 8.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.313 2.009 . . . . 0.0 113.029 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' CB ' HG22 ' A' ' 3' ' ' THR . 50.1 m-20 -69.25 -52.79 24.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.85 -174.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.584 HG12 HG21 ' A' ' 3' ' ' THR . 19.8 mt -65.12 -36.53 78.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.391 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.2 tmm_? -56.32 -37.93 70.61 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.73 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.608 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -80.43 -50.99 9.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.537 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 4.9 mm-40 -79.18 -53.51 6.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -167.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.886 ' HB2' HD13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -62.53 -40.69 67.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.641 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 27.5 Cg_endo -59.44 -40.74 64.25 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 121.378 1.385 . . . . 0.0 111.468 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.608 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 51.6 mtmt -56.28 -36.06 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.556 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.547 ' OH ' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.81 -43.23 80.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.534 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.628 ' HB1' ' CZ2' ' A' ' 75' ' ' TRP . . . -75.81 -56.26 4.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.434 -174.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.757 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -175.47 -53.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.253 1.025 . . . . 0.0 109.362 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.757 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.73 150.64 57.18 Favored Pre-proline 0 C--O 1.218 -0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 113.484 -176.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 68' ' ' TRP . 10.3 Cg_exo -64.1 -39.12 32.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.211 1.941 . . . . 0.0 110.113 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 47.6 p -143.12 -129.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.728 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.889 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.4 m-85 -137.86 -171.85 0.29 Allowed Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.528 -0.733 . . . . 0.0 109.141 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.889 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.57 156.07 82.31 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 120.933 1.369 . . . . 0.0 114.469 -0.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.668 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.9 mt-30 -142.08 133.58 26.67 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.264 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.512 ' CD2' HD13 ' A' ' 40' ' ' LEU . 3.3 tm? -94.06 138.13 32.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.628 ' CZ2' ' HB1' ' A' ' 66' ' ' ALA . 58.9 m95 -124.28 128.03 48.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.257 0.551 . . . . 0.0 110.828 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.793 HG22 HD13 ' A' ' 100' ' ' ILE . 66.8 t -110.54 120.96 62.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.588 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 32.6 t70 56.39 27.44 12.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.917 1.341 . . . . 0.0 110.01 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.524 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 77.38 29.34 56.15 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.905 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -125.83 132.62 52.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 56.3 tp -69.81 130.29 41.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 86' ' ' ILE . 88.3 t -108.35 -55.75 5.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.346 172.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.488 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 144.29 131.41 2.43 Favored Glycine 0 C--O 1.22 -0.768 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -85.36 -62.33 1.65 Allowed Glycine 0 C--O 1.222 -0.641 0 C-N-CA 119.593 -1.289 . . . . 0.0 116.1 -168.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 p -77.52 -67.85 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.759 -0.848 . . . . 0.0 112.934 -170.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -79.04 -45.0 21.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.023 -173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' HA3' ' A' ' 82' ' ' GLY . 48.0 mm -58.01 -47.01 87.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.505 HG11 HD22 ' A' ' 96' ' ' LEU . 60.5 t -57.29 -51.86 64.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.568 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 45.6 mm -59.83 -50.39 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.686 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 42.7 tt0 -61.04 -51.51 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.694 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.667 ' HG2' ' N ' ' A' ' 96' ' ' LEU . 46.5 ttm -63.88 -32.59 74.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.098 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.899 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 7.8 t80 -57.35 -52.05 66.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.657 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.1 mt-30 -62.83 -38.28 90.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.14 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.686 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -59.12 -32.84 70.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.062 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.04 17.64 79.54 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.571 -171.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.641 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 88.9 mt-10 -90.87 -27.17 18.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.525 177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.667 ' N ' ' HG2' ' A' ' 90' ' ' MET . 61.7 tp -60.1 -53.66 55.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.579 0.704 . . . . 0.0 109.462 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.796 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 14.1 pt20 -64.31 -26.62 68.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.28 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.63 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.59 -44.16 91.52 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.175 0.512 . . . . 0.0 109.713 175.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 25.4 mt -69.95 -46.46 65.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.57 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.793 HD13 HG22 ' A' ' 76' ' ' VAL . 50.4 mm -61.08 -45.23 98.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.148 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 113' ' ' ASP . 36.4 ttpt -55.96 -48.78 75.18 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.49 -44.03 96.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.13 0.49 . . . . 0.0 110.373 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.588 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 42.1 m -75.33 -52.2 11.39 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.58 94.12 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.261 -0.274 . . . . 0.0 111.154 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.3 80.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.635 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -75.04 -27.03 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.153 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.608 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 44.4 m-85 -80.73 -45.77 16.54 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.063 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.556 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -76.64 -156.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.4 p -82.45 -147.75 0.08 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -76.81 46.51 0.46 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.916 0.389 . . . . 0.0 110.925 171.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -68.34 129.06 93.02 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.894 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.15 111.38 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.399 2.066 . . . . 0.0 112.721 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.58 ' CB ' ' HA ' ' A' ' 101' ' ' LYS . 31.1 t70 -88.09 -117.59 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 172.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.596 ' CB ' ' HB2' ' A' ' 97' ' ' GLN . . . -69.7 39.3 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 113' ' ' ASP . 16.8 tp10 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.232 -0.889 . . . . 0.0 109.5 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtm . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.6 p 50.91 -117.01 1.03 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.024 0.53 . . . . 0.0 111.569 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 4' ' ' THR . 23.7 m -151.94 -130.74 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 3' ' ' THR . 60.3 p -146.83 -147.53 0.22 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.851 0.75 . . . . 0.0 111.121 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.692 ' CG2' HE21 ' A' ' 9' ' ' GLN . 91.5 mt -57.45 -37.51 58.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.981 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.566 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 33.8 mm-40 -51.28 -53.71 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 111.429 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.78 -40.19 88.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.304 0.573 . . . . 0.0 110.674 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.926 HG21 ' HG ' ' A' ' 62' ' ' LEU . 83.4 mt -59.76 -46.14 93.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.616 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.692 HE21 ' CG2' ' A' ' 5' ' ' ILE . 69.3 mt-30 -61.77 -35.24 77.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.662 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -60.82 -38.54 85.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.172 175.086 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.533 ' HG2' ' HA ' ' A' ' 8' ' ' ILE . 17.2 pt20 -79.68 -39.81 30.47 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.009 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.465 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 22.3 mt -61.88 -45.22 99.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.218 0.533 . . . . 0.0 110.429 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.6 91.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.1 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.0 pt-20 -70.43 -30.15 66.93 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.828 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.462 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.74 126.87 85.32 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.275 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' ASN . 51.0 Cg_exo -60.29 -43.56 33.93 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.911 2.407 . . . . 0.0 112.56 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.2 mm -139.92 120.61 14.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.578 HD11 HG21 ' A' ' 50' ' ' VAL . 20.0 tp -133.76 142.26 47.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.375 -169.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 14.5 tp -137.52 116.62 12.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.17 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.559 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 6.6 m-85 -96.35 118.83 33.69 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.305 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.831 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 24.2 ptt? -147.44 -167.44 2.79 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.618 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 65.9 tttm -97.11 108.68 21.46 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -94.63 71.15 1.13 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.328 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.9 m -78.67 146.71 69.73 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.92 -41.69 74.62 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.479 2.119 . . . . 0.0 112.288 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.88 -31.45 71.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.545 HD23 ' H ' ' A' ' 29' ' ' SER . 2.5 tt -157.58 115.22 1.88 Allowed Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.84 22.12 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.674 2.25 . . . . 0.0 113.713 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.831 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 15.7 p -163.14 50.48 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.014 0.526 . . . . 0.0 109.903 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.618 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 37.6 t -71.93 53.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.288 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.12 -134.38 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.152 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 1.034 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 63.3 m-85 -76.43 -23.16 53.95 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -74.82 -11.54 60.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.664 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -50.76 -43.4 58.29 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.534 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -77.42 -39.13 48.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.068 0.461 . . . . 0.0 110.107 176.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.34 89.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.102 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 38' ' ' GLN . 11.6 p -56.8 -39.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.321 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.519 ' N ' HG11 ' A' ' 37' ' ' VAL . 1.7 mm100 -66.89 -47.35 72.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.858 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . . . -59.36 -42.86 92.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.984 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.531 HD11 ' CD2' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -62.37 -57.08 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 110.036 -175.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.03 69.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.204 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 38' ' ' GLN . . . -72.82 -50.62 23.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.557 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -76.5 -52.99 8.73 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.246 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.64 -135.59 8.99 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.486 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 26.3 mt-10 -141.95 -147.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.101 -0.549 . . . . 0.0 111.348 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 34.3 mmt-85 -48.02 146.96 2.28 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.359 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 21.6 p90 -159.38 150.86 20.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.876 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.99 144.06 28.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.557 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.518 ' CG ' ' HE2' ' A' ' 21' ' ' MET . 2.7 p90 -130.78 149.74 52.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 18' ' ' LEU . 44.0 t -124.31 128.04 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.0 p30 -78.46 132.2 37.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.393 0.616 . . . . 0.0 110.166 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.658 HD13 ' CB ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -142.53 -34.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.342 -173.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.593 ' HB2' ' CB ' ' A' ' 22' ' ' LYS . 1.8 mm? -67.19 -8.68 33.2 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.116 167.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.25 -47.12 5.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.698 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.656 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.1 m-20 -73.78 131.35 81.96 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 121.958 -0.464 . . . . 0.0 111.419 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.76 -43.63 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.364 2.043 . . . . 0.0 112.924 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -76.1 -55.5 5.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.78 -33.38 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.656 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 28.1 ttm180 -49.73 -40.4 40.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.612 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.39 18.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.425 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 56.7 mm-40 -78.86 -60.08 2.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -161.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.92 -25.18 0.49 Allowed Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -170.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.701 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 14.1 Cg_endo -55.24 -41.82 74.66 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 121.682 1.637 . . . . 0.0 110.682 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -48.38 -41.93 30.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.777 175.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.55 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -71.97 -41.7 67.39 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.149 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.702 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . . . -72.53 -57.56 4.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.64 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.686 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 50.3 t30 -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.256 1.027 . . . . 0.0 109.861 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.686 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -60.78 148.07 83.39 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 113.12 -1.854 . . . . 0.0 112.738 -176.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -61.95 -33.94 82.45 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.194 1.93 . . . . 0.0 110.145 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -143.0 -126.64 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.917 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.906 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.3 m-85 -142.28 -164.49 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.906 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 2.1 Cg_endo -74.32 154.9 99.88 Favored 'Cis proline' 0 C--N 1.362 1.278 0 CA-C-N 121.503 1.572 . . . . 0.0 113.282 -2.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.632 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 61.8 mt-30 -144.02 135.4 25.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.704 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.531 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -93.55 137.04 33.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.702 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 59.1 m95 -121.26 132.56 54.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.236 0.541 . . . . 0.0 111.083 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 100' ' ' ILE . 85.0 t -117.06 120.88 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.59 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 30.6 t70 56.38 28.35 13.38 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.799 1.285 . . . . 0.0 110.43 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.51 28.21 55.77 Favored Glycine 0 C--N 1.311 -0.821 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.887 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -127.76 133.84 49.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.501 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 52.0 tp -69.44 130.25 41.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.771 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.995 HG11 HG22 ' A' ' 86' ' ' ILE . 81.6 t -107.35 -54.4 5.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.902 173.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 144.59 140.78 3.64 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.16 -67.66 1.4 Allowed Glycine 0 C--O 1.217 -0.951 0 C-N-CA 118.549 -1.786 . . . . 0.0 116.1 -167.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 1.034 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 42.0 t -81.76 -68.03 0.73 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.767 1.283 . . . . 0.0 112.657 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 86' ' ' ILE . 1.5 m-20 -65.53 -49.62 68.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.6 -169.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.995 HG22 HG11 ' A' ' 81' ' ' VAL . 2.6 mp -63.58 -43.15 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.992 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.572 ' HA ' HD13 ' A' ' 96' ' ' LEU . 53.1 t -59.84 -51.39 73.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.441 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.56 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.1 mm -59.02 -48.77 85.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.928 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.735 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.2 tt0 -62.28 -52.11 64.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.096 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.664 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.9 mmt -60.43 -34.78 74.47 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.605 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 7.6 t80 -58.2 -50.04 74.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.772 172.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.4 mt-30 -64.31 -40.81 96.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.11 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -61.96 -34.53 76.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.584 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.77 -23.53 32.33 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.824 -171.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.749 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 4.7 mm-40 -56.4 -39.69 73.41 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.824 0.45 . . . . 0.0 112.179 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.8 tt -60.31 -52.7 64.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.186 -176.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.712 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -64.68 -26.75 68.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -68.61 -46.83 68.23 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.108 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 53.5 mt -63.44 -46.19 87.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.06 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 76' ' ' VAL . 48.8 mm -62.1 -45.17 99.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.145 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.638 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 26.0 ttpp -53.03 -52.7 57.61 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.234 0.54 . . . . 0.0 111.375 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 87.7 tt0 -65.2 -46.6 80.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.547 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.949 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 91.4 m -66.87 -46.99 73.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.368 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 100' ' ' ILE . . . -62.93 -42.29 99.75 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.58 78.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' A' ' 103' ' ' THR 0.255 0.0 OUTLIER -77.79 -26.97 50.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.349 178.631 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.689 ' CE2' ' HE3' ' A' ' 106' ' ' LYS . 93.8 m-85 -87.95 -49.55 6.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.521 171.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -101.82 135.9 42.57 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 p -58.17 115.84 3.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 49.47 43.23 23.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.396 -1.729 . . . . 0.0 114.143 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -78.33 117.69 67.73 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.38 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.18 59.03 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.697 2.931 . . . . 0.0 114.431 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.505 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 55.1 m-20 -53.84 -63.68 1.07 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.638 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -73.57 -41.75 62.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.998 0.428 . . . . 0.0 110.972 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.442 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 38.8 tt0 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 117.781 -1.104 . . . . 0.0 108.426 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.7 mpp? . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.838 0.352 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 t -66.69 -46.59 75.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.168 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.3 p -149.96 131.48 14.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.255 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.401 ' O ' HG13 ' A' ' 8' ' ' ILE . 22.9 m -158.25 -46.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.69 ' CG2' HE21 ' A' ' 9' ' ' GLN . 62.2 mt -54.4 -36.85 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.127 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -54.42 -45.67 73.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.002 0.43 . . . . 0.0 110.331 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -71.64 -40.19 69.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.051 174.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.847 HD13 ' HB3' ' A' ' 62' ' ' LEU . 72.3 mt -57.51 -43.66 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.56 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.69 HE21 ' CG2' ' A' ' 5' ' ' ILE . 73.1 mt-30 -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.587 HH21 ' HB3' ' A' ' 13' ' ' ALA . 5.7 tpm_? -60.01 -38.24 82.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.383 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 53.0 tt0 -68.0 -45.8 73.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.124 0.487 . . . . 0.0 110.948 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.709 HG22 ' HA2' ' A' ' 78' ' ' GLY . 29.3 mt -66.56 -46.64 85.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.009 0.433 . . . . 0.0 110.722 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.587 ' HB3' HH21 ' A' ' 10' ' ' ARG . . . -61.49 -38.69 88.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.4 pt-20 -66.93 -34.39 77.68 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.353 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 70.2 m-80 -77.34 128.38 80.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.582 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.4 Cg_exo -60.22 -42.93 38.54 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 123.063 2.509 . . . . 0.0 112.075 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 100' ' ' ILE . 36.0 mm -139.4 125.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.611 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 27.5 tp -133.44 141.21 47.72 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.386 -170.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.3 tp -136.43 119.06 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.602 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -96.98 119.36 35.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.972 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.4 ptt? -146.19 -169.38 3.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.299 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.041 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.8 tttt -97.68 115.04 27.16 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.665 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.62 70.21 1.0 Allowed Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.399 -175.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.4 p -79.05 143.37 61.21 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.777 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.3 -41.51 65.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.389 2.059 . . . . 0.0 112.278 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -65.0 -32.29 73.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.418 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 29' ' ' SER . 51.3 tp -158.72 116.92 1.72 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.532 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 11.3 Cg_exo -71.86 27.97 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.3 2.0 . . . . 0.0 112.736 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 27' ' ' LEU . 40.6 p -162.84 51.56 0.18 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.179 0.514 . . . . 0.0 111.889 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.628 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 40.4 t -72.84 59.19 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.225 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.07 -139.81 2.97 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.82 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.488 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 55.1 m-85 -74.88 -17.7 60.54 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 120.994 0.426 . . . . 0.0 111.632 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 30.2 p -69.92 -18.45 63.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -48.65 -42.23 33.81 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.581 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.71 -38.97 58.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.141 0.496 . . . . 0.0 109.853 178.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.49 92.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.048 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.538 HG11 ' N ' ' A' ' 38' ' ' GLN . 10.1 p -57.98 -39.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.028 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 1.8 mm100 -67.11 -44.28 80.33 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -58.91 -47.35 85.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.991 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.572 HD12 HD21 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -61.37 -51.83 67.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.9 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.75 67.98 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.883 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -71.65 -48.66 46.22 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.15 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.926 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -70.45 -9.18 55.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.811 170.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 40' ' ' LEU . . . -10.59 120.48 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.967 0 CA-C-N 110.684 -2.962 . . . . 0.0 119.056 -160.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.761 ' OE2' ' HA ' ' A' ' 97' ' ' GLN . 3.6 mp0 -133.43 138.19 46.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 109.95 -3.125 . . . . 0.0 103.887 164.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -56.39 129.41 40.45 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.643 -170.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 14.7 p90 -140.47 148.08 40.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.04 -166.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.36 152.94 21.0 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.929 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.5 p90 -136.38 153.18 51.18 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.441 ' CG2' HD13 ' A' ' 18' ' ' LEU . 61.4 t -128.95 131.45 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.5 p30 -76.51 132.37 39.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 110.368 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.602 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.2 pp -147.64 -37.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 1.041 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -65.56 -7.66 15.86 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.22 173.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -42.84 7.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.433 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.4 m-20 -77.09 123.26 87.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.5 -45.23 11.99 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.121 1.881 . . . . 0.0 112.763 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.04 -56.72 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.993 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HD21 ' A' ' 62' ' ' LEU . 33.2 mt -61.73 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.473 -175.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 78.9 ttt180 -52.8 -31.93 41.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.7 -47.36 8.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.4 -60.61 2.26 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -163.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.847 ' HB3' HD13 ' A' ' 8' ' ' ILE . 1.8 pt? -68.36 -33.49 4.78 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.5 Cg_endo -53.94 -42.11 69.4 Favored 'Trans proline' 0 C--N 1.353 0.81 0 CA-C-N 120.939 1.371 . . . . 0.0 110.785 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.13 -40.53 61.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.28 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.502 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.3 -43.98 76.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.6 -57.59 3.77 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.816 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.744 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.3 t-20 -174.99 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.109 0.957 . . . . 0.0 109.972 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.744 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -57.67 149.18 53.44 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 113.303 -1.772 . . . . 0.0 113.351 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -62.18 -37.11 65.17 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.426 2.084 . . . . 0.0 110.194 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 57.8 p -141.86 -124.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.278 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.917 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 46.0 m-85 -141.43 -170.58 0.24 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.917 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 58.5 Cg_endo -69.71 154.2 93.06 Favored 'Cis proline' 0 C--N 1.357 1.004 0 CA-C-N 121.27 1.489 . . . . 0.0 114.349 -1.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.58 HE22 ' HA ' ' A' ' 63' ' ' PRO . 61.2 mt-30 -144.96 134.92 23.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.655 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 40' ' ' LEU . 3.3 tm? -98.63 137.52 37.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.029 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 60.3 m95 -123.81 132.19 53.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.276 0.56 . . . . 0.0 111.222 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.756 HG21 HD12 ' A' ' 99' ' ' LEU . 38.9 t -114.31 118.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.2 t70 55.61 26.9 9.74 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.388 1.566 . . . . 0.0 108.72 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.709 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.82 28.54 46.02 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.607 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.47 133.33 47.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.973 0.416 . . . . 0.0 111.077 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 55.5 tp -68.81 133.44 48.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 76' ' ' VAL . 90.1 t -110.41 -54.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.069 170.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 147.48 135.03 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.54 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -85.1 -63.56 1.58 Allowed Glycine 0 C--O 1.219 -0.803 0 C-N-CA 119.291 -1.433 . . . . 0.0 116.589 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.9 p -78.89 -67.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.427 -1.043 . . . . 0.0 113.373 -168.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.21 -43.34 28.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.689 HG22 HG12 ' A' ' 81' ' ' VAL . 48.4 mm -57.18 -45.61 84.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.157 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 83' ' ' GLY . 71.8 t -58.67 -48.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.44 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.691 HD12 ' HB1' ' A' ' 39' ' ' ALA . 36.9 mm -58.59 -53.42 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.09 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.719 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.4 tt0 -63.2 -49.36 74.53 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.246 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -61.09 -37.64 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 2.3 t80 -57.86 -49.39 76.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.553 173.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.5 mt-30 -64.16 -39.64 94.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.719 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.1 mmm180 -57.49 -33.55 68.13 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.639 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 89.82 -24.05 17.16 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.211 -170.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.1 mt-10 -60.92 -26.44 67.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 7.9 tt -73.08 -53.96 9.74 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.926 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 17.5 pt20 -57.89 -25.92 61.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.181 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.3 mm100 -69.23 -53.27 20.75 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.667 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 76' ' ' VAL . 2.8 pp -71.58 -35.39 70.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.746 HG13 HD22 ' A' ' 96' ' ' LEU . 29.4 mm -66.1 -48.38 81.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.173 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.893 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.9 ttpt -56.31 -51.07 69.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.683 0.278 . . . . 0.0 110.953 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -55.96 -48.02 76.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.876 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 63.7 m -63.15 -48.31 78.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.512 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.64 ' HB1' ' HZ3' ' A' ' 108' ' ' LYS . . . -60.15 -46.44 89.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.94 88.48 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.132 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -20.8 61.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.771 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.582 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 33.0 m-85 -81.83 -46.77 13.7 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.64 ' HZ3' ' HB1' ' A' ' 104' ' ' ALA . 1.0 OUTLIER -87.09 -151.65 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.311 170.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -86.55 -153.82 0.21 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.7 51.43 0.11 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.471 0.309 . . . . 0.0 111.771 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.462 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 56.7 mm-40 -70.58 122.81 87.72 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.152 0.501 . . . . 0.0 112.021 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.67 65.35 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.337 2.692 . . . . 0.0 113.271 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.625 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 31.4 m-20 -61.49 -109.21 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.482 -178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.893 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . . . -50.69 -45.18 58.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -170.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.545 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 41.9 tt0 . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.161 -0.923 . . . . 0.0 109.131 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 119.904 -0.093 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 m 50.44 47.79 23.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.033 0.444 . . . . 0.0 111.504 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.6 t -68.41 139.32 55.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.567 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 8' ' ' ILE . 60.1 m -155.3 -50.69 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.091 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.641 ' CG2' HE21 ' A' ' 9' ' ' GLN . 63.7 mt -62.12 -37.89 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -54.73 -44.12 73.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.636 0.255 . . . . 0.0 110.787 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.4 -45.11 73.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 62' ' ' LEU . 69.0 mt -59.53 -45.06 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.641 HE21 ' CG2' ' A' ' 5' ' ' ILE . 69.9 mt-30 -64.3 -38.36 90.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.474 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.444 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 13.3 mmp_? -62.61 -37.01 84.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 109.868 172.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.69 -46.0 70.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.6 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.714 HG22 ' HA2' ' A' ' 78' ' ' GLY . 35.7 mt -65.72 -44.43 93.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.094 0.473 . . . . 0.0 110.53 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.01 95.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.089 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 23.5 pt-20 -66.55 -32.75 74.29 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.33 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -77.16 127.24 83.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.595 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 15' ' ' ASN . 52.1 Cg_exo -59.68 -43.44 38.57 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.752 2.301 . . . . 0.0 112.576 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 100' ' ' ILE . 31.6 mm -140.27 124.2 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.618 HD21 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -134.32 142.15 47.16 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.625 -169.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.5 tp -135.15 116.95 15.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.525 ' HE1' HD22 ' A' ' 18' ' ' LEU . 10.8 m-85 -96.83 117.94 32.18 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.795 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.669 ' O ' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -147.12 -158.15 0.88 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 64.9 tttm -98.85 107.95 20.51 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.648 -0.657 . . . . 0.0 109.756 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.65 126.19 8.68 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.062 -1.065 . . . . 0.0 111.79 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 37.2 t -146.4 145.16 22.81 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -41.13 79.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.204 1.936 . . . . 0.0 111.18 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.421 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.4 pttt -65.72 -32.36 73.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.667 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 29' ' ' SER . 0.4 OUTLIER -160.49 119.98 1.59 Allowed Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.463 ' O ' ' SD ' ' A' ' 21' ' ' MET . 44.0 Cg_endo -73.34 20.69 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.382 0 C-N-CA 122.41 2.073 . . . . 0.0 114.121 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.583 ' H ' HD13 ' A' ' 27' ' ' LEU . 22.1 p -169.51 52.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.532 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.9 t -55.8 -37.7 68.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -168.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.707 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -68.83 -135.65 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.924 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -74.18 -32.61 63.15 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 122.204 -0.586 . . . . 0.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.499 ' HG ' ' HB2' ' A' ' 29' ' ' SER . 20.7 p -46.54 -22.09 0.24 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.271 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.96 32.14 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.231 0.332 . . . . 0.0 111.867 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 36' ' ' ALA . 1.3 pm0 -80.69 -35.5 33.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.266 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' HE21 ' A' ' 35' ' ' GLN . . . -68.97 -44.3 73.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -175.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.561 HG21 ' HZ ' ' A' ' 47' ' ' PHE . 8.0 p -53.4 -38.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.484 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.2 mm100 -63.74 -46.82 83.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.077 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.624 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.15 -42.04 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.839 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -61.95 -56.23 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.511 . . . . 0.0 109.895 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.31 71.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.294 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -71.39 -47.43 56.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.776 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.6 m -72.23 -57.98 3.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -103.87 -148.62 19.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.314 -0.946 . . . . 0.0 114.421 -175.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.8 mm-40 -105.98 -154.4 0.52 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 37.1 mmt-85 -62.2 152.7 32.53 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.558 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.561 ' HZ ' HG21 ' A' ' 37' ' ' VAL . 24.4 p90 -151.87 156.14 39.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.142 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.51 149.67 22.49 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.2 p90 -136.63 151.74 49.65 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 18' ' ' LEU . 54.0 t -130.98 129.5 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.377 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 2.7 p30 -75.01 134.19 41.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.503 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.669 HD11 ' O ' ' A' ' 21' ' ' MET . 1.3 pp -149.28 -34.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.6 mm? -67.87 -7.57 29.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.583 169.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.43 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.59 -38.42 10.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.861 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.2 m-20 -79.39 128.03 76.71 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 120.642 0.258 . . . . 0.0 111.009 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.86 -45.0 6.86 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.333 2.022 . . . . 0.0 112.928 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -84.52 -49.73 8.35 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.495 HG22 HG22 ' A' ' 52' ' ' ILE . 40.9 mt -58.39 -33.32 47.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.35 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.676 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -50.53 -38.7 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.976 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.632 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -91.42 -35.34 14.42 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.65 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 51.7 mt-10 -76.18 -61.62 1.88 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -162.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.676 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 2.0 pt? -70.71 -32.49 2.57 Favored Pre-proline 0 N--CA 1.468 0.433 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 18.9 Cg_endo -56.09 -40.04 87.43 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 120.925 1.366 . . . . 0.0 110.85 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.65 ' NZ ' ' HA ' ' A' ' 61' ' ' GLU . 31.6 mtmm -56.25 -38.34 70.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.519 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -66.48 -43.12 86.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.136 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.585 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . . . -75.4 -57.1 4.1 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.104 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.673 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.2 t30 -175.87 -53.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.167 0.984 . . . . 0.0 109.47 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.673 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -54.9 149.24 24.1 Favored Pre-proline 0 C--O 1.217 -0.623 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.388 -176.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -62.77 -37.75 53.8 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.242 1.961 . . . . 0.0 110.191 171.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 59' ' ' ARG . 60.9 p -142.01 -130.43 0.1 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.635 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.817 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 17.1 m-85 -137.67 -166.15 0.11 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.817 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.1 Cg_endo -65.87 153.28 80.0 Favored 'Cis proline' 0 C--N 1.362 1.274 0 CA-C-N 121.586 1.602 . . . . 0.0 113.744 -1.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.623 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.1 mt-30 -141.74 133.11 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.53 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.489 ' CD2' HD12 ' A' ' 40' ' ' LEU . 3.3 tm? -93.96 138.4 32.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.585 ' CH2' ' HB3' ' A' ' 66' ' ' ALA . 59.6 m95 -126.77 130.19 49.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.799 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' HB ' HD12 ' A' ' 100' ' ' ILE . 2.4 p -125.63 123.79 65.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.594 ' HB2' HG22 ' A' ' 103' ' ' THR . 10.5 t70 61.28 28.25 17.81 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.468 1.604 . . . . 0.0 108.091 -171.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.714 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 68.2 25.67 74.46 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 113.029 -1.896 . . . . 0.0 112.95 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 37.0 mm-40 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.805 0.442 . . . . 0.0 110.559 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 66' ' ' ALA . 44.6 tp -71.93 125.13 26.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.764 0.316 . . . . 0.0 111.567 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 86' ' ' ILE . 71.8 t -106.27 -53.04 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.934 172.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 141.46 134.45 3.02 Favored Glycine 0 C--O 1.221 -0.693 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -85.23 -62.63 1.64 Allowed Glycine 0 C--O 1.22 -0.742 0 C-N-CA 119.498 -1.334 . . . . 0.0 116.292 -168.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.4 p -77.24 -68.25 0.63 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.683 -0.892 . . . . 0.0 112.903 -170.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.4 -44.59 28.69 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 111.289 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.487 HG13 ' HA3' ' A' ' 82' ' ' GLY . 45.0 mm -59.33 -44.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.258 -172.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 83' ' ' GLY . 69.1 t -58.02 -49.51 81.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 91' ' ' TYR . 37.9 mm -60.58 -48.56 88.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.497 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.818 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -62.24 -52.88 61.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.593 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.569 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.4 mmt -57.35 -36.52 71.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.581 0.229 . . . . 0.0 111.35 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.771 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 19.6 t80 -56.23 -51.27 68.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.995 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -65.59 -44.85 85.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.691 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 2.1 mmp_? -60.64 -33.94 73.53 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.978 0.418 . . . . 0.0 111.281 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 98.6 -25.24 28.74 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.716 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.2 mt-10 -56.0 -32.33 63.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 61.7 tp -57.41 -55.71 31.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.181 0.515 . . . . 0.0 110.703 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.776 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.3 pt20 -65.61 -26.22 67.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.627 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.8 mm100 -63.83 -46.42 85.12 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.0 mt -67.76 -46.49 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.149 177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.533 HD11 HG22 ' A' ' 17' ' ' ILE . 32.8 mm -63.7 -42.47 96.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.847 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.565 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 28.2 ttpt -54.72 -56.09 22.96 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.505 0.669 . . . . 0.0 110.863 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -58.75 -45.95 88.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.567 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 77' ' ' ASP . 88.5 m -69.85 -49.07 56.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.26 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -59.27 -44.36 92.45 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.267 -0.271 . . . . 0.0 110.314 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.48 93.68 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.598 0.561 . . . . 0.0 111.798 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -18.57 62.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.45 ' HE2' HG22 ' A' ' 103' ' ' THR . 57.1 m-85 -92.08 -47.52 7.21 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.261 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.418 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 46.2 mtmt -101.03 -147.18 0.35 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.952 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -64.92 155.53 34.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.884 164.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.49 55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -174.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -65.08 121.26 73.21 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.23 60.21 1.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.697 2.932 . . . . 0.0 113.434 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.431 ' HB2' ' CA ' ' A' ' 101' ' ' LYS . 1.2 m-20 -44.55 -51.68 8.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 0.0 112.01 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.565 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -105.95 -120.87 0.23 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.059 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.117 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.3 m 58.06 43.59 20.69 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.422 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t 178.92 -41.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.186 0.517 . . . . 0.0 109.899 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 8' ' ' ILE . 35.6 p -63.37 -52.1 63.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.039 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.651 ' CG2' HE21 ' A' ' 9' ' ' GLN . 52.9 mt -59.22 -36.4 63.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.513 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -57.02 -47.0 81.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -67.16 -43.89 81.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.805 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.676 HD13 ' HB3' ' A' ' 62' ' ' LEU . 69.7 mt -59.6 -48.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.651 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.1 mt-30 -61.55 -39.74 92.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.396 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.748 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mmp_? -59.49 -40.4 86.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -71.92 -43.13 65.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 78' ' ' GLY . 39.8 mt -60.08 -42.09 88.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.208 0.528 . . . . 0.0 109.577 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -36.68 78.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.718 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.748 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 83.0 mt-10 -58.68 -46.46 87.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.598 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.0 m-80 -79.31 124.27 84.28 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.254 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 32.1 Cg_exo -62.9 -43.45 19.92 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 C-N-CA 122.355 2.037 . . . . 0.0 111.77 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mm -128.9 120.89 53.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 12' ' ' ILE . 20.8 tp -133.54 140.56 47.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.452 -169.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.465 HD23 ' CE1' ' A' ' 47' ' ' PHE . 11.6 tp -134.69 116.93 15.48 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.351 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.636 ' HB3' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -97.93 115.94 29.15 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.011 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.58 ' HE2' ' HB2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.72 -154.36 0.55 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.917 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 2.2 tmtp? -98.04 97.1 8.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -170.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.668 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.23 71.73 1.39 Allowed Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.499 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.527 ' HB2' ' HE2' ' A' ' 22' ' ' LYS . 38.5 t -78.59 145.14 66.64 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.95 -40.07 87.5 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.058 1.838 . . . . 0.0 111.475 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -70.01 -30.74 68.12 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.605 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD11 ' HD2' ' A' ' 28' ' ' PRO . 54.2 tp -157.88 118.38 1.94 Allowed Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HD2' HD11 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -70.73 22.28 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.509 2.139 . . . . 0.0 113.647 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 27' ' ' LEU . 10.9 p -164.95 48.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 110.883 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.917 ' HB3' ' HD2' ' A' ' 22' ' ' LYS . 42.6 t -70.42 58.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.442 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.25 -139.4 2.63 Favored Glycine 0 C--N 1.314 -0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' A' ' 34' ' ' ALA . 40.3 m-85 -78.05 -45.73 22.79 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 117.63 0.715 . . . . 0.0 111.582 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.48 ' O ' HG13 ' A' ' 37' ' ' VAL . 35.5 t -52.21 -10.26 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 32' ' ' PHE . . . -49.52 -41.87 42.25 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 119.265 -0.397 . . . . 0.0 110.401 170.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.553 HE21 ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -81.29 -30.48 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 172.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.553 ' N ' HE21 ' A' ' 35' ' ' GLN . . . -67.27 -42.69 83.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 33' ' ' SER . 26.9 m -54.67 -41.59 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.879 ' H ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -56.92 -47.9 79.53 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 122.443 0.297 . . . . 0.0 110.29 178.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.4 88.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.859 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.533 HD13 ' CG ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -64.55 -55.09 22.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -177.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.32 74.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.959 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.51 -45.5 68.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.649 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 27.2 p -76.81 -56.11 4.89 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -173.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.663 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.16 -144.85 16.66 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.066 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.29 -153.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 155.39 40.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.627 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CG ' HD13 ' A' ' 40' ' ' LEU . 17.6 p90 -145.01 158.41 43.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 -169.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 152.05 19.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.58 ' HB2' ' HE2' ' A' ' 21' ' ' MET . 1.5 p90 -138.67 154.41 48.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.582 HG23 HD13 ' A' ' 18' ' ' LEU . 48.4 t -131.45 129.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.668 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.2 p30 -78.97 133.33 36.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 110.523 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.711 HD11 ' CG ' ' A' ' 71' ' ' PHE . 1.3 pp -147.47 -35.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 -173.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.622 ' N ' HD13 ' A' ' 52' ' ' ILE . 1.4 mm? -66.21 -9.6 33.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.304 169.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 -42.94 8.02 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.674 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -78.84 123.26 85.27 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.322 -0.237 . . . . 0.0 110.707 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.81 -45.06 9.05 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.099 1.866 . . . . 0.0 112.802 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.17 -52.95 12.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.441 ' O ' HD23 ' A' ' 62' ' ' LEU . 37.6 mt -61.77 -36.97 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.522 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.593 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 54.6 ttp85 -51.24 -35.19 35.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.459 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -85.0 -47.12 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -170.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -78.87 -59.52 2.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -161.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.676 ' HB3' HD13 ' A' ' 8' ' ' ILE . 2.2 pt? -67.48 -33.37 5.43 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -173.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 12.3 Cg_endo -55.1 -41.15 81.48 Favored 'Trans proline' 0 C--N 1.352 0.714 0 CA-C-N 121.167 1.452 . . . . 0.0 111.125 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.1 mtmp? -58.58 -34.01 70.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.682 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -66.6 -44.17 82.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.935 176.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB1' ' CZ2' ' A' ' 75' ' ' TRP . . . -75.66 -57.33 3.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.592 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.73 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.1 t-20 -175.67 -56.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.158 0.98 . . . . 0.0 109.636 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.73 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -56.58 151.27 31.0 Favored Pre-proline 0 C--O 1.22 -0.458 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.257 -176.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -64.13 -36.96 44.62 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.312 2.008 . . . . 0.0 110.024 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.3 p -142.1 -125.09 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.765 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.831 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 22.0 m-85 -141.53 -164.8 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.831 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.44 153.46 82.21 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 121.849 1.696 . . . . 0.0 113.699 -1.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.727 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.2 mt-30 -142.5 132.04 23.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.495 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.493 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -94.81 135.11 36.7 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.64 ' CZ2' ' HB1' ' A' ' 66' ' ' ALA . 62.2 m95 -119.02 128.87 54.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.43 0.634 . . . . 0.0 110.789 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.602 HG22 HD12 ' A' ' 100' ' ' ILE . 92.5 t -115.53 120.49 64.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.222 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 103' ' ' THR . 32.4 t70 57.73 28.55 16.02 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.034 1.397 . . . . 0.0 109.889 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 76.01 28.29 60.81 Favored Glycine 0 C--N 1.312 -0.781 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.047 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.4 135.09 46.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.498 . . . . 0.0 111.305 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.572 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 54.9 tp -69.22 131.13 44.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.377 -174.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.404 HG11 HG23 ' A' ' 86' ' ' ILE . 96.8 t -110.57 -51.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.028 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.459 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 144.64 133.6 2.67 Favored Glycine 0 C--O 1.222 -0.615 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -84.56 -62.44 1.71 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.492 -1.337 . . . . 0.0 116.064 -168.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 20.5 p -78.99 -67.55 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.689 -0.889 . . . . 0.0 112.955 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -78.59 -43.8 25.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.66 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.459 HG13 ' HA3' ' A' ' 82' ' ' GLY . 49.9 mm -59.86 -44.51 94.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.772 -173.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 83' ' ' GLY . 96.0 t -57.69 -48.91 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.661 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 35.6 mm -60.11 -51.59 71.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.758 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 84.2 tt0 -59.37 -54.74 43.23 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.38 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.669 ' HB2' HD22 ' A' ' 96' ' ' LEU . 26.4 mmt -58.15 -37.95 75.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.534 0.207 . . . . 0.0 110.743 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.493 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.0 t80 -57.16 -49.81 74.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.391 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -64.79 -38.56 91.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.113 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 1.2 mmm180 -62.34 -32.0 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.767 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 21.24 58.45 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.555 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.728 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.9 mm-40 -90.39 -32.41 16.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.404 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -60.47 -53.43 57.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.54 -172.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.733 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.0 pm0 -62.57 -28.88 70.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.58 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.0 mm100 -66.12 -45.98 79.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.4 mt -67.4 -45.14 77.05 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.03 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.602 HD12 HG22 ' A' ' 76' ' ' VAL . 51.0 mm -64.97 -42.5 94.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.465 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.563 ' HE3' ' HB2' ' A' ' 114' ' ' ALA . 31.9 ttmt -52.0 -56.66 12.91 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.453 0.644 . . . . 0.0 111.225 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.58 -43.99 89.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.255 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 77' ' ' ASP . 73.1 m -72.41 -44.05 63.01 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.783 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.532 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -65.98 -44.11 85.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.481 -0.762 . . . . 0.0 110.167 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.11 95.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.808 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' HG3' ' N ' ' A' ' 107' ' ' TYR . 17.1 ptpt -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.014 -0.429 . . . . 0.0 110.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.601 ' HD2' ' O ' ' A' ' 103' ' ' THR . 81.1 m-85 -77.99 -45.73 23.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -97.55 -150.33 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.733 177.485 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.467 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 11.1 p -67.93 169.66 9.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 166.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.72 60.39 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 65.8 mm-40 -58.44 126.36 78.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.778 0.799 . . . . 0.0 111.73 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 73.9 Cg_endo -94.15 56.75 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 123.416 2.744 . . . . 0.0 113.039 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.663 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.5 m-20 -50.56 -56.6 10.97 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.05 -169.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' A' ' 97' ' ' GLN . . . -88.86 -40.53 13.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.993 0.425 . . . . 0.0 110.97 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.47 ' H ' ' HE2' ' A' ' 101' ' ' LYS . 66.3 mm-40 . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.206 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttp . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.469 ' O ' ' HB ' ' A' ' 3' ' ' THR . 55.0 p -84.11 132.23 34.72 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 170.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 2' ' ' SER . 89.8 m 72.72 131.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 109.927 -171.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 5' ' ' ILE . 10.2 m -156.78 -148.62 0.22 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.685 ' H ' HG22 ' A' ' 4' ' ' THR . 95.1 mt -53.44 -40.54 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 123.11 0.564 . . . . 0.0 112.466 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.73 -49.33 68.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.7 mptt -72.54 -39.62 67.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.034 175.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.942 HD13 ' HB3' ' A' ' 62' ' ' LEU . 71.8 mt -58.21 -47.65 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.011 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.629 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.9 mt-30 -61.03 -32.79 72.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.483 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 17.2 mmt180 -60.06 -37.54 80.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.419 . . . . 0.0 110.51 173.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 45.4 tt0 -72.97 -45.46 57.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.378 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.644 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 21.8 mt -63.78 -42.8 97.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.228 0.537 . . . . 0.0 110.111 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.28 98.3 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.788 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.4 pt-20 -65.07 -38.56 91.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.264 -175.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -78.74 127.15 81.1 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 31.8 Cg_endo -64.25 -41.24 22.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.011 2.474 . . . . 0.0 112.384 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 100' ' ' ILE . 34.2 mm -132.87 123.59 48.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.644 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 33.2 tp -133.8 143.45 48.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.436 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.43 118.5 15.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.345 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.549 ' HE1' HD21 ' A' ' 18' ' ' LEU . 7.6 m-85 -96.46 119.13 34.38 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.273 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 22.8 ptt? -146.5 -168.08 2.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.896 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.049 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 40.1 ttmt -96.75 138.15 34.75 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -140.49 135.15 6.86 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 118.287 -1.911 . . . . 0.0 112.975 174.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 t -121.29 150.61 54.47 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.626 -1.287 . . . . 0.0 108.466 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.03 -38.14 58.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.023 1.815 . . . . 0.0 111.664 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -70.49 -35.09 73.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.773 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 29' ' ' SER . 59.0 tp -159.43 114.62 1.55 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.557 ' O ' ' HE1' ' A' ' 21' ' ' MET . 52.2 Cg_endo -73.38 32.51 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.081 2.521 . . . . 0.0 113.891 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.815 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 11.3 p -165.47 47.3 0.09 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.01 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 49.1 t -74.39 53.07 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.885 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.31 -141.22 3.14 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -76.4 -36.04 58.29 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.299 0.571 . . . . 0.0 109.847 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.573 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 48.7 p -52.35 -22.87 5.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.748 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.75 -44.43 28.14 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.473 0.483 . . . . 0.0 111.656 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.627 ' HG2' HD12 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -80.92 -35.34 32.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.582 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.608 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.571 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -54.47 -37.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.1 mm100 -65.76 -45.4 82.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.77 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -57.69 -44.73 86.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.509 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.613 HD12 ' CD1' ' A' ' 74' ' ' LEU . 1.2 tt -62.24 -57.13 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.481 . . . . 0.0 110.362 -175.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.49 71.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.123 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.21 -49.53 42.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.629 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.731 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.7 p -76.4 -49.97 15.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.344 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.47 -131.47 7.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.064 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.589 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 4.6 mm-40 -140.39 -152.56 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.149 0.579 . . . . 0.0 111.04 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 42.2 mmm-85 -55.68 148.02 17.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.832 0.825 . . . . 0.0 112.387 -173.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.571 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 21.9 p90 -156.65 155.36 31.65 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.292 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.01 159.25 15.09 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.687 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -143.7 154.32 43.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.43 127.81 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' MET . 12.1 p-10 -81.25 131.5 35.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.573 . . . . 0.0 110.585 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 21' ' ' MET . 1.2 pp -146.69 -32.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.287 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 1.049 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -67.32 -8.49 32.77 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.545 171.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.425 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -97.42 -48.55 5.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.33 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.609 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.3 m-20 -79.66 116.03 57.89 Favored Pre-proline 0 N--CA 1.472 0.647 0 O-C-N 122.118 -0.364 . . . . 0.0 110.784 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 24.7 Cg_exo -64.14 -44.34 12.63 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.981 2.454 . . . . 0.0 113.402 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -66.42 -54.64 21.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -62.28 -34.76 65.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 29.2 ttm180 -53.16 -40.91 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.031 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.463 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -79.61 -38.6 33.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -167.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.88 -59.21 2.87 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -161.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.942 ' HB3' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.17 -26.94 0.57 Allowed Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -170.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.734 ' HD3' HD11 ' A' ' 62' ' ' LEU . 18.4 Cg_endo -57.08 -41.61 72.76 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.603 1.608 . . . . 0.0 111.521 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 53.6 mtmt -59.58 -34.24 72.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.701 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.578 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -66.15 -42.2 89.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . . . -75.95 -56.86 4.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.446 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.701 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 22.6 t-20 -175.71 -55.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 122.159 0.981 . . . . 0.0 109.613 170.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.701 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.8 OUTLIER -56.82 150.37 38.04 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.645 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -63.79 -38.83 37.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.419 2.079 . . . . 0.0 110.283 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.9 p -141.4 -125.97 0.1 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.388 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.76 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.4 m-85 -141.13 -166.1 0.11 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.76 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 39.1 Cg_endo -65.65 156.7 78.42 Favored 'Cis proline' 0 C--N 1.362 1.244 0 CA-C-N 121.597 1.606 . . . . 0.0 113.836 -2.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.681 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 70.9 mt-30 -146.52 131.39 18.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.805 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.613 ' CD1' HD12 ' A' ' 40' ' ' LEU . 61.1 tp -91.32 137.84 32.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.625 174.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.61 ' CZ2' ' HB3' ' A' ' 66' ' ' ALA . 58.2 m95 -121.9 125.21 45.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.284 0.564 . . . . 0.0 109.921 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.491 HG22 HD13 ' A' ' 100' ' ' ILE . 66.4 t -110.04 119.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.197 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 58.24 28.85 17.17 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 123.403 1.573 . . . . 0.0 108.589 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.494 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 75.62 29.8 59.07 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.726 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 48.9 mt-10 -126.97 131.0 51.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.661 0.267 . . . . 0.0 110.359 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.57 HD23 ' CZ3' ' A' ' 68' ' ' TRP . 47.6 tp -67.66 130.9 44.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -173.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 86' ' ' ILE . 94.4 t -112.29 -52.52 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.123 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 145.85 136.0 2.88 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.511 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -86.88 -64.09 1.43 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.377 -1.392 . . . . 0.0 116.471 -169.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.0 p -80.13 -66.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.692 -0.887 . . . . 0.0 112.831 -171.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -74.03 -46.36 43.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.026 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 81' ' ' VAL . 2.0 mp -60.98 -46.79 95.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.21 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.608 ' HB ' ' HB1' ' A' ' 36' ' ' ALA . 70.9 t -55.76 -49.4 74.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.258 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.627 HD12 ' HG2' ' A' ' 35' ' ' GLN . 36.9 mm -62.12 -50.71 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.947 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.6 tt0 -62.46 -51.93 65.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.679 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.602 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -58.95 -33.63 70.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.308 0.243 . . . . 0.0 111.543 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.668 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.2 t80 -59.06 -52.48 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.129 172.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.0 mt-30 -62.88 -42.88 99.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.418 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 38.5 mmm-85 -62.58 -34.55 77.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.248 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 102.58 -23.79 32.91 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.945 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.779 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.3 mt-10 -56.11 -33.27 64.95 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.6 tt -69.77 -50.04 47.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.184 0.516 . . . . 0.0 109.669 -174.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.731 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.2 pt20 -61.55 -25.22 67.16 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.058 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.5 mm100 -69.79 -48.08 60.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.53 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 54.1 mt -63.9 -46.11 86.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.201 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.491 HD13 HG22 ' A' ' 76' ' ' VAL . 50.5 mm -64.43 -44.48 97.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.818 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.469 ' CE ' ' HB1' ' A' ' 114' ' ' ALA . 37.4 ttmt -48.74 -52.14 25.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.352 0.596 . . . . 0.0 111.144 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -62.24 -50.82 70.22 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.432 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.578 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 95.3 m -71.18 -48.94 48.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.514 ' HB2' ' OD2' ' A' ' 113' ' ' ASP . . . -61.67 -46.37 90.0 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.141 -0.349 . . . . 0.0 110.55 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . . . -61.77 -32.85 73.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.911 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.663 ' HZ3' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -80.44 -17.86 50.51 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.654 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 53.9 m-85 -90.5 -50.52 5.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.858 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.588 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 2.1 mppt? -103.06 121.23 42.15 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 165.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 p -46.26 113.19 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 105' ' ' ALA . 53.5 mt-10 49.66 44.56 24.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.317 -1.765 . . . . 0.0 113.355 172.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.588 ' OE1' ' HB2' ' A' ' 108' ' ' LYS . 8.9 pt-20 -75.67 130.16 79.8 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.521 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 3.7 Cg_exo -79.56 121.62 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.743 2.295 . . . . 0.0 111.611 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.589 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 43.7 m-20 -109.13 -63.23 1.38 Allowed 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 97' ' ' GLN . . . -78.11 -38.4 44.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.416 ' CD ' ' HZ3' ' A' ' 101' ' ' LYS . 12.2 pm0 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.243 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.589 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 57.4 p -163.7 51.87 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.913 -172.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 p -70.99 -136.35 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.538 HG21 HG13 ' A' ' 8' ' ' ILE . 26.9 m -60.38 -31.79 70.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.864 -175.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.691 ' CG2' HE21 ' A' ' 9' ' ' GLN . 59.9 mt -51.1 -38.78 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.589 ' HG3' ' HB2' ' A' ' 2' ' ' SER . 3.7 mm-40 -59.92 -43.54 94.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 0.0 110.065 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -63.75 -45.22 90.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.038 172.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.892 HD13 ' HB3' ' A' ' 62' ' ' LEU . 74.4 mt -60.94 -43.86 96.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.659 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.691 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.8 mt-30 -63.24 -38.71 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.299 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -60.75 -37.01 80.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.32 0.581 . . . . 0.0 109.766 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 38.2 tt0 -68.09 -45.45 73.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.001 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.432 HG21 ' HA2' ' A' ' 78' ' ' GLY . 36.4 mt -70.43 -44.59 77.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 110.661 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.26 77.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.2 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.34 -34.04 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.829 -176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 76.9 m-20 -77.61 128.63 79.26 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-O 121.166 0.508 . . . . 0.0 111.112 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 15' ' ' ASN . 44.5 Cg_exo -61.78 -42.92 28.68 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 123.008 2.472 . . . . 0.0 112.679 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mm -139.61 122.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' CD2' ' HE1' ' A' ' 20' ' ' TYR . 23.2 tp -134.15 141.34 47.06 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.505 -169.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.493 ' HG ' ' HG3' ' A' ' 21' ' ' MET . 12.1 tp -135.45 117.21 15.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.525 -176.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.542 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 8.7 m-85 -97.33 117.99 32.8 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.938 174.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.575 ' HE2' ' CD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.09 -159.48 1.04 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.727 177.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.047 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 34.7 ttpt -99.65 117.75 34.68 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.374 -0.829 . . . . 0.0 110.562 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.579 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.84 70.6 0.95 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.512 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -78.21 140.68 61.41 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.45 -41.3 74.29 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.054 1.836 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -69.46 -30.35 68.23 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.041 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tt -156.57 105.91 2.0 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.44 ' O ' ' SD ' ' A' ' 21' ' ' MET . 15.0 Cg_exo -73.66 28.57 0.31 Allowed 'Trans proline' 0 C--O 1.223 -0.225 0 C-N-CA 122.642 2.228 . . . . 0.0 114.052 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -166.09 52.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.836 0.351 . . . . 0.0 111.484 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.655 ' HB3' ' HE3' ' A' ' 22' ' ' LYS . 46.3 t -71.32 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.08 -139.29 47.8 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.203 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.472 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 37.9 m-85 -79.29 -20.88 46.92 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 21' ' ' MET . 30.6 p -70.2 -11.71 61.08 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -170.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.24 -43.89 22.32 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.352 0.407 . . . . 0.0 111.864 -175.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.566 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.02 -40.02 40.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.617 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' A' ' 87' ' ' VAL . . . -64.16 -44.96 90.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.154 -173.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p -55.75 -38.8 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.559 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.502 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -67.24 -46.66 73.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.891 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . . . -59.87 -42.31 93.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.862 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.522 HD12 ' CD2' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -62.09 -56.74 15.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.374 0.607 . . . . 0.0 109.704 -175.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.06 72.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.486 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -46.34 64.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.901 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.4 m -71.91 -59.36 2.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.04 -145.01 13.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.371 -0.918 . . . . 0.0 114.499 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.813 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 32.2 mm-40 -120.37 -150.41 0.45 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.857 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 43.2 mmm-85 -55.54 144.98 24.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.058 0.933 . . . . 0.0 113.262 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -150.83 152.56 33.93 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.386 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.7 152.71 19.35 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.479 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.575 ' CD1' ' HE2' ' A' ' 21' ' ' MET . 2.9 p90 -137.36 150.58 47.81 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.56 126.56 63.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.579 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.4 p30 -76.23 129.55 36.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.3 pp -145.59 -36.41 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 1.047 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.99 -11.58 30.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.423 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.43 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.51 -41.78 8.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.405 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -87.93 116.14 65.26 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 122.198 -0.313 . . . . 0.0 110.667 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.16 -43.83 13.94 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.167 1.912 . . . . 0.0 113.28 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.16 -50.67 67.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.029 0.443 . . . . 0.0 111.8 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.0 -40.67 81.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.63 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 78.9 ttt180 -52.1 -37.69 54.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.89 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.41 -49.16 44.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.2 -59.17 2.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -163.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.892 ' HB3' HD13 ' A' ' 8' ' ' ILE . 2.1 pt? -66.1 -33.21 6.58 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -168.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.706 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 12.8 Cg_endo -55.16 -40.13 87.38 Favored 'Trans proline' 0 C--N 1.348 0.501 0 CA-C-N 121.182 1.458 . . . . 0.0 110.573 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -51.71 -41.02 61.16 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.759 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.537 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -70.68 -42.94 70.07 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.446 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.79 -59.92 2.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.703 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.72 ' HB2' ' HE3' ' A' ' 68' ' ' TRP . 8.4 m120 -168.61 -59.42 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.971 0.908 . . . . 0.0 109.172 168.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.72 ' HE3' ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -53.46 149.84 13.83 Favored Pre-proline 0 C--O 1.217 -0.61 0 CA-C-N 113.118 -1.855 . . . . 0.0 113.697 -174.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.99 -37.36 43.83 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 121.873 1.716 . . . . 0.0 110.229 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 74.5 p -142.12 -123.41 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.279 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.841 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.6 m-85 -141.03 -168.04 0.17 Allowed Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.841 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.3 Cg_endo -67.8 153.41 87.0 Favored 'Cis proline' 0 C--N 1.362 1.261 0 CA-C-N 121.309 1.503 . . . . 0.0 114.286 -1.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.622 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.7 mt-30 -141.41 134.77 29.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.661 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.522 ' CD2' HD12 ' A' ' 40' ' ' LEU . 3.3 tm? -99.22 135.17 41.02 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -119.63 131.11 55.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.795 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.701 HG21 HD12 ' A' ' 100' ' ' ILE . 89.2 t -116.66 120.6 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.533 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t0 54.8 37.74 29.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 123.242 1.496 . . . . 0.0 108.595 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.432 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 67.19 29.09 73.97 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.957 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -132.5 134.85 45.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.382 0.611 . . . . 0.0 111.366 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.602 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 60.8 tp -67.36 130.35 42.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.818 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 86' ' ' ILE . 99.3 t -106.03 -54.28 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.772 170.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.32 134.16 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.71 -63.98 1.58 Allowed Glycine 0 C--O 1.219 -0.829 0 C-N-CA 119.047 -1.549 . . . . 0.0 116.316 -167.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 22.4 p -80.21 -67.45 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.429 1.115 . . . . 0.0 112.956 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.33 -45.29 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.316 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.739 HG23 HG12 ' A' ' 81' ' ' VAL . 50.4 mm -57.8 -44.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.338 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.606 HG11 HD23 ' A' ' 96' ' ' LEU . 79.4 t -58.02 -48.51 84.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.99 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 38.1 mm -59.78 -49.91 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.388 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.758 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 35.5 tt0 -60.79 -52.95 62.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.291 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.511 ' HG3' ' CA ' ' A' ' 96' ' ' LEU . 41.7 tpp -60.88 -34.81 75.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.901 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 16.8 t80 -58.81 -51.45 69.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.014 171.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.6 mt-30 -62.38 -39.29 92.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.991 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.758 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 45.6 mmm-85 -60.75 -30.72 70.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.73 175.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.02 -23.69 10.45 Favored Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.725 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.9 mt-10 -62.51 -21.32 65.42 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.606 HD23 HG11 ' A' ' 87' ' ' VAL . 62.5 tp -61.35 -54.86 38.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.343 0.592 . . . . 0.0 110.669 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 11.8 pt20 -64.03 -25.53 68.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.374 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 13.3 mm100 -64.2 -48.08 77.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.272 0.558 . . . . 0.0 109.599 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 38.5 mt -65.74 -45.88 80.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.155 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.701 HD12 HG21 ' A' ' 76' ' ' VAL . 50.8 mm -63.82 -44.35 98.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.144 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 28.7 ttmt -51.89 -57.69 8.66 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 111.2 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.5 -45.79 92.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.165 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 80.7 m -68.99 -46.85 67.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.426 ' HA ' ' HZ2' ' A' ' 108' ' ' LYS . . . -60.75 -45.93 92.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.37 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.09 82.01 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.754 0.659 . . . . 0.0 112.323 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.06 -33.39 63.66 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.747 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.497 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 80.1 m-85 -80.19 -51.55 8.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.641 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.426 ' HZ2' ' HA ' ' A' ' 104' ' ' ALA . 1.1 mppt? -106.29 131.34 53.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m -51.82 125.44 15.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.471 0.653 . . . . 0.0 112.267 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 35.13 52.0 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.293 -1.776 . . . . 0.0 114.969 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 27.4 tt0 -77.37 120.49 81.73 Favored Pre-proline 0 N--CA 1.427 -1.592 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 6.1 Cg_exo -86.73 60.75 4.27 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.55 2.833 . . . . 0.0 114.563 -170.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.813 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.8 m-20 -50.95 -70.48 0.08 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 97' ' ' GLN . . . -83.81 -48.44 10.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.263 0.554 . . . . 0.0 110.966 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.446 ' H ' ' HE2' ' A' ' 101' ' ' LYS . 34.4 tt0 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.161 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.9 mtp . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -66.41 -43.61 85.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.844 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.594 ' O ' HG21 ' A' ' 4' ' ' THR . 74.7 p 56.19 115.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.3 1.04 . . . . 0.0 112.401 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.594 HG21 ' O ' ' A' ' 3' ' ' THR . 11.8 p -163.0 144.15 9.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.955 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.651 ' CG2' HE21 ' A' ' 9' ' ' GLN . 41.2 mt -54.61 -34.05 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.22 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.62 -51.15 64.01 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.484 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 20.4 ptmt -67.53 -40.37 85.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.44 0.638 . . . . 0.0 109.599 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 62' ' ' LEU . 73.9 mt -57.54 -49.09 81.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.941 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.651 HE21 ' CG2' ' A' ' 5' ' ' ILE . 68.3 mt-30 -61.71 -40.75 96.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.597 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -57.75 -37.07 72.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.296 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.544 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.01 -47.19 69.13 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.122 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.735 HG21 ' HA2' ' A' ' 78' ' ' GLY . 22.2 mt -67.52 -39.15 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.789 0.804 . . . . 0.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.71 88.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.512 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.6 pt-20 -70.33 -38.49 74.88 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 18' ' ' LEU . 1.6 p30 -77.17 135.44 66.38 Favored Pre-proline 0 CA--C 1.512 -0.514 0 CA-C-O 121.652 0.739 . . . . 0.0 111.877 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 33.7 Cg_exo -62.75 -42.17 26.91 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 122.801 2.334 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.5 mm -139.38 120.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.599 ' CD2' ' HE1' ' A' ' 20' ' ' TYR . 27.7 tp -131.66 142.89 49.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.483 0.659 . . . . 0.0 111.855 -171.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.9 tp -136.94 123.85 21.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.442 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.604 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.2 m-85 -98.86 119.99 38.55 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.801 -0.562 . . . . 0.0 111.702 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.591 ' O ' HD13 ' A' ' 52' ' ' ILE . 18.5 ptt? -146.23 -165.77 2.3 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.852 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 63.8 tttm -99.08 121.45 41.01 Favored 'General case' 0 C--O 1.208 -1.122 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.69 69.19 1.03 Allowed Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.332 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -79.94 148.54 68.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.818 -0.225 . . . . 0.0 111.233 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.85 -41.5 68.67 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.19 1.927 . . . . 0.0 111.121 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.596 ' HE3' ' SG ' ' A' ' 30' ' ' CYS . 60.8 pttt -66.7 -31.31 71.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.66 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 29' ' ' SER . 49.6 tp -160.43 122.84 1.82 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 2.8 Cg_exo -73.9 29.36 0.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 27' ' ' LEU . 8.3 t -165.35 47.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.48 173.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.596 ' SG ' ' HE3' ' A' ' 26' ' ' LYS . 34.6 t -71.24 57.08 0.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.86 -136.4 2.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -76.71 -38.65 53.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 117.607 0.703 . . . . 0.0 110.992 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.831 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 33.1 t -55.13 -10.15 0.5 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.54 -40.74 60.26 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.194 0.198 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.519 ' HG2' HD12 ' A' ' 88' ' ' ILE . 1.2 pm0 -80.49 -35.72 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.922 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 87' ' ' VAL . . . -64.24 -43.64 94.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.142 0.577 . . . . 0.0 112.518 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 38' ' ' GLN . 11.2 p -56.23 -36.13 44.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.337 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.528 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.3 mm100 -66.12 -43.8 86.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.102 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.626 ' HB1' HD11 ' A' ' 88' ' ' ILE . . . -57.08 -45.21 83.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.456 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.548 HD12 HD22 ' A' ' 74' ' ' LEU . 1.8 mt -61.84 -59.41 5.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.01 67.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -73.38 -49.13 28.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.402 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.818 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.1 p -75.55 -57.23 4.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.199 -171.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.25 -142.15 12.21 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.439 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 90.7 mt-10 -100.2 -151.46 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.943 0.878 . . . . 0.0 111.248 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.94 158.29 35.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.57 174.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.466 ' CE1' HD21 ' A' ' 19' ' ' LEU . 13.5 p90 -151.82 160.83 43.42 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.688 -171.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.19 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.6 p90 -140.3 152.56 45.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.557 HG22 HD11 ' A' ' 18' ' ' LEU . 51.5 t -129.37 132.19 66.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.804 0.335 . . . . 0.0 110.339 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 21' ' ' MET . 32.3 p-10 -76.64 129.32 36.22 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.543 0.687 . . . . 0.0 110.686 173.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.663 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.2 pp -144.4 -36.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.903 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.852 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -65.6 -10.42 35.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.814 168.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -43.8 7.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.603 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -83.86 113.94 50.81 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 122.137 -0.352 . . . . 0.0 110.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.9 -45.54 28.12 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.966 2.444 . . . . 0.0 113.381 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.504 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.89 -38.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.138 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 58.3 ttt-85 -49.81 -35.78 24.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.425 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.77 -41.28 14.24 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -174.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -79.57 -60.94 2.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -162.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.878 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -73.09 -27.66 0.88 Allowed Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -172.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.759 ' HD3' HD11 ' A' ' 62' ' ' LEU . 17.9 Cg_endo -57.2 -41.17 76.7 Favored 'Trans proline' 0 C--N 1.357 1.006 0 CA-C-N 121.368 1.524 . . . . 0.0 110.853 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 39.1 mtmt -54.86 -39.37 68.56 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.733 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -68.43 -41.52 80.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.871 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.564 ' HB1' ' CH2' ' A' ' 75' ' ' TRP . . . -74.91 -57.7 3.74 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.562 -176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.648 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 48.6 t30 -175.0 -53.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.947 0.88 . . . . 0.0 109.987 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.648 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.93 146.62 81.65 Favored Pre-proline 0 C--O 1.218 -0.6 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.208 -176.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.01 -35.99 84.81 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.127 1.885 . . . . 0.0 110.667 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.1 p -141.79 -128.58 0.1 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.568 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.854 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 30.5 m-85 -142.23 -173.75 0.38 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.854 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.6 Cg_endo -66.99 160.16 78.87 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 120.848 1.339 . . . . 0.0 114.36 -0.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.64 ' HA ' ' CA ' ' A' ' 83' ' ' GLY . 56.0 mt-30 -150.78 129.45 12.3 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.179 172.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.548 HD22 HD12 ' A' ' 40' ' ' LEU . 3.1 tm? -89.58 137.38 32.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.024 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.564 ' CH2' ' HB1' ' A' ' 66' ' ' ALA . 58.6 m95 -121.64 131.34 54.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.206 0.526 . . . . 0.0 110.87 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.957 HG23 HD12 ' A' ' 100' ' ' ILE . 67.2 t -116.6 119.52 62.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.617 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t70 54.75 41.5 31.87 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.993 1.378 . . . . 0.0 108.933 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.735 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 62.76 28.28 71.41 Favored Glycine 0 C--N 1.31 -0.897 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.696 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -129.04 134.8 48.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 111.107 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 54.3 tp -66.64 136.96 56.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.618 -173.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 86' ' ' ILE . 96.2 t -115.08 -56.26 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.813 170.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.754 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 155.73 133.74 1.73 Allowed Glycine 0 C--O 1.225 -0.431 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.64 ' CA ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.67 -61.37 1.7 Allowed Glycine 0 C--O 1.218 -0.886 0 C-N-CA 119.999 -1.096 . . . . 0.0 115.625 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.58 -67.9 0.73 Allowed 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.705 -0.88 . . . . 0.0 112.262 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -80.72 -51.32 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.9 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.754 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 50.1 mm -55.8 -53.5 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.459 -171.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.668 HG13 ' HB2' ' A' ' 36' ' ' ALA . 10.4 p -59.8 -43.12 91.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.34 -173.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.626 HD11 ' HB1' ' A' ' 39' ' ' ALA . 34.8 mm -59.14 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.489 175.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.722 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.9 tt0 -62.54 -48.94 77.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.483 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 25.6 mmt -54.62 -39.79 68.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.922 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.789 ' HB2' HD13 ' A' ' 96' ' ' LEU . 6.8 t80 -59.01 -52.68 64.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 174.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.1 -38.66 91.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.742 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 23.1 mmm180 -61.64 -32.07 72.2 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.402 0.62 . . . . 0.0 109.824 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 83.61 21.43 58.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.611 -174.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 62.8 mm-40 -90.34 -31.36 16.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 110.737 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 91' ' ' TYR . 1.4 tt -57.77 -54.75 43.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.204 -175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.818 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.1 pt20 -62.18 -27.43 68.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.394 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 9.4 mm-40 -68.83 -44.26 73.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.295 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 40.6 mt -65.84 -48.08 72.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.686 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.957 HD12 HG23 ' A' ' 76' ' ' VAL . 42.5 mm -60.86 -48.28 89.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.102 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.684 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 39.7 ttpt -58.17 -47.26 83.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.643 0.259 . . . . 0.0 111.676 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -59.49 -48.32 82.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.018 0.437 . . . . 0.0 110.046 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.617 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 60.2 m -69.74 -46.25 66.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.372 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.7 ' HB2' ' HE2' ' A' ' 108' ' ' LYS . . . -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.56 86.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.8 -26.57 64.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.877 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.592 ' HH ' ' CG ' ' A' ' 77' ' ' ASP . 92.3 m-85 -91.48 -48.9 6.61 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.531 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.7 ' HE2' ' HB2' ' A' ' 104' ' ' ALA . 39.4 mtmt -91.72 110.22 21.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -61.64 125.76 24.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.098 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 55.87 45.28 24.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.371 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 5.5 mm-40 -121.87 67.13 22.36 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.214 176.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.08 115.98 3.44 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.797 1.665 . . . . 0.0 112.431 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -77.21 -59.19 2.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.195 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -68.7 -58.04 4.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.058 0.456 . . . . 0.0 111.797 -172.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.479 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 9.7 tm-20 . . . . . 0 C--O 1.248 0.98 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.49 0.186 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 t 59.83 -129.62 1.05 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.201 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.8 m -148.03 53.62 1.03 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.999 0.905 . . . . 0.0 108.765 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.7 p -66.63 149.45 50.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.41 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.663 ' CG2' HE21 ' A' ' 9' ' ' GLN . 57.7 mt -52.24 -35.8 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.832 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.507 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 97.3 mt-10 -56.55 -46.01 80.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.342 . . . . 0.0 110.43 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.806 ' HZ3' ' HB3' ' A' ' 7' ' ' LYS . 3.7 mmmp? -65.21 -44.09 89.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 172.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 1.078 HG21 HD22 ' A' ' 62' ' ' LEU . 91.1 mt -60.31 -46.96 94.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.599 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.663 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.6 mt-30 -62.55 -43.6 98.41 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.803 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -59.09 -33.9 71.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.591 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.4 tt0 -72.35 -44.77 62.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.077 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.785 HG23 HD22 ' A' ' 18' ' ' LEU . 38.1 mt -67.31 -43.11 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.173 0.511 . . . . 0.0 110.184 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.41 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.211 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -66.8 -32.71 74.17 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.613 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -78.43 127.04 82.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.84 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 69.3 Cg_exo -58.47 -42.61 53.36 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.992 2.462 . . . . 0.0 111.973 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.3 mm -138.28 123.23 22.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD22 HG23 ' A' ' 12' ' ' ILE . 21.2 tp -133.92 141.24 47.25 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -171.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' CD2' ' HE1' ' A' ' 21' ' ' MET . 13.5 tp -138.98 118.87 13.24 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.749 -173.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.644 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 m-85 -97.69 124.75 42.14 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.332 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 13.3 ptp -145.03 -168.21 2.88 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.241 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.881 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 64.2 tttm -97.68 111.87 23.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.57 127.78 9.31 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 119.619 -1.276 . . . . 0.0 112.628 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 m -142.73 141.54 20.49 Favored Pre-proline 0 N--CA 1.442 -0.844 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -52.98 -41.16 73.42 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.331 2.021 . . . . 0.0 111.981 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.14 -27.24 62.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.164 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.453 HD21 ' H ' ' A' ' 29' ' ' SER . 1.4 tt -158.71 113.22 1.65 Allowed Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' O ' ' SD ' ' A' ' 21' ' ' MET . 39.3 Cg_endo -71.63 15.86 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.566 2.178 . . . . 0.0 114.156 -176.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.769 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.8 p -161.69 51.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 39.0 t -68.71 51.58 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.465 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.0 -137.02 2.11 Favored Glycine 0 C--N 1.316 -0.564 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.176 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.27 -39.79 53.46 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 117.11 0.455 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.799 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 19.2 t -57.64 -11.21 1.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.455 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' O ' HG11 ' A' ' 37' ' ' VAL . . . -53.31 -43.67 67.76 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.35 0.406 . . . . 0.0 111.521 176.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HG2' HD13 ' A' ' 88' ' ' ILE . 1.2 pm0 -80.25 -31.94 38.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.746 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.58 85.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.216 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.726 ' HB ' ' HE2' ' A' ' 21' ' ' MET . 9.5 p -54.46 -37.09 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.219 0.533 . . . . 0.0 110.447 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.512 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -64.56 -46.3 83.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -58.62 -44.08 89.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.577 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.53 HD13 HD23 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -62.73 -55.83 23.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.437 . . . . 0.0 110.376 -175.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.88 70.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.182 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.97 -48.6 43.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.509 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.7 p -75.69 -50.54 15.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.43 -130.51 7.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.092 -0.575 . . . . 0.0 114.419 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.616 ' OE2' ' HB1' ' A' ' 104' ' ' ALA . 2.4 pp20? -128.89 -152.74 0.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.457 -0.872 . . . . 0.0 109.65 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 -64.17 152.96 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.608 0.718 . . . . 0.0 111.421 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.49 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 20.8 p90 -158.78 150.01 20.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.866 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.05 144.24 28.42 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.193 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.2 p90 -124.87 154.61 40.79 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.4 t -130.66 130.14 64.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' MET . 11.3 p-10 -74.94 132.29 41.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.228 175.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -149.21 -31.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.965 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.881 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -68.34 -9.34 47.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.269 167.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.82 -47.68 6.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.984 176.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.4 m-20 -73.8 126.27 89.7 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 120.502 0.191 . . . . 0.0 110.653 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.98 -42.89 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.246 1.964 . . . . 0.0 113.16 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.86 -53.31 8.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.945 0.402 . . . . 0.0 112.021 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.525 HG21 HD23 ' A' ' 62' ' ' LEU . 37.3 mt -60.8 -32.34 51.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.49 0.662 . . . . 0.0 110.33 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.711 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 29.8 ttm180 -53.16 -34.91 58.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.167 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.4 6.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 61' ' ' GLU . 4.7 mm-40 -76.64 -55.0 5.9 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -163.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 1.078 HD22 HG21 ' A' ' 8' ' ' ILE . 3.6 pp -68.39 -35.89 7.78 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.711 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 25.6 Cg_endo -58.21 -42.43 56.76 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.393 1.396 . . . . 0.0 111.394 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -58.31 -34.17 70.29 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.073 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -65.65 -39.99 91.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.937 177.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.58 -53.53 11.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.575 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.897 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.5 t-20 -171.55 -47.83 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.022 174.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.897 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 33.5 p90 -124.8 146.33 52.68 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -40.19 -36.8 1.64 Allowed 'Trans proline' 0 C--N 1.352 0.715 1 C-N-CA 125.4 4.067 . . . . 0.0 117.152 -169.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 p -140.5 -135.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 119.076 0.853 . . . . 0.0 111.951 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.869 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 49.2 m-85 -145.15 -172.43 0.31 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.869 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 21.1 Cg_endo -62.91 154.53 69.04 Favored 'Cis proline' 0 C--N 1.36 1.184 0 CA-C-N 120.6 1.25 . . . . 0.0 114.33 -0.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.704 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 25.2 mt-30 -139.97 131.7 27.39 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.352 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.67 HD11 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -95.94 139.35 32.26 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.339 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.67 ' N ' HD11 ' A' ' 74' ' ' LEU . 57.7 m95 -127.73 127.79 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.384 0.611 . . . . 0.0 110.739 177.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 99' ' ' LEU . 57.3 t -113.2 118.33 57.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.273 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.587 ' HB2' HG21 ' A' ' 103' ' ' THR . 10.6 t70 57.03 32.26 21.37 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 123.757 1.741 . . . . 0.0 108.711 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.773 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.33 28.43 67.96 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 113.488 -1.687 . . . . 0.0 113.04 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 40.5 mt-10 -119.44 133.37 55.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.668 HD22 ' CZ3' ' A' ' 68' ' ' TRP . 18.9 tp -65.57 131.44 46.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.781 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.581 ' O ' HD11 ' A' ' 86' ' ' ILE . 84.6 t -117.76 -52.84 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.931 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.744 ' HA2' ' HH2' ' A' ' 68' ' ' TRP . . . 134.08 133.24 3.3 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.421 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.37 -60.82 1.87 Allowed Glycine 0 C--O 1.222 -0.634 0 N-CA-C 116.367 1.307 . . . . 0.0 116.367 -166.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -75.24 -68.95 0.51 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.439 -1.036 . . . . 0.0 113.378 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -78.71 -43.9 24.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.443 0.639 . . . . 0.0 110.629 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.581 HD11 ' O ' ' A' ' 81' ' ' VAL . 43.7 mt -60.34 -42.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.456 -171.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -59.93 -50.38 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.055 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.512 HD12 ' HB1' ' A' ' 39' ' ' ALA . 37.7 mm -60.73 -49.04 86.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.447 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.776 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.9 tt0 -61.89 -54.35 43.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.918 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.406 ' HA ' ' HB2' ' A' ' 93' ' ' ARG . 55.1 mtt -58.43 -32.46 68.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.586 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.2 t80 -58.57 -53.19 61.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.73 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.1 mt-30 -65.12 -39.45 93.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.48 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.776 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.0 mmt180 -59.37 -33.6 71.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.657 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.608 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 94.8 -24.37 28.51 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -169.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.664 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.8 mt-10 -57.57 -31.22 65.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.601 HD11 HD12 ' A' ' 99' ' ' LEU . 56.3 tp -68.91 -55.42 11.08 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.585 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.916 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 10.2 pt20 -57.56 -24.71 57.66 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.15 171.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.3 mm100 -71.01 -56.75 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 76' ' ' VAL . 2.2 pp -70.67 -34.72 72.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.668 ' N ' HD13 ' A' ' 99' ' ' LEU . 38.1 mm -62.03 -42.32 94.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 39.5 ttmt -52.32 -56.8 12.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.183 0.516 . . . . 0.0 112.072 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.38 -45.9 90.17 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.582 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.587 HG21 ' HB2' ' A' ' 77' ' ' ASP . 58.8 m -66.45 -51.09 60.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.351 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.616 ' HB1' ' OE2' ' A' ' 45' ' ' GLU . . . -60.94 -51.66 68.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.87 -175.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.61 73.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.515 -176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.578 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.58 -25.73 50.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.042 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 54.4 m-85 -84.93 -48.59 9.14 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.09 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.428 ' HZ2' ' CD ' ' A' ' 45' ' ' GLU . 2.5 mppt? -102.66 108.41 19.67 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 163.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 m -53.46 122.76 10.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.416 0.627 . . . . 0.0 110.787 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 49.31 38.98 14.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.736 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 45' ' ' GLU . 38.7 tt0 -77.49 133.32 67.52 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.05 128.26 23.61 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.865 1.71 . . . . 0.0 112.65 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -98.6 -129.49 0.19 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.694 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.916 ' HB3' ' HB2' ' A' ' 97' ' ' GLN . . . -82.01 -46.64 13.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.901 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.596 -1.192 . . . . 0.0 108.558 -171.061 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.783 0.325 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 p -177.59 142.65 0.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.555 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -71.52 -127.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.122 0.264 . . . . 0.0 110.861 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG13 ' A' ' 8' ' ' ILE . 44.6 p -143.47 -134.66 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 0.0 111.2 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.664 ' CG2' HE21 ' A' ' 9' ' ' GLN . 77.8 mt -51.19 -37.08 17.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.478 0.711 . . . . 0.0 112.607 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.97 -44.03 82.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.144 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.651 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -70.79 -45.45 64.66 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.956 0.408 . . . . 0.0 110.175 171.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.618 HD11 HD23 ' A' ' 62' ' ' LEU . 79.4 mt -54.35 -47.09 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.664 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.7 mt-30 -63.62 -39.74 95.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.596 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 12.1 mmp_? -61.09 -34.22 74.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.343 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -74.63 -41.27 60.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.469 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.768 HG22 ' HA2' ' A' ' 78' ' ' GLY . 30.5 mt -66.5 -46.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.712 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.468 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.13 -39.96 94.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.862 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' OE2' ' HA ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -65.5 -32.5 74.13 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.113 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -76.68 125.44 87.25 Favored Pre-proline 0 CA--C 1.517 -0.312 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.846 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HA ' ' CE2' ' A' ' 107' ' ' TYR . 45.7 Cg_exo -62.26 -42.91 25.84 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 122.462 2.108 . . . . 0.0 112.225 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.7 mm -136.27 121.71 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.582 HD13 HG22 ' A' ' 50' ' ' VAL . 22.0 tp -133.05 142.08 48.58 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.327 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.1 tp -137.21 119.9 16.16 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.151 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.66 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -97.36 120.03 36.99 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.986 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.68 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 21.1 ptt? -146.29 -170.92 3.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.126 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.026 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.2 119.87 35.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.387 -0.821 . . . . 0.0 109.576 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.77 71.62 1.29 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.077 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.403 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 36.6 t -78.54 142.56 62.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.85 -40.9 82.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.019 1.812 . . . . 0.0 111.459 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.7 pttt -67.99 -30.36 69.61 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.805 177.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 29' ' ' SER . 49.1 tp -160.62 115.97 1.4 Allowed Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' O ' ' HE1' ' A' ' 21' ' ' MET . 12.2 Cg_exo -71.19 29.73 0.22 Allowed 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 123.145 2.563 . . . . 0.0 112.985 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.68 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 11.9 p -162.58 46.61 0.15 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 42.6 t -64.64 147.57 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.678 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.55 -141.35 15.27 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.799 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -78.2 -38.27 43.69 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.0 p -46.77 -19.61 0.1 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.35 -42.99 53.94 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.985 0.178 . . . . 0.0 111.095 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.602 HE21 ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.35 -37.11 38.26 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' N ' HE21 ' A' ' 35' ' ' GLN . . . -66.6 -45.79 78.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.556 HG12 HE21 ' A' ' 38' ' ' GLN . 13.1 p -56.36 -36.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.73 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.556 HE21 HG12 ' A' ' 37' ' ' VAL . 32.3 mm-40 -66.78 -46.85 73.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.285 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 91' ' ' TYR . . . -59.05 -40.09 84.02 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.15 0.281 . . . . 0.0 111.609 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.56 HD11 HD21 ' A' ' 74' ' ' LEU . 1.3 tt -62.43 -57.26 11.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.938 -175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 -35.19 79.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.386 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.12 -47.67 76.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.016 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.717 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.3 m -73.08 -55.57 6.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.2 -133.14 8.01 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.308 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 113' ' ' ASP . 64.5 mm-40 -137.36 -150.64 0.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.708 -0.746 . . . . 0.0 110.241 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.585 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -60.07 150.72 28.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.476 0.655 . . . . 0.0 112.487 -172.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.421 ' CE1' HD23 ' A' ' 19' ' ' LEU . 20.3 p90 -157.93 156.72 31.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.359 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -98.34 152.94 18.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.621 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.5 p90 -138.1 152.63 48.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.582 HG22 HD13 ' A' ' 18' ' ' LEU . 58.6 t -129.66 130.91 67.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 110.27 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' MET . 9.5 p-10 -76.53 128.12 34.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.58 175.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.66 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -145.22 -38.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 1.026 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -60.46 -17.81 47.2 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.003 0.82 . . . . 0.0 110.822 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.677 HE22 ' ND2' ' A' ' 55' ' ' ASN . 3.1 pp0? -95.34 -33.97 12.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.677 ' ND2' HE22 ' A' ' 54' ' ' GLN . 77.9 m-20 -74.72 131.22 79.91 Favored Pre-proline 0 N--CA 1.477 0.88 0 O-C-N 122.178 -0.326 . . . . 0.0 110.709 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.79 -43.99 4.68 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.467 2.111 . . . . 0.0 112.943 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.58 -57.95 3.56 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.63 HG22 ' CG2' ' A' ' 52' ' ' ILE . 37.5 mt -59.71 -35.28 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.688 -173.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.565 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -55.72 -27.99 53.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.95 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.51 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -89.14 -48.08 7.64 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -171.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.646 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 52.7 mt-10 -78.93 -60.05 2.53 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.294 1.591 . . . . 0.0 115.294 -162.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.678 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 1.8 pt? -67.47 -34.64 7.05 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 19.1 Cg_endo -56.11 -38.22 95.2 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.405 1.403 . . . . 0.0 110.997 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 42.8 mtmt -55.23 -41.99 72.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.439 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.535 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.63 -38.86 84.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.093 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . . . -68.75 -53.54 21.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.158 -175.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.934 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.6 t-20 -172.35 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.658 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.934 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 31.2 p90 -126.49 149.42 67.68 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.736 -167.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.62 -37.48 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 125.256 3.971 . . . . 0.0 117.05 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.9 p -140.78 -137.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.202 0.91 . . . . 0.0 111.961 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.864 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 42.6 m-85 -140.57 -170.71 0.25 Allowed Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -173.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.864 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.0 Cg_endo -64.41 148.62 70.15 Favored 'Cis proline' 0 C--N 1.36 1.149 0 CA-C-N 120.864 1.344 . . . . 0.0 113.495 -2.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.624 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 68.2 mt-30 -133.5 130.59 38.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.758 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.56 HD21 HD11 ' A' ' 40' ' ' LEU . 3.3 tm? -92.31 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.539 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 67.3 m95 -125.03 129.4 50.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.69 0.757 . . . . 0.0 111.323 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.547 HG23 HD12 ' A' ' 100' ' ' ILE . 86.5 t -115.91 120.08 63.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.1 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.493 ' N ' HG21 ' A' ' 103' ' ' THR . 10.1 t70 56.93 32.08 20.9 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 123.078 1.418 . . . . 0.0 109.145 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.768 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.17 28.19 70.59 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 114.044 -1.435 . . . . 0.0 113.264 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -127.95 135.14 49.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 111.126 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.763 HD22 ' CZ3' ' A' ' 68' ' ' TRP . 19.4 tp -64.65 136.13 56.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.67 -172.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.3 t -120.8 -53.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.358 170.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.862 ' HA2' ' HH2' ' A' ' 68' ' ' TRP . . . 129.7 133.32 3.58 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.567 ' HA2' HG23 ' A' ' 87' ' ' VAL . . . -85.73 -61.37 1.7 Allowed Glycine 0 C--O 1.221 -0.69 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -167.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.18 -68.91 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.632 -0.922 . . . . 0.0 113.431 -166.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -80.72 -41.91 22.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.077 0.465 . . . . 0.0 110.469 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.445 ' CD1' ' H ' ' A' ' 86' ' ' ILE . 2.5 mp -60.41 -45.7 96.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.58 -171.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.708 HG12 HD23 ' A' ' 96' ' ' LEU . 71.0 t -58.83 -47.67 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.715 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.525 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 32.8 mm -60.15 -46.61 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.02 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.715 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 85.2 tt0 -61.11 -54.66 41.82 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.932 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.578 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.3 mmt -57.97 -36.32 72.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.712 0.292 . . . . 0.0 111.512 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.703 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 18.7 t80 -56.36 -51.43 68.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.781 172.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 77.2 mt-30 -65.32 -38.46 90.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.715 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.9 mmm180 -58.94 -34.37 71.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.072 176.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 86.88 -23.93 9.78 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -168.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.78 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.6 mt-10 -58.01 -29.39 65.27 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 87' ' ' VAL . 63.7 tp -60.14 -56.63 19.19 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.201 0.524 . . . . 0.0 111.063 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.717 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.2 pt20 -63.12 -28.99 70.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.917 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.6 mm100 -62.27 -47.15 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.038 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 37.0 mt -66.19 -45.36 81.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 96' ' ' LEU . 49.5 mm -61.38 -47.88 91.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.721 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.844 ' HD3' ' H ' ' A' ' 115' ' ' GLU . 39.7 ttpt -62.01 -49.46 75.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.553 0.216 . . . . 0.0 111.339 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -55.42 -44.95 76.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.614 0.721 . . . . 0.0 109.957 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.493 HG21 ' N ' ' A' ' 77' ' ' ASP . 92.9 m -70.53 -45.86 64.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.472 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.509 ' HA ' ' HZ3' ' A' ' 108' ' ' LYS . . . -59.65 -44.23 93.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 109' ' ' SER . . . -61.01 -41.84 97.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.478 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -72.87 -31.78 64.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.333 -178.494 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.561 ' CE2' ' HA ' ' A' ' 16' ' ' PRO . 60.0 m-85 -78.47 -47.09 18.15 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.533 ' CE ' ' HG3' ' A' ' 111' ' ' GLU . 3.1 mppt? -98.82 -145.47 0.32 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.496 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 105' ' ' ALA . 50.4 m -83.57 -155.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -70.08 59.91 0.18 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.533 ' HG3' ' CE ' ' A' ' 108' ' ' LYS . 58.5 mm-40 -59.48 121.94 60.61 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -92.7 48.14 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.656 2.237 . . . . 0.0 113.924 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.1 m-20 -51.27 -51.27 55.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.113 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.677 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -88.63 -48.04 7.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.043 0.449 . . . . 0.0 111.304 176.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.844 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 3.5 tm-20 . . . . . 0 C--O 1.244 0.793 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 pmm? . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.872 0.368 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 p -168.84 -42.89 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.369 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.6 p -74.29 46.24 0.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.902 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 p -69.63 137.59 52.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.944 0.402 . . . . 0.0 110.558 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.665 ' CG2' HE21 ' A' ' 9' ' ' GLN . 61.1 mt -58.23 -31.28 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.681 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -55.61 -47.1 77.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.21 -43.5 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.48 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.867 HD11 ' HB2' ' A' ' 62' ' ' LEU . 85.2 mt -62.32 -47.83 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.435 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.665 HE21 ' CG2' ' A' ' 5' ' ' ILE . 73.0 mt-30 -62.91 -39.35 94.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.224 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -58.86 -34.5 71.66 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 8.2 tt0 -73.14 -50.35 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.64 HG21 ' HA2' ' A' ' 78' ' ' GLY . 26.5 mt -63.4 -38.13 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.873 0.845 . . . . 0.0 111.042 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.4 83.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.269 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -73.78 -35.82 65.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.861 -171.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.652 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -77.21 131.28 72.69 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 121.494 0.664 . . . . 0.0 111.323 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 50.2 Cg_exo -59.44 -42.06 52.05 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.24 2.626 . . . . 0.0 112.492 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.463 HG23 HD11 ' A' ' 100' ' ' ILE . 33.9 mm -141.9 121.33 10.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.652 HD22 ' OD1' ' A' ' 15' ' ' ASN . 22.8 tp -131.83 142.67 49.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 0.0 111.313 -170.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.663 HD23 ' SD ' ' A' ' 21' ' ' MET . 11.8 tp -137.22 121.45 18.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.359 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.651 ' HB3' HG12 ' A' ' 52' ' ' ILE . 8.0 m-85 -97.92 115.69 28.62 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.901 ' HE1' ' HB3' ' A' ' 33' ' ' SER . 14.2 ptm -148.06 -157.18 0.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.016 173.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 tttt -98.28 125.98 43.59 Favored 'General case' 0 C--O 1.213 -0.857 0 O-C-N 121.232 -0.917 . . . . 0.0 112.154 -169.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 67.91 0.94 Allowed Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.442 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 p -77.09 145.04 72.75 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -51.62 -41.48 60.97 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.616 2.211 . . . . 0.0 112.127 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.75 -29.08 68.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.131 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 29' ' ' SER . 2.8 tt -159.96 118.0 1.57 Allowed Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -173.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.66 17.84 0.13 Allowed 'Trans proline' 0 N--CA 1.47 0.141 0 C-N-CA 122.801 2.334 . . . . 0.0 114.471 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.82 ' HB2' ' HE3' ' A' ' 21' ' ' MET . 11.2 p -164.12 61.11 0.15 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.42 0.629 . . . . 0.0 112.605 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 39.1 t -80.67 -143.3 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.946 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 65.42 -152.89 51.27 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 122.409 -0.182 . . . . 0.0 113.432 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 17.6 m-85 -78.19 -35.95 48.0 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.901 ' HB3' ' HE1' ' A' ' 21' ' ' MET . 32.4 t -59.72 -7.3 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.036 -0.415 . . . . 0.0 112.091 -172.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' HG13 ' A' ' 37' ' ' VAL . . . -45.28 -42.05 9.27 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.527 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.01 -38.86 61.43 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.244 0.545 . . . . 0.0 109.708 177.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -65.72 -43.97 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.383 -175.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 34' ' ' ALA . 11.1 p -55.87 -37.6 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.449 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.531 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 1.5 mm100 -67.78 -45.44 74.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.783 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HB3' ' CG ' ' A' ' 91' ' ' TYR . . . -58.0 -44.69 87.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.644 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -61.25 -57.49 12.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.955 0.407 . . . . 0.0 110.271 -175.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.05 -32.17 70.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.567 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 38' ' ' GLN . . . -69.35 -48.6 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.2 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.3 p -74.47 -54.58 7.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.18 -130.2 6.93 Favored Glycine 0 N--CA 1.454 -0.151 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.933 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.674 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 49.5 mt-10 -140.84 -149.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.168 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -48.1 146.64 2.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.47 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 20.0 p90 -158.5 153.15 24.66 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.35 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.61 152.77 19.24 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.682 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -132.12 148.44 52.48 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.602 HG21 HD12 ' A' ' 18' ' ' LEU . 43.3 t -123.2 131.12 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.6 p30 -81.63 131.23 35.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.365 0.602 . . . . 0.0 109.957 176.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.651 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.2 pp -147.49 -28.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.741 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.9 mm? -65.87 -14.5 61.58 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 -46.12 6.58 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.858 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.8 m-20 -77.28 121.33 84.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.615 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 18.5 Cg_exo -66.89 -43.66 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.974 2.449 . . . . 0.0 112.939 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.78 -51.08 29.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mt -63.52 -34.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.172 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.621 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 47.9 ttt85 -50.88 -35.32 32.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.195 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.606 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -90.89 -51.87 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 56.6 mm-40 -76.93 -55.46 5.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -167.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.867 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -61.55 -43.57 89.12 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -172.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.621 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 20.4 Cg_endo -57.81 -41.54 68.62 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 121.334 1.356 . . . . 0.0 111.217 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 52.4 mtmt -57.04 -35.27 69.1 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.766 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -67.0 -43.22 83.48 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.943 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.493 ' HB1' ' CZ2' ' A' ' 75' ' ' TRP . . . -75.08 -56.88 4.29 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.799 -175.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.703 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 25.8 t-20 -174.85 -55.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.34 1.067 . . . . 0.0 109.507 172.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.703 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.3 m-90 -58.79 147.28 72.58 Favored Pre-proline 0 C--O 1.216 -0.687 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.339 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.71 -38.27 72.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.345 2.03 . . . . 0.0 110.306 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.9 p -142.66 -124.73 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.462 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.918 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 53.6 m-85 -139.61 -172.27 0.31 Allowed Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.918 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 64.3 Cg_endo -71.37 165.05 81.99 Favored 'Cis proline' 0 C--N 1.357 1.014 0 CA-C-N 120.777 1.313 . . . . 0.0 114.611 -1.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.778 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.6 pt20 -156.74 133.67 10.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.038 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.586 ' CD1' HD11 ' A' ' 40' ' ' LEU . 61.4 tp -90.72 141.91 28.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.734 178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.644 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 52.1 m95 -129.16 125.13 36.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 110.329 175.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 100' ' ' ILE . 60.6 t -106.04 117.37 51.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.653 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 60.6 t0 57.09 33.99 24.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 123.117 1.437 . . . . 0.0 109.465 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.64 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 71.41 29.24 68.42 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.071 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -127.31 129.04 46.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.312 . . . . 0.0 110.492 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.492 HD23 ' CZ3' ' A' ' 68' ' ' TRP . 59.2 tp -67.95 135.56 52.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.806 -170.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 86' ' ' ILE . 97.9 t -117.48 -53.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.194 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' O ' HG22 ' A' ' 87' ' ' VAL . . . 146.54 140.03 3.4 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.02 -67.35 1.41 Allowed Glycine 0 C--O 1.216 -0.994 0 C-N-CA 118.226 -1.94 . . . . 0.0 116.258 -167.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 41.8 t -81.61 -68.72 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.728 1.264 . . . . 0.0 113.088 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.88 -47.13 60.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.404 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 81' ' ' VAL . 45.7 mm -58.36 -43.78 87.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.388 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 69.3 t -59.46 -49.23 84.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.974 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.514 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.3 mm -58.22 -49.68 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.36 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.72 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.2 tt0 -61.25 -54.28 46.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.693 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.753 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 24.9 mmt -58.58 -35.03 71.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.5 t80 -58.62 -50.63 73.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.767 173.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.2 mt-30 -62.69 -41.32 99.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.72 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 28.8 mmm180 -58.74 -33.88 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.699 178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.9 17.37 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.65 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.808 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 41.0 mt-10 -57.49 -36.92 72.12 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 122.96 0.504 . . . . 0.0 111.728 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.753 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.9 tt -61.29 -54.63 41.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.128 0.49 . . . . 0.0 109.92 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.758 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 18.9 pt20 -64.91 -28.96 69.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.889 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 2.0 tp-100 -63.93 -44.13 93.81 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.239 0.616 . . . . 0.0 110.032 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.808 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 43.0 mt -68.78 -47.53 65.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.907 174.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.709 HD12 HG21 ' A' ' 76' ' ' VAL . 46.3 mm -57.56 -47.65 84.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.432 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.793 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 26.7 ttpp -55.26 -50.73 68.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.664 0.269 . . . . 0.0 111.692 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -48.77 80.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.653 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.0 m -65.17 -53.24 47.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.399 0.619 . . . . 0.0 111.694 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.633 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.71 -44.14 97.0 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.822 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.62 75.92 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.399 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.46 -29.34 67.0 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.131 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.584 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 46.9 m-85 -79.56 -46.06 18.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.633 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -77.77 -163.73 0.43 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.097 0.475 . . . . 0.0 110.395 170.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 17.0 p -87.45 59.63 5.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.156 0.979 . . . . 0.0 111.964 175.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 57.07 47.47 17.35 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.777 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 108' ' ' LYS . 43.1 mm-40 -67.78 135.89 92.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.858 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.8 Cg_exo -80.43 51.37 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 124.589 3.526 . . . . 0.0 113.017 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.676 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.4 m-20 -44.98 -59.16 2.72 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.793 ' HB1' ' HB2' ' A' ' 101' ' ' LYS . . . -87.15 -34.43 19.06 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--O 1.247 0.933 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.089 -167.64 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.634 ' HA ' HD11 ' A' ' 58' ' ' ILE . 20.9 ptp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.705 0.288 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.453 ' HG ' ' HB2' ' A' ' 7' ' ' LYS . 35.8 t -70.79 126.23 29.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.051 0.453 . . . . 0.0 110.791 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.5 p -86.05 -40.54 15.66 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.785 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 8' ' ' ILE . 41.7 p -59.96 126.16 26.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.981 -175.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.67 ' CG2' HE21 ' A' ' 9' ' ' GLN . 74.7 mt -59.53 -39.17 78.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.716 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 9.7 pt-20 -52.06 -46.57 65.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.023 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HB2' ' HG ' ' A' ' 2' ' ' SER . 47.5 mmtm -73.54 -43.69 59.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.015 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.775 HD13 ' HB3' ' A' ' 62' ' ' LEU . 66.9 mt -53.23 -44.45 53.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.67 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.1 mt-30 -63.14 -33.57 75.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.937 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -58.08 -40.26 80.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.359 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.686 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.8 mp0 -73.69 -46.41 46.46 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.504 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 18.4 mt -59.94 -44.61 94.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.39 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.58 95.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.955 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.4 pt-20 -66.44 -31.38 72.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.269 -176.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -76.63 125.87 86.75 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.927 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.515 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 51.5 Cg_exo -60.38 -42.98 37.01 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 123.058 2.505 . . . . 0.0 112.437 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.8 mm -141.13 123.26 14.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.654 ' HB3' ' HB2' ' A' ' 75' ' ' TRP . 20.0 tp -133.51 142.09 48.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.16 -167.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.2 tp -136.37 117.99 14.94 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.326 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.763 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.9 m-85 -97.25 121.76 39.51 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.993 -0.442 . . . . 0.0 112.012 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.989 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 45.3 mmm -147.16 -158.49 0.92 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.987 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.93 112.82 24.41 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.777 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.9 68.04 1.5 Allowed Glycine 0 C--N 1.306 -1.118 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.095 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 p -77.71 144.57 69.3 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -52.74 -40.25 74.58 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.267 1.978 . . . . 0.0 111.529 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -66.7 -32.56 73.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.153 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 27' ' ' LEU . 2.8 tt -156.17 115.91 2.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -176.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.34 15.6 0.2 Allowed 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.895 2.397 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.49 ' H ' HD23 ' A' ' 27' ' ' LEU . 31.4 p -164.83 47.08 0.1 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.141 0.496 . . . . 0.0 111.177 177.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 45.2 t -65.81 124.12 21.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.306 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.84 -134.71 6.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.424 -175.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.32 -42.14 31.58 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.672 ' CB ' ' HG3' ' A' ' 21' ' ' MET . 29.6 t -55.0 -10.12 0.46 Allowed 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.61 11.29 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.653 0.206 . . . . 0.0 110.893 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.499 HE21 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pm0 -81.53 -36.99 28.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.008 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB3' HE21 ' A' ' 35' ' ' GLN . . . -67.36 -44.74 78.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.483 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.38 -37.95 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.716 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 1.3 mm100 -62.29 -45.1 94.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.113 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . . . -60.3 -45.9 91.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.42 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD12 ' CD2' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -62.77 -56.59 16.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.526 -174.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.49 -32.14 69.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -71.24 -48.56 50.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.042 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.854 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 31.7 p -71.73 -56.29 6.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.327 -171.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.809 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -102.51 -146.09 17.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.456 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -102.39 -153.55 0.47 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.283 -0.458 . . . . 0.0 111.337 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HD2' ' C ' ' A' ' 46' ' ' ARG . 6.5 ppt_? -71.56 150.35 44.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -176.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.483 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 12.9 p90 -141.35 156.31 45.84 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.541 -170.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 18' ' ' LEU . . . -97.43 152.47 18.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.888 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.9 p90 -136.77 153.97 50.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.71 130.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.777 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -78.64 134.9 37.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.48 0.657 . . . . 0.0 110.907 175.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.763 HG12 ' HD2' ' A' ' 20' ' ' TYR . 1.3 pp -153.08 -34.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.616 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.987 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.2 mm? -69.8 -5.84 28.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.368 168.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.85 -43.21 7.59 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.256 176.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 75.2 m-80 -82.21 124.9 78.05 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.029 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.18 -44.22 9.79 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 121.992 1.795 . . . . 0.0 112.524 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -56.3 6.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.036 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 1' ' ' MET . 28.9 mt -61.72 -33.92 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.39 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.607 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 59.8 ttp180 -51.93 -34.0 39.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.982 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -87.15 -41.59 13.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.57 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -77.96 -61.65 1.93 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -164.37 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.775 ' HB3' HD13 ' A' ' 8' ' ' ILE . 2.2 pt? -71.46 -34.0 2.99 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -171.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.74 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 19.8 Cg_endo -56.04 -38.72 94.34 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.348 1.365 . . . . 0.0 110.772 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 61' ' ' GLU . 8.8 mtmp? -54.11 -39.1 66.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.776 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.601 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -70.6 -38.28 73.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.643 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.505 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . . . -70.76 -54.31 12.21 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.562 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.838 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.5 t-20 -171.94 -54.22 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.347 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.838 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 32.8 p90 -105.55 144.71 29.38 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.096 -1.411 . . . . 0.0 114.511 -167.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -40.84 -37.0 2.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 125.07 3.847 . . . . 0.0 115.919 -172.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -140.41 -133.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.223 0.465 . . . . 0.0 111.409 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.884 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 45.5 m-85 -141.81 -174.17 0.4 Allowed Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -170.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.989 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 42.6 Cg_endo -65.99 172.58 32.22 Favored 'Cis proline' 0 C--N 1.357 0.989 0 CA-C-N 120.1 1.072 . . . . 0.0 114.032 -0.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.86 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.9 pt20 -160.58 132.43 5.95 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.395 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.538 HD21 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -96.6 137.68 35.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.217 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.663 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 55.5 m95 -126.36 125.8 42.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.438 0.637 . . . . 0.0 110.637 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.845 HG22 HD13 ' A' ' 100' ' ' ILE . 64.8 t -106.77 119.72 56.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.907 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.556 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 35.1 t70 55.79 28.72 12.73 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.764 1.269 . . . . 0.0 110.268 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 77.82 29.89 53.54 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.048 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 46.9 mt-10 -126.33 133.83 51.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.706 0.289 . . . . 0.0 111.172 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.68 HD23 ' CZ3' ' A' ' 68' ' ' TRP . 24.6 tp -63.76 135.6 56.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.193 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.496 ' O ' HG21 ' A' ' 86' ' ' ILE . 98.4 t -124.33 -51.95 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.765 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.698 ' HA2' ' CH2' ' A' ' 68' ' ' TRP . . . 135.29 135.88 3.53 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 87' ' ' VAL . . . -84.35 -61.8 1.78 Allowed Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.682 -1.247 . . . . 0.0 116.208 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 17.6 p -79.86 -67.83 0.73 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 -44.92 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.673 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.511 HG13 ' HA3' ' A' ' 82' ' ' GLY . 50.8 mm -56.27 -45.94 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.045 -174.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 HD22 ' A' ' 96' ' ' LEU . 79.5 t -58.34 -49.1 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 91' ' ' TYR . 37.6 mm -60.7 -50.64 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.606 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.4 tt0 -61.19 -52.36 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.071 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 59.9 mtt -61.7 -31.14 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.9 t80 -58.35 -51.86 68.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 171.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.1 mt-30 -64.96 -40.3 94.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.231 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 42.7 mmm-85 -57.81 -33.29 68.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.464 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.695 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.38 -25.81 18.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.903 -173.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.772 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 55.6 mt-10 -53.57 -37.27 62.75 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.631 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.9 tp -59.68 -54.69 43.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 110.575 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.854 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 12.3 pt20 -65.32 -26.01 67.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.663 175.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.695 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 97.3 mm-40 -65.71 -44.57 85.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.266 0.555 . . . . 0.0 109.611 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 44.1 mt -69.65 -47.14 64.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.144 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.845 HD13 HG22 ' A' ' 76' ' ' VAL . 45.7 mm -61.98 -42.26 94.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.789 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 29.7 ttmt -51.34 -59.14 4.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.37 0.605 . . . . 0.0 111.584 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.41 -42.74 99.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.484 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.556 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 74.8 m -69.03 -48.58 62.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.752 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.638 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -60.39 -45.96 91.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.601 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.42 81.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.53 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -73.59 -26.38 60.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.242 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 54.3 m-85 -83.68 -47.23 11.43 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.638 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -83.41 -154.81 0.15 Allowed 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 36.6 m -75.37 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.78 46.93 0.23 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.868 0.366 . . . . 0.0 111.774 174.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -76.86 110.17 11.06 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.347 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.582 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 9.3 Cg_endo -90.8 120.93 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.432 . . . . 0.0 111.81 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.809 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 21.0 m-20 -82.96 -72.15 0.46 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.019 0.437 . . . . 0.0 111.627 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' A' ' 97' ' ' GLN . . . -81.28 48.47 1.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.165 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 42.3 tp10 . . . . . 0 C--O 1.246 0.892 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -170.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.41 0.148 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p -171.59 -46.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.692 0.282 . . . . 0.0 111.463 177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.69 ' HA ' ' OE2' ' A' ' 6' ' ' GLU . 12.5 t -69.39 141.02 54.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.793 0.33 . . . . 0.0 110.406 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t -161.2 -134.46 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.816 -173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 1.001 HG22 ' HG3' ' A' ' 9' ' ' GLN . 30.2 mm -53.68 -31.43 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 118.053 0.388 . . . . 0.0 111.598 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.69 ' OE2' ' HA ' ' A' ' 3' ' ' THR . 13.6 pt-20 -40.68 -48.32 2.93 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 75.3 mmtt -62.76 -43.8 97.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 110.303 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 1.007 HD11 ' HB3' ' A' ' 62' ' ' LEU . 71.9 mt -65.53 -50.05 74.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.631 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 1.001 ' HG3' HG22 ' A' ' 5' ' ' ILE . 64.9 mt-30 -56.01 -40.48 73.44 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.9 mmp_? -60.93 -33.88 73.84 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.977 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.4 tt0 -72.21 -42.98 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.439 174.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.693 ' HA ' HD13 ' A' ' 18' ' ' LEU . 18.8 mt -64.16 -45.27 96.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.04 0.448 . . . . 0.0 110.376 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -41.01 96.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.936 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 14.0 pt-20 -64.26 -37.42 87.43 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.64 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.453 ' CB ' ' HG ' ' A' ' 18' ' ' LEU . 77.5 m-20 -77.2 120.56 82.09 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 49.2 Cg_exo -62.17 -42.05 31.56 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.541 2.161 . . . . 0.0 111.829 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 100' ' ' ILE . 31.4 mm -131.93 125.32 54.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.693 HD13 ' HA ' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -131.69 143.4 50.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.276 -169.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 17.0 tp -136.67 113.24 10.12 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.394 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.513 ' HB3' HG12 ' A' ' 52' ' ' ILE . 8.0 m-85 -96.01 115.06 26.85 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.815 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.619 ' HE1' ' O ' ' A' ' 28' ' ' PRO . 24.5 ptt? -145.97 -157.31 0.79 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.113 -176.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.735 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 79.6 tttt -98.42 143.38 28.92 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -142.75 130.18 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.204 -171.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 27.9 t -146.56 143.68 19.29 Favored Pre-proline 0 C--N 1.312 -1.029 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.71 -36.54 82.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.143 1.895 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.434 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 18.4 ptpt -64.65 -35.15 80.08 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.178 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.466 ' C ' HD22 ' A' ' 27' ' ' LEU . 3.2 tt -159.52 113.27 1.52 Allowed Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.619 ' O ' ' HE1' ' A' ' 21' ' ' MET . 36.5 Cg_endo -72.85 19.63 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 114.649 -174.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.3 p -164.14 49.69 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.468 0.651 . . . . 0.0 111.295 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.735 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 2.2 p -69.44 49.67 0.09 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.32 -136.15 2.15 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.704 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.627 ' HB3' ' SG ' ' A' ' 84' ' ' CYS . 4.2 m-85 -74.63 -40.31 61.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.869 0.843 . . . . 0.0 109.466 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.584 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 51.2 p -54.17 -18.07 3.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.548 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.65 -39.47 36.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 110.401 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.857 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -79.89 -38.88 31.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 175.637 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 33' ' ' SER . . . -67.75 -44.28 77.91 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.541 HG11 ' N ' ' A' ' 38' ' ' GLN . 10.5 p -54.38 -39.38 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.119 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.541 ' N ' HG11 ' A' ' 37' ' ' VAL . 1.6 mm100 -64.42 -43.87 92.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.329 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.613 ' HB2' ' CG ' ' A' ' 91' ' ' TYR . . . -58.38 -42.09 86.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.743 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.538 HD13 HD22 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -63.18 -55.97 20.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.146 0.498 . . . . 0.0 110.023 -175.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.08 70.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.468 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . -72.04 -46.26 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.47 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.698 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -77.71 -55.25 5.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.52 -135.33 8.82 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.064 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 30.8 mt-10 -134.9 -148.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.957 0.503 . . . . 0.0 110.909 177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 26.0 mmm180 -50.6 146.42 5.62 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.498 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.533 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 26.6 p90 -158.22 153.77 26.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.962 -175.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.38 143.5 29.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.3 p90 -124.86 148.36 48.29 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG21 HD21 ' A' ' 18' ' ' LEU . 57.7 t -124.81 130.8 73.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.198 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.409 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 41.6 p-10 -78.27 132.07 37.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.604 0.716 . . . . 0.0 110.22 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.966 HD13 ' HG ' ' A' ' 53' ' ' LEU . 1.4 pp -148.68 -34.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.124 -172.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.966 ' HG ' HD13 ' A' ' 52' ' ' ILE . 36.4 mt -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.779 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -46.21 6.25 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.5 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 m-20 -76.42 120.36 81.32 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 120.579 0.228 . . . . 0.0 110.729 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.19 -44.77 11.36 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.261 1.974 . . . . 0.0 113.039 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.05 -54.13 14.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.0 -36.02 71.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 110.279 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.63 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 60.5 ttp180 -51.5 -32.44 27.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.801 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -90.7 -39.14 12.61 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 14.8 tp10 -79.64 -62.09 1.8 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -163.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 1.007 ' HB3' HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -74.28 -26.36 0.69 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -173.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.694 ' HD3' HD11 ' A' ' 62' ' ' LEU . 31.9 Cg_endo -59.73 -40.76 61.36 Favored 'Trans proline' 0 C--N 1.358 1.069 0 CA-C-N 121.352 1.519 . . . . 0.0 110.683 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 8.6 mtmp? -56.54 -39.25 73.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.352 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.618 ' CD2' HG21 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -64.38 -44.03 92.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . . . -77.88 -57.23 3.91 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.504 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.653 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.3 t30 -174.68 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.026 0.917 . . . . 0.0 110.45 169.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.684 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.49 147.11 51.22 Favored Pre-proline 0 C--O 1.222 -0.38 0 CA-C-N 113.358 -1.747 . . . . 0.0 113.311 -174.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.5 -36.52 76.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.232 1.955 . . . . 0.0 110.045 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.482 HG23 ' HG2' ' A' ' 59' ' ' ARG . 41.6 p -142.69 -126.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.181 176.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.782 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 10.9 m-85 -143.47 -164.26 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.782 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.2 Cg_endo -67.09 154.92 84.86 Favored 'Cis proline' 0 C--N 1.364 1.385 0 CA-C-N 121.993 1.747 . . . . 0.0 114.057 -1.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.684 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 21.0 mt-30 -142.62 134.13 26.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.641 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 40' ' ' LEU . 3.0 tm? -91.09 137.91 32.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.597 ' CH2' ' HB3' ' A' ' 66' ' ' ALA . 69.5 m95 -125.19 128.7 48.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 0.0 110.935 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.605 HG21 HD11 ' A' ' 100' ' ' ILE . 96.4 t -112.9 115.23 49.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.57 ' HB2' HG23 ' A' ' 103' ' ' THR . 11.7 t70 57.58 30.56 18.96 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.633 1.682 . . . . 0.0 108.809 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.614 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 73.14 29.01 65.23 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 113.485 -1.688 . . . . 0.0 113.05 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 91.4 mt-10 -115.94 130.57 56.88 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.568 HD23 ' HB2' ' A' ' 66' ' ' ALA . 47.0 tp -69.32 134.56 49.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 111.756 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.45 ' O ' HG21 ' A' ' 86' ' ' ILE . 93.9 t -119.32 -50.33 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.145 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.28 132.88 2.91 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.615 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -84.77 -64.12 1.57 Allowed Glycine 0 C--O 1.222 -0.631 0 C-N-CA 118.895 -1.621 . . . . 0.0 116.644 -166.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 32' ' ' PHE . 42.2 t -80.3 -68.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.428 1.114 . . . . 0.0 112.3 -170.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.22 -43.98 66.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.498 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 81' ' ' VAL . 2.4 mp -62.16 -44.1 98.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.151 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 83' ' ' GLY . 73.4 t -57.21 -49.2 80.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.244 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.857 HD11 ' HG2' ' A' ' 35' ' ' GLN . 35.7 mm -60.1 -49.92 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.043 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.733 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.2 tt0 -62.16 -51.62 67.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.845 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.572 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.0 mmt -58.77 -35.12 72.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.505 0.193 . . . . 0.0 111.307 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.613 ' CG ' ' HB2' ' A' ' 39' ' ' ALA . 9.7 t80 -58.58 -51.23 70.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.205 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.0 mt-30 -64.77 -41.01 96.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.089 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.733 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.3 mmm-85 -60.43 -34.66 74.3 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.654 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.676 ' O ' ' HG3' ' A' ' 98' ' ' GLN . . . 95.36 -24.79 27.51 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.27 -174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.704 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -58.7 -30.03 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.3 tp -59.3 -54.57 45.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.645 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.698 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 15.9 pt20 -63.45 -28.08 69.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.002 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.676 ' HG3' ' O ' ' A' ' 94' ' ' GLY . 75.2 mt-30 -62.79 -46.04 89.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 49.1 mt -65.39 -44.58 87.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.856 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.27 -46.77 95.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.492 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.787 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 38.7 ttpt -59.17 -50.73 72.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.882 0.373 . . . . 0.0 110.989 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -52.15 -45.53 65.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.32 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.57 HG23 ' HB2' ' A' ' 77' ' ' ASP . 86.0 m -77.06 -48.6 17.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.971 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 108' ' ' LYS . . . -59.54 -43.69 93.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.37 96.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.549 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.06 -32.34 64.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.281 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.502 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 65.7 m-85 -79.1 -47.47 16.06 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.72 -150.73 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 21.1 p -88.15 -150.54 0.18 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.935 169.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -70.6 54.47 0.16 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -69.44 114.9 27.44 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 110.411 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -93.2 52.59 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.335 2.69 . . . . 0.0 113.795 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.3 m-20 -50.15 -57.85 6.84 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -172.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.787 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -75.51 -47.11 28.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 111.727 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 38.8 tt0 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.769 -1.11 . . . . 0.0 109.651 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.484 0.183 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 t 69.67 121.92 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 124.15 0.906 . . . . 0.0 111.358 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.55 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 32.3 p -95.98 55.34 1.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.368 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.6 p -57.37 -43.58 83.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.523 HG12 ' CB ' ' A' ' 65' ' ' TYR . 2.0 mp -65.73 -42.94 93.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 24.8 pt-20 -55.25 -40.4 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.607 0.639 . . . . 0.0 110.246 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.32 -43.38 88.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.521 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.822 HD11 ' HB3' ' A' ' 62' ' ' LEU . 77.9 mt -65.71 -47.47 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.876 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.727 ' NE2' ' HE2' ' A' ' 65' ' ' TYR . 59.5 mm-40 -62.16 -25.97 68.07 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.278 -173.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 3.4 mmp_? -50.85 -41.28 57.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 94.4 mm-40 -75.06 -49.35 20.01 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.296 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.562 HG22 ' HA2' ' A' ' 78' ' ' GLY . 4.6 mt -61.44 -43.11 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.601 0.715 . . . . 0.0 111.016 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.83 79.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.759 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 10.5 pt-20 -73.33 -36.26 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -173.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.628 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 3.6 p30 -77.63 134.12 65.96 Favored Pre-proline 0 CA--C 1.517 -0.307 0 CA-C-O 121.793 0.806 . . . . 0.0 112.092 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 31.3 Cg_exo -63.33 -42.09 23.89 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.047 2.498 . . . . 0.0 111.723 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.5 mm -139.59 119.16 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.628 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . 31.1 tp -128.6 142.39 51.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -171.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.16 120.29 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.658 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.626 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 8.9 m-85 -98.87 122.1 41.67 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.848 -0.533 . . . . 0.0 111.396 173.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.783 ' HE1' ' HD1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -147.84 -155.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.748 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 57.1 tttp -99.31 121.37 40.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.618 -0.676 . . . . 0.0 109.321 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.36 121.51 7.01 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.246 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 37.9 t -125.77 140.65 37.14 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.38 -41.3 79.55 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.167 1.911 . . . . 0.0 111.665 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -74.44 -28.39 61.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.535 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.516 ' C ' HD21 ' A' ' 27' ' ' LEU . 3.5 tt -154.66 104.95 2.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' O ' ' SD ' ' A' ' 21' ' ' MET . 16.8 Cg_exo -72.29 35.47 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 114.476 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.464 ' H ' HD21 ' A' ' 27' ' ' LEU . 7.0 p -169.74 49.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.095 0.558 . . . . 0.0 111.187 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.697 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 51.3 t -54.76 -36.65 65.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.15 -137.69 0.17 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.166 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.457 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.1 m-85 -75.95 -18.61 59.27 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.504 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 35.8 t -64.75 -12.16 44.27 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.003 -0.436 . . . . 0.0 111.891 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.86 -42.4 26.53 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.559 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -80.24 -41.68 24.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.07 0.462 . . . . 0.0 110.263 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.62 96.65 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.682 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.726 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 13.9 p -56.66 -39.48 63.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.348 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.548 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.8 mm100 -68.91 -46.15 69.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB3' ' CG ' ' A' ' 91' ' ' TYR . . . -59.95 -42.8 94.86 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.294 0.371 . . . . 0.0 111.505 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD13 HD21 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -63.15 -55.11 27.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.412 0.625 . . . . 0.0 109.681 -176.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.16 69.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.478 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 -49.13 19.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.506 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.761 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.6 p -74.52 -53.36 9.62 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.457 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.5 -141.0 11.51 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.87 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 69.8 mm-40 -117.87 -152.15 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.832 0.453 . . . . 0.0 111.144 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' HE ' ' N ' ' A' ' 46' ' ' ARG . 3.4 mmp_? -65.44 158.23 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.46 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.726 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 17.0 p90 -154.35 159.07 40.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.551 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.86 154.09 17.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.805 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.783 ' HD1' ' HE1' ' A' ' 21' ' ' MET . 1.8 p90 -143.6 153.89 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -174.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.603 HG22 HD12 ' A' ' 18' ' ' LEU . 57.6 t -133.79 130.29 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.504 0.193 . . . . 0.0 110.56 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -74.49 131.9 41.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.485 0.659 . . . . 0.0 110.924 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 21' ' ' MET . 1.4 pp -147.85 -35.63 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.861 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.748 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -65.35 -11.62 43.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.412 167.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -97.52 -44.94 6.61 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.465 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.9 m-20 -82.25 118.12 70.83 Favored Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 122.192 -0.318 . . . . 0.0 110.437 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.69 -44.09 14.8 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.434 2.089 . . . . 0.0 113.756 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -72.53 -52.71 14.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.078 0.466 . . . . 0.0 111.573 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -62.46 -35.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.268 0.556 . . . . 0.0 110.424 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 62.4 ttp180 -52.89 -32.43 45.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.202 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.644 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -88.19 -41.53 12.91 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.576 -166.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 32.0 tp10 -78.79 -59.67 2.69 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -158.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 8' ' ' ILE . 1.9 pt? -68.11 -31.39 3.25 Favored Pre-proline 0 N--CA 1.474 0.726 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.705 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 18.5 Cg_endo -57.82 -43.44 49.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 121.103 1.43 . . . . 0.0 111.138 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.644 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 48.6 mtmt -55.68 -37.88 68.9 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.035 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.727 ' HE2' ' NE2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -65.21 -50.83 64.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.477 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB3' HD23 ' A' ' 80' ' ' LEU . . . -73.3 -55.7 6.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.379 -0.929 . . . . 0.0 112.935 -170.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.635 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 46.8 t30 -175.41 -52.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.211 1.005 . . . . 0.0 110.237 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.635 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -59.75 150.33 68.15 Favored Pre-proline 0 C--O 1.215 -0.743 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.936 -177.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -63.54 -36.76 52.05 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 121.954 1.769 . . . . 0.0 109.912 171.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -141.79 -124.28 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.003 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.819 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 25.7 m-85 -140.72 -165.61 0.1 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.819 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.1 Cg_endo -67.09 153.51 84.62 Favored 'Cis proline' 0 C--N 1.361 1.216 0 CA-C-N 121.691 1.64 . . . . 0.0 113.885 -1.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.581 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 70.6 mt-30 -143.21 135.19 26.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.706 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 40' ' ' LEU . 3.3 tm? -100.08 135.17 41.91 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.588 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.585 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 49.4 m95 -121.91 125.77 47.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.242 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 100' ' ' ILE . 58.5 t -105.91 119.04 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.554 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.1 t70 56.74 27.95 13.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 123.722 1.725 . . . . 0.0 108.622 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.07 29.3 54.38 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.375 -1.739 . . . . 0.0 113.044 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -124.68 130.97 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.322 . . . . 0.0 110.472 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.581 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 40.6 tp -68.95 127.31 32.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.406 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.764 HG13 HG23 ' A' ' 86' ' ' ILE . 87.3 t -105.28 -55.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.759 170.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.463 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 147.39 135.23 2.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.29 -65.52 1.52 Allowed Glycine 0 C--O 1.217 -0.943 0 C-N-CA 118.584 -1.77 . . . . 0.0 116.482 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 21.8 p -80.56 -68.05 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.76 1.28 . . . . 0.0 113.231 -171.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.26 -46.82 63.62 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.939 0.399 . . . . 0.0 111.244 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.764 HG23 HG13 ' A' ' 81' ' ' VAL . 46.1 mm -59.99 -44.79 95.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.013 -172.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 91' ' ' TYR . 56.0 t -58.27 -49.03 83.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.289 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.482 ' O ' ' HD2' ' A' ' 91' ' ' TYR . 39.4 mm -58.1 -53.21 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.41 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.722 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 87.8 tt0 -65.97 -47.43 74.64 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.882 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.733 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.2 mmt -58.62 -36.55 74.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.633 0.254 . . . . 0.0 111.057 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.587 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -58.03 -48.81 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 172.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.537 ' HG2' ' CD2' ' A' ' 91' ' ' TYR . 15.2 mm-40 -62.58 -43.75 98.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.013 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 44.4 mmm-85 -62.93 -33.99 76.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.777 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 96.13 -25.29 26.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.744 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.5 mt-10 -55.54 -35.53 65.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 63.6 tp -62.37 -54.66 37.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.761 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -63.49 -26.78 68.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.024 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.6 mm-40 -64.0 -46.63 83.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.132 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 46.4 mt -67.6 -44.75 77.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.903 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.594 HD12 HG21 ' A' ' 76' ' ' VAL . 50.0 mm -60.62 -46.26 96.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.482 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 113' ' ' ASP . 39.4 ttpt -59.06 -52.86 63.91 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.3 -43.14 82.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.259 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 46.7 m -72.07 -50.17 30.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.076 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.05 92.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.565 -177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.31 72.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.589 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.77 -29.58 51.03 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.959 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 62.9 m-85 -86.83 -49.54 7.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.005 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.813 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -96.03 119.82 35.21 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.148 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -54.32 117.04 2.96 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 52.07 37.49 21.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.245 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 60.6 mm-40 -80.46 123.65 82.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.634 174.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.1 Cg_endo -83.94 109.41 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.696 2.264 . . . . 0.0 112.45 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.63 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.2 m-20 -91.34 -93.22 0.14 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.394 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB1' ' CG ' ' A' ' 97' ' ' GLN . . . -67.47 -48.16 67.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -171.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.699 -1.143 . . . . 0.0 109.698 -170.004 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 120.648 0.261 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.3 p -70.24 -119.4 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.416 ' HB ' ' H ' ' A' ' 4' ' ' THR . 42.3 p -81.06 -150.37 0.08 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.941 0.4 . . . . 0.0 111.717 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.632 ' O ' ' HG2' ' A' ' 7' ' ' LYS . 9.0 t 171.76 -38.59 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.962 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.731 HG22 HE21 ' A' ' 9' ' ' GLN . 37.5 mt -55.11 -25.47 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.036 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 96.1 mt-10 -49.27 -47.55 46.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.545 0.212 . . . . 0.0 111.556 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.2 ptpt -61.79 -43.42 98.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.612 0.72 . . . . 0.0 110.116 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.647 HD12 HD21 ' A' ' 62' ' ' LEU . 72.2 mt -66.26 -46.84 86.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.936 -174.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.731 HE21 HG22 ' A' ' 5' ' ' ILE . 72.1 mt-30 -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.549 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.532 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.0 mmp_? -59.89 -37.55 79.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.851 0.358 . . . . 0.0 110.361 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 51.7 tt0 -71.03 -49.21 47.41 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.15 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.805 HG23 ' HA2' ' A' ' 78' ' ' GLY . 17.3 mt -65.88 -39.52 84.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.667 0.746 . . . . 0.0 110.835 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 9' ' ' GLN . . . -62.7 -36.12 81.94 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.637 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 24.0 pt-20 -72.81 -39.24 66.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.661 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -76.58 134.18 69.8 Favored Pre-proline 0 CA--C 1.515 -0.384 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -176.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 20.1 Cg_endo -61.94 -40.84 40.89 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.158 2.572 . . . . 0.0 112.056 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.7 mm -139.27 120.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.661 HD22 ' OD1' ' A' ' 15' ' ' ASN . 28.1 tp -132.02 143.14 49.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.376 0.608 . . . . 0.0 111.414 -173.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.86 HD23 ' HE3' ' A' ' 21' ' ' MET . 16.1 tp -138.95 120.6 15.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.362 -176.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.653 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -96.66 124.5 40.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.752 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.861 ' HE2' ' HB2' ' A' ' 33' ' ' SER . 8.0 ptp -145.26 -171.09 3.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.524 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.809 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.3 tttm -95.97 140.62 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -138.67 129.5 4.52 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 118.941 -1.6 . . . . 0.0 113.696 -165.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.409 ' HB3' ' HG ' ' A' ' 30' ' ' CYS . 80.1 p -150.43 142.72 15.82 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.0 -38.99 60.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.598 2.199 . . . . 0.0 112.025 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -62.99 -33.08 74.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.325 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' SER . 2.9 tt -160.02 108.7 1.42 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.85 19.97 0.18 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.239 1.959 . . . . 0.0 114.34 -174.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.809 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 13.5 p -164.22 49.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.287 0.565 . . . . 0.0 111.532 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.749 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 3.6 p -65.83 54.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.65 -137.58 2.24 Favored Glycine 0 C--N 1.321 -0.267 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.8 -39.67 61.57 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.761 0.791 . . . . 0.0 108.952 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.861 ' HB2' ' HE2' ' A' ' 21' ' ' MET . 20.6 p -48.1 -24.14 1.03 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.695 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -51.52 -41.76 61.25 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.286 0.366 . . . . 0.0 111.652 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -33.24 43.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.352 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.17 66.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.132 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.807 ' HB ' ' HE1' ' A' ' 21' ' ' MET . 8.5 p -52.25 -38.12 24.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.7 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.576 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 1.1 mm100 -62.25 -46.94 86.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.819 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 91' ' ' TYR . . . -60.61 -43.84 97.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.087 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.546 HD22 ' C ' ' A' ' 40' ' ' LEU . 1.5 tt -61.85 -55.15 32.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -176.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.36 76.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.441 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 38' ' ' GLN . . . -67.77 -49.59 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.37 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.744 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.5 m -72.84 -56.02 5.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.49 -134.85 8.63 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.153 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.4 mm-40 -140.88 -152.17 0.4 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.822 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.494 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 28.8 mmm180 -58.15 143.67 43.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.823 0.82 . . . . 0.0 112.636 -169.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.649 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 16.6 p90 -152.93 156.42 38.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.878 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.45 146.87 25.31 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.1 p90 -136.83 150.21 48.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.588 HG22 HD12 ' A' ' 18' ' ' LEU . 48.3 t -127.6 127.66 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.631 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.8 p30 -77.9 133.9 38.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.293 0.568 . . . . 0.0 109.83 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.653 HG12 ' HD2' ' A' ' 20' ' ' TYR . 1.1 pp -148.1 -32.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.264 -171.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.757 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -66.54 -11.09 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.098 167.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.38 -43.27 8.46 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.07 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -77.63 123.99 86.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 121.026 0.441 . . . . 0.0 110.925 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.32 -42.94 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.373 2.049 . . . . 0.0 113.523 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -82.94 -50.89 8.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.672 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.473 HG21 ' CG2' ' A' ' 52' ' ' ILE . 36.0 mt -56.8 -37.11 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.249 0.547 . . . . 0.0 110.635 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.611 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 58.7 ttp180 -53.16 -31.24 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.158 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.35 -35.98 19.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -78.27 -61.14 2.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -162.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.669 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 1.9 pt? -76.8 -31.88 0.96 Allowed Pre-proline 0 N--CA 1.472 0.626 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.818 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 11.7 Cg_endo -55.21 -39.7 89.59 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 CA-C-N 120.917 1.363 . . . . 0.0 110.53 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -53.91 -41.36 67.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.543 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.602 ' HH ' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -68.56 -41.9 79.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.461 -178.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.6 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . . . -73.49 -58.32 3.39 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.988 -176.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.439 ' HB2' ' CE3' ' A' ' 68' ' ' TRP . 24.4 m-20 -173.27 -57.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.052 0.93 . . . . 0.0 109.539 168.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 63' ' ' PRO . 1.2 m-90 -53.88 147.8 22.62 Favored Pre-proline 0 C--O 1.215 -0.713 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.381 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.7 -36.21 53.47 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.289 1.993 . . . . 0.0 110.096 171.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -142.04 -127.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.372 -1.286 . . . . 0.0 109.698 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.93 ' HD2' ' HG2' ' A' ' 73' ' ' GLN . 36.0 m-85 -142.78 -170.63 0.24 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.9 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 38.4 Cg_endo -68.34 157.76 87.22 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 120.981 1.386 . . . . 0.0 114.525 -1.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.93 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.7 pt20 -148.57 133.72 18.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.741 174.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.506 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.4 tm? -95.38 138.37 33.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.999 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.764 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 56.1 m95 -127.07 126.93 43.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.497 0.665 . . . . 0.0 110.894 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.897 HG22 HD13 ' A' ' 100' ' ' ILE . 50.2 t -106.28 114.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.483 -0.781 . . . . 0.0 108.919 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.528 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 25.1 t70 54.42 32.08 15.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 123.108 1.432 . . . . 0.0 110.364 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 79.7 28.74 50.41 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 113.789 -1.551 . . . . 0.0 113.565 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -127.29 131.3 50.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.904 173.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.558 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.5 tp -68.95 130.2 42.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.607 -174.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.443 ' O ' HG21 ' A' ' 86' ' ' ILE . 91.7 t -107.09 -54.11 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.447 168.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 87' ' ' VAL . . . 144.88 132.82 2.55 Favored Glycine 0 C--O 1.22 -0.761 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.56 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.13 -62.43 1.66 Allowed Glycine 0 C--O 1.221 -0.678 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.863 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.2 p -77.18 -67.6 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.798 -0.825 . . . . 0.0 112.557 -171.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -73.6 -48.77 30.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.488 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 43.1 mm -61.92 -42.27 94.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.382 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 82' ' ' GLY . 65.6 t -58.74 -48.22 86.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.792 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.554 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.0 mm -60.9 -47.31 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.595 0.236 . . . . 0.0 110.831 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.75 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.9 tt0 -59.79 -55.21 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.651 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.584 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -60.07 -35.67 75.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.35 0.26 . . . . 0.0 111.276 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.744 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 17.7 t80 -56.79 -50.96 70.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.848 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -63.76 -40.68 97.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.75 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.1 mmm-85 -63.63 -33.94 76.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.15 -24.39 25.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.169 -171.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.564 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.7 mt-10 -58.22 -27.23 63.74 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.584 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 6.2 tt -60.44 -58.95 6.33 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.707 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.5 pt20 -60.27 -27.04 66.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.35 176.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.2 mm100 -65.07 -55.66 17.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 96' ' ' LEU . 2.5 pp -70.76 -32.34 69.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.665 177.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.897 HD13 HG22 ' A' ' 76' ' ' VAL . 34.3 mm -64.57 -48.23 85.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.254 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 39.1 ttpt -56.81 -52.05 66.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.369 -176.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.91 -44.58 78.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 32.6 m -71.0 -50.55 32.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.613 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.48 93.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.537 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 101' ' ' LYS . . . -60.18 -41.72 93.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -176.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.885 ' HZ2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -73.46 -26.86 61.11 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.985 -178.33 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.479 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 43.0 m-85 -87.68 -47.21 8.84 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.092 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.624 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -75.71 -158.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 6.2 p -76.18 -167.36 0.74 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.674 165.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.71 57.34 0.13 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -73.12 124.63 90.84 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.359 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -96.44 53.03 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.962 3.108 . . . . 0.0 113.991 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.517 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 28.6 m-20 -51.12 -61.23 2.36 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -171.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.544 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -73.94 -45.93 47.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 0.0 111.871 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 5.4 tm-20 . . . . . 0 C--N 1.319 -0.756 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -173.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.411 ' N ' ' SD ' ' A' ' 1' ' ' MET . 61.4 p -78.18 60.91 2.57 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.604 0.362 . . . . 0.0 111.089 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 4' ' ' THR . 5.0 m -70.1 -132.25 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.591 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.506 ' H ' HG22 ' A' ' 3' ' ' THR . 37.9 p -76.03 37.77 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -175.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.638 ' CG2' HE21 ' A' ' 9' ' ' GLN . 44.4 mt -63.72 -38.09 81.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 176.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 54.3 mt-10 -55.55 -47.42 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.582 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -62.68 -43.51 98.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 110.648 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 62' ' ' LEU . 75.5 mt -60.95 -45.77 97.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.929 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.638 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.6 mt-30 -64.92 -33.26 75.6 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.365 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 4.3 mmp_? -55.94 -42.26 75.9 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -69.14 -44.35 72.51 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.953 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.417 HG22 ' HA2' ' A' ' 78' ' ' GLY . 19.9 mt -65.56 -43.34 94.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.442 0.639 . . . . 0.0 110.171 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.47 68.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.481 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 32.0 mt-10 -62.18 -46.65 87.99 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.077 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -78.45 125.17 85.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.231 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 37.3 Cg_endo -66.25 -42.0 11.39 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.467 2.111 . . . . 0.0 112.21 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.423 HG21 ' HB2' ' A' ' 47' ' ' PHE . 27.5 mm -127.12 119.82 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.593 HD12 HG22 ' A' ' 50' ' ' VAL . 21.5 tp -133.59 141.34 47.63 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.98 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.3 tp -138.27 120.1 15.32 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.306 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.642 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.8 m-85 -97.28 120.53 37.81 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.582 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.577 ' O ' HD11 ' A' ' 52' ' ' ILE . 20.0 ptt? -146.6 -163.77 1.83 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 29.2 tptp -96.73 127.63 42.91 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.144 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.37 125.46 8.38 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.618 -1.753 . . . . 0.0 111.74 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 46.4 t -138.5 141.22 30.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -54.01 -41.09 78.14 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.246 1.964 . . . . 0.0 111.453 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -71.71 -28.48 63.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.894 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 24' ' ' SER . 2.2 tt -161.5 121.72 1.55 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.42 ' N ' HD22 ' A' ' 27' ' ' LEU . 50.1 Cg_endo -71.71 29.38 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.277 1.984 . . . . 0.0 113.307 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.62 ' OG ' ' HB3' ' A' ' 33' ' ' SER . 11.8 t -165.78 54.69 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 42.7 t -55.59 -36.88 67.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.698 -173.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.626 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -73.42 -138.68 0.37 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 36.4 m-85 -77.58 -20.87 53.31 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.635 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 32.8 t -69.02 -10.21 56.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.423 -0.798 . . . . 0.0 111.083 -174.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.26 -40.84 17.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.542 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.94 -38.04 38.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 178.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.86 91.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.931 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 8.7 p -56.19 -36.47 45.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.887 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 2.1 mm100 -67.73 -42.07 82.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.719 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 87' ' ' VAL . . . -57.27 -48.08 79.81 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.07 0.231 . . . . 0.0 111.183 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.533 HD12 HD23 ' A' ' 74' ' ' LEU . 9.9 mt -58.97 -62.29 1.99 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.952 0.882 . . . . 0.0 112.567 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.19 -28.51 58.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.134 -176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 38' ' ' GLN . . . -74.51 -56.32 4.96 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.319 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.955 ' SG ' ' HB3' ' A' ' 97' ' ' GLN . 42.6 t -72.21 -59.13 2.89 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.815 -167.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.62 ' HA3' ' C ' ' A' ' 115' ' ' GLU . . . -103.12 -125.59 5.68 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.354 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.11 -148.34 0.24 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.483 -0.859 . . . . 0.0 111.49 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -61.46 143.24 56.21 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.992 0.901 . . . . 0.0 112.119 -165.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HZ ' HG22 ' A' ' 37' ' ' VAL . 14.6 p90 -154.21 152.45 30.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.963 -1.472 . . . . 0.0 109.039 -173.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.59 149.66 23.04 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.372 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -134.34 151.12 51.05 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.593 HG22 HD12 ' A' ' 18' ' ' LEU . 61.9 t -127.16 128.19 70.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.869 0.366 . . . . 0.0 110.099 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.1 p30 -75.65 130.61 39.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.739 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.642 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.2 pp -146.1 -34.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.751 -173.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -63.05 -14.5 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.906 167.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -95.15 -42.9 8.35 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.778 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.6 m-20 -79.2 122.34 84.12 Favored Pre-proline 0 N--CA 1.472 0.635 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.91 -44.72 9.5 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.147 1.898 . . . . 0.0 113.118 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -75.74 -47.68 24.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.2 -38.25 81.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.176 0.512 . . . . 0.0 110.487 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.581 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 77.4 ttt180 -50.88 -36.3 37.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.212 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.559 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -83.84 -42.19 16.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 50.3 mm-40 -78.0 -59.31 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -161.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.806 ' HB3' HD12 ' A' ' 8' ' ' ILE . 2.2 pt? -70.45 -32.59 2.74 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.3 Cg_endo -53.68 -42.25 67.61 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.324 1.349 . . . . 0.0 111.415 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 46.2 mtmt -54.57 -38.87 67.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.709 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -69.26 -41.09 77.37 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.144 -179.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . . . -78.74 -57.35 3.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.583 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.6 t30 -175.0 -53.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 0.0 110.084 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.679 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -59.62 150.48 66.32 Favored Pre-proline 0 C--O 1.215 -0.746 0 CA-C-N 113.347 -1.752 . . . . 0.0 113.058 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.77 -33.81 42.62 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 121.828 1.685 . . . . 0.0 110.235 171.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 50.7 p -142.47 -124.2 0.09 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.083 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.895 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 55.0 m-85 -141.8 -167.51 0.15 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.895 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 56.9 Cg_endo -68.77 153.42 90.27 Favored 'Cis proline' 0 C--N 1.36 1.179 0 CA-C-N 121.631 1.618 . . . . 0.0 114.107 -1.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.618 HE22 ' HA ' ' A' ' 63' ' ' PRO . 58.2 mt-30 -145.27 133.32 21.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 40' ' ' LEU . 3.2 tm? -95.56 137.46 34.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.806 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 61.2 m95 -122.4 127.42 49.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 1.027 HG22 HD11 ' A' ' 100' ' ' ILE . 46.4 t -106.02 115.2 47.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.602 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 28.5 t70 55.9 32.65 20.14 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 123.251 1.5 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.69 28.54 60.97 Favored Glycine 0 C--N 1.308 -0.988 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.989 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -124.69 129.75 51.1 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.175 0.19 . . . . 0.0 110.778 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 73' ' ' GLN . 51.8 tp -69.94 136.59 50.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 86' ' ' ILE . 92.5 t -119.31 -53.8 3.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.94 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 147.12 137.0 2.91 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 87' ' ' VAL . . . -84.62 -65.82 1.49 Allowed Glycine 0 C--O 1.216 -0.98 0 C-N-CA 118.929 -1.605 . . . . 0.0 116.338 -168.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 1.9 p -79.33 -69.29 0.59 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.744 1.272 . . . . 0.0 113.388 -173.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.56 -48.4 64.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.415 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.598 HG22 HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.81 -46.8 93.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.642 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 83' ' ' GLY . 77.3 t -58.23 -50.48 78.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.082 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 39.0 mm -56.04 -51.24 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.221 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.702 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.2 tt0 -62.59 -49.79 73.83 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.317 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.899 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 96.3 mmm -59.86 -38.36 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.636 ' HD1' ' HB2' ' A' ' 43' ' ' CYS . 3.0 t80 -60.05 -46.35 89.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.158 0.583 . . . . 0.0 110.475 173.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.2 mt-30 -64.59 -40.16 95.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.779 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 29.0 mmm180 -59.01 -33.87 71.21 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.053 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.25 20.16 79.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.313 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.626 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 53.7 mt-10 -98.8 -24.58 14.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.106 0.479 . . . . 0.0 111.28 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.899 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 23.5 tp -75.2 -43.23 53.17 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.955 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 5.2 pt20 -57.99 -26.9 62.97 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.266 170.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 3.3 mm100 -72.95 -48.03 40.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 39.7 mt -66.33 -48.0 71.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.741 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 1.027 HD11 HG22 ' A' ' 76' ' ' VAL . 26.5 mm -62.04 -47.14 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.162 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.519 ' HB2' ' HA ' ' A' ' 114' ' ' ALA . 35.6 ttpt -55.67 -47.25 77.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 123.253 0.345 . . . . 0.0 111.795 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.07 -46.81 78.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.008 0.432 . . . . 0.0 109.922 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.602 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 89.7 m -68.45 -54.69 15.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.164 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.567 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.66 -49.93 74.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.992 -174.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.86 -41.24 82.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.43 -24.5 61.23 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.423 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.462 ' HE2' HG23 ' A' ' 103' ' ' THR . 35.5 m-85 -88.53 -41.7 12.55 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.688 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 108' ' ' LYS . 9.5 mmpt? -72.99 -156.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.56 0.695 . . . . 0.0 109.849 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 111' ' ' GLU . 35.7 t -82.22 -146.27 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.722 170.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -79.93 44.68 0.67 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.33 0.586 . . . . 0.0 109.467 169.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 50.5 mm-40 -73.63 135.02 78.49 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.311 -172.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.95 42.86 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.69 2.927 . . . . 0.0 114.188 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.63 152.52 18.38 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.672 0.789 . . . . 0.0 112.935 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.708 ' HB1' ' HB2' ' A' ' 97' ' ' GLN . . . -122.85 -116.57 0.3 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 111.882 -2.417 . . . . 0.0 106.621 160.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.75 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 75.5 tt0 . . . . . 0 C--N 1.317 -0.831 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.944 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 48.2 mt . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.37 -44.3 84.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.27 -47.34 77.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.162 174.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.743 HD13 HD22 ' A' ' 62' ' ' LEU . 84.4 mt -57.8 -44.63 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.249 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.403 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 33.7 mt-30 -61.87 -40.38 95.16 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.594 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.2 mmp_? -60.86 -36.47 79.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 73.5 mt-30 -71.79 -45.12 62.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.415 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.817 HG22 ' HA2' ' A' ' 78' ' ' GLY . 27.2 mt -63.4 -44.28 98.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.095 0.474 . . . . 0.0 110.107 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.14 96.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 11.9 pt-20 -69.23 -37.48 78.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.694 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.33 126.42 86.45 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 121.315 0.579 . . . . 0.0 110.615 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.531 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.5 Cg_exo -62.1 -42.22 31.0 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 112.82 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.3 mm -136.75 119.48 20.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 18.0 tp -132.8 139.95 47.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.345 -170.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.4 tp -136.39 122.98 20.95 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.02 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.744 ' CE2' HD21 ' A' ' 62' ' ' LEU . 6.0 m-85 -98.95 118.06 34.87 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.491 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.9 ptt? -145.99 -166.18 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.662 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.056 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.9 tttt -99.61 118.48 36.24 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.467 -0.771 . . . . 0.0 110.079 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.93 68.46 1.02 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.096 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.4 m -77.71 139.24 62.47 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -53.68 -41.28 75.32 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.086 1.857 . . . . 0.0 111.724 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.87 -35.67 81.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.881 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -154.93 111.38 2.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.463 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 39.0 Cg_endo -74.41 32.29 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.654 2.236 . . . . 0.0 113.868 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -165.07 46.52 0.09 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.163 0.506 . . . . 0.0 110.132 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.759 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 37.5 t -71.65 66.97 0.54 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.158 -173.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.91 -140.81 3.08 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -76.91 -33.79 57.75 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.145 0.498 . . . . 0.0 110.699 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.856 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 15.1 p -49.88 -21.06 1.03 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.592 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.18 -42.73 30.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.409 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.47 -34.94 35.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.233 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.46 -43.08 73.98 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.489 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 7.9 p -53.38 -37.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.108 0.48 . . . . 0.0 110.729 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -63.13 -46.18 88.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.842 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.9 -44.41 97.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.876 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -60.65 -55.48 32.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 109.675 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.75 70.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.476 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.93 -48.34 46.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.727 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.3 m -68.62 -57.42 5.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.83 -147.59 20.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.452 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.0 mm-40 -100.36 -153.58 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.53 0.681 . . . . 0.0 111.184 174.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.487 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.05 154.16 42.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.872 177.241 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 19' ' ' LEU . 17.4 p90 -145.97 158.89 43.86 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.006 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.57 146.34 25.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -137.72 149.16 46.26 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.501 HG23 HD11 ' A' ' 18' ' ' LEU . 52.9 t -122.63 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' MET . 10.5 p-10 -74.11 130.33 39.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.081 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.641 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -146.68 -34.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.651 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.056 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -63.4 -13.2 37.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.518 171.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 19.7 tm0? -96.47 -45.44 6.76 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.347 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -76.31 116.02 52.38 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.953 0.342 . . . . 0.0 110.742 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 50.1 Cg_exo -59.74 -45.18 26.4 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.0 2.467 . . . . 0.0 113.608 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.41 -54.33 14.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.507 0.67 . . . . 0.0 111.126 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.569 HG22 HD23 ' A' ' 62' ' ' LEU . 36.2 mt -63.6 -35.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.2 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.721 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 61.9 ttt-85 -57.61 -33.36 68.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.095 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.563 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -90.62 -52.68 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.62 -54.63 5.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -168.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.754 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -55.22 -44.39 99.6 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.721 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 22.1 Cg_endo -58.13 -41.74 64.4 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 121.465 1.444 . . . . 0.0 111.447 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.6 mtmp? -61.1 -32.37 72.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.751 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.544 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -63.15 -43.2 99.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.818 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -78.16 -57.66 3.67 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.404 -0.918 . . . . 0.0 112.389 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.507 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 41.5 t30 -174.73 -54.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.784 0.802 . . . . 0.0 110.323 168.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -55.6 148.58 34.3 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.835 -1.53 . . . . 0.0 113.274 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -61.62 -38.96 57.84 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.461 2.107 . . . . 0.0 110.459 172.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -143.06 -127.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.253 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.967 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 47.8 m-85 -138.15 -170.99 0.25 Allowed Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.967 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.6 Cg_endo -67.17 155.57 84.83 Favored 'Cis proline' 0 C--N 1.352 0.757 0 CA-C-N 121.132 1.44 . . . . 0.0 114.613 -0.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.487 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 59.3 mt-30 -147.51 132.66 18.33 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.429 173.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.85 138.56 33.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.987 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.526 ' N ' HD13 ' A' ' 74' ' ' LEU . 55.9 m95 -125.06 127.47 46.99 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.18 0.514 . . . . 0.0 110.73 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 100' ' ' ILE . 65.4 t -111.61 121.16 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 176.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 57.15 29.12 16.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.507 1.622 . . . . 0.0 108.691 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.817 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.41 29.11 64.52 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 113.6 -1.637 . . . . 0.0 113.152 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.57 132.15 51.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 110.807 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.818 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.0 tp -65.71 132.42 48.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.801 -172.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.489 ' O ' HG21 ' A' ' 86' ' ' ILE . 78.1 t -110.49 -53.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.199 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 142.19 135.11 3.05 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.36 -62.25 1.66 Allowed Glycine 0 C--O 1.223 -0.584 0 C-N-CA 119.525 -1.322 . . . . 0.0 116.232 -168.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -78.01 -70.76 0.46 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -168.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -80.19 -40.59 26.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.489 HG21 ' O ' ' A' ' 81' ' ' VAL . 48.3 mm -55.9 -45.64 79.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.265 -174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.495 HG13 HD11 ' A' ' 96' ' ' LEU . 86.0 t -59.26 -49.24 84.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.206 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 39' ' ' ALA . 39.6 mm -60.28 -48.79 86.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.456 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.751 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 40.0 tt0 -61.63 -53.28 58.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.69 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.579 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 80.8 mtp -62.64 -30.61 71.49 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.783 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 14.1 t80 -57.34 -52.24 66.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.69 170.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -63.55 -40.59 97.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.101 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 46.3 mmm-85 -59.62 -33.95 72.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.363 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 90.28 -24.66 15.31 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.286 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 91.0 mt-10 -60.07 -29.78 68.79 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 6.5 tt -61.74 -54.5 41.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.071 0.463 . . . . 0.0 110.208 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.864 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 10.8 pt20 -63.86 -26.58 68.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.775 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 90.9 mm-40 -62.9 -44.82 95.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 24.5 mt -69.9 -46.83 64.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.178 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.523 HG22 ' OD2' ' A' ' 113' ' ' ASP . 47.7 mm -60.62 -46.31 95.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.679 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 38.7 ttpt -55.54 -53.59 54.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.193 0.308 . . . . 0.0 111.424 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 37.8 tt0 -63.85 -44.48 93.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.119 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.449 ' O ' ' HD2' ' A' ' 107' ' ' TYR . 61.9 m -63.29 -47.14 83.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.645 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.639 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.11 -45.15 94.74 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.389 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.2 95.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.551 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -70.31 -33.19 71.23 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.841 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.457 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 58.0 m-85 -78.68 -47.29 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.639 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -100.38 -147.32 0.35 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 51.6 p -74.45 -155.62 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.969 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.3 57.16 0.87 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.809 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.31 114.18 6.77 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.158 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -95.59 47.31 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 122.699 2.266 . . . . 0.0 112.919 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.523 ' OD2' HG22 ' A' ' 100' ' ' ILE . 7.6 m-20 . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.143 -168.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' A' ' 65' ' ' TYR . 33.5 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.591 0.234 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.3 -44.51 68.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.336 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -76.05 -38.41 57.17 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.659 HD13 ' HB3' ' A' ' 62' ' ' LEU . 75.1 mt -58.63 -46.9 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.914 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.551 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 34.2 mt-30 -62.3 -40.48 96.44 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.76 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -60.39 -35.56 76.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.79 0.329 . . . . 0.0 110.668 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.94 -44.35 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.774 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.774 HG23 HD23 ' A' ' 18' ' ' LEU . 28.9 mt -67.23 -47.34 81.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -59.42 -39.35 83.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.85 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.79 -30.63 70.12 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.946 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 32.8 m120 -76.31 126.77 86.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.069 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.608 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.7 Cg_exo -61.92 -42.95 27.68 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.849 2.366 . . . . 0.0 112.431 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 16' ' ' PRO . 27.2 mm -137.37 121.1 22.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 12' ' ' ILE . 24.5 tp -133.04 141.21 48.12 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.64 -170.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.8 tp -137.39 119.0 14.93 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.986 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.607 ' CE2' HD11 ' A' ' 62' ' ' LEU . 6.8 m-85 -96.51 119.6 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.036 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.685 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 23.2 ptt? -145.92 -166.99 2.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.417 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 86.9 tttt -95.76 90.04 5.52 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -91.84 67.69 2.1 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.463 -170.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -77.87 146.55 72.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.366 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.76 -39.78 89.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.995 1.797 . . . . 0.0 111.066 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.57 -34.36 77.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.617 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 30' ' ' CYS . 1.8 tt -161.42 112.59 1.24 Allowed Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.522 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -69.56 14.3 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.807 2.338 . . . . 0.0 114.11 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.685 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 24.8 p -163.21 47.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.31 0.576 . . . . 0.0 110.613 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.677 ' HA ' HD13 ' A' ' 27' ' ' LEU . 48.0 t -56.46 -40.63 75.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.658 -173.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.644 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.33 -134.48 0.13 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.237 -0.506 . . . . 0.0 114.275 -175.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 41.6 m-85 -74.23 -18.01 60.81 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 121.057 0.456 . . . . 0.0 111.872 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 21' ' ' MET . 8.4 p -63.78 -19.5 65.04 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.9 -42.84 13.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -78.85 -38.88 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.299 0.571 . . . . 0.0 110.198 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.03 88.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.909 -175.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 9.3 p -55.23 -39.18 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.523 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 30.0 mm-40 -67.02 -48.71 67.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -58.29 -45.12 88.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.89 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.3 tt -61.18 -55.38 32.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.232 0.539 . . . . 0.0 110.197 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.02 -32.35 71.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.175 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -47.52 59.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.664 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.3 p -77.16 -51.44 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.846 0.355 . . . . 0.0 111.098 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.78 -134.68 8.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.831 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.25 -152.12 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.561 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' ARG . 36.8 mmt180 -64.8 150.42 47.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.543 0.687 . . . . 0.0 112.777 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.502 ' CD2' HD13 ' A' ' 40' ' ' LEU . 16.5 p90 -149.4 157.35 43.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.732 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.25 146.94 25.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -137.7 153.36 49.79 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.543 HG23 HD11 ' A' ' 18' ' ' LEU . 52.4 t -130.18 129.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.533 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -74.62 135.2 42.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.662 HD12 HD22 ' A' ' 53' ' ' LEU . 1.1 pp -151.63 -37.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.522 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -64.39 -11.44 32.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.726 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tm0? -95.57 -41.77 8.76 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.504 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.568 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 74.7 m-20 -76.76 131.64 73.32 Favored Pre-proline 0 N--CA 1.473 0.712 0 O-C-N 122.241 -0.287 . . . . 0.0 110.376 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 16.6 Cg_exo -68.3 -44.45 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.468 2.112 . . . . 0.0 112.421 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.589 ' OD1' HG13 ' A' ' 58' ' ' ILE . 1.3 p30 -77.78 -56.0 4.87 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.589 HG13 ' OD1' ' A' ' 57' ' ' ASP . 48.7 mt -60.42 -32.88 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.45 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.572 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 80.0 ttt180 -51.63 -36.25 45.17 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.222 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.39 -44.64 11.89 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -77.32 -60.23 2.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -160.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.733 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.0 pt? -69.14 -31.81 2.95 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 14.1 Cg_endo -54.93 -41.36 79.37 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.533 1.489 . . . . 0.0 110.509 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.64 -39.4 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.494 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.564 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.83 -42.48 70.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.038 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.827 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.69 -57.99 3.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.484 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.715 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.9 t-20 -175.89 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 122.102 0.953 . . . . 0.0 109.407 169.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.715 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -57.32 148.53 52.95 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.209 -1.814 . . . . 0.0 113.328 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -62.85 -35.98 64.27 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.279 1.986 . . . . 0.0 110.314 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 p -143.19 -128.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.036 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.97 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.8 m-85 -139.09 -167.85 0.17 Allowed Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.97 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 48.4 Cg_endo -67.42 151.12 84.17 Favored 'Cis proline' 0 C--N 1.359 1.091 0 CA-C-N 121.318 1.507 . . . . 0.0 114.006 -1.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 19.3 mt-30 -139.15 132.57 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.188 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -95.75 137.23 35.11 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 67.9 m95 -122.99 132.48 54.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 110.92 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.904 HG21 HD13 ' A' ' 99' ' ' LEU . 58.0 t -118.54 119.73 62.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.483 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.534 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 33.3 t70 56.68 25.53 10.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.857 1.313 . . . . 0.0 110.02 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.614 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.49 28.4 47.99 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.135 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.11 135.58 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.996 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.827 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.1 tp -70.97 129.16 38.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.261 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.568 HG12 ' CG2' ' A' ' 86' ' ' ILE . 98.5 t -105.62 -54.74 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.824 170.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 141.01 133.4 2.93 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -86.11 -64.84 1.45 Allowed Glycine 0 C--O 1.217 -0.907 0 C-N-CA 119.046 -1.549 . . . . 0.0 116.436 -167.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.4 p -78.94 -59.61 2.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.21 1.005 . . . . 0.0 113.031 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.3 -46.11 21.0 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 120.886 0.374 . . . . 0.0 111.0 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.568 ' CG2' HG12 ' A' ' 81' ' ' VAL . 46.0 mm -63.4 -42.69 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.73 -171.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.6 t -59.5 -48.35 87.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.141 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.5 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.1 mm -59.03 -49.01 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.759 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 39.7 tt0 -61.61 -54.49 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.679 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.617 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -56.21 -36.27 68.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.536 0.208 . . . . 0.0 111.412 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.579 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.0 t80 -59.6 -50.85 72.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.062 174.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.6 mt-30 -66.01 -44.02 85.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.9 mmm-85 -58.93 -33.71 70.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.695 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.23 21.67 64.54 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.567 -1.197 . . . . 0.0 112.152 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.3 mt-10 -88.35 -29.4 20.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.379 0.609 . . . . 0.0 110.851 173.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 60.3 tp -62.16 -55.0 33.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.048 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.713 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 16.3 pt20 -59.22 -26.26 64.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.632 174.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.695 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.1 mm-40 -68.81 -55.14 12.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.801 0.334 . . . . 0.0 111.404 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.904 HD13 HG21 ' A' ' 76' ' ' VAL . 2.3 pp -71.19 -36.09 71.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.044 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 99' ' ' LEU . 46.2 mm -62.31 -44.67 99.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 113' ' ' ASP . 21.9 ttmt -49.29 -57.6 6.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.51 0.672 . . . . 0.0 111.793 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 88.2 tt0 -62.15 -46.09 90.55 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.528 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 86.6 m -67.22 -49.73 63.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.97 89.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.581 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.73 91.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -67.3 -26.79 66.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.79 -177.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.526 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 37.8 m-85 -79.19 -46.61 17.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.204 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.418 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 48.0 mtmt -91.94 -158.27 0.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.308 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 p -84.84 55.25 3.37 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.353 1.073 . . . . 0.0 112.015 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 53.86 47.23 24.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.319 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 40.0 mm-40 -62.44 136.34 95.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.585 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.39 132.25 20.41 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.084 2.523 . . . . 0.0 112.401 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 10.9 t70 . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.672 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.419 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 65.1 mt . . . . . 0 C--O 1.232 0.139 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 52.6 mm-40 -53.96 -47.62 71.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -67.12 -43.93 81.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.283 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.694 HG21 HD13 ' A' ' 62' ' ' LEU . 81.4 mt -59.23 -44.48 92.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.404 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 33.9 mt-30 -61.34 -43.46 98.83 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.486 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.3 mmp_? -61.15 -35.84 78.17 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -68.08 -45.75 72.92 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.655 HG23 HD23 ' A' ' 18' ' ' LEU . 41.3 mt -63.55 -41.14 91.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.918 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -34.27 71.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.347 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 72.8 mt-10 -59.84 -50.42 73.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.898 0.38 . . . . 0.0 111.07 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -79.33 128.81 74.3 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.111 -171.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' O ' HD13 ' A' ' 17' ' ' ILE . 50.8 Cg_exo -59.05 -42.6 49.86 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 123.144 2.563 . . . . 0.0 112.03 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.6 mm -133.88 122.64 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.655 HD23 HG23 ' A' ' 12' ' ' ILE . 20.8 tp -133.87 141.7 47.49 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.2 -171.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.4 tp -136.61 119.87 16.75 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.096 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.702 ' CE2' HD21 ' A' ' 62' ' ' LEU . 6.2 m-85 -98.26 119.33 36.74 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.795 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 23.0 ptt? -146.19 -166.81 2.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.206 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 84.4 tttt -96.57 144.74 26.35 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.66 121.2 3.55 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.508 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.579 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 41.5 t -132.93 144.87 54.66 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.59 -39.89 86.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.475 2.117 . . . . 0.0 111.277 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -68.43 -34.34 75.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.496 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.09 117.56 1.87 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -74.99 26.3 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.5 2.134 . . . . 0.0 114.434 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.1 p -164.33 49.86 0.12 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.529 0.681 . . . . 0.0 111.448 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.653 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 1.6 p -67.06 61.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.426 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.81 -138.69 2.57 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 42.9 m-85 -76.9 -19.86 56.92 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 25.8 p -69.52 -15.2 63.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -46.95 -42.12 17.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -78.74 -40.87 32.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.085 0.469 . . . . 0.0 110.438 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.84 97.99 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.922 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.4 p -55.8 -38.49 51.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.583 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 28.9 mm-40 -68.13 -46.01 72.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.367 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.36 -45.41 88.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -63.42 -55.43 24.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.164 0.507 . . . . 0.0 110.364 -175.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.34 70.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.05 -48.63 57.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.312 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.759 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -73.3 -58.17 3.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.05 -143.31 13.79 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.465 -0.874 . . . . 0.0 114.164 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.673 ' OE2' ' HB3' ' A' ' 111' ' ' GLU . 51.8 mt-10 -97.37 -154.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.437 0.637 . . . . 0.0 111.337 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -66.88 153.3 43.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.164 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 24.4 p90 -147.67 153.43 39.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.3 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.21 144.85 27.22 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -132.67 153.27 51.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG23 HD11 ' A' ' 18' ' ' LEU . 58.3 t -128.35 129.73 69.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' MET . 43.2 p-10 -75.34 135.64 40.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.63 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.773 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 1.1 pp -149.68 -37.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.76 -11.05 23.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.613 170.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -94.8 -40.56 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.073 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.773 ' ND2' ' HA ' ' A' ' 52' ' ' ILE . 19.8 p30 -80.23 140.85 53.14 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 121.389 0.614 . . . . 0.0 111.428 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.23 -41.79 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.995 1.797 . . . . 0.0 112.524 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -78.74 -55.84 4.86 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -170.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.552 HG22 HD23 ' A' ' 62' ' ' LEU . 51.3 mt -62.9 -39.1 83.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.392 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.1 ttt180 -53.93 -34.72 60.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.048 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.17 -54.16 5.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 64' ' ' LYS . 42.1 mt-10 -79.84 -51.36 9.24 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.802 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -58.07 -43.29 98.29 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -171.004 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.594 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 21.2 Cg_endo -57.76 -38.71 92.0 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 121.631 1.554 . . . . 0.0 111.197 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 61' ' ' GLU . 5.0 mtpm? -55.09 -39.48 69.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.04 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.563 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.79 -41.62 91.76 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.133 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.77 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -80.72 -56.93 3.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.97 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.73 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -174.99 -55.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.319 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.73 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.27 151.36 58.89 Favored Pre-proline 0 C--O 1.222 -0.365 0 CA-C-N 113.646 -1.615 . . . . 0.0 113.72 -175.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.21 -39.21 39.84 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.318 2.012 . . . . 0.0 110.336 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.552 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 67.9 p -142.44 -124.38 0.09 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.66 172.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.984 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 24.1 m-85 -138.67 -168.26 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.984 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 41.6 Cg_endo -67.4 155.34 85.75 Favored 'Cis proline' 0 C--N 1.361 1.228 0 CA-C-N 121.235 1.477 . . . . 0.0 114.466 -1.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.726 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 18.8 mt-30 -143.6 133.07 23.44 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.507 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.8 137.42 34.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.998 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.524 ' N ' HD13 ' A' ' 74' ' ' LEU . 61.4 m95 -122.66 129.3 51.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.283 0.563 . . . . 0.0 110.805 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.914 HG21 HD13 ' A' ' 99' ' ' LEU . 48.7 t -115.16 119.96 63.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.3 t70 56.22 30.33 16.39 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 123.563 1.649 . . . . 0.0 108.812 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.605 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 74.53 29.06 62.28 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.381 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 49.5 mt-10 -125.37 133.71 52.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.383 . . . . 0.0 110.782 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.77 HD22 ' HB1' ' A' ' 66' ' ' ALA . 55.4 tp -71.05 130.95 42.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.609 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.534 HG12 ' CG2' ' A' ' 86' ' ' ILE . 99.3 t -110.37 -52.05 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.199 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 145.64 134.92 2.75 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.484 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.47 -64.63 1.56 Allowed Glycine 0 C--O 1.218 -0.897 0 C-N-CA 118.751 -1.69 . . . . 0.0 116.526 -166.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.516 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 25.1 p -80.62 -69.04 0.63 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.285 1.042 . . . . 0.0 112.824 -170.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 40.5 m-20 -74.42 -43.7 55.12 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.263 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 81' ' ' VAL . 50.7 mm -58.54 -45.31 90.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.937 -174.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 39' ' ' ALA . 74.5 t -57.44 -48.01 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.185 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 39' ' ' ALA . 44.0 mm -60.29 -51.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.973 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.7 tt0 -62.19 -50.17 72.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.795 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.4 mmt -57.81 -39.73 78.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.843 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 13.3 t80 -60.15 -49.14 78.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.805 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.3 mt-30 -65.5 -40.09 92.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.83 0.348 . . . . 0.0 110.168 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.7 mmm-85 -57.82 -33.24 68.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.143 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.22 21.64 64.62 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.602 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 93.0 mt-10 -99.06 -13.85 19.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 0.0 111.543 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.661 HD12 HD11 ' A' ' 99' ' ' LEU . 55.7 tp -72.12 -53.06 13.89 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.759 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.2 pm0 -56.31 -25.66 49.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.703 170.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 11.7 mm-40 -71.17 -50.52 32.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.845 0.355 . . . . 0.0 111.58 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.914 HD13 HG21 ' A' ' 76' ' ' VAL . 2.6 pp -74.59 -36.22 63.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 99' ' ' LEU . 42.6 mm -63.63 -42.11 94.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 173.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 21.8 ttmm -52.42 -56.24 16.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.303 0.573 . . . . 0.0 111.25 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -57.3 -48.61 78.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.924 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.8 m -69.4 -47.95 62.58 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.615 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -61.22 -47.93 83.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.005 0.431 . . . . 0.0 110.307 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.69 95.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -68.92 -29.76 68.09 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.11 -0.369 . . . . 0.0 111.863 -178.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.523 ' HE2' HG23 ' A' ' 103' ' ' THR . 52.8 m-85 -78.78 -46.6 18.46 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.245 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.615 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.68 -160.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.681 174.12 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.7 p -84.73 -140.1 0.07 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.953 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.77 45.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.959 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.673 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . 5.0 mm-40 -70.81 130.58 88.4 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.996 0.427 . . . . 0.0 111.373 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 1.5 Cg_endo -82.98 116.42 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.837 2.358 . . . . 0.0 112.318 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD2' HG22 ' A' ' 100' ' ' ILE . 12.9 t70 . . . . . 0 C--N 1.322 -0.596 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.975 HG22 ' HG3' ' A' ' 9' ' ' GLN . 22.4 mm . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 70.6 mm-40 -44.69 -45.79 9.94 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -62.16 -43.76 98.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.074 0.464 . . . . 0.0 110.93 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 62' ' ' LEU . 73.0 mt -68.3 -40.55 82.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.626 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.975 ' HG3' HG22 ' A' ' 5' ' ' ILE . 36.3 mt-30 -58.54 -44.2 89.51 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -55.54 -34.73 64.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.268 175.13 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.645 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 16.9 tt0 -68.44 -48.41 64.66 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.431 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.551 HG22 ' HA2' ' A' ' 78' ' ' GLY . 21.0 mt -68.32 -39.24 80.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.77 0.795 . . . . 0.0 110.472 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.46 81.0 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.839 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.1 pt-20 -70.03 -39.28 75.86 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -173.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 2.7 p30 -79.22 134.96 58.35 Favored Pre-proline 0 CA--C 1.518 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 112.737 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.524 ' O ' HD13 ' A' ' 17' ' ' ILE . 32.7 Cg_exo -64.24 -41.73 20.5 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 123.165 2.576 . . . . 0.0 111.648 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 16' ' ' PRO . 24.1 mm -138.52 121.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.757 HD11 HG23 ' A' ' 50' ' ' VAL . 25.6 tp -132.43 141.25 48.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.232 0.539 . . . . 0.0 111.959 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.5 tp -132.34 120.67 22.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.791 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.793 ' CE2' HD21 ' A' ' 62' ' ' LEU . 7.5 m-85 -99.53 120.99 40.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.703 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.527 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -148.1 -154.05 0.53 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.755 ' HD3' ' HB3' ' A' ' 30' ' ' CYS . 64.6 tttm -100.7 112.01 24.34 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.43 69.5 1.06 Allowed Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.674 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -78.85 143.97 63.26 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.198 . . . . 0.0 111.068 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.04 -40.23 85.38 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.119 1.879 . . . . 0.0 110.94 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -65.27 -33.09 75.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.765 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -160.46 116.67 1.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.511 ' O ' ' SD ' ' A' ' 21' ' ' MET . 9.3 Cg_exo -72.94 31.43 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.738 2.292 . . . . 0.0 113.984 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -169.61 51.82 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.454 0.702 . . . . 0.0 110.241 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.755 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.8 t -56.37 -37.07 69.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.554 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -70.5 -135.82 0.11 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.5 -36.4 57.81 Favored 'General case' 0 C--O 1.219 -0.529 0 O-C-N 122.353 -0.498 . . . . 0.0 111.943 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.486 ' CB ' ' HB3' ' A' ' 21' ' ' MET . 34.6 t -54.01 -10.39 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.41 -42.32 42.2 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.083 0.24 . . . . 0.0 111.325 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.56 -34.85 35.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.234 177.327 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.26 -42.75 83.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.304 -175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.527 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.54 -37.41 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.305 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -64.81 -46.08 83.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.306 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.65 -43.95 93.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.618 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -64.12 -57.88 8.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.618 -174.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.41 ' HB2' ' HE2' ' A' ' 47' ' ' PHE . . . -59.56 -34.41 72.65 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.271 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.52 -48.84 59.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.681 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.5 p -72.81 -54.25 9.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.795 -173.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.774 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.38 -142.45 12.75 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.451 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 17.1 pt-20 -99.95 -154.68 0.48 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.52 . . . . 0.0 111.082 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.79 158.68 33.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.991 170.36 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.527 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 15.5 p90 -152.96 159.73 42.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.297 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.54 151.98 19.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.475 ' HD1' ' HE2' ' A' ' 21' ' ' MET . 2.0 p90 -138.05 151.59 48.0 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.757 HG23 HD11 ' A' ' 18' ' ' LEU . 46.2 t -132.3 126.78 56.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.61 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.8 p30 -76.59 131.39 38.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.277 0.56 . . . . 0.0 110.73 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.681 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -143.5 -33.93 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.709 -174.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 52' ' ' ILE . 1.6 mm? -65.74 -9.47 28.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.142 166.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -96.87 -46.82 6.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.236 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -83.44 116.57 65.16 Favored Pre-proline 0 N--CA 1.476 0.842 0 O-C-N 122.059 -0.401 . . . . 0.0 111.025 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.93 -44.81 18.78 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.792 2.328 . . . . 0.0 113.248 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -61.5 -55.07 35.16 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.443 0.64 . . . . 0.0 111.341 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.457 HG22 HD23 ' A' ' 62' ' ' LEU . 41.9 mt -67.34 -36.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.365 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.3 ttt180 -56.98 -33.68 67.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.72 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.51 7.33 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.749 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 55.3 mm-40 -84.7 -51.05 7.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -167.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.793 HD21 ' CE2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -60.09 -41.67 85.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -172.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.626 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 32.4 Cg_endo -59.52 -39.28 76.95 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 C-N-CA 121.282 1.321 . . . . 0.0 111.168 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 37.9 mtmt -55.55 -41.75 73.68 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.219 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.666 ' HD2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -63.32 -44.89 93.64 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.111 -176.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.816 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.1 -56.11 5.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.462 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.738 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.5 t-20 -174.82 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.188 0.994 . . . . 0.0 110.006 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.738 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.12 148.25 62.31 Favored Pre-proline 0 C--O 1.219 -0.542 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.365 -175.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.77 -37.36 68.1 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 121.912 1.741 . . . . 0.0 110.437 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 37.2 p -143.07 -128.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.58 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.6 m-85 -137.11 -169.7 0.22 Allowed Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.968 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.55 153.39 82.59 Favored 'Cis proline' 0 C--N 1.361 1.22 0 CA-C-N 121.374 1.527 . . . . 0.0 114.14 -0.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.549 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 30.5 mt-30 -142.28 135.45 28.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.298 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.2 tm? -99.3 133.71 43.2 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 59.4 m95 -116.9 131.33 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.314 0.578 . . . . 0.0 110.863 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.827 HG21 HD13 ' A' ' 99' ' ' LEU . 86.4 t -121.67 122.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' HB2' HG23 ' A' ' 103' ' ' THR . 37.3 t70 58.22 30.12 18.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.811 1.291 . . . . 0.0 109.332 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.68 28.77 66.62 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.16 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -137.04 137.56 39.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 111.479 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.816 HD22 ' HB1' ' A' ' 66' ' ' ALA . 46.3 tp -66.96 132.48 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.229 -172.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.572 HG12 ' CG2' ' A' ' 86' ' ' ILE . 76.1 t -110.32 -54.65 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.921 171.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.63 134.49 2.7 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.87 -62.39 1.69 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -168.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.1 p -78.67 -68.12 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.701 -0.882 . . . . 0.0 112.992 -170.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.94 -47.65 43.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.031 0.444 . . . . 0.0 111.008 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.572 ' CG2' HG12 ' A' ' 81' ' ' VAL . 44.4 mm -59.95 -46.82 93.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.754 -170.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -56.11 -50.33 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.361 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 39' ' ' ALA . 36.7 mm -61.94 -50.66 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.631 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.781 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.3 tt0 -63.25 -50.48 70.02 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.422 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.463 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.3 mmt -57.54 -38.02 74.02 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.0 t80 -58.02 -51.64 68.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.149 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.0 mt-30 -63.93 -39.85 95.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.649 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.781 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 25.9 mmm180 -63.6 -33.89 76.6 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.821 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 99.59 -24.09 33.58 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.34 -170.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 5.1 mm-40 -52.14 -36.14 50.52 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.61 HD12 HD11 ' A' ' 99' ' ' LEU . 53.3 tp -64.77 -54.99 22.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.68 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.5 pt20 -61.18 -26.47 67.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.405 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 10.4 mm100 -66.81 -54.54 21.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.633 0.254 . . . . 0.0 111.407 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 HG21 ' A' ' 76' ' ' VAL . 3.0 pp -70.28 -35.26 73.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.558 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 99' ' ' LEU . 35.7 mm -62.97 -48.6 87.22 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -55.62 -52.22 64.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 111.753 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -57.1 -45.32 83.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.949 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 77' ' ' ASP . 91.1 m -68.0 -47.97 67.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.417 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.06 99.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.025 0.441 . . . . 0.0 110.06 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.65 99.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -72.14 -33.6 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.643 -178.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.465 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 80.0 m-85 -79.57 -46.69 16.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.767 173.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.636 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -89.58 -149.91 0.2 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.184 -177.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 25.3 t -82.84 -148.36 0.08 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.331 170.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -75.11 54.3 0.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.877 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 38.5 mm-40 -66.11 117.56 44.07 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 121.178 0.514 . . . . 0.0 110.398 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -99.7 49.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.598 2.865 . . . . 0.0 113.233 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.774 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 36.4 m-20 . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.423 HD13 ' CB ' ' A' ' 65' ' ' TYR . 73.3 mt . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -53.38 -47.29 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.982 0.42 . . . . 0.0 110.725 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.951 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -68.43 -45.35 72.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.56 175.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.63 HG21 HD22 ' A' ' 62' ' ' LEU . 82.6 mt -56.69 -44.2 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -60.35 -35.84 76.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.831 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -60.23 -35.68 76.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.494 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -72.36 -42.11 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.542 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.649 HG23 HD23 ' A' ' 18' ' ' LEU . 19.6 mt -68.39 -45.66 81.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.119 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -37.81 78.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.169 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.2 pt-20 -68.57 -34.8 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -78.55 127.57 80.15 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-O 120.901 0.381 . . . . 0.0 111.273 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.611 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.7 Cg_exo -61.8 -42.84 29.05 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.019 2.48 . . . . 0.0 112.333 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 16' ' ' PRO . 32.1 mm -137.47 120.95 21.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD23 HG23 ' A' ' 12' ' ' ILE . 21.5 tp -133.41 142.43 48.34 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.466 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.3 tp -136.32 120.28 17.55 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.12 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.769 ' CE2' HD21 ' A' ' 62' ' ' LEU . 5.5 m-85 -97.35 117.92 32.66 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.848 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.532 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 21.6 ptt? -146.84 -164.89 2.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.4 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.948 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 61.9 tttm -98.34 103.16 15.08 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.24 67.0 1.76 Allowed Glycine 0 C--N 1.309 -0.926 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.437 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 t -76.07 141.3 70.85 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.6 -41.42 45.11 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.253 1.969 . . . . 0.0 112.188 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -65.14 -35.62 81.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.844 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -158.57 118.99 1.84 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -172.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.552 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.1 Cg_exo -71.99 20.37 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.798 2.332 . . . . 0.0 114.303 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.7 p -161.97 52.35 0.23 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.517 0.675 . . . . 0.0 111.037 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 43.4 t -71.54 56.24 0.25 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.126 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.23 -136.53 2.02 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.695 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 28.2 m-85 -76.25 -38.28 56.48 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 117.481 0.64 . . . . 0.0 109.518 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 35.1 p -46.4 -24.58 0.52 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.195 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.99 -42.2 48.6 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.555 0.216 . . . . 0.0 111.097 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' O ' ' A' ' 32' ' ' PHE . 1.8 pp0? -77.41 -37.94 50.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 10.6 p -57.53 -38.98 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 29.3 mm-40 -65.42 -41.92 93.07 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.924 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.519 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.1 -43.33 95.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.604 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.08 -56.0 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 0.0 109.908 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.35 72.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.885 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.6 m -70.41 -60.36 2.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.33 -138.91 9.57 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -115.09 -151.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.621 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -59.38 152.68 20.73 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.628 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.51 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 26.1 p90 -155.64 154.16 31.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.057 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 151.71 20.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.947 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.3 p90 -135.72 153.91 51.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.648 HG23 HD11 ' A' ' 18' ' ' LEU . 61.6 t -131.43 134.51 60.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.651 ' OD1' ' HB3' ' A' ' 54' ' ' GLN . 7.9 t70 -73.13 138.89 46.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.185 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.1 pp -152.0 -35.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.387 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.948 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -65.25 -18.0 64.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.387 174.251 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.651 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 12.7 tm0? -94.94 -43.23 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.616 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -71.51 118.55 67.27 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 117.797 0.271 . . . . 0.0 110.503 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.81 -43.98 8.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.313 2.009 . . . . 0.0 113.029 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -69.25 -52.79 24.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.85 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.568 HG22 HD23 ' A' ' 62' ' ' LEU . 19.8 mt -65.12 -36.53 78.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.391 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.2 tmm_? -56.32 -37.93 70.61 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.73 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.609 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -80.43 -50.99 9.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.596 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 4.9 mm-40 -79.18 -53.51 6.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -167.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -62.53 -40.69 67.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.63 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 27.5 Cg_endo -59.44 -40.74 64.25 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 121.378 1.385 . . . . 0.0 111.468 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 51.6 mtmt -56.28 -36.06 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.556 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.557 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.81 -43.23 80.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.534 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.781 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.81 -56.26 4.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.434 -174.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.765 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -175.47 -53.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.253 1.025 . . . . 0.0 109.362 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.765 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.73 150.64 57.18 Favored Pre-proline 0 C--O 1.218 -0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 113.484 -176.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 68' ' ' TRP . 10.3 Cg_exo -64.1 -39.12 32.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.211 1.941 . . . . 0.0 110.113 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.5 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 47.6 p -143.12 -129.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.728 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 1.011 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.4 m-85 -137.86 -171.85 0.29 Allowed Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.528 -0.733 . . . . 0.0 109.141 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.011 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.57 156.07 82.31 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 120.933 1.369 . . . . 0.0 114.469 -0.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.678 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.9 mt-30 -142.08 133.58 26.67 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.264 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -94.06 138.13 32.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 58.9 m95 -124.28 128.03 48.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.257 0.551 . . . . 0.0 110.828 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.54 120.96 62.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.587 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 32.6 t70 56.39 27.44 12.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.917 1.341 . . . . 0.0 110.01 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.646 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 77.38 29.34 56.15 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.905 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -125.83 132.62 52.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.781 HD22 ' HB1' ' A' ' 66' ' ' ALA . 56.3 tp -69.81 130.29 41.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.472 HG12 ' CG2' ' A' ' 86' ' ' ILE . 88.3 t -108.35 -55.75 5.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.346 172.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.29 131.41 2.43 Favored Glycine 0 C--O 1.22 -0.768 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.468 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.36 -62.33 1.65 Allowed Glycine 0 C--O 1.222 -0.641 0 C-N-CA 119.593 -1.289 . . . . 0.0 116.1 -168.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 p -77.52 -67.85 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.759 -0.848 . . . . 0.0 112.934 -170.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -79.04 -45.0 21.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.023 -173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG13 ' HA3' ' A' ' 82' ' ' GLY . 48.0 mm -58.01 -47.01 87.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 82' ' ' GLY . 60.5 t -57.29 -51.86 64.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.568 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.519 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 45.6 mm -59.83 -50.39 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 42.7 tt0 -61.04 -51.51 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.694 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.683 ' HG2' ' N ' ' A' ' 96' ' ' LEU . 46.5 ttm -63.88 -32.59 74.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.098 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.885 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 7.8 t80 -57.35 -52.05 66.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.657 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.1 mt-30 -62.83 -38.28 90.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.14 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -59.12 -32.84 70.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.062 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.04 17.64 79.54 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.571 -171.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.666 ' HA ' ' HB3' ' A' ' 98' ' ' GLN . 88.9 mt-10 -90.87 -27.17 18.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.525 177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.683 ' N ' ' HG2' ' A' ' 90' ' ' MET . 61.7 tp -60.1 -53.66 55.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.579 0.704 . . . . 0.0 109.462 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.825 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 14.1 pt20 -64.31 -26.62 68.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.28 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 17.5 tp60 -64.59 -44.16 91.52 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.175 0.512 . . . . 0.0 109.713 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 25.4 mt -69.95 -46.46 65.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.57 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.08 -45.23 98.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.148 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' A' ' 113' ' ' ASP . 36.4 ttpt -55.96 -48.78 75.18 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.49 -44.03 96.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.13 0.49 . . . . 0.0 110.373 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.587 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 42.1 m -75.33 -52.2 11.39 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.58 94.12 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.261 -0.274 . . . . 0.0 111.154 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.3 80.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.635 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -75.04 -27.03 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.153 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.611 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 44.4 m-85 -80.73 -45.77 16.54 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.063 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -76.64 -156.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.025 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.4 p -82.45 -147.75 0.08 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -76.81 46.51 0.46 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.916 0.389 . . . . 0.0 110.925 171.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -68.34 129.06 93.02 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.894 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.15 111.38 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.399 2.066 . . . . 0.0 112.721 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 101' ' ' LYS . 31.1 t70 . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 62' ' ' LEU . 91.5 mt . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 33.8 mm-40 -51.28 -53.71 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 111.429 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.78 -40.19 88.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.304 0.573 . . . . 0.0 110.674 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.918 HG21 ' HG ' ' A' ' 62' ' ' LEU . 83.4 mt -59.76 -46.14 93.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.616 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 32.4 mt-30 -61.77 -35.24 77.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.662 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -60.82 -38.54 85.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.172 175.086 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 8' ' ' ILE . 17.2 pt20 -79.68 -39.81 30.47 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.009 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.643 HG22 ' HA2' ' A' ' 78' ' ' GLY . 22.3 mt -61.88 -45.22 99.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.218 0.533 . . . . 0.0 110.429 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.6 91.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.1 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.0 pt-20 -70.43 -30.15 66.93 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.828 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 31.8 m120 -76.74 126.87 85.32 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.275 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.632 ' O ' HD13 ' A' ' 17' ' ' ILE . 51.0 Cg_exo -60.29 -43.56 33.93 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.911 2.407 . . . . 0.0 112.56 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 16' ' ' PRO . 26.2 mm -139.92 120.61 14.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD23 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -133.76 142.26 47.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.375 -169.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 14.5 tp -137.52 116.62 12.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.17 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.561 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 6.6 m-85 -96.35 118.83 33.69 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.305 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.848 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 24.2 ptt? -147.44 -167.44 2.79 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 65.9 tttm -97.11 108.68 21.46 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -94.63 71.15 1.13 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.328 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.9 m -78.67 146.71 69.73 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.92 -41.69 74.62 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.479 2.119 . . . . 0.0 112.288 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.88 -31.45 71.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 tt -157.58 115.22 1.88 Allowed Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 40.2 Cg_endo -71.84 22.12 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.674 2.25 . . . . 0.0 113.713 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.848 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 15.7 p -163.14 50.48 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.014 0.526 . . . . 0.0 109.903 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.63 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 37.6 t -71.93 53.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.288 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.12 -134.38 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.152 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 1.037 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 63.3 m-85 -76.43 -23.16 53.95 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.405 ' N ' ' HG2' ' A' ' 72' ' ' PRO . 23.3 t -74.82 -11.54 60.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.664 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -50.76 -43.4 58.29 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -77.42 -39.13 48.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.068 0.461 . . . . 0.0 110.107 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.34 89.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.102 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -56.8 -39.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.321 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 28.3 mm-40 -66.89 -47.35 72.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.858 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.36 -42.86 92.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.984 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -62.37 -57.08 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 110.036 -175.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.03 69.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.204 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.82 -50.62 23.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.557 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -76.5 -52.99 8.73 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.246 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.64 -135.59 8.99 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.486 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 26.3 mt-10 -141.95 -147.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.101 -0.549 . . . . 0.0 111.348 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 34.3 mmt-85 -48.02 146.96 2.28 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.359 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' HD13 ' A' ' 40' ' ' LEU . 21.6 p90 -159.38 150.86 20.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.876 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.99 144.06 28.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.557 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 p90 -130.78 149.74 52.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.485 HG23 HD11 ' A' ' 18' ' ' LEU . 44.0 t -124.31 128.04 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.535 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.0 p30 -78.46 132.2 37.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.393 0.616 . . . . 0.0 110.166 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.664 HD12 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -142.53 -34.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.342 -173.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.664 HD22 HD12 ' A' ' 52' ' ' ILE . 1.8 mm? -67.19 -8.68 33.2 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.116 167.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -97.25 -47.12 5.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.698 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.674 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.1 m-20 -73.78 131.35 81.96 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 121.958 -0.464 . . . . 0.0 111.419 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.76 -43.63 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.364 2.043 . . . . 0.0 112.924 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -76.1 -55.5 5.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.78 -33.38 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.674 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 28.1 ttm180 -49.73 -40.4 40.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.612 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.39 18.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 56.7 mm-40 -78.86 -60.08 2.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -161.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.918 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.92 -25.18 0.49 Allowed Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -170.001 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.687 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 14.1 Cg_endo -55.24 -41.82 74.66 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 121.682 1.637 . . . . 0.0 110.682 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -48.38 -41.93 30.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.777 175.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.639 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -71.97 -41.7 67.39 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.149 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.824 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -72.53 -57.56 4.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.64 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.689 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 50.3 t30 -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.256 1.027 . . . . 0.0 109.861 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.689 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -60.78 148.07 83.39 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 113.12 -1.854 . . . . 0.0 112.738 -176.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -61.95 -33.94 82.45 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.194 1.93 . . . . 0.0 110.145 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -143.0 -126.64 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.917 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.966 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.3 m-85 -142.28 -164.49 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.966 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 2.1 Cg_endo -74.32 154.9 99.88 Favored 'Cis proline' 0 C--N 1.362 1.278 0 CA-C-N 121.503 1.572 . . . . 0.0 113.282 -2.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.51 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 25.3 mt-30 -144.02 135.4 25.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.704 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -93.55 137.04 33.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 59.1 m95 -121.26 132.56 54.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.236 0.541 . . . . 0.0 111.083 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.06 120.88 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.591 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 30.6 t70 56.38 28.35 13.38 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.799 1.285 . . . . 0.0 110.43 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.51 28.21 55.77 Favored Glycine 0 C--N 1.311 -0.821 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.887 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -127.76 133.84 49.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.824 HD22 ' HB1' ' A' ' 66' ' ' ALA . 52.0 tp -69.44 130.25 41.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.771 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' CG2' ' A' ' 86' ' ' ILE . 81.6 t -107.35 -54.4 5.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.902 173.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.59 140.78 3.64 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.16 -67.66 1.4 Allowed Glycine 0 C--O 1.217 -0.951 0 C-N-CA 118.549 -1.786 . . . . 0.0 116.1 -167.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 1.037 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 42.0 t -81.76 -68.03 0.73 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.767 1.283 . . . . 0.0 112.657 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 86' ' ' ILE . 1.5 m-20 -65.53 -49.62 68.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.6 -169.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.6 mp -63.58 -43.15 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.992 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 HD11 ' A' ' 96' ' ' LEU . 53.1 t -59.84 -51.39 73.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.441 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.1 mm -59.02 -48.77 85.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.928 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.736 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.2 tt0 -62.28 -52.11 64.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.096 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.685 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.9 mmt -60.43 -34.78 74.47 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.611 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 7.6 t80 -58.2 -50.04 74.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.772 172.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.4 mt-30 -64.31 -40.81 96.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.11 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -61.96 -34.53 76.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.584 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.77 -23.53 32.33 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.824 -171.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.755 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 4.7 mm-40 -56.4 -39.69 73.41 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.824 0.45 . . . . 0.0 112.179 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.8 tt -60.31 -52.7 64.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.186 -176.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.708 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -64.68 -26.75 68.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -68.61 -46.83 68.23 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.108 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 53.5 mt -63.44 -46.19 87.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.06 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 96' ' ' LEU . 48.8 mm -62.1 -45.17 99.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.145 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.464 ' HA ' ' OD2' ' A' ' 113' ' ' ASP . 26.0 ttpp -53.03 -52.7 57.61 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.234 0.54 . . . . 0.0 111.375 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 87.7 tt0 -65.2 -46.6 80.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.547 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.951 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 91.4 m -66.87 -46.99 73.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.368 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.49 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.93 -42.29 99.75 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.58 78.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.951 ' HE2' ' HA ' ' A' ' 103' ' ' THR 0.255 0.0 OUTLIER -77.79 -26.97 50.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.349 178.631 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.692 ' CE2' ' HE3' ' A' ' 106' ' ' LYS . 93.8 m-85 -87.95 -49.55 6.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.521 171.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -101.82 135.9 42.57 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 p -58.17 115.84 3.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 49.47 43.23 23.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.396 -1.729 . . . . 0.0 114.143 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -78.33 117.69 67.73 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.38 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.18 59.03 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.697 2.931 . . . . 0.0 114.431 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.529 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 55.1 m-20 . . . . . 0 C--N 1.314 -0.947 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.505 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 62.2 mt . . . . . 0 C--O 1.225 -0.229 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -54.42 -45.67 73.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.002 0.43 . . . . 0.0 110.331 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -71.64 -40.19 69.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.051 174.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.695 HD13 HD22 ' A' ' 62' ' ' LEU . 72.3 mt -57.51 -43.66 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.56 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 7' ' ' LYS . 5.7 tpm_? -60.01 -38.24 82.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.383 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 53.0 tt0 -68.0 -45.8 73.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.124 0.487 . . . . 0.0 110.948 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.785 HG22 ' HA2' ' A' ' 78' ' ' GLY . 29.3 mt -66.56 -46.64 85.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.009 0.433 . . . . 0.0 110.722 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.69 88.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.4 pt-20 -66.93 -34.39 77.68 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.353 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 70.2 m-80 -77.34 128.38 80.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.607 ' O ' HD13 ' A' ' 17' ' ' ILE . 50.4 Cg_exo -60.22 -42.93 38.54 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 123.063 2.509 . . . . 0.0 112.075 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 16' ' ' PRO . 36.0 mm -139.4 125.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.685 HD11 HG23 ' A' ' 50' ' ' VAL . 27.5 tp -133.44 141.21 47.72 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.386 -170.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.3 tp -136.43 119.06 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.601 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -96.98 119.36 35.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.972 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.4 ptt? -146.19 -169.38 3.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.299 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.022 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.8 tttt -97.68 115.04 27.16 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.665 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.62 70.21 1.0 Allowed Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.399 -175.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 30' ' ' CYS . 80.4 p -79.05 143.37 61.21 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.777 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.3 -41.51 65.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.389 2.059 . . . . 0.0 112.278 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -65.0 -32.29 73.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.418 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 29' ' ' SER . 51.3 tp -158.72 116.92 1.72 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.594 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 11.3 Cg_exo -71.86 27.97 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.3 2.0 . . . . 0.0 112.736 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 40.6 p -162.84 51.56 0.18 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.179 0.514 . . . . 0.0 111.889 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.598 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 40.4 t -72.84 59.19 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.225 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.07 -139.81 2.97 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.82 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 55.1 m-85 -74.88 -17.7 60.54 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 120.994 0.426 . . . . 0.0 111.632 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 30.2 p -69.92 -18.45 63.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -48.65 -42.23 33.81 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.461 ' O ' HD11 ' A' ' 88' ' ' ILE . 12.2 mp0 -75.71 -38.97 58.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.141 0.496 . . . . 0.0 109.853 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.49 92.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.048 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.98 -39.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.028 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 30.0 mm-40 -67.11 -44.28 80.33 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.91 -47.35 85.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.991 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -61.37 -51.83 67.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.9 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.75 67.98 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.883 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 44' ' ' GLY . . . -71.65 -48.66 46.22 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.15 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.961 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -70.45 -9.18 55.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.811 170.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -10.59 120.48 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.967 0 CA-C-N 110.684 -2.962 . . . . 0.0 119.056 -160.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.779 ' OE2' ' HA ' ' A' ' 97' ' ' GLN . 3.6 mp0 -133.43 138.19 46.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 109.95 -3.125 . . . . 0.0 103.887 164.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -56.39 129.41 40.45 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.643 -170.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 14.7 p90 -140.47 148.08 40.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.04 -166.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.36 152.94 21.0 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.929 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.5 p90 -136.38 153.18 51.18 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.685 HG23 HD11 ' A' ' 18' ' ' LEU . 61.4 t -128.95 131.45 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.5 p30 -76.51 132.37 39.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 110.368 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.626 HD12 HD22 ' A' ' 53' ' ' LEU . 1.2 pp -147.64 -37.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.022 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -65.56 -7.66 15.86 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.22 173.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -96.22 -42.84 7.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.433 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.4 m-20 -77.09 123.26 87.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.5 -45.23 11.99 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.121 1.881 . . . . 0.0 112.763 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.04 -56.72 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.993 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.73 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.473 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.619 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 78.9 ttt180 -52.8 -31.93 41.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.7 -47.36 8.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.4 -60.61 2.26 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -163.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.695 HD22 HD13 ' A' ' 8' ' ' ILE . 1.8 pt? -68.36 -33.49 4.78 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.694 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.5 Cg_endo -53.94 -42.11 69.4 Favored 'Trans proline' 0 C--N 1.353 0.81 0 CA-C-N 120.939 1.371 . . . . 0.0 110.785 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.13 -40.53 61.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.28 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.509 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.3 -43.98 76.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.779 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -76.6 -57.59 3.77 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.816 -174.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.3 t-20 -174.99 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.109 0.957 . . . . 0.0 109.972 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -57.67 149.18 53.44 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 113.303 -1.772 . . . . 0.0 113.351 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -62.18 -37.11 65.17 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.426 2.084 . . . . 0.0 110.194 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 57.8 p -141.86 -124.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.278 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.998 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 46.0 m-85 -141.43 -170.58 0.24 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.998 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 58.5 Cg_endo -69.71 154.2 93.06 Favored 'Cis proline' 0 C--N 1.357 1.004 0 CA-C-N 121.27 1.489 . . . . 0.0 114.349 -1.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.617 HE22 ' HA ' ' A' ' 63' ' ' PRO . 61.2 mt-30 -144.96 134.92 23.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.655 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -98.63 137.52 37.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.029 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.535 ' N ' HD13 ' A' ' 74' ' ' LEU . 60.3 m95 -123.81 132.19 53.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.276 0.56 . . . . 0.0 111.222 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 99' ' ' LEU . 38.9 t -114.31 118.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.536 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.2 t70 55.61 26.9 9.74 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.388 1.566 . . . . 0.0 108.72 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.785 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.82 28.54 46.02 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.607 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.47 133.33 47.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.973 0.416 . . . . 0.0 111.077 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.779 HD22 ' HB1' ' A' ' 66' ' ' ALA . 55.5 tp -68.81 133.44 48.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.556 HG12 ' CG2' ' A' ' 86' ' ' ILE . 90.1 t -110.41 -54.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.069 170.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.48 135.03 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.475 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -85.1 -63.56 1.58 Allowed Glycine 0 C--O 1.219 -0.803 0 C-N-CA 119.291 -1.433 . . . . 0.0 116.589 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.9 p -78.89 -67.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.427 -1.043 . . . . 0.0 113.373 -168.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.21 -43.34 28.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.556 ' CG2' HG12 ' A' ' 81' ' ' VAL . 48.4 mm -57.18 -45.61 84.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.157 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.8 t -58.67 -48.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.44 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.844 HD13 ' HB2' ' A' ' 39' ' ' ALA . 36.9 mm -58.59 -53.42 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.09 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.4 tt0 -63.2 -49.36 74.53 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.246 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.816 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -61.09 -37.64 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 2.3 t80 -57.86 -49.39 76.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.553 173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.5 mt-30 -64.16 -39.64 94.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.1 mmm180 -57.49 -33.55 68.13 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.639 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.541 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 89.82 -24.05 17.16 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.211 -170.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.511 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.1 mt-10 -60.92 -26.44 67.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 7.9 tt -73.08 -53.96 9.74 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.961 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 11.4 pt20 -57.89 -25.92 61.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.181 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 45.1 mm-40 -69.23 -53.27 20.75 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.667 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.802 HD13 HG21 ' A' ' 76' ' ' VAL . 2.8 pp -71.58 -35.39 70.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.713 ' HB ' ' OE2' ' A' ' 45' ' ' GLU . 29.4 mm -66.1 -48.38 81.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.173 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -56.31 -51.07 69.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.683 0.278 . . . . 0.0 110.953 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 85.9 tt0 -55.96 -48.02 76.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.876 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 63.7 m -63.15 -48.31 78.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.512 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.677 ' HB1' ' NZ ' ' A' ' 108' ' ' LYS . . . -60.15 -46.44 89.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.94 88.48 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.132 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -72.77 -20.8 61.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.771 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 33.0 m-85 -81.83 -46.77 13.7 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.677 ' NZ ' ' HB1' ' A' ' 104' ' ' ALA . 1.0 OUTLIER -87.09 -151.65 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.311 170.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -86.55 -153.82 0.21 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.7 51.43 0.11 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.471 0.309 . . . . 0.0 111.771 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.476 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 56.7 mm-40 -70.58 122.81 87.72 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.152 0.501 . . . . 0.0 112.021 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.67 65.35 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.337 2.692 . . . . 0.0 113.271 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 31.4 m-20 . . . . . 0 C--N 1.314 -0.943 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.482 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.441 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 63.7 mt . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -54.73 -44.12 73.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.636 0.255 . . . . 0.0 110.787 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.4 -45.11 73.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.667 HG21 HD13 ' A' ' 62' ' ' LEU . 69.0 mt -59.53 -45.06 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 31.9 mt-30 -64.3 -38.36 90.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.474 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 13.3 mmp_? -62.61 -37.01 84.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 109.868 172.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.69 -46.0 70.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.6 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.805 HG22 ' HA2' ' A' ' 78' ' ' GLY . 35.7 mt -65.72 -44.43 93.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.094 0.473 . . . . 0.0 110.53 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.01 95.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.089 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 23.5 pt-20 -66.55 -32.75 74.29 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.33 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.471 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -77.16 127.24 83.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.595 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.599 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.1 Cg_exo -59.68 -43.44 38.57 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.752 2.301 . . . . 0.0 112.576 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 16' ' ' PRO . 31.6 mm -140.27 124.2 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.701 HD23 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -134.32 142.15 47.16 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.625 -169.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.5 tp -135.15 116.95 15.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.64 ' CE2' HD11 ' A' ' 62' ' ' LEU . 10.8 m-85 -96.83 117.94 32.18 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.795 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.566 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -147.12 -158.15 0.88 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.737 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 64.9 tttm -98.85 107.95 20.51 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.648 -0.657 . . . . 0.0 109.756 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.65 126.19 8.68 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.062 -1.065 . . . . 0.0 111.79 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.441 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 37.2 t -146.4 145.16 22.81 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -41.13 79.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.204 1.936 . . . . 0.0 111.18 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.4 pttt -65.72 -32.36 73.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.667 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.467 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -160.49 119.98 1.59 Allowed Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HD2' HD13 ' A' ' 27' ' ' LEU . 44.0 Cg_endo -73.34 20.69 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.382 0 C-N-CA 122.41 2.073 . . . . 0.0 114.121 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 22.1 p -169.51 52.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.9 t -55.8 -37.7 68.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -168.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -68.83 -135.65 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.924 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -74.18 -32.61 63.15 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 122.204 -0.586 . . . . 0.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.7 p -46.54 -22.09 0.24 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.271 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.96 32.14 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.231 0.332 . . . . 0.0 111.867 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -35.5 33.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.266 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.97 -44.3 73.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.539 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.0 p -53.4 -38.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.484 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -63.74 -46.82 83.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.077 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.15 -42.04 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.839 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -61.95 -56.23 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.511 . . . . 0.0 109.895 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.31 71.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.294 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.39 -47.43 56.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.805 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.6 m -72.23 -57.98 3.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -103.87 -148.62 19.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.314 -0.946 . . . . 0.0 114.421 -175.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.8 mm-40 -105.98 -154.4 0.52 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 37.1 mmt-85 -62.2 152.7 32.53 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.558 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 24.4 p90 -151.87 156.14 39.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.142 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.51 149.67 22.49 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.2 p90 -136.63 151.74 49.65 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG23 HD11 ' A' ' 18' ' ' LEU . 54.0 t -130.98 129.5 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.377 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 2.7 p30 -75.01 134.19 41.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.503 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.677 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -149.28 -34.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.677 HD22 HD12 ' A' ' 52' ' ' ILE . 1.6 mm? -67.87 -7.57 29.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.583 169.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -95.59 -38.42 10.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.861 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 34.4 m120 -79.39 128.03 76.71 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 120.642 0.258 . . . . 0.0 111.009 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.86 -45.0 6.86 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.333 2.022 . . . . 0.0 112.928 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -84.52 -49.73 8.35 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.529 HG22 HG22 ' A' ' 52' ' ' ILE . 40.9 mt -58.39 -33.32 47.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.35 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.697 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -50.53 -38.7 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.976 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.654 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -91.42 -35.34 14.42 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.674 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 51.7 mt-10 -76.18 -61.62 1.88 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -162.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.0 pt? -70.71 -32.49 2.57 Favored Pre-proline 0 N--CA 1.468 0.433 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.697 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 18.9 Cg_endo -56.09 -40.04 87.43 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 120.925 1.366 . . . . 0.0 110.85 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.674 ' NZ ' ' HA ' ' A' ' 61' ' ' GLU . 31.6 mtmm -56.25 -38.34 70.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.519 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -66.48 -43.12 86.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.136 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.93 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.4 -57.1 4.1 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.104 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.2 t30 -175.87 -53.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.167 0.984 . . . . 0.0 109.47 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.679 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -54.9 149.24 24.1 Favored Pre-proline 0 C--O 1.217 -0.623 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.388 -176.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -62.77 -37.75 53.8 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.242 1.961 . . . . 0.0 110.191 171.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.9 p -142.01 -130.43 0.1 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.635 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.922 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 17.1 m-85 -137.67 -166.15 0.11 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.922 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.1 Cg_endo -65.87 153.28 80.0 Favored 'Cis proline' 0 C--N 1.362 1.274 0 CA-C-N 121.586 1.602 . . . . 0.0 113.744 -1.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.466 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 29.6 mt-30 -141.74 133.11 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.53 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -93.96 138.4 32.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 59.6 m95 -126.77 130.19 49.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.799 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' CG2' HD13 ' A' ' 100' ' ' ILE . 2.4 p -125.63 123.79 65.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.5 t70 61.28 28.25 17.81 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.468 1.604 . . . . 0.0 108.091 -171.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.805 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 68.2 25.67 74.46 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 113.029 -1.896 . . . . 0.0 112.95 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 37.0 mm-40 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.805 0.442 . . . . 0.0 110.559 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.93 HD22 ' HB1' ' A' ' 66' ' ' ALA . 44.6 tp -71.93 125.13 26.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.764 0.316 . . . . 0.0 111.567 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.578 HG12 ' CG2' ' A' ' 86' ' ' ILE . 71.8 t -106.27 -53.04 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.934 172.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.564 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 141.46 134.45 3.02 Favored Glycine 0 C--O 1.221 -0.693 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.462 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -85.23 -62.63 1.64 Allowed Glycine 0 C--O 1.22 -0.742 0 C-N-CA 119.498 -1.334 . . . . 0.0 116.292 -168.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.4 p -77.24 -68.25 0.63 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.683 -0.892 . . . . 0.0 112.903 -170.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.4 -44.59 28.69 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 111.289 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.578 ' CG2' HG12 ' A' ' 81' ' ' VAL . 45.0 mm -59.33 -44.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.258 -172.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 82' ' ' GLY . 69.1 t -58.02 -49.51 81.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.9 mm -60.58 -48.56 88.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.497 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.823 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -62.24 -52.88 61.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.593 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.579 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.4 mmt -57.35 -36.52 71.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.581 0.229 . . . . 0.0 111.35 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.768 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 19.6 t80 -56.23 -51.27 68.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.995 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -65.59 -44.85 85.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.691 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 2.1 mmp_? -60.64 -33.94 73.53 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.978 0.418 . . . . 0.0 111.281 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.641 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 98.6 -25.24 28.74 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.72 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.2 mt-10 -56.0 -32.33 63.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 61.7 tp -57.41 -55.71 31.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.181 0.515 . . . . 0.0 110.703 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.805 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 10.9 pt20 -65.61 -26.22 67.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.627 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 52.9 mm-40 -63.83 -46.42 85.12 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.0 mt -67.76 -46.49 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.149 177.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 96' ' ' LEU . 32.8 mm -63.7 -42.47 96.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.847 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 28.2 ttpt -54.72 -56.09 22.96 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.505 0.669 . . . . 0.0 110.863 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 15.6 tp10 -58.75 -45.95 88.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.567 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 88.5 m -69.85 -49.07 56.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.26 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.36 92.45 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.267 -0.271 . . . . 0.0 110.314 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.48 93.68 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.598 0.561 . . . . 0.0 111.798 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -71.57 -18.57 62.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.475 ' HE2' HG23 ' A' ' 103' ' ' THR . 57.1 m-85 -92.08 -47.52 7.21 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.261 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 46.2 mtmt -101.03 -147.18 0.35 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.952 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -64.92 155.53 34.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.884 164.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.49 55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -174.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -65.08 121.26 73.21 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.23 60.21 1.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.697 2.932 . . . . 0.0 113.434 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.425 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.2 m-20 . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 0.0 112.01 -174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.573 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 52.9 mt . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 65.0 mm-40 -57.02 -47.0 81.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -67.16 -43.89 81.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.805 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.664 HG21 HD13 ' A' ' 62' ' ' LEU . 69.7 mt -59.6 -48.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.478 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 34.3 mt-30 -61.55 -39.74 92.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.396 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.775 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mmp_? -59.49 -40.4 86.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -71.92 -43.13 65.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.717 HG22 ' HA2' ' A' ' 78' ' ' GLY . 39.8 mt -60.08 -42.09 88.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.208 0.528 . . . . 0.0 109.577 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -36.68 78.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.718 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.775 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 83.0 mt-10 -58.68 -46.46 87.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.598 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.0 m-80 -79.31 124.27 84.28 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.254 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.492 ' O ' HD13 ' A' ' 17' ' ' ILE . 32.1 Cg_exo -62.9 -43.45 19.92 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 C-N-CA 122.355 2.037 . . . . 0.0 111.77 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 16' ' ' PRO . 23.0 mm -128.9 120.89 53.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.645 HD23 HG23 ' A' ' 12' ' ' ILE . 20.8 tp -133.54 140.56 47.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.452 -169.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD21 HG12 ' A' ' 37' ' ' VAL . 11.6 tp -134.69 116.93 15.48 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.351 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.635 ' HB3' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -97.93 115.94 29.15 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.011 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HE3' ' HB2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.72 -154.36 0.55 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.943 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 2.2 tmtp? -98.04 97.1 8.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -170.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.675 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.23 71.73 1.39 Allowed Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.499 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.509 ' HB2' ' HE2' ' A' ' 22' ' ' LYS . 38.5 t -78.59 145.14 66.64 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.95 -40.07 87.5 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.058 1.838 . . . . 0.0 111.475 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -70.01 -30.74 68.12 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.605 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 28' ' ' PRO . 54.2 tp -157.88 118.38 1.94 Allowed Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -70.73 22.28 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.509 2.139 . . . . 0.0 113.647 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -164.95 48.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 110.883 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.943 ' HB3' ' HD2' ' A' ' 22' ' ' LYS . 42.6 t -70.42 58.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.442 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.25 -139.4 2.63 Favored Glycine 0 C--N 1.314 -0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -78.05 -45.73 22.79 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 117.63 0.715 . . . . 0.0 111.582 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' HG13 ' A' ' 37' ' ' VAL . 35.5 t -52.21 -10.26 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.52 -41.87 42.25 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 119.265 -0.397 . . . . 0.0 110.401 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.552 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -81.29 -30.48 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 172.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 33' ' ' SER . . . -67.27 -42.69 83.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 33' ' ' SER . 26.9 m -54.67 -41.59 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -56.92 -47.9 79.53 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 122.443 0.297 . . . . 0.0 110.29 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.675 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.3 -45.4 88.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.859 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.48 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -64.55 -55.09 22.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -177.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.32 74.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.959 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.51 -45.5 68.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.649 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 27.2 p -76.81 -56.11 4.89 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -173.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.16 -144.85 16.66 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.066 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.686 ' OE2' ' HB1' ' A' ' 104' ' ' ALA . 13.1 pt-20 -100.29 -153.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 155.39 40.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.627 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CD2' HD13 ' A' ' 40' ' ' LEU . 17.6 p90 -145.01 158.41 43.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 -169.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 152.05 19.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.466 ' HB2' ' HE3' ' A' ' 21' ' ' MET . 1.5 p90 -138.67 154.41 48.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG23 HD11 ' A' ' 18' ' ' LEU . 48.4 t -131.45 129.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.675 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.2 p30 -78.97 133.33 36.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 110.523 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.721 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -147.47 -35.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 -173.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.721 ' H ' HD12 ' A' ' 52' ' ' ILE . 1.4 mm? -66.21 -9.6 33.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.304 169.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? -96.0 -42.94 8.02 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.674 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 34.6 m120 -78.84 123.26 85.27 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.322 -0.237 . . . . 0.0 110.707 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.81 -45.06 9.05 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.099 1.866 . . . . 0.0 112.802 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.17 -52.95 12.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.436 HG22 HG22 ' A' ' 52' ' ' ILE . 37.6 mt -61.77 -36.97 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.522 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 54.6 ttp85 -51.24 -35.19 35.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.46 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -85.0 -47.12 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -170.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -78.87 -59.52 2.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -161.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.665 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 2.2 pt? -67.48 -33.37 5.43 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -173.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 12.3 Cg_endo -55.1 -41.15 81.48 Favored 'Trans proline' 0 C--N 1.352 0.714 0 CA-C-N 121.167 1.452 . . . . 0.0 111.125 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.1 mtmp? -58.58 -34.01 70.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.682 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -66.6 -44.17 82.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.935 176.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.799 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.66 -57.33 3.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.592 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.726 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.1 t-20 -175.67 -56.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.158 0.98 . . . . 0.0 109.636 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.728 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.58 151.27 31.0 Favored Pre-proline 0 C--O 1.22 -0.458 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.257 -176.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -64.13 -36.96 44.62 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.312 2.008 . . . . 0.0 110.024 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.3 p -142.1 -125.09 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.765 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.942 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 22.0 m-85 -141.53 -164.8 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.942 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.44 153.46 82.21 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 121.849 1.696 . . . . 0.0 113.699 -1.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.2 mt-30 -142.5 132.04 23.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.495 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.48 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -94.81 135.11 36.7 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 62.2 m95 -119.02 128.87 54.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.43 0.634 . . . . 0.0 110.789 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 99' ' ' LEU . 92.5 t -115.53 120.49 64.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.222 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' H ' HG21 ' A' ' 103' ' ' THR . 32.4 t70 57.73 28.55 16.02 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.034 1.397 . . . . 0.0 109.889 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.717 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 76.01 28.29 60.81 Favored Glycine 0 C--N 1.312 -0.781 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.047 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.4 135.09 46.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.498 . . . . 0.0 111.305 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.799 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.9 tp -69.22 131.13 44.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.377 -174.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.537 HG12 ' CG2' ' A' ' 86' ' ' ILE . 96.8 t -110.57 -51.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.028 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.495 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 144.64 133.6 2.67 Favored Glycine 0 C--O 1.222 -0.615 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.447 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.56 -62.44 1.71 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.492 -1.337 . . . . 0.0 116.064 -168.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.413 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 20.5 p -78.99 -67.55 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.689 -0.889 . . . . 0.0 112.955 -170.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -78.59 -43.8 25.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.66 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.537 ' CG2' HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.86 -44.51 94.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.772 -173.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 39' ' ' ALA . 96.0 t -57.69 -48.91 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.675 HD13 ' HB2' ' A' ' 39' ' ' ALA . 35.6 mm -60.11 -51.59 71.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.758 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 84.2 tt0 -59.37 -54.74 43.23 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.38 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.828 ' HB2' HD23 ' A' ' 96' ' ' LEU . 26.4 mmt -58.15 -37.95 75.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.534 0.207 . . . . 0.0 110.743 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.504 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.0 t80 -57.16 -49.81 74.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.391 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.652 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -64.79 -38.56 91.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.113 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 1.2 mmm180 -62.34 -32.0 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.767 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 21.24 58.45 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.555 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.731 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.9 mm-40 -90.39 -32.41 16.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.404 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -60.47 -53.43 57.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.54 -172.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.768 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.0 pm0 -62.57 -28.88 70.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.58 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.415 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.0 mm100 -66.12 -45.98 79.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.4 mt -67.4 -45.14 77.05 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.03 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 96' ' ' LEU . 51.0 mm -64.97 -42.5 94.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.465 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 31.9 ttmt -52.0 -56.66 12.91 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.453 0.644 . . . . 0.0 111.225 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.58 -43.99 89.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.255 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.598 ' O ' ' HD2' ' A' ' 107' ' ' TYR . 73.1 m -72.41 -44.05 63.01 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.783 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB1' ' OE2' ' A' ' 45' ' ' GLU . . . -65.98 -44.11 85.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.481 -0.762 . . . . 0.0 110.167 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.11 95.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.808 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 107' ' ' TYR . 17.1 ptpt -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.014 -0.429 . . . . 0.0 110.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.598 ' HD2' ' O ' ' A' ' 103' ' ' THR . 81.1 m-85 -77.99 -45.73 23.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -97.55 -150.33 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.733 177.485 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 111' ' ' GLU . 11.1 p -67.93 169.66 9.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 166.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.72 60.39 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 65.8 mm-40 -58.44 126.36 78.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.778 0.799 . . . . 0.0 111.73 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 73.9 Cg_endo -94.15 56.75 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 123.416 2.744 . . . . 0.0 113.039 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.685 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.5 m-20 . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.05 -169.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.561 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 95.1 mt . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.73 -49.33 68.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.7 mptt -72.54 -39.62 67.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.034 175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.864 HG21 ' HG ' ' A' ' 62' ' ' LEU . 71.8 mt -58.21 -47.65 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.011 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -61.03 -32.79 72.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.483 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 17.2 mmt180 -60.06 -37.54 80.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.419 . . . . 0.0 110.51 173.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 45.4 tt0 -72.97 -45.46 57.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.378 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.661 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 21.8 mt -63.78 -42.8 97.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.228 0.537 . . . . 0.0 110.111 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.28 98.3 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.788 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.4 pt-20 -65.07 -38.56 91.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.264 -175.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -78.74 127.15 81.1 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 31.8 Cg_endo -64.25 -41.24 22.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.011 2.474 . . . . 0.0 112.384 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 16' ' ' PRO . 34.2 mm -132.87 123.59 48.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.684 HD11 HG23 ' A' ' 50' ' ' VAL . 33.2 tp -133.8 143.45 48.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.436 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.43 118.5 15.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.345 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.604 ' HE1' HD21 ' A' ' 18' ' ' LEU . 7.6 m-85 -96.46 119.13 34.38 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.273 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.598 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 22.8 ptt? -146.5 -168.08 2.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.896 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.074 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 40.1 ttmt -96.75 138.15 34.75 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 28' ' ' PRO . . . -140.49 135.15 6.86 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 118.287 -1.911 . . . . 0.0 112.975 174.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 t -121.29 150.61 54.47 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.626 -1.287 . . . . 0.0 108.466 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.03 -38.14 58.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.023 1.815 . . . . 0.0 111.664 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -70.49 -35.09 73.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.773 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.0 tp -159.43 114.62 1.55 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.426 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 52.2 Cg_endo -73.38 32.51 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.081 2.521 . . . . 0.0 113.891 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 11.3 p -165.47 47.3 0.09 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.01 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.608 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 49.1 t -74.39 53.07 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.885 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.31 -141.22 3.14 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -76.4 -36.04 58.29 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.299 0.571 . . . . 0.0 109.847 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.598 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 48.7 p -52.35 -22.87 5.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.748 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.75 -44.43 28.14 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.473 0.483 . . . . 0.0 111.656 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.617 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.92 -35.34 32.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.582 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.427 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -54.47 -37.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 19.0 mm-40 -65.76 -45.4 82.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.77 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -57.69 -44.73 86.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.509 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.24 -57.13 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.481 . . . . 0.0 110.362 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.49 71.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.123 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.21 -49.53 42.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.629 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.7 p -76.4 -49.97 15.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.344 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.47 -131.47 7.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.064 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 4.6 mm-40 -140.39 -152.56 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.149 0.579 . . . . 0.0 111.04 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.489 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 42.2 mmm-85 -55.68 148.02 17.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.832 0.825 . . . . 0.0 112.387 -173.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 21.9 p90 -156.65 155.36 31.65 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.292 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.01 159.25 15.09 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.687 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -143.7 154.32 43.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.684 HG23 HD11 ' A' ' 18' ' ' LEU . 47.1 t -133.43 127.81 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' MET . 12.1 p-10 -81.25 131.5 35.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.573 . . . . 0.0 110.585 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.626 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -146.69 -32.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.287 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.074 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -67.32 -8.49 32.77 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.545 171.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -97.42 -48.55 5.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.33 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.3 m-20 -79.66 116.03 57.89 Favored Pre-proline 0 N--CA 1.472 0.647 0 O-C-N 122.118 -0.364 . . . . 0.0 110.784 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 24.7 Cg_exo -64.14 -44.34 12.63 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.981 2.454 . . . . 0.0 113.402 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -66.42 -54.64 21.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -62.28 -34.76 65.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 29.2 ttm180 -53.16 -40.91 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.031 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.466 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -79.61 -38.6 33.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -167.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.88 -59.21 2.87 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -161.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.864 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.17 -26.94 0.57 Allowed Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -170.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.744 ' HD3' HD13 ' A' ' 62' ' ' LEU . 18.4 Cg_endo -57.08 -41.61 72.76 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.603 1.608 . . . . 0.0 111.521 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 53.6 mtmt -59.58 -34.24 72.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.701 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.504 ' CD2' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -66.15 -42.2 89.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.299 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.807 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.95 -56.86 4.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.446 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.699 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 22.6 t-20 -175.71 -55.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 122.159 0.981 . . . . 0.0 109.613 170.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.699 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.8 OUTLIER -56.82 150.37 38.04 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.645 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -63.79 -38.83 37.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.419 2.079 . . . . 0.0 110.283 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.9 p -141.4 -125.97 0.1 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.388 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.863 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.4 m-85 -141.13 -166.1 0.11 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.863 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 39.1 Cg_endo -65.65 156.7 78.42 Favored 'Cis proline' 0 C--N 1.362 1.244 0 CA-C-N 121.597 1.606 . . . . 0.0 113.836 -2.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 30.4 mt-30 -146.52 131.39 18.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.805 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 18' ' ' LEU . 61.1 tp -91.32 137.84 32.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.625 174.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 58.2 m95 -121.9 125.21 45.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.284 0.564 . . . . 0.0 109.921 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.4 t -110.04 119.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.197 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.57 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 58.24 28.85 17.17 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 123.403 1.573 . . . . 0.0 108.589 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.62 29.8 59.07 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.726 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 48.9 mt-10 -126.97 131.0 51.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.661 0.267 . . . . 0.0 110.359 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.807 HD22 ' HB1' ' A' ' 66' ' ' ALA . 47.6 tp -67.66 130.9 44.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -173.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.622 HG12 ' CG2' ' A' ' 86' ' ' ILE . 94.4 t -112.29 -52.52 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.123 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.85 136.0 2.88 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.518 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -86.88 -64.09 1.43 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.377 -1.392 . . . . 0.0 116.471 -169.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.0 p -80.13 -66.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.692 -0.887 . . . . 0.0 112.831 -171.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -74.03 -46.36 43.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.026 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.622 ' CG2' HG12 ' A' ' 81' ' ' VAL . 2.0 mp -60.98 -46.79 95.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.21 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -55.76 -49.4 74.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.258 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 35' ' ' GLN . 36.9 mm -62.12 -50.71 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.947 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.6 tt0 -62.46 -51.93 65.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.679 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.62 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -58.95 -33.63 70.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.308 0.243 . . . . 0.0 111.543 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.688 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.2 t80 -59.06 -52.48 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.129 172.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.0 mt-30 -62.88 -42.88 99.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.418 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 38.5 mmm-85 -62.58 -34.55 77.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.248 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 102.58 -23.79 32.91 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.945 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.783 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.3 mt-10 -56.11 -33.27 64.95 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.693 HD22 ' SG ' ' A' ' 43' ' ' CYS . 5.6 tt -69.77 -50.04 47.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.184 0.516 . . . . 0.0 109.669 -174.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 9.2 pt20 -61.55 -25.22 67.16 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.058 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 48.6 mm-40 -69.79 -48.08 60.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.53 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 54.1 mt -63.9 -46.11 86.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.201 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.539 HG22 ' OD2' ' A' ' 113' ' ' ASP . 50.5 mm -64.43 -44.48 97.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.818 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 37.4 ttmt -48.74 -52.14 25.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.352 0.596 . . . . 0.0 111.144 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -62.24 -50.82 70.22 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.432 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.57 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 95.3 m -71.18 -48.94 48.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.489 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . . . -61.67 -46.37 90.0 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.141 -0.349 . . . . 0.0 110.55 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 110' ' ' GLU . . . -61.77 -32.85 73.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.911 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.603 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -80.44 -17.86 50.51 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.654 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.597 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 53.9 m-85 -90.5 -50.52 5.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.858 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.599 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 2.1 mppt? -103.06 121.23 42.15 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 165.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 p -46.26 113.19 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.561 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 53.5 mt-10 49.66 44.56 24.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.317 -1.765 . . . . 0.0 113.355 172.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.599 ' OE1' ' HB2' ' A' ' 108' ' ' LYS . 8.9 pt-20 -75.67 130.16 79.8 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.521 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 3.7 Cg_exo -79.56 121.62 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.743 2.295 . . . . 0.0 111.611 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.613 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 43.7 m-20 . . . . . 0 CA--C 1.513 -0.461 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 59.9 mt . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.92 -43.54 94.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 0.0 110.065 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -63.75 -45.22 90.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.038 172.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.721 HD13 HD22 ' A' ' 62' ' ' LEU . 74.4 mt -60.94 -43.86 96.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.659 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -63.24 -38.71 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.299 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -60.75 -37.01 80.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.32 0.581 . . . . 0.0 109.766 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 15.9 tt0 -68.09 -45.45 73.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.001 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.712 HG23 HD23 ' A' ' 18' ' ' LEU . 36.4 mt -70.43 -44.59 77.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 110.661 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.26 77.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.2 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.34 -34.04 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.829 -176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 76.9 m-20 -77.61 128.63 79.26 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-O 121.166 0.508 . . . . 0.0 111.112 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.553 ' O ' HD13 ' A' ' 17' ' ' ILE . 44.5 Cg_exo -61.78 -42.92 28.68 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 123.008 2.472 . . . . 0.0 112.679 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.2 mm -139.61 122.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.712 HD23 HG23 ' A' ' 12' ' ' ILE . 23.2 tp -134.15 141.34 47.06 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.505 -169.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' A' ' 21' ' ' MET . 12.1 tp -135.45 117.21 15.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.525 -176.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE2' HD11 ' A' ' 62' ' ' LEU . 8.7 m-85 -97.33 117.99 32.8 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.938 174.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.731 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -148.09 -159.48 1.04 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.727 177.628 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.044 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 34.7 ttpt -99.65 117.75 34.68 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.374 -0.829 . . . . 0.0 110.562 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.599 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.84 70.6 0.95 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.512 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -78.21 140.68 61.41 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.45 -41.3 74.29 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.054 1.836 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -69.46 -30.35 68.23 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.041 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tt -156.57 105.91 2.0 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.44 ' O ' ' SD ' ' A' ' 21' ' ' MET . 15.0 Cg_exo -73.66 28.57 0.31 Allowed 'Trans proline' 0 C--O 1.223 -0.225 0 C-N-CA 122.642 2.228 . . . . 0.0 114.052 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -166.09 52.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.836 0.351 . . . . 0.0 111.484 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 22' ' ' LYS . 46.3 t -71.32 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 61.08 -139.29 47.8 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.203 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.48 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 37.9 m-85 -79.29 -20.88 46.92 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 21' ' ' MET . 30.6 p -70.2 -11.71 61.08 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -170.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.24 -43.89 22.32 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.352 0.407 . . . . 0.0 111.864 -175.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -78.02 -40.02 40.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.617 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.96 90.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.154 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p -55.75 -38.8 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.559 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 26.4 mm-40 -67.24 -46.66 73.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.891 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.87 -42.31 93.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.862 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -62.09 -56.74 15.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.374 0.607 . . . . 0.0 109.704 -175.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.06 72.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.486 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -46.34 64.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.82 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.4 m -71.91 -59.36 2.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.04 -145.01 13.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.371 -0.918 . . . . 0.0 114.499 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.849 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 32.2 mm-40 -120.37 -150.41 0.45 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.857 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 43.2 mmm-85 -55.54 144.98 24.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.058 0.933 . . . . 0.0 113.262 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 40' ' ' LEU . 26.3 p90 -150.83 152.56 33.93 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.386 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.7 152.71 19.35 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.479 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -137.36 150.58 47.81 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.561 HG23 HD11 ' A' ' 18' ' ' LEU . 46.5 t -129.56 126.56 63.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.599 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.4 p30 -76.23 129.55 36.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -145.59 -36.41 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.044 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.99 -11.58 30.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.423 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -96.51 -41.78 8.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.405 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -87.93 116.14 65.26 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 122.198 -0.313 . . . . 0.0 110.667 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.16 -43.83 13.94 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.167 1.912 . . . . 0.0 113.28 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.16 -50.67 67.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.029 0.443 . . . . 0.0 111.8 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.0 -40.67 81.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 78.9 ttt180 -52.1 -37.69 54.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.89 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.41 -49.16 44.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.2 -59.17 2.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -163.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 8' ' ' ILE . 2.1 pt? -66.1 -33.21 6.58 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -168.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.706 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 12.8 Cg_endo -55.16 -40.13 87.38 Favored 'Trans proline' 0 C--N 1.348 0.501 0 CA-C-N 121.182 1.458 . . . . 0.0 110.573 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -51.71 -41.02 61.16 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.759 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.536 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.68 -42.94 70.07 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.446 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.843 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.79 -59.92 2.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.703 -174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.741 ' HB2' ' HE3' ' A' ' 68' ' ' TRP . 8.4 m120 -168.61 -59.42 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.971 0.908 . . . . 0.0 109.172 168.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.741 ' HE3' ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -53.46 149.84 13.83 Favored Pre-proline 0 C--O 1.217 -0.61 0 CA-C-N 113.118 -1.855 . . . . 0.0 113.697 -174.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.99 -37.36 43.83 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 121.873 1.716 . . . . 0.0 110.229 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 74.5 p -142.12 -123.41 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.279 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.958 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.6 m-85 -141.03 -168.04 0.17 Allowed Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.958 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.3 Cg_endo -67.8 153.41 87.0 Favored 'Cis proline' 0 C--N 1.362 1.261 0 CA-C-N 121.309 1.503 . . . . 0.0 114.286 -1.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.611 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 31.2 mt-30 -141.41 134.77 29.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.661 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -99.22 135.17 41.02 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -119.63 131.11 55.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.795 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.2 t -116.66 120.6 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t0 54.8 37.74 29.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 123.242 1.496 . . . . 0.0 108.595 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.634 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 67.19 29.09 73.97 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.957 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -132.5 134.85 45.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.382 0.611 . . . . 0.0 111.366 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.843 HD22 ' HB1' ' A' ' 66' ' ' ALA . 60.8 tp -67.36 130.35 42.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.818 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.51 HG12 ' CG2' ' A' ' 86' ' ' ILE . 99.3 t -106.03 -54.28 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.772 170.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.32 134.16 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.71 -63.98 1.58 Allowed Glycine 0 C--O 1.219 -0.829 0 C-N-CA 119.047 -1.549 . . . . 0.0 116.316 -167.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 22.4 p -80.21 -67.45 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.429 1.115 . . . . 0.0 112.956 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.33 -45.29 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.316 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.51 ' CG2' HG12 ' A' ' 81' ' ' VAL . 50.4 mm -57.8 -44.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.338 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 82' ' ' GLY . 79.4 t -58.02 -48.51 84.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.99 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.504 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 38.1 mm -59.78 -49.91 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.388 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.765 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 35.5 tt0 -60.79 -52.95 62.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.291 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.532 ' HG3' ' CA ' ' A' ' 96' ' ' LEU . 41.7 tpp -60.88 -34.81 75.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.82 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 16.8 t80 -58.81 -51.45 69.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.014 171.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.6 mt-30 -62.38 -39.29 92.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.991 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 45.6 mmm-85 -60.75 -30.72 70.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.73 175.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.02 -23.69 10.45 Favored Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.726 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.9 mt-10 -62.51 -21.32 65.42 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' MET . 62.5 tp -61.35 -54.86 38.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.343 0.592 . . . . 0.0 110.669 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.81 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 11.8 pt20 -64.03 -25.53 68.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.374 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 13.3 mm100 -64.2 -48.08 77.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.272 0.558 . . . . 0.0 109.599 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 38.5 mt -65.74 -45.88 80.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.155 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.8 mm -63.82 -44.35 98.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.144 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 28.7 ttmt -51.89 -57.69 8.66 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 111.2 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.5 -45.79 92.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.165 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 80.7 m -68.99 -46.85 67.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.455 ' HA ' ' HZ3' ' A' ' 108' ' ' LYS . . . -60.75 -45.93 92.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.37 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.09 82.01 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.754 0.659 . . . . 0.0 112.323 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.503 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.06 -33.39 63.66 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.747 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.503 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 80.1 m-85 -80.19 -51.55 8.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.641 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HZ3' ' HA ' ' A' ' 104' ' ' ALA . 1.1 mppt? -106.29 131.34 53.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m -51.82 125.44 15.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.471 0.653 . . . . 0.0 112.267 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 35.13 52.0 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.293 -1.776 . . . . 0.0 114.969 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 27.4 tt0 -77.37 120.49 81.73 Favored Pre-proline 0 N--CA 1.427 -1.592 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 6.1 Cg_exo -86.73 60.75 4.27 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.55 2.833 . . . . 0.0 114.563 -170.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.849 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.8 m-20 . . . . . 0 C--N 1.317 -0.806 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 62' ' ' LEU . 41.2 mt . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 120.352 0.12 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.62 -51.15 64.01 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 20.4 ptmt -67.53 -40.37 85.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.44 0.638 . . . . 0.0 109.599 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG21 ' HG ' ' A' ' 62' ' ' LEU . 73.9 mt -57.54 -49.09 81.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.941 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 31.2 mt-30 -61.71 -40.75 96.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.597 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -57.75 -37.07 72.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.296 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.01 -47.19 69.13 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.122 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.794 HG22 ' HA2' ' A' ' 78' ' ' GLY . 22.2 mt -67.52 -39.15 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.789 0.804 . . . . 0.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.71 88.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.512 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.6 pt-20 -70.33 -38.49 74.88 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.554 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 1.6 p30 -77.17 135.44 66.38 Favored Pre-proline 0 CA--C 1.512 -0.514 0 CA-C-O 121.652 0.739 . . . . 0.0 111.877 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.609 ' O ' HD13 ' A' ' 17' ' ' ILE . 33.7 Cg_exo -62.75 -42.17 26.91 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 122.801 2.334 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 16' ' ' PRO . 25.5 mm -139.38 120.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.726 HD11 HG23 ' A' ' 50' ' ' VAL . 27.7 tp -131.66 142.89 49.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.483 0.659 . . . . 0.0 111.855 -171.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.9 tp -136.94 123.85 21.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.442 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.601 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 7.2 m-85 -98.86 119.99 38.55 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.801 -0.562 . . . . 0.0 111.702 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 18.5 ptt? -146.23 -165.77 2.3 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 63.8 tttm -99.08 121.45 41.01 Favored 'General case' 0 C--O 1.208 -1.122 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.69 69.19 1.03 Allowed Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.332 -175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -79.94 148.54 68.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.818 -0.225 . . . . 0.0 111.233 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.85 -41.5 68.67 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.19 1.927 . . . . 0.0 111.121 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.615 ' HE3' ' SG ' ' A' ' 30' ' ' CYS . 60.8 pttt -66.7 -31.31 71.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.66 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 49.6 tp -160.43 122.84 1.82 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 2.8 Cg_exo -73.9 29.36 0.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.432 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 8.3 t -165.35 47.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.48 173.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.615 ' SG ' ' HE3' ' A' ' 26' ' ' LYS . 34.6 t -71.24 57.08 0.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.86 -136.4 2.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -76.71 -38.65 53.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 117.607 0.703 . . . . 0.0 110.992 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.876 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 33.1 t -55.13 -10.15 0.5 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.54 -40.74 60.26 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.194 0.198 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.424 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.49 -35.72 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.922 176.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 87' ' ' VAL . . . -64.24 -43.64 94.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.142 0.577 . . . . 0.0 112.518 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.23 -36.13 44.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.337 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -66.12 -43.8 86.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.102 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.716 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -57.08 -45.21 83.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.456 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 74' ' ' LEU . 1.8 mt -61.84 -59.41 5.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.01 67.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.38 -49.13 28.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.402 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.841 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.1 p -75.55 -57.23 4.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.199 -171.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.25 -142.15 12.21 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.439 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 90.7 mt-10 -100.2 -151.46 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.943 0.878 . . . . 0.0 111.248 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.94 158.29 35.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.57 174.054 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CG ' HD13 ' A' ' 40' ' ' LEU . 13.5 p90 -151.82 160.83 43.42 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.688 -171.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.19 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.6 p90 -140.3 152.56 45.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 18' ' ' LEU . 51.5 t -129.37 132.19 66.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.804 0.335 . . . . 0.0 110.339 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' MET . 32.3 p-10 -76.64 129.32 36.22 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.543 0.687 . . . . 0.0 110.686 173.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.704 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -144.4 -36.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.903 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.84 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -65.6 -10.42 35.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.814 168.415 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -96.37 -43.8 7.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.603 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -83.86 113.94 50.81 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 122.137 -0.352 . . . . 0.0 110.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.9 -45.54 28.12 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.966 2.444 . . . . 0.0 113.381 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.504 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.89 -38.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.138 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.665 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 58.3 ttt-85 -49.81 -35.78 24.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.425 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -86.77 -41.28 14.24 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -174.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -79.57 -60.94 2.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -162.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.766 HD13 ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -73.09 -27.66 0.88 Allowed Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -172.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.766 ' HD3' HD13 ' A' ' 62' ' ' LEU . 17.9 Cg_endo -57.2 -41.17 76.7 Favored 'Trans proline' 0 C--N 1.357 1.006 0 CA-C-N 121.368 1.524 . . . . 0.0 110.853 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 39.1 mtmt -54.86 -39.37 68.56 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.733 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.611 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.43 -41.52 80.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.871 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.797 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.91 -57.7 3.74 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.562 -176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.6 t30 -175.0 -53.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.947 0.88 . . . . 0.0 109.987 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.644 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.93 146.62 81.65 Favored Pre-proline 0 C--O 1.218 -0.6 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.208 -176.045 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.01 -35.99 84.81 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.127 1.885 . . . . 0.0 110.667 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.1 p -141.79 -128.58 0.1 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.568 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.963 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 30.5 m-85 -142.23 -173.75 0.38 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.963 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.6 Cg_endo -66.99 160.16 78.87 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 120.848 1.339 . . . . 0.0 114.36 -0.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.634 ' HA ' ' CA ' ' A' ' 83' ' ' GLY . 56.0 mt-30 -150.78 129.45 12.3 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.179 172.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.475 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.1 tm? -89.58 137.38 32.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.024 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 58.6 m95 -121.64 131.34 54.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.206 0.526 . . . . 0.0 110.87 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 100' ' ' ILE . 67.2 t -116.6 119.52 62.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.608 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t70 54.75 41.5 31.87 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.993 1.378 . . . . 0.0 108.933 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.794 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 62.76 28.28 71.41 Favored Glycine 0 C--N 1.31 -0.897 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.696 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -129.04 134.8 48.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 111.107 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.3 tp -66.64 136.96 56.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.618 -173.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' HG21 ' A' ' 86' ' ' ILE . 96.2 t -115.08 -56.26 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.813 170.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.763 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 155.73 133.74 1.73 Allowed Glycine 0 C--O 1.225 -0.431 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.67 -61.37 1.7 Allowed Glycine 0 C--O 1.218 -0.886 0 C-N-CA 119.999 -1.096 . . . . 0.0 115.625 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.58 -67.9 0.73 Allowed 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.705 -0.88 . . . . 0.0 112.262 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -80.72 -51.32 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.9 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.763 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 50.1 mm -55.8 -53.5 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.459 -171.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 96' ' ' LEU . 10.4 p -59.8 -43.12 91.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.34 -173.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.716 HD13 ' HB2' ' A' ' 39' ' ' ALA . 34.8 mm -59.14 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.489 175.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.726 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.9 tt0 -62.54 -48.94 77.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.483 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.404 ' C ' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -54.62 -39.79 68.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.922 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.573 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.8 t80 -59.01 -52.68 64.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 174.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.1 -38.66 91.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.742 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 23.1 mmm180 -61.64 -32.07 72.2 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.402 0.62 . . . . 0.0 109.824 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 83.61 21.43 58.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.611 -174.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.635 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 62.8 mm-40 -90.34 -31.36 16.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 110.737 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.598 HD11 HG22 ' A' ' 87' ' ' VAL . 1.4 tt -57.77 -54.75 43.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.204 -175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.841 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 10.0 pt20 -62.18 -27.43 68.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.394 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 9.4 mm-40 -68.83 -44.26 73.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.295 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 40.6 mt -65.84 -48.08 72.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.686 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 17' ' ' ILE . 42.5 mm -60.86 -48.28 89.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.102 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 39.7 ttpt -58.17 -47.26 83.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.643 0.259 . . . . 0.0 111.676 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -59.49 -48.32 82.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.018 0.437 . . . . 0.0 110.046 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.608 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 60.2 m -69.74 -46.25 66.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.372 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.844 ' HB1' ' HE2' ' A' ' 108' ' ' LYS . . . -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.56 86.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.8 -26.57 64.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.877 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.537 ' CE2' ' HD2' ' A' ' 106' ' ' LYS . 92.3 m-85 -91.48 -48.9 6.61 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.531 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.844 ' HE2' ' HB1' ' A' ' 104' ' ' ALA . 39.4 mtmt -91.72 110.22 21.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -61.64 125.76 24.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.098 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' C ' ' HD3' ' A' ' 112' ' ' PRO . 48.2 mt-10 55.87 45.28 24.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.371 175.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 5.5 mm-40 -121.87 67.13 22.36 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.214 176.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 110' ' ' GLU . 26.9 Cg_exo -64.08 115.98 3.44 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.797 1.665 . . . . 0.0 112.431 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 57.7 mt . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.517 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 97.3 mt-10 -56.55 -46.01 80.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.342 . . . . 0.0 110.43 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.55 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 3.7 mmmp? -65.21 -44.09 89.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 172.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.824 HD13 ' HB3' ' A' ' 62' ' ' LEU . 91.1 mt -60.31 -46.96 94.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.599 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.55 -43.6 98.41 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.803 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -59.09 -33.9 71.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.591 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.4 tt0 -72.35 -44.77 62.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.077 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.785 HG22 ' HA2' ' A' ' 78' ' ' GLY . 38.1 mt -67.31 -43.11 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.173 0.511 . . . . 0.0 110.184 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.41 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.211 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -66.8 -32.71 74.17 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.613 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -78.43 127.04 82.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.84 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' O ' HD13 ' A' ' 17' ' ' ILE . 69.3 Cg_exo -58.47 -42.61 53.36 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.992 2.462 . . . . 0.0 111.973 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 16' ' ' PRO . 24.3 mm -138.28 123.23 22.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.72 HD23 HG23 ' A' ' 12' ' ' ILE . 21.2 tp -133.92 141.24 47.25 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -171.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.5 tp -138.98 118.87 13.24 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.749 -173.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.637 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 m-85 -97.69 124.75 42.14 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.332 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.782 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 13.3 ptp -145.03 -168.21 2.88 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.241 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.89 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 64.2 tttm -97.68 111.87 23.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.57 127.78 9.31 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 119.619 -1.276 . . . . 0.0 112.628 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 m -142.73 141.54 20.49 Favored Pre-proline 0 N--CA 1.442 -0.844 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -52.98 -41.16 73.42 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.331 2.021 . . . . 0.0 111.981 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.14 -27.24 62.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.164 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.471 HD22 ' H ' ' A' ' 29' ' ' SER . 1.4 tt -158.71 113.22 1.65 Allowed Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' O ' ' SD ' ' A' ' 21' ' ' MET . 39.3 Cg_endo -71.63 15.86 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.566 2.178 . . . . 0.0 114.156 -176.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.782 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.8 p -161.69 51.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 39.0 t -68.71 51.58 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.465 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.0 -137.02 2.11 Favored Glycine 0 C--N 1.316 -0.564 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.176 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.27 -39.79 53.46 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 117.11 0.455 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.823 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 19.2 t -57.64 -11.21 1.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.455 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 37' ' ' VAL . . . -53.31 -43.67 67.76 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.35 0.406 . . . . 0.0 111.521 176.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.25 -31.94 38.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.746 179.366 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.58 85.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.216 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 34' ' ' ALA . 9.5 p -54.46 -37.09 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.219 0.533 . . . . 0.0 110.447 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -64.56 -46.3 83.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.464 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.62 -44.08 89.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.577 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.487 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -62.73 -55.83 23.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.437 . . . . 0.0 110.376 -175.372 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 47' ' ' PHE . . . -59.35 -32.88 70.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.182 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.97 -48.6 43.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.509 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.7 p -75.69 -50.54 15.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.43 -130.51 7.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.092 -0.575 . . . . 0.0 114.419 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.657 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 2.4 pp20? -128.89 -152.74 0.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.457 -0.872 . . . . 0.0 109.65 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 -64.17 152.96 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.608 0.718 . . . . 0.0 111.421 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.487 ' CG ' HD13 ' A' ' 40' ' ' LEU . 20.8 p90 -158.78 150.01 20.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.866 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.05 144.24 28.42 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.193 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.2 p90 -124.87 154.61 40.79 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.436 HG23 HD11 ' A' ' 18' ' ' LEU . 48.4 t -130.66 130.14 64.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' MET . 11.3 p-10 -74.94 132.29 41.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.228 175.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.695 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -149.21 -31.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.965 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.89 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -68.34 -9.34 47.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.269 167.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -95.82 -47.68 6.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.984 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.669 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.4 m-20 -73.8 126.27 89.7 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 120.502 0.191 . . . . 0.0 110.653 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.98 -42.89 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.246 1.964 . . . . 0.0 113.16 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.86 -53.31 8.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.945 0.402 . . . . 0.0 112.021 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.3 mt -60.8 -32.34 51.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.49 0.662 . . . . 0.0 110.33 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.727 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 29.8 ttm180 -53.16 -34.91 58.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.167 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.4 6.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.64 -55.0 5.9 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -163.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.824 ' HB3' HD13 ' A' ' 8' ' ' ILE . 3.6 pp -68.39 -35.89 7.78 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.727 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 25.6 Cg_endo -58.21 -42.43 56.76 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.393 1.396 . . . . 0.0 111.394 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -58.31 -34.17 70.29 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.073 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.521 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.65 -39.99 91.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.937 177.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -72.58 -53.53 11.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.575 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.859 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.5 t-20 -171.55 -47.83 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.022 174.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.859 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 33.5 p90 -124.8 146.33 52.68 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -40.19 -36.8 1.64 Allowed 'Trans proline' 0 C--N 1.352 0.715 1 C-N-CA 125.4 4.067 . . . . 0.0 117.152 -169.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 p -140.5 -135.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 119.076 0.853 . . . . 0.0 111.951 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.975 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 49.2 m-85 -145.15 -172.43 0.31 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.975 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 21.1 Cg_endo -62.91 154.53 69.04 Favored 'Cis proline' 0 C--N 1.36 1.184 0 CA-C-N 120.6 1.25 . . . . 0.0 114.33 -0.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.711 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 82.2 mt-30 -139.97 131.7 27.39 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.352 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -95.94 139.35 32.26 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.339 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.675 ' N ' HD13 ' A' ' 74' ' ' LEU . 57.7 m95 -127.73 127.79 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.384 0.611 . . . . 0.0 110.739 177.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 99' ' ' LEU . 57.3 t -113.2 118.33 57.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.273 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.6 t70 57.03 32.26 21.37 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 123.757 1.741 . . . . 0.0 108.711 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.785 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.33 28.43 67.96 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 113.488 -1.687 . . . . 0.0 113.04 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 40.5 mt-10 -119.44 133.37 55.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.786 HD21 ' HZ3' ' A' ' 68' ' ' TRP . 18.9 tp -65.57 131.44 46.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.781 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 86' ' ' ILE . 84.6 t -117.76 -52.84 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.931 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.82 ' HA3' HD12 ' A' ' 86' ' ' ILE . . . 134.08 133.24 3.3 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.37 -60.82 1.87 Allowed Glycine 0 C--O 1.222 -0.634 0 N-CA-C 116.367 1.307 . . . . 0.0 116.367 -166.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -75.24 -68.95 0.51 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.439 -1.036 . . . . 0.0 113.378 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -78.71 -43.9 24.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.443 0.639 . . . . 0.0 110.629 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.82 HD12 ' HA3' ' A' ' 82' ' ' GLY . 43.7 mt -60.34 -42.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.456 -171.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -59.93 -50.38 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.055 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.7 mm -60.73 -49.04 86.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.447 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.78 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.9 tt0 -61.89 -54.35 43.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.918 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.408 ' HA ' ' HB2' ' A' ' 93' ' ' ARG . 55.1 mtt -58.43 -32.46 68.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.605 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.2 t80 -58.57 -53.19 61.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.73 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.1 mt-30 -65.12 -39.45 93.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.48 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.78 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.0 mmt180 -59.37 -33.6 71.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.657 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.623 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 94.8 -24.37 28.51 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -169.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.673 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.8 mt-10 -57.57 -31.22 65.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 99' ' ' LEU . 56.3 tp -68.91 -55.42 11.08 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.585 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.8 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 10.2 pt20 -57.56 -24.71 57.66 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.15 171.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 45.5 mm-40 -71.01 -56.75 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 76' ' ' VAL . 2.2 pp -70.67 -34.72 72.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 99' ' ' LEU . 38.1 mm -62.03 -42.32 94.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 39.5 ttmt -52.32 -56.8 12.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.183 0.516 . . . . 0.0 112.072 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.38 -45.9 90.17 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.582 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 58.8 m -66.45 -51.09 60.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.351 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 45' ' ' GLU . . . -60.94 -51.66 68.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.87 -175.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.61 73.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.515 -176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.57 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.58 -25.73 50.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.042 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.472 ' HE2' HG23 ' A' ' 103' ' ' THR . 54.4 m-85 -84.93 -48.59 9.14 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.09 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -102.66 108.41 19.67 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 m -53.46 122.76 10.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.416 0.627 . . . . 0.0 110.787 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 49.31 38.98 14.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.736 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.415 ' OE2' ' HB2' ' A' ' 45' ' ' GLU . 38.7 tt0 -77.49 133.32 67.52 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.05 128.26 23.61 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.865 1.71 . . . . 0.0 112.65 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 N--CA 1.445 -0.7 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.694 -177.79 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.542 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 77.8 mt . . . . . 0 N--CA 1.461 0.113 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.97 -44.03 82.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.144 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.69 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -70.79 -45.45 64.66 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.956 0.408 . . . . 0.0 110.175 171.551 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.62 HD13 HD22 ' A' ' 62' ' ' LEU . 79.4 mt -54.35 -47.09 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 32.6 mt-30 -63.62 -39.74 95.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.606 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 12.1 mmp_? -61.09 -34.22 74.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.343 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.529 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 17.3 tm0? -74.63 -41.27 60.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.469 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.843 HG22 ' HA2' ' A' ' 78' ' ' GLY . 30.5 mt -66.5 -46.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.712 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.13 -39.96 94.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.862 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -65.5 -32.5 74.13 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.113 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -76.68 125.44 87.25 Favored Pre-proline 0 CA--C 1.517 -0.312 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.846 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HA ' ' CE2' ' A' ' 107' ' ' TYR . 45.7 Cg_exo -62.26 -42.91 25.84 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 122.462 2.108 . . . . 0.0 112.225 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.7 mm -136.27 121.71 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.648 HD23 HG23 ' A' ' 12' ' ' ILE . 22.0 tp -133.05 142.08 48.58 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.327 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.1 tp -137.21 119.9 16.16 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.151 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.653 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -97.36 120.03 36.99 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.986 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.699 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 21.1 ptt? -146.29 -170.92 3.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.126 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.008 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.2 119.87 35.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.387 -0.821 . . . . 0.0 109.576 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.77 71.62 1.29 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.077 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 36.6 t -78.54 142.56 62.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.85 -40.9 82.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.019 1.812 . . . . 0.0 111.459 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.7 pttt -67.99 -30.36 69.61 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.805 177.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 29' ' ' SER . 49.1 tp -160.62 115.97 1.4 Allowed Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.2 Cg_exo -71.19 29.73 0.22 Allowed 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 123.145 2.563 . . . . 0.0 112.985 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.699 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 11.9 p -162.58 46.61 0.15 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 42.6 t -64.64 147.57 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.678 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.55 -141.35 15.27 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.799 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.56 ' HB3' HE22 ' A' ' 35' ' ' GLN . 15.5 m-85 -78.2 -38.27 43.69 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.0 p -46.77 -19.61 0.1 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.35 -42.99 53.94 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.985 0.178 . . . . 0.0 111.095 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.56 HE22 ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -79.35 -37.11 38.26 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 33' ' ' SER . . . -66.6 -45.79 78.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.1 p -56.36 -36.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.73 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -66.78 -46.85 73.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.285 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.584 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.05 -40.09 84.02 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.15 0.281 . . . . 0.0 111.609 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.3 tt -62.43 -57.26 11.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.938 -175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 -35.19 79.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.386 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.12 -47.67 76.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.016 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.738 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.3 m -73.08 -55.57 6.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.2 -133.14 8.01 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.308 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 113' ' ' ASP . 64.5 mm-40 -137.36 -150.64 0.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.708 -0.746 . . . . 0.0 110.241 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -60.07 150.72 28.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.476 0.655 . . . . 0.0 112.487 -172.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.465 ' CD2' HD13 ' A' ' 40' ' ' LEU . 20.3 p90 -157.93 156.72 31.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.359 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.34 152.94 18.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.621 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.5 p90 -138.1 152.63 48.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.611 HG23 HD11 ' A' ' 18' ' ' LEU . 58.6 t -129.66 130.91 67.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 110.27 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' MET . 9.5 p-10 -76.53 128.12 34.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.58 175.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -145.22 -38.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.008 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -60.46 -17.81 47.2 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.003 0.82 . . . . 0.0 110.822 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -33.97 12.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -74.72 131.22 79.91 Favored Pre-proline 0 N--CA 1.477 0.88 0 O-C-N 122.178 -0.326 . . . . 0.0 110.709 172.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.79 -43.99 4.68 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.467 2.111 . . . . 0.0 112.943 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.58 -57.95 3.56 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.71 -35.28 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.688 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.591 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -55.72 -27.99 53.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.95 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -89.14 -48.08 7.64 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -171.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 52.7 mt-10 -78.93 -60.05 2.53 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.294 1.591 . . . . 0.0 115.294 -162.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.687 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 1.8 pt? -67.47 -34.64 7.05 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 19.1 Cg_endo -56.11 -38.22 95.2 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.405 1.403 . . . . 0.0 110.997 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 42.8 mtmt -55.23 -41.99 72.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.439 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.591 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.63 -38.86 84.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.093 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB1' HD13 ' A' ' 80' ' ' LEU . . . -68.75 -53.54 21.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.158 -175.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.949 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.6 t-20 -172.35 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.658 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.949 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 31.2 p90 -126.49 149.42 67.68 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.736 -167.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.62 -37.48 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 125.256 3.971 . . . . 0.0 117.05 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.9 p -140.78 -137.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.202 0.91 . . . . 0.0 111.961 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 42.6 m-85 -140.57 -170.71 0.25 Allowed Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -173.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.968 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.0 Cg_endo -64.41 148.62 70.15 Favored 'Cis proline' 0 C--N 1.36 1.149 0 CA-C-N 120.864 1.344 . . . . 0.0 113.495 -2.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.623 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 68.2 mt-30 -133.5 130.59 38.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.758 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -92.31 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.572 ' N ' HD13 ' A' ' 74' ' ' LEU . 67.3 m95 -125.03 129.4 50.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.69 0.757 . . . . 0.0 111.323 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.499 HG11 ' HB3' ' A' ' 99' ' ' LEU . 86.5 t -115.91 120.08 63.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.1 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.462 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.1 t70 56.93 32.08 20.9 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 123.078 1.418 . . . . 0.0 109.145 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.843 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.17 28.19 70.59 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 114.044 -1.435 . . . . 0.0 113.264 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -127.95 135.14 49.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 111.126 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.873 HD21 ' HZ3' ' A' ' 68' ' ' TRP . 19.4 tp -64.65 136.13 56.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.67 -172.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.539 ' O ' HG21 ' A' ' 86' ' ' ILE . 91.3 t -120.8 -53.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.358 170.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.9 ' HA2' ' HH2' ' A' ' 68' ' ' TRP . . . 129.7 133.32 3.58 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.73 -61.37 1.7 Allowed Glycine 0 C--O 1.221 -0.69 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -167.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.18 -68.91 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.632 -0.922 . . . . 0.0 113.431 -166.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -80.72 -41.91 22.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.077 0.465 . . . . 0.0 110.469 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.628 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.5 mp -60.41 -45.7 96.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.58 -171.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.0 t -58.83 -47.67 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.715 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 39' ' ' ALA . 32.8 mm -60.15 -46.61 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.02 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.728 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 85.2 tt0 -61.11 -54.66 41.82 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.932 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.587 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.3 mmt -57.97 -36.32 72.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.712 0.292 . . . . 0.0 111.512 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.696 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 18.7 t80 -56.36 -51.43 68.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.781 172.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 77.2 mt-30 -65.32 -38.46 90.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.9 mmm180 -58.94 -34.37 71.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.072 176.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 86.88 -23.93 9.78 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -168.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.782 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.6 mt-10 -58.01 -29.39 65.27 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.588 ' O ' HG12 ' A' ' 100' ' ' ILE . 63.7 tp -60.14 -56.63 19.19 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.201 0.524 . . . . 0.0 111.063 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.738 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 11.2 pt20 -63.12 -28.99 70.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.917 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 49.5 mm-40 -62.27 -47.15 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.038 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 37.0 mt -66.19 -45.36 81.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 96' ' ' LEU . 49.5 mm -61.38 -47.88 91.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.721 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 39.7 ttpt -62.01 -49.46 75.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.553 0.216 . . . . 0.0 111.339 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -55.42 -44.95 76.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.614 0.721 . . . . 0.0 109.957 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.489 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 92.9 m -70.53 -45.86 64.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.472 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.407 ' O ' ' HE2' ' A' ' 108' ' ' LYS . . . -59.65 -44.23 93.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 109' ' ' SER . . . -61.01 -41.84 97.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.478 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -72.87 -31.78 64.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.333 -178.494 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' A' ' 16' ' ' PRO . 60.0 m-85 -78.47 -47.09 18.15 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.55 ' CE ' ' HG3' ' A' ' 111' ' ' GLU . 3.1 mppt? -98.82 -145.47 0.32 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.496 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 105' ' ' ALA . 50.4 m -83.57 -155.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -70.08 59.91 0.18 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.55 ' HG3' ' CE ' ' A' ' 108' ' ' LYS . 58.5 mm-40 -59.48 121.94 60.61 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -92.7 48.14 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.656 2.237 . . . . 0.0 113.924 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.1 m-20 . . . . . 0 C--N 1.309 -1.179 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.113 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.434 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 61.1 mt . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -55.61 -47.1 77.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.21 -43.5 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.48 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.86 HD13 ' HB2' ' A' ' 62' ' ' LEU . 85.2 mt -62.32 -47.83 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.435 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.445 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 33.2 mt-30 -62.91 -39.35 94.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.224 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -58.86 -34.5 71.66 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 65.6 tt0 -73.14 -50.35 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.784 HG22 ' HA2' ' A' ' 78' ' ' GLY . 26.5 mt -63.4 -38.13 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.873 0.845 . . . . 0.0 111.042 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.4 83.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.269 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -73.78 -35.82 65.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.861 -171.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.712 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -77.21 131.28 72.69 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 121.494 0.664 . . . . 0.0 111.323 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 50.2 Cg_exo -59.44 -42.06 52.05 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.24 2.626 . . . . 0.0 112.492 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.9 mm -141.9 121.33 10.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.712 HD22 ' OD1' ' A' ' 15' ' ' ASN . 22.8 tp -131.83 142.67 49.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 0.0 111.313 -170.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 21' ' ' MET . 11.8 tp -137.22 121.45 18.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.359 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.818 ' CE2' HD21 ' A' ' 62' ' ' LEU . 8.0 m-85 -97.92 115.69 28.62 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.808 ' HE3' ' HB3' ' A' ' 33' ' ' SER . 14.2 ptm -148.06 -157.18 0.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.016 173.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.671 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 tttt -98.28 125.98 43.59 Favored 'General case' 0 C--O 1.213 -0.857 0 O-C-N 121.232 -0.917 . . . . 0.0 112.154 -169.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 67.91 0.94 Allowed Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.442 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 p -77.09 145.04 72.75 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -51.62 -41.48 60.97 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.616 2.211 . . . . 0.0 112.127 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.75 -29.08 68.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.131 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tt -159.96 118.0 1.57 Allowed Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.66 17.84 0.13 Allowed 'Trans proline' 0 N--CA 1.47 0.141 0 C-N-CA 122.801 2.334 . . . . 0.0 114.471 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.76 ' HB2' ' CE ' ' A' ' 21' ' ' MET . 11.2 p -164.12 61.11 0.15 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.42 0.629 . . . . 0.0 112.605 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.547 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 39.1 t -80.67 -143.3 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.946 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 65.42 -152.89 51.27 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 122.409 -0.182 . . . . 0.0 113.432 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 17.6 m-85 -78.19 -35.95 48.0 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.808 ' HB3' ' HE3' ' A' ' 21' ' ' MET . 32.4 t -59.72 -7.3 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.036 -0.415 . . . . 0.0 112.091 -172.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.28 -42.05 9.27 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -75.01 -38.86 61.43 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.244 0.545 . . . . 0.0 109.708 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.72 -43.97 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.383 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 34' ' ' ALA . 11.1 p -55.87 -37.6 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.449 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 26.3 mm-40 -67.78 -45.44 74.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.783 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -58.0 -44.69 87.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.644 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.419 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.25 -57.49 12.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.955 0.407 . . . . 0.0 110.271 -175.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.05 -32.17 70.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.567 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.6 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.2 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.755 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.3 p -74.47 -54.58 7.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.18 -130.2 6.93 Favored Glycine 0 N--CA 1.454 -0.151 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.933 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.669 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 49.5 mt-10 -140.84 -149.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.168 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 40.3 mmt180 -48.1 146.64 2.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.421 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 20.0 p90 -158.5 153.15 24.66 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.35 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.61 152.77 19.24 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.682 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -132.12 148.44 52.48 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.656 HG23 HD11 ' A' ' 18' ' ' LEU . 43.3 t -123.2 131.12 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.6 p30 -81.63 131.23 35.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.365 0.602 . . . . 0.0 109.957 176.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 53' ' ' LEU . 1.2 pp -147.49 -28.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.741 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.734 HD22 HD12 ' A' ' 52' ' ' ILE . 1.9 mm? -65.87 -14.5 61.58 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -96.18 -46.12 6.58 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.858 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 32.0 m120 -77.28 121.33 84.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.615 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 18.5 Cg_exo -66.89 -43.66 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.974 2.449 . . . . 0.0 112.939 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.78 -51.08 29.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 62' ' ' LEU . 33.1 mt -63.52 -34.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.172 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.64 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 47.9 ttt85 -50.88 -35.32 32.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.195 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.611 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -90.89 -51.87 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.495 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 56.6 mm-40 -76.93 -55.46 5.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -167.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.86 ' HB2' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -61.55 -43.57 89.12 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -172.334 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 20.4 Cg_endo -57.81 -41.54 68.62 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 121.334 1.356 . . . . 0.0 111.217 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 52.4 mtmt -57.04 -35.27 69.1 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.766 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.606 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.0 -43.22 83.48 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.943 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.811 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.08 -56.88 4.29 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.799 -175.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.707 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 25.8 t-20 -174.85 -55.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.34 1.067 . . . . 0.0 109.507 172.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.707 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.3 m-90 -58.79 147.28 72.58 Favored Pre-proline 0 C--O 1.216 -0.687 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.339 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.71 -38.27 72.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.345 2.03 . . . . 0.0 110.306 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.9 p -142.66 -124.73 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.462 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.97 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 53.6 m-85 -139.61 -172.27 0.31 Allowed Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.97 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 64.3 Cg_endo -71.37 165.05 81.99 Favored 'Cis proline' 0 C--N 1.357 1.014 0 CA-C-N 120.777 1.313 . . . . 0.0 114.611 -1.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.777 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.6 pt20 -156.74 133.67 10.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.038 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 87' ' ' VAL . 61.4 tp -90.72 141.91 28.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.734 178.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.655 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 52.1 m95 -129.16 125.13 36.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 110.329 175.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.04 117.37 51.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.654 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 60.6 t0 57.09 33.99 24.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 123.117 1.437 . . . . 0.0 109.465 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.784 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.41 29.24 68.42 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.071 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -127.31 129.04 46.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.312 . . . . 0.0 110.492 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.811 HD22 ' HB1' ' A' ' 66' ' ' ALA . 59.2 tp -67.95 135.56 52.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.806 -170.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.597 ' O ' HG21 ' A' ' 86' ' ' ILE . 97.9 t -117.48 -53.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.194 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.54 140.03 3.4 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.02 -67.35 1.41 Allowed Glycine 0 C--O 1.216 -0.994 0 C-N-CA 118.226 -1.94 . . . . 0.0 116.258 -167.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 41.8 t -81.61 -68.72 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.728 1.264 . . . . 0.0 113.088 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.88 -47.13 60.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.404 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.597 HG21 ' O ' ' A' ' 81' ' ' VAL . 45.7 mm -58.36 -43.78 87.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.388 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.647 HG13 HD11 ' A' ' 96' ' ' LEU . 69.3 t -59.46 -49.23 84.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.974 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.3 mm -58.22 -49.68 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.36 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.729 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.2 tt0 -61.25 -54.28 46.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.693 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 24.9 mmt -58.58 -35.03 71.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.599 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.5 t80 -58.62 -50.63 73.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.767 173.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.2 mt-30 -62.69 -41.32 99.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 28.8 mmm180 -58.74 -33.88 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.699 178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.9 17.37 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.65 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.813 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 41.0 mt-10 -57.49 -36.92 72.12 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 122.96 0.504 . . . . 0.0 111.728 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.9 tt -61.29 -54.63 41.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.128 0.49 . . . . 0.0 109.92 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 18.9 pt20 -64.91 -28.96 69.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.889 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 31.7 tp60 -63.93 -44.13 93.81 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.239 0.616 . . . . 0.0 110.032 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.813 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 43.0 mt -68.78 -47.53 65.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.907 174.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 96' ' ' LEU . 46.3 mm -57.56 -47.65 84.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.432 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 26.7 ttpp -55.26 -50.73 68.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.664 0.269 . . . . 0.0 111.692 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -48.77 80.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.654 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.0 m -65.17 -53.24 47.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.399 0.619 . . . . 0.0 111.694 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.657 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.71 -44.14 97.0 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.822 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.62 75.92 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.399 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.46 -29.34 67.0 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.131 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.571 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 46.9 m-85 -79.56 -46.06 18.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -77.77 -163.73 0.43 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.097 0.475 . . . . 0.0 110.395 170.092 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 p -87.45 59.63 5.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.156 0.979 . . . . 0.0 111.964 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 57.07 47.47 17.35 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.777 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.625 ' HG2' ' HB3' ' A' ' 108' ' ' LYS . 43.1 mm-40 -67.78 135.89 92.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.858 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.8 Cg_exo -80.43 51.37 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 124.589 3.526 . . . . 0.0 113.017 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.674 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.4 m-20 . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.434 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 74.7 mt . . . . . 0 C--O 1.232 0.171 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 9.7 pt-20 -52.06 -46.57 65.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.023 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 47.5 mmtm -73.54 -43.69 59.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.015 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.698 HD13 HD22 ' A' ' 62' ' ' LEU . 66.9 mt -53.23 -44.45 53.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -63.14 -33.57 75.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.937 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -58.08 -40.26 80.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.359 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.695 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.8 mp0 -73.69 -46.41 46.46 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' OH ' ' A' ' 65' ' ' TYR . 18.4 mt -59.94 -44.61 94.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.39 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.01 -40.58 95.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.955 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.695 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.4 pt-20 -66.44 -31.38 72.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.269 -176.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 33.7 m120 -76.63 125.87 86.75 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.927 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' HD13 ' A' ' 17' ' ' ILE . 51.5 Cg_exo -60.38 -42.98 37.01 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 123.058 2.505 . . . . 0.0 112.437 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.8 mm -141.13 123.26 14.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 50' ' ' VAL . 20.0 tp -133.51 142.09 48.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.16 -167.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.2 tp -136.37 117.99 14.94 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.326 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.774 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.9 m-85 -97.25 121.76 39.51 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.993 -0.442 . . . . 0.0 112.012 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.982 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 45.3 mmm -147.16 -158.49 0.92 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.011 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.93 112.82 24.41 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.788 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.9 68.04 1.5 Allowed Glycine 0 C--N 1.306 -1.118 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.095 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 p -77.71 144.57 69.3 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -52.74 -40.25 74.58 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.267 1.978 . . . . 0.0 111.529 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -66.7 -32.56 73.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.153 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.17 115.91 2.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.34 15.6 0.2 Allowed 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.895 2.397 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.4 p -164.83 47.08 0.1 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.141 0.496 . . . . 0.0 111.177 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.674 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 45.2 t -65.81 124.12 21.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.306 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.84 -134.71 6.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.424 -175.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.32 -42.14 31.58 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.68 ' CB ' ' HG3' ' A' ' 21' ' ' MET . 29.6 t -55.0 -10.12 0.46 Allowed 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.61 11.29 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.653 0.206 . . . . 0.0 110.893 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.519 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -81.53 -36.99 28.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.008 175.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.36 -44.74 78.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -174.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.581 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.38 -37.95 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.716 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -62.29 -45.1 94.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.113 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -60.3 -45.9 91.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.42 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.77 -56.59 16.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.526 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.49 -32.14 69.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.24 -48.56 50.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.042 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.877 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 31.7 p -71.73 -56.29 6.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.327 -171.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -102.51 -146.09 17.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.456 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 92.5 mt-10 -102.39 -153.55 0.47 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.283 -0.458 . . . . 0.0 111.337 174.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HD2' ' C ' ' A' ' 46' ' ' ARG . 6.5 ppt_? -71.56 150.35 44.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -176.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 12.9 p90 -141.35 156.31 45.84 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.541 -170.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -97.43 152.47 18.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.888 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.9 p90 -136.77 153.97 50.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.744 HG23 HD11 ' A' ' 18' ' ' LEU . 47.3 t -131.71 130.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.788 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -78.64 134.9 37.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.48 0.657 . . . . 0.0 110.907 175.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.774 HG12 ' HD2' ' A' ' 20' ' ' TYR . 1.3 pp -153.08 -34.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.616 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.011 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.2 mm? -69.8 -5.84 28.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.368 168.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -96.85 -43.21 7.59 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.256 176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 75.2 m-80 -82.21 124.9 78.05 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.029 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.18 -44.22 9.79 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 121.992 1.795 . . . . 0.0 112.524 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -56.3 6.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.036 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.9 mt -61.72 -33.92 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.39 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.628 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 59.8 ttp180 -51.93 -34.0 39.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.982 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.499 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -87.15 -41.59 13.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.62 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -77.96 -61.65 1.93 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -164.37 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 20' ' ' TYR . 2.2 pt? -71.46 -34.0 2.99 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -171.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.729 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 19.8 Cg_endo -56.04 -38.72 94.34 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.348 1.365 . . . . 0.0 110.772 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.62 ' HE3' ' HA ' ' A' ' 61' ' ' GLU . 8.8 mtmp? -54.11 -39.1 66.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.776 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.639 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.6 -38.28 73.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.643 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -70.76 -54.31 12.21 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.562 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.824 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.5 t-20 -171.94 -54.22 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.347 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.862 ' CH2' HD11 ' A' ' 80' ' ' LEU . 32.8 p90 -105.55 144.71 29.38 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.096 -1.411 . . . . 0.0 114.511 -167.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -40.84 -37.0 2.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 125.07 3.847 . . . . 0.0 115.919 -172.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -140.41 -133.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.223 0.465 . . . . 0.0 111.409 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.964 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 45.5 m-85 -141.81 -174.17 0.4 Allowed Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -170.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.982 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 42.6 Cg_endo -65.99 172.58 32.22 Favored 'Cis proline' 0 C--N 1.357 0.989 0 CA-C-N 120.1 1.072 . . . . 0.0 114.032 -0.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.862 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.9 pt20 -160.58 132.43 5.95 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.395 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -96.6 137.68 35.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.217 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.678 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -126.36 125.8 42.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.438 0.637 . . . . 0.0 110.637 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 99' ' ' LEU . 64.8 t -106.77 119.72 56.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.907 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB2' HG23 ' A' ' 103' ' ' THR . 35.1 t70 55.79 28.72 12.73 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.764 1.269 . . . . 0.0 110.268 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.633 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 77.82 29.89 53.54 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.048 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 46.9 mt-10 -126.33 133.83 51.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.706 0.289 . . . . 0.0 111.172 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.862 HD11 ' CH2' ' A' ' 68' ' ' TRP . 24.6 tp -63.76 135.6 56.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.193 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.566 ' O ' HG21 ' A' ' 86' ' ' ILE . 98.4 t -124.33 -51.95 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.765 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.723 ' HA2' ' CH2' ' A' ' 68' ' ' TRP . . . 135.29 135.88 3.53 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -84.35 -61.8 1.78 Allowed Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.682 -1.247 . . . . 0.0 116.208 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 17.6 p -79.86 -67.83 0.73 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 -44.92 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.673 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.566 HG21 ' O ' ' A' ' 81' ' ' VAL . 50.8 mm -56.27 -45.94 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.045 -174.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.5 t -58.34 -49.1 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.6 mm -60.7 -50.64 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.606 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.4 tt0 -61.19 -52.36 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.071 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 59.9 mtt -61.7 -31.14 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.9 t80 -58.35 -51.86 68.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 171.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.1 mt-30 -64.96 -40.3 94.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.231 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 42.7 mmm-85 -57.81 -33.29 68.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.464 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.706 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.38 -25.81 18.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.903 -173.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.775 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 55.6 mt-10 -53.57 -37.27 62.75 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.9 tp -59.68 -54.69 43.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 110.575 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.877 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 12.3 pt20 -65.32 -26.01 67.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.663 175.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 97.3 mm-40 -65.71 -44.57 85.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.266 0.555 . . . . 0.0 109.611 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 44.1 mt -69.65 -47.14 64.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.144 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.703 HG22 ' OD2' ' A' ' 113' ' ' ASP . 45.7 mm -61.98 -42.26 94.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.789 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 29.7 ttmt -51.34 -59.14 4.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.37 0.605 . . . . 0.0 111.584 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.41 -42.74 99.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.484 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 77' ' ' ASP . 74.8 m -69.03 -48.58 62.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.752 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.664 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -60.39 -45.96 91.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.601 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.42 81.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.53 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -73.59 -26.38 60.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.242 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.509 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 54.3 m-85 -83.68 -47.23 11.43 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.664 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -83.41 -154.81 0.15 Allowed 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 36.6 m -75.37 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.78 46.93 0.23 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.868 0.366 . . . . 0.0 111.774 174.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -76.86 110.17 11.06 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.347 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -90.8 120.93 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.432 . . . . 0.0 111.81 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.834 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 21.0 m-20 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.019 0.437 . . . . 0.0 111.627 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.983 HG22 ' HG3' ' A' ' 9' ' ' GLN . 30.2 mm . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 13.6 pt-20 -40.68 -48.32 2.93 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.529 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 75.3 mmtt -62.76 -43.8 97.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 110.303 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.765 HG21 ' HG ' ' A' ' 62' ' ' LEU . 71.9 mt -65.53 -50.05 74.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.631 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.983 ' HG3' HG22 ' A' ' 5' ' ' ILE . 36.0 mt-30 -56.01 -40.48 73.44 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.9 mmp_? -60.93 -33.88 73.84 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.977 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.499 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 66.2 tt0 -72.21 -42.98 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.439 174.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.749 HG22 ' HA2' ' A' ' 78' ' ' GLY . 18.8 mt -64.16 -45.27 96.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.04 0.448 . . . . 0.0 110.376 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -41.01 96.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.936 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 14.0 pt-20 -64.26 -37.42 87.43 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.64 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.465 ' CB ' ' HG ' ' A' ' 18' ' ' LEU . 33.2 m120 -77.2 120.56 82.09 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.534 ' O ' HD13 ' A' ' 17' ' ' ILE . 49.2 Cg_exo -62.17 -42.05 31.56 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.541 2.161 . . . . 0.0 111.829 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.595 HG23 HD12 ' A' ' 100' ' ' ILE . 31.4 mm -131.93 125.32 54.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.777 HD13 ' HE1' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -131.69 143.4 50.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.276 -169.186 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 17.0 tp -136.67 113.24 10.12 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.394 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.777 ' HE1' HD13 ' A' ' 18' ' ' LEU . 8.0 m-85 -96.01 115.06 26.85 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.815 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.605 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 24.5 ptt? -145.97 -157.31 0.79 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.113 -176.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.741 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 79.6 tttt -98.42 143.38 28.92 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -142.75 130.18 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.204 -171.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.444 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 27.9 t -146.56 143.68 19.29 Favored Pre-proline 0 C--N 1.312 -1.029 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.71 -36.54 82.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.143 1.895 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 18.4 ptpt -64.65 -35.15 80.08 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.178 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -159.52 113.27 1.52 Allowed Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.85 19.63 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 114.649 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.3 p -164.14 49.69 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.468 0.651 . . . . 0.0 111.295 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.741 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 2.2 p -69.44 49.67 0.09 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.32 -136.15 2.15 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.704 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.636 ' HB3' ' SG ' ' A' ' 84' ' ' CYS . 4.2 m-85 -74.63 -40.31 61.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.869 0.843 . . . . 0.0 109.466 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.605 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 51.2 p -54.17 -18.07 3.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.548 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.65 -39.47 36.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 110.401 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.631 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -79.89 -38.88 31.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 175.637 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.28 77.91 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -54.38 -39.38 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.119 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 29.0 mm-40 -64.42 -43.87 92.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.329 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.504 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.38 -42.09 86.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.743 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -55.97 20.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.146 0.498 . . . . 0.0 110.023 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.08 70.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.468 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.26 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.47 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.701 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -77.71 -55.25 5.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.52 -135.33 8.82 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.064 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 30.8 mt-10 -134.9 -148.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.957 0.503 . . . . 0.0 110.909 177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 26.0 mmm180 -50.6 146.42 5.62 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.498 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.424 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 26.6 p90 -158.22 153.77 26.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.962 -175.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.38 143.5 29.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.3 p90 -124.86 148.36 48.29 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG23 HD21 ' A' ' 18' ' ' LEU . 57.7 t -124.81 130.8 73.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.198 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.42 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 41.6 p-10 -78.27 132.07 37.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.604 0.716 . . . . 0.0 110.22 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.966 HD12 ' HG ' ' A' ' 53' ' ' LEU . 1.4 pp -148.68 -34.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.124 -172.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.966 ' HG ' HD12 ' A' ' 52' ' ' ILE . 36.4 mt -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.779 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -97.12 -46.21 6.25 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.5 174.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 m-20 -76.42 120.36 81.32 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 120.579 0.228 . . . . 0.0 110.729 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.19 -44.77 11.36 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.261 1.974 . . . . 0.0 113.039 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.05 -54.13 14.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.0 -36.02 71.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 110.279 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.65 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 60.5 ttp180 -51.5 -32.44 27.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.801 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -90.7 -39.14 12.61 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.456 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 14.8 tp10 -79.64 -62.09 1.8 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -163.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.765 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -74.28 -26.36 0.69 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -173.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.732 ' HD3' HD13 ' A' ' 62' ' ' LEU . 31.9 Cg_endo -59.73 -40.76 61.36 Favored 'Trans proline' 0 C--N 1.358 1.069 0 CA-C-N 121.352 1.519 . . . . 0.0 110.683 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 8.6 mtmp? -56.54 -39.25 73.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.352 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.563 ' HD2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -64.38 -44.03 92.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.874 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -77.88 -57.23 3.91 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.504 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.655 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.3 t30 -174.68 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.026 0.917 . . . . 0.0 110.45 169.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.681 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.49 147.11 51.22 Favored Pre-proline 0 C--O 1.222 -0.38 0 CA-C-N 113.358 -1.747 . . . . 0.0 113.311 -174.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.5 -36.52 76.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.232 1.955 . . . . 0.0 110.045 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -142.69 -126.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.181 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.868 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 10.9 m-85 -143.47 -164.26 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.868 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.2 Cg_endo -67.09 154.92 84.86 Favored 'Cis proline' 0 C--N 1.364 1.385 0 CA-C-N 121.993 1.747 . . . . 0.0 114.057 -1.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.681 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 21.0 mt-30 -142.62 134.13 26.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.641 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -91.09 137.91 32.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.623 ' N ' HD13 ' A' ' 74' ' ' LEU . 69.5 m95 -125.19 128.7 48.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 0.0 110.935 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 99' ' ' LEU . 96.4 t -112.9 115.23 49.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.7 t70 57.58 30.56 18.96 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.633 1.682 . . . . 0.0 108.809 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.749 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.14 29.01 65.23 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 113.485 -1.688 . . . . 0.0 113.05 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 91.4 mt-10 -115.94 130.57 56.88 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.874 HD22 ' HB1' ' A' ' 66' ' ' ALA . 47.0 tp -69.32 134.56 49.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 111.756 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.586 HG12 ' CG2' ' A' ' 86' ' ' ILE . 93.9 t -119.32 -50.33 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.145 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.28 132.88 2.91 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.489 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.77 -64.12 1.57 Allowed Glycine 0 C--O 1.222 -0.631 0 C-N-CA 118.895 -1.621 . . . . 0.0 116.644 -166.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 32' ' ' PHE . 42.2 t -80.3 -68.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.428 1.114 . . . . 0.0 112.3 -170.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.22 -43.98 66.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.498 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.586 ' CG2' HG12 ' A' ' 81' ' ' VAL . 2.4 mp -62.16 -44.1 98.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.151 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.463 HG13 HD21 ' A' ' 96' ' ' LEU . 73.4 t -57.21 -49.2 80.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.244 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.631 HD11 ' HG2' ' A' ' 35' ' ' GLN . 35.7 mm -60.1 -49.92 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.043 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.735 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.2 tt0 -62.16 -51.62 67.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.845 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.586 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.0 mmt -58.77 -35.12 72.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.505 0.193 . . . . 0.0 111.307 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.568 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t80 -58.58 -51.23 70.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.205 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.0 mt-30 -64.77 -41.01 96.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.089 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.3 mmm-85 -60.43 -34.66 74.3 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.654 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.686 ' O ' ' HG3' ' A' ' 98' ' ' GLN . . . 95.36 -24.79 27.51 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.27 -174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.707 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -58.7 -30.03 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.3 tp -59.3 -54.57 45.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.645 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.701 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 15.9 pt20 -63.45 -28.08 69.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.002 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 94' ' ' GLY . 75.2 mt-30 -62.79 -46.04 89.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 49.1 mt -65.39 -44.58 87.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.856 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.635 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.27 -46.77 95.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.492 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 113' ' ' ASP . 38.7 ttpt -59.17 -50.73 72.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.882 0.373 . . . . 0.0 110.989 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -52.15 -45.53 65.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.32 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 86.0 m -77.06 -48.6 17.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.971 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 108' ' ' LYS . . . -59.54 -43.69 93.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.37 96.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.549 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.06 -32.34 64.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.281 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.505 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 65.7 m-85 -79.1 -47.47 16.06 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.72 -150.73 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.298 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 p -88.15 -150.54 0.18 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.935 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -70.6 54.47 0.16 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 108' ' ' LYS . 31.3 mm-40 -69.44 114.9 27.44 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 110.411 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -93.2 52.59 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.335 2.69 . . . . 0.0 113.795 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.3 m-20 . . . . . 0 C--N 1.315 -0.925 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -172.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.53 HG12 ' CB ' ' A' ' 65' ' ' TYR . 2.0 mp . . . . . 0 C--O 1.225 -0.237 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 24.8 pt-20 -55.25 -40.4 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.607 0.639 . . . . 0.0 110.246 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.32 -43.38 88.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.521 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.693 HD13 ' HB3' ' A' ' 62' ' ' LEU . 77.9 mt -65.71 -47.47 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.876 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.696 ' NE2' ' HE2' ' A' ' 65' ' ' TYR . 59.5 mm-40 -62.16 -25.97 68.07 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.278 -173.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 3.4 mmp_? -50.85 -41.28 57.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 94.4 mm-40 -75.06 -49.35 20.01 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.296 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.627 HG23 HD23 ' A' ' 18' ' ' LEU . 4.6 mt -61.44 -43.11 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.601 0.715 . . . . 0.0 111.016 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.83 79.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.759 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 10.5 pt-20 -73.33 -36.26 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -173.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.64 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 3.6 p30 -77.63 134.12 65.96 Favored Pre-proline 0 CA--C 1.517 -0.307 0 CA-C-O 121.793 0.806 . . . . 0.0 112.092 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' O ' HD13 ' A' ' 17' ' ' ILE . 31.3 Cg_exo -63.33 -42.09 23.89 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.047 2.498 . . . . 0.0 111.723 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 16' ' ' PRO . 27.5 mm -139.59 119.16 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.741 HD21 ' HE1' ' A' ' 20' ' ' TYR . 31.1 tp -128.6 142.39 51.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -171.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.16 120.29 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.658 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.741 ' HE1' HD21 ' A' ' 18' ' ' LEU . 8.9 m-85 -98.87 122.1 41.67 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.848 -0.533 . . . . 0.0 111.396 173.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.557 ' O ' ' HE3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -147.84 -155.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.598 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.752 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 57.1 tttp -99.31 121.37 40.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.618 -0.676 . . . . 0.0 109.321 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.36 121.51 7.01 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.246 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 37.9 t -125.77 140.65 37.14 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.38 -41.3 79.55 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.167 1.911 . . . . 0.0 111.665 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -74.44 -28.39 61.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.535 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.5 tt -154.66 104.95 2.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.471 ' O ' ' SD ' ' A' ' 21' ' ' MET . 16.8 Cg_exo -72.29 35.47 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 114.476 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.446 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 7.0 p -169.74 49.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.095 0.558 . . . . 0.0 111.187 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.684 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 51.3 t -54.76 -36.65 65.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.15 -137.69 0.17 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.166 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.42 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 23.1 m-85 -75.95 -18.61 59.27 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 35.8 t -64.75 -12.16 44.27 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.003 -0.436 . . . . 0.0 111.891 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.86 -42.4 26.53 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -80.24 -41.68 24.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.07 0.462 . . . . 0.0 110.263 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.62 96.65 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.682 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.67 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 13.9 p -56.66 -39.48 63.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.348 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 30.4 mm-40 -68.91 -46.15 69.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.95 -42.8 94.86 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.294 0.371 . . . . 0.0 111.505 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.497 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -63.15 -55.11 27.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.412 0.625 . . . . 0.0 109.681 -176.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.16 69.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.478 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 -49.13 19.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.506 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.753 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.6 p -74.52 -53.36 9.62 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.457 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.5 -141.0 11.51 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.87 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 69.8 mm-40 -117.87 -152.15 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.832 0.453 . . . . 0.0 111.144 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HE ' ' N ' ' A' ' 46' ' ' ARG . 3.4 mmp_? -65.44 158.23 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.46 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.67 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 17.0 p90 -154.35 159.07 40.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.551 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.86 154.09 17.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.805 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -143.6 153.89 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -174.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.678 HG23 HD11 ' A' ' 18' ' ' LEU . 57.6 t -133.79 130.29 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.504 0.193 . . . . 0.0 110.56 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.509 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 36.5 p-10 -74.49 131.9 41.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.485 0.659 . . . . 0.0 110.924 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.705 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.4 pp -147.85 -35.63 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.861 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -65.35 -11.62 43.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.412 167.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tm0? -97.52 -44.94 6.61 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.465 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.9 m-20 -82.25 118.12 70.83 Favored Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 122.192 -0.318 . . . . 0.0 110.437 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.69 -44.09 14.8 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.434 2.089 . . . . 0.0 113.756 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -72.53 -52.71 14.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.078 0.466 . . . . 0.0 111.573 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -62.46 -35.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.268 0.556 . . . . 0.0 110.424 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 62.4 ttp180 -52.89 -32.43 45.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.202 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -88.19 -41.53 12.91 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.576 -166.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.549 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 32.0 tp10 -78.79 -59.67 2.69 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -158.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.711 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.9 pt? -68.11 -31.39 3.25 Favored Pre-proline 0 N--CA 1.474 0.726 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 18.5 Cg_endo -57.82 -43.44 49.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 121.103 1.43 . . . . 0.0 111.138 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.641 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 48.6 mtmt -55.68 -37.88 68.9 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.035 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.696 ' HE2' ' NE2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -65.21 -50.83 64.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.477 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.929 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -73.3 -55.7 6.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.379 -0.929 . . . . 0.0 112.935 -170.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.632 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.8 t30 -175.41 -52.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.211 1.005 . . . . 0.0 110.237 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.632 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -59.75 150.33 68.15 Favored Pre-proline 0 C--O 1.215 -0.743 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.936 -177.619 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -63.54 -36.76 52.05 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 121.954 1.769 . . . . 0.0 109.912 171.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -141.79 -124.28 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.003 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.923 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 25.7 m-85 -140.72 -165.61 0.1 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.923 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.1 Cg_endo -67.09 153.51 84.62 Favored 'Cis proline' 0 C--N 1.361 1.216 0 CA-C-N 121.691 1.64 . . . . 0.0 113.885 -1.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.593 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 30.7 mt-30 -143.21 135.19 26.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.706 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -100.08 135.17 41.91 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.588 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.61 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 49.4 m95 -121.91 125.77 47.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.242 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.5 t -105.91 119.04 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.557 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.1 t70 56.74 27.95 13.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 123.722 1.725 . . . . 0.0 108.622 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.07 29.3 54.38 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.375 -1.739 . . . . 0.0 113.044 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -124.68 130.97 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.322 . . . . 0.0 110.472 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.929 HD22 ' HB1' ' A' ' 66' ' ' ALA . 40.6 tp -68.95 127.31 32.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.406 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.548 HG12 ' CG2' ' A' ' 86' ' ' ILE . 87.3 t -105.28 -55.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.759 170.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.39 135.23 2.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.29 -65.52 1.52 Allowed Glycine 0 C--O 1.217 -0.943 0 C-N-CA 118.584 -1.77 . . . . 0.0 116.482 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 21.8 p -80.56 -68.05 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.76 1.28 . . . . 0.0 113.231 -171.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.26 -46.82 63.62 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.939 0.399 . . . . 0.0 111.244 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 81' ' ' VAL . 46.1 mm -59.99 -44.79 95.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.013 -172.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 82' ' ' GLY . 56.0 t -58.27 -49.03 83.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.289 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.478 ' O ' ' HD2' ' A' ' 91' ' ' TYR . 39.4 mm -58.1 -53.21 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.41 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 87.8 tt0 -65.97 -47.43 74.64 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.882 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.767 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.2 mmt -58.62 -36.55 74.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.633 0.254 . . . . 0.0 111.057 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.601 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -58.03 -48.81 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 172.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.538 ' HG2' ' CD2' ' A' ' 91' ' ' TYR . 15.2 mm-40 -62.58 -43.75 98.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.013 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 44.4 mmm-85 -62.93 -33.99 76.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.777 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 96.13 -25.29 26.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.747 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.5 mt-10 -55.54 -35.53 65.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.767 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 63.6 tp -62.37 -54.66 37.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.753 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -63.49 -26.78 68.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.024 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.6 mm-40 -64.0 -46.63 83.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.132 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 46.4 mt -67.6 -44.75 77.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.903 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.0 mm -60.62 -46.26 96.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.482 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 113' ' ' ASP . 39.4 ttpt -59.06 -52.86 63.91 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.3 -43.14 82.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.259 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.557 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 46.7 m -72.07 -50.17 30.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.076 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.05 92.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.565 -177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.31 72.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.77 -29.58 51.03 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.959 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.562 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 62.9 m-85 -86.83 -49.54 7.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.005 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.813 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -96.03 119.82 35.21 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.148 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -54.32 117.04 2.96 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 52.07 37.49 21.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.245 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 60.6 mm-40 -80.46 123.65 82.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.634 174.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.1 Cg_endo -83.94 109.41 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.696 2.264 . . . . 0.0 112.45 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.2 m-20 . . . . . 0 C--N 1.321 -0.66 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.394 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 65' ' ' TYR . 37.5 mt . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 96.1 mt-10 -49.27 -47.55 46.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.545 0.212 . . . . 0.0 111.556 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 19.2 ptpt -61.79 -43.42 98.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.612 0.72 . . . . 0.0 110.116 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.595 HG21 ' HB3' ' A' ' 62' ' ' LEU . 72.2 mt -66.26 -46.84 86.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.936 -174.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.549 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.0 mmp_? -59.89 -37.55 79.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.851 0.358 . . . . 0.0 110.361 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 51.7 tt0 -71.03 -49.21 47.41 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.15 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.829 HG22 ' HA2' ' A' ' 78' ' ' GLY . 17.3 mt -65.88 -39.52 84.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.667 0.746 . . . . 0.0 110.835 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.12 81.94 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.637 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 24.0 pt-20 -72.81 -39.24 66.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.672 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -76.58 134.18 69.8 Favored Pre-proline 0 CA--C 1.515 -0.384 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -176.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' HD13 ' A' ' 17' ' ' ILE . 20.1 Cg_endo -61.94 -40.84 40.89 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.158 2.572 . . . . 0.0 112.056 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 16' ' ' PRO . 26.7 mm -139.27 120.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.672 HD22 ' OD1' ' A' ' 15' ' ' ASN . 28.1 tp -132.02 143.14 49.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.376 0.608 . . . . 0.0 111.414 -173.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 16.1 tp -138.95 120.6 15.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.362 -176.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.666 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -96.66 124.5 40.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.752 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 8.0 ptp -145.26 -171.09 3.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.524 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.817 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.3 tttm -95.97 140.62 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -138.67 129.5 4.52 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 118.941 -1.6 . . . . 0.0 113.696 -165.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -150.43 142.72 15.82 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.0 -38.99 60.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.598 2.199 . . . . 0.0 112.025 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -62.99 -33.08 74.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.325 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tt -160.02 108.7 1.42 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.85 19.97 0.18 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.239 1.959 . . . . 0.0 114.34 -174.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.817 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 13.5 p -164.22 49.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.287 0.565 . . . . 0.0 111.532 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.757 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 3.6 p -65.83 54.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.65 -137.58 2.24 Favored Glycine 0 C--N 1.321 -0.267 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.8 -39.67 61.57 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.761 0.791 . . . . 0.0 108.952 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 20.6 p -48.1 -24.14 1.03 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.695 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -51.52 -41.76 61.25 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.286 0.366 . . . . 0.0 111.652 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -33.24 43.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.352 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.17 66.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.132 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.661 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.5 p -52.25 -38.12 24.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.7 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 20.8 mm-40 -62.25 -46.94 86.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.819 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -60.61 -43.84 97.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.087 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.5 tt -61.85 -55.15 32.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -176.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.36 76.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.441 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -49.59 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.37 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.732 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.5 m -72.84 -56.02 5.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.49 -134.85 8.63 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.153 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.4 mm-40 -140.88 -152.17 0.4 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.822 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 28.8 mmm180 -58.15 143.67 43.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.823 0.82 . . . . 0.0 112.636 -169.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.661 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 16.6 p90 -152.93 156.42 38.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.878 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.45 146.87 25.31 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.1 p90 -136.83 150.21 48.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.576 HG23 HD11 ' A' ' 18' ' ' LEU . 48.3 t -127.6 127.66 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.8 p30 -77.9 133.9 38.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.293 0.568 . . . . 0.0 109.83 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 53' ' ' LEU . 1.1 pp -148.1 -32.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.264 -171.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.762 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -66.54 -11.09 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.098 167.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.6 tm0? -94.38 -43.27 8.46 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.07 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -77.63 123.99 86.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 121.026 0.441 . . . . 0.0 110.925 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.32 -42.94 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.373 2.049 . . . . 0.0 113.523 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -82.94 -50.89 8.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.672 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 mt -56.8 -37.11 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.249 0.547 . . . . 0.0 110.635 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.637 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 58.7 ttp180 -53.16 -31.24 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.158 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.35 -35.98 19.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -78.27 -61.14 2.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -162.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.709 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.9 pt? -76.8 -31.88 0.96 Allowed Pre-proline 0 N--CA 1.472 0.626 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.81 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 11.7 Cg_endo -55.21 -39.7 89.59 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 CA-C-N 120.917 1.363 . . . . 0.0 110.53 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -53.91 -41.36 67.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.543 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.698 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -68.56 -41.9 79.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.461 -178.153 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.947 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -73.49 -58.32 3.39 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.988 -176.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.458 ' HB2' ' CE3' ' A' ' 68' ' ' TRP . 6.1 m120 -173.27 -57.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.052 0.93 . . . . 0.0 109.539 168.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.567 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -53.88 147.8 22.62 Favored Pre-proline 0 C--O 1.215 -0.713 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.381 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.7 -36.21 53.47 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.289 1.993 . . . . 0.0 110.096 171.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.476 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -142.04 -127.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.372 -1.286 . . . . 0.0 109.698 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 1.004 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 36.0 m-85 -142.78 -170.63 0.24 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.004 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 38.4 Cg_endo -68.34 157.76 87.22 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 120.981 1.386 . . . . 0.0 114.525 -1.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.916 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 17.7 pt20 -148.57 133.72 18.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.741 174.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.38 138.37 33.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.999 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.772 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 56.1 m95 -127.07 126.93 43.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.497 0.665 . . . . 0.0 110.894 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.952 HG21 HD13 ' A' ' 99' ' ' LEU . 50.2 t -106.28 114.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.483 -0.781 . . . . 0.0 108.919 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' HB2' HG21 ' A' ' 103' ' ' THR . 25.1 t70 54.42 32.08 15.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 123.108 1.432 . . . . 0.0 110.364 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.829 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 79.7 28.74 50.41 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 113.789 -1.551 . . . . 0.0 113.565 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -127.29 131.3 50.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.904 173.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.947 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.5 tp -68.95 130.2 42.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.607 -174.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.579 HG12 ' CG2' ' A' ' 86' ' ' ILE . 91.7 t -107.09 -54.11 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.447 168.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.88 132.82 2.55 Favored Glycine 0 C--O 1.22 -0.761 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.566 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.13 -62.43 1.66 Allowed Glycine 0 C--O 1.221 -0.678 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.863 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.2 p -77.18 -67.6 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.798 -0.825 . . . . 0.0 112.557 -171.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -73.6 -48.77 30.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.579 ' CG2' HG12 ' A' ' 81' ' ' VAL . 43.1 mm -61.92 -42.27 94.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.382 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 82' ' ' GLY . 65.6 t -58.74 -48.22 86.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.792 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.555 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.0 mm -60.9 -47.31 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.595 0.236 . . . . 0.0 110.831 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.9 tt0 -59.79 -55.21 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.651 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.592 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -60.07 -35.67 75.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.35 0.26 . . . . 0.0 111.276 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.732 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 17.7 t80 -56.79 -50.96 70.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.848 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -63.76 -40.68 97.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.1 mmm-85 -63.63 -33.94 76.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.604 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.15 -24.39 25.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.169 -171.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.7 mt-10 -58.22 -27.23 63.74 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.592 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 6.2 tt -60.44 -58.95 6.33 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 11.4 pt20 -60.27 -27.04 66.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.35 176.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 46.1 mm-40 -65.07 -55.66 17.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.952 HD13 HG21 ' A' ' 76' ' ' VAL . 2.5 pp -70.76 -32.34 69.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.665 177.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 99' ' ' LEU . 34.3 mm -64.57 -48.23 85.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.254 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -56.81 -52.05 66.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.369 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.91 -44.58 78.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.542 HG21 ' HB2' ' A' ' 77' ' ' ASP . 32.6 m -71.0 -50.55 32.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.613 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.48 93.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.537 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.72 93.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -73.46 -26.86 61.11 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.985 -178.33 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.497 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 43.0 m-85 -87.68 -47.21 8.84 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.092 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.625 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -75.71 -158.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -76.18 -167.36 0.74 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.674 165.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.71 57.34 0.13 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 53.9 mm-40 -73.12 124.63 90.84 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.359 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 93.0 Cg_endo -96.44 53.03 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.962 3.108 . . . . 0.0 113.991 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 28.6 m-20 . . . . . 0 C--N 1.313 -1.007 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -171.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 54.3 mt-10 -55.55 -47.42 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.582 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -62.68 -43.51 98.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 110.648 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.73 HG21 ' HB3' ' A' ' 62' ' ' LEU . 75.5 mt -60.95 -45.77 97.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.929 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -64.92 -33.26 75.6 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.365 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.644 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 4.3 mmp_? -55.94 -42.26 75.9 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -69.14 -44.35 72.51 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.953 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.627 HG23 HD23 ' A' ' 18' ' ' LEU . 19.9 mt -65.56 -43.34 94.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.442 0.639 . . . . 0.0 110.171 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.47 68.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.481 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.644 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 32.0 mt-10 -62.18 -46.65 87.99 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.077 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -78.45 125.17 85.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.231 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 37.3 Cg_endo -66.25 -42.0 11.39 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.467 2.111 . . . . 0.0 112.21 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.61 HD12 HG23 ' A' ' 100' ' ' ILE . 27.5 mm -127.12 119.82 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.679 HD11 HG23 ' A' ' 50' ' ' VAL . 21.5 tp -133.59 141.34 47.63 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.98 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.3 tp -138.27 120.1 15.32 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.306 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.631 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.8 m-85 -97.28 120.53 37.81 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.582 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.502 ' SD ' ' HB2' ' A' ' 29' ' ' SER . 20.0 ptt? -146.6 -163.77 1.83 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 29.2 tptp -96.73 127.63 42.91 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.144 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.37 125.46 8.38 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.618 -1.753 . . . . 0.0 111.74 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 46.4 t -138.5 141.22 30.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -54.01 -41.09 78.14 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.246 1.964 . . . . 0.0 111.453 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -71.71 -28.48 63.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.894 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.52 HD23 ' HD2' ' A' ' 28' ' ' PRO . 2.2 tt -161.5 121.72 1.55 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.52 ' HD2' HD23 ' A' ' 27' ' ' LEU . 50.1 Cg_endo -71.71 29.38 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.277 1.984 . . . . 0.0 113.307 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.613 ' OG ' ' HB3' ' A' ' 33' ' ' SER . 11.8 t -165.78 54.69 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.584 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 42.7 t -55.59 -36.88 67.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.698 -173.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.665 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -73.42 -138.68 0.37 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 36.4 m-85 -77.58 -20.87 53.31 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 32.8 t -69.02 -10.21 56.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.423 -0.798 . . . . 0.0 111.083 -174.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.26 -40.84 17.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.414 ' O ' HD11 ' A' ' 88' ' ' ILE . 12.3 mp0 -78.94 -38.04 38.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.86 91.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.931 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -56.19 -36.47 45.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.887 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 32.5 mm-40 -67.73 -42.07 82.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.719 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -57.27 -48.08 79.81 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.07 0.231 . . . . 0.0 111.183 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD12 HD22 ' A' ' 19' ' ' LEU . 9.9 mt -58.97 -62.29 1.99 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.952 0.882 . . . . 0.0 112.567 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.19 -28.51 58.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.134 -176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.51 -56.32 4.96 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.319 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.956 ' SG ' ' HB3' ' A' ' 97' ' ' GLN . 42.6 t -72.21 -59.13 2.89 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.815 -167.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -103.12 -125.59 5.68 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.354 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 44.6 mt-10 -142.11 -148.34 0.24 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.483 -0.859 . . . . 0.0 111.49 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.417 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 33.3 mmt180 -61.46 143.24 56.21 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.992 0.901 . . . . 0.0 112.119 -165.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.21 152.45 30.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.963 -1.472 . . . . 0.0 109.039 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.59 149.66 23.04 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.372 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -134.34 151.12 51.05 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.679 HG23 HD11 ' A' ' 18' ' ' LEU . 61.9 t -127.16 128.19 70.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.869 0.366 . . . . 0.0 110.099 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.1 p30 -75.65 130.61 39.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.739 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.689 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -146.1 -34.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.751 -173.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.689 ' H ' HD12 ' A' ' 52' ' ' ILE . 1.3 mm? -63.05 -14.5 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.906 167.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 17.8 tm0? -95.15 -42.9 8.35 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.778 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 32.6 m120 -79.2 122.34 84.12 Favored Pre-proline 0 N--CA 1.472 0.635 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.91 -44.72 9.5 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.147 1.898 . . . . 0.0 113.118 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -75.74 -47.68 24.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.2 -38.25 81.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.176 0.512 . . . . 0.0 110.487 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.603 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 77.4 ttt180 -50.88 -36.3 37.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.212 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.558 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -83.84 -42.19 16.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 50.3 mm-40 -78.0 -59.31 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -161.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.73 ' HB3' HG21 ' A' ' 8' ' ' ILE . 2.2 pt? -70.45 -32.59 2.74 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.3 Cg_endo -53.68 -42.25 67.61 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.324 1.349 . . . . 0.0 111.415 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 46.2 mtmt -54.57 -38.87 67.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.709 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.596 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.26 -41.09 77.37 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.144 -179.544 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.858 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -78.74 -57.35 3.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.583 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.68 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.6 t30 -175.0 -53.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 0.0 110.084 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.68 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -59.62 150.48 66.32 Favored Pre-proline 0 C--O 1.215 -0.746 0 CA-C-N 113.347 -1.752 . . . . 0.0 113.058 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.77 -33.81 42.62 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 121.828 1.685 . . . . 0.0 110.235 171.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 50.7 p -142.47 -124.2 0.09 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.083 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 1.006 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 55.0 m-85 -141.8 -167.51 0.15 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.006 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 56.9 Cg_endo -68.77 153.42 90.27 Favored 'Cis proline' 0 C--N 1.36 1.179 0 CA-C-N 121.631 1.618 . . . . 0.0 114.107 -1.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.655 HE22 ' HA ' ' A' ' 63' ' ' PRO . 58.2 mt-30 -145.27 133.32 21.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.2 tm? -95.56 137.46 34.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.806 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.605 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 61.2 m95 -122.4 127.42 49.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.572 HG22 HD13 ' A' ' 100' ' ' ILE . 46.4 t -106.02 115.2 47.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.603 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 28.5 t70 55.9 32.65 20.14 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 123.251 1.5 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.69 28.54 60.97 Favored Glycine 0 C--N 1.308 -0.988 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.989 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -124.69 129.75 51.1 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.175 0.19 . . . . 0.0 110.778 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.858 HD22 ' HB1' ' A' ' 66' ' ' ALA . 51.8 tp -69.94 136.59 50.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.596 HG12 ' CG2' ' A' ' 86' ' ' ILE . 92.5 t -119.31 -53.8 3.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.94 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.12 137.0 2.91 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.62 -65.82 1.49 Allowed Glycine 0 C--O 1.216 -0.98 0 C-N-CA 118.929 -1.605 . . . . 0.0 116.338 -168.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 1.9 p -79.33 -69.29 0.59 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.744 1.272 . . . . 0.0 113.388 -173.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.56 -48.4 64.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.415 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.596 ' CG2' HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.81 -46.8 93.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.642 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -58.23 -50.48 78.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.082 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.613 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 39.0 mm -56.04 -51.24 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.221 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.2 tt0 -62.59 -49.79 73.83 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.317 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.913 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 96.3 mmm -59.86 -38.36 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.63 ' HD1' ' HB2' ' A' ' 43' ' ' CYS . 3.0 t80 -60.05 -46.35 89.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.158 0.583 . . . . 0.0 110.475 173.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.613 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.2 mt-30 -64.59 -40.16 95.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.779 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 29.0 mmm180 -59.01 -33.87 71.21 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.053 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.25 20.16 79.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.313 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.631 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 53.7 mt-10 -98.8 -24.58 14.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.106 0.479 . . . . 0.0 111.28 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 23.5 tp -75.2 -43.23 53.17 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.956 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 5.4 pt20 -57.99 -26.9 62.97 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.266 170.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 44.1 mm-40 -72.95 -48.03 40.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 39.7 mt -66.33 -48.0 71.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.741 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.61 HG23 HD12 ' A' ' 17' ' ' ILE . 26.5 mm -62.04 -47.14 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.162 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -55.67 -47.25 77.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 123.253 0.345 . . . . 0.0 111.795 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.07 -46.81 78.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.008 0.432 . . . . 0.0 109.922 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.603 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 89.7 m -68.45 -54.69 15.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.164 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.577 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.66 -49.93 74.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.992 -174.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.86 -41.24 82.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.43 -24.5 61.23 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.423 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.533 ' HE2' HG23 ' A' ' 103' ' ' THR . 35.5 m-85 -88.53 -41.7 12.55 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.688 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 108' ' ' LYS . 9.5 mmpt? -72.99 -156.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.56 0.695 . . . . 0.0 109.849 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.7 t -82.22 -146.27 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.722 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -79.93 44.68 0.67 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.33 0.586 . . . . 0.0 109.467 169.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.489 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 50.5 mm-40 -73.63 135.02 78.49 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.311 -172.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.95 42.86 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.69 2.927 . . . . 0.0 114.188 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 123.672 0.789 . . . . 0.0 112.935 179.465 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 m -62.63 123.74 19.16 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.6 t -72.97 46.4 0.17 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.44 0.638 . . . . 0.0 111.918 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 8' ' ' ILE . 10.2 t -168.03 -46.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.855 -0.528 . . . . 0.0 111.088 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 48.2 mt -58.02 -40.27 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 118.005 0.366 . . . . 0.0 111.647 176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.37 -44.3 84.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.27 -47.34 77.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.162 174.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.743 HD13 HD22 ' A' ' 62' ' ' LEU . 84.4 mt -57.8 -44.63 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.249 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.403 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 33.7 mt-30 -61.87 -40.38 95.16 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.594 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.2 mmp_? -60.86 -36.47 79.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 73.5 mt-30 -71.79 -45.12 62.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.415 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.817 HG22 ' HA2' ' A' ' 78' ' ' GLY . 27.2 mt -63.4 -44.28 98.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.095 0.474 . . . . 0.0 110.107 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.14 96.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 11.9 pt-20 -69.23 -37.48 78.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.694 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.33 126.42 86.45 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 121.315 0.579 . . . . 0.0 110.615 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.531 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.5 Cg_exo -62.1 -42.22 31.0 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 112.82 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.3 mm -136.75 119.48 20.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 18.0 tp -132.8 139.95 47.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.345 -170.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.4 tp -136.39 122.98 20.95 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.02 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.744 ' CE2' HD21 ' A' ' 62' ' ' LEU . 6.0 m-85 -98.95 118.06 34.87 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.491 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.9 ptt? -145.99 -166.18 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.662 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.056 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.9 tttt -99.61 118.48 36.24 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.467 -0.771 . . . . 0.0 110.079 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.93 68.46 1.02 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.096 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.4 m -77.71 139.24 62.47 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -53.68 -41.28 75.32 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.086 1.857 . . . . 0.0 111.724 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.87 -35.67 81.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.881 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -154.93 111.38 2.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.463 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 39.0 Cg_endo -74.41 32.29 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.654 2.236 . . . . 0.0 113.868 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -165.07 46.52 0.09 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.163 0.506 . . . . 0.0 110.132 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.759 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 37.5 t -71.65 66.97 0.54 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.158 -173.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.91 -140.81 3.08 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -76.91 -33.79 57.75 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.145 0.498 . . . . 0.0 110.699 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.856 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 15.1 p -49.88 -21.06 1.03 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.592 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.18 -42.73 30.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.409 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.47 -34.94 35.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.233 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.46 -43.08 73.98 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.489 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 7.9 p -53.38 -37.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.108 0.48 . . . . 0.0 110.729 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -63.13 -46.18 88.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.842 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.9 -44.41 97.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.876 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -60.65 -55.48 32.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 109.675 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.75 70.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.476 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.93 -48.34 46.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.727 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.3 m -68.62 -57.42 5.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.83 -147.59 20.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.452 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.0 mm-40 -100.36 -153.58 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.53 0.681 . . . . 0.0 111.184 174.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.487 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.05 154.16 42.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.872 177.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 19' ' ' LEU . 17.4 p90 -145.97 158.89 43.86 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.006 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.57 146.34 25.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -137.72 149.16 46.26 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.501 HG23 HD11 ' A' ' 18' ' ' LEU . 52.9 t -122.63 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' MET . 10.5 p-10 -74.11 130.33 39.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.081 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.641 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -146.68 -34.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.651 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.056 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -63.4 -13.2 37.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.518 171.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 19.7 tm0? -96.47 -45.44 6.76 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.347 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -76.31 116.02 52.38 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.953 0.342 . . . . 0.0 110.742 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 50.1 Cg_exo -59.74 -45.18 26.4 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.0 2.467 . . . . 0.0 113.608 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.41 -54.33 14.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.507 0.67 . . . . 0.0 111.126 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.569 HG22 HD23 ' A' ' 62' ' ' LEU . 36.2 mt -63.6 -35.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.2 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.721 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 61.9 ttt-85 -57.61 -33.36 68.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.095 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -90.62 -52.68 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.62 -54.63 5.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -168.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.754 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -55.22 -44.39 99.6 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.721 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 22.1 Cg_endo -58.13 -41.74 64.4 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 121.465 1.444 . . . . 0.0 111.447 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.6 mtmp? -61.1 -32.37 72.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.751 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.544 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -63.15 -43.2 99.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.818 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -78.16 -57.66 3.67 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.404 -0.918 . . . . 0.0 112.389 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.507 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 41.5 t30 -174.73 -54.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.784 0.802 . . . . 0.0 110.323 168.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -55.6 148.58 34.3 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.835 -1.53 . . . . 0.0 113.274 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -61.62 -38.96 57.84 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.461 2.107 . . . . 0.0 110.459 172.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -143.06 -127.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.253 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.967 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 47.8 m-85 -138.15 -170.99 0.25 Allowed Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.967 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.6 Cg_endo -67.17 155.57 84.83 Favored 'Cis proline' 0 C--N 1.352 0.757 0 CA-C-N 121.132 1.44 . . . . 0.0 114.613 -0.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.487 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 59.3 mt-30 -147.51 132.66 18.33 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.429 173.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.85 138.56 33.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.987 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.526 ' N ' HD13 ' A' ' 74' ' ' LEU . 55.9 m95 -125.06 127.47 46.99 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.18 0.514 . . . . 0.0 110.73 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 100' ' ' ILE . 65.4 t -111.61 121.16 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 176.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 57.15 29.12 16.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.507 1.622 . . . . 0.0 108.691 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.817 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.41 29.11 64.52 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 113.6 -1.637 . . . . 0.0 113.152 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.57 132.15 51.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 110.807 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.818 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.0 tp -65.71 132.42 48.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.801 -172.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.489 ' O ' HG21 ' A' ' 86' ' ' ILE . 78.1 t -110.49 -53.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.199 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 142.19 135.11 3.05 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.36 -62.25 1.66 Allowed Glycine 0 C--O 1.223 -0.584 0 C-N-CA 119.525 -1.322 . . . . 0.0 116.232 -168.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -78.01 -70.76 0.46 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -168.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -80.19 -40.59 26.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.489 HG21 ' O ' ' A' ' 81' ' ' VAL . 48.3 mm -55.9 -45.64 79.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.265 -174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.495 HG13 HD11 ' A' ' 96' ' ' LEU . 86.0 t -59.26 -49.24 84.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.206 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 39' ' ' ALA . 39.6 mm -60.28 -48.79 86.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.456 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.751 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 40.0 tt0 -61.63 -53.28 58.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.69 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.579 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 80.8 mtp -62.64 -30.61 71.49 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.787 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 14.1 t80 -57.34 -52.24 66.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.69 170.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -63.55 -40.59 97.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.101 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 46.3 mmm-85 -59.62 -33.95 72.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.363 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 90.28 -24.66 15.31 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.286 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 91.0 mt-10 -60.07 -29.78 68.79 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 6.5 tt -61.74 -54.5 41.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.071 0.463 . . . . 0.0 110.208 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.864 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.1 pt20 -63.86 -26.58 68.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.775 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 90.9 mm-40 -62.9 -44.82 95.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 24.5 mt -69.9 -46.83 64.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.178 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.523 HG22 ' OD2' ' A' ' 113' ' ' ASP . 47.7 mm -60.62 -46.31 95.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.679 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.923 ' HD3' ' H ' ' A' ' 115' ' ' GLU . 38.7 ttpt -55.54 -53.59 54.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.193 0.308 . . . . 0.0 111.424 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 37.8 tt0 -63.85 -44.48 93.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.119 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.449 ' O ' ' HD2' ' A' ' 107' ' ' TYR . 61.9 m -63.29 -47.14 83.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.645 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.639 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.11 -45.15 94.74 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.389 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.2 95.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.551 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -70.31 -33.19 71.23 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.841 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.457 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 58.0 m-85 -78.68 -47.29 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.639 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -100.38 -147.32 0.35 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 51.6 p -74.45 -155.62 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.969 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.3 57.16 0.87 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.809 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.31 114.18 6.77 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.158 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -95.59 47.31 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 122.699 2.266 . . . . 0.0 112.919 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.523 ' OD2' HG22 ' A' ' 100' ' ' ILE . 7.6 m-20 -52.35 -66.64 0.35 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.143 -168.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.686 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -77.97 -52.19 9.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.305 0.574 . . . . 0.0 110.682 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.923 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 39.6 tt0 . . . . . 0 C--O 1.253 1.289 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.971 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtm . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p -168.01 138.37 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.945 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -72.4 125.05 26.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.808 ' HB ' ' HG2' ' A' ' 6' ' ' GLU . 41.0 p -73.3 131.0 41.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.068 0.461 . . . . 0.0 111.134 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' A' ' 65' ' ' TYR . 33.5 mt -60.11 -32.16 49.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.249 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.808 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 10.8 pt-20 -53.3 -44.51 68.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.336 176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.1 ptmt -76.05 -38.41 57.17 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.659 HD13 ' HB3' ' A' ' 62' ' ' LEU . 75.1 mt -58.63 -46.9 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.914 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.551 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 34.2 mt-30 -62.3 -40.48 96.44 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.76 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -60.39 -35.56 76.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.79 0.329 . . . . 0.0 110.668 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.94 -44.35 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.774 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.774 HG23 HD23 ' A' ' 18' ' ' LEU . 28.9 mt -67.23 -47.34 81.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -59.42 -39.35 83.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.85 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.79 -30.63 70.12 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.946 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 32.8 m120 -76.31 126.77 86.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.069 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.608 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.7 Cg_exo -61.92 -42.95 27.68 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.849 2.366 . . . . 0.0 112.431 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 16' ' ' PRO . 27.2 mm -137.37 121.1 22.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 12' ' ' ILE . 24.5 tp -133.04 141.21 48.12 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.64 -170.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.8 tp -137.39 119.0 14.93 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.986 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.607 ' CE2' HD11 ' A' ' 62' ' ' LEU . 6.8 m-85 -96.51 119.6 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.036 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.685 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 23.2 ptt? -145.92 -166.99 2.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.417 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 86.9 tttt -95.76 90.04 5.52 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -91.84 67.69 2.1 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.463 -170.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -77.87 146.55 72.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.366 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.76 -39.78 89.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.995 1.797 . . . . 0.0 111.066 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.57 -34.36 77.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.617 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 30' ' ' CYS . 1.8 tt -161.42 112.59 1.24 Allowed Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.522 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -69.56 14.3 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.807 2.338 . . . . 0.0 114.11 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.685 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 24.8 p -163.21 47.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.31 0.576 . . . . 0.0 110.613 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.677 ' HA ' HD13 ' A' ' 27' ' ' LEU . 48.0 t -56.46 -40.63 75.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.658 -173.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.644 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.33 -134.48 0.13 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.237 -0.506 . . . . 0.0 114.275 -175.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 41.6 m-85 -74.23 -18.01 60.81 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 121.057 0.456 . . . . 0.0 111.872 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 21' ' ' MET . 8.4 p -63.78 -19.5 65.04 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.9 -42.84 13.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -78.85 -38.88 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.299 0.571 . . . . 0.0 110.198 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.03 88.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.909 -175.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 9.3 p -55.23 -39.18 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.523 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 30.0 mm-40 -67.02 -48.71 67.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -58.29 -45.12 88.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.89 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.3 tt -61.18 -55.38 32.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.232 0.539 . . . . 0.0 110.197 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.02 -32.35 71.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.175 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -47.52 59.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.664 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.3 p -77.16 -51.44 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.846 0.355 . . . . 0.0 111.098 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.78 -134.68 8.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.831 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.25 -152.12 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.561 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' ARG . 36.8 mmt180 -64.8 150.42 47.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.543 0.687 . . . . 0.0 112.777 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.502 ' CD2' HD13 ' A' ' 40' ' ' LEU . 16.5 p90 -149.4 157.35 43.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.732 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.25 146.94 25.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -137.7 153.36 49.79 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.543 HG23 HD11 ' A' ' 18' ' ' LEU . 52.4 t -130.18 129.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.533 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -74.62 135.2 42.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.662 HD12 HD22 ' A' ' 53' ' ' LEU . 1.1 pp -151.63 -37.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.522 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -64.39 -11.44 32.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.726 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tm0? -95.57 -41.77 8.76 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.504 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.568 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 74.7 m-20 -76.76 131.64 73.32 Favored Pre-proline 0 N--CA 1.473 0.712 0 O-C-N 122.241 -0.287 . . . . 0.0 110.376 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 16.6 Cg_exo -68.3 -44.45 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.468 2.112 . . . . 0.0 112.421 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.589 ' OD1' HG13 ' A' ' 58' ' ' ILE . 1.3 p30 -77.78 -56.0 4.87 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.589 HG13 ' OD1' ' A' ' 57' ' ' ASP . 48.7 mt -60.42 -32.88 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.45 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.572 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 80.0 ttt180 -51.63 -36.25 45.17 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.222 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.39 -44.64 11.89 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -77.32 -60.23 2.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -160.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.733 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.0 pt? -69.14 -31.81 2.95 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 14.1 Cg_endo -54.93 -41.36 79.37 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.533 1.489 . . . . 0.0 110.509 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.64 -39.4 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.494 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.564 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.83 -42.48 70.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.038 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.827 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.69 -57.99 3.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.484 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.715 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.9 t-20 -175.89 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 122.102 0.953 . . . . 0.0 109.407 169.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.715 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -57.32 148.53 52.95 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.209 -1.814 . . . . 0.0 113.328 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -62.85 -35.98 64.27 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.279 1.986 . . . . 0.0 110.314 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 p -143.19 -128.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.036 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.97 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.8 m-85 -139.09 -167.85 0.17 Allowed Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.97 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 48.4 Cg_endo -67.42 151.12 84.17 Favored 'Cis proline' 0 C--N 1.359 1.091 0 CA-C-N 121.318 1.507 . . . . 0.0 114.006 -1.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 19.3 mt-30 -139.15 132.57 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.188 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -95.75 137.23 35.11 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 67.9 m95 -122.99 132.48 54.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 110.92 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.904 HG21 HD13 ' A' ' 99' ' ' LEU . 58.0 t -118.54 119.73 62.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.483 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.534 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 33.3 t70 56.68 25.53 10.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.857 1.313 . . . . 0.0 110.02 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.614 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.49 28.4 47.99 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.135 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.11 135.58 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.996 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.827 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.1 tp -70.97 129.16 38.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.261 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.568 HG12 ' CG2' ' A' ' 86' ' ' ILE . 98.5 t -105.62 -54.74 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.824 170.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 141.01 133.4 2.93 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -86.11 -64.84 1.45 Allowed Glycine 0 C--O 1.217 -0.907 0 C-N-CA 119.046 -1.549 . . . . 0.0 116.436 -167.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.4 p -78.94 -59.61 2.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.21 1.005 . . . . 0.0 113.031 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.3 -46.11 21.0 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 120.886 0.374 . . . . 0.0 111.0 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.568 ' CG2' HG12 ' A' ' 81' ' ' VAL . 46.0 mm -63.4 -42.69 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.73 -171.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.6 t -59.5 -48.35 87.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.141 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.5 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.1 mm -59.03 -49.01 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.759 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 39.7 tt0 -61.61 -54.49 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.679 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.617 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -56.21 -36.27 68.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.536 0.208 . . . . 0.0 111.412 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.579 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.0 t80 -59.6 -50.85 72.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.062 174.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.6 mt-30 -66.01 -44.02 85.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.9 mmm-85 -58.93 -33.71 70.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.695 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.23 21.67 64.54 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.567 -1.197 . . . . 0.0 112.152 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.3 mt-10 -88.35 -29.4 20.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.379 0.609 . . . . 0.0 110.851 173.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 60.3 tp -62.16 -55.0 33.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.048 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.999 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 16.3 pt20 -59.22 -26.26 64.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.632 174.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.695 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.1 mm-40 -68.81 -55.14 12.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.801 0.334 . . . . 0.0 111.404 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.904 HD13 HG21 ' A' ' 76' ' ' VAL . 2.3 pp -71.19 -36.09 71.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.044 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 99' ' ' LEU . 46.2 mm -62.31 -44.67 99.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 113' ' ' ASP . 21.9 ttmt -49.29 -57.6 6.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.51 0.672 . . . . 0.0 111.793 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 88.2 tt0 -62.15 -46.09 90.55 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.528 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 86.6 m -67.22 -49.73 63.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.97 89.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.581 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.73 91.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -67.3 -26.79 66.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.79 -177.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.526 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 37.8 m-85 -79.19 -46.61 17.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.204 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.418 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 48.0 mtmt -91.94 -158.27 0.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.308 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 p -84.84 55.25 3.37 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.353 1.073 . . . . 0.0 112.015 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 53.86 47.23 24.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.319 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 40.0 mm-40 -62.44 136.34 95.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.585 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.39 132.25 20.41 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.084 2.523 . . . . 0.0 112.401 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 10.9 t70 -120.69 -104.96 0.39 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.672 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.999 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -64.25 -33.03 74.87 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.481 0.658 . . . . 0.0 110.182 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.861 -172.798 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ppp? . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 p -79.12 -125.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.614 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.0 m 74.17 -24.18 0.21 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.772 0.429 . . . . 0.0 112.062 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 8' ' ' ILE . 31.7 m -51.57 -49.6 61.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.542 0.337 . . . . 0.0 111.32 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 65.1 mt -60.43 -37.46 74.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 52.6 mm-40 -53.96 -47.62 71.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -67.12 -43.93 81.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.283 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.694 HG21 HD13 ' A' ' 62' ' ' LEU . 81.4 mt -59.23 -44.48 92.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.404 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 33.9 mt-30 -61.34 -43.46 98.83 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.486 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.3 mmp_? -61.15 -35.84 78.17 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -68.08 -45.75 72.92 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.655 HG23 HD23 ' A' ' 18' ' ' LEU . 41.3 mt -63.55 -41.14 91.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.918 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -34.27 71.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.347 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 72.8 mt-10 -59.84 -50.42 73.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.898 0.38 . . . . 0.0 111.07 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -79.33 128.81 74.3 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.111 -171.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' O ' HD13 ' A' ' 17' ' ' ILE . 50.8 Cg_exo -59.05 -42.6 49.86 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 123.144 2.563 . . . . 0.0 112.03 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.6 mm -133.88 122.64 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.655 HD23 HG23 ' A' ' 12' ' ' ILE . 20.8 tp -133.87 141.7 47.49 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.2 -171.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.4 tp -136.61 119.87 16.75 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.096 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.702 ' CE2' HD21 ' A' ' 62' ' ' LEU . 6.2 m-85 -98.26 119.33 36.74 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.795 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 23.0 ptt? -146.19 -166.81 2.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.206 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 84.4 tttt -96.57 144.74 26.35 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.66 121.2 3.55 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.508 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.579 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 41.5 t -132.93 144.87 54.66 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.59 -39.89 86.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.475 2.117 . . . . 0.0 111.277 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -68.43 -34.34 75.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.496 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.09 117.56 1.87 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -74.99 26.3 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.5 2.134 . . . . 0.0 114.434 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.1 p -164.33 49.86 0.12 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.529 0.681 . . . . 0.0 111.448 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.653 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 1.6 p -67.06 61.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.426 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.81 -138.69 2.57 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.516 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 42.9 m-85 -76.9 -19.86 56.92 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 25.8 p -69.52 -15.2 63.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -46.95 -42.12 17.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -78.74 -40.87 32.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.085 0.469 . . . . 0.0 110.438 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.84 97.99 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.922 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.4 p -55.8 -38.49 51.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.583 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 28.9 mm-40 -68.13 -46.01 72.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.367 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.36 -45.41 88.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -63.42 -55.43 24.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.164 0.507 . . . . 0.0 110.364 -175.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.34 70.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.05 -48.63 57.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.312 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.759 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -73.3 -58.17 3.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.05 -143.31 13.79 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.465 -0.874 . . . . 0.0 114.164 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.673 ' OE2' ' HB3' ' A' ' 111' ' ' GLU . 51.8 mt-10 -97.37 -154.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.437 0.637 . . . . 0.0 111.337 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -66.88 153.3 43.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.164 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 24.4 p90 -147.67 153.43 39.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.3 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.21 144.85 27.22 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -132.67 153.27 51.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG23 HD11 ' A' ' 18' ' ' LEU . 58.3 t -128.35 129.73 69.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' MET . 43.2 p-10 -75.34 135.64 40.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.63 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.773 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 1.1 pp -149.68 -37.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.76 -11.05 23.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.613 170.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -94.8 -40.56 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.073 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.773 ' ND2' ' HA ' ' A' ' 52' ' ' ILE . 19.8 p30 -80.23 140.85 53.14 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 121.389 0.614 . . . . 0.0 111.428 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.23 -41.79 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.995 1.797 . . . . 0.0 112.524 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -78.74 -55.84 4.86 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -170.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.552 HG22 HD23 ' A' ' 62' ' ' LEU . 51.3 mt -62.9 -39.1 83.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.392 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.1 ttt180 -53.93 -34.72 60.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.048 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.17 -54.16 5.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 64' ' ' LYS . 42.1 mt-10 -79.84 -51.36 9.24 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.802 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -58.07 -43.29 98.29 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -171.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.594 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 21.2 Cg_endo -57.76 -38.71 92.0 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 121.631 1.554 . . . . 0.0 111.197 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 61' ' ' GLU . 5.0 mtpm? -55.09 -39.48 69.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.04 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.563 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.79 -41.62 91.76 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.133 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.77 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -80.72 -56.93 3.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.97 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.73 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -174.99 -55.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.319 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.73 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.27 151.36 58.89 Favored Pre-proline 0 C--O 1.222 -0.365 0 CA-C-N 113.646 -1.615 . . . . 0.0 113.72 -175.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.21 -39.21 39.84 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.318 2.012 . . . . 0.0 110.336 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.552 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 67.9 p -142.44 -124.38 0.09 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.66 172.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.984 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 24.1 m-85 -138.67 -168.26 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.984 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 41.6 Cg_endo -67.4 155.34 85.75 Favored 'Cis proline' 0 C--N 1.361 1.228 0 CA-C-N 121.235 1.477 . . . . 0.0 114.466 -1.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.726 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 18.8 mt-30 -143.6 133.07 23.44 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.507 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.8 137.42 34.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.998 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.524 ' N ' HD13 ' A' ' 74' ' ' LEU . 61.4 m95 -122.66 129.3 51.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.283 0.563 . . . . 0.0 110.805 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.914 HG21 HD13 ' A' ' 99' ' ' LEU . 48.7 t -115.16 119.96 63.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.3 t70 56.22 30.33 16.39 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 123.563 1.649 . . . . 0.0 108.812 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.605 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 74.53 29.06 62.28 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.381 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 49.5 mt-10 -125.37 133.71 52.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.383 . . . . 0.0 110.782 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.77 HD22 ' HB1' ' A' ' 66' ' ' ALA . 55.4 tp -71.05 130.95 42.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.609 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.534 HG12 ' CG2' ' A' ' 86' ' ' ILE . 99.3 t -110.37 -52.05 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.199 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 145.64 134.92 2.75 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.484 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.47 -64.63 1.56 Allowed Glycine 0 C--O 1.218 -0.897 0 C-N-CA 118.751 -1.69 . . . . 0.0 116.526 -166.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.516 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 25.1 p -80.62 -69.04 0.63 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.285 1.042 . . . . 0.0 112.824 -170.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 40.5 m-20 -74.42 -43.7 55.12 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.263 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 81' ' ' VAL . 50.7 mm -58.54 -45.31 90.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.937 -174.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 39' ' ' ALA . 74.5 t -57.44 -48.01 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.185 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 39' ' ' ALA . 44.0 mm -60.29 -51.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.973 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.7 tt0 -62.19 -50.17 72.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.795 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.4 mmt -57.81 -39.73 78.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.843 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 13.3 t80 -60.15 -49.14 78.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.805 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.3 mt-30 -65.5 -40.09 92.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.83 0.348 . . . . 0.0 110.168 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.7 mmm-85 -57.82 -33.24 68.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.143 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.22 21.64 64.62 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.602 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 93.0 mt-10 -99.06 -13.85 19.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 0.0 111.543 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.661 HD12 HD11 ' A' ' 99' ' ' LEU . 55.7 tp -72.12 -53.06 13.89 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 4.2 pm0 -56.31 -25.66 49.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.703 170.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 11.7 mm-40 -71.17 -50.52 32.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.845 0.355 . . . . 0.0 111.58 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.914 HD13 HG21 ' A' ' 76' ' ' VAL . 2.6 pp -74.59 -36.22 63.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 99' ' ' LEU . 42.6 mm -63.63 -42.11 94.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 173.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 21.8 ttmm -52.42 -56.24 16.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.303 0.573 . . . . 0.0 111.25 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -57.3 -48.61 78.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.924 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.8 m -69.4 -47.95 62.58 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.615 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -61.22 -47.93 83.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.005 0.431 . . . . 0.0 110.307 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.69 95.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -68.92 -29.76 68.09 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.11 -0.369 . . . . 0.0 111.863 -178.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.523 ' HE2' HG23 ' A' ' 103' ' ' THR . 52.8 m-85 -78.78 -46.6 18.46 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.245 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.615 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.68 -160.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.681 174.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.7 p -84.73 -140.1 0.07 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.953 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.77 45.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.959 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.673 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . 5.0 mm-40 -70.81 130.58 88.4 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.996 0.427 . . . . 0.0 111.373 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 1.5 Cg_endo -82.98 116.42 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.837 2.358 . . . . 0.0 112.318 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD2' HG22 ' A' ' 100' ' ' ILE . 12.9 t70 -84.01 -124.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.856 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -61.18 -42.7 99.04 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.362 0.601 . . . . 0.0 110.299 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 117.539 -1.22 . . . . 0.0 108.046 175.738 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.176 0.036 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 m 70.82 -41.42 0.5 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.565 0.746 . . . . 0.0 112.042 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.9 p -57.09 135.73 56.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.341 0.591 . . . . 0.0 112.456 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.4 m -62.48 -25.55 68.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.212 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.975 HG22 ' HG3' ' A' ' 9' ' ' GLN . 22.4 mm -53.88 -34.77 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.878 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 70.6 mm-40 -44.69 -45.79 9.94 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -62.16 -43.76 98.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.074 0.464 . . . . 0.0 110.93 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 62' ' ' LEU . 73.0 mt -68.3 -40.55 82.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.626 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.975 ' HG3' HG22 ' A' ' 5' ' ' ILE . 36.3 mt-30 -58.54 -44.2 89.51 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -55.54 -34.73 64.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.268 175.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.645 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 16.9 tt0 -68.44 -48.41 64.66 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.431 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.551 HG22 ' HA2' ' A' ' 78' ' ' GLY . 21.0 mt -68.32 -39.24 80.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.77 0.795 . . . . 0.0 110.472 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.46 81.0 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.839 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.1 pt-20 -70.03 -39.28 75.86 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -173.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 2.7 p30 -79.22 134.96 58.35 Favored Pre-proline 0 CA--C 1.518 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 112.737 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.524 ' O ' HD13 ' A' ' 17' ' ' ILE . 32.7 Cg_exo -64.24 -41.73 20.5 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 123.165 2.576 . . . . 0.0 111.648 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 16' ' ' PRO . 24.1 mm -138.52 121.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.757 HD11 HG23 ' A' ' 50' ' ' VAL . 25.6 tp -132.43 141.25 48.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.232 0.539 . . . . 0.0 111.959 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.5 tp -132.34 120.67 22.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.791 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.793 ' CE2' HD21 ' A' ' 62' ' ' LEU . 7.5 m-85 -99.53 120.99 40.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.703 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.527 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -148.1 -154.05 0.53 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.755 ' HD3' ' HB3' ' A' ' 30' ' ' CYS . 64.6 tttm -100.7 112.01 24.34 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.43 69.5 1.06 Allowed Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.674 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -78.85 143.97 63.26 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.198 . . . . 0.0 111.068 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.04 -40.23 85.38 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.119 1.879 . . . . 0.0 110.94 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -65.27 -33.09 75.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.765 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -160.46 116.67 1.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.511 ' O ' ' SD ' ' A' ' 21' ' ' MET . 9.3 Cg_exo -72.94 31.43 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.738 2.292 . . . . 0.0 113.984 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -169.61 51.82 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.454 0.702 . . . . 0.0 110.241 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.755 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.8 t -56.37 -37.07 69.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.554 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -70.5 -135.82 0.11 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.5 -36.4 57.81 Favored 'General case' 0 C--O 1.219 -0.529 0 O-C-N 122.353 -0.498 . . . . 0.0 111.943 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.486 ' CB ' ' HB3' ' A' ' 21' ' ' MET . 34.6 t -54.01 -10.39 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.41 -42.32 42.2 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.083 0.24 . . . . 0.0 111.325 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.56 -34.85 35.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.234 177.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.26 -42.75 83.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.304 -175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.527 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.54 -37.41 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.305 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -64.81 -46.08 83.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.306 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.65 -43.95 93.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.618 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -64.12 -57.88 8.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.618 -174.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.41 ' HB2' ' HE2' ' A' ' 47' ' ' PHE . . . -59.56 -34.41 72.65 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.271 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.52 -48.84 59.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.681 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.5 p -72.81 -54.25 9.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.795 -173.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.774 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.38 -142.45 12.75 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.451 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 17.1 pt-20 -99.95 -154.68 0.48 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.52 . . . . 0.0 111.082 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.79 158.68 33.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.991 170.36 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.527 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 15.5 p90 -152.96 159.73 42.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.297 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.54 151.98 19.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.475 ' HD1' ' HE2' ' A' ' 21' ' ' MET . 2.0 p90 -138.05 151.59 48.0 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.757 HG23 HD11 ' A' ' 18' ' ' LEU . 46.2 t -132.3 126.78 56.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.61 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.8 p30 -76.59 131.39 38.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.277 0.56 . . . . 0.0 110.73 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.681 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -143.5 -33.93 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.709 -174.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 52' ' ' ILE . 1.6 mm? -65.74 -9.47 28.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.142 166.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -96.87 -46.82 6.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.236 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -83.44 116.57 65.16 Favored Pre-proline 0 N--CA 1.476 0.842 0 O-C-N 122.059 -0.401 . . . . 0.0 111.025 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.93 -44.81 18.78 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.792 2.328 . . . . 0.0 113.248 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -61.5 -55.07 35.16 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.443 0.64 . . . . 0.0 111.341 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.457 HG22 HD23 ' A' ' 62' ' ' LEU . 41.9 mt -67.34 -36.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.365 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.3 ttt180 -56.98 -33.68 67.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.72 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.51 7.33 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.749 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 55.3 mm-40 -84.7 -51.05 7.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -167.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.793 HD21 ' CE2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -60.09 -41.67 85.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -172.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.626 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 32.4 Cg_endo -59.52 -39.28 76.95 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 C-N-CA 121.282 1.321 . . . . 0.0 111.168 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 37.9 mtmt -55.55 -41.75 73.68 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.219 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.666 ' HD2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -63.32 -44.89 93.64 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.111 -176.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.816 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.1 -56.11 5.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.462 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.738 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.5 t-20 -174.82 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.188 0.994 . . . . 0.0 110.006 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.738 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.12 148.25 62.31 Favored Pre-proline 0 C--O 1.219 -0.542 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.365 -175.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.77 -37.36 68.1 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 121.912 1.741 . . . . 0.0 110.437 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 37.2 p -143.07 -128.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.58 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.6 m-85 -137.11 -169.7 0.22 Allowed Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.968 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.55 153.39 82.59 Favored 'Cis proline' 0 C--N 1.361 1.22 0 CA-C-N 121.374 1.527 . . . . 0.0 114.14 -0.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.549 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 30.5 mt-30 -142.28 135.45 28.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.298 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.2 tm? -99.3 133.71 43.2 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 59.4 m95 -116.9 131.33 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.314 0.578 . . . . 0.0 110.863 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.827 HG21 HD13 ' A' ' 99' ' ' LEU . 86.4 t -121.67 122.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' HB2' HG23 ' A' ' 103' ' ' THR . 37.3 t70 58.22 30.12 18.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.811 1.291 . . . . 0.0 109.332 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.68 28.77 66.62 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.16 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -137.04 137.56 39.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 111.479 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.816 HD22 ' HB1' ' A' ' 66' ' ' ALA . 46.3 tp -66.96 132.48 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.229 -172.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.572 HG12 ' CG2' ' A' ' 86' ' ' ILE . 76.1 t -110.32 -54.65 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.921 171.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.63 134.49 2.7 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.87 -62.39 1.69 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -168.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.1 p -78.67 -68.12 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.701 -0.882 . . . . 0.0 112.992 -170.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.94 -47.65 43.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.031 0.444 . . . . 0.0 111.008 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.572 ' CG2' HG12 ' A' ' 81' ' ' VAL . 44.4 mm -59.95 -46.82 93.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.754 -170.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -56.11 -50.33 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.361 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 39' ' ' ALA . 36.7 mm -61.94 -50.66 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.631 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.781 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.3 tt0 -63.25 -50.48 70.02 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.422 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.463 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.3 mmt -57.54 -38.02 74.02 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.0 t80 -58.02 -51.64 68.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.149 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.0 mt-30 -63.93 -39.85 95.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.649 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.781 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 25.9 mmm180 -63.6 -33.89 76.6 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.821 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 99.59 -24.09 33.58 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.34 -170.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 5.1 mm-40 -52.14 -36.14 50.52 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.61 HD12 HD11 ' A' ' 99' ' ' LEU . 53.3 tp -64.77 -54.99 22.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.68 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.5 pt20 -61.18 -26.47 67.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.405 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 10.4 mm100 -66.81 -54.54 21.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.633 0.254 . . . . 0.0 111.407 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 HG21 ' A' ' 76' ' ' VAL . 3.0 pp -70.28 -35.26 73.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.558 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 99' ' ' LEU . 35.7 mm -62.97 -48.6 87.22 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -55.62 -52.22 64.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 111.753 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -57.1 -45.32 83.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.949 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 77' ' ' ASP . 91.1 m -68.0 -47.97 67.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.417 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.06 99.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.025 0.441 . . . . 0.0 110.06 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.65 99.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -72.14 -33.6 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.643 -178.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.465 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 80.0 m-85 -79.57 -46.69 16.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.767 173.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.636 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -89.58 -149.91 0.2 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.184 -177.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 25.3 t -82.84 -148.36 0.08 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.331 170.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -75.11 54.3 0.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.877 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 38.5 mm-40 -66.11 117.56 44.07 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 121.178 0.514 . . . . 0.0 110.398 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -99.7 49.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.598 2.865 . . . . 0.0 113.233 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.774 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 36.4 m-20 -50.31 -61.23 2.29 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.62 -53.62 6.67 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.016 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.136 -175.236 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 111.482 0.178 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -59.31 136.65 58.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.101 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 4' ' ' THR . 68.5 p 53.09 -121.48 1.88 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.166 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 3' ' ' THR . 58.5 m 75.18 132.5 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.4 0.619 . . . . 0.0 110.82 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.423 HD13 ' CB ' ' A' ' 65' ' ' TYR . 73.3 mt -53.75 -37.48 32.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.6 -175.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -53.38 -47.29 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.982 0.42 . . . . 0.0 110.725 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.951 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -68.43 -45.35 72.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.56 175.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.63 HG21 HD22 ' A' ' 62' ' ' LEU . 82.6 mt -56.69 -44.2 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -60.35 -35.84 76.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.831 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -60.23 -35.68 76.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.494 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -72.36 -42.11 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.542 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.649 HG23 HD23 ' A' ' 18' ' ' LEU . 19.6 mt -68.39 -45.66 81.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.119 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -37.81 78.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.169 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.2 pt-20 -68.57 -34.8 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -78.55 127.57 80.15 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-O 120.901 0.381 . . . . 0.0 111.273 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.611 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.7 Cg_exo -61.8 -42.84 29.05 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.019 2.48 . . . . 0.0 112.333 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 16' ' ' PRO . 32.1 mm -137.47 120.95 21.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD23 HG23 ' A' ' 12' ' ' ILE . 21.5 tp -133.41 142.43 48.34 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.466 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.3 tp -136.32 120.28 17.55 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.12 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.769 ' CE2' HD21 ' A' ' 62' ' ' LEU . 5.5 m-85 -97.35 117.92 32.66 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.848 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.532 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 21.6 ptt? -146.84 -164.89 2.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.4 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.948 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 61.9 tttm -98.34 103.16 15.08 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.24 67.0 1.76 Allowed Glycine 0 C--N 1.309 -0.926 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.437 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 t -76.07 141.3 70.85 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.6 -41.42 45.11 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.253 1.969 . . . . 0.0 112.188 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -65.14 -35.62 81.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.844 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -158.57 118.99 1.84 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -172.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.552 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.1 Cg_exo -71.99 20.37 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.798 2.332 . . . . 0.0 114.303 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.7 p -161.97 52.35 0.23 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.517 0.675 . . . . 0.0 111.037 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 43.4 t -71.54 56.24 0.25 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.126 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.23 -136.53 2.02 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.695 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 28.2 m-85 -76.25 -38.28 56.48 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 117.481 0.64 . . . . 0.0 109.518 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 35.1 p -46.4 -24.58 0.52 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.195 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.99 -42.2 48.6 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.555 0.216 . . . . 0.0 111.097 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' O ' ' A' ' 32' ' ' PHE . 1.8 pp0? -77.41 -37.94 50.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 10.6 p -57.53 -38.98 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 29.3 mm-40 -65.42 -41.92 93.07 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.924 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.1 -43.33 95.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.604 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.08 -56.0 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 0.0 109.908 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.35 72.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.885 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.6 m -70.41 -60.36 2.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.33 -138.91 9.57 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -115.09 -151.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.621 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -59.38 152.68 20.73 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.628 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.51 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 26.1 p90 -155.64 154.16 31.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.057 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 151.71 20.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.947 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.3 p90 -135.72 153.91 51.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.648 HG23 HD11 ' A' ' 18' ' ' LEU . 61.6 t -131.43 134.51 60.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.651 ' OD1' ' HB3' ' A' ' 54' ' ' GLN . 7.9 t70 -73.13 138.89 46.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.185 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.1 pp -152.0 -35.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.387 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.948 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -65.25 -18.0 64.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.387 174.251 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.651 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 12.7 tm0? -94.94 -43.23 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.616 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -71.51 118.55 67.27 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 117.797 0.271 . . . . 0.0 110.503 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.81 -43.98 8.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.313 2.009 . . . . 0.0 113.029 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -69.25 -52.79 24.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.85 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.568 HG22 HD23 ' A' ' 62' ' ' LEU . 19.8 mt -65.12 -36.53 78.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.391 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.2 tmm_? -56.32 -37.93 70.61 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.73 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.609 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -80.43 -50.99 9.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.596 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 4.9 mm-40 -79.18 -53.51 6.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -167.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -62.53 -40.69 67.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.63 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 27.5 Cg_endo -59.44 -40.74 64.25 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 121.378 1.385 . . . . 0.0 111.468 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 51.6 mtmt -56.28 -36.06 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.556 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.557 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.81 -43.23 80.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.534 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.781 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.81 -56.26 4.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.434 -174.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.765 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -175.47 -53.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.253 1.025 . . . . 0.0 109.362 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.765 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.73 150.64 57.18 Favored Pre-proline 0 C--O 1.218 -0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 113.484 -176.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 68' ' ' TRP . 10.3 Cg_exo -64.1 -39.12 32.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.211 1.941 . . . . 0.0 110.113 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.5 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 47.6 p -143.12 -129.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.728 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 1.011 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.4 m-85 -137.86 -171.85 0.29 Allowed Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.528 -0.733 . . . . 0.0 109.141 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.011 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.57 156.07 82.31 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 120.933 1.369 . . . . 0.0 114.469 -0.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.678 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.9 mt-30 -142.08 133.58 26.67 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.264 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -94.06 138.13 32.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 58.9 m95 -124.28 128.03 48.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.257 0.551 . . . . 0.0 110.828 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.54 120.96 62.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.587 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 32.6 t70 56.39 27.44 12.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.917 1.341 . . . . 0.0 110.01 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.646 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 77.38 29.34 56.15 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.905 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -125.83 132.62 52.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.781 HD22 ' HB1' ' A' ' 66' ' ' ALA . 56.3 tp -69.81 130.29 41.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.472 HG12 ' CG2' ' A' ' 86' ' ' ILE . 88.3 t -108.35 -55.75 5.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.346 172.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.29 131.41 2.43 Favored Glycine 0 C--O 1.22 -0.768 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.468 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.36 -62.33 1.65 Allowed Glycine 0 C--O 1.222 -0.641 0 C-N-CA 119.593 -1.289 . . . . 0.0 116.1 -168.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 p -77.52 -67.85 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.759 -0.848 . . . . 0.0 112.934 -170.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -79.04 -45.0 21.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.023 -173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG13 ' HA3' ' A' ' 82' ' ' GLY . 48.0 mm -58.01 -47.01 87.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 82' ' ' GLY . 60.5 t -57.29 -51.86 64.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.568 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.519 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 45.6 mm -59.83 -50.39 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 42.7 tt0 -61.04 -51.51 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.694 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.683 ' HG2' ' N ' ' A' ' 96' ' ' LEU . 46.5 ttm -63.88 -32.59 74.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.098 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.885 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 7.8 t80 -57.35 -52.05 66.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.657 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.1 mt-30 -62.83 -38.28 90.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.14 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -59.12 -32.84 70.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.062 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.04 17.64 79.54 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.571 -171.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.666 ' HA ' ' HB3' ' A' ' 98' ' ' GLN . 88.9 mt-10 -90.87 -27.17 18.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.525 177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.683 ' N ' ' HG2' ' A' ' 90' ' ' MET . 61.7 tp -60.1 -53.66 55.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.579 0.704 . . . . 0.0 109.462 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 1.078 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 14.1 pt20 -64.31 -26.62 68.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.28 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 17.5 tp60 -64.59 -44.16 91.52 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.175 0.512 . . . . 0.0 109.713 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 25.4 mt -69.95 -46.46 65.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.57 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.08 -45.23 98.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.148 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' A' ' 113' ' ' ASP . 36.4 ttpt -55.96 -48.78 75.18 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.49 -44.03 96.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.13 0.49 . . . . 0.0 110.373 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.587 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 42.1 m -75.33 -52.2 11.39 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.58 94.12 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.261 -0.274 . . . . 0.0 111.154 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.3 80.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.635 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -75.04 -27.03 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.153 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.611 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 44.4 m-85 -80.73 -45.77 16.54 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.063 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -76.64 -156.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.025 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.4 p -82.45 -147.75 0.08 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -76.81 46.51 0.46 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.916 0.389 . . . . 0.0 110.925 171.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -68.34 129.06 93.02 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.894 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.15 111.38 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.399 2.066 . . . . 0.0 112.721 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 101' ' ' LYS . 31.1 t70 -88.09 -117.59 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 172.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.078 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -69.7 39.3 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.232 -0.889 . . . . 0.0 109.5 178.371 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtm . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.6 p 50.91 -117.01 1.03 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.024 0.53 . . . . 0.0 111.569 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 4' ' ' THR . 23.7 m -151.94 -130.74 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.626 ' H ' HG22 ' A' ' 3' ' ' THR . 60.3 p -146.83 -147.53 0.22 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.851 0.75 . . . . 0.0 111.121 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 62' ' ' LEU . 91.5 mt -57.45 -37.51 58.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.981 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 33.8 mm-40 -51.28 -53.71 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 111.429 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.78 -40.19 88.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.304 0.573 . . . . 0.0 110.674 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.918 HG21 ' HG ' ' A' ' 62' ' ' LEU . 83.4 mt -59.76 -46.14 93.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.616 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 32.4 mt-30 -61.77 -35.24 77.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.662 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -60.82 -38.54 85.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.172 175.086 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 8' ' ' ILE . 17.2 pt20 -79.68 -39.81 30.47 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.009 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.643 HG22 ' HA2' ' A' ' 78' ' ' GLY . 22.3 mt -61.88 -45.22 99.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.218 0.533 . . . . 0.0 110.429 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.6 91.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.1 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.0 pt-20 -70.43 -30.15 66.93 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.828 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 31.8 m120 -76.74 126.87 85.32 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.275 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.632 ' O ' HD13 ' A' ' 17' ' ' ILE . 51.0 Cg_exo -60.29 -43.56 33.93 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.911 2.407 . . . . 0.0 112.56 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 16' ' ' PRO . 26.2 mm -139.92 120.61 14.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD23 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -133.76 142.26 47.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.375 -169.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 14.5 tp -137.52 116.62 12.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.17 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 6.6 m-85 -96.35 118.83 33.69 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.305 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.848 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 24.2 ptt? -147.44 -167.44 2.79 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 65.9 tttm -97.11 108.68 21.46 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -94.63 71.15 1.13 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.328 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.9 m -78.67 146.71 69.73 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.92 -41.69 74.62 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.479 2.119 . . . . 0.0 112.288 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.88 -31.45 71.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 tt -157.58 115.22 1.88 Allowed Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 40.2 Cg_endo -71.84 22.12 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.674 2.25 . . . . 0.0 113.713 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.848 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 15.7 p -163.14 50.48 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.014 0.526 . . . . 0.0 109.903 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.63 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 37.6 t -71.93 53.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.288 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.12 -134.38 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.152 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 1.037 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 63.3 m-85 -76.43 -23.16 53.95 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.405 ' N ' ' HG2' ' A' ' 72' ' ' PRO . 23.3 t -74.82 -11.54 60.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.664 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -50.76 -43.4 58.29 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -77.42 -39.13 48.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.068 0.461 . . . . 0.0 110.107 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.34 89.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.102 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -56.8 -39.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.321 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 28.3 mm-40 -66.89 -47.35 72.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.858 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.36 -42.86 92.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.984 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -62.37 -57.08 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 110.036 -175.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.03 69.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.204 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.82 -50.62 23.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.557 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -76.5 -52.99 8.73 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.246 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.64 -135.59 8.99 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.486 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 26.3 mt-10 -141.95 -147.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.101 -0.549 . . . . 0.0 111.348 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 34.3 mmt-85 -48.02 146.96 2.28 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.359 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' HD13 ' A' ' 40' ' ' LEU . 21.6 p90 -159.38 150.86 20.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.876 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.99 144.06 28.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.557 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 p90 -130.78 149.74 52.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.485 HG23 HD11 ' A' ' 18' ' ' LEU . 44.0 t -124.31 128.04 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.535 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.0 p30 -78.46 132.2 37.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.393 0.616 . . . . 0.0 110.166 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.664 HD12 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -142.53 -34.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.342 -173.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.664 HD22 HD12 ' A' ' 52' ' ' ILE . 1.8 mm? -67.19 -8.68 33.2 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.116 167.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -97.25 -47.12 5.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.698 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.674 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.1 m-20 -73.78 131.35 81.96 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 121.958 -0.464 . . . . 0.0 111.419 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.76 -43.63 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.364 2.043 . . . . 0.0 112.924 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -76.1 -55.5 5.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.78 -33.38 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.674 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 28.1 ttm180 -49.73 -40.4 40.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.612 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.39 18.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 56.7 mm-40 -78.86 -60.08 2.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -161.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.918 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.92 -25.18 0.49 Allowed Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -170.001 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.687 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 14.1 Cg_endo -55.24 -41.82 74.66 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 121.682 1.637 . . . . 0.0 110.682 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -48.38 -41.93 30.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.777 175.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.639 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -71.97 -41.7 67.39 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.149 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.824 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -72.53 -57.56 4.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.64 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.689 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 50.3 t30 -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.256 1.027 . . . . 0.0 109.861 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.689 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -60.78 148.07 83.39 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 113.12 -1.854 . . . . 0.0 112.738 -176.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -61.95 -33.94 82.45 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.194 1.93 . . . . 0.0 110.145 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -143.0 -126.64 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.917 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.966 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.3 m-85 -142.28 -164.49 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.966 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 2.1 Cg_endo -74.32 154.9 99.88 Favored 'Cis proline' 0 C--N 1.362 1.278 0 CA-C-N 121.503 1.572 . . . . 0.0 113.282 -2.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.51 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 25.3 mt-30 -144.02 135.4 25.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.704 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -93.55 137.04 33.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 59.1 m95 -121.26 132.56 54.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.236 0.541 . . . . 0.0 111.083 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.06 120.88 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.591 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 30.6 t70 56.38 28.35 13.38 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.799 1.285 . . . . 0.0 110.43 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.51 28.21 55.77 Favored Glycine 0 C--N 1.311 -0.821 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.887 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -127.76 133.84 49.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.824 HD22 ' HB1' ' A' ' 66' ' ' ALA . 52.0 tp -69.44 130.25 41.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.771 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' CG2' ' A' ' 86' ' ' ILE . 81.6 t -107.35 -54.4 5.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.902 173.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.59 140.78 3.64 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.16 -67.66 1.4 Allowed Glycine 0 C--O 1.217 -0.951 0 C-N-CA 118.549 -1.786 . . . . 0.0 116.1 -167.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 1.037 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 42.0 t -81.76 -68.03 0.73 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.767 1.283 . . . . 0.0 112.657 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 86' ' ' ILE . 1.5 m-20 -65.53 -49.62 68.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.6 -169.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.6 mp -63.58 -43.15 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.992 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 HD11 ' A' ' 96' ' ' LEU . 53.1 t -59.84 -51.39 73.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.441 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.1 mm -59.02 -48.77 85.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.928 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.736 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.2 tt0 -62.28 -52.11 64.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.096 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.685 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.9 mmt -60.43 -34.78 74.47 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.611 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 7.6 t80 -58.2 -50.04 74.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.772 172.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.4 mt-30 -64.31 -40.81 96.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.11 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -61.96 -34.53 76.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.584 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.77 -23.53 32.33 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.824 -171.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.755 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 4.7 mm-40 -56.4 -39.69 73.41 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.824 0.45 . . . . 0.0 112.179 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.8 tt -60.31 -52.7 64.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.186 -176.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.708 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -64.68 -26.75 68.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -68.61 -46.83 68.23 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.108 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 53.5 mt -63.44 -46.19 87.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.06 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 96' ' ' LEU . 48.8 mm -62.1 -45.17 99.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.145 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.685 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 26.0 ttpp -53.03 -52.7 57.61 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.234 0.54 . . . . 0.0 111.375 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 87.7 tt0 -65.2 -46.6 80.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.547 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.951 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 91.4 m -66.87 -46.99 73.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.368 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.49 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.93 -42.29 99.75 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.58 78.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.951 ' HE2' ' HA ' ' A' ' 103' ' ' THR 0.255 0.0 OUTLIER -77.79 -26.97 50.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.349 178.631 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.692 ' CE2' ' HE3' ' A' ' 106' ' ' LYS . 93.8 m-85 -87.95 -49.55 6.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.521 171.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -101.82 135.9 42.57 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 p -58.17 115.84 3.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 49.47 43.23 23.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.396 -1.729 . . . . 0.0 114.143 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -78.33 117.69 67.73 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.38 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.18 59.03 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.697 2.931 . . . . 0.0 114.431 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.529 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 55.1 m-20 -53.84 -63.68 1.07 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.685 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -73.57 -41.75 62.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.998 0.428 . . . . 0.0 110.972 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.448 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 38.8 tt0 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 117.781 -1.104 . . . . 0.0 108.426 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.838 0.352 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 t -66.69 -46.59 75.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.168 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.3 p -149.96 131.48 14.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.255 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.456 HG21 ' OE1' ' A' ' 61' ' ' GLU . 22.9 m -158.25 -46.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.505 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 62.2 mt -54.4 -36.85 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.127 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -54.42 -45.67 73.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.002 0.43 . . . . 0.0 110.331 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -71.64 -40.19 69.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.051 174.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.695 HD13 HD22 ' A' ' 62' ' ' LEU . 72.3 mt -57.51 -43.66 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.56 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 7' ' ' LYS . 5.7 tpm_? -60.01 -38.24 82.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.383 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 53.0 tt0 -68.0 -45.8 73.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.124 0.487 . . . . 0.0 110.948 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.785 HG22 ' HA2' ' A' ' 78' ' ' GLY . 29.3 mt -66.56 -46.64 85.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.009 0.433 . . . . 0.0 110.722 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.69 88.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.4 pt-20 -66.93 -34.39 77.68 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.353 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 70.2 m-80 -77.34 128.38 80.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.607 ' O ' HD13 ' A' ' 17' ' ' ILE . 50.4 Cg_exo -60.22 -42.93 38.54 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 123.063 2.509 . . . . 0.0 112.075 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 16' ' ' PRO . 36.0 mm -139.4 125.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.685 HD11 HG23 ' A' ' 50' ' ' VAL . 27.5 tp -133.44 141.21 47.72 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.386 -170.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.3 tp -136.43 119.06 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.601 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -96.98 119.36 35.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.972 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.4 ptt? -146.19 -169.38 3.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.299 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.022 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.8 tttt -97.68 115.04 27.16 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.665 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.62 70.21 1.0 Allowed Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.399 -175.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 30' ' ' CYS . 80.4 p -79.05 143.37 61.21 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.777 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.3 -41.51 65.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.389 2.059 . . . . 0.0 112.278 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -65.0 -32.29 73.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.418 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 29' ' ' SER . 51.3 tp -158.72 116.92 1.72 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.594 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 11.3 Cg_exo -71.86 27.97 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.3 2.0 . . . . 0.0 112.736 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 40.6 p -162.84 51.56 0.18 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.179 0.514 . . . . 0.0 111.889 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.598 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 40.4 t -72.84 59.19 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.225 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.07 -139.81 2.97 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.82 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 55.1 m-85 -74.88 -17.7 60.54 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 120.994 0.426 . . . . 0.0 111.632 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 30.2 p -69.92 -18.45 63.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -48.65 -42.23 33.81 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.461 ' O ' HD11 ' A' ' 88' ' ' ILE . 12.2 mp0 -75.71 -38.97 58.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.141 0.496 . . . . 0.0 109.853 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.49 92.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.048 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.98 -39.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.028 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 30.0 mm-40 -67.11 -44.28 80.33 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.91 -47.35 85.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.991 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -61.37 -51.83 67.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.9 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.75 67.98 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.883 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 44' ' ' GLY . . . -71.65 -48.66 46.22 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.15 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.961 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -70.45 -9.18 55.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.811 170.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -10.59 120.48 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.967 0 CA-C-N 110.684 -2.962 . . . . 0.0 119.056 -160.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.779 ' OE2' ' HA ' ' A' ' 97' ' ' GLN . 3.6 mp0 -133.43 138.19 46.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 109.95 -3.125 . . . . 0.0 103.887 164.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -56.39 129.41 40.45 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.643 -170.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 14.7 p90 -140.47 148.08 40.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.04 -166.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.36 152.94 21.0 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.929 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.5 p90 -136.38 153.18 51.18 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.685 HG23 HD11 ' A' ' 18' ' ' LEU . 61.4 t -128.95 131.45 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.5 p30 -76.51 132.37 39.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 110.368 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.626 HD12 HD22 ' A' ' 53' ' ' LEU . 1.2 pp -147.64 -37.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.022 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -65.56 -7.66 15.86 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.22 173.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -96.22 -42.84 7.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.433 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.4 m-20 -77.09 123.26 87.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.5 -45.23 11.99 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.121 1.881 . . . . 0.0 112.763 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.04 -56.72 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.993 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.73 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.473 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.619 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 78.9 ttt180 -52.8 -31.93 41.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.7 -47.36 8.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.456 ' OE1' HG21 ' A' ' 4' ' ' THR . 50.1 mt-10 -76.4 -60.61 2.26 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -163.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.695 HD22 HD13 ' A' ' 8' ' ' ILE . 1.8 pt? -68.36 -33.49 4.78 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.694 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.5 Cg_endo -53.94 -42.11 69.4 Favored 'Trans proline' 0 C--N 1.353 0.81 0 CA-C-N 120.939 1.371 . . . . 0.0 110.785 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.13 -40.53 61.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.28 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.509 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.3 -43.98 76.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.779 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -76.6 -57.59 3.77 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.816 -174.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.3 t-20 -174.99 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.109 0.957 . . . . 0.0 109.972 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -57.67 149.18 53.44 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 113.303 -1.772 . . . . 0.0 113.351 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -62.18 -37.11 65.17 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.426 2.084 . . . . 0.0 110.194 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 57.8 p -141.86 -124.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.278 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.998 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 46.0 m-85 -141.43 -170.58 0.24 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.998 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 58.5 Cg_endo -69.71 154.2 93.06 Favored 'Cis proline' 0 C--N 1.357 1.004 0 CA-C-N 121.27 1.489 . . . . 0.0 114.349 -1.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.617 HE22 ' HA ' ' A' ' 63' ' ' PRO . 61.2 mt-30 -144.96 134.92 23.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.655 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -98.63 137.52 37.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.029 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.535 ' N ' HD13 ' A' ' 74' ' ' LEU . 60.3 m95 -123.81 132.19 53.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.276 0.56 . . . . 0.0 111.222 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 99' ' ' LEU . 38.9 t -114.31 118.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.536 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.2 t70 55.61 26.9 9.74 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.388 1.566 . . . . 0.0 108.72 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.785 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.82 28.54 46.02 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.607 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.47 133.33 47.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.973 0.416 . . . . 0.0 111.077 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.779 HD22 ' HB1' ' A' ' 66' ' ' ALA . 55.5 tp -68.81 133.44 48.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.556 HG12 ' CG2' ' A' ' 86' ' ' ILE . 90.1 t -110.41 -54.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.069 170.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.48 135.03 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.475 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -85.1 -63.56 1.58 Allowed Glycine 0 C--O 1.219 -0.803 0 C-N-CA 119.291 -1.433 . . . . 0.0 116.589 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.9 p -78.89 -67.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.427 -1.043 . . . . 0.0 113.373 -168.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.21 -43.34 28.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.556 ' CG2' HG12 ' A' ' 81' ' ' VAL . 48.4 mm -57.18 -45.61 84.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.157 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.8 t -58.67 -48.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.44 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.844 HD13 ' HB2' ' A' ' 39' ' ' ALA . 36.9 mm -58.59 -53.42 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.09 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.4 tt0 -63.2 -49.36 74.53 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.246 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.816 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -61.09 -37.64 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 2.3 t80 -57.86 -49.39 76.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.553 173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.5 mt-30 -64.16 -39.64 94.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.1 mmm180 -57.49 -33.55 68.13 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.639 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.541 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 89.82 -24.05 17.16 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.211 -170.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.511 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.1 mt-10 -60.92 -26.44 67.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 7.9 tt -73.08 -53.96 9.74 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.961 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 17.5 pt20 -57.89 -25.92 61.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.181 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 45.1 mm-40 -69.23 -53.27 20.75 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.667 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.802 HD13 HG21 ' A' ' 76' ' ' VAL . 2.8 pp -71.58 -35.39 70.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.713 ' HB ' ' OE2' ' A' ' 45' ' ' GLU . 29.4 mm -66.1 -48.38 81.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.173 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.618 ' HD3' ' H ' ' A' ' 115' ' ' GLU . 38.9 ttpt -56.31 -51.07 69.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.683 0.278 . . . . 0.0 110.953 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 85.9 tt0 -55.96 -48.02 76.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.876 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 63.7 m -63.15 -48.31 78.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.512 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.677 ' HB1' ' NZ ' ' A' ' 108' ' ' LYS . . . -60.15 -46.44 89.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.94 88.48 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.132 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -72.77 -20.8 61.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.771 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 33.0 m-85 -81.83 -46.77 13.7 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.677 ' NZ ' ' HB1' ' A' ' 104' ' ' ALA . 1.0 OUTLIER -87.09 -151.65 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.311 170.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -86.55 -153.82 0.21 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.7 51.43 0.11 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.471 0.309 . . . . 0.0 111.771 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.476 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 56.7 mm-40 -70.58 122.81 87.72 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.152 0.501 . . . . 0.0 112.021 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.67 65.35 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.337 2.692 . . . . 0.0 113.271 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 31.4 m-20 -61.49 -109.21 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.482 -178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.932 ' HB1' ' HB2' ' A' ' 97' ' ' GLN . . . -50.69 -45.18 58.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -170.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.618 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 41.9 tt0 . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.161 -0.923 . . . . 0.0 109.131 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 119.904 -0.093 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 m 50.44 47.79 23.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.033 0.444 . . . . 0.0 111.504 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.6 t -68.41 139.32 55.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.567 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.504 HG21 ' OE1' ' A' ' 61' ' ' GLU . 60.1 m -155.3 -50.69 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.091 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 63.7 mt -62.12 -37.89 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -54.73 -44.12 73.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.636 0.255 . . . . 0.0 110.787 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.4 -45.11 73.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.667 HG21 HD13 ' A' ' 62' ' ' LEU . 69.0 mt -59.53 -45.06 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 31.9 mt-30 -64.3 -38.36 90.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.474 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 13.3 mmp_? -62.61 -37.01 84.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 109.868 172.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.69 -46.0 70.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.6 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.805 HG22 ' HA2' ' A' ' 78' ' ' GLY . 35.7 mt -65.72 -44.43 93.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.094 0.473 . . . . 0.0 110.53 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.01 95.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.089 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 23.5 pt-20 -66.55 -32.75 74.29 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.33 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.471 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -77.16 127.24 83.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.595 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.1 Cg_exo -59.68 -43.44 38.57 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.752 2.301 . . . . 0.0 112.576 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 16' ' ' PRO . 31.6 mm -140.27 124.2 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.701 HD23 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -134.32 142.15 47.16 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.625 -169.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.5 tp -135.15 116.95 15.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.64 ' CE2' HD11 ' A' ' 62' ' ' LEU . 10.8 m-85 -96.83 117.94 32.18 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.795 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.566 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -147.12 -158.15 0.88 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.737 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 64.9 tttm -98.85 107.95 20.51 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.648 -0.657 . . . . 0.0 109.756 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.65 126.19 8.68 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.062 -1.065 . . . . 0.0 111.79 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.441 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 37.2 t -146.4 145.16 22.81 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -41.13 79.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.204 1.936 . . . . 0.0 111.18 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.4 pttt -65.72 -32.36 73.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.667 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.467 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -160.49 119.98 1.59 Allowed Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HD2' HD13 ' A' ' 27' ' ' LEU . 44.0 Cg_endo -73.34 20.69 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.382 0 C-N-CA 122.41 2.073 . . . . 0.0 114.121 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 22.1 p -169.51 52.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.9 t -55.8 -37.7 68.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -168.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -68.83 -135.65 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.924 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -74.18 -32.61 63.15 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 122.204 -0.586 . . . . 0.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.7 p -46.54 -22.09 0.24 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.271 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.96 32.14 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.231 0.332 . . . . 0.0 111.867 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -35.5 33.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.266 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.97 -44.3 73.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.539 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.0 p -53.4 -38.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.484 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -63.74 -46.82 83.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.077 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.15 -42.04 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.839 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -61.95 -56.23 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.511 . . . . 0.0 109.895 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.31 71.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.294 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.39 -47.43 56.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.805 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.6 m -72.23 -57.98 3.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -103.87 -148.62 19.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.314 -0.946 . . . . 0.0 114.421 -175.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.8 mm-40 -105.98 -154.4 0.52 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 37.1 mmt-85 -62.2 152.7 32.53 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.558 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 24.4 p90 -151.87 156.14 39.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.142 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.51 149.67 22.49 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.2 p90 -136.63 151.74 49.65 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG23 HD11 ' A' ' 18' ' ' LEU . 54.0 t -130.98 129.5 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.377 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 2.7 p30 -75.01 134.19 41.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.503 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.677 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -149.28 -34.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.677 HD22 HD12 ' A' ' 52' ' ' ILE . 1.6 mm? -67.87 -7.57 29.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.583 169.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -95.59 -38.42 10.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.861 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 34.4 m120 -79.39 128.03 76.71 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 120.642 0.258 . . . . 0.0 111.009 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.86 -45.0 6.86 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.333 2.022 . . . . 0.0 112.928 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -84.52 -49.73 8.35 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.529 HG22 HG22 ' A' ' 52' ' ' ILE . 40.9 mt -58.39 -33.32 47.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.35 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.697 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -50.53 -38.7 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.976 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.654 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -91.42 -35.34 14.42 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.674 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 51.7 mt-10 -76.18 -61.62 1.88 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -162.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.0 pt? -70.71 -32.49 2.57 Favored Pre-proline 0 N--CA 1.468 0.433 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.697 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 18.9 Cg_endo -56.09 -40.04 87.43 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 120.925 1.366 . . . . 0.0 110.85 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.674 ' NZ ' ' HA ' ' A' ' 61' ' ' GLU . 31.6 mtmm -56.25 -38.34 70.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.519 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -66.48 -43.12 86.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.136 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.93 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.4 -57.1 4.1 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.104 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.2 t30 -175.87 -53.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.167 0.984 . . . . 0.0 109.47 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.679 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -54.9 149.24 24.1 Favored Pre-proline 0 C--O 1.217 -0.623 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.388 -176.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -62.77 -37.75 53.8 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.242 1.961 . . . . 0.0 110.191 171.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.9 p -142.01 -130.43 0.1 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.635 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.922 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 17.1 m-85 -137.67 -166.15 0.11 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.922 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.1 Cg_endo -65.87 153.28 80.0 Favored 'Cis proline' 0 C--N 1.362 1.274 0 CA-C-N 121.586 1.602 . . . . 0.0 113.744 -1.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.466 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 29.6 mt-30 -141.74 133.11 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.53 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -93.96 138.4 32.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 59.6 m95 -126.77 130.19 49.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.799 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' CG2' HD13 ' A' ' 100' ' ' ILE . 2.4 p -125.63 123.79 65.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.5 t70 61.28 28.25 17.81 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.468 1.604 . . . . 0.0 108.091 -171.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.805 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 68.2 25.67 74.46 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 113.029 -1.896 . . . . 0.0 112.95 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 37.0 mm-40 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.805 0.442 . . . . 0.0 110.559 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.93 HD22 ' HB1' ' A' ' 66' ' ' ALA . 44.6 tp -71.93 125.13 26.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.764 0.316 . . . . 0.0 111.567 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.578 HG12 ' CG2' ' A' ' 86' ' ' ILE . 71.8 t -106.27 -53.04 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.934 172.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.564 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 141.46 134.45 3.02 Favored Glycine 0 C--O 1.221 -0.693 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.462 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -85.23 -62.63 1.64 Allowed Glycine 0 C--O 1.22 -0.742 0 C-N-CA 119.498 -1.334 . . . . 0.0 116.292 -168.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.4 p -77.24 -68.25 0.63 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.683 -0.892 . . . . 0.0 112.903 -170.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.4 -44.59 28.69 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 111.289 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.578 ' CG2' HG12 ' A' ' 81' ' ' VAL . 45.0 mm -59.33 -44.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.258 -172.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 82' ' ' GLY . 69.1 t -58.02 -49.51 81.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.9 mm -60.58 -48.56 88.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.497 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.823 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -62.24 -52.88 61.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.593 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.579 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.4 mmt -57.35 -36.52 71.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.581 0.229 . . . . 0.0 111.35 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.794 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 19.6 t80 -56.23 -51.27 68.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.995 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -65.59 -44.85 85.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.691 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 2.1 mmp_? -60.64 -33.94 73.53 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.978 0.418 . . . . 0.0 111.281 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.641 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 98.6 -25.24 28.74 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.72 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.2 mt-10 -56.0 -32.33 63.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 61.7 tp -57.41 -55.71 31.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.181 0.515 . . . . 0.0 110.703 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.805 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.3 pt20 -65.61 -26.22 67.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.627 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 52.9 mm-40 -63.83 -46.42 85.12 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.0 mt -67.76 -46.49 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.149 177.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 96' ' ' LEU . 32.8 mm -63.7 -42.47 96.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.847 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.632 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 28.2 ttpt -54.72 -56.09 22.96 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.505 0.669 . . . . 0.0 110.863 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 15.6 tp10 -58.75 -45.95 88.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.567 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 88.5 m -69.85 -49.07 56.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.26 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.36 92.45 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.267 -0.271 . . . . 0.0 110.314 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.48 93.68 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.598 0.561 . . . . 0.0 111.798 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -71.57 -18.57 62.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.475 ' HE2' HG23 ' A' ' 103' ' ' THR . 57.1 m-85 -92.08 -47.52 7.21 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.261 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 46.2 mtmt -101.03 -147.18 0.35 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.952 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -64.92 155.53 34.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.884 164.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.49 55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -174.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -65.08 121.26 73.21 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.23 60.21 1.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.697 2.932 . . . . 0.0 113.434 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.425 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.2 m-20 -44.55 -51.68 8.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 0.0 112.01 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.632 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -105.95 -120.87 0.23 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.059 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.117 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.3 m 58.06 43.59 20.69 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.422 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t 178.92 -41.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.186 0.517 . . . . 0.0 109.899 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 8' ' ' ILE . 35.6 p -63.37 -52.1 63.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.039 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.573 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 52.9 mt -59.22 -36.4 63.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.513 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 65.0 mm-40 -57.02 -47.0 81.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -67.16 -43.89 81.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.805 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.664 HG21 HD13 ' A' ' 62' ' ' LEU . 69.7 mt -59.6 -48.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.478 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 34.3 mt-30 -61.55 -39.74 92.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.396 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.775 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mmp_? -59.49 -40.4 86.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -71.92 -43.13 65.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.717 HG22 ' HA2' ' A' ' 78' ' ' GLY . 39.8 mt -60.08 -42.09 88.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.208 0.528 . . . . 0.0 109.577 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -36.68 78.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.718 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.775 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 83.0 mt-10 -58.68 -46.46 87.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.598 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.0 m-80 -79.31 124.27 84.28 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.254 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.492 ' O ' HD13 ' A' ' 17' ' ' ILE . 32.1 Cg_exo -62.9 -43.45 19.92 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 C-N-CA 122.355 2.037 . . . . 0.0 111.77 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 16' ' ' PRO . 23.0 mm -128.9 120.89 53.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.645 HD23 HG23 ' A' ' 12' ' ' ILE . 20.8 tp -133.54 140.56 47.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.452 -169.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD21 HG12 ' A' ' 37' ' ' VAL . 11.6 tp -134.69 116.93 15.48 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.351 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.635 ' HB3' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -97.93 115.94 29.15 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.011 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HE3' ' HB2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.72 -154.36 0.55 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.943 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 2.2 tmtp? -98.04 97.1 8.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -170.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.675 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.23 71.73 1.39 Allowed Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.499 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.509 ' HB2' ' HE2' ' A' ' 22' ' ' LYS . 38.5 t -78.59 145.14 66.64 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.95 -40.07 87.5 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.058 1.838 . . . . 0.0 111.475 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -70.01 -30.74 68.12 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.605 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 28' ' ' PRO . 54.2 tp -157.88 118.38 1.94 Allowed Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -70.73 22.28 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.509 2.139 . . . . 0.0 113.647 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -164.95 48.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 110.883 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.943 ' HB3' ' HD2' ' A' ' 22' ' ' LYS . 42.6 t -70.42 58.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.442 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.25 -139.4 2.63 Favored Glycine 0 C--N 1.314 -0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -78.05 -45.73 22.79 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 117.63 0.715 . . . . 0.0 111.582 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' HG13 ' A' ' 37' ' ' VAL . 35.5 t -52.21 -10.26 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.52 -41.87 42.25 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 119.265 -0.397 . . . . 0.0 110.401 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.552 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -81.29 -30.48 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 172.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 33' ' ' SER . . . -67.27 -42.69 83.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 33' ' ' SER . 26.9 m -54.67 -41.59 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -56.92 -47.9 79.53 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 122.443 0.297 . . . . 0.0 110.29 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.675 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.3 -45.4 88.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.859 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.48 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -64.55 -55.09 22.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -177.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.32 74.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.959 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.51 -45.5 68.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.649 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 27.2 p -76.81 -56.11 4.89 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -173.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.16 -144.85 16.66 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.066 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.686 ' OE2' ' HB1' ' A' ' 104' ' ' ALA . 13.1 pt-20 -100.29 -153.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 155.39 40.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.627 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CD2' HD13 ' A' ' 40' ' ' LEU . 17.6 p90 -145.01 158.41 43.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 -169.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 152.05 19.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.466 ' HB2' ' HE3' ' A' ' 21' ' ' MET . 1.5 p90 -138.67 154.41 48.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG23 HD11 ' A' ' 18' ' ' LEU . 48.4 t -131.45 129.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.675 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.2 p30 -78.97 133.33 36.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 110.523 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.721 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -147.47 -35.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 -173.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.721 ' H ' HD12 ' A' ' 52' ' ' ILE . 1.4 mm? -66.21 -9.6 33.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.304 169.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? -96.0 -42.94 8.02 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.674 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 34.6 m120 -78.84 123.26 85.27 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.322 -0.237 . . . . 0.0 110.707 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.81 -45.06 9.05 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.099 1.866 . . . . 0.0 112.802 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.17 -52.95 12.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.436 HG22 HG22 ' A' ' 52' ' ' ILE . 37.6 mt -61.77 -36.97 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.522 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 54.6 ttp85 -51.24 -35.19 35.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.46 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -85.0 -47.12 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -170.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -78.87 -59.52 2.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -161.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.665 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 2.2 pt? -67.48 -33.37 5.43 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -173.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 12.3 Cg_endo -55.1 -41.15 81.48 Favored 'Trans proline' 0 C--N 1.352 0.714 0 CA-C-N 121.167 1.452 . . . . 0.0 111.125 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.1 mtmp? -58.58 -34.01 70.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.682 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -66.6 -44.17 82.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.935 176.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.799 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.66 -57.33 3.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.592 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.726 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.1 t-20 -175.67 -56.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.158 0.98 . . . . 0.0 109.636 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.728 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.58 151.27 31.0 Favored Pre-proline 0 C--O 1.22 -0.458 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.257 -176.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -64.13 -36.96 44.62 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.312 2.008 . . . . 0.0 110.024 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.3 p -142.1 -125.09 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.765 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.942 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 22.0 m-85 -141.53 -164.8 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.942 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.44 153.46 82.21 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 121.849 1.696 . . . . 0.0 113.699 -1.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.2 mt-30 -142.5 132.04 23.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.495 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.48 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -94.81 135.11 36.7 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 62.2 m95 -119.02 128.87 54.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.43 0.634 . . . . 0.0 110.789 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 99' ' ' LEU . 92.5 t -115.53 120.49 64.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.222 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' H ' HG21 ' A' ' 103' ' ' THR . 32.4 t70 57.73 28.55 16.02 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.034 1.397 . . . . 0.0 109.889 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.717 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 76.01 28.29 60.81 Favored Glycine 0 C--N 1.312 -0.781 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.047 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.4 135.09 46.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.498 . . . . 0.0 111.305 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.799 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.9 tp -69.22 131.13 44.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.377 -174.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.537 HG12 ' CG2' ' A' ' 86' ' ' ILE . 96.8 t -110.57 -51.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.028 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.495 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 144.64 133.6 2.67 Favored Glycine 0 C--O 1.222 -0.615 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.447 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.56 -62.44 1.71 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.492 -1.337 . . . . 0.0 116.064 -168.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.413 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 20.5 p -78.99 -67.55 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.689 -0.889 . . . . 0.0 112.955 -170.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -78.59 -43.8 25.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.66 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.537 ' CG2' HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.86 -44.51 94.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.772 -173.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 39' ' ' ALA . 96.0 t -57.69 -48.91 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.675 HD13 ' HB2' ' A' ' 39' ' ' ALA . 35.6 mm -60.11 -51.59 71.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.758 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 84.2 tt0 -59.37 -54.74 43.23 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.38 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.828 ' HB2' HD23 ' A' ' 96' ' ' LEU . 26.4 mmt -58.15 -37.95 75.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.534 0.207 . . . . 0.0 110.743 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.504 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.0 t80 -57.16 -49.81 74.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.391 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.652 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -64.79 -38.56 91.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.113 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 1.2 mmm180 -62.34 -32.0 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.767 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 21.24 58.45 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.555 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.731 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.9 mm-40 -90.39 -32.41 16.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.404 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -60.47 -53.43 57.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.54 -172.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.768 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.0 pm0 -62.57 -28.88 70.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.58 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.415 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.0 mm100 -66.12 -45.98 79.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.4 mt -67.4 -45.14 77.05 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.03 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 96' ' ' LEU . 51.0 mm -64.97 -42.5 94.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.465 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.766 ' HE3' ' HB3' ' A' ' 114' ' ' ALA . 31.9 ttmt -52.0 -56.66 12.91 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.453 0.644 . . . . 0.0 111.225 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.58 -43.99 89.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.255 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.598 ' O ' ' HD2' ' A' ' 107' ' ' TYR . 73.1 m -72.41 -44.05 63.01 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.783 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB1' ' OE2' ' A' ' 45' ' ' GLU . . . -65.98 -44.11 85.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.481 -0.762 . . . . 0.0 110.167 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.11 95.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.808 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 107' ' ' TYR . 17.1 ptpt -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.014 -0.429 . . . . 0.0 110.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.598 ' HD2' ' O ' ' A' ' 103' ' ' THR . 81.1 m-85 -77.99 -45.73 23.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -97.55 -150.33 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.733 177.485 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 111' ' ' GLU . 11.1 p -67.93 169.66 9.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 166.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.72 60.39 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 65.8 mm-40 -58.44 126.36 78.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.778 0.799 . . . . 0.0 111.73 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 73.9 Cg_endo -94.15 56.75 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 123.416 2.744 . . . . 0.0 113.039 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.685 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.5 m-20 -50.56 -56.6 10.97 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.05 -169.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.766 ' HB3' ' HE3' ' A' ' 101' ' ' LYS . . . -88.86 -40.53 13.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.993 0.425 . . . . 0.0 110.97 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.501 ' H ' ' HE2' ' A' ' 101' ' ' LYS . 66.3 mm-40 . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.206 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttp . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 3' ' ' THR . 55.0 p -84.11 132.23 34.72 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 170.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 2' ' ' SER . 89.8 m 72.72 131.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 109.927 -171.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.917 HG22 ' H ' ' A' ' 5' ' ' ILE . 10.2 m -156.78 -148.62 0.22 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.917 ' H ' HG22 ' A' ' 4' ' ' THR . 95.1 mt -53.44 -40.54 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 123.11 0.564 . . . . 0.0 112.466 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.73 -49.33 68.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.7 mptt -72.54 -39.62 67.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.034 175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.864 HG21 ' HG ' ' A' ' 62' ' ' LEU . 71.8 mt -58.21 -47.65 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.011 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -61.03 -32.79 72.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.483 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 17.2 mmt180 -60.06 -37.54 80.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.419 . . . . 0.0 110.51 173.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 45.4 tt0 -72.97 -45.46 57.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.378 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.661 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 21.8 mt -63.78 -42.8 97.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.228 0.537 . . . . 0.0 110.111 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.28 98.3 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.788 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.4 pt-20 -65.07 -38.56 91.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.264 -175.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -78.74 127.15 81.1 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 31.8 Cg_endo -64.25 -41.24 22.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.011 2.474 . . . . 0.0 112.384 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 16' ' ' PRO . 34.2 mm -132.87 123.59 48.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.684 HD11 HG23 ' A' ' 50' ' ' VAL . 33.2 tp -133.8 143.45 48.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.436 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.43 118.5 15.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.345 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.604 ' HE1' HD21 ' A' ' 18' ' ' LEU . 7.6 m-85 -96.46 119.13 34.38 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.273 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.598 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 22.8 ptt? -146.5 -168.08 2.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.896 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.074 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 40.1 ttmt -96.75 138.15 34.75 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 28' ' ' PRO . . . -140.49 135.15 6.86 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 118.287 -1.911 . . . . 0.0 112.975 174.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 t -121.29 150.61 54.47 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.626 -1.287 . . . . 0.0 108.466 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.03 -38.14 58.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.023 1.815 . . . . 0.0 111.664 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -70.49 -35.09 73.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.773 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.0 tp -159.43 114.62 1.55 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.426 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 52.2 Cg_endo -73.38 32.51 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.081 2.521 . . . . 0.0 113.891 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 11.3 p -165.47 47.3 0.09 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.01 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.608 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 49.1 t -74.39 53.07 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.885 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.31 -141.22 3.14 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -76.4 -36.04 58.29 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.299 0.571 . . . . 0.0 109.847 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.598 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 48.7 p -52.35 -22.87 5.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.748 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.75 -44.43 28.14 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.473 0.483 . . . . 0.0 111.656 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.617 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.92 -35.34 32.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.582 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -54.47 -37.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 19.0 mm-40 -65.76 -45.4 82.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.77 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -57.69 -44.73 86.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.509 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.24 -57.13 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.481 . . . . 0.0 110.362 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.49 71.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.123 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.21 -49.53 42.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.629 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.7 p -76.4 -49.97 15.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.344 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.47 -131.47 7.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.064 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 4.6 mm-40 -140.39 -152.56 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.149 0.579 . . . . 0.0 111.04 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.489 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 42.2 mmm-85 -55.68 148.02 17.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.832 0.825 . . . . 0.0 112.387 -173.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 21.9 p90 -156.65 155.36 31.65 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.292 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.01 159.25 15.09 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.687 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -143.7 154.32 43.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.684 HG23 HD11 ' A' ' 18' ' ' LEU . 47.1 t -133.43 127.81 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' MET . 12.1 p-10 -81.25 131.5 35.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.573 . . . . 0.0 110.585 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.626 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -146.69 -32.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.287 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.074 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -67.32 -8.49 32.77 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.545 171.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -97.42 -48.55 5.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.33 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.3 m-20 -79.66 116.03 57.89 Favored Pre-proline 0 N--CA 1.472 0.647 0 O-C-N 122.118 -0.364 . . . . 0.0 110.784 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 24.7 Cg_exo -64.14 -44.34 12.63 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.981 2.454 . . . . 0.0 113.402 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -66.42 -54.64 21.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -62.28 -34.76 65.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 29.2 ttm180 -53.16 -40.91 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.031 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.466 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -79.61 -38.6 33.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -167.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.533 ' CD ' HG23 ' A' ' 4' ' ' THR . 47.9 mt-10 -77.88 -59.21 2.87 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -161.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.864 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.17 -26.94 0.57 Allowed Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -170.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.744 ' HD3' HD13 ' A' ' 62' ' ' LEU . 18.4 Cg_endo -57.08 -41.61 72.76 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.603 1.608 . . . . 0.0 111.521 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 53.6 mtmt -59.58 -34.24 72.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.701 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.504 ' CD2' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -66.15 -42.2 89.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.299 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.807 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.95 -56.86 4.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.446 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.699 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 22.6 t-20 -175.71 -55.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 122.159 0.981 . . . . 0.0 109.613 170.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.699 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.8 OUTLIER -56.82 150.37 38.04 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.645 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -63.79 -38.83 37.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.419 2.079 . . . . 0.0 110.283 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.9 p -141.4 -125.97 0.1 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.388 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.863 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.4 m-85 -141.13 -166.1 0.11 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.863 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 39.1 Cg_endo -65.65 156.7 78.42 Favored 'Cis proline' 0 C--N 1.362 1.244 0 CA-C-N 121.597 1.606 . . . . 0.0 113.836 -2.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 30.4 mt-30 -146.52 131.39 18.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.805 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 18' ' ' LEU . 61.1 tp -91.32 137.84 32.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.625 174.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 58.2 m95 -121.9 125.21 45.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.284 0.564 . . . . 0.0 109.921 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.4 t -110.04 119.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.197 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.57 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 58.24 28.85 17.17 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 123.403 1.573 . . . . 0.0 108.589 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.62 29.8 59.07 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.726 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 48.9 mt-10 -126.97 131.0 51.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.661 0.267 . . . . 0.0 110.359 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.807 HD22 ' HB1' ' A' ' 66' ' ' ALA . 47.6 tp -67.66 130.9 44.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -173.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.622 HG12 ' CG2' ' A' ' 86' ' ' ILE . 94.4 t -112.29 -52.52 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.123 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.85 136.0 2.88 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.518 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -86.88 -64.09 1.43 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.377 -1.392 . . . . 0.0 116.471 -169.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.0 p -80.13 -66.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.692 -0.887 . . . . 0.0 112.831 -171.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -74.03 -46.36 43.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.026 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.622 ' CG2' HG12 ' A' ' 81' ' ' VAL . 2.0 mp -60.98 -46.79 95.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.21 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -55.76 -49.4 74.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.258 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 35' ' ' GLN . 36.9 mm -62.12 -50.71 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.947 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.6 tt0 -62.46 -51.93 65.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.679 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.62 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -58.95 -33.63 70.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.308 0.243 . . . . 0.0 111.543 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.688 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.2 t80 -59.06 -52.48 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.129 172.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.0 mt-30 -62.88 -42.88 99.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.418 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 38.5 mmm-85 -62.58 -34.55 77.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.248 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 102.58 -23.79 32.91 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.945 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.783 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.3 mt-10 -56.11 -33.27 64.95 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.693 HD22 ' SG ' ' A' ' 43' ' ' CYS . 5.6 tt -69.77 -50.04 47.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.184 0.516 . . . . 0.0 109.669 -174.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.2 pt20 -61.55 -25.22 67.16 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.058 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 48.6 mm-40 -69.79 -48.08 60.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.53 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 54.1 mt -63.9 -46.11 86.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.201 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.539 HG22 ' OD2' ' A' ' 113' ' ' ASP . 50.5 mm -64.43 -44.48 97.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.818 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' CE ' ' HB3' ' A' ' 114' ' ' ALA . 37.4 ttmt -48.74 -52.14 25.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.352 0.596 . . . . 0.0 111.144 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -62.24 -50.82 70.22 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.432 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.57 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 95.3 m -71.18 -48.94 48.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.489 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . . . -61.67 -46.37 90.0 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.141 -0.349 . . . . 0.0 110.55 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 110' ' ' GLU . . . -61.77 -32.85 73.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.911 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.603 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -80.44 -17.86 50.51 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.654 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.597 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 53.9 m-85 -90.5 -50.52 5.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.858 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.599 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 2.1 mppt? -103.06 121.23 42.15 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 165.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 p -46.26 113.19 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.561 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 53.5 mt-10 49.66 44.56 24.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.317 -1.765 . . . . 0.0 113.355 172.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.599 ' OE1' ' HB2' ' A' ' 108' ' ' LYS . 8.9 pt-20 -75.67 130.16 79.8 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.521 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 3.7 Cg_exo -79.56 121.62 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.743 2.295 . . . . 0.0 111.611 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.613 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 43.7 m-20 -109.13 -63.23 1.38 Allowed 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -78.11 -38.4 44.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.243 173.676 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' HG23 ' A' ' 3' ' ' THR . 49.2 tpp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.606 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 57.4 p -163.7 51.87 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.913 -172.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.447 HG23 ' SD ' ' A' ' 1' ' ' MET . 61.5 p -70.99 -136.35 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.538 HG22 HG13 ' A' ' 8' ' ' ILE . 26.9 m -60.38 -31.79 70.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.864 -175.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 59.9 mt -51.1 -38.78 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 2' ' ' SER . 3.7 mm-40 -59.92 -43.54 94.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 0.0 110.065 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -63.75 -45.22 90.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.038 172.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.721 HD13 HD22 ' A' ' 62' ' ' LEU . 74.4 mt -60.94 -43.86 96.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.659 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -63.24 -38.71 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.299 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -60.75 -37.01 80.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.32 0.581 . . . . 0.0 109.766 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 15.9 tt0 -68.09 -45.45 73.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.001 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.712 HG23 HD23 ' A' ' 18' ' ' LEU . 36.4 mt -70.43 -44.59 77.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 110.661 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.26 77.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.2 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.34 -34.04 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.829 -176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 76.9 m-20 -77.61 128.63 79.26 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-O 121.166 0.508 . . . . 0.0 111.112 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.553 ' O ' HD13 ' A' ' 17' ' ' ILE . 44.5 Cg_exo -61.78 -42.92 28.68 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 123.008 2.472 . . . . 0.0 112.679 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.2 mm -139.61 122.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.712 HD23 HG23 ' A' ' 12' ' ' ILE . 23.2 tp -134.15 141.34 47.06 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.505 -169.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' A' ' 21' ' ' MET . 12.1 tp -135.45 117.21 15.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.525 -176.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE2' HD11 ' A' ' 62' ' ' LEU . 8.7 m-85 -97.33 117.99 32.8 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.938 174.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.731 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -148.09 -159.48 1.04 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.727 177.628 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.044 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 34.7 ttpt -99.65 117.75 34.68 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.374 -0.829 . . . . 0.0 110.562 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.599 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.84 70.6 0.95 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.512 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -78.21 140.68 61.41 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.45 -41.3 74.29 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.054 1.836 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -69.46 -30.35 68.23 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.041 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tt -156.57 105.91 2.0 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.44 ' O ' ' SD ' ' A' ' 21' ' ' MET . 15.0 Cg_exo -73.66 28.57 0.31 Allowed 'Trans proline' 0 C--O 1.223 -0.225 0 C-N-CA 122.642 2.228 . . . . 0.0 114.052 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -166.09 52.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.836 0.351 . . . . 0.0 111.484 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 22' ' ' LYS . 46.3 t -71.32 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 61.08 -139.29 47.8 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.203 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.48 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 37.9 m-85 -79.29 -20.88 46.92 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 21' ' ' MET . 30.6 p -70.2 -11.71 61.08 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -170.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.24 -43.89 22.32 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.352 0.407 . . . . 0.0 111.864 -175.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -78.02 -40.02 40.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.617 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.96 90.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.154 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p -55.75 -38.8 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.559 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 26.4 mm-40 -67.24 -46.66 73.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.891 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.87 -42.31 93.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.862 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -62.09 -56.74 15.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.374 0.607 . . . . 0.0 109.704 -175.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.06 72.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.486 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -46.34 64.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.82 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.4 m -71.91 -59.36 2.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.04 -145.01 13.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.371 -0.918 . . . . 0.0 114.499 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.849 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 32.2 mm-40 -120.37 -150.41 0.45 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.857 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 43.2 mmm-85 -55.54 144.98 24.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.058 0.933 . . . . 0.0 113.262 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 40' ' ' LEU . 26.3 p90 -150.83 152.56 33.93 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.386 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.7 152.71 19.35 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.479 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -137.36 150.58 47.81 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.561 HG23 HD11 ' A' ' 18' ' ' LEU . 46.5 t -129.56 126.56 63.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.599 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.4 p30 -76.23 129.55 36.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -145.59 -36.41 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.044 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.99 -11.58 30.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.423 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -96.51 -41.78 8.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.405 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -87.93 116.14 65.26 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 122.198 -0.313 . . . . 0.0 110.667 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.16 -43.83 13.94 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.167 1.912 . . . . 0.0 113.28 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.16 -50.67 67.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.029 0.443 . . . . 0.0 111.8 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.0 -40.67 81.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 78.9 ttt180 -52.1 -37.69 54.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.89 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.41 -49.16 44.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.2 -59.17 2.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -163.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 8' ' ' ILE . 2.1 pt? -66.1 -33.21 6.58 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -168.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.706 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 12.8 Cg_endo -55.16 -40.13 87.38 Favored 'Trans proline' 0 C--N 1.348 0.501 0 CA-C-N 121.182 1.458 . . . . 0.0 110.573 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -51.71 -41.02 61.16 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.759 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.536 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.68 -42.94 70.07 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.446 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.843 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.79 -59.92 2.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.703 -174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.741 ' HB2' ' HE3' ' A' ' 68' ' ' TRP . 8.4 m120 -168.61 -59.42 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.971 0.908 . . . . 0.0 109.172 168.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.741 ' HE3' ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -53.46 149.84 13.83 Favored Pre-proline 0 C--O 1.217 -0.61 0 CA-C-N 113.118 -1.855 . . . . 0.0 113.697 -174.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.99 -37.36 43.83 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 121.873 1.716 . . . . 0.0 110.229 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 74.5 p -142.12 -123.41 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.279 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.958 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.6 m-85 -141.03 -168.04 0.17 Allowed Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.958 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.3 Cg_endo -67.8 153.41 87.0 Favored 'Cis proline' 0 C--N 1.362 1.261 0 CA-C-N 121.309 1.503 . . . . 0.0 114.286 -1.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.611 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 31.2 mt-30 -141.41 134.77 29.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.661 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -99.22 135.17 41.02 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -119.63 131.11 55.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.795 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.2 t -116.66 120.6 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t0 54.8 37.74 29.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 123.242 1.496 . . . . 0.0 108.595 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.634 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 67.19 29.09 73.97 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.957 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -132.5 134.85 45.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.382 0.611 . . . . 0.0 111.366 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.843 HD22 ' HB1' ' A' ' 66' ' ' ALA . 60.8 tp -67.36 130.35 42.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.818 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.51 HG12 ' CG2' ' A' ' 86' ' ' ILE . 99.3 t -106.03 -54.28 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.772 170.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.32 134.16 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.71 -63.98 1.58 Allowed Glycine 0 C--O 1.219 -0.829 0 C-N-CA 119.047 -1.549 . . . . 0.0 116.316 -167.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 22.4 p -80.21 -67.45 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.429 1.115 . . . . 0.0 112.956 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.33 -45.29 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.316 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.51 ' CG2' HG12 ' A' ' 81' ' ' VAL . 50.4 mm -57.8 -44.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.338 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 82' ' ' GLY . 79.4 t -58.02 -48.51 84.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.99 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.504 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 38.1 mm -59.78 -49.91 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.388 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.765 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 35.5 tt0 -60.79 -52.95 62.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.291 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.532 ' HG3' ' CA ' ' A' ' 96' ' ' LEU . 41.7 tpp -60.88 -34.81 75.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.82 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 16.8 t80 -58.81 -51.45 69.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.014 171.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.6 mt-30 -62.38 -39.29 92.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.991 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 45.6 mmm-85 -60.75 -30.72 70.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.73 175.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.02 -23.69 10.45 Favored Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.726 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.9 mt-10 -62.51 -21.32 65.42 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' MET . 62.5 tp -61.35 -54.86 38.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.343 0.592 . . . . 0.0 110.669 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.81 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 11.8 pt20 -64.03 -25.53 68.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.374 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 13.3 mm100 -64.2 -48.08 77.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.272 0.558 . . . . 0.0 109.599 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 38.5 mt -65.74 -45.88 80.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.155 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.8 mm -63.82 -44.35 98.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.144 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.557 ' HE3' ' HB3' ' A' ' 114' ' ' ALA . 28.7 ttmt -51.89 -57.69 8.66 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 111.2 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.5 -45.79 92.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.165 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 80.7 m -68.99 -46.85 67.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.455 ' HA ' ' HZ3' ' A' ' 108' ' ' LYS . . . -60.75 -45.93 92.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.37 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.09 82.01 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.754 0.659 . . . . 0.0 112.323 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.503 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.06 -33.39 63.66 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.747 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.503 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 80.1 m-85 -80.19 -51.55 8.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.641 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HZ3' ' HA ' ' A' ' 104' ' ' ALA . 1.1 mppt? -106.29 131.34 53.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m -51.82 125.44 15.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.471 0.653 . . . . 0.0 112.267 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 35.13 52.0 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.293 -1.776 . . . . 0.0 114.969 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 27.4 tt0 -77.37 120.49 81.73 Favored Pre-proline 0 N--CA 1.427 -1.592 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 6.1 Cg_exo -86.73 60.75 4.27 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.55 2.833 . . . . 0.0 114.563 -170.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.849 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.8 m-20 -50.95 -70.48 0.08 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -83.81 -48.44 10.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.263 0.554 . . . . 0.0 110.966 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.466 ' H ' ' HE2' ' A' ' 101' ' ' LYS . 34.4 tt0 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.161 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.9 mtp . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -66.41 -43.61 85.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.844 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 4' ' ' THR . 74.7 p 56.19 115.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.3 1.04 . . . . 0.0 112.401 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 3' ' ' THR . 11.8 p -163.0 144.15 9.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.955 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 62' ' ' LEU . 41.2 mt -54.61 -34.05 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.22 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.62 -51.15 64.01 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 20.4 ptmt -67.53 -40.37 85.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.44 0.638 . . . . 0.0 109.599 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG21 ' HG ' ' A' ' 62' ' ' LEU . 73.9 mt -57.54 -49.09 81.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.941 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 31.2 mt-30 -61.71 -40.75 96.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.597 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -57.75 -37.07 72.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.296 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.01 -47.19 69.13 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.122 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.794 HG22 ' HA2' ' A' ' 78' ' ' GLY . 22.2 mt -67.52 -39.15 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.789 0.804 . . . . 0.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.71 88.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.512 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.6 pt-20 -70.33 -38.49 74.88 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.554 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 1.6 p30 -77.17 135.44 66.38 Favored Pre-proline 0 CA--C 1.512 -0.514 0 CA-C-O 121.652 0.739 . . . . 0.0 111.877 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.609 ' O ' HD13 ' A' ' 17' ' ' ILE . 33.7 Cg_exo -62.75 -42.17 26.91 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 122.801 2.334 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 16' ' ' PRO . 25.5 mm -139.38 120.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.726 HD11 HG23 ' A' ' 50' ' ' VAL . 27.7 tp -131.66 142.89 49.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.483 0.659 . . . . 0.0 111.855 -171.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.9 tp -136.94 123.85 21.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.442 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.601 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 7.2 m-85 -98.86 119.99 38.55 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.801 -0.562 . . . . 0.0 111.702 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 18.5 ptt? -146.23 -165.77 2.3 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 63.8 tttm -99.08 121.45 41.01 Favored 'General case' 0 C--O 1.208 -1.122 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.69 69.19 1.03 Allowed Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.332 -175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -79.94 148.54 68.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.818 -0.225 . . . . 0.0 111.233 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.85 -41.5 68.67 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.19 1.927 . . . . 0.0 111.121 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.615 ' HE3' ' SG ' ' A' ' 30' ' ' CYS . 60.8 pttt -66.7 -31.31 71.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.66 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 49.6 tp -160.43 122.84 1.82 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 2.8 Cg_exo -73.9 29.36 0.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.432 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 8.3 t -165.35 47.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.48 173.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.615 ' SG ' ' HE3' ' A' ' 26' ' ' LYS . 34.6 t -71.24 57.08 0.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.86 -136.4 2.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -76.71 -38.65 53.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 117.607 0.703 . . . . 0.0 110.992 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.876 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 33.1 t -55.13 -10.15 0.5 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.54 -40.74 60.26 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.194 0.198 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.424 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.49 -35.72 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.922 176.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 87' ' ' VAL . . . -64.24 -43.64 94.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.142 0.577 . . . . 0.0 112.518 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.23 -36.13 44.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.337 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -66.12 -43.8 86.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.102 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.716 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -57.08 -45.21 83.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.456 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 74' ' ' LEU . 1.8 mt -61.84 -59.41 5.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.01 67.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.38 -49.13 28.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.402 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.841 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.1 p -75.55 -57.23 4.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.199 -171.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.25 -142.15 12.21 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.439 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 90.7 mt-10 -100.2 -151.46 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.943 0.878 . . . . 0.0 111.248 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.94 158.29 35.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.57 174.054 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CG ' HD13 ' A' ' 40' ' ' LEU . 13.5 p90 -151.82 160.83 43.42 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.688 -171.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.19 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.6 p90 -140.3 152.56 45.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 18' ' ' LEU . 51.5 t -129.37 132.19 66.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.804 0.335 . . . . 0.0 110.339 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' MET . 32.3 p-10 -76.64 129.32 36.22 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.543 0.687 . . . . 0.0 110.686 173.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.704 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -144.4 -36.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.903 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.84 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -65.6 -10.42 35.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.814 168.415 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -96.37 -43.8 7.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.603 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -83.86 113.94 50.81 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 122.137 -0.352 . . . . 0.0 110.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.9 -45.54 28.12 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.966 2.444 . . . . 0.0 113.381 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.504 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.89 -38.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.138 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.665 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 58.3 ttt-85 -49.81 -35.78 24.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.425 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -86.77 -41.28 14.24 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -174.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -79.57 -60.94 2.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -162.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.766 HD13 ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -73.09 -27.66 0.88 Allowed Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -172.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.766 ' HD3' HD13 ' A' ' 62' ' ' LEU . 17.9 Cg_endo -57.2 -41.17 76.7 Favored 'Trans proline' 0 C--N 1.357 1.006 0 CA-C-N 121.368 1.524 . . . . 0.0 110.853 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 39.1 mtmt -54.86 -39.37 68.56 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.733 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.611 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.43 -41.52 80.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.871 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.797 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.91 -57.7 3.74 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.562 -176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.6 t30 -175.0 -53.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.947 0.88 . . . . 0.0 109.987 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.644 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.93 146.62 81.65 Favored Pre-proline 0 C--O 1.218 -0.6 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.208 -176.045 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.01 -35.99 84.81 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.127 1.885 . . . . 0.0 110.667 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.1 p -141.79 -128.58 0.1 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.568 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.963 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 30.5 m-85 -142.23 -173.75 0.38 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.963 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.6 Cg_endo -66.99 160.16 78.87 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 120.848 1.339 . . . . 0.0 114.36 -0.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.634 ' HA ' ' CA ' ' A' ' 83' ' ' GLY . 56.0 mt-30 -150.78 129.45 12.3 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.179 172.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.475 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.1 tm? -89.58 137.38 32.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.024 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 58.6 m95 -121.64 131.34 54.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.206 0.526 . . . . 0.0 110.87 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 100' ' ' ILE . 67.2 t -116.6 119.52 62.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.608 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t70 54.75 41.5 31.87 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.993 1.378 . . . . 0.0 108.933 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.794 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 62.76 28.28 71.41 Favored Glycine 0 C--N 1.31 -0.897 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.696 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -129.04 134.8 48.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 111.107 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.3 tp -66.64 136.96 56.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.618 -173.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' HG21 ' A' ' 86' ' ' ILE . 96.2 t -115.08 -56.26 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.813 170.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.763 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 155.73 133.74 1.73 Allowed Glycine 0 C--O 1.225 -0.431 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.67 -61.37 1.7 Allowed Glycine 0 C--O 1.218 -0.886 0 C-N-CA 119.999 -1.096 . . . . 0.0 115.625 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.58 -67.9 0.73 Allowed 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.705 -0.88 . . . . 0.0 112.262 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -80.72 -51.32 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.9 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.763 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 50.1 mm -55.8 -53.5 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.459 -171.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 96' ' ' LEU . 10.4 p -59.8 -43.12 91.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.34 -173.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.716 HD13 ' HB2' ' A' ' 39' ' ' ALA . 34.8 mm -59.14 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.489 175.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.726 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.9 tt0 -62.54 -48.94 77.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.483 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.404 ' C ' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -54.62 -39.79 68.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.922 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.573 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.8 t80 -59.01 -52.68 64.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 174.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.1 -38.66 91.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.742 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 23.1 mmm180 -61.64 -32.07 72.2 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.402 0.62 . . . . 0.0 109.824 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 83.61 21.43 58.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.611 -174.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.635 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 62.8 mm-40 -90.34 -31.36 16.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 110.737 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.598 HD11 HG22 ' A' ' 87' ' ' VAL . 1.4 tt -57.77 -54.75 43.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.204 -175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.841 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.1 pt20 -62.18 -27.43 68.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.394 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 9.4 mm-40 -68.83 -44.26 73.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.295 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 40.6 mt -65.84 -48.08 72.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.686 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 17' ' ' ILE . 42.5 mm -60.86 -48.28 89.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.102 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.694 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 39.7 ttpt -58.17 -47.26 83.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.643 0.259 . . . . 0.0 111.676 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -59.49 -48.32 82.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.018 0.437 . . . . 0.0 110.046 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.608 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 60.2 m -69.74 -46.25 66.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.372 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.844 ' HB1' ' HE2' ' A' ' 108' ' ' LYS . . . -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.56 86.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.8 -26.57 64.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.877 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.537 ' CE2' ' HD2' ' A' ' 106' ' ' LYS . 92.3 m-85 -91.48 -48.9 6.61 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.531 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.844 ' HE2' ' HB1' ' A' ' 104' ' ' ALA . 39.4 mtmt -91.72 110.22 21.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -61.64 125.76 24.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.098 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' C ' ' HD3' ' A' ' 112' ' ' PRO . 48.2 mt-10 55.87 45.28 24.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.371 175.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 5.5 mm-40 -121.87 67.13 22.36 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.214 176.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 110' ' ' GLU . 26.9 Cg_exo -64.08 115.98 3.44 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.797 1.665 . . . . 0.0 112.431 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -77.21 -59.19 2.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.195 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.694 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -68.7 -58.04 4.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.058 0.456 . . . . 0.0 111.797 -172.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.518 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 9.7 tm-20 . . . . . 0 C--O 1.248 0.98 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.49 0.186 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 t 59.83 -129.62 1.05 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.201 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.557 HG21 HG12 ' A' ' 58' ' ' ILE . 26.8 m -148.03 53.62 1.03 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.999 0.905 . . . . 0.0 108.765 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.7 p -66.63 149.45 50.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.41 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 57.7 mt -52.24 -35.8 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.832 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 97.3 mt-10 -56.55 -46.01 80.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.342 . . . . 0.0 110.43 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.55 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 3.7 mmmp? -65.21 -44.09 89.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 172.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.824 HD13 ' HB3' ' A' ' 62' ' ' LEU . 91.1 mt -60.31 -46.96 94.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.599 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.55 -43.6 98.41 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.803 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -59.09 -33.9 71.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.591 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.4 tt0 -72.35 -44.77 62.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.077 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.785 HG22 ' HA2' ' A' ' 78' ' ' GLY . 38.1 mt -67.31 -43.11 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.173 0.511 . . . . 0.0 110.184 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.41 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.211 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -66.8 -32.71 74.17 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.613 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -78.43 127.04 82.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.84 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' O ' HD13 ' A' ' 17' ' ' ILE . 69.3 Cg_exo -58.47 -42.61 53.36 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.992 2.462 . . . . 0.0 111.973 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 16' ' ' PRO . 24.3 mm -138.28 123.23 22.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.72 HD23 HG23 ' A' ' 12' ' ' ILE . 21.2 tp -133.92 141.24 47.25 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -171.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.5 tp -138.98 118.87 13.24 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.749 -173.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.637 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 m-85 -97.69 124.75 42.14 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.332 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.782 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 13.3 ptp -145.03 -168.21 2.88 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.241 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.89 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 64.2 tttm -97.68 111.87 23.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.57 127.78 9.31 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 119.619 -1.276 . . . . 0.0 112.628 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 m -142.73 141.54 20.49 Favored Pre-proline 0 N--CA 1.442 -0.844 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -52.98 -41.16 73.42 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.331 2.021 . . . . 0.0 111.981 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.14 -27.24 62.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.164 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.471 HD22 ' H ' ' A' ' 29' ' ' SER . 1.4 tt -158.71 113.22 1.65 Allowed Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' O ' ' SD ' ' A' ' 21' ' ' MET . 39.3 Cg_endo -71.63 15.86 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.566 2.178 . . . . 0.0 114.156 -176.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.782 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.8 p -161.69 51.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 39.0 t -68.71 51.58 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.465 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.0 -137.02 2.11 Favored Glycine 0 C--N 1.316 -0.564 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.176 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.27 -39.79 53.46 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 117.11 0.455 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.823 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 19.2 t -57.64 -11.21 1.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.455 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 37' ' ' VAL . . . -53.31 -43.67 67.76 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.35 0.406 . . . . 0.0 111.521 176.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -80.25 -31.94 38.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.746 179.366 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.58 85.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.216 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 34' ' ' ALA . 9.5 p -54.46 -37.09 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.219 0.533 . . . . 0.0 110.447 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -64.56 -46.3 83.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.464 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.62 -44.08 89.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.577 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.487 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -62.73 -55.83 23.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.437 . . . . 0.0 110.376 -175.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 47' ' ' PHE . . . -59.35 -32.88 70.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.182 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.97 -48.6 43.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.509 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.7 p -75.69 -50.54 15.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.43 -130.51 7.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.092 -0.575 . . . . 0.0 114.419 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.657 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 2.4 pp20? -128.89 -152.74 0.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.457 -0.872 . . . . 0.0 109.65 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 -64.17 152.96 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.608 0.718 . . . . 0.0 111.421 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.487 ' CG ' HD13 ' A' ' 40' ' ' LEU . 20.8 p90 -158.78 150.01 20.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.866 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.05 144.24 28.42 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.193 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.2 p90 -124.87 154.61 40.79 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.436 HG23 HD11 ' A' ' 18' ' ' LEU . 48.4 t -130.66 130.14 64.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' MET . 11.3 p-10 -74.94 132.29 41.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.228 175.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.695 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -149.21 -31.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.965 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.89 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -68.34 -9.34 47.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.269 167.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -95.82 -47.68 6.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.984 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.669 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.4 m-20 -73.8 126.27 89.7 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 120.502 0.191 . . . . 0.0 110.653 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.98 -42.89 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.246 1.964 . . . . 0.0 113.16 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.86 -53.31 8.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.945 0.402 . . . . 0.0 112.021 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.557 HG12 HG21 ' A' ' 3' ' ' THR . 37.3 mt -60.8 -32.34 51.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.49 0.662 . . . . 0.0 110.33 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.727 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 29.8 ttm180 -53.16 -34.91 58.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.167 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.4 6.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.64 -55.0 5.9 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -163.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.824 ' HB3' HD13 ' A' ' 8' ' ' ILE . 3.6 pp -68.39 -35.89 7.78 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.727 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 25.6 Cg_endo -58.21 -42.43 56.76 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.393 1.396 . . . . 0.0 111.394 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -58.31 -34.17 70.29 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.073 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.521 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.65 -39.99 91.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.937 177.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -72.58 -53.53 11.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.575 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.859 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.5 t-20 -171.55 -47.83 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.022 174.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.859 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 33.5 p90 -124.8 146.33 52.68 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -40.19 -36.8 1.64 Allowed 'Trans proline' 0 C--N 1.352 0.715 1 C-N-CA 125.4 4.067 . . . . 0.0 117.152 -169.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 p -140.5 -135.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 119.076 0.853 . . . . 0.0 111.951 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.975 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 49.2 m-85 -145.15 -172.43 0.31 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.975 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 21.1 Cg_endo -62.91 154.53 69.04 Favored 'Cis proline' 0 C--N 1.36 1.184 0 CA-C-N 120.6 1.25 . . . . 0.0 114.33 -0.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.711 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 82.2 mt-30 -139.97 131.7 27.39 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.352 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -95.94 139.35 32.26 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.339 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.675 ' N ' HD13 ' A' ' 74' ' ' LEU . 57.7 m95 -127.73 127.79 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.384 0.611 . . . . 0.0 110.739 177.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 99' ' ' LEU . 57.3 t -113.2 118.33 57.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.273 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.6 t70 57.03 32.26 21.37 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 123.757 1.741 . . . . 0.0 108.711 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.785 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.33 28.43 67.96 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 113.488 -1.687 . . . . 0.0 113.04 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 40.5 mt-10 -119.44 133.37 55.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.786 HD21 ' HZ3' ' A' ' 68' ' ' TRP . 18.9 tp -65.57 131.44 46.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.781 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 86' ' ' ILE . 84.6 t -117.76 -52.84 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.931 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.82 ' HA3' HD12 ' A' ' 86' ' ' ILE . . . 134.08 133.24 3.3 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.37 -60.82 1.87 Allowed Glycine 0 C--O 1.222 -0.634 0 N-CA-C 116.367 1.307 . . . . 0.0 116.367 -166.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -75.24 -68.95 0.51 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.439 -1.036 . . . . 0.0 113.378 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -78.71 -43.9 24.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.443 0.639 . . . . 0.0 110.629 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.82 HD12 ' HA3' ' A' ' 82' ' ' GLY . 43.7 mt -60.34 -42.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.456 -171.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -59.93 -50.38 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.055 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.7 mm -60.73 -49.04 86.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.447 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.78 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.9 tt0 -61.89 -54.35 43.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.918 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.408 ' HA ' ' HB2' ' A' ' 93' ' ' ARG . 55.1 mtt -58.43 -32.46 68.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.605 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.2 t80 -58.57 -53.19 61.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.73 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.1 mt-30 -65.12 -39.45 93.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.48 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.78 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.0 mmt180 -59.37 -33.6 71.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.657 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.623 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 94.8 -24.37 28.51 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -169.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.673 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.8 mt-10 -57.57 -31.22 65.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 99' ' ' LEU . 56.3 tp -68.91 -55.42 11.08 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.585 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 1.019 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 10.2 pt20 -57.56 -24.71 57.66 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.15 171.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 45.5 mm-40 -71.01 -56.75 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 76' ' ' VAL . 2.2 pp -70.67 -34.72 72.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 99' ' ' LEU . 38.1 mm -62.03 -42.32 94.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 39.5 ttmt -52.32 -56.8 12.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.183 0.516 . . . . 0.0 112.072 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.38 -45.9 90.17 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.582 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 58.8 m -66.45 -51.09 60.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.351 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 45' ' ' GLU . . . -60.94 -51.66 68.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.87 -175.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.61 73.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.515 -176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.57 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.58 -25.73 50.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.042 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.472 ' HE2' HG23 ' A' ' 103' ' ' THR . 54.4 m-85 -84.93 -48.59 9.14 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.09 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -102.66 108.41 19.67 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 m -53.46 122.76 10.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.416 0.627 . . . . 0.0 110.787 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 49.31 38.98 14.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.736 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.415 ' OE2' ' HB2' ' A' ' 45' ' ' GLU . 38.7 tt0 -77.49 133.32 67.52 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.05 128.26 23.61 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.865 1.71 . . . . 0.0 112.65 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -98.6 -129.49 0.19 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.694 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.019 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -82.01 -46.64 13.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.901 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.596 -1.192 . . . . 0.0 108.558 -171.061 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.783 0.325 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 p -177.59 142.65 0.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.555 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -71.52 -127.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.122 0.264 . . . . 0.0 110.861 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG13 ' A' ' 8' ' ' ILE . 44.6 p -143.47 -134.66 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 0.0 111.2 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.542 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 77.8 mt -51.19 -37.08 17.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.478 0.711 . . . . 0.0 112.607 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.97 -44.03 82.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.144 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.69 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -70.79 -45.45 64.66 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.956 0.408 . . . . 0.0 110.175 171.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.62 HD13 HD22 ' A' ' 62' ' ' LEU . 79.4 mt -54.35 -47.09 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 32.6 mt-30 -63.62 -39.74 95.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.606 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 12.1 mmp_? -61.09 -34.22 74.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.343 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.529 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 17.3 tm0? -74.63 -41.27 60.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.469 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.843 HG22 ' HA2' ' A' ' 78' ' ' GLY . 30.5 mt -66.5 -46.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.712 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.13 -39.96 94.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.862 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -65.5 -32.5 74.13 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.113 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -76.68 125.44 87.25 Favored Pre-proline 0 CA--C 1.517 -0.312 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.846 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HA ' ' CE2' ' A' ' 107' ' ' TYR . 45.7 Cg_exo -62.26 -42.91 25.84 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 122.462 2.108 . . . . 0.0 112.225 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.7 mm -136.27 121.71 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.648 HD23 HG23 ' A' ' 12' ' ' ILE . 22.0 tp -133.05 142.08 48.58 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.327 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.1 tp -137.21 119.9 16.16 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.151 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.653 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -97.36 120.03 36.99 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.986 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.699 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 21.1 ptt? -146.29 -170.92 3.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.126 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.008 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.2 119.87 35.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.387 -0.821 . . . . 0.0 109.576 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.77 71.62 1.29 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.077 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 36.6 t -78.54 142.56 62.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.85 -40.9 82.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.019 1.812 . . . . 0.0 111.459 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.7 pttt -67.99 -30.36 69.61 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.805 177.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 29' ' ' SER . 49.1 tp -160.62 115.97 1.4 Allowed Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.2 Cg_exo -71.19 29.73 0.22 Allowed 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 123.145 2.563 . . . . 0.0 112.985 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.699 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 11.9 p -162.58 46.61 0.15 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 42.6 t -64.64 147.57 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.678 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.55 -141.35 15.27 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.799 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.56 ' HB3' HE22 ' A' ' 35' ' ' GLN . 15.5 m-85 -78.2 -38.27 43.69 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.0 p -46.77 -19.61 0.1 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.35 -42.99 53.94 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.985 0.178 . . . . 0.0 111.095 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.56 HE22 ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -79.35 -37.11 38.26 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 33' ' ' SER . . . -66.6 -45.79 78.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.1 p -56.36 -36.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.73 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -66.78 -46.85 73.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.285 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.584 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.05 -40.09 84.02 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.15 0.281 . . . . 0.0 111.609 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.3 tt -62.43 -57.26 11.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.938 -175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 -35.19 79.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.386 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.12 -47.67 76.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.016 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.895 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.3 m -73.08 -55.57 6.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.2 -133.14 8.01 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.308 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 113' ' ' ASP . 64.5 mm-40 -137.36 -150.64 0.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.708 -0.746 . . . . 0.0 110.241 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -60.07 150.72 28.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.476 0.655 . . . . 0.0 112.487 -172.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.465 ' CD2' HD13 ' A' ' 40' ' ' LEU . 20.3 p90 -157.93 156.72 31.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.359 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.34 152.94 18.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.621 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.5 p90 -138.1 152.63 48.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.611 HG23 HD11 ' A' ' 18' ' ' LEU . 58.6 t -129.66 130.91 67.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 110.27 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' MET . 9.5 p-10 -76.53 128.12 34.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.58 175.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -145.22 -38.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.008 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -60.46 -17.81 47.2 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.003 0.82 . . . . 0.0 110.822 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -33.97 12.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -74.72 131.22 79.91 Favored Pre-proline 0 N--CA 1.477 0.88 0 O-C-N 122.178 -0.326 . . . . 0.0 110.709 172.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.79 -43.99 4.68 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.467 2.111 . . . . 0.0 112.943 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.58 -57.95 3.56 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.71 -35.28 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.688 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.591 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -55.72 -27.99 53.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.95 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -89.14 -48.08 7.64 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -171.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 52.7 mt-10 -78.93 -60.05 2.53 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.294 1.591 . . . . 0.0 115.294 -162.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.687 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 1.8 pt? -67.47 -34.64 7.05 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 19.1 Cg_endo -56.11 -38.22 95.2 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.405 1.403 . . . . 0.0 110.997 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 42.8 mtmt -55.23 -41.99 72.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.439 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.591 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.63 -38.86 84.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.093 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB1' HD13 ' A' ' 80' ' ' LEU . . . -68.75 -53.54 21.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.158 -175.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.949 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.6 t-20 -172.35 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.658 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.949 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 31.2 p90 -126.49 149.42 67.68 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.736 -167.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.62 -37.48 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 125.256 3.971 . . . . 0.0 117.05 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.9 p -140.78 -137.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.202 0.91 . . . . 0.0 111.961 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 42.6 m-85 -140.57 -170.71 0.25 Allowed Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -173.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.968 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.0 Cg_endo -64.41 148.62 70.15 Favored 'Cis proline' 0 C--N 1.36 1.149 0 CA-C-N 120.864 1.344 . . . . 0.0 113.495 -2.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.623 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 68.2 mt-30 -133.5 130.59 38.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.758 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -92.31 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.572 ' N ' HD13 ' A' ' 74' ' ' LEU . 67.3 m95 -125.03 129.4 50.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.69 0.757 . . . . 0.0 111.323 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.499 HG11 ' HB3' ' A' ' 99' ' ' LEU . 86.5 t -115.91 120.08 63.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.1 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.462 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.1 t70 56.93 32.08 20.9 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 123.078 1.418 . . . . 0.0 109.145 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.843 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.17 28.19 70.59 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 114.044 -1.435 . . . . 0.0 113.264 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -127.95 135.14 49.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 111.126 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.873 HD21 ' HZ3' ' A' ' 68' ' ' TRP . 19.4 tp -64.65 136.13 56.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.67 -172.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.539 ' O ' HG21 ' A' ' 86' ' ' ILE . 91.3 t -120.8 -53.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.358 170.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.9 ' HA2' ' HH2' ' A' ' 68' ' ' TRP . . . 129.7 133.32 3.58 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.73 -61.37 1.7 Allowed Glycine 0 C--O 1.221 -0.69 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -167.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.18 -68.91 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.632 -0.922 . . . . 0.0 113.431 -166.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -80.72 -41.91 22.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.077 0.465 . . . . 0.0 110.469 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.628 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.5 mp -60.41 -45.7 96.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.58 -171.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.0 t -58.83 -47.67 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.715 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 39' ' ' ALA . 32.8 mm -60.15 -46.61 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.02 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.728 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 85.2 tt0 -61.11 -54.66 41.82 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.932 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.587 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.3 mmt -57.97 -36.32 72.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.712 0.292 . . . . 0.0 111.512 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.895 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 18.7 t80 -56.36 -51.43 68.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.781 172.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 77.2 mt-30 -65.32 -38.46 90.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.9 mmm180 -58.94 -34.37 71.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.072 176.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 86.88 -23.93 9.78 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -168.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.782 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.6 mt-10 -58.01 -29.39 65.27 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.588 ' O ' HG12 ' A' ' 100' ' ' ILE . 63.7 tp -60.14 -56.63 19.19 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.201 0.524 . . . . 0.0 111.063 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.738 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.2 pt20 -63.12 -28.99 70.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.917 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 49.5 mm-40 -62.27 -47.15 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.038 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 37.0 mt -66.19 -45.36 81.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 96' ' ' LEU . 49.5 mm -61.38 -47.88 91.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.721 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.884 ' HD3' ' H ' ' A' ' 115' ' ' GLU . 39.7 ttpt -62.01 -49.46 75.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.553 0.216 . . . . 0.0 111.339 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -55.42 -44.95 76.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.614 0.721 . . . . 0.0 109.957 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.489 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 92.9 m -70.53 -45.86 64.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.472 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.407 ' O ' ' HE2' ' A' ' 108' ' ' LYS . . . -59.65 -44.23 93.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 109' ' ' SER . . . -61.01 -41.84 97.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.478 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -72.87 -31.78 64.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.333 -178.494 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' A' ' 16' ' ' PRO . 60.0 m-85 -78.47 -47.09 18.15 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.55 ' CE ' ' HG3' ' A' ' 111' ' ' GLU . 3.1 mppt? -98.82 -145.47 0.32 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.496 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 105' ' ' ALA . 50.4 m -83.57 -155.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -70.08 59.91 0.18 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.55 ' HG3' ' CE ' ' A' ' 108' ' ' LYS . 58.5 mm-40 -59.48 121.94 60.61 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -92.7 48.14 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.656 2.237 . . . . 0.0 113.924 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.1 m-20 -51.27 -51.27 55.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.113 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.758 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -88.63 -48.04 7.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.043 0.449 . . . . 0.0 111.304 176.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.884 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 3.5 tm-20 . . . . . 0 C--O 1.244 0.793 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.872 0.368 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 p -168.84 -42.89 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.369 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.6 p -74.29 46.24 0.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.902 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 p -69.63 137.59 52.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.944 0.402 . . . . 0.0 110.558 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.434 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 61.1 mt -58.23 -31.28 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.681 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -55.61 -47.1 77.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.21 -43.5 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.48 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.86 HD13 ' HB2' ' A' ' 62' ' ' LEU . 85.2 mt -62.32 -47.83 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.435 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.445 ' HG2' ' CZ ' ' A' ' 65' ' ' TYR . 33.2 mt-30 -62.91 -39.35 94.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.224 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -58.86 -34.5 71.66 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 65.6 tt0 -73.14 -50.35 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.784 HG22 ' HA2' ' A' ' 78' ' ' GLY . 26.5 mt -63.4 -38.13 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.873 0.845 . . . . 0.0 111.042 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.4 83.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.269 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -73.78 -35.82 65.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.861 -171.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.712 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -77.21 131.28 72.69 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 121.494 0.664 . . . . 0.0 111.323 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 50.2 Cg_exo -59.44 -42.06 52.05 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.24 2.626 . . . . 0.0 112.492 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.9 mm -141.9 121.33 10.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.712 HD22 ' OD1' ' A' ' 15' ' ' ASN . 22.8 tp -131.83 142.67 49.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 0.0 111.313 -170.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 21' ' ' MET . 11.8 tp -137.22 121.45 18.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.359 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.818 ' CE2' HD21 ' A' ' 62' ' ' LEU . 8.0 m-85 -97.92 115.69 28.62 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.808 ' HE3' ' HB3' ' A' ' 33' ' ' SER . 14.2 ptm -148.06 -157.18 0.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.016 173.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.671 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 tttt -98.28 125.98 43.59 Favored 'General case' 0 C--O 1.213 -0.857 0 O-C-N 121.232 -0.917 . . . . 0.0 112.154 -169.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 67.91 0.94 Allowed Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.442 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 p -77.09 145.04 72.75 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -51.62 -41.48 60.97 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.616 2.211 . . . . 0.0 112.127 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.75 -29.08 68.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.131 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tt -159.96 118.0 1.57 Allowed Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.66 17.84 0.13 Allowed 'Trans proline' 0 N--CA 1.47 0.141 0 C-N-CA 122.801 2.334 . . . . 0.0 114.471 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.76 ' HB2' ' CE ' ' A' ' 21' ' ' MET . 11.2 p -164.12 61.11 0.15 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.42 0.629 . . . . 0.0 112.605 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.547 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 39.1 t -80.67 -143.3 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.946 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 65.42 -152.89 51.27 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 122.409 -0.182 . . . . 0.0 113.432 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 17.6 m-85 -78.19 -35.95 48.0 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.808 ' HB3' ' HE3' ' A' ' 21' ' ' MET . 32.4 t -59.72 -7.3 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.036 -0.415 . . . . 0.0 112.091 -172.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.28 -42.05 9.27 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -75.01 -38.86 61.43 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.244 0.545 . . . . 0.0 109.708 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.72 -43.97 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.383 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 34' ' ' ALA . 11.1 p -55.87 -37.6 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.449 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 26.3 mm-40 -67.78 -45.44 74.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.783 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -58.0 -44.69 87.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.644 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.419 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.25 -57.49 12.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.955 0.407 . . . . 0.0 110.271 -175.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.05 -32.17 70.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.567 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.6 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.2 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.755 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.3 p -74.47 -54.58 7.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.18 -130.2 6.93 Favored Glycine 0 N--CA 1.454 -0.151 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.933 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.669 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 49.5 mt-10 -140.84 -149.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.168 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 40.3 mmt180 -48.1 146.64 2.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.421 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 20.0 p90 -158.5 153.15 24.66 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.35 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.61 152.77 19.24 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.682 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -132.12 148.44 52.48 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.656 HG23 HD11 ' A' ' 18' ' ' LEU . 43.3 t -123.2 131.12 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.6 p30 -81.63 131.23 35.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.365 0.602 . . . . 0.0 109.957 176.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 53' ' ' LEU . 1.2 pp -147.49 -28.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.741 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.734 HD22 HD12 ' A' ' 52' ' ' ILE . 1.9 mm? -65.87 -14.5 61.58 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -96.18 -46.12 6.58 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.858 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 32.0 m120 -77.28 121.33 84.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.615 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 18.5 Cg_exo -66.89 -43.66 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.974 2.449 . . . . 0.0 112.939 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.78 -51.08 29.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 62' ' ' LEU . 33.1 mt -63.52 -34.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.172 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.64 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 47.9 ttt85 -50.88 -35.32 32.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.195 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.611 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -90.89 -51.87 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.495 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 56.6 mm-40 -76.93 -55.46 5.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -167.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.86 ' HB2' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -61.55 -43.57 89.12 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -172.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 20.4 Cg_endo -57.81 -41.54 68.62 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 121.334 1.356 . . . . 0.0 111.217 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 52.4 mtmt -57.04 -35.27 69.1 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.766 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.606 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.0 -43.22 83.48 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.943 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.811 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.08 -56.88 4.29 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.799 -175.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.707 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 25.8 t-20 -174.85 -55.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.34 1.067 . . . . 0.0 109.507 172.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.707 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.3 m-90 -58.79 147.28 72.58 Favored Pre-proline 0 C--O 1.216 -0.687 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.339 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.71 -38.27 72.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.345 2.03 . . . . 0.0 110.306 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.9 p -142.66 -124.73 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.462 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.97 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 53.6 m-85 -139.61 -172.27 0.31 Allowed Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.97 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 64.3 Cg_endo -71.37 165.05 81.99 Favored 'Cis proline' 0 C--N 1.357 1.014 0 CA-C-N 120.777 1.313 . . . . 0.0 114.611 -1.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.777 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.6 pt20 -156.74 133.67 10.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.038 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 87' ' ' VAL . 61.4 tp -90.72 141.91 28.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.734 178.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.655 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 52.1 m95 -129.16 125.13 36.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 110.329 175.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.04 117.37 51.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.654 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 60.6 t0 57.09 33.99 24.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 123.117 1.437 . . . . 0.0 109.465 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.784 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.41 29.24 68.42 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.071 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -127.31 129.04 46.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.312 . . . . 0.0 110.492 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.811 HD22 ' HB1' ' A' ' 66' ' ' ALA . 59.2 tp -67.95 135.56 52.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.806 -170.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.597 ' O ' HG21 ' A' ' 86' ' ' ILE . 97.9 t -117.48 -53.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.194 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.54 140.03 3.4 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.02 -67.35 1.41 Allowed Glycine 0 C--O 1.216 -0.994 0 C-N-CA 118.226 -1.94 . . . . 0.0 116.258 -167.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 41.8 t -81.61 -68.72 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.728 1.264 . . . . 0.0 113.088 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.88 -47.13 60.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.404 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.597 HG21 ' O ' ' A' ' 81' ' ' VAL . 45.7 mm -58.36 -43.78 87.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.388 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.647 HG13 HD11 ' A' ' 96' ' ' LEU . 69.3 t -59.46 -49.23 84.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.974 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.3 mm -58.22 -49.68 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.36 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.729 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.2 tt0 -61.25 -54.28 46.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.693 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 24.9 mmt -58.58 -35.03 71.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.599 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.5 t80 -58.62 -50.63 73.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.767 173.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.2 mt-30 -62.69 -41.32 99.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 28.8 mmm180 -58.74 -33.88 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.699 178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.9 17.37 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.65 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.813 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 41.0 mt-10 -57.49 -36.92 72.12 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 122.96 0.504 . . . . 0.0 111.728 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.9 tt -61.29 -54.63 41.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.128 0.49 . . . . 0.0 109.92 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 18.9 pt20 -64.91 -28.96 69.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.889 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 31.7 tp60 -63.93 -44.13 93.81 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.239 0.616 . . . . 0.0 110.032 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.813 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 43.0 mt -68.78 -47.53 65.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.907 174.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 96' ' ' LEU . 46.3 mm -57.56 -47.65 84.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.432 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 26.7 ttpp -55.26 -50.73 68.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.664 0.269 . . . . 0.0 111.692 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -48.77 80.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.654 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.0 m -65.17 -53.24 47.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.399 0.619 . . . . 0.0 111.694 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.657 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.71 -44.14 97.0 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.822 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.62 75.92 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.399 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.46 -29.34 67.0 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.131 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.571 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 46.9 m-85 -79.56 -46.06 18.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -77.77 -163.73 0.43 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.097 0.475 . . . . 0.0 110.395 170.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 p -87.45 59.63 5.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.156 0.979 . . . . 0.0 111.964 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 57.07 47.47 17.35 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.777 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.625 ' HG2' ' HB3' ' A' ' 108' ' ' LYS . 43.1 mm-40 -67.78 135.89 92.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.858 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.8 Cg_exo -80.43 51.37 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 124.589 3.526 . . . . 0.0 113.017 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.674 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.4 m-20 -44.98 -59.16 2.72 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 97' ' ' GLN . . . -87.15 -34.43 19.06 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--O 1.247 0.933 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.089 -167.64 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.881 ' HA ' HD11 ' A' ' 58' ' ' ILE . 20.9 ptp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.705 0.288 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t -70.79 126.23 29.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.051 0.453 . . . . 0.0 110.791 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.5 p -86.05 -40.54 15.66 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.785 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.504 ' HB ' ' HG2' ' A' ' 6' ' ' GLU . 41.7 p -59.96 126.16 26.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.981 -175.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.434 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 74.7 mt -59.53 -39.17 78.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.716 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 9.7 pt-20 -52.06 -46.57 65.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.023 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 47.5 mmtm -73.54 -43.69 59.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.015 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.698 HD13 HD22 ' A' ' 62' ' ' LEU . 66.9 mt -53.23 -44.45 53.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -63.14 -33.57 75.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.937 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -58.08 -40.26 80.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.359 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.695 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.8 mp0 -73.69 -46.41 46.46 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' OH ' ' A' ' 65' ' ' TYR . 18.4 mt -59.94 -44.61 94.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.39 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.01 -40.58 95.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.955 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.695 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.4 pt-20 -66.44 -31.38 72.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.269 -176.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 33.7 m120 -76.63 125.87 86.75 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.927 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' HD13 ' A' ' 17' ' ' ILE . 51.5 Cg_exo -60.38 -42.98 37.01 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 123.058 2.505 . . . . 0.0 112.437 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.8 mm -141.13 123.26 14.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 50' ' ' VAL . 20.0 tp -133.51 142.09 48.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.16 -167.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.2 tp -136.37 117.99 14.94 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.326 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.774 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.9 m-85 -97.25 121.76 39.51 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.993 -0.442 . . . . 0.0 112.012 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.982 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 45.3 mmm -147.16 -158.49 0.92 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.011 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.93 112.82 24.41 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.788 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.9 68.04 1.5 Allowed Glycine 0 C--N 1.306 -1.118 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.095 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 p -77.71 144.57 69.3 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -52.74 -40.25 74.58 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.267 1.978 . . . . 0.0 111.529 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -66.7 -32.56 73.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.153 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.17 115.91 2.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.34 15.6 0.2 Allowed 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.895 2.397 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.4 p -164.83 47.08 0.1 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.141 0.496 . . . . 0.0 111.177 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.674 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 45.2 t -65.81 124.12 21.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.306 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.84 -134.71 6.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.424 -175.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.32 -42.14 31.58 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.68 ' CB ' ' HG3' ' A' ' 21' ' ' MET . 29.6 t -55.0 -10.12 0.46 Allowed 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.61 11.29 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.653 0.206 . . . . 0.0 110.893 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.519 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -81.53 -36.99 28.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.008 175.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.36 -44.74 78.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -174.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.581 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.38 -37.95 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.716 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -62.29 -45.1 94.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.113 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -60.3 -45.9 91.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.42 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.77 -56.59 16.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.526 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.49 -32.14 69.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.24 -48.56 50.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.042 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.877 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 31.7 p -71.73 -56.29 6.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.327 -171.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -102.51 -146.09 17.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.456 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 92.5 mt-10 -102.39 -153.55 0.47 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.283 -0.458 . . . . 0.0 111.337 174.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HD2' ' C ' ' A' ' 46' ' ' ARG . 6.5 ppt_? -71.56 150.35 44.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -176.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 12.9 p90 -141.35 156.31 45.84 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.541 -170.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -97.43 152.47 18.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.888 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.9 p90 -136.77 153.97 50.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.744 HG23 HD11 ' A' ' 18' ' ' LEU . 47.3 t -131.71 130.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.788 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -78.64 134.9 37.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.48 0.657 . . . . 0.0 110.907 175.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.774 HG12 ' HD2' ' A' ' 20' ' ' TYR . 1.3 pp -153.08 -34.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.616 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.011 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.2 mm? -69.8 -5.84 28.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.368 168.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -96.85 -43.21 7.59 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.256 176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 75.2 m-80 -82.21 124.9 78.05 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.029 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.18 -44.22 9.79 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 121.992 1.795 . . . . 0.0 112.524 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -56.3 6.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.036 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.881 HD11 ' HA ' ' A' ' 1' ' ' MET . 28.9 mt -61.72 -33.92 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.39 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.628 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 59.8 ttp180 -51.93 -34.0 39.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.982 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.499 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -87.15 -41.59 13.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.62 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -77.96 -61.65 1.93 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -164.37 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 20' ' ' TYR . 2.2 pt? -71.46 -34.0 2.99 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -171.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.729 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 19.8 Cg_endo -56.04 -38.72 94.34 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.348 1.365 . . . . 0.0 110.772 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.62 ' HE3' ' HA ' ' A' ' 61' ' ' GLU . 8.8 mtmp? -54.11 -39.1 66.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.776 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.639 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.6 -38.28 73.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.643 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -70.76 -54.31 12.21 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.562 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.824 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.5 t-20 -171.94 -54.22 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.347 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.862 ' CH2' HD11 ' A' ' 80' ' ' LEU . 32.8 p90 -105.55 144.71 29.38 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.096 -1.411 . . . . 0.0 114.511 -167.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -40.84 -37.0 2.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 125.07 3.847 . . . . 0.0 115.919 -172.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -140.41 -133.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.223 0.465 . . . . 0.0 111.409 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.964 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 45.5 m-85 -141.81 -174.17 0.4 Allowed Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -170.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.982 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 42.6 Cg_endo -65.99 172.58 32.22 Favored 'Cis proline' 0 C--N 1.357 0.989 0 CA-C-N 120.1 1.072 . . . . 0.0 114.032 -0.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.862 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.9 pt20 -160.58 132.43 5.95 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.395 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -96.6 137.68 35.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.217 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.678 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -126.36 125.8 42.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.438 0.637 . . . . 0.0 110.637 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 99' ' ' LEU . 64.8 t -106.77 119.72 56.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.907 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB2' HG23 ' A' ' 103' ' ' THR . 35.1 t70 55.79 28.72 12.73 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.764 1.269 . . . . 0.0 110.268 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.633 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 77.82 29.89 53.54 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.048 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 46.9 mt-10 -126.33 133.83 51.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.706 0.289 . . . . 0.0 111.172 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.862 HD11 ' CH2' ' A' ' 68' ' ' TRP . 24.6 tp -63.76 135.6 56.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.193 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.566 ' O ' HG21 ' A' ' 86' ' ' ILE . 98.4 t -124.33 -51.95 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.765 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.723 ' HA2' ' CH2' ' A' ' 68' ' ' TRP . . . 135.29 135.88 3.53 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -84.35 -61.8 1.78 Allowed Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.682 -1.247 . . . . 0.0 116.208 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 17.6 p -79.86 -67.83 0.73 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 -44.92 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.673 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.566 HG21 ' O ' ' A' ' 81' ' ' VAL . 50.8 mm -56.27 -45.94 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.045 -174.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.5 t -58.34 -49.1 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.6 mm -60.7 -50.64 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.606 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.4 tt0 -61.19 -52.36 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.071 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 59.9 mtt -61.7 -31.14 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.9 t80 -58.35 -51.86 68.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 171.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.1 mt-30 -64.96 -40.3 94.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.231 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 42.7 mmm-85 -57.81 -33.29 68.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.464 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.706 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.38 -25.81 18.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.903 -173.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.775 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 55.6 mt-10 -53.57 -37.27 62.75 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.9 tp -59.68 -54.69 43.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 110.575 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.877 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 12.3 pt20 -65.32 -26.01 67.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.663 175.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 97.3 mm-40 -65.71 -44.57 85.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.266 0.555 . . . . 0.0 109.611 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 44.1 mt -69.65 -47.14 64.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.144 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.703 HG22 ' OD2' ' A' ' 113' ' ' ASP . 45.7 mm -61.98 -42.26 94.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.789 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.586 ' HE3' ' HB3' ' A' ' 114' ' ' ALA . 29.7 ttmt -51.34 -59.14 4.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.37 0.605 . . . . 0.0 111.584 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.41 -42.74 99.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.484 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 77' ' ' ASP . 74.8 m -69.03 -48.58 62.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.752 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.664 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -60.39 -45.96 91.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.601 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.42 81.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.53 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -73.59 -26.38 60.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.242 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.509 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 54.3 m-85 -83.68 -47.23 11.43 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.664 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -83.41 -154.81 0.15 Allowed 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 36.6 m -75.37 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.78 46.93 0.23 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.868 0.366 . . . . 0.0 111.774 174.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -76.86 110.17 11.06 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.347 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.597 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 9.3 Cg_endo -90.8 120.93 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.432 . . . . 0.0 111.81 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.834 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 21.0 m-20 -82.96 -72.15 0.46 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.019 0.437 . . . . 0.0 111.627 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -81.28 48.47 1.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.165 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 42.3 tp10 . . . . . 0 C--O 1.246 0.892 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -170.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.41 0.148 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p -171.59 -46.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.692 0.282 . . . . 0.0 111.463 177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.698 ' HA ' ' OE2' ' A' ' 6' ' ' GLU . 12.5 t -69.39 141.02 54.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.793 0.33 . . . . 0.0 110.406 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t -161.2 -134.46 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.816 -173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.983 HG22 ' HG3' ' A' ' 9' ' ' GLN . 30.2 mm -53.68 -31.43 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 118.053 0.388 . . . . 0.0 111.598 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.698 ' OE2' ' HA ' ' A' ' 3' ' ' THR . 13.6 pt-20 -40.68 -48.32 2.93 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.529 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 75.3 mmtt -62.76 -43.8 97.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 110.303 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.765 HG21 ' HG ' ' A' ' 62' ' ' LEU . 71.9 mt -65.53 -50.05 74.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.631 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.983 ' HG3' HG22 ' A' ' 5' ' ' ILE . 36.0 mt-30 -56.01 -40.48 73.44 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.9 mmp_? -60.93 -33.88 73.84 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.977 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.499 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 66.2 tt0 -72.21 -42.98 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.439 174.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.749 HG22 ' HA2' ' A' ' 78' ' ' GLY . 18.8 mt -64.16 -45.27 96.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.04 0.448 . . . . 0.0 110.376 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -41.01 96.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.936 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 14.0 pt-20 -64.26 -37.42 87.43 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.64 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' CB ' ' HG ' ' A' ' 18' ' ' LEU . 33.2 m120 -77.2 120.56 82.09 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' O ' HD13 ' A' ' 17' ' ' ILE . 49.2 Cg_exo -62.17 -42.05 31.56 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.541 2.161 . . . . 0.0 111.829 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.595 HG23 HD12 ' A' ' 100' ' ' ILE . 31.4 mm -131.93 125.32 54.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.777 HD13 ' HE1' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -131.69 143.4 50.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.276 -169.186 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 17.0 tp -136.67 113.24 10.12 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.394 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.777 ' HE1' HD13 ' A' ' 18' ' ' LEU . 8.0 m-85 -96.01 115.06 26.85 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.815 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.605 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 24.5 ptt? -145.97 -157.31 0.79 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.113 -176.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.741 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 79.6 tttt -98.42 143.38 28.92 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -142.75 130.18 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.204 -171.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.444 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 27.9 t -146.56 143.68 19.29 Favored Pre-proline 0 C--N 1.312 -1.029 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.71 -36.54 82.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.143 1.895 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 18.4 ptpt -64.65 -35.15 80.08 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.178 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -159.52 113.27 1.52 Allowed Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.85 19.63 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 114.649 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.3 p -164.14 49.69 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.468 0.651 . . . . 0.0 111.295 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.741 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 2.2 p -69.44 49.67 0.09 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.32 -136.15 2.15 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.704 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.636 ' HB3' ' SG ' ' A' ' 84' ' ' CYS . 4.2 m-85 -74.63 -40.31 61.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.869 0.843 . . . . 0.0 109.466 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.605 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 51.2 p -54.17 -18.07 3.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.548 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.65 -39.47 36.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 110.401 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.631 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -79.89 -38.88 31.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 175.637 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.28 77.91 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -54.38 -39.38 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.119 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 29.0 mm-40 -64.42 -43.87 92.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.329 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.504 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.38 -42.09 86.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.743 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -55.97 20.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.146 0.498 . . . . 0.0 110.023 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.08 70.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.468 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.26 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.47 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.701 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -77.71 -55.25 5.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.52 -135.33 8.82 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.064 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 30.8 mt-10 -134.9 -148.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.957 0.503 . . . . 0.0 110.909 177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 26.0 mmm180 -50.6 146.42 5.62 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.498 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.424 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 26.6 p90 -158.22 153.77 26.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.962 -175.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.38 143.5 29.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.3 p90 -124.86 148.36 48.29 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG23 HD21 ' A' ' 18' ' ' LEU . 57.7 t -124.81 130.8 73.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.198 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.42 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 41.6 p-10 -78.27 132.07 37.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.604 0.716 . . . . 0.0 110.22 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.966 HD12 ' HG ' ' A' ' 53' ' ' LEU . 1.4 pp -148.68 -34.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.124 -172.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.966 ' HG ' HD12 ' A' ' 52' ' ' ILE . 36.4 mt -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.779 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -97.12 -46.21 6.25 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.5 174.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 m-20 -76.42 120.36 81.32 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 120.579 0.228 . . . . 0.0 110.729 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.19 -44.77 11.36 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.261 1.974 . . . . 0.0 113.039 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.05 -54.13 14.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.0 -36.02 71.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 110.279 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.65 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 60.5 ttp180 -51.5 -32.44 27.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.801 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -90.7 -39.14 12.61 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.456 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 14.8 tp10 -79.64 -62.09 1.8 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -163.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.765 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -74.28 -26.36 0.69 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -173.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.732 ' HD3' HD13 ' A' ' 62' ' ' LEU . 31.9 Cg_endo -59.73 -40.76 61.36 Favored 'Trans proline' 0 C--N 1.358 1.069 0 CA-C-N 121.352 1.519 . . . . 0.0 110.683 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 8.6 mtmp? -56.54 -39.25 73.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.352 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.563 ' HD2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -64.38 -44.03 92.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.874 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -77.88 -57.23 3.91 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.504 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.655 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.3 t30 -174.68 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.026 0.917 . . . . 0.0 110.45 169.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.681 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.49 147.11 51.22 Favored Pre-proline 0 C--O 1.222 -0.38 0 CA-C-N 113.358 -1.747 . . . . 0.0 113.311 -174.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.5 -36.52 76.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.232 1.955 . . . . 0.0 110.045 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -142.69 -126.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.181 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.868 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 10.9 m-85 -143.47 -164.26 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.868 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.2 Cg_endo -67.09 154.92 84.86 Favored 'Cis proline' 0 C--N 1.364 1.385 0 CA-C-N 121.993 1.747 . . . . 0.0 114.057 -1.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.681 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 21.0 mt-30 -142.62 134.13 26.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.641 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -91.09 137.91 32.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.623 ' N ' HD13 ' A' ' 74' ' ' LEU . 69.5 m95 -125.19 128.7 48.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 0.0 110.935 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 99' ' ' LEU . 96.4 t -112.9 115.23 49.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.7 t70 57.58 30.56 18.96 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.633 1.682 . . . . 0.0 108.809 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.749 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.14 29.01 65.23 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 113.485 -1.688 . . . . 0.0 113.05 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 91.4 mt-10 -115.94 130.57 56.88 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.874 HD22 ' HB1' ' A' ' 66' ' ' ALA . 47.0 tp -69.32 134.56 49.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 111.756 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.586 HG12 ' CG2' ' A' ' 86' ' ' ILE . 93.9 t -119.32 -50.33 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.145 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.28 132.88 2.91 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.489 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.77 -64.12 1.57 Allowed Glycine 0 C--O 1.222 -0.631 0 C-N-CA 118.895 -1.621 . . . . 0.0 116.644 -166.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 32' ' ' PHE . 42.2 t -80.3 -68.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.428 1.114 . . . . 0.0 112.3 -170.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.22 -43.98 66.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.498 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.586 ' CG2' HG12 ' A' ' 81' ' ' VAL . 2.4 mp -62.16 -44.1 98.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.151 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.463 HG13 HD21 ' A' ' 96' ' ' LEU . 73.4 t -57.21 -49.2 80.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.244 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.631 HD11 ' HG2' ' A' ' 35' ' ' GLN . 35.7 mm -60.1 -49.92 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.043 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.735 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.2 tt0 -62.16 -51.62 67.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.845 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.586 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.0 mmt -58.77 -35.12 72.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.505 0.193 . . . . 0.0 111.307 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.568 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t80 -58.58 -51.23 70.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.205 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.0 mt-30 -64.77 -41.01 96.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.089 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.3 mmm-85 -60.43 -34.66 74.3 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.654 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.686 ' O ' ' HG3' ' A' ' 98' ' ' GLN . . . 95.36 -24.79 27.51 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.27 -174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.707 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -58.7 -30.03 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.3 tp -59.3 -54.57 45.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.645 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.701 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 15.9 pt20 -63.45 -28.08 69.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.002 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 94' ' ' GLY . 75.2 mt-30 -62.79 -46.04 89.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 49.1 mt -65.39 -44.58 87.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.856 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.635 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.27 -46.77 95.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.492 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.803 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 38.7 ttpt -59.17 -50.73 72.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.882 0.373 . . . . 0.0 110.989 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -52.15 -45.53 65.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.32 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 86.0 m -77.06 -48.6 17.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.971 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 108' ' ' LYS . . . -59.54 -43.69 93.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.37 96.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.549 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.06 -32.34 64.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.281 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.505 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 65.7 m-85 -79.1 -47.47 16.06 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.72 -150.73 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.298 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 p -88.15 -150.54 0.18 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.935 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -70.6 54.47 0.16 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 108' ' ' LYS . 31.3 mm-40 -69.44 114.9 27.44 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 110.411 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -93.2 52.59 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.335 2.69 . . . . 0.0 113.795 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.3 m-20 -50.15 -57.85 6.84 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -172.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.803 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -75.51 -47.11 28.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 111.727 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.509 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 38.8 tt0 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.769 -1.11 . . . . 0.0 109.651 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.484 0.183 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 t 69.67 121.92 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 124.15 0.906 . . . . 0.0 111.358 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 32.3 p -95.98 55.34 1.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.368 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.6 p -57.37 -43.58 83.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.53 HG12 ' CB ' ' A' ' 65' ' ' TYR . 2.0 mp -65.73 -42.94 93.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 3' ' ' THR . 24.8 pt-20 -55.25 -40.4 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.607 0.639 . . . . 0.0 110.246 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.32 -43.38 88.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.521 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.693 HD13 ' HB3' ' A' ' 62' ' ' LEU . 77.9 mt -65.71 -47.47 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.876 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.696 ' NE2' ' HE2' ' A' ' 65' ' ' TYR . 59.5 mm-40 -62.16 -25.97 68.07 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.278 -173.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 3.4 mmp_? -50.85 -41.28 57.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 94.4 mm-40 -75.06 -49.35 20.01 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.296 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.627 HG23 HD23 ' A' ' 18' ' ' LEU . 4.6 mt -61.44 -43.11 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.601 0.715 . . . . 0.0 111.016 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.83 79.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.759 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 10.5 pt-20 -73.33 -36.26 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -173.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.64 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 3.6 p30 -77.63 134.12 65.96 Favored Pre-proline 0 CA--C 1.517 -0.307 0 CA-C-O 121.793 0.806 . . . . 0.0 112.092 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' O ' HD13 ' A' ' 17' ' ' ILE . 31.3 Cg_exo -63.33 -42.09 23.89 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.047 2.498 . . . . 0.0 111.723 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 16' ' ' PRO . 27.5 mm -139.59 119.16 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.741 HD21 ' HE1' ' A' ' 20' ' ' TYR . 31.1 tp -128.6 142.39 51.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -171.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.16 120.29 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.658 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.741 ' HE1' HD21 ' A' ' 18' ' ' LEU . 8.9 m-85 -98.87 122.1 41.67 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.848 -0.533 . . . . 0.0 111.396 173.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.557 ' O ' ' HE3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -147.84 -155.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.598 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.752 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 57.1 tttp -99.31 121.37 40.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.618 -0.676 . . . . 0.0 109.321 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.36 121.51 7.01 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.246 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 37.9 t -125.77 140.65 37.14 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.38 -41.3 79.55 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.167 1.911 . . . . 0.0 111.665 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -74.44 -28.39 61.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.535 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.5 tt -154.66 104.95 2.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' O ' ' SD ' ' A' ' 21' ' ' MET . 16.8 Cg_exo -72.29 35.47 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 114.476 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.446 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 7.0 p -169.74 49.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.095 0.558 . . . . 0.0 111.187 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.684 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 51.3 t -54.76 -36.65 65.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.15 -137.69 0.17 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.166 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.42 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 23.1 m-85 -75.95 -18.61 59.27 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 35.8 t -64.75 -12.16 44.27 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.003 -0.436 . . . . 0.0 111.891 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.86 -42.4 26.53 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -80.24 -41.68 24.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.07 0.462 . . . . 0.0 110.263 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.62 96.65 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.682 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.67 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 13.9 p -56.66 -39.48 63.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.348 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 30.4 mm-40 -68.91 -46.15 69.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.95 -42.8 94.86 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.294 0.371 . . . . 0.0 111.505 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.497 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -63.15 -55.11 27.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.412 0.625 . . . . 0.0 109.681 -176.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.16 69.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.478 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 -49.13 19.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.506 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.753 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.6 p -74.52 -53.36 9.62 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.457 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.5 -141.0 11.51 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.87 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 69.8 mm-40 -117.87 -152.15 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.832 0.453 . . . . 0.0 111.144 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HE ' ' N ' ' A' ' 46' ' ' ARG . 3.4 mmp_? -65.44 158.23 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.46 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.67 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 17.0 p90 -154.35 159.07 40.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.551 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.86 154.09 17.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.805 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -143.6 153.89 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -174.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.678 HG23 HD11 ' A' ' 18' ' ' LEU . 57.6 t -133.79 130.29 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.504 0.193 . . . . 0.0 110.56 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.509 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 36.5 p-10 -74.49 131.9 41.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.485 0.659 . . . . 0.0 110.924 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.705 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.4 pp -147.85 -35.63 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.861 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -65.35 -11.62 43.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.412 167.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tm0? -97.52 -44.94 6.61 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.465 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.9 m-20 -82.25 118.12 70.83 Favored Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 122.192 -0.318 . . . . 0.0 110.437 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.69 -44.09 14.8 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.434 2.089 . . . . 0.0 113.756 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -72.53 -52.71 14.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.078 0.466 . . . . 0.0 111.573 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -62.46 -35.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.268 0.556 . . . . 0.0 110.424 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 62.4 ttp180 -52.89 -32.43 45.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.202 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -88.19 -41.53 12.91 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.576 -166.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.549 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 32.0 tp10 -78.79 -59.67 2.69 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -158.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.711 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.9 pt? -68.11 -31.39 3.25 Favored Pre-proline 0 N--CA 1.474 0.726 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 18.5 Cg_endo -57.82 -43.44 49.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 121.103 1.43 . . . . 0.0 111.138 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.641 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 48.6 mtmt -55.68 -37.88 68.9 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.035 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.696 ' HE2' ' NE2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -65.21 -50.83 64.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.477 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.929 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -73.3 -55.7 6.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.379 -0.929 . . . . 0.0 112.935 -170.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.632 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.8 t30 -175.41 -52.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.211 1.005 . . . . 0.0 110.237 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.632 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -59.75 150.33 68.15 Favored Pre-proline 0 C--O 1.215 -0.743 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.936 -177.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -63.54 -36.76 52.05 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 121.954 1.769 . . . . 0.0 109.912 171.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -141.79 -124.28 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.003 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.923 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 25.7 m-85 -140.72 -165.61 0.1 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.923 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.1 Cg_endo -67.09 153.51 84.62 Favored 'Cis proline' 0 C--N 1.361 1.216 0 CA-C-N 121.691 1.64 . . . . 0.0 113.885 -1.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.593 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 30.7 mt-30 -143.21 135.19 26.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.706 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -100.08 135.17 41.91 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.588 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.61 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 49.4 m95 -121.91 125.77 47.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.242 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.5 t -105.91 119.04 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.557 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.1 t70 56.74 27.95 13.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 123.722 1.725 . . . . 0.0 108.622 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.07 29.3 54.38 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.375 -1.739 . . . . 0.0 113.044 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -124.68 130.97 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.322 . . . . 0.0 110.472 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.929 HD22 ' HB1' ' A' ' 66' ' ' ALA . 40.6 tp -68.95 127.31 32.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.406 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.548 HG12 ' CG2' ' A' ' 86' ' ' ILE . 87.3 t -105.28 -55.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.759 170.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.39 135.23 2.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.29 -65.52 1.52 Allowed Glycine 0 C--O 1.217 -0.943 0 C-N-CA 118.584 -1.77 . . . . 0.0 116.482 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 21.8 p -80.56 -68.05 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.76 1.28 . . . . 0.0 113.231 -171.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.26 -46.82 63.62 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.939 0.399 . . . . 0.0 111.244 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 81' ' ' VAL . 46.1 mm -59.99 -44.79 95.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.013 -172.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 82' ' ' GLY . 56.0 t -58.27 -49.03 83.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.289 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.478 ' O ' ' HD2' ' A' ' 91' ' ' TYR . 39.4 mm -58.1 -53.21 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.41 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 87.8 tt0 -65.97 -47.43 74.64 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.882 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.767 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.2 mmt -58.62 -36.55 74.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.633 0.254 . . . . 0.0 111.057 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.601 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -58.03 -48.81 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 172.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.538 ' HG2' ' CD2' ' A' ' 91' ' ' TYR . 15.2 mm-40 -62.58 -43.75 98.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.013 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 44.4 mmm-85 -62.93 -33.99 76.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.777 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 96.13 -25.29 26.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.747 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.5 mt-10 -55.54 -35.53 65.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.767 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 63.6 tp -62.37 -54.66 37.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.753 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -63.49 -26.78 68.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.024 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.6 mm-40 -64.0 -46.63 83.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.132 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 46.4 mt -67.6 -44.75 77.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.903 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.0 mm -60.62 -46.26 96.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.482 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 113' ' ' ASP . 39.4 ttpt -59.06 -52.86 63.91 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.3 -43.14 82.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.259 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.557 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 46.7 m -72.07 -50.17 30.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.076 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.05 92.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.565 -177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.31 72.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.77 -29.58 51.03 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.959 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.562 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 62.9 m-85 -86.83 -49.54 7.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.005 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.813 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -96.03 119.82 35.21 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.148 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -54.32 117.04 2.96 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 52.07 37.49 21.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.245 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 60.6 mm-40 -80.46 123.65 82.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.634 174.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.1 Cg_endo -83.94 109.41 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.696 2.264 . . . . 0.0 112.45 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.2 m-20 -91.34 -93.22 0.14 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.394 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -67.47 -48.16 67.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -171.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.427 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 46.5 tp10 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.699 -1.143 . . . . 0.0 109.698 -170.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 120.648 0.261 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.3 p -70.24 -119.4 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 4' ' ' THR . 42.3 p -81.06 -150.37 0.08 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.941 0.4 . . . . 0.0 111.717 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.639 ' O ' ' HG2' ' A' ' 7' ' ' LYS . 9.0 t 171.76 -38.59 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.962 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 65' ' ' TYR . 37.5 mt -55.11 -25.47 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.036 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 96.1 mt-10 -49.27 -47.55 46.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.545 0.212 . . . . 0.0 111.556 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.2 ptpt -61.79 -43.42 98.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.612 0.72 . . . . 0.0 110.116 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.595 HG21 ' HB3' ' A' ' 62' ' ' LEU . 72.2 mt -66.26 -46.84 86.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.936 -174.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.549 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.0 mmp_? -59.89 -37.55 79.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.851 0.358 . . . . 0.0 110.361 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 51.7 tt0 -71.03 -49.21 47.41 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.15 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.829 HG22 ' HA2' ' A' ' 78' ' ' GLY . 17.3 mt -65.88 -39.52 84.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.667 0.746 . . . . 0.0 110.835 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.12 81.94 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.637 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 24.0 pt-20 -72.81 -39.24 66.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.672 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -76.58 134.18 69.8 Favored Pre-proline 0 CA--C 1.515 -0.384 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -176.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' HD13 ' A' ' 17' ' ' ILE . 20.1 Cg_endo -61.94 -40.84 40.89 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.158 2.572 . . . . 0.0 112.056 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 16' ' ' PRO . 26.7 mm -139.27 120.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.672 HD22 ' OD1' ' A' ' 15' ' ' ASN . 28.1 tp -132.02 143.14 49.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.376 0.608 . . . . 0.0 111.414 -173.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 16.1 tp -138.95 120.6 15.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.362 -176.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.666 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -96.66 124.5 40.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.752 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 8.0 ptp -145.26 -171.09 3.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.524 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.817 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.3 tttm -95.97 140.62 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -138.67 129.5 4.52 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 118.941 -1.6 . . . . 0.0 113.696 -165.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -150.43 142.72 15.82 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.0 -38.99 60.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.598 2.199 . . . . 0.0 112.025 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -62.99 -33.08 74.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.325 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tt -160.02 108.7 1.42 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.85 19.97 0.18 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.239 1.959 . . . . 0.0 114.34 -174.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.817 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 13.5 p -164.22 49.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.287 0.565 . . . . 0.0 111.532 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.757 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 3.6 p -65.83 54.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.65 -137.58 2.24 Favored Glycine 0 C--N 1.321 -0.267 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.8 -39.67 61.57 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.761 0.791 . . . . 0.0 108.952 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 20.6 p -48.1 -24.14 1.03 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.695 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -51.52 -41.76 61.25 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.286 0.366 . . . . 0.0 111.652 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -33.24 43.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.352 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.17 66.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.132 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.661 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.5 p -52.25 -38.12 24.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.7 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 20.8 mm-40 -62.25 -46.94 86.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.819 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -60.61 -43.84 97.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.087 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.5 tt -61.85 -55.15 32.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -176.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.36 76.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.441 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -49.59 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.37 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.898 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.5 m -72.84 -56.02 5.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.49 -134.85 8.63 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.153 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.4 mm-40 -140.88 -152.17 0.4 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.822 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 28.8 mmm180 -58.15 143.67 43.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.823 0.82 . . . . 0.0 112.636 -169.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.661 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 16.6 p90 -152.93 156.42 38.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.878 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.45 146.87 25.31 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.1 p90 -136.83 150.21 48.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG23 HD11 ' A' ' 18' ' ' LEU . 48.3 t -127.6 127.66 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.8 p30 -77.9 133.9 38.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.293 0.568 . . . . 0.0 109.83 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 53' ' ' LEU . 1.1 pp -148.1 -32.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.264 -171.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.762 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -66.54 -11.09 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.098 167.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.6 tm0? -94.38 -43.27 8.46 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.07 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -77.63 123.99 86.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 121.026 0.441 . . . . 0.0 110.925 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.32 -42.94 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.373 2.049 . . . . 0.0 113.523 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -82.94 -50.89 8.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.672 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 mt -56.8 -37.11 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.249 0.547 . . . . 0.0 110.635 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.637 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 58.7 ttp180 -53.16 -31.24 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.158 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.35 -35.98 19.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -78.27 -61.14 2.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -162.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.709 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.9 pt? -76.8 -31.88 0.96 Allowed Pre-proline 0 N--CA 1.472 0.626 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.81 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 11.7 Cg_endo -55.21 -39.7 89.59 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 CA-C-N 120.917 1.363 . . . . 0.0 110.53 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -53.91 -41.36 67.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.543 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.698 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -68.56 -41.9 79.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.461 -178.153 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.947 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -73.49 -58.32 3.39 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.988 -176.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.458 ' HB2' ' CE3' ' A' ' 68' ' ' TRP . 6.1 m120 -173.27 -57.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.052 0.93 . . . . 0.0 109.539 168.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.567 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -53.88 147.8 22.62 Favored Pre-proline 0 C--O 1.215 -0.713 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.381 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.7 -36.21 53.47 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.289 1.993 . . . . 0.0 110.096 171.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.476 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -142.04 -127.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.372 -1.286 . . . . 0.0 109.698 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 1.004 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 36.0 m-85 -142.78 -170.63 0.24 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.004 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 38.4 Cg_endo -68.34 157.76 87.22 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 120.981 1.386 . . . . 0.0 114.525 -1.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.916 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 17.7 pt20 -148.57 133.72 18.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.741 174.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.38 138.37 33.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.999 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.772 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 56.1 m95 -127.07 126.93 43.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.497 0.665 . . . . 0.0 110.894 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.952 HG21 HD13 ' A' ' 99' ' ' LEU . 50.2 t -106.28 114.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.483 -0.781 . . . . 0.0 108.919 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' HB2' HG21 ' A' ' 103' ' ' THR . 25.1 t70 54.42 32.08 15.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 123.108 1.432 . . . . 0.0 110.364 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.829 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 79.7 28.74 50.41 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 113.789 -1.551 . . . . 0.0 113.565 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -127.29 131.3 50.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.904 173.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.947 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.5 tp -68.95 130.2 42.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.607 -174.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.579 HG12 ' CG2' ' A' ' 86' ' ' ILE . 91.7 t -107.09 -54.11 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.447 168.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.88 132.82 2.55 Favored Glycine 0 C--O 1.22 -0.761 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.566 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.13 -62.43 1.66 Allowed Glycine 0 C--O 1.221 -0.678 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.863 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.2 p -77.18 -67.6 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.798 -0.825 . . . . 0.0 112.557 -171.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -73.6 -48.77 30.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.579 ' CG2' HG12 ' A' ' 81' ' ' VAL . 43.1 mm -61.92 -42.27 94.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.382 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 82' ' ' GLY . 65.6 t -58.74 -48.22 86.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.792 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.555 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.0 mm -60.9 -47.31 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.595 0.236 . . . . 0.0 110.831 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.9 tt0 -59.79 -55.21 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.651 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.592 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -60.07 -35.67 75.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.35 0.26 . . . . 0.0 111.276 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.898 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 17.7 t80 -56.79 -50.96 70.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.848 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -63.76 -40.68 97.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.1 mmm-85 -63.63 -33.94 76.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.604 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.15 -24.39 25.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.169 -171.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.7 mt-10 -58.22 -27.23 63.74 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.592 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 6.2 tt -60.44 -58.95 6.33 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.5 pt20 -60.27 -27.04 66.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.35 176.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 46.1 mm-40 -65.07 -55.66 17.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.952 HD13 HG21 ' A' ' 76' ' ' VAL . 2.5 pp -70.76 -32.34 69.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.665 177.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 99' ' ' LEU . 34.3 mm -64.57 -48.23 85.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.254 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.574 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 39.1 ttpt -56.81 -52.05 66.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.369 -176.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.91 -44.58 78.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.542 HG21 ' HB2' ' A' ' 77' ' ' ASP . 32.6 m -71.0 -50.55 32.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.613 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.48 93.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.537 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.72 93.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -73.46 -26.86 61.11 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.985 -178.33 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.497 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 43.0 m-85 -87.68 -47.21 8.84 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.092 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.625 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -75.71 -158.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -76.18 -167.36 0.74 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.674 165.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.71 57.34 0.13 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 53.9 mm-40 -73.12 124.63 90.84 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.359 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 93.0 Cg_endo -96.44 53.03 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.962 3.108 . . . . 0.0 113.991 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 28.6 m-20 -51.12 -61.23 2.36 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.574 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -73.94 -45.93 47.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 0.0 111.871 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.445 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 5.4 tm-20 . . . . . 0 C--N 1.319 -0.756 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -173.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.411 ' N ' ' SD ' ' A' ' 1' ' ' MET . 61.4 p -78.18 60.91 2.57 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.604 0.362 . . . . 0.0 111.089 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.509 HG22 ' H ' ' A' ' 4' ' ' THR . 5.0 m -70.1 -132.25 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.591 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.509 ' H ' HG22 ' A' ' 3' ' ' THR . 37.9 p -76.03 37.77 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -175.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.4 mt -63.72 -38.09 81.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 54.3 mt-10 -55.55 -47.42 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.582 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -62.68 -43.51 98.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 110.648 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.73 HG21 ' HB3' ' A' ' 62' ' ' LEU . 75.5 mt -60.95 -45.77 97.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.929 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -64.92 -33.26 75.6 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.365 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.644 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 4.3 mmp_? -55.94 -42.26 75.9 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -69.14 -44.35 72.51 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.953 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.627 HG23 HD23 ' A' ' 18' ' ' LEU . 19.9 mt -65.56 -43.34 94.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.442 0.639 . . . . 0.0 110.171 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.47 68.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.481 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.644 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 32.0 mt-10 -62.18 -46.65 87.99 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.077 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -78.45 125.17 85.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.231 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 37.3 Cg_endo -66.25 -42.0 11.39 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.467 2.111 . . . . 0.0 112.21 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.61 HD12 HG23 ' A' ' 100' ' ' ILE . 27.5 mm -127.12 119.82 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.679 HD11 HG23 ' A' ' 50' ' ' VAL . 21.5 tp -133.59 141.34 47.63 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.98 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.3 tp -138.27 120.1 15.32 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.306 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.631 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.8 m-85 -97.28 120.53 37.81 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.582 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.502 ' SD ' ' HB2' ' A' ' 29' ' ' SER . 20.0 ptt? -146.6 -163.77 1.83 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 29.2 tptp -96.73 127.63 42.91 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.144 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.37 125.46 8.38 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.618 -1.753 . . . . 0.0 111.74 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 46.4 t -138.5 141.22 30.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -54.01 -41.09 78.14 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.246 1.964 . . . . 0.0 111.453 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -71.71 -28.48 63.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.894 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.52 HD23 ' HD2' ' A' ' 28' ' ' PRO . 2.2 tt -161.5 121.72 1.55 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.52 ' HD2' HD23 ' A' ' 27' ' ' LEU . 50.1 Cg_endo -71.71 29.38 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.277 1.984 . . . . 0.0 113.307 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.613 ' OG ' ' HB3' ' A' ' 33' ' ' SER . 11.8 t -165.78 54.69 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.584 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 42.7 t -55.59 -36.88 67.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.698 -173.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.665 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -73.42 -138.68 0.37 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 36.4 m-85 -77.58 -20.87 53.31 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 32.8 t -69.02 -10.21 56.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.423 -0.798 . . . . 0.0 111.083 -174.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.26 -40.84 17.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.414 ' O ' HD11 ' A' ' 88' ' ' ILE . 12.3 mp0 -78.94 -38.04 38.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.86 91.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.931 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -56.19 -36.47 45.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.887 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 32.5 mm-40 -67.73 -42.07 82.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.719 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -57.27 -48.08 79.81 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.07 0.231 . . . . 0.0 111.183 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.847 HD23 ' HG2' ' A' ' 115' ' ' GLU . 9.9 mt -58.97 -62.29 1.99 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.952 0.882 . . . . 0.0 112.567 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.19 -28.51 58.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.134 -176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.51 -56.32 4.96 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.319 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.956 ' SG ' ' HB3' ' A' ' 97' ' ' GLN . 42.6 t -72.21 -59.13 2.89 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.815 -167.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.616 ' HA3' ' C ' ' A' ' 115' ' ' GLU . . . -103.12 -125.59 5.68 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.354 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 44.6 mt-10 -142.11 -148.34 0.24 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.483 -0.859 . . . . 0.0 111.49 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 33.3 mmt180 -61.46 143.24 56.21 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.992 0.901 . . . . 0.0 112.119 -165.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.21 152.45 30.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.963 -1.472 . . . . 0.0 109.039 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.59 149.66 23.04 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.372 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -134.34 151.12 51.05 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.679 HG23 HD11 ' A' ' 18' ' ' LEU . 61.9 t -127.16 128.19 70.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.869 0.366 . . . . 0.0 110.099 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.1 p30 -75.65 130.61 39.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.739 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.689 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -146.1 -34.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.751 -173.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.689 ' H ' HD12 ' A' ' 52' ' ' ILE . 1.3 mm? -63.05 -14.5 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.906 167.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 17.8 tm0? -95.15 -42.9 8.35 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.778 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 32.6 m120 -79.2 122.34 84.12 Favored Pre-proline 0 N--CA 1.472 0.635 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.91 -44.72 9.5 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.147 1.898 . . . . 0.0 113.118 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -75.74 -47.68 24.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.2 -38.25 81.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.176 0.512 . . . . 0.0 110.487 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.603 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 77.4 ttt180 -50.88 -36.3 37.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.212 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.558 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -83.84 -42.19 16.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 50.3 mm-40 -78.0 -59.31 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -161.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.73 ' HB3' HG21 ' A' ' 8' ' ' ILE . 2.2 pt? -70.45 -32.59 2.74 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.3 Cg_endo -53.68 -42.25 67.61 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.324 1.349 . . . . 0.0 111.415 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 46.2 mtmt -54.57 -38.87 67.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.709 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.596 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.26 -41.09 77.37 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.144 -179.544 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.858 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -78.74 -57.35 3.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.583 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.68 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.6 t30 -175.0 -53.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 0.0 110.084 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.68 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -59.62 150.48 66.32 Favored Pre-proline 0 C--O 1.215 -0.746 0 CA-C-N 113.347 -1.752 . . . . 0.0 113.058 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.77 -33.81 42.62 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 121.828 1.685 . . . . 0.0 110.235 171.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 50.7 p -142.47 -124.2 0.09 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.083 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 1.006 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 55.0 m-85 -141.8 -167.51 0.15 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.006 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 56.9 Cg_endo -68.77 153.42 90.27 Favored 'Cis proline' 0 C--N 1.36 1.179 0 CA-C-N 121.631 1.618 . . . . 0.0 114.107 -1.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.655 HE22 ' HA ' ' A' ' 63' ' ' PRO . 58.2 mt-30 -145.27 133.32 21.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.2 tm? -95.56 137.46 34.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.806 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.605 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 61.2 m95 -122.4 127.42 49.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG22 HD13 ' A' ' 100' ' ' ILE . 46.4 t -106.02 115.2 47.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.603 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 28.5 t70 55.9 32.65 20.14 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 123.251 1.5 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.69 28.54 60.97 Favored Glycine 0 C--N 1.308 -0.988 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.989 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -124.69 129.75 51.1 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.175 0.19 . . . . 0.0 110.778 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.858 HD22 ' HB1' ' A' ' 66' ' ' ALA . 51.8 tp -69.94 136.59 50.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.596 HG12 ' CG2' ' A' ' 86' ' ' ILE . 92.5 t -119.31 -53.8 3.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.94 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.12 137.0 2.91 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.62 -65.82 1.49 Allowed Glycine 0 C--O 1.216 -0.98 0 C-N-CA 118.929 -1.605 . . . . 0.0 116.338 -168.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 1.9 p -79.33 -69.29 0.59 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.744 1.272 . . . . 0.0 113.388 -173.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.56 -48.4 64.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.415 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.596 ' CG2' HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.81 -46.8 93.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.642 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -58.23 -50.48 78.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.082 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.613 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 39.0 mm -56.04 -51.24 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.221 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.2 tt0 -62.59 -49.79 73.83 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.317 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.913 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 96.3 mmm -59.86 -38.36 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.63 ' HD1' ' HB2' ' A' ' 43' ' ' CYS . 3.0 t80 -60.05 -46.35 89.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.158 0.583 . . . . 0.0 110.475 173.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.613 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.2 mt-30 -64.59 -40.16 95.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.779 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 29.0 mmm180 -59.01 -33.87 71.21 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.053 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.25 20.16 79.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.313 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.631 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 53.7 mt-10 -98.8 -24.58 14.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.106 0.479 . . . . 0.0 111.28 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 23.5 tp -75.2 -43.23 53.17 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.956 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 5.4 pt20 -57.99 -26.9 62.97 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.266 170.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 44.1 mm-40 -72.95 -48.03 40.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 39.7 mt -66.33 -48.0 71.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.741 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' A' ' 115' ' ' GLU . 26.5 mm -62.04 -47.14 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.162 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 114' ' ' ALA . 35.6 ttpt -55.67 -47.25 77.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 123.253 0.345 . . . . 0.0 111.795 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.07 -46.81 78.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.008 0.432 . . . . 0.0 109.922 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.603 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 89.7 m -68.45 -54.69 15.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.164 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.577 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.66 -49.93 74.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.992 -174.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.86 -41.24 82.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.43 -24.5 61.23 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.423 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.533 ' HE2' HG23 ' A' ' 103' ' ' THR . 35.5 m-85 -88.53 -41.7 12.55 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.688 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 108' ' ' LYS . 9.5 mmpt? -72.99 -156.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.56 0.695 . . . . 0.0 109.849 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.7 t -82.22 -146.27 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.722 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -79.93 44.68 0.67 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.33 0.586 . . . . 0.0 109.467 169.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.489 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 50.5 mm-40 -73.63 135.02 78.49 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.311 -172.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.95 42.86 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.69 2.927 . . . . 0.0 114.188 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.63 152.52 18.38 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.672 0.789 . . . . 0.0 112.935 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.778 ' HB1' ' HB2' ' A' ' 97' ' ' GLN . . . -122.85 -116.57 0.3 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 111.882 -2.417 . . . . 0.0 106.621 160.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.847 ' HG2' HD23 ' A' ' 40' ' ' LEU . 75.5 tt0 . . . . . 0 C--N 1.317 -0.831 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.944 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.702 ' CG2' HE21 ' A' ' 9' ' ' GLN . 48.2 mt . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.37 -44.3 84.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.27 -47.34 77.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.162 174.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.743 HD13 HD22 ' A' ' 62' ' ' LEU . 84.4 mt -57.8 -44.63 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.249 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.702 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.9 mt-30 -61.87 -40.38 95.16 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.594 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.2 mmp_? -60.86 -36.47 79.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 73.5 mt-30 -71.79 -45.12 62.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.415 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.817 HG22 ' HA2' ' A' ' 78' ' ' GLY . 27.2 mt -63.4 -44.28 98.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.095 0.474 . . . . 0.0 110.107 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.14 96.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 11.9 pt-20 -69.23 -37.48 78.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.694 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.33 126.42 86.45 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 121.315 0.579 . . . . 0.0 110.615 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.531 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.5 Cg_exo -62.1 -42.22 31.0 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 112.82 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.3 mm -136.75 119.48 20.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 18.0 tp -132.8 139.95 47.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.345 -170.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.4 tp -136.39 122.98 20.95 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.02 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.744 ' CE2' HD21 ' A' ' 62' ' ' LEU . 6.0 m-85 -98.95 118.06 34.87 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.491 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.9 ptt? -145.99 -166.18 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.662 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.056 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.9 tttt -99.61 118.48 36.24 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.467 -0.771 . . . . 0.0 110.079 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.93 68.46 1.02 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.096 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.4 m -77.71 139.24 62.47 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -53.68 -41.28 75.32 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.086 1.857 . . . . 0.0 111.724 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.87 -35.67 81.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.881 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -154.93 111.38 2.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.463 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 39.0 Cg_endo -74.41 32.29 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.654 2.236 . . . . 0.0 113.868 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -165.07 46.52 0.09 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.163 0.506 . . . . 0.0 110.132 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.759 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 37.5 t -71.65 66.97 0.54 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.158 -173.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.91 -140.81 3.08 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -76.91 -33.79 57.75 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.145 0.498 . . . . 0.0 110.699 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.856 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 15.1 p -49.88 -21.06 1.03 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.592 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.18 -42.73 30.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 36' ' ' ALA . 1.7 pm0 -80.47 -34.94 35.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.233 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB2' HE21 ' A' ' 35' ' ' GLN . . . -69.46 -43.08 73.98 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.489 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 7.9 p -53.38 -37.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.108 0.48 . . . . 0.0 110.729 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.582 ' HA ' HE21 ' A' ' 38' ' ' GLN . 0.9 OUTLIER -63.13 -46.18 88.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.842 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.9 -44.41 97.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.876 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -60.65 -55.48 32.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 109.675 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.75 70.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.476 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.93 -48.34 46.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.727 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.3 m -68.62 -57.42 5.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.83 -147.59 20.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.452 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.0 mm-40 -100.36 -153.58 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.53 0.681 . . . . 0.0 111.184 174.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.487 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.05 154.16 42.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.872 177.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 19' ' ' LEU . 17.4 p90 -145.97 158.89 43.86 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.006 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.57 146.34 25.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -137.72 149.16 46.26 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.501 HG23 HD11 ' A' ' 18' ' ' LEU . 52.9 t -122.63 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' MET . 10.5 p-10 -74.11 130.33 39.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.081 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.641 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -146.68 -34.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.651 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.056 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -63.4 -13.2 37.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.518 171.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -96.47 -45.44 6.76 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.347 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -76.31 116.02 52.38 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.953 0.342 . . . . 0.0 110.742 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 50.1 Cg_exo -59.74 -45.18 26.4 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.0 2.467 . . . . 0.0 113.608 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.41 -54.33 14.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.507 0.67 . . . . 0.0 111.126 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.569 HG22 HD23 ' A' ' 62' ' ' LEU . 36.2 mt -63.6 -35.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.2 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.721 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 61.9 ttt-85 -57.61 -33.36 68.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.095 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.563 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -90.62 -52.68 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.62 -54.63 5.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -168.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.754 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -55.22 -44.39 99.6 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.721 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 22.1 Cg_endo -58.13 -41.74 64.4 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 121.465 1.444 . . . . 0.0 111.447 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.6 mtmp? -61.1 -32.37 72.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.751 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.544 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -63.15 -43.2 99.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.818 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -78.16 -57.66 3.67 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.404 -0.918 . . . . 0.0 112.389 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.507 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 41.5 t30 -174.73 -54.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.784 0.802 . . . . 0.0 110.323 168.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -55.6 148.58 34.3 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.835 -1.53 . . . . 0.0 113.274 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -61.62 -38.96 57.84 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.461 2.107 . . . . 0.0 110.459 172.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -143.06 -127.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.253 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.967 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 47.8 m-85 -138.15 -170.99 0.25 Allowed Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.967 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.6 Cg_endo -67.17 155.57 84.83 Favored 'Cis proline' 0 C--N 1.352 0.757 0 CA-C-N 121.132 1.44 . . . . 0.0 114.613 -0.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.487 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 59.3 mt-30 -147.51 132.66 18.33 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.429 173.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.85 138.56 33.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.987 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.526 ' N ' HD13 ' A' ' 74' ' ' LEU . 55.9 m95 -125.06 127.47 46.99 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.18 0.514 . . . . 0.0 110.73 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 100' ' ' ILE . 65.4 t -111.61 121.16 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 176.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 57.15 29.12 16.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.507 1.622 . . . . 0.0 108.691 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.817 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.41 29.11 64.52 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 113.6 -1.637 . . . . 0.0 113.152 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.57 132.15 51.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 110.807 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.818 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.0 tp -65.71 132.42 48.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.801 -172.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.489 ' O ' HG21 ' A' ' 86' ' ' ILE . 78.1 t -110.49 -53.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.199 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 142.19 135.11 3.05 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.36 -62.25 1.66 Allowed Glycine 0 C--O 1.223 -0.584 0 C-N-CA 119.525 -1.322 . . . . 0.0 116.232 -168.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -78.01 -70.76 0.46 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -168.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -80.19 -40.59 26.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.489 HG21 ' O ' ' A' ' 81' ' ' VAL . 48.3 mm -55.9 -45.64 79.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.265 -174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.495 HG13 HD11 ' A' ' 96' ' ' LEU . 86.0 t -59.26 -49.24 84.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.206 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 39' ' ' ALA . 39.6 mm -60.28 -48.79 86.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.456 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.751 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 40.0 tt0 -61.63 -53.28 58.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.69 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.579 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 80.8 mtp -62.64 -30.61 71.49 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.787 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 14.1 t80 -57.34 -52.24 66.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.69 170.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -63.55 -40.59 97.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.101 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 46.3 mmm-85 -59.62 -33.95 72.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.363 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 90.28 -24.66 15.31 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.286 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 91.0 mt-10 -60.07 -29.78 68.79 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 6.5 tt -61.74 -54.5 41.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.071 0.463 . . . . 0.0 110.208 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.864 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.1 pt20 -63.86 -26.58 68.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.775 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 90.9 mm-40 -62.9 -44.82 95.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 24.5 mt -69.9 -46.83 64.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.178 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.523 HG22 ' OD2' ' A' ' 113' ' ' ASP . 47.7 mm -60.62 -46.31 95.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.679 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 38.7 ttpt -55.54 -53.59 54.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.193 0.308 . . . . 0.0 111.424 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 37.8 tt0 -63.85 -44.48 93.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.119 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.449 ' O ' ' HD2' ' A' ' 107' ' ' TYR . 61.9 m -63.29 -47.14 83.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.645 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.639 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.11 -45.15 94.74 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.389 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.2 95.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.551 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -70.31 -33.19 71.23 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.841 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.457 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 58.0 m-85 -78.68 -47.29 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.639 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -100.38 -147.32 0.35 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 51.6 p -74.45 -155.62 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.969 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.3 57.16 0.87 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.809 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.31 114.18 6.77 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.158 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -95.59 47.31 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 122.699 2.266 . . . . 0.0 112.919 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.523 ' OD2' HG22 ' A' ' 100' ' ' ILE . 7.6 m-20 . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.143 -168.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.709 ' CG2' HE21 ' A' ' 9' ' ' GLN . 33.5 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.591 0.234 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.3 -44.51 68.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.336 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -76.05 -38.41 57.17 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.659 HD13 ' HB3' ' A' ' 62' ' ' LEU . 75.1 mt -58.63 -46.9 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.914 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.709 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.0 mt-30 -62.3 -40.48 96.44 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.76 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -60.39 -35.56 76.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.79 0.329 . . . . 0.0 110.668 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.94 -44.35 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.774 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.774 HG23 HD23 ' A' ' 18' ' ' LEU . 28.9 mt -67.23 -47.34 81.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -59.42 -39.35 83.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.85 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.79 -30.63 70.12 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.946 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 76.5 m-20 -76.31 126.77 86.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.069 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.608 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.7 Cg_exo -61.92 -42.95 27.68 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.849 2.366 . . . . 0.0 112.431 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 16' ' ' PRO . 27.2 mm -137.37 121.1 22.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 12' ' ' ILE . 24.5 tp -133.04 141.21 48.12 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.64 -170.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.8 tp -137.39 119.0 14.93 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.986 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.607 ' CE2' HD11 ' A' ' 62' ' ' LEU . 6.8 m-85 -96.51 119.6 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.036 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.685 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 23.2 ptt? -145.92 -166.99 2.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.417 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 86.9 tttt -95.76 90.04 5.52 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -91.84 67.69 2.1 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.463 -170.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -77.87 146.55 72.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.366 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.76 -39.78 89.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.995 1.797 . . . . 0.0 111.066 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.57 -34.36 77.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.617 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 30' ' ' CYS . 1.8 tt -161.42 112.59 1.24 Allowed Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.522 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -69.56 14.3 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.807 2.338 . . . . 0.0 114.11 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.685 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 24.8 p -163.21 47.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.31 0.576 . . . . 0.0 110.613 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.677 ' HA ' HD13 ' A' ' 27' ' ' LEU . 48.0 t -56.46 -40.63 75.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.658 -173.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.644 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.33 -134.48 0.13 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.237 -0.506 . . . . 0.0 114.275 -175.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 41.6 m-85 -74.23 -18.01 60.81 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 121.057 0.456 . . . . 0.0 111.872 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 21' ' ' MET . 8.4 p -63.78 -19.5 65.04 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.9 -42.84 13.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.656 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.85 -38.88 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.299 0.571 . . . . 0.0 110.198 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.03 88.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.909 -175.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 9.3 p -55.23 -39.18 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.523 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.591 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.7 mm100 -67.02 -48.71 67.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -58.29 -45.12 88.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.89 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.3 tt -61.18 -55.38 32.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.232 0.539 . . . . 0.0 110.197 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.02 -32.35 71.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.175 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -47.52 59.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.664 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.3 p -77.16 -51.44 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.846 0.355 . . . . 0.0 111.098 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.78 -134.68 8.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.831 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.25 -152.12 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.561 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' ARG . 36.8 mmt180 -64.8 150.42 47.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.543 0.687 . . . . 0.0 112.777 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.502 ' CD2' HD13 ' A' ' 40' ' ' LEU . 16.5 p90 -149.4 157.35 43.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.732 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.25 146.94 25.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -137.7 153.36 49.79 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.543 HG23 HD11 ' A' ' 18' ' ' LEU . 52.4 t -130.18 129.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.533 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -74.62 135.2 42.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.662 HD12 HD22 ' A' ' 53' ' ' LEU . 1.1 pp -151.63 -37.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.522 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -64.39 -11.44 32.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.726 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.57 -41.77 8.76 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.504 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.568 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 74.7 m-20 -76.76 131.64 73.32 Favored Pre-proline 0 N--CA 1.473 0.712 0 O-C-N 122.241 -0.287 . . . . 0.0 110.376 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 16.6 Cg_exo -68.3 -44.45 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.468 2.112 . . . . 0.0 112.421 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.589 ' OD1' HG13 ' A' ' 58' ' ' ILE . 1.3 p30 -77.78 -56.0 4.87 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.589 HG13 ' OD1' ' A' ' 57' ' ' ASP . 48.7 mt -60.42 -32.88 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.45 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.572 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 80.0 ttt180 -51.63 -36.25 45.17 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.222 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.39 -44.64 11.89 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -77.32 -60.23 2.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -160.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.733 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.0 pt? -69.14 -31.81 2.95 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 14.1 Cg_endo -54.93 -41.36 79.37 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.533 1.489 . . . . 0.0 110.509 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.64 -39.4 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.494 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.564 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.83 -42.48 70.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.038 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.827 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.69 -57.99 3.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.484 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.715 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.9 t-20 -175.89 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 122.102 0.953 . . . . 0.0 109.407 169.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.715 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -57.32 148.53 52.95 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.209 -1.814 . . . . 0.0 113.328 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -62.85 -35.98 64.27 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.279 1.986 . . . . 0.0 110.314 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 p -143.19 -128.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.036 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.97 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.8 m-85 -139.09 -167.85 0.17 Allowed Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.97 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 48.4 Cg_endo -67.42 151.12 84.17 Favored 'Cis proline' 0 C--N 1.359 1.091 0 CA-C-N 121.318 1.507 . . . . 0.0 114.006 -1.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 19.3 mt-30 -139.15 132.57 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.188 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -95.75 137.23 35.11 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 67.9 m95 -122.99 132.48 54.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 110.92 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.904 HG21 HD13 ' A' ' 99' ' ' LEU . 58.0 t -118.54 119.73 62.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.483 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.534 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 33.3 t70 56.68 25.53 10.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.857 1.313 . . . . 0.0 110.02 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.614 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.49 28.4 47.99 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.135 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.11 135.58 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.996 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.827 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.1 tp -70.97 129.16 38.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.261 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.568 HG12 ' CG2' ' A' ' 86' ' ' ILE . 98.5 t -105.62 -54.74 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.824 170.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 141.01 133.4 2.93 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -86.11 -64.84 1.45 Allowed Glycine 0 C--O 1.217 -0.907 0 C-N-CA 119.046 -1.549 . . . . 0.0 116.436 -167.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.4 p -78.94 -59.61 2.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.21 1.005 . . . . 0.0 113.031 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.3 -46.11 21.0 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 120.886 0.374 . . . . 0.0 111.0 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.568 ' CG2' HG12 ' A' ' 81' ' ' VAL . 46.0 mm -63.4 -42.69 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.73 -171.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.6 t -59.5 -48.35 87.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.141 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.5 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.1 mm -59.03 -49.01 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.759 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 39.7 tt0 -61.61 -54.49 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.679 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.617 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -56.21 -36.27 68.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.536 0.208 . . . . 0.0 111.412 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.579 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.0 t80 -59.6 -50.85 72.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.062 174.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.6 mt-30 -66.01 -44.02 85.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.9 mmm-85 -58.93 -33.71 70.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.695 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.23 21.67 64.54 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.567 -1.197 . . . . 0.0 112.152 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.3 mt-10 -88.35 -29.4 20.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.379 0.609 . . . . 0.0 110.851 173.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 60.3 tp -62.16 -55.0 33.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.048 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.713 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 16.3 pt20 -59.22 -26.26 64.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.632 174.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.695 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.1 mm-40 -68.81 -55.14 12.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.801 0.334 . . . . 0.0 111.404 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.904 HD13 HG21 ' A' ' 76' ' ' VAL . 2.3 pp -71.19 -36.09 71.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.044 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 99' ' ' LEU . 46.2 mm -62.31 -44.67 99.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 113' ' ' ASP . 21.9 ttmt -49.29 -57.6 6.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.51 0.672 . . . . 0.0 111.793 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 88.2 tt0 -62.15 -46.09 90.55 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.528 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 86.6 m -67.22 -49.73 63.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.97 89.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.581 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.73 91.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -67.3 -26.79 66.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.79 -177.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.526 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 37.8 m-85 -79.19 -46.61 17.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.204 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.418 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 48.0 mtmt -91.94 -158.27 0.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.308 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 p -84.84 55.25 3.37 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.353 1.073 . . . . 0.0 112.015 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 53.86 47.23 24.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.319 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 40.0 mm-40 -62.44 136.34 95.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.585 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.39 132.25 20.41 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.084 2.523 . . . . 0.0 112.401 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 10.9 t70 . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.672 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.732 ' CG2' HE21 ' A' ' 9' ' ' GLN . 65.1 mt . . . . . 0 C--O 1.232 0.139 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 52.6 mm-40 -53.96 -47.62 71.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -67.12 -43.93 81.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.283 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.694 HG21 HD13 ' A' ' 62' ' ' LEU . 81.4 mt -59.23 -44.48 92.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.732 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.3 mt-30 -61.34 -43.46 98.83 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.486 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.3 mmp_? -61.15 -35.84 78.17 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -68.08 -45.75 72.92 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.655 HG23 HD23 ' A' ' 18' ' ' LEU . 41.3 mt -63.55 -41.14 91.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.918 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -34.27 71.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.347 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 72.8 mt-10 -59.84 -50.42 73.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.898 0.38 . . . . 0.0 111.07 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -79.33 128.81 74.3 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.111 -171.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' O ' HD13 ' A' ' 17' ' ' ILE . 50.8 Cg_exo -59.05 -42.6 49.86 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 123.144 2.563 . . . . 0.0 112.03 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.6 mm -133.88 122.64 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.655 HD23 HG23 ' A' ' 12' ' ' ILE . 20.8 tp -133.87 141.7 47.49 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.2 -171.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.4 tp -136.61 119.87 16.75 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.096 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.702 ' CE2' HD21 ' A' ' 62' ' ' LEU . 6.2 m-85 -98.26 119.33 36.74 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.795 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 23.0 ptt? -146.19 -166.81 2.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.206 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 84.4 tttt -96.57 144.74 26.35 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.66 121.2 3.55 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.508 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.579 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 41.5 t -132.93 144.87 54.66 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.59 -39.89 86.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.475 2.117 . . . . 0.0 111.277 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -68.43 -34.34 75.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.496 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.09 117.56 1.87 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -74.99 26.3 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.5 2.134 . . . . 0.0 114.434 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.1 p -164.33 49.86 0.12 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.529 0.681 . . . . 0.0 111.448 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.653 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 1.6 p -67.06 61.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.426 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.81 -138.69 2.57 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 42.9 m-85 -76.9 -19.86 56.92 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 25.8 p -69.52 -15.2 63.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -46.95 -42.12 17.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.663 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.74 -40.87 32.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.085 0.469 . . . . 0.0 110.438 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.84 97.99 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.922 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.4 p -55.8 -38.49 51.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.583 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.598 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.7 mm100 -68.13 -46.01 72.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.367 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.36 -45.41 88.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -63.42 -55.43 24.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.164 0.507 . . . . 0.0 110.364 -175.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.34 70.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.05 -48.63 57.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.312 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.759 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -73.3 -58.17 3.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.05 -143.31 13.79 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.465 -0.874 . . . . 0.0 114.164 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.673 ' OE2' ' HB3' ' A' ' 111' ' ' GLU . 51.8 mt-10 -97.37 -154.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.437 0.637 . . . . 0.0 111.337 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -66.88 153.3 43.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.164 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 24.4 p90 -147.67 153.43 39.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.3 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.21 144.85 27.22 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -132.67 153.27 51.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG23 HD11 ' A' ' 18' ' ' LEU . 58.3 t -128.35 129.73 69.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' MET . 43.2 p-10 -75.34 135.64 40.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.63 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.773 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 1.1 pp -149.68 -37.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.76 -11.05 23.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.613 170.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 -40.56 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.073 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.773 ' ND2' ' HA ' ' A' ' 52' ' ' ILE . 19.8 p30 -80.23 140.85 53.14 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 121.389 0.614 . . . . 0.0 111.428 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.23 -41.79 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.995 1.797 . . . . 0.0 112.524 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -78.74 -55.84 4.86 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -170.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.552 HG22 HD23 ' A' ' 62' ' ' LEU . 51.3 mt -62.9 -39.1 83.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.392 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.1 ttt180 -53.93 -34.72 60.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.048 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.17 -54.16 5.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 64' ' ' LYS . 42.1 mt-10 -79.84 -51.36 9.24 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.802 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -58.07 -43.29 98.29 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -171.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.594 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 21.2 Cg_endo -57.76 -38.71 92.0 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 121.631 1.554 . . . . 0.0 111.197 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 61' ' ' GLU . 5.0 mtpm? -55.09 -39.48 69.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.04 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.563 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.79 -41.62 91.76 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.133 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.77 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -80.72 -56.93 3.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.97 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.73 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -174.99 -55.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.319 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.73 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.27 151.36 58.89 Favored Pre-proline 0 C--O 1.222 -0.365 0 CA-C-N 113.646 -1.615 . . . . 0.0 113.72 -175.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.21 -39.21 39.84 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.318 2.012 . . . . 0.0 110.336 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.552 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 67.9 p -142.44 -124.38 0.09 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.66 172.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.984 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 24.1 m-85 -138.67 -168.26 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.984 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 41.6 Cg_endo -67.4 155.34 85.75 Favored 'Cis proline' 0 C--N 1.361 1.228 0 CA-C-N 121.235 1.477 . . . . 0.0 114.466 -1.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.726 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 18.8 mt-30 -143.6 133.07 23.44 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.507 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.8 137.42 34.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.998 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.524 ' N ' HD13 ' A' ' 74' ' ' LEU . 61.4 m95 -122.66 129.3 51.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.283 0.563 . . . . 0.0 110.805 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.914 HG21 HD13 ' A' ' 99' ' ' LEU . 48.7 t -115.16 119.96 63.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.3 t70 56.22 30.33 16.39 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 123.563 1.649 . . . . 0.0 108.812 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.605 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 74.53 29.06 62.28 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.381 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 49.5 mt-10 -125.37 133.71 52.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.383 . . . . 0.0 110.782 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.77 HD22 ' HB1' ' A' ' 66' ' ' ALA . 55.4 tp -71.05 130.95 42.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.609 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.534 HG12 ' CG2' ' A' ' 86' ' ' ILE . 99.3 t -110.37 -52.05 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.199 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 145.64 134.92 2.75 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.484 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.47 -64.63 1.56 Allowed Glycine 0 C--O 1.218 -0.897 0 C-N-CA 118.751 -1.69 . . . . 0.0 116.526 -166.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.516 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 25.1 p -80.62 -69.04 0.63 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.285 1.042 . . . . 0.0 112.824 -170.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 40.5 m-20 -74.42 -43.7 55.12 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.263 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 81' ' ' VAL . 50.7 mm -58.54 -45.31 90.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.937 -174.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 39' ' ' ALA . 74.5 t -57.44 -48.01 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.185 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 39' ' ' ALA . 44.0 mm -60.29 -51.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.973 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.7 tt0 -62.19 -50.17 72.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.795 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.4 mmt -57.81 -39.73 78.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.843 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 13.3 t80 -60.15 -49.14 78.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.805 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.3 mt-30 -65.5 -40.09 92.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.83 0.348 . . . . 0.0 110.168 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.7 mmm-85 -57.82 -33.24 68.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.143 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.22 21.64 64.62 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.602 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 93.0 mt-10 -99.06 -13.85 19.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 0.0 111.543 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.661 HD12 HD11 ' A' ' 99' ' ' LEU . 55.7 tp -72.12 -53.06 13.89 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.759 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.2 pm0 -56.31 -25.66 49.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.703 170.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 11.7 mm-40 -71.17 -50.52 32.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.845 0.355 . . . . 0.0 111.58 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.914 HD13 HG21 ' A' ' 76' ' ' VAL . 2.6 pp -74.59 -36.22 63.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 99' ' ' LEU . 42.6 mm -63.63 -42.11 94.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 173.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 21.8 ttmm -52.42 -56.24 16.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.303 0.573 . . . . 0.0 111.25 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -57.3 -48.61 78.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.924 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.8 m -69.4 -47.95 62.58 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.615 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -61.22 -47.93 83.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.005 0.431 . . . . 0.0 110.307 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.69 95.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -68.92 -29.76 68.09 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.11 -0.369 . . . . 0.0 111.863 -178.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.523 ' HE2' HG23 ' A' ' 103' ' ' THR . 52.8 m-85 -78.78 -46.6 18.46 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.245 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.615 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.68 -160.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.681 174.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.7 p -84.73 -140.1 0.07 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.953 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.77 45.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.959 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.673 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . 5.0 mm-40 -70.81 130.58 88.4 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.996 0.427 . . . . 0.0 111.373 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 1.5 Cg_endo -82.98 116.42 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.837 2.358 . . . . 0.0 112.318 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD2' HG22 ' A' ' 100' ' ' ILE . 12.9 t70 . . . . . 0 C--N 1.322 -0.596 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.975 HG22 ' HG3' ' A' ' 9' ' ' GLN . 22.4 mm . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 70.6 mm-40 -44.69 -45.79 9.94 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -62.16 -43.76 98.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.074 0.464 . . . . 0.0 110.93 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 62' ' ' LEU . 73.0 mt -68.3 -40.55 82.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.626 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.975 ' HG3' HG22 ' A' ' 5' ' ' ILE . 62.7 mt-30 -58.54 -44.2 89.51 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -55.54 -34.73 64.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.268 175.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.645 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 38.6 tt0 -68.44 -48.41 64.66 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.431 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.551 HG22 ' HA2' ' A' ' 78' ' ' GLY . 21.0 mt -68.32 -39.24 80.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.77 0.795 . . . . 0.0 110.472 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.46 81.0 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.839 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.1 pt-20 -70.03 -39.28 75.86 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -173.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 2.7 p30 -79.22 134.96 58.35 Favored Pre-proline 0 CA--C 1.518 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 112.737 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.524 ' O ' HD13 ' A' ' 17' ' ' ILE . 32.7 Cg_exo -64.24 -41.73 20.5 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 123.165 2.576 . . . . 0.0 111.648 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 16' ' ' PRO . 24.1 mm -138.52 121.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.757 HD11 HG23 ' A' ' 50' ' ' VAL . 25.6 tp -132.43 141.25 48.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.232 0.539 . . . . 0.0 111.959 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.5 tp -132.34 120.67 22.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.791 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.793 ' CE2' HD21 ' A' ' 62' ' ' LEU . 7.5 m-85 -99.53 120.99 40.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.703 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.527 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -148.1 -154.05 0.53 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.755 ' HD3' ' HB3' ' A' ' 30' ' ' CYS . 64.6 tttm -100.7 112.01 24.34 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.43 69.5 1.06 Allowed Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.674 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -78.85 143.97 63.26 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.198 . . . . 0.0 111.068 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.04 -40.23 85.38 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.119 1.879 . . . . 0.0 110.94 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -65.27 -33.09 75.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.765 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -160.46 116.67 1.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.511 ' O ' ' SD ' ' A' ' 21' ' ' MET . 9.3 Cg_exo -72.94 31.43 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.738 2.292 . . . . 0.0 113.984 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -169.61 51.82 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.454 0.702 . . . . 0.0 110.241 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.755 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.8 t -56.37 -37.07 69.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.554 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -70.5 -135.82 0.11 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.5 -36.4 57.81 Favored 'General case' 0 C--O 1.219 -0.529 0 O-C-N 122.353 -0.498 . . . . 0.0 111.943 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.486 ' CB ' ' HB3' ' A' ' 21' ' ' MET . 34.6 t -54.01 -10.39 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.41 -42.32 42.2 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.083 0.24 . . . . 0.0 111.325 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' ' 36' ' ' ALA . 1.5 pm0 -80.56 -34.85 35.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.234 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB2' HE21 ' A' ' 35' ' ' GLN . . . -67.26 -42.75 83.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.304 -175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.527 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.54 -37.41 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.305 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.619 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.8 mm100 -64.81 -46.08 83.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.306 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.65 -43.95 93.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.618 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -64.12 -57.88 8.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.618 -174.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.41 ' HB2' ' HE2' ' A' ' 47' ' ' PHE . . . -59.56 -34.41 72.65 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.271 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.52 -48.84 59.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.681 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.5 p -72.81 -54.25 9.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.795 -173.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.774 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.38 -142.45 12.75 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.451 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 17.1 pt-20 -99.95 -154.68 0.48 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.52 . . . . 0.0 111.082 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.79 158.68 33.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.991 170.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.527 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 15.5 p90 -152.96 159.73 42.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.297 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.54 151.98 19.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.475 ' HD1' ' HE2' ' A' ' 21' ' ' MET . 2.0 p90 -138.05 151.59 48.0 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.757 HG23 HD11 ' A' ' 18' ' ' LEU . 46.2 t -132.3 126.78 56.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.61 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.8 p30 -76.59 131.39 38.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.277 0.56 . . . . 0.0 110.73 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.681 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -143.5 -33.93 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.709 -174.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 52' ' ' ILE . 1.6 mm? -65.74 -9.47 28.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.142 166.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -46.82 6.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.236 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -83.44 116.57 65.16 Favored Pre-proline 0 N--CA 1.476 0.842 0 O-C-N 122.059 -0.401 . . . . 0.0 111.025 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.93 -44.81 18.78 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.792 2.328 . . . . 0.0 113.248 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -61.5 -55.07 35.16 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.443 0.64 . . . . 0.0 111.341 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.457 HG22 HD23 ' A' ' 62' ' ' LEU . 41.9 mt -67.34 -36.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.365 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.3 ttt180 -56.98 -33.68 67.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.72 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.51 7.33 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.749 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 55.3 mm-40 -84.7 -51.05 7.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -167.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.793 HD21 ' CE2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -60.09 -41.67 85.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -172.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.626 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 32.4 Cg_endo -59.52 -39.28 76.95 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 C-N-CA 121.282 1.321 . . . . 0.0 111.168 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 37.9 mtmt -55.55 -41.75 73.68 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.219 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.666 ' HD2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -63.32 -44.89 93.64 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.111 -176.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.816 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.1 -56.11 5.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.462 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.738 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.5 t-20 -174.82 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.188 0.994 . . . . 0.0 110.006 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.738 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.12 148.25 62.31 Favored Pre-proline 0 C--O 1.219 -0.542 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.365 -175.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.77 -37.36 68.1 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 121.912 1.741 . . . . 0.0 110.437 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 37.2 p -143.07 -128.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.58 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.6 m-85 -137.11 -169.7 0.22 Allowed Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.968 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.55 153.39 82.59 Favored 'Cis proline' 0 C--N 1.361 1.22 0 CA-C-N 121.374 1.527 . . . . 0.0 114.14 -0.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.688 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.6 mt-30 -142.28 135.45 28.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.298 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.2 tm? -99.3 133.71 43.2 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 59.4 m95 -116.9 131.33 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.314 0.578 . . . . 0.0 110.863 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.827 HG21 HD13 ' A' ' 99' ' ' LEU . 86.4 t -121.67 122.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' HB2' HG23 ' A' ' 103' ' ' THR . 37.3 t70 58.22 30.12 18.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.811 1.291 . . . . 0.0 109.332 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.68 28.77 66.62 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.16 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -137.04 137.56 39.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 111.479 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.816 HD22 ' HB1' ' A' ' 66' ' ' ALA . 46.3 tp -66.96 132.48 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.229 -172.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.572 HG12 ' CG2' ' A' ' 86' ' ' ILE . 76.1 t -110.32 -54.65 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.921 171.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.63 134.49 2.7 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.87 -62.39 1.69 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -168.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.1 p -78.67 -68.12 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.701 -0.882 . . . . 0.0 112.992 -170.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.94 -47.65 43.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.031 0.444 . . . . 0.0 111.008 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.572 ' CG2' HG12 ' A' ' 81' ' ' VAL . 44.4 mm -59.95 -46.82 93.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.754 -170.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -56.11 -50.33 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.361 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 39' ' ' ALA . 36.7 mm -61.94 -50.66 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.631 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.781 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.3 tt0 -63.25 -50.48 70.02 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.422 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.463 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.3 mmt -57.54 -38.02 74.02 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.0 t80 -58.02 -51.64 68.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.149 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.0 mt-30 -63.93 -39.85 95.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.649 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.781 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 25.9 mmm180 -63.6 -33.89 76.6 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.821 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 99.59 -24.09 33.58 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.34 -170.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 5.1 mm-40 -52.14 -36.14 50.52 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.61 HD12 HD11 ' A' ' 99' ' ' LEU . 53.3 tp -64.77 -54.99 22.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.68 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.5 pt20 -61.18 -26.47 67.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.405 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 10.4 mm100 -66.81 -54.54 21.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.633 0.254 . . . . 0.0 111.407 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 HG21 ' A' ' 76' ' ' VAL . 3.0 pp -70.28 -35.26 73.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.558 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 99' ' ' LEU . 35.7 mm -62.97 -48.6 87.22 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -55.62 -52.22 64.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 111.753 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -57.1 -45.32 83.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.949 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 77' ' ' ASP . 91.1 m -68.0 -47.97 67.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.417 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.06 99.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.025 0.441 . . . . 0.0 110.06 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.65 99.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -72.14 -33.6 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.643 -178.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.465 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 80.0 m-85 -79.57 -46.69 16.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.767 173.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.636 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -89.58 -149.91 0.2 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.184 -177.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 25.3 t -82.84 -148.36 0.08 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.331 170.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -75.11 54.3 0.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.877 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 38.5 mm-40 -66.11 117.56 44.07 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 121.178 0.514 . . . . 0.0 110.398 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -99.7 49.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.598 2.865 . . . . 0.0 113.233 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.774 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 36.4 m-20 . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.822 HG22 HE21 ' A' ' 9' ' ' GLN . 73.3 mt . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -53.38 -47.29 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.982 0.42 . . . . 0.0 110.725 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.951 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -68.43 -45.35 72.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.56 175.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.63 HG21 HD22 ' A' ' 62' ' ' LEU . 82.6 mt -56.69 -44.2 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.822 HE21 HG22 ' A' ' 5' ' ' ILE . 71.7 mt-30 -60.35 -35.84 76.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.831 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -60.23 -35.68 76.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.494 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -72.36 -42.11 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.542 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.649 HG23 HD23 ' A' ' 18' ' ' LEU . 19.6 mt -68.39 -45.66 81.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.119 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -37.81 78.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.169 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.2 pt-20 -68.57 -34.8 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -78.55 127.57 80.15 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-O 120.901 0.381 . . . . 0.0 111.273 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.611 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.7 Cg_exo -61.8 -42.84 29.05 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.019 2.48 . . . . 0.0 112.333 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 16' ' ' PRO . 32.1 mm -137.47 120.95 21.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD23 HG23 ' A' ' 12' ' ' ILE . 21.5 tp -133.41 142.43 48.34 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.466 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.3 tp -136.32 120.28 17.55 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.12 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.769 ' CE2' HD21 ' A' ' 62' ' ' LEU . 5.5 m-85 -97.35 117.92 32.66 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.848 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.532 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 21.6 ptt? -146.84 -164.89 2.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.4 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.948 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 61.9 tttm -98.34 103.16 15.08 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.24 67.0 1.76 Allowed Glycine 0 C--N 1.309 -0.926 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.437 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 t -76.07 141.3 70.85 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.6 -41.42 45.11 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.253 1.969 . . . . 0.0 112.188 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -65.14 -35.62 81.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.844 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -158.57 118.99 1.84 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -172.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.552 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.1 Cg_exo -71.99 20.37 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.798 2.332 . . . . 0.0 114.303 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.7 p -161.97 52.35 0.23 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.517 0.675 . . . . 0.0 111.037 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 43.4 t -71.54 56.24 0.25 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.126 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.23 -136.53 2.02 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.695 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 28.2 m-85 -76.25 -38.28 56.48 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 117.481 0.64 . . . . 0.0 109.518 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 35.1 p -46.4 -24.58 0.52 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.195 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.99 -42.2 48.6 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.555 0.216 . . . . 0.0 111.097 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' O ' ' A' ' 32' ' ' PHE . 1.8 pp0? -77.41 -37.94 50.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 10.6 p -57.53 -38.98 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 1.8 mm100 -65.42 -41.92 93.07 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.924 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.519 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.1 -43.33 95.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.604 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.08 -56.0 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 0.0 109.908 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.35 72.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.885 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.6 m -70.41 -60.36 2.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.33 -138.91 9.57 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -115.09 -151.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.621 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -59.38 152.68 20.73 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.628 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.51 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 26.1 p90 -155.64 154.16 31.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.057 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 151.71 20.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.947 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.3 p90 -135.72 153.91 51.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.648 HG23 HD11 ' A' ' 18' ' ' LEU . 61.6 t -131.43 134.51 60.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.651 ' OD1' ' HB3' ' A' ' 54' ' ' GLN . 7.9 t70 -73.13 138.89 46.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.185 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.1 pp -152.0 -35.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.387 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.948 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -65.25 -18.0 64.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.387 174.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.651 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -94.94 -43.23 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.616 176.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -71.51 118.55 67.27 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 117.797 0.271 . . . . 0.0 110.503 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.81 -43.98 8.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.313 2.009 . . . . 0.0 113.029 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -69.25 -52.79 24.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.85 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.568 HG22 HD23 ' A' ' 62' ' ' LEU . 19.8 mt -65.12 -36.53 78.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.391 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.2 tmm_? -56.32 -37.93 70.61 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.73 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.609 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -80.43 -50.99 9.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.596 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 4.9 mm-40 -79.18 -53.51 6.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -167.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -62.53 -40.69 67.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.63 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 27.5 Cg_endo -59.44 -40.74 64.25 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 121.378 1.385 . . . . 0.0 111.468 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 51.6 mtmt -56.28 -36.06 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.556 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.557 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.81 -43.23 80.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.534 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.781 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.81 -56.26 4.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.434 -174.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.765 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -175.47 -53.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.253 1.025 . . . . 0.0 109.362 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.765 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.73 150.64 57.18 Favored Pre-proline 0 C--O 1.218 -0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 113.484 -176.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 68' ' ' TRP . 10.3 Cg_exo -64.1 -39.12 32.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.211 1.941 . . . . 0.0 110.113 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.5 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 47.6 p -143.12 -129.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.728 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 1.011 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.4 m-85 -137.86 -171.85 0.29 Allowed Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.528 -0.733 . . . . 0.0 109.141 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.011 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.57 156.07 82.31 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 120.933 1.369 . . . . 0.0 114.469 -0.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.678 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.9 mt-30 -142.08 133.58 26.67 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.264 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -94.06 138.13 32.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 58.9 m95 -124.28 128.03 48.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.257 0.551 . . . . 0.0 110.828 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.54 120.96 62.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.587 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 32.6 t70 56.39 27.44 12.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.917 1.341 . . . . 0.0 110.01 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.646 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 77.38 29.34 56.15 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.905 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -125.83 132.62 52.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.781 HD22 ' HB1' ' A' ' 66' ' ' ALA . 56.3 tp -69.81 130.29 41.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.472 HG12 ' CG2' ' A' ' 86' ' ' ILE . 88.3 t -108.35 -55.75 5.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.346 172.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.29 131.41 2.43 Favored Glycine 0 C--O 1.22 -0.768 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.468 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.36 -62.33 1.65 Allowed Glycine 0 C--O 1.222 -0.641 0 C-N-CA 119.593 -1.289 . . . . 0.0 116.1 -168.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 p -77.52 -67.85 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.759 -0.848 . . . . 0.0 112.934 -170.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -79.04 -45.0 21.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.023 -173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG13 ' HA3' ' A' ' 82' ' ' GLY . 48.0 mm -58.01 -47.01 87.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 82' ' ' GLY . 60.5 t -57.29 -51.86 64.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.568 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.519 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 45.6 mm -59.83 -50.39 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 42.7 tt0 -61.04 -51.51 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.694 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.683 ' HG2' ' N ' ' A' ' 96' ' ' LEU . 46.5 ttm -63.88 -32.59 74.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.098 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.885 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 7.8 t80 -57.35 -52.05 66.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.657 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.1 mt-30 -62.83 -38.28 90.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.14 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -59.12 -32.84 70.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.062 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.04 17.64 79.54 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.571 -171.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.666 ' HA ' ' HB3' ' A' ' 98' ' ' GLN . 88.9 mt-10 -90.87 -27.17 18.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.525 177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.683 ' N ' ' HG2' ' A' ' 90' ' ' MET . 61.7 tp -60.1 -53.66 55.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.579 0.704 . . . . 0.0 109.462 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.825 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 14.1 pt20 -64.31 -26.62 68.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.28 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.59 -44.16 91.52 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.175 0.512 . . . . 0.0 109.713 175.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 25.4 mt -69.95 -46.46 65.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.57 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.08 -45.23 98.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.148 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' A' ' 113' ' ' ASP . 36.4 ttpt -55.96 -48.78 75.18 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.49 -44.03 96.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.13 0.49 . . . . 0.0 110.373 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.587 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 42.1 m -75.33 -52.2 11.39 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.58 94.12 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.261 -0.274 . . . . 0.0 111.154 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.3 80.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.635 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -75.04 -27.03 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.153 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.611 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 44.4 m-85 -80.73 -45.77 16.54 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.063 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -76.64 -156.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.4 p -82.45 -147.75 0.08 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -76.81 46.51 0.46 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.916 0.389 . . . . 0.0 110.925 171.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -68.34 129.06 93.02 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.894 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.15 111.38 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.399 2.066 . . . . 0.0 112.721 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 101' ' ' LYS . 31.1 t70 . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.71 ' CG2' HE21 ' A' ' 9' ' ' GLN . 91.5 mt . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 33.8 mm-40 -51.28 -53.71 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 111.429 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.78 -40.19 88.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.304 0.573 . . . . 0.0 110.674 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.918 HG21 ' HG ' ' A' ' 62' ' ' LEU . 83.4 mt -59.76 -46.14 93.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.616 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.71 HE21 ' CG2' ' A' ' 5' ' ' ILE . 69.3 mt-30 -61.77 -35.24 77.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.662 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -60.82 -38.54 85.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.172 175.086 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 8' ' ' ILE . 17.2 pt20 -79.68 -39.81 30.47 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.009 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.643 HG22 ' HA2' ' A' ' 78' ' ' GLY . 22.3 mt -61.88 -45.22 99.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.218 0.533 . . . . 0.0 110.429 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.6 91.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.1 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.0 pt-20 -70.43 -30.15 66.93 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.828 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.74 126.87 85.32 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.275 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.632 ' O ' HD13 ' A' ' 17' ' ' ILE . 51.0 Cg_exo -60.29 -43.56 33.93 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.911 2.407 . . . . 0.0 112.56 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 16' ' ' PRO . 26.2 mm -139.92 120.61 14.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD23 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -133.76 142.26 47.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.375 -169.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 14.5 tp -137.52 116.62 12.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.17 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.561 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 6.6 m-85 -96.35 118.83 33.69 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.305 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.848 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 24.2 ptt? -147.44 -167.44 2.79 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 65.9 tttm -97.11 108.68 21.46 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -94.63 71.15 1.13 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.328 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.9 m -78.67 146.71 69.73 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.92 -41.69 74.62 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.479 2.119 . . . . 0.0 112.288 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.88 -31.45 71.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 tt -157.58 115.22 1.88 Allowed Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 40.2 Cg_endo -71.84 22.12 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.674 2.25 . . . . 0.0 113.713 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.848 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 15.7 p -163.14 50.48 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.014 0.526 . . . . 0.0 109.903 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.63 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 37.6 t -71.93 53.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.288 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.12 -134.38 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.152 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 1.037 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 63.3 m-85 -76.43 -23.16 53.95 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.405 ' N ' ' HG2' ' A' ' 72' ' ' PRO . 23.3 t -74.82 -11.54 60.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.664 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -50.76 -43.4 58.29 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.622 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -77.42 -39.13 48.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.068 0.461 . . . . 0.0 110.107 176.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.34 89.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.102 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -56.8 -39.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.321 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.598 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.7 mm100 -66.89 -47.35 72.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.858 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.36 -42.86 92.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.984 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -62.37 -57.08 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 110.036 -175.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.03 69.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.204 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.82 -50.62 23.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.557 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -76.5 -52.99 8.73 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.246 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.64 -135.59 8.99 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.486 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 26.3 mt-10 -141.95 -147.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.101 -0.549 . . . . 0.0 111.348 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 34.3 mmt-85 -48.02 146.96 2.28 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.359 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' HD13 ' A' ' 40' ' ' LEU . 21.6 p90 -159.38 150.86 20.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.876 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.99 144.06 28.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.557 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 p90 -130.78 149.74 52.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.485 HG23 HD11 ' A' ' 18' ' ' LEU . 44.0 t -124.31 128.04 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.535 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.0 p30 -78.46 132.2 37.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.393 0.616 . . . . 0.0 110.166 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.664 HD12 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -142.53 -34.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.342 -173.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.664 HD22 HD12 ' A' ' 52' ' ' ILE . 1.8 mm? -67.19 -8.68 33.2 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.116 167.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.25 -47.12 5.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.698 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.674 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.1 m-20 -73.78 131.35 81.96 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 121.958 -0.464 . . . . 0.0 111.419 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.76 -43.63 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.364 2.043 . . . . 0.0 112.924 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -76.1 -55.5 5.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.78 -33.38 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.674 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 28.1 ttm180 -49.73 -40.4 40.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.612 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.39 18.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 56.7 mm-40 -78.86 -60.08 2.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -161.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.918 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.92 -25.18 0.49 Allowed Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -170.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.687 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 14.1 Cg_endo -55.24 -41.82 74.66 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 121.682 1.637 . . . . 0.0 110.682 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -48.38 -41.93 30.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.777 175.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.639 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -71.97 -41.7 67.39 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.149 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.824 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -72.53 -57.56 4.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.64 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.689 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 50.3 t30 -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.256 1.027 . . . . 0.0 109.861 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.689 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -60.78 148.07 83.39 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 113.12 -1.854 . . . . 0.0 112.738 -176.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -61.95 -33.94 82.45 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.194 1.93 . . . . 0.0 110.145 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -143.0 -126.64 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.917 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.966 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.3 m-85 -142.28 -164.49 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.966 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 2.1 Cg_endo -74.32 154.9 99.88 Favored 'Cis proline' 0 C--N 1.362 1.278 0 CA-C-N 121.503 1.572 . . . . 0.0 113.282 -2.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.618 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 61.8 mt-30 -144.02 135.4 25.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.704 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -93.55 137.04 33.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 59.1 m95 -121.26 132.56 54.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.236 0.541 . . . . 0.0 111.083 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.06 120.88 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.591 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 30.6 t70 56.38 28.35 13.38 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.799 1.285 . . . . 0.0 110.43 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.51 28.21 55.77 Favored Glycine 0 C--N 1.311 -0.821 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.887 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -127.76 133.84 49.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.824 HD22 ' HB1' ' A' ' 66' ' ' ALA . 52.0 tp -69.44 130.25 41.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.771 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' CG2' ' A' ' 86' ' ' ILE . 81.6 t -107.35 -54.4 5.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.902 173.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.59 140.78 3.64 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.16 -67.66 1.4 Allowed Glycine 0 C--O 1.217 -0.951 0 C-N-CA 118.549 -1.786 . . . . 0.0 116.1 -167.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 1.037 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 42.0 t -81.76 -68.03 0.73 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.767 1.283 . . . . 0.0 112.657 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 86' ' ' ILE . 1.5 m-20 -65.53 -49.62 68.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.6 -169.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.6 mp -63.58 -43.15 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.992 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 HD11 ' A' ' 96' ' ' LEU . 53.1 t -59.84 -51.39 73.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.441 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.1 mm -59.02 -48.77 85.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.928 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.736 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.2 tt0 -62.28 -52.11 64.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.096 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.685 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.9 mmt -60.43 -34.78 74.47 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.611 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 7.6 t80 -58.2 -50.04 74.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.772 172.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.4 mt-30 -64.31 -40.81 96.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.11 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -61.96 -34.53 76.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.584 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.77 -23.53 32.33 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.824 -171.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.755 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 4.7 mm-40 -56.4 -39.69 73.41 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.824 0.45 . . . . 0.0 112.179 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.8 tt -60.31 -52.7 64.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.186 -176.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.708 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -64.68 -26.75 68.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -68.61 -46.83 68.23 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.108 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 53.5 mt -63.44 -46.19 87.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.06 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 96' ' ' LEU . 48.8 mm -62.1 -45.17 99.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.145 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.464 ' HA ' ' OD2' ' A' ' 113' ' ' ASP . 26.0 ttpp -53.03 -52.7 57.61 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.234 0.54 . . . . 0.0 111.375 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 87.7 tt0 -65.2 -46.6 80.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.547 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.951 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 91.4 m -66.87 -46.99 73.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.368 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.49 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.93 -42.29 99.75 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.58 78.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.951 ' HE2' ' HA ' ' A' ' 103' ' ' THR 0.255 0.0 OUTLIER -77.79 -26.97 50.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.349 178.631 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.692 ' CE2' ' HE3' ' A' ' 106' ' ' LYS . 93.8 m-85 -87.95 -49.55 6.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.521 171.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -101.82 135.9 42.57 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 p -58.17 115.84 3.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 49.47 43.23 23.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.396 -1.729 . . . . 0.0 114.143 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -78.33 117.69 67.73 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.38 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.18 59.03 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.697 2.931 . . . . 0.0 114.431 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.529 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 55.1 m-20 . . . . . 0 C--N 1.314 -0.947 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.731 ' CG2' HE21 ' A' ' 9' ' ' GLN . 62.2 mt . . . . . 0 C--O 1.225 -0.229 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -54.42 -45.67 73.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.002 0.43 . . . . 0.0 110.331 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -71.64 -40.19 69.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.051 174.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.695 HD13 HD22 ' A' ' 62' ' ' LEU . 72.3 mt -57.51 -43.66 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.56 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.731 HE21 ' CG2' ' A' ' 5' ' ' ILE . 73.1 mt-30 -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 7' ' ' LYS . 5.7 tpm_? -60.01 -38.24 82.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.383 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 53.0 tt0 -68.0 -45.8 73.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.124 0.487 . . . . 0.0 110.948 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.785 HG22 ' HA2' ' A' ' 78' ' ' GLY . 29.3 mt -66.56 -46.64 85.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.009 0.433 . . . . 0.0 110.722 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.69 88.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.4 pt-20 -66.93 -34.39 77.68 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.353 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 70.2 m-80 -77.34 128.38 80.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.607 ' O ' HD13 ' A' ' 17' ' ' ILE . 50.4 Cg_exo -60.22 -42.93 38.54 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 123.063 2.509 . . . . 0.0 112.075 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 16' ' ' PRO . 36.0 mm -139.4 125.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.685 HD11 HG23 ' A' ' 50' ' ' VAL . 27.5 tp -133.44 141.21 47.72 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.386 -170.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.3 tp -136.43 119.06 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.601 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -96.98 119.36 35.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.972 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.4 ptt? -146.19 -169.38 3.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.299 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.022 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.8 tttt -97.68 115.04 27.16 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.665 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.62 70.21 1.0 Allowed Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.399 -175.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 30' ' ' CYS . 80.4 p -79.05 143.37 61.21 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.777 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.3 -41.51 65.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.389 2.059 . . . . 0.0 112.278 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -65.0 -32.29 73.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.418 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 29' ' ' SER . 51.3 tp -158.72 116.92 1.72 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.594 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 11.3 Cg_exo -71.86 27.97 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.3 2.0 . . . . 0.0 112.736 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 40.6 p -162.84 51.56 0.18 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.179 0.514 . . . . 0.0 111.889 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.598 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 40.4 t -72.84 59.19 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.225 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.07 -139.81 2.97 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.82 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 55.1 m-85 -74.88 -17.7 60.54 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 120.994 0.426 . . . . 0.0 111.632 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 30.2 p -69.92 -18.45 63.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -48.65 -42.23 33.81 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.663 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.71 -38.97 58.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.141 0.496 . . . . 0.0 109.853 178.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.49 92.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.048 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.98 -39.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.028 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 1.8 mm100 -67.11 -44.28 80.33 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.91 -47.35 85.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.991 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -61.37 -51.83 67.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.9 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.75 67.98 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.883 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 44' ' ' GLY . . . -71.65 -48.66 46.22 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.15 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.961 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -70.45 -9.18 55.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.811 170.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -10.59 120.48 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.967 0 CA-C-N 110.684 -2.962 . . . . 0.0 119.056 -160.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.779 ' OE2' ' HA ' ' A' ' 97' ' ' GLN . 3.6 mp0 -133.43 138.19 46.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 109.95 -3.125 . . . . 0.0 103.887 164.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -56.39 129.41 40.45 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.643 -170.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 14.7 p90 -140.47 148.08 40.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.04 -166.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.36 152.94 21.0 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.929 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.5 p90 -136.38 153.18 51.18 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.685 HG23 HD11 ' A' ' 18' ' ' LEU . 61.4 t -128.95 131.45 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.5 p30 -76.51 132.37 39.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 110.368 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.626 HD12 HD22 ' A' ' 53' ' ' LEU . 1.2 pp -147.64 -37.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.022 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -65.56 -7.66 15.86 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.22 173.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HB3' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.22 -42.84 7.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.433 177.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.4 m-20 -77.09 123.26 87.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.5 -45.23 11.99 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.121 1.881 . . . . 0.0 112.763 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.04 -56.72 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.993 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.73 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.473 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.619 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 78.9 ttt180 -52.8 -31.93 41.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.7 -47.36 8.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.4 -60.61 2.26 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -163.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.695 HD22 HD13 ' A' ' 8' ' ' ILE . 1.8 pt? -68.36 -33.49 4.78 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.694 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.5 Cg_endo -53.94 -42.11 69.4 Favored 'Trans proline' 0 C--N 1.353 0.81 0 CA-C-N 120.939 1.371 . . . . 0.0 110.785 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.13 -40.53 61.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.28 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.509 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.3 -43.98 76.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.779 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -76.6 -57.59 3.77 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.816 -174.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.3 t-20 -174.99 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.109 0.957 . . . . 0.0 109.972 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -57.67 149.18 53.44 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 113.303 -1.772 . . . . 0.0 113.351 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -62.18 -37.11 65.17 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.426 2.084 . . . . 0.0 110.194 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 57.8 p -141.86 -124.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.278 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.998 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 46.0 m-85 -141.43 -170.58 0.24 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.998 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 58.5 Cg_endo -69.71 154.2 93.06 Favored 'Cis proline' 0 C--N 1.357 1.004 0 CA-C-N 121.27 1.489 . . . . 0.0 114.349 -1.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.617 HE22 ' HA ' ' A' ' 63' ' ' PRO . 61.2 mt-30 -144.96 134.92 23.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.655 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -98.63 137.52 37.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.029 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.535 ' N ' HD13 ' A' ' 74' ' ' LEU . 60.3 m95 -123.81 132.19 53.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.276 0.56 . . . . 0.0 111.222 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 99' ' ' LEU . 38.9 t -114.31 118.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.536 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.2 t70 55.61 26.9 9.74 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.388 1.566 . . . . 0.0 108.72 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.785 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.82 28.54 46.02 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.607 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.47 133.33 47.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.973 0.416 . . . . 0.0 111.077 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.779 HD22 ' HB1' ' A' ' 66' ' ' ALA . 55.5 tp -68.81 133.44 48.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.556 HG12 ' CG2' ' A' ' 86' ' ' ILE . 90.1 t -110.41 -54.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.069 170.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.48 135.03 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.475 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -85.1 -63.56 1.58 Allowed Glycine 0 C--O 1.219 -0.803 0 C-N-CA 119.291 -1.433 . . . . 0.0 116.589 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.9 p -78.89 -67.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.427 -1.043 . . . . 0.0 113.373 -168.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.21 -43.34 28.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.556 ' CG2' HG12 ' A' ' 81' ' ' VAL . 48.4 mm -57.18 -45.61 84.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.157 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.8 t -58.67 -48.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.44 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.844 HD13 ' HB2' ' A' ' 39' ' ' ALA . 36.9 mm -58.59 -53.42 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.09 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.4 tt0 -63.2 -49.36 74.53 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.246 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.816 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -61.09 -37.64 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 2.3 t80 -57.86 -49.39 76.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.553 173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.5 mt-30 -64.16 -39.64 94.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.1 mmm180 -57.49 -33.55 68.13 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.639 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.541 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 89.82 -24.05 17.16 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.211 -170.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.511 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.1 mt-10 -60.92 -26.44 67.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 7.9 tt -73.08 -53.96 9.74 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.961 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 17.5 pt20 -57.89 -25.92 61.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.181 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.3 mm100 -69.23 -53.27 20.75 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.667 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.802 HD13 HG21 ' A' ' 76' ' ' VAL . 2.8 pp -71.58 -35.39 70.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.713 ' HB ' ' OE2' ' A' ' 45' ' ' GLU . 29.4 mm -66.1 -48.38 81.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.173 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -56.31 -51.07 69.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.683 0.278 . . . . 0.0 110.953 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 85.9 tt0 -55.96 -48.02 76.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.876 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 63.7 m -63.15 -48.31 78.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.512 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.677 ' HB1' ' NZ ' ' A' ' 108' ' ' LYS . . . -60.15 -46.44 89.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.94 88.48 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.132 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -72.77 -20.8 61.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.771 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 33.0 m-85 -81.83 -46.77 13.7 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.677 ' NZ ' ' HB1' ' A' ' 104' ' ' ALA . 1.0 OUTLIER -87.09 -151.65 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.311 170.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -86.55 -153.82 0.21 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.7 51.43 0.11 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.471 0.309 . . . . 0.0 111.771 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.476 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 56.7 mm-40 -70.58 122.81 87.72 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.152 0.501 . . . . 0.0 112.021 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.67 65.35 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.337 2.692 . . . . 0.0 113.271 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 31.4 m-20 . . . . . 0 C--N 1.314 -0.943 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.482 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.673 ' CG2' HE21 ' A' ' 9' ' ' GLN . 63.7 mt . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -54.73 -44.12 73.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.636 0.255 . . . . 0.0 110.787 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.4 -45.11 73.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.667 HG21 HD13 ' A' ' 62' ' ' LEU . 69.0 mt -59.53 -45.06 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.673 HE21 ' CG2' ' A' ' 5' ' ' ILE . 69.9 mt-30 -64.3 -38.36 90.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.474 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 13.3 mmp_? -62.61 -37.01 84.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 109.868 172.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.69 -46.0 70.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.6 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.805 HG22 ' HA2' ' A' ' 78' ' ' GLY . 35.7 mt -65.72 -44.43 93.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.094 0.473 . . . . 0.0 110.53 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.01 95.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.089 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 23.5 pt-20 -66.55 -32.75 74.29 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.33 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.471 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -77.16 127.24 83.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.595 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.599 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.1 Cg_exo -59.68 -43.44 38.57 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.752 2.301 . . . . 0.0 112.576 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 16' ' ' PRO . 31.6 mm -140.27 124.2 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.701 HD23 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -134.32 142.15 47.16 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.625 -169.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.5 tp -135.15 116.95 15.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.64 ' CE2' HD11 ' A' ' 62' ' ' LEU . 10.8 m-85 -96.83 117.94 32.18 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.795 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.566 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -147.12 -158.15 0.88 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.737 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 64.9 tttm -98.85 107.95 20.51 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.648 -0.657 . . . . 0.0 109.756 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.65 126.19 8.68 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.062 -1.065 . . . . 0.0 111.79 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.441 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 37.2 t -146.4 145.16 22.81 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -41.13 79.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.204 1.936 . . . . 0.0 111.18 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.4 pttt -65.72 -32.36 73.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.667 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.467 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -160.49 119.98 1.59 Allowed Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HD2' HD13 ' A' ' 27' ' ' LEU . 44.0 Cg_endo -73.34 20.69 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.382 0 C-N-CA 122.41 2.073 . . . . 0.0 114.121 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 22.1 p -169.51 52.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.9 t -55.8 -37.7 68.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -168.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -68.83 -135.65 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.924 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -74.18 -32.61 63.15 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 122.204 -0.586 . . . . 0.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.7 p -46.54 -22.09 0.24 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.271 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.96 32.14 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.231 0.332 . . . . 0.0 111.867 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.461 HE21 ' HB2' ' A' ' 36' ' ' ALA . 1.3 pm0 -80.69 -35.5 33.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.266 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB2' HE21 ' A' ' 35' ' ' GLN . . . -68.97 -44.3 73.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.539 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.0 p -53.4 -38.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.484 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.559 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.2 mm100 -63.74 -46.82 83.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.077 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.15 -42.04 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.839 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -61.95 -56.23 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.511 . . . . 0.0 109.895 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.31 71.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.294 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.39 -47.43 56.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.805 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.6 m -72.23 -57.98 3.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -103.87 -148.62 19.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.314 -0.946 . . . . 0.0 114.421 -175.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.8 mm-40 -105.98 -154.4 0.52 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 37.1 mmt-85 -62.2 152.7 32.53 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.558 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 24.4 p90 -151.87 156.14 39.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.142 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.51 149.67 22.49 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.2 p90 -136.63 151.74 49.65 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG23 HD11 ' A' ' 18' ' ' LEU . 54.0 t -130.98 129.5 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.377 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 2.7 p30 -75.01 134.19 41.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.503 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.677 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -149.28 -34.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.677 HD22 HD12 ' A' ' 52' ' ' ILE . 1.6 mm? -67.87 -7.57 29.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.583 169.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.425 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.59 -38.42 10.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.861 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.2 m-20 -79.39 128.03 76.71 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 120.642 0.258 . . . . 0.0 111.009 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.86 -45.0 6.86 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.333 2.022 . . . . 0.0 112.928 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -84.52 -49.73 8.35 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.529 HG22 HG22 ' A' ' 52' ' ' ILE . 40.9 mt -58.39 -33.32 47.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.35 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.697 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -50.53 -38.7 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.976 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.654 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -91.42 -35.34 14.42 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.674 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 51.7 mt-10 -76.18 -61.62 1.88 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -162.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.0 pt? -70.71 -32.49 2.57 Favored Pre-proline 0 N--CA 1.468 0.433 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.697 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 18.9 Cg_endo -56.09 -40.04 87.43 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 120.925 1.366 . . . . 0.0 110.85 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.674 ' NZ ' ' HA ' ' A' ' 61' ' ' GLU . 31.6 mtmm -56.25 -38.34 70.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.519 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -66.48 -43.12 86.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.136 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.93 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.4 -57.1 4.1 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.104 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.2 t30 -175.87 -53.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.167 0.984 . . . . 0.0 109.47 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.679 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -54.9 149.24 24.1 Favored Pre-proline 0 C--O 1.217 -0.623 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.388 -176.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -62.77 -37.75 53.8 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.242 1.961 . . . . 0.0 110.191 171.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.9 p -142.01 -130.43 0.1 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.635 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.922 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 17.1 m-85 -137.67 -166.15 0.11 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.922 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.1 Cg_endo -65.87 153.28 80.0 Favored 'Cis proline' 0 C--N 1.362 1.274 0 CA-C-N 121.586 1.602 . . . . 0.0 113.744 -1.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.608 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.1 mt-30 -141.74 133.11 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.53 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -93.96 138.4 32.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 59.6 m95 -126.77 130.19 49.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.799 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' CG2' HD13 ' A' ' 100' ' ' ILE . 2.4 p -125.63 123.79 65.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.5 t70 61.28 28.25 17.81 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.468 1.604 . . . . 0.0 108.091 -171.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.805 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 68.2 25.67 74.46 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 113.029 -1.896 . . . . 0.0 112.95 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 37.0 mm-40 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.805 0.442 . . . . 0.0 110.559 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.93 HD22 ' HB1' ' A' ' 66' ' ' ALA . 44.6 tp -71.93 125.13 26.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.764 0.316 . . . . 0.0 111.567 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.578 HG12 ' CG2' ' A' ' 86' ' ' ILE . 71.8 t -106.27 -53.04 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.934 172.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.564 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 141.46 134.45 3.02 Favored Glycine 0 C--O 1.221 -0.693 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.462 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -85.23 -62.63 1.64 Allowed Glycine 0 C--O 1.22 -0.742 0 C-N-CA 119.498 -1.334 . . . . 0.0 116.292 -168.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.4 p -77.24 -68.25 0.63 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.683 -0.892 . . . . 0.0 112.903 -170.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.4 -44.59 28.69 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 111.289 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.578 ' CG2' HG12 ' A' ' 81' ' ' VAL . 45.0 mm -59.33 -44.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.258 -172.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 82' ' ' GLY . 69.1 t -58.02 -49.51 81.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.9 mm -60.58 -48.56 88.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.497 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.823 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -62.24 -52.88 61.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.593 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.579 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.4 mmt -57.35 -36.52 71.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.581 0.229 . . . . 0.0 111.35 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.794 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 19.6 t80 -56.23 -51.27 68.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.995 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -65.59 -44.85 85.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.691 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 2.1 mmp_? -60.64 -33.94 73.53 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.978 0.418 . . . . 0.0 111.281 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.641 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 98.6 -25.24 28.74 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.72 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.2 mt-10 -56.0 -32.33 63.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 61.7 tp -57.41 -55.71 31.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.181 0.515 . . . . 0.0 110.703 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.805 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.3 pt20 -65.61 -26.22 67.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.627 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.8 mm100 -63.83 -46.42 85.12 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.0 mt -67.76 -46.49 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.149 177.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 96' ' ' LEU . 32.8 mm -63.7 -42.47 96.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.847 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 28.2 ttpt -54.72 -56.09 22.96 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.505 0.669 . . . . 0.0 110.863 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 15.6 tp10 -58.75 -45.95 88.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.567 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 88.5 m -69.85 -49.07 56.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.26 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.36 92.45 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.267 -0.271 . . . . 0.0 110.314 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.48 93.68 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.598 0.561 . . . . 0.0 111.798 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -71.57 -18.57 62.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.475 ' HE2' HG23 ' A' ' 103' ' ' THR . 57.1 m-85 -92.08 -47.52 7.21 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.261 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 46.2 mtmt -101.03 -147.18 0.35 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.952 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -64.92 155.53 34.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.884 164.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.49 55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -174.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -65.08 121.26 73.21 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.23 60.21 1.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.697 2.932 . . . . 0.0 113.434 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.425 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.2 m-20 . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 0.0 112.01 -174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.692 ' CG2' HE21 ' A' ' 9' ' ' GLN . 52.9 mt . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 65.0 mm-40 -57.02 -47.0 81.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -67.16 -43.89 81.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.805 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.664 HG21 HD13 ' A' ' 62' ' ' LEU . 69.7 mt -59.6 -48.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.692 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.1 mt-30 -61.55 -39.74 92.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.396 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.775 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mmp_? -59.49 -40.4 86.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -71.92 -43.13 65.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.717 HG22 ' HA2' ' A' ' 78' ' ' GLY . 39.8 mt -60.08 -42.09 88.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.208 0.528 . . . . 0.0 109.577 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -36.68 78.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.718 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.775 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 83.0 mt-10 -58.68 -46.46 87.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.598 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.0 m-80 -79.31 124.27 84.28 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.254 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.492 ' O ' HD13 ' A' ' 17' ' ' ILE . 32.1 Cg_exo -62.9 -43.45 19.92 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 C-N-CA 122.355 2.037 . . . . 0.0 111.77 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 16' ' ' PRO . 23.0 mm -128.9 120.89 53.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.645 HD23 HG23 ' A' ' 12' ' ' ILE . 20.8 tp -133.54 140.56 47.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.452 -169.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD21 HG12 ' A' ' 37' ' ' VAL . 11.6 tp -134.69 116.93 15.48 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.351 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.635 ' HB3' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -97.93 115.94 29.15 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.011 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HE3' ' HB2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.72 -154.36 0.55 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.943 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 2.2 tmtp? -98.04 97.1 8.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -170.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.675 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.23 71.73 1.39 Allowed Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.499 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.509 ' HB2' ' HE2' ' A' ' 22' ' ' LYS . 38.5 t -78.59 145.14 66.64 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.95 -40.07 87.5 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.058 1.838 . . . . 0.0 111.475 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -70.01 -30.74 68.12 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.605 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 28' ' ' PRO . 54.2 tp -157.88 118.38 1.94 Allowed Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -70.73 22.28 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.509 2.139 . . . . 0.0 113.647 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -164.95 48.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 110.883 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.943 ' HB3' ' HD2' ' A' ' 22' ' ' LYS . 42.6 t -70.42 58.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.442 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.25 -139.4 2.63 Favored Glycine 0 C--N 1.314 -0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -78.05 -45.73 22.79 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 117.63 0.715 . . . . 0.0 111.582 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' HG13 ' A' ' 37' ' ' VAL . 35.5 t -52.21 -10.26 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.52 -41.87 42.25 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 119.265 -0.397 . . . . 0.0 110.401 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.586 HE21 ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -81.29 -30.48 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 172.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.586 ' N ' HE21 ' A' ' 35' ' ' GLN . . . -67.27 -42.69 83.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 33' ' ' SER . 26.9 m -54.67 -41.59 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.96 ' H ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -56.92 -47.9 79.53 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 122.443 0.297 . . . . 0.0 110.29 178.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.675 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.3 -45.4 88.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.859 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.48 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -64.55 -55.09 22.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -177.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.32 74.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.959 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.51 -45.5 68.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.649 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 27.2 p -76.81 -56.11 4.89 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -173.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.16 -144.85 16.66 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.066 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.686 ' OE2' ' HB1' ' A' ' 104' ' ' ALA . 13.1 pt-20 -100.29 -153.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 155.39 40.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.627 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CD2' HD13 ' A' ' 40' ' ' LEU . 17.6 p90 -145.01 158.41 43.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 -169.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 152.05 19.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.466 ' HB2' ' HE3' ' A' ' 21' ' ' MET . 1.5 p90 -138.67 154.41 48.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG23 HD11 ' A' ' 18' ' ' LEU . 48.4 t -131.45 129.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.675 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.2 p30 -78.97 133.33 36.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 110.523 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.721 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -147.47 -35.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 -173.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.721 ' H ' HD12 ' A' ' 52' ' ' ILE . 1.4 mm? -66.21 -9.6 33.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.304 169.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 -42.94 8.02 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.674 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -78.84 123.26 85.27 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.322 -0.237 . . . . 0.0 110.707 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.81 -45.06 9.05 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.099 1.866 . . . . 0.0 112.802 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.17 -52.95 12.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.436 HG22 HG22 ' A' ' 52' ' ' ILE . 37.6 mt -61.77 -36.97 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.522 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 54.6 ttp85 -51.24 -35.19 35.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.46 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -85.0 -47.12 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -170.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -78.87 -59.52 2.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -161.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.665 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 2.2 pt? -67.48 -33.37 5.43 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -173.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 12.3 Cg_endo -55.1 -41.15 81.48 Favored 'Trans proline' 0 C--N 1.352 0.714 0 CA-C-N 121.167 1.452 . . . . 0.0 111.125 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.1 mtmp? -58.58 -34.01 70.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.682 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -66.6 -44.17 82.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.935 176.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.799 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.66 -57.33 3.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.592 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.726 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.1 t-20 -175.67 -56.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.158 0.98 . . . . 0.0 109.636 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.728 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.58 151.27 31.0 Favored Pre-proline 0 C--O 1.22 -0.458 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.257 -176.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -64.13 -36.96 44.62 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.312 2.008 . . . . 0.0 110.024 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.3 p -142.1 -125.09 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.765 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.942 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 22.0 m-85 -141.53 -164.8 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.942 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.44 153.46 82.21 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 121.849 1.696 . . . . 0.0 113.699 -1.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.2 mt-30 -142.5 132.04 23.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.495 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.48 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -94.81 135.11 36.7 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 62.2 m95 -119.02 128.87 54.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.43 0.634 . . . . 0.0 110.789 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 99' ' ' LEU . 92.5 t -115.53 120.49 64.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.222 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' H ' HG21 ' A' ' 103' ' ' THR . 32.4 t70 57.73 28.55 16.02 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.034 1.397 . . . . 0.0 109.889 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.717 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 76.01 28.29 60.81 Favored Glycine 0 C--N 1.312 -0.781 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.047 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.4 135.09 46.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.498 . . . . 0.0 111.305 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.799 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.9 tp -69.22 131.13 44.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.377 -174.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.537 HG12 ' CG2' ' A' ' 86' ' ' ILE . 96.8 t -110.57 -51.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.028 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.495 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 144.64 133.6 2.67 Favored Glycine 0 C--O 1.222 -0.615 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.447 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.56 -62.44 1.71 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.492 -1.337 . . . . 0.0 116.064 -168.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.413 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 20.5 p -78.99 -67.55 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.689 -0.889 . . . . 0.0 112.955 -170.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -78.59 -43.8 25.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.66 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.537 ' CG2' HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.86 -44.51 94.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.772 -173.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 39' ' ' ALA . 96.0 t -57.69 -48.91 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.675 HD13 ' HB2' ' A' ' 39' ' ' ALA . 35.6 mm -60.11 -51.59 71.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.758 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 84.2 tt0 -59.37 -54.74 43.23 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.38 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.828 ' HB2' HD23 ' A' ' 96' ' ' LEU . 26.4 mmt -58.15 -37.95 75.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.534 0.207 . . . . 0.0 110.743 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.504 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.0 t80 -57.16 -49.81 74.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.391 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.652 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -64.79 -38.56 91.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.113 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 1.2 mmm180 -62.34 -32.0 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.767 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 21.24 58.45 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.555 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.731 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.9 mm-40 -90.39 -32.41 16.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.404 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -60.47 -53.43 57.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.54 -172.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.768 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.0 pm0 -62.57 -28.88 70.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.58 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.415 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.0 mm100 -66.12 -45.98 79.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.4 mt -67.4 -45.14 77.05 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.03 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 96' ' ' LEU . 51.0 mm -64.97 -42.5 94.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.465 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 31.9 ttmt -52.0 -56.66 12.91 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.453 0.644 . . . . 0.0 111.225 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.58 -43.99 89.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.255 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.598 ' O ' ' HD2' ' A' ' 107' ' ' TYR . 73.1 m -72.41 -44.05 63.01 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.783 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB1' ' OE2' ' A' ' 45' ' ' GLU . . . -65.98 -44.11 85.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.481 -0.762 . . . . 0.0 110.167 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.11 95.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.808 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 107' ' ' TYR . 17.1 ptpt -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.014 -0.429 . . . . 0.0 110.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.598 ' HD2' ' O ' ' A' ' 103' ' ' THR . 81.1 m-85 -77.99 -45.73 23.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -97.55 -150.33 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.733 177.485 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 111' ' ' GLU . 11.1 p -67.93 169.66 9.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 166.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.72 60.39 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 65.8 mm-40 -58.44 126.36 78.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.778 0.799 . . . . 0.0 111.73 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 73.9 Cg_endo -94.15 56.75 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 123.416 2.744 . . . . 0.0 113.039 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.685 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.5 m-20 . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.05 -169.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.673 ' CG2' HE21 ' A' ' 9' ' ' GLN . 95.1 mt . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.73 -49.33 68.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.7 mptt -72.54 -39.62 67.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.034 175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.864 HG21 ' HG ' ' A' ' 62' ' ' LEU . 71.8 mt -58.21 -47.65 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.011 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.673 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.9 mt-30 -61.03 -32.79 72.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.483 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 17.2 mmt180 -60.06 -37.54 80.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.419 . . . . 0.0 110.51 173.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 45.4 tt0 -72.97 -45.46 57.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.378 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.661 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 21.8 mt -63.78 -42.8 97.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.228 0.537 . . . . 0.0 110.111 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.28 98.3 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.788 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.4 pt-20 -65.07 -38.56 91.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.264 -175.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -78.74 127.15 81.1 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 31.8 Cg_endo -64.25 -41.24 22.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.011 2.474 . . . . 0.0 112.384 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 16' ' ' PRO . 34.2 mm -132.87 123.59 48.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.684 HD11 HG23 ' A' ' 50' ' ' VAL . 33.2 tp -133.8 143.45 48.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.436 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.43 118.5 15.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.345 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.604 ' HE1' HD21 ' A' ' 18' ' ' LEU . 7.6 m-85 -96.46 119.13 34.38 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.273 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.598 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 22.8 ptt? -146.5 -168.08 2.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.896 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.074 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 40.1 ttmt -96.75 138.15 34.75 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 28' ' ' PRO . . . -140.49 135.15 6.86 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 118.287 -1.911 . . . . 0.0 112.975 174.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 t -121.29 150.61 54.47 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.626 -1.287 . . . . 0.0 108.466 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.03 -38.14 58.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.023 1.815 . . . . 0.0 111.664 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -70.49 -35.09 73.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.773 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.0 tp -159.43 114.62 1.55 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.426 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 52.2 Cg_endo -73.38 32.51 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.081 2.521 . . . . 0.0 113.891 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 11.3 p -165.47 47.3 0.09 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.01 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.608 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 49.1 t -74.39 53.07 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.885 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.31 -141.22 3.14 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -76.4 -36.04 58.29 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.299 0.571 . . . . 0.0 109.847 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.598 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 48.7 p -52.35 -22.87 5.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.748 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.75 -44.43 28.14 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.473 0.483 . . . . 0.0 111.656 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.617 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -80.92 -35.34 32.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.582 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.427 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -54.47 -37.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.586 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.1 mm100 -65.76 -45.4 82.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.77 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -57.69 -44.73 86.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.509 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.24 -57.13 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.481 . . . . 0.0 110.362 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.49 71.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.123 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.21 -49.53 42.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.629 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.7 p -76.4 -49.97 15.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.344 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.47 -131.47 7.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.064 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 4.6 mm-40 -140.39 -152.56 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.149 0.579 . . . . 0.0 111.04 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.489 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 42.2 mmm-85 -55.68 148.02 17.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.832 0.825 . . . . 0.0 112.387 -173.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 21.9 p90 -156.65 155.36 31.65 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.292 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.01 159.25 15.09 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.687 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -143.7 154.32 43.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.684 HG23 HD11 ' A' ' 18' ' ' LEU . 47.1 t -133.43 127.81 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' MET . 12.1 p-10 -81.25 131.5 35.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.573 . . . . 0.0 110.585 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.626 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -146.69 -32.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.287 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.074 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -67.32 -8.49 32.77 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.545 171.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -97.42 -48.55 5.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.33 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.3 m-20 -79.66 116.03 57.89 Favored Pre-proline 0 N--CA 1.472 0.647 0 O-C-N 122.118 -0.364 . . . . 0.0 110.784 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 24.7 Cg_exo -64.14 -44.34 12.63 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.981 2.454 . . . . 0.0 113.402 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -66.42 -54.64 21.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -62.28 -34.76 65.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 29.2 ttm180 -53.16 -40.91 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.031 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.466 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -79.61 -38.6 33.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -167.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.88 -59.21 2.87 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -161.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.864 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.17 -26.94 0.57 Allowed Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -170.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.744 ' HD3' HD13 ' A' ' 62' ' ' LEU . 18.4 Cg_endo -57.08 -41.61 72.76 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.603 1.608 . . . . 0.0 111.521 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 53.6 mtmt -59.58 -34.24 72.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.701 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.504 ' CD2' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -66.15 -42.2 89.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.807 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.95 -56.86 4.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.446 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.699 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 22.6 t-20 -175.71 -55.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 122.159 0.981 . . . . 0.0 109.613 170.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.699 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.8 OUTLIER -56.82 150.37 38.04 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.645 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -63.79 -38.83 37.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.419 2.079 . . . . 0.0 110.283 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.9 p -141.4 -125.97 0.1 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.388 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.863 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.4 m-85 -141.13 -166.1 0.11 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.863 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 39.1 Cg_endo -65.65 156.7 78.42 Favored 'Cis proline' 0 C--N 1.362 1.244 0 CA-C-N 121.597 1.606 . . . . 0.0 113.836 -2.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.667 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 70.9 mt-30 -146.52 131.39 18.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.805 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 18' ' ' LEU . 61.1 tp -91.32 137.84 32.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.625 174.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 58.2 m95 -121.9 125.21 45.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.284 0.564 . . . . 0.0 109.921 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.4 t -110.04 119.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.197 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.57 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 58.24 28.85 17.17 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 123.403 1.573 . . . . 0.0 108.589 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.62 29.8 59.07 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.726 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 48.9 mt-10 -126.97 131.0 51.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.661 0.267 . . . . 0.0 110.359 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.807 HD22 ' HB1' ' A' ' 66' ' ' ALA . 47.6 tp -67.66 130.9 44.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -173.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.622 HG12 ' CG2' ' A' ' 86' ' ' ILE . 94.4 t -112.29 -52.52 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.123 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.85 136.0 2.88 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.518 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -86.88 -64.09 1.43 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.377 -1.392 . . . . 0.0 116.471 -169.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.0 p -80.13 -66.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.692 -0.887 . . . . 0.0 112.831 -171.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -74.03 -46.36 43.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.026 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.622 ' CG2' HG12 ' A' ' 81' ' ' VAL . 2.0 mp -60.98 -46.79 95.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.21 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -55.76 -49.4 74.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.258 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 35' ' ' GLN . 36.9 mm -62.12 -50.71 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.947 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.6 tt0 -62.46 -51.93 65.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.679 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.62 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -58.95 -33.63 70.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.308 0.243 . . . . 0.0 111.543 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.688 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.2 t80 -59.06 -52.48 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.129 172.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.0 mt-30 -62.88 -42.88 99.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.418 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 38.5 mmm-85 -62.58 -34.55 77.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.248 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 102.58 -23.79 32.91 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.945 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.783 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.3 mt-10 -56.11 -33.27 64.95 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.693 HD22 ' SG ' ' A' ' 43' ' ' CYS . 5.6 tt -69.77 -50.04 47.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.184 0.516 . . . . 0.0 109.669 -174.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.2 pt20 -61.55 -25.22 67.16 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.058 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.5 mm100 -69.79 -48.08 60.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.53 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 54.1 mt -63.9 -46.11 86.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.201 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.539 HG22 ' OD2' ' A' ' 113' ' ' ASP . 50.5 mm -64.43 -44.48 97.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.818 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 37.4 ttmt -48.74 -52.14 25.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.352 0.596 . . . . 0.0 111.144 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -62.24 -50.82 70.22 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.432 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.57 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 95.3 m -71.18 -48.94 48.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.489 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . . . -61.67 -46.37 90.0 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.141 -0.349 . . . . 0.0 110.55 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 110' ' ' GLU . . . -61.77 -32.85 73.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.911 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.603 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -80.44 -17.86 50.51 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.654 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.597 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 53.9 m-85 -90.5 -50.52 5.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.858 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.599 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 2.1 mppt? -103.06 121.23 42.15 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 165.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 p -46.26 113.19 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.561 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 53.5 mt-10 49.66 44.56 24.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.317 -1.765 . . . . 0.0 113.355 172.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.599 ' OE1' ' HB2' ' A' ' 108' ' ' LYS . 8.9 pt-20 -75.67 130.16 79.8 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.521 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 3.7 Cg_exo -79.56 121.62 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.743 2.295 . . . . 0.0 111.611 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.613 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 43.7 m-20 . . . . . 0 CA--C 1.513 -0.461 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.73 ' CG2' HE21 ' A' ' 9' ' ' GLN . 59.9 mt . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.92 -43.54 94.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 0.0 110.065 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -63.75 -45.22 90.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.038 172.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.721 HD13 HD22 ' A' ' 62' ' ' LEU . 74.4 mt -60.94 -43.86 96.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.659 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.73 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.8 mt-30 -63.24 -38.71 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.299 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -60.75 -37.01 80.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.32 0.581 . . . . 0.0 109.766 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 38.2 tt0 -68.09 -45.45 73.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.001 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.712 HG23 HD23 ' A' ' 18' ' ' LEU . 36.4 mt -70.43 -44.59 77.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 110.661 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.26 77.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.2 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.34 -34.04 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.829 -176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 76.9 m-20 -77.61 128.63 79.26 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-O 121.166 0.508 . . . . 0.0 111.112 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.553 ' O ' HD13 ' A' ' 17' ' ' ILE . 44.5 Cg_exo -61.78 -42.92 28.68 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 123.008 2.472 . . . . 0.0 112.679 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.2 mm -139.61 122.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.712 HD23 HG23 ' A' ' 12' ' ' ILE . 23.2 tp -134.15 141.34 47.06 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.505 -169.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' A' ' 21' ' ' MET . 12.1 tp -135.45 117.21 15.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.525 -176.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE2' HD11 ' A' ' 62' ' ' LEU . 8.7 m-85 -97.33 117.99 32.8 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.938 174.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.731 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -148.09 -159.48 1.04 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.727 177.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.044 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 34.7 ttpt -99.65 117.75 34.68 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.374 -0.829 . . . . 0.0 110.562 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.599 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.84 70.6 0.95 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.512 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -78.21 140.68 61.41 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.45 -41.3 74.29 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.054 1.836 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -69.46 -30.35 68.23 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.041 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tt -156.57 105.91 2.0 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.44 ' O ' ' SD ' ' A' ' 21' ' ' MET . 15.0 Cg_exo -73.66 28.57 0.31 Allowed 'Trans proline' 0 C--O 1.223 -0.225 0 C-N-CA 122.642 2.228 . . . . 0.0 114.052 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -166.09 52.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.836 0.351 . . . . 0.0 111.484 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 22' ' ' LYS . 46.3 t -71.32 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 61.08 -139.29 47.8 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.203 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.48 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 37.9 m-85 -79.29 -20.88 46.92 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 21' ' ' MET . 30.6 p -70.2 -11.71 61.08 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -170.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.24 -43.89 22.32 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.352 0.407 . . . . 0.0 111.864 -175.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.645 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.02 -40.02 40.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.617 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.96 90.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.154 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p -55.75 -38.8 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.559 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.578 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -67.24 -46.66 73.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.891 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.87 -42.31 93.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.862 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -62.09 -56.74 15.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.374 0.607 . . . . 0.0 109.704 -175.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.06 72.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.486 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -46.34 64.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.82 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.4 m -71.91 -59.36 2.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.04 -145.01 13.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.371 -0.918 . . . . 0.0 114.499 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.849 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 32.2 mm-40 -120.37 -150.41 0.45 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.857 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 43.2 mmm-85 -55.54 144.98 24.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.058 0.933 . . . . 0.0 113.262 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 40' ' ' LEU . 26.3 p90 -150.83 152.56 33.93 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.386 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.7 152.71 19.35 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.479 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -137.36 150.58 47.81 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.561 HG23 HD11 ' A' ' 18' ' ' LEU . 46.5 t -129.56 126.56 63.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.599 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.4 p30 -76.23 129.55 36.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -145.59 -36.41 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.044 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.99 -11.58 30.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.423 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.51 -41.78 8.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.405 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -87.93 116.14 65.26 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 122.198 -0.313 . . . . 0.0 110.667 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.16 -43.83 13.94 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.167 1.912 . . . . 0.0 113.28 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.16 -50.67 67.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.029 0.443 . . . . 0.0 111.8 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.0 -40.67 81.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 78.9 ttt180 -52.1 -37.69 54.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.89 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.41 -49.16 44.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.2 -59.17 2.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -163.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 8' ' ' ILE . 2.1 pt? -66.1 -33.21 6.58 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -168.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.706 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 12.8 Cg_endo -55.16 -40.13 87.38 Favored 'Trans proline' 0 C--N 1.348 0.501 0 CA-C-N 121.182 1.458 . . . . 0.0 110.573 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -51.71 -41.02 61.16 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.759 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.536 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.68 -42.94 70.07 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.446 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.843 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.79 -59.92 2.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.703 -174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.741 ' HB2' ' HE3' ' A' ' 68' ' ' TRP . 8.4 m120 -168.61 -59.42 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.971 0.908 . . . . 0.0 109.172 168.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.741 ' HE3' ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -53.46 149.84 13.83 Favored Pre-proline 0 C--O 1.217 -0.61 0 CA-C-N 113.118 -1.855 . . . . 0.0 113.697 -174.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.99 -37.36 43.83 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 121.873 1.716 . . . . 0.0 110.229 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 74.5 p -142.12 -123.41 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.279 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.958 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.6 m-85 -141.03 -168.04 0.17 Allowed Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.958 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.3 Cg_endo -67.8 153.41 87.0 Favored 'Cis proline' 0 C--N 1.362 1.261 0 CA-C-N 121.309 1.503 . . . . 0.0 114.286 -1.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.614 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.7 mt-30 -141.41 134.77 29.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.661 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -99.22 135.17 41.02 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -119.63 131.11 55.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.795 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.2 t -116.66 120.6 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t0 54.8 37.74 29.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 123.242 1.496 . . . . 0.0 108.595 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.634 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 67.19 29.09 73.97 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.957 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -132.5 134.85 45.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.382 0.611 . . . . 0.0 111.366 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.843 HD22 ' HB1' ' A' ' 66' ' ' ALA . 60.8 tp -67.36 130.35 42.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.818 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.51 HG12 ' CG2' ' A' ' 86' ' ' ILE . 99.3 t -106.03 -54.28 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.772 170.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.32 134.16 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.71 -63.98 1.58 Allowed Glycine 0 C--O 1.219 -0.829 0 C-N-CA 119.047 -1.549 . . . . 0.0 116.316 -167.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 22.4 p -80.21 -67.45 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.429 1.115 . . . . 0.0 112.956 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.33 -45.29 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.316 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.51 ' CG2' HG12 ' A' ' 81' ' ' VAL . 50.4 mm -57.8 -44.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.338 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 82' ' ' GLY . 79.4 t -58.02 -48.51 84.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.99 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.504 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 38.1 mm -59.78 -49.91 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.388 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.765 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 35.5 tt0 -60.79 -52.95 62.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.291 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.532 ' HG3' ' CA ' ' A' ' 96' ' ' LEU . 41.7 tpp -60.88 -34.81 75.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.82 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 16.8 t80 -58.81 -51.45 69.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.014 171.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.6 mt-30 -62.38 -39.29 92.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.991 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 45.6 mmm-85 -60.75 -30.72 70.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.73 175.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.02 -23.69 10.45 Favored Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.726 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.9 mt-10 -62.51 -21.32 65.42 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' MET . 62.5 tp -61.35 -54.86 38.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.343 0.592 . . . . 0.0 110.669 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.81 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 11.8 pt20 -64.03 -25.53 68.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.374 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 13.3 mm100 -64.2 -48.08 77.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.272 0.558 . . . . 0.0 109.599 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 38.5 mt -65.74 -45.88 80.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.155 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.8 mm -63.82 -44.35 98.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.144 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 28.7 ttmt -51.89 -57.69 8.66 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 111.2 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.5 -45.79 92.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.165 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 80.7 m -68.99 -46.85 67.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.455 ' HA ' ' HZ3' ' A' ' 108' ' ' LYS . . . -60.75 -45.93 92.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.37 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.09 82.01 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.754 0.659 . . . . 0.0 112.323 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.503 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.06 -33.39 63.66 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.747 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.503 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 80.1 m-85 -80.19 -51.55 8.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.641 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HZ3' ' HA ' ' A' ' 104' ' ' ALA . 1.1 mppt? -106.29 131.34 53.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m -51.82 125.44 15.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.471 0.653 . . . . 0.0 112.267 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 35.13 52.0 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.293 -1.776 . . . . 0.0 114.969 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 27.4 tt0 -77.37 120.49 81.73 Favored Pre-proline 0 N--CA 1.427 -1.592 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 6.1 Cg_exo -86.73 60.75 4.27 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.55 2.833 . . . . 0.0 114.563 -170.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.849 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.8 m-20 . . . . . 0 C--N 1.317 -0.806 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.682 ' CG2' HE21 ' A' ' 9' ' ' GLN . 41.2 mt . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 120.352 0.12 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.62 -51.15 64.01 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 20.4 ptmt -67.53 -40.37 85.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.44 0.638 . . . . 0.0 109.599 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG21 ' HG ' ' A' ' 62' ' ' LEU . 73.9 mt -57.54 -49.09 81.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.941 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.682 HE21 ' CG2' ' A' ' 5' ' ' ILE . 68.3 mt-30 -61.71 -40.75 96.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.597 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -57.75 -37.07 72.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.296 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.01 -47.19 69.13 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.122 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.794 HG22 ' HA2' ' A' ' 78' ' ' GLY . 22.2 mt -67.52 -39.15 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.789 0.804 . . . . 0.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.71 88.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.512 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.6 pt-20 -70.33 -38.49 74.88 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.554 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 1.6 p30 -77.17 135.44 66.38 Favored Pre-proline 0 CA--C 1.512 -0.514 0 CA-C-O 121.652 0.739 . . . . 0.0 111.877 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.609 ' O ' HD13 ' A' ' 17' ' ' ILE . 33.7 Cg_exo -62.75 -42.17 26.91 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 122.801 2.334 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 16' ' ' PRO . 25.5 mm -139.38 120.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.726 HD11 HG23 ' A' ' 50' ' ' VAL . 27.7 tp -131.66 142.89 49.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.483 0.659 . . . . 0.0 111.855 -171.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.9 tp -136.94 123.85 21.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.442 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.601 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 7.2 m-85 -98.86 119.99 38.55 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.801 -0.562 . . . . 0.0 111.702 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 18.5 ptt? -146.23 -165.77 2.3 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 63.8 tttm -99.08 121.45 41.01 Favored 'General case' 0 C--O 1.208 -1.122 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.69 69.19 1.03 Allowed Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.332 -175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -79.94 148.54 68.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.818 -0.225 . . . . 0.0 111.233 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.85 -41.5 68.67 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.19 1.927 . . . . 0.0 111.121 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.615 ' HE3' ' SG ' ' A' ' 30' ' ' CYS . 60.8 pttt -66.7 -31.31 71.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.66 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 49.6 tp -160.43 122.84 1.82 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 2.8 Cg_exo -73.9 29.36 0.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.432 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 8.3 t -165.35 47.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.48 173.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.615 ' SG ' ' HE3' ' A' ' 26' ' ' LYS . 34.6 t -71.24 57.08 0.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.86 -136.4 2.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -76.71 -38.65 53.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 117.607 0.703 . . . . 0.0 110.992 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.876 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 33.1 t -55.13 -10.15 0.5 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.54 -40.74 60.26 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.194 0.198 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.424 ' O ' HD11 ' A' ' 88' ' ' ILE . 1.2 pm0 -80.49 -35.72 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.922 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 87' ' ' VAL . . . -64.24 -43.64 94.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.142 0.577 . . . . 0.0 112.518 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.23 -36.13 44.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.337 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.576 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.3 mm100 -66.12 -43.8 86.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.102 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.716 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -57.08 -45.21 83.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.456 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 74' ' ' LEU . 1.8 mt -61.84 -59.41 5.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.01 67.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.38 -49.13 28.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.402 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.841 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.1 p -75.55 -57.23 4.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.199 -171.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.25 -142.15 12.21 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.439 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 90.7 mt-10 -100.2 -151.46 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.943 0.878 . . . . 0.0 111.248 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.94 158.29 35.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.57 174.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CG ' HD13 ' A' ' 40' ' ' LEU . 13.5 p90 -151.82 160.83 43.42 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.688 -171.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.19 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.6 p90 -140.3 152.56 45.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 18' ' ' LEU . 51.5 t -129.37 132.19 66.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.804 0.335 . . . . 0.0 110.339 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' MET . 32.3 p-10 -76.64 129.32 36.22 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.543 0.687 . . . . 0.0 110.686 173.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.704 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -144.4 -36.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.903 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.84 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -65.6 -10.42 35.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.814 168.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -43.8 7.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.603 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -83.86 113.94 50.81 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 122.137 -0.352 . . . . 0.0 110.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.9 -45.54 28.12 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.966 2.444 . . . . 0.0 113.381 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.504 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.89 -38.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.138 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.665 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 58.3 ttt-85 -49.81 -35.78 24.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.425 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -86.77 -41.28 14.24 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -174.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -79.57 -60.94 2.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -162.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.766 HD13 ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -73.09 -27.66 0.88 Allowed Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -172.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.766 ' HD3' HD13 ' A' ' 62' ' ' LEU . 17.9 Cg_endo -57.2 -41.17 76.7 Favored 'Trans proline' 0 C--N 1.357 1.006 0 CA-C-N 121.368 1.524 . . . . 0.0 110.853 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 39.1 mtmt -54.86 -39.37 68.56 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.733 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.611 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.43 -41.52 80.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.871 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.797 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.91 -57.7 3.74 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.562 -176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.6 t30 -175.0 -53.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.947 0.88 . . . . 0.0 109.987 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.644 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.93 146.62 81.65 Favored Pre-proline 0 C--O 1.218 -0.6 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.208 -176.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.01 -35.99 84.81 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.127 1.885 . . . . 0.0 110.667 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.1 p -141.79 -128.58 0.1 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.568 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.963 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 30.5 m-85 -142.23 -173.75 0.38 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.963 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.6 Cg_endo -66.99 160.16 78.87 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 120.848 1.339 . . . . 0.0 114.36 -0.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.634 ' HA ' ' CA ' ' A' ' 83' ' ' GLY . 56.0 mt-30 -150.78 129.45 12.3 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.179 172.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.475 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.1 tm? -89.58 137.38 32.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.024 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 58.6 m95 -121.64 131.34 54.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.206 0.526 . . . . 0.0 110.87 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 100' ' ' ILE . 67.2 t -116.6 119.52 62.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.608 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t70 54.75 41.5 31.87 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.993 1.378 . . . . 0.0 108.933 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.794 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 62.76 28.28 71.41 Favored Glycine 0 C--N 1.31 -0.897 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.696 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -129.04 134.8 48.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 111.107 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.3 tp -66.64 136.96 56.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.618 -173.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' HG21 ' A' ' 86' ' ' ILE . 96.2 t -115.08 -56.26 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.813 170.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.763 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 155.73 133.74 1.73 Allowed Glycine 0 C--O 1.225 -0.431 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.67 -61.37 1.7 Allowed Glycine 0 C--O 1.218 -0.886 0 C-N-CA 119.999 -1.096 . . . . 0.0 115.625 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.58 -67.9 0.73 Allowed 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.705 -0.88 . . . . 0.0 112.262 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -80.72 -51.32 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.9 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.763 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 50.1 mm -55.8 -53.5 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.459 -171.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 96' ' ' LEU . 10.4 p -59.8 -43.12 91.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.34 -173.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.716 HD13 ' HB2' ' A' ' 39' ' ' ALA . 34.8 mm -59.14 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.489 175.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.726 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.9 tt0 -62.54 -48.94 77.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.483 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.404 ' C ' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -54.62 -39.79 68.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.922 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.573 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.8 t80 -59.01 -52.68 64.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 174.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.1 -38.66 91.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.742 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 23.1 mmm180 -61.64 -32.07 72.2 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.402 0.62 . . . . 0.0 109.824 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 83.61 21.43 58.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.611 -174.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.635 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 62.8 mm-40 -90.34 -31.36 16.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 110.737 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.598 HD11 HG22 ' A' ' 87' ' ' VAL . 1.4 tt -57.77 -54.75 43.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.204 -175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.841 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.1 pt20 -62.18 -27.43 68.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.394 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 9.4 mm-40 -68.83 -44.26 73.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.295 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 40.6 mt -65.84 -48.08 72.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.686 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 17' ' ' ILE . 42.5 mm -60.86 -48.28 89.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.102 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 39.7 ttpt -58.17 -47.26 83.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.643 0.259 . . . . 0.0 111.676 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -59.49 -48.32 82.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.018 0.437 . . . . 0.0 110.046 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.608 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 60.2 m -69.74 -46.25 66.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.372 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.844 ' HB1' ' HE2' ' A' ' 108' ' ' LYS . . . -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.56 86.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.8 -26.57 64.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.877 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.537 ' CE2' ' HD2' ' A' ' 106' ' ' LYS . 92.3 m-85 -91.48 -48.9 6.61 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.531 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.844 ' HE2' ' HB1' ' A' ' 104' ' ' ALA . 39.4 mtmt -91.72 110.22 21.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -61.64 125.76 24.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.098 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' C ' ' HD3' ' A' ' 112' ' ' PRO . 48.2 mt-10 55.87 45.28 24.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.371 175.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 5.5 mm-40 -121.87 67.13 22.36 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.214 176.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 110' ' ' GLU . 26.9 Cg_exo -64.08 115.98 3.44 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.797 1.665 . . . . 0.0 112.431 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.703 ' CG2' HE21 ' A' ' 9' ' ' GLN . 57.7 mt . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.517 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 97.3 mt-10 -56.55 -46.01 80.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.342 . . . . 0.0 110.43 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.55 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 3.7 mmmp? -65.21 -44.09 89.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 172.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.824 HD13 ' HB3' ' A' ' 62' ' ' LEU . 91.1 mt -60.31 -46.96 94.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.599 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.703 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.6 mt-30 -62.55 -43.6 98.41 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.803 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -59.09 -33.9 71.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.591 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.4 tt0 -72.35 -44.77 62.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.077 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.785 HG22 ' HA2' ' A' ' 78' ' ' GLY . 38.1 mt -67.31 -43.11 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.173 0.511 . . . . 0.0 110.184 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.41 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.211 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -66.8 -32.71 74.17 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.613 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -78.43 127.04 82.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.84 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' O ' HD13 ' A' ' 17' ' ' ILE . 69.3 Cg_exo -58.47 -42.61 53.36 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.992 2.462 . . . . 0.0 111.973 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 16' ' ' PRO . 24.3 mm -138.28 123.23 22.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.72 HD23 HG23 ' A' ' 12' ' ' ILE . 21.2 tp -133.92 141.24 47.25 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -171.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.5 tp -138.98 118.87 13.24 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.749 -173.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.637 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 m-85 -97.69 124.75 42.14 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.332 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.782 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 13.3 ptp -145.03 -168.21 2.88 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.241 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.89 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 64.2 tttm -97.68 111.87 23.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.57 127.78 9.31 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 119.619 -1.276 . . . . 0.0 112.628 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 m -142.73 141.54 20.49 Favored Pre-proline 0 N--CA 1.442 -0.844 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -52.98 -41.16 73.42 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.331 2.021 . . . . 0.0 111.981 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.14 -27.24 62.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.164 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.471 HD22 ' H ' ' A' ' 29' ' ' SER . 1.4 tt -158.71 113.22 1.65 Allowed Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' O ' ' SD ' ' A' ' 21' ' ' MET . 39.3 Cg_endo -71.63 15.86 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.566 2.178 . . . . 0.0 114.156 -176.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.782 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.8 p -161.69 51.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 39.0 t -68.71 51.58 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.465 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.0 -137.02 2.11 Favored Glycine 0 C--N 1.316 -0.564 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.176 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.27 -39.79 53.46 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 117.11 0.455 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.823 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 19.2 t -57.64 -11.21 1.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.455 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 37' ' ' VAL . . . -53.31 -43.67 67.76 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.35 0.406 . . . . 0.0 111.521 176.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HG2' HD11 ' A' ' 88' ' ' ILE . 1.2 pm0 -80.25 -31.94 38.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.746 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.58 85.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.216 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 34' ' ' ALA . 9.5 p -54.46 -37.09 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.219 0.533 . . . . 0.0 110.447 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.577 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -64.56 -46.3 83.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.62 -44.08 89.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.577 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.487 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -62.73 -55.83 23.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.437 . . . . 0.0 110.376 -175.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 47' ' ' PHE . . . -59.35 -32.88 70.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.182 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.97 -48.6 43.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.509 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.7 p -75.69 -50.54 15.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.43 -130.51 7.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.092 -0.575 . . . . 0.0 114.419 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.657 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 2.4 pp20? -128.89 -152.74 0.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.457 -0.872 . . . . 0.0 109.65 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 -64.17 152.96 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.608 0.718 . . . . 0.0 111.421 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.487 ' CG ' HD13 ' A' ' 40' ' ' LEU . 20.8 p90 -158.78 150.01 20.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.866 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.05 144.24 28.42 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.193 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.2 p90 -124.87 154.61 40.79 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.436 HG23 HD11 ' A' ' 18' ' ' LEU . 48.4 t -130.66 130.14 64.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' MET . 11.3 p-10 -74.94 132.29 41.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.228 175.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.695 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -149.21 -31.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.965 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.89 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -68.34 -9.34 47.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.269 167.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.82 -47.68 6.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.984 176.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.669 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.4 m-20 -73.8 126.27 89.7 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 120.502 0.191 . . . . 0.0 110.653 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.98 -42.89 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.246 1.964 . . . . 0.0 113.16 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.86 -53.31 8.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.945 0.402 . . . . 0.0 112.021 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.3 mt -60.8 -32.34 51.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.49 0.662 . . . . 0.0 110.33 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.727 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 29.8 ttm180 -53.16 -34.91 58.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.167 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.4 6.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.64 -55.0 5.9 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -163.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.824 ' HB3' HD13 ' A' ' 8' ' ' ILE . 3.6 pp -68.39 -35.89 7.78 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.727 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 25.6 Cg_endo -58.21 -42.43 56.76 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.393 1.396 . . . . 0.0 111.394 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -58.31 -34.17 70.29 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.073 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.521 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.65 -39.99 91.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.937 177.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -72.58 -53.53 11.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.575 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.859 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.5 t-20 -171.55 -47.83 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.022 174.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.859 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 33.5 p90 -124.8 146.33 52.68 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -40.19 -36.8 1.64 Allowed 'Trans proline' 0 C--N 1.352 0.715 1 C-N-CA 125.4 4.067 . . . . 0.0 117.152 -169.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 p -140.5 -135.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 119.076 0.853 . . . . 0.0 111.951 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.975 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 49.2 m-85 -145.15 -172.43 0.31 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.975 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 21.1 Cg_endo -62.91 154.53 69.04 Favored 'Cis proline' 0 C--N 1.36 1.184 0 CA-C-N 120.6 1.25 . . . . 0.0 114.33 -0.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.711 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 25.2 mt-30 -139.97 131.7 27.39 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.352 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -95.94 139.35 32.26 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.339 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.675 ' N ' HD13 ' A' ' 74' ' ' LEU . 57.7 m95 -127.73 127.79 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.384 0.611 . . . . 0.0 110.739 177.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 99' ' ' LEU . 57.3 t -113.2 118.33 57.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.273 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.6 t70 57.03 32.26 21.37 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 123.757 1.741 . . . . 0.0 108.711 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.785 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.33 28.43 67.96 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 113.488 -1.687 . . . . 0.0 113.04 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 40.5 mt-10 -119.44 133.37 55.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.786 HD21 ' HZ3' ' A' ' 68' ' ' TRP . 18.9 tp -65.57 131.44 46.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.781 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 86' ' ' ILE . 84.6 t -117.76 -52.84 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.931 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.82 ' HA3' HD12 ' A' ' 86' ' ' ILE . . . 134.08 133.24 3.3 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.37 -60.82 1.87 Allowed Glycine 0 C--O 1.222 -0.634 0 N-CA-C 116.367 1.307 . . . . 0.0 116.367 -166.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -75.24 -68.95 0.51 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.439 -1.036 . . . . 0.0 113.378 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -78.71 -43.9 24.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.443 0.639 . . . . 0.0 110.629 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.82 HD12 ' HA3' ' A' ' 82' ' ' GLY . 43.7 mt -60.34 -42.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.456 -171.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -59.93 -50.38 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.055 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.7 mm -60.73 -49.04 86.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.447 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.78 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.9 tt0 -61.89 -54.35 43.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.918 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.408 ' HA ' ' HB2' ' A' ' 93' ' ' ARG . 55.1 mtt -58.43 -32.46 68.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.605 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.2 t80 -58.57 -53.19 61.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.73 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.1 mt-30 -65.12 -39.45 93.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.48 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.78 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.0 mmt180 -59.37 -33.6 71.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.657 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.623 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 94.8 -24.37 28.51 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -169.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.673 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.8 mt-10 -57.57 -31.22 65.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 99' ' ' LEU . 56.3 tp -68.91 -55.42 11.08 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.585 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.8 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 10.2 pt20 -57.56 -24.71 57.66 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.15 171.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.3 mm100 -71.01 -56.75 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 76' ' ' VAL . 2.2 pp -70.67 -34.72 72.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 99' ' ' LEU . 38.1 mm -62.03 -42.32 94.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 39.5 ttmt -52.32 -56.8 12.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.183 0.516 . . . . 0.0 112.072 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.38 -45.9 90.17 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.582 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 58.8 m -66.45 -51.09 60.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.351 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 45' ' ' GLU . . . -60.94 -51.66 68.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.87 -175.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.61 73.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.515 -176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.57 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.58 -25.73 50.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.042 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.472 ' HE2' HG23 ' A' ' 103' ' ' THR . 54.4 m-85 -84.93 -48.59 9.14 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.09 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -102.66 108.41 19.67 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 m -53.46 122.76 10.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.416 0.627 . . . . 0.0 110.787 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 49.31 38.98 14.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.736 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.415 ' OE2' ' HB2' ' A' ' 45' ' ' GLU . 38.7 tt0 -77.49 133.32 67.52 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.05 128.26 23.61 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.865 1.71 . . . . 0.0 112.65 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 N--CA 1.445 -0.7 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.694 -177.79 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.701 ' CG2' HE21 ' A' ' 9' ' ' GLN . 77.8 mt . . . . . 0 N--CA 1.461 0.113 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.97 -44.03 82.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.144 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.69 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -70.79 -45.45 64.66 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.956 0.408 . . . . 0.0 110.175 171.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.62 HD13 HD22 ' A' ' 62' ' ' LEU . 79.4 mt -54.35 -47.09 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.701 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.7 mt-30 -63.62 -39.74 95.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.606 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 12.1 mmp_? -61.09 -34.22 74.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.343 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.529 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -74.63 -41.27 60.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.469 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.843 HG22 ' HA2' ' A' ' 78' ' ' GLY . 30.5 mt -66.5 -46.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.712 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.13 -39.96 94.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.862 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -65.5 -32.5 74.13 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.113 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -76.68 125.44 87.25 Favored Pre-proline 0 CA--C 1.517 -0.312 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.846 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HA ' ' CE2' ' A' ' 107' ' ' TYR . 45.7 Cg_exo -62.26 -42.91 25.84 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 122.462 2.108 . . . . 0.0 112.225 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.7 mm -136.27 121.71 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.648 HD23 HG23 ' A' ' 12' ' ' ILE . 22.0 tp -133.05 142.08 48.58 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.327 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.1 tp -137.21 119.9 16.16 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.151 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.653 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -97.36 120.03 36.99 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.986 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.699 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 21.1 ptt? -146.29 -170.92 3.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.126 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.008 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.2 119.87 35.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.387 -0.821 . . . . 0.0 109.576 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.77 71.62 1.29 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.077 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 36.6 t -78.54 142.56 62.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.85 -40.9 82.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.019 1.812 . . . . 0.0 111.459 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.7 pttt -67.99 -30.36 69.61 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.805 177.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 29' ' ' SER . 49.1 tp -160.62 115.97 1.4 Allowed Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.2 Cg_exo -71.19 29.73 0.22 Allowed 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 123.145 2.563 . . . . 0.0 112.985 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.699 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 11.9 p -162.58 46.61 0.15 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 42.6 t -64.64 147.57 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.678 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.55 -141.35 15.27 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.799 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -78.2 -38.27 43.69 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.0 p -46.77 -19.61 0.1 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.35 -42.99 53.94 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.985 0.178 . . . . 0.0 111.095 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.638 HE21 ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.35 -37.11 38.26 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.638 ' N ' HE21 ' A' ' 35' ' ' GLN . . . -66.6 -45.79 78.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.656 HG13 HE21 ' A' ' 38' ' ' GLN . 13.1 p -56.36 -36.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.73 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.656 HE21 HG13 ' A' ' 37' ' ' VAL . 32.3 mm-40 -66.78 -46.85 73.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.285 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.584 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.05 -40.09 84.02 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.15 0.281 . . . . 0.0 111.609 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.3 tt -62.43 -57.26 11.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.938 -175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 -35.19 79.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.386 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.12 -47.67 76.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.016 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.895 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.3 m -73.08 -55.57 6.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.2 -133.14 8.01 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.308 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 113' ' ' ASP . 64.5 mm-40 -137.36 -150.64 0.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.708 -0.746 . . . . 0.0 110.241 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -60.07 150.72 28.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.476 0.655 . . . . 0.0 112.487 -172.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.465 ' CD2' HD13 ' A' ' 40' ' ' LEU . 20.3 p90 -157.93 156.72 31.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.359 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.34 152.94 18.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.621 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.5 p90 -138.1 152.63 48.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.611 HG23 HD11 ' A' ' 18' ' ' LEU . 58.6 t -129.66 130.91 67.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 110.27 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' MET . 9.5 p-10 -76.53 128.12 34.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.58 175.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -145.22 -38.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.008 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -60.46 -17.81 47.2 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.003 0.82 . . . . 0.0 110.822 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.724 HE22 ' ND2' ' A' ' 55' ' ' ASN . 3.1 pp0? -95.34 -33.97 12.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.724 ' ND2' HE22 ' A' ' 54' ' ' GLN . 77.9 m-20 -74.72 131.22 79.91 Favored Pre-proline 0 N--CA 1.477 0.88 0 O-C-N 122.178 -0.326 . . . . 0.0 110.709 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.79 -43.99 4.68 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.467 2.111 . . . . 0.0 112.943 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.58 -57.95 3.56 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.71 -35.28 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.688 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.591 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -55.72 -27.99 53.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.95 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -89.14 -48.08 7.64 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -171.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 52.7 mt-10 -78.93 -60.05 2.53 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.294 1.591 . . . . 0.0 115.294 -162.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.687 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 1.8 pt? -67.47 -34.64 7.05 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 19.1 Cg_endo -56.11 -38.22 95.2 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.405 1.403 . . . . 0.0 110.997 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 42.8 mtmt -55.23 -41.99 72.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.439 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.591 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.63 -38.86 84.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.093 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB1' HD13 ' A' ' 80' ' ' LEU . . . -68.75 -53.54 21.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.158 -175.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.949 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.6 t-20 -172.35 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.658 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.949 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 31.2 p90 -126.49 149.42 67.68 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.736 -167.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.62 -37.48 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 125.256 3.971 . . . . 0.0 117.05 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.9 p -140.78 -137.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.202 0.91 . . . . 0.0 111.961 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 42.6 m-85 -140.57 -170.71 0.25 Allowed Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -173.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.968 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.0 Cg_endo -64.41 148.62 70.15 Favored 'Cis proline' 0 C--N 1.36 1.149 0 CA-C-N 120.864 1.344 . . . . 0.0 113.495 -2.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.623 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 68.2 mt-30 -133.5 130.59 38.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.758 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -92.31 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.572 ' N ' HD13 ' A' ' 74' ' ' LEU . 67.3 m95 -125.03 129.4 50.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.69 0.757 . . . . 0.0 111.323 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.499 HG11 ' HB3' ' A' ' 99' ' ' LEU . 86.5 t -115.91 120.08 63.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.1 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.462 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.1 t70 56.93 32.08 20.9 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 123.078 1.418 . . . . 0.0 109.145 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.843 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.17 28.19 70.59 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 114.044 -1.435 . . . . 0.0 113.264 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -127.95 135.14 49.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 111.126 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.873 HD21 ' HZ3' ' A' ' 68' ' ' TRP . 19.4 tp -64.65 136.13 56.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.67 -172.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.539 ' O ' HG21 ' A' ' 86' ' ' ILE . 91.3 t -120.8 -53.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.358 170.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.9 ' HA2' ' HH2' ' A' ' 68' ' ' TRP . . . 129.7 133.32 3.58 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.73 -61.37 1.7 Allowed Glycine 0 C--O 1.221 -0.69 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -167.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.18 -68.91 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.632 -0.922 . . . . 0.0 113.431 -166.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -80.72 -41.91 22.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.077 0.465 . . . . 0.0 110.469 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.628 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.5 mp -60.41 -45.7 96.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.58 -171.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.0 t -58.83 -47.67 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.715 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 39' ' ' ALA . 32.8 mm -60.15 -46.61 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.02 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.728 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 85.2 tt0 -61.11 -54.66 41.82 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.932 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.587 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.3 mmt -57.97 -36.32 72.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.712 0.292 . . . . 0.0 111.512 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.895 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 18.7 t80 -56.36 -51.43 68.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.781 172.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 77.2 mt-30 -65.32 -38.46 90.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.9 mmm180 -58.94 -34.37 71.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.072 176.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 86.88 -23.93 9.78 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -168.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.782 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.6 mt-10 -58.01 -29.39 65.27 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.588 ' O ' HG12 ' A' ' 100' ' ' ILE . 63.7 tp -60.14 -56.63 19.19 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.201 0.524 . . . . 0.0 111.063 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.738 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.2 pt20 -63.12 -28.99 70.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.917 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.6 mm100 -62.27 -47.15 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.038 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 37.0 mt -66.19 -45.36 81.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 96' ' ' LEU . 49.5 mm -61.38 -47.88 91.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.721 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 39.7 ttpt -62.01 -49.46 75.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.553 0.216 . . . . 0.0 111.339 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -55.42 -44.95 76.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.614 0.721 . . . . 0.0 109.957 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.489 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 92.9 m -70.53 -45.86 64.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.472 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.407 ' O ' ' HE2' ' A' ' 108' ' ' LYS . . . -59.65 -44.23 93.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 109' ' ' SER . . . -61.01 -41.84 97.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.478 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -72.87 -31.78 64.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.333 -178.494 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' A' ' 16' ' ' PRO . 60.0 m-85 -78.47 -47.09 18.15 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.55 ' CE ' ' HG3' ' A' ' 111' ' ' GLU . 3.1 mppt? -98.82 -145.47 0.32 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.496 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 105' ' ' ALA . 50.4 m -83.57 -155.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -70.08 59.91 0.18 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.55 ' HG3' ' CE ' ' A' ' 108' ' ' LYS . 58.5 mm-40 -59.48 121.94 60.61 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -92.7 48.14 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.656 2.237 . . . . 0.0 113.924 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.1 m-20 . . . . . 0 C--N 1.309 -1.179 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.113 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.692 ' CG2' HE21 ' A' ' 9' ' ' GLN . 61.1 mt . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -55.61 -47.1 77.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.21 -43.5 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.48 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.86 HD13 ' HB2' ' A' ' 62' ' ' LEU . 85.2 mt -62.32 -47.83 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.435 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.692 HE21 ' CG2' ' A' ' 5' ' ' ILE . 73.0 mt-30 -62.91 -39.35 94.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.224 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -58.86 -34.5 71.66 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 8.2 tt0 -73.14 -50.35 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.784 HG22 ' HA2' ' A' ' 78' ' ' GLY . 26.5 mt -63.4 -38.13 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.873 0.845 . . . . 0.0 111.042 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.4 83.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.269 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -73.78 -35.82 65.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.861 -171.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.712 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -77.21 131.28 72.69 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 121.494 0.664 . . . . 0.0 111.323 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 50.2 Cg_exo -59.44 -42.06 52.05 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.24 2.626 . . . . 0.0 112.492 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.9 mm -141.9 121.33 10.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.712 HD22 ' OD1' ' A' ' 15' ' ' ASN . 22.8 tp -131.83 142.67 49.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 0.0 111.313 -170.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 21' ' ' MET . 11.8 tp -137.22 121.45 18.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.359 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.818 ' CE2' HD21 ' A' ' 62' ' ' LEU . 8.0 m-85 -97.92 115.69 28.62 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.808 ' HE3' ' HB3' ' A' ' 33' ' ' SER . 14.2 ptm -148.06 -157.18 0.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.016 173.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.671 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 tttt -98.28 125.98 43.59 Favored 'General case' 0 C--O 1.213 -0.857 0 O-C-N 121.232 -0.917 . . . . 0.0 112.154 -169.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 67.91 0.94 Allowed Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.442 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 p -77.09 145.04 72.75 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -51.62 -41.48 60.97 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.616 2.211 . . . . 0.0 112.127 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.75 -29.08 68.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.131 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tt -159.96 118.0 1.57 Allowed Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.66 17.84 0.13 Allowed 'Trans proline' 0 N--CA 1.47 0.141 0 C-N-CA 122.801 2.334 . . . . 0.0 114.471 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.76 ' HB2' ' CE ' ' A' ' 21' ' ' MET . 11.2 p -164.12 61.11 0.15 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.42 0.629 . . . . 0.0 112.605 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.547 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 39.1 t -80.67 -143.3 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.946 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 65.42 -152.89 51.27 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 122.409 -0.182 . . . . 0.0 113.432 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 17.6 m-85 -78.19 -35.95 48.0 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.808 ' HB3' ' HE3' ' A' ' 21' ' ' MET . 32.4 t -59.72 -7.3 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.036 -0.415 . . . . 0.0 112.091 -172.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.28 -42.05 9.27 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.612 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.01 -38.86 61.43 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.244 0.545 . . . . 0.0 109.708 177.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.72 -43.97 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.383 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 34' ' ' ALA . 11.1 p -55.87 -37.6 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.449 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.597 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.5 mm100 -67.78 -45.44 74.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.783 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -58.0 -44.69 87.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.644 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.419 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.25 -57.49 12.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.955 0.407 . . . . 0.0 110.271 -175.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.05 -32.17 70.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.567 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.6 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.2 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.755 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.3 p -74.47 -54.58 7.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.18 -130.2 6.93 Favored Glycine 0 N--CA 1.454 -0.151 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.933 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.669 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 49.5 mt-10 -140.84 -149.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.168 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 40.3 mmt180 -48.1 146.64 2.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.421 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 20.0 p90 -158.5 153.15 24.66 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.35 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.61 152.77 19.24 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.682 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -132.12 148.44 52.48 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.656 HG23 HD11 ' A' ' 18' ' ' LEU . 43.3 t -123.2 131.12 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.6 p30 -81.63 131.23 35.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.365 0.602 . . . . 0.0 109.957 176.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 53' ' ' LEU . 1.2 pp -147.49 -28.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.741 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.734 HD22 HD12 ' A' ' 52' ' ' ILE . 1.9 mm? -65.87 -14.5 61.58 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 -46.12 6.58 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.858 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.8 m-20 -77.28 121.33 84.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.615 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 18.5 Cg_exo -66.89 -43.66 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.974 2.449 . . . . 0.0 112.939 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.78 -51.08 29.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 62' ' ' LEU . 33.1 mt -63.52 -34.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.172 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.64 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 47.9 ttt85 -50.88 -35.32 32.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.195 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.611 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -90.89 -51.87 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.495 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 56.6 mm-40 -76.93 -55.46 5.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -167.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.86 ' HB2' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -61.55 -43.57 89.12 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -172.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 20.4 Cg_endo -57.81 -41.54 68.62 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 121.334 1.356 . . . . 0.0 111.217 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 52.4 mtmt -57.04 -35.27 69.1 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.766 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.606 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.0 -43.22 83.48 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.943 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.811 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.08 -56.88 4.29 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.799 -175.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.707 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 25.8 t-20 -174.85 -55.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.34 1.067 . . . . 0.0 109.507 172.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.707 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.3 m-90 -58.79 147.28 72.58 Favored Pre-proline 0 C--O 1.216 -0.687 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.339 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.71 -38.27 72.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.345 2.03 . . . . 0.0 110.306 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.9 p -142.66 -124.73 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.462 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.97 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 53.6 m-85 -139.61 -172.27 0.31 Allowed Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.97 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 64.3 Cg_endo -71.37 165.05 81.99 Favored 'Cis proline' 0 C--N 1.357 1.014 0 CA-C-N 120.777 1.313 . . . . 0.0 114.611 -1.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.777 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.6 pt20 -156.74 133.67 10.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.038 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 87' ' ' VAL . 61.4 tp -90.72 141.91 28.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.734 178.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.655 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 52.1 m95 -129.16 125.13 36.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 110.329 175.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.04 117.37 51.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.654 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 60.6 t0 57.09 33.99 24.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 123.117 1.437 . . . . 0.0 109.465 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.784 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.41 29.24 68.42 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.071 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -127.31 129.04 46.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.312 . . . . 0.0 110.492 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.811 HD22 ' HB1' ' A' ' 66' ' ' ALA . 59.2 tp -67.95 135.56 52.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.806 -170.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.597 ' O ' HG21 ' A' ' 86' ' ' ILE . 97.9 t -117.48 -53.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.194 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.54 140.03 3.4 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.02 -67.35 1.41 Allowed Glycine 0 C--O 1.216 -0.994 0 C-N-CA 118.226 -1.94 . . . . 0.0 116.258 -167.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 41.8 t -81.61 -68.72 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.728 1.264 . . . . 0.0 113.088 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.88 -47.13 60.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.404 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.597 HG21 ' O ' ' A' ' 81' ' ' VAL . 45.7 mm -58.36 -43.78 87.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.388 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.647 HG13 HD11 ' A' ' 96' ' ' LEU . 69.3 t -59.46 -49.23 84.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.974 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.3 mm -58.22 -49.68 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.36 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.729 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.2 tt0 -61.25 -54.28 46.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.693 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 24.9 mmt -58.58 -35.03 71.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.599 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.5 t80 -58.62 -50.63 73.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.767 173.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.2 mt-30 -62.69 -41.32 99.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 28.8 mmm180 -58.74 -33.88 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.699 178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.9 17.37 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.65 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.813 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 41.0 mt-10 -57.49 -36.92 72.12 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 122.96 0.504 . . . . 0.0 111.728 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.9 tt -61.29 -54.63 41.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.128 0.49 . . . . 0.0 109.92 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 18.9 pt20 -64.91 -28.96 69.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.889 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 2.0 tp-100 -63.93 -44.13 93.81 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.239 0.616 . . . . 0.0 110.032 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.813 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 43.0 mt -68.78 -47.53 65.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.907 174.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 96' ' ' LEU . 46.3 mm -57.56 -47.65 84.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.432 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 26.7 ttpp -55.26 -50.73 68.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.664 0.269 . . . . 0.0 111.692 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -48.77 80.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.654 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.0 m -65.17 -53.24 47.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.399 0.619 . . . . 0.0 111.694 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.657 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.71 -44.14 97.0 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.822 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.62 75.92 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.399 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.46 -29.34 67.0 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.131 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.571 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 46.9 m-85 -79.56 -46.06 18.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -77.77 -163.73 0.43 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.097 0.475 . . . . 0.0 110.395 170.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 p -87.45 59.63 5.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.156 0.979 . . . . 0.0 111.964 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 57.07 47.47 17.35 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.777 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.625 ' HG2' ' HB3' ' A' ' 108' ' ' LYS . 43.1 mm-40 -67.78 135.89 92.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.858 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.8 Cg_exo -80.43 51.37 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 124.589 3.526 . . . . 0.0 113.017 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.674 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.4 m-20 . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.714 ' CG2' HE21 ' A' ' 9' ' ' GLN . 74.7 mt . . . . . 0 C--O 1.232 0.171 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 9.7 pt-20 -52.06 -46.57 65.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.023 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 47.5 mmtm -73.54 -43.69 59.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.015 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.698 HD13 HD22 ' A' ' 62' ' ' LEU . 66.9 mt -53.23 -44.45 53.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.714 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.1 mt-30 -63.14 -33.57 75.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.937 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -58.08 -40.26 80.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.359 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.695 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.8 mp0 -73.69 -46.41 46.46 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' OH ' ' A' ' 65' ' ' TYR . 18.4 mt -59.94 -44.61 94.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.39 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.01 -40.58 95.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.955 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.695 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.4 pt-20 -66.44 -31.38 72.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.269 -176.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -76.63 125.87 86.75 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.927 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' HD13 ' A' ' 17' ' ' ILE . 51.5 Cg_exo -60.38 -42.98 37.01 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 123.058 2.505 . . . . 0.0 112.437 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.8 mm -141.13 123.26 14.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 50' ' ' VAL . 20.0 tp -133.51 142.09 48.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.16 -167.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.2 tp -136.37 117.99 14.94 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.326 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.774 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.9 m-85 -97.25 121.76 39.51 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.993 -0.442 . . . . 0.0 112.012 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.982 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 45.3 mmm -147.16 -158.49 0.92 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.011 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.93 112.82 24.41 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.788 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.9 68.04 1.5 Allowed Glycine 0 C--N 1.306 -1.118 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.095 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 p -77.71 144.57 69.3 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -52.74 -40.25 74.58 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.267 1.978 . . . . 0.0 111.529 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -66.7 -32.56 73.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.153 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.17 115.91 2.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.34 15.6 0.2 Allowed 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.895 2.397 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.4 p -164.83 47.08 0.1 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.141 0.496 . . . . 0.0 111.177 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.674 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 45.2 t -65.81 124.12 21.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.306 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.84 -134.71 6.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.424 -175.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.32 -42.14 31.58 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.68 ' CB ' ' HG3' ' A' ' 21' ' ' MET . 29.6 t -55.0 -10.12 0.46 Allowed 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.61 11.29 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.653 0.206 . . . . 0.0 110.893 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.519 ' O ' HD11 ' A' ' 88' ' ' ILE . 1.6 pm0 -81.53 -36.99 28.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.008 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.48 ' HB2' HE21 ' A' ' 35' ' ' GLN . . . -67.36 -44.74 78.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.581 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.38 -37.95 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.716 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.584 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.3 mm100 -62.29 -45.1 94.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.113 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -60.3 -45.9 91.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.42 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.77 -56.59 16.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.526 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.49 -32.14 69.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.24 -48.56 50.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.042 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.877 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 31.7 p -71.73 -56.29 6.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.327 -171.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -102.51 -146.09 17.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.456 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 92.5 mt-10 -102.39 -153.55 0.47 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.283 -0.458 . . . . 0.0 111.337 174.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HD2' ' C ' ' A' ' 46' ' ' ARG . 6.5 ppt_? -71.56 150.35 44.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -176.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 12.9 p90 -141.35 156.31 45.84 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.541 -170.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -97.43 152.47 18.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.888 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.9 p90 -136.77 153.97 50.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.744 HG23 HD11 ' A' ' 18' ' ' LEU . 47.3 t -131.71 130.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.788 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -78.64 134.9 37.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.48 0.657 . . . . 0.0 110.907 175.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.774 HG12 ' HD2' ' A' ' 20' ' ' TYR . 1.3 pp -153.08 -34.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.616 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.011 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.2 mm? -69.8 -5.84 28.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.368 168.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.85 -43.21 7.59 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.256 176.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 75.2 m-80 -82.21 124.9 78.05 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.029 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.18 -44.22 9.79 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 121.992 1.795 . . . . 0.0 112.524 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -56.3 6.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.036 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.9 mt -61.72 -33.92 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.39 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.628 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 59.8 ttp180 -51.93 -34.0 39.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.982 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.499 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -87.15 -41.59 13.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.62 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -77.96 -61.65 1.93 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -164.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 20' ' ' TYR . 2.2 pt? -71.46 -34.0 2.99 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -171.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.729 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 19.8 Cg_endo -56.04 -38.72 94.34 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.348 1.365 . . . . 0.0 110.772 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.62 ' HE3' ' HA ' ' A' ' 61' ' ' GLU . 8.8 mtmp? -54.11 -39.1 66.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.776 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.639 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.6 -38.28 73.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.643 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -70.76 -54.31 12.21 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.562 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.824 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.5 t-20 -171.94 -54.22 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.347 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.862 ' CH2' HD11 ' A' ' 80' ' ' LEU . 32.8 p90 -105.55 144.71 29.38 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.096 -1.411 . . . . 0.0 114.511 -167.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -40.84 -37.0 2.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 125.07 3.847 . . . . 0.0 115.919 -172.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -140.41 -133.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.223 0.465 . . . . 0.0 111.409 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.964 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 45.5 m-85 -141.81 -174.17 0.4 Allowed Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -170.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.982 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 42.6 Cg_endo -65.99 172.58 32.22 Favored 'Cis proline' 0 C--N 1.357 0.989 0 CA-C-N 120.1 1.072 . . . . 0.0 114.032 -0.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.862 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.9 pt20 -160.58 132.43 5.95 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.395 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -96.6 137.68 35.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.217 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.678 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -126.36 125.8 42.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.438 0.637 . . . . 0.0 110.637 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 99' ' ' LEU . 64.8 t -106.77 119.72 56.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.907 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB2' HG23 ' A' ' 103' ' ' THR . 35.1 t70 55.79 28.72 12.73 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.764 1.269 . . . . 0.0 110.268 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.633 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 77.82 29.89 53.54 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.048 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 46.9 mt-10 -126.33 133.83 51.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.706 0.289 . . . . 0.0 111.172 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.862 HD11 ' CH2' ' A' ' 68' ' ' TRP . 24.6 tp -63.76 135.6 56.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.193 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.566 ' O ' HG21 ' A' ' 86' ' ' ILE . 98.4 t -124.33 -51.95 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.765 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.723 ' HA2' ' CH2' ' A' ' 68' ' ' TRP . . . 135.29 135.88 3.53 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -84.35 -61.8 1.78 Allowed Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.682 -1.247 . . . . 0.0 116.208 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 17.6 p -79.86 -67.83 0.73 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 -44.92 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.673 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.566 HG21 ' O ' ' A' ' 81' ' ' VAL . 50.8 mm -56.27 -45.94 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.045 -174.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.5 t -58.34 -49.1 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.6 mm -60.7 -50.64 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.606 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.4 tt0 -61.19 -52.36 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.071 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 59.9 mtt -61.7 -31.14 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.9 t80 -58.35 -51.86 68.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 171.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.1 mt-30 -64.96 -40.3 94.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.231 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 42.7 mmm-85 -57.81 -33.29 68.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.464 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.706 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.38 -25.81 18.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.903 -173.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.775 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 55.6 mt-10 -53.57 -37.27 62.75 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.9 tp -59.68 -54.69 43.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 110.575 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.877 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 12.3 pt20 -65.32 -26.01 67.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.663 175.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 97.3 mm-40 -65.71 -44.57 85.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.266 0.555 . . . . 0.0 109.611 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 44.1 mt -69.65 -47.14 64.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.144 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.703 HG22 ' OD2' ' A' ' 113' ' ' ASP . 45.7 mm -61.98 -42.26 94.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.789 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 29.7 ttmt -51.34 -59.14 4.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.37 0.605 . . . . 0.0 111.584 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.41 -42.74 99.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.484 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 77' ' ' ASP . 74.8 m -69.03 -48.58 62.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.752 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.664 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -60.39 -45.96 91.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.601 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.42 81.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.53 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -73.59 -26.38 60.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.242 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.509 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 54.3 m-85 -83.68 -47.23 11.43 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.664 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -83.41 -154.81 0.15 Allowed 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 36.6 m -75.37 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.78 46.93 0.23 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.868 0.366 . . . . 0.0 111.774 174.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -76.86 110.17 11.06 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.347 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -90.8 120.93 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.432 . . . . 0.0 111.81 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.834 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 21.0 m-20 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.019 0.437 . . . . 0.0 111.627 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.983 HG22 ' HG3' ' A' ' 9' ' ' GLN . 30.2 mm . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 13.6 pt-20 -40.68 -48.32 2.93 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.529 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 75.3 mmtt -62.76 -43.8 97.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 110.303 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.765 HG21 ' HG ' ' A' ' 62' ' ' LEU . 71.9 mt -65.53 -50.05 74.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.631 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.983 ' HG3' HG22 ' A' ' 5' ' ' ILE . 64.9 mt-30 -56.01 -40.48 73.44 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.9 mmp_? -60.93 -33.88 73.84 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.977 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.499 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.4 tt0 -72.21 -42.98 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.439 174.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.749 HG22 ' HA2' ' A' ' 78' ' ' GLY . 18.8 mt -64.16 -45.27 96.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.04 0.448 . . . . 0.0 110.376 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -41.01 96.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.936 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 14.0 pt-20 -64.26 -37.42 87.43 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.64 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.465 ' CB ' ' HG ' ' A' ' 18' ' ' LEU . 77.5 m-20 -77.2 120.56 82.09 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.534 ' O ' HD13 ' A' ' 17' ' ' ILE . 49.2 Cg_exo -62.17 -42.05 31.56 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.541 2.161 . . . . 0.0 111.829 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.595 HG23 HD12 ' A' ' 100' ' ' ILE . 31.4 mm -131.93 125.32 54.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.777 HD13 ' HE1' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -131.69 143.4 50.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.276 -169.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 17.0 tp -136.67 113.24 10.12 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.394 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.777 ' HE1' HD13 ' A' ' 18' ' ' LEU . 8.0 m-85 -96.01 115.06 26.85 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.815 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.605 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 24.5 ptt? -145.97 -157.31 0.79 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.113 -176.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.741 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 79.6 tttt -98.42 143.38 28.92 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -142.75 130.18 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.204 -171.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.444 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 27.9 t -146.56 143.68 19.29 Favored Pre-proline 0 C--N 1.312 -1.029 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.71 -36.54 82.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.143 1.895 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 18.4 ptpt -64.65 -35.15 80.08 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.178 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -159.52 113.27 1.52 Allowed Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.85 19.63 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 114.649 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.3 p -164.14 49.69 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.468 0.651 . . . . 0.0 111.295 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.741 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 2.2 p -69.44 49.67 0.09 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.32 -136.15 2.15 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.704 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.636 ' HB3' ' SG ' ' A' ' 84' ' ' CYS . 4.2 m-85 -74.63 -40.31 61.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.869 0.843 . . . . 0.0 109.466 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.605 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 51.2 p -54.17 -18.07 3.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.548 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.65 -39.47 36.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 110.401 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.631 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -79.89 -38.88 31.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 175.637 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.28 77.91 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -54.38 -39.38 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.119 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.594 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -64.42 -43.87 92.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.329 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.504 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.38 -42.09 86.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.743 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -55.97 20.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.146 0.498 . . . . 0.0 110.023 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.08 70.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.468 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.26 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.47 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.701 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -77.71 -55.25 5.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.52 -135.33 8.82 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.064 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 30.8 mt-10 -134.9 -148.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.957 0.503 . . . . 0.0 110.909 177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 26.0 mmm180 -50.6 146.42 5.62 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.498 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.424 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 26.6 p90 -158.22 153.77 26.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.962 -175.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.38 143.5 29.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.3 p90 -124.86 148.36 48.29 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG23 HD21 ' A' ' 18' ' ' LEU . 57.7 t -124.81 130.8 73.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.198 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.42 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 41.6 p-10 -78.27 132.07 37.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.604 0.716 . . . . 0.0 110.22 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.966 HD12 ' HG ' ' A' ' 53' ' ' LEU . 1.4 pp -148.68 -34.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.124 -172.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.966 ' HG ' HD12 ' A' ' 52' ' ' ILE . 36.4 mt -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.779 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -46.21 6.25 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.5 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 m-20 -76.42 120.36 81.32 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 120.579 0.228 . . . . 0.0 110.729 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.19 -44.77 11.36 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.261 1.974 . . . . 0.0 113.039 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.05 -54.13 14.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.0 -36.02 71.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 110.279 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.65 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 60.5 ttp180 -51.5 -32.44 27.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.801 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -90.7 -39.14 12.61 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.456 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 14.8 tp10 -79.64 -62.09 1.8 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -163.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.765 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -74.28 -26.36 0.69 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -173.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.732 ' HD3' HD13 ' A' ' 62' ' ' LEU . 31.9 Cg_endo -59.73 -40.76 61.36 Favored 'Trans proline' 0 C--N 1.358 1.069 0 CA-C-N 121.352 1.519 . . . . 0.0 110.683 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 8.6 mtmp? -56.54 -39.25 73.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.352 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.563 ' HD2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -64.38 -44.03 92.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.874 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -77.88 -57.23 3.91 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.504 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.655 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.3 t30 -174.68 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.026 0.917 . . . . 0.0 110.45 169.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.681 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.49 147.11 51.22 Favored Pre-proline 0 C--O 1.222 -0.38 0 CA-C-N 113.358 -1.747 . . . . 0.0 113.311 -174.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.5 -36.52 76.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.232 1.955 . . . . 0.0 110.045 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -142.69 -126.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.181 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.868 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 10.9 m-85 -143.47 -164.26 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.868 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.2 Cg_endo -67.09 154.92 84.86 Favored 'Cis proline' 0 C--N 1.364 1.385 0 CA-C-N 121.993 1.747 . . . . 0.0 114.057 -1.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.681 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 21.0 mt-30 -142.62 134.13 26.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.641 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -91.09 137.91 32.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.623 ' N ' HD13 ' A' ' 74' ' ' LEU . 69.5 m95 -125.19 128.7 48.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 0.0 110.935 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 99' ' ' LEU . 96.4 t -112.9 115.23 49.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.7 t70 57.58 30.56 18.96 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.633 1.682 . . . . 0.0 108.809 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.749 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.14 29.01 65.23 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 113.485 -1.688 . . . . 0.0 113.05 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 91.4 mt-10 -115.94 130.57 56.88 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.874 HD22 ' HB1' ' A' ' 66' ' ' ALA . 47.0 tp -69.32 134.56 49.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 111.756 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.586 HG12 ' CG2' ' A' ' 86' ' ' ILE . 93.9 t -119.32 -50.33 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.145 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.28 132.88 2.91 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.489 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.77 -64.12 1.57 Allowed Glycine 0 C--O 1.222 -0.631 0 C-N-CA 118.895 -1.621 . . . . 0.0 116.644 -166.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 32' ' ' PHE . 42.2 t -80.3 -68.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.428 1.114 . . . . 0.0 112.3 -170.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.22 -43.98 66.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.498 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.586 ' CG2' HG12 ' A' ' 81' ' ' VAL . 2.4 mp -62.16 -44.1 98.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.151 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.463 HG13 HD21 ' A' ' 96' ' ' LEU . 73.4 t -57.21 -49.2 80.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.244 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.631 HD11 ' HG2' ' A' ' 35' ' ' GLN . 35.7 mm -60.1 -49.92 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.043 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.735 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.2 tt0 -62.16 -51.62 67.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.845 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.586 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.0 mmt -58.77 -35.12 72.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.505 0.193 . . . . 0.0 111.307 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.568 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t80 -58.58 -51.23 70.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.205 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.0 mt-30 -64.77 -41.01 96.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.089 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.3 mmm-85 -60.43 -34.66 74.3 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.654 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.686 ' O ' ' HG3' ' A' ' 98' ' ' GLN . . . 95.36 -24.79 27.51 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.27 -174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.707 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -58.7 -30.03 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.3 tp -59.3 -54.57 45.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.645 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.701 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 15.9 pt20 -63.45 -28.08 69.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.002 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 94' ' ' GLY . 75.2 mt-30 -62.79 -46.04 89.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 49.1 mt -65.39 -44.58 87.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.856 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.635 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.27 -46.77 95.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.492 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 113' ' ' ASP . 38.7 ttpt -59.17 -50.73 72.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.882 0.373 . . . . 0.0 110.989 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -52.15 -45.53 65.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.32 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 86.0 m -77.06 -48.6 17.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.971 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 108' ' ' LYS . . . -59.54 -43.69 93.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.37 96.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.549 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.06 -32.34 64.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.281 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.505 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 65.7 m-85 -79.1 -47.47 16.06 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.72 -150.73 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 p -88.15 -150.54 0.18 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.935 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -70.6 54.47 0.16 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 108' ' ' LYS . 31.3 mm-40 -69.44 114.9 27.44 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 110.411 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -93.2 52.59 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.335 2.69 . . . . 0.0 113.795 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.3 m-20 . . . . . 0 C--N 1.315 -0.925 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -172.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.53 HG12 ' CB ' ' A' ' 65' ' ' TYR . 2.0 mp . . . . . 0 C--O 1.225 -0.237 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 24.8 pt-20 -55.25 -40.4 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.607 0.639 . . . . 0.0 110.246 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.32 -43.38 88.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.521 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.693 HD13 ' HB3' ' A' ' 62' ' ' LEU . 77.9 mt -65.71 -47.47 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.876 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.696 ' NE2' ' HE2' ' A' ' 65' ' ' TYR . 59.5 mm-40 -62.16 -25.97 68.07 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.278 -173.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 3.4 mmp_? -50.85 -41.28 57.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 94.4 mm-40 -75.06 -49.35 20.01 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.296 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.627 HG23 HD23 ' A' ' 18' ' ' LEU . 4.6 mt -61.44 -43.11 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.601 0.715 . . . . 0.0 111.016 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.83 79.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.759 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 10.5 pt-20 -73.33 -36.26 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -173.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.64 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 3.6 p30 -77.63 134.12 65.96 Favored Pre-proline 0 CA--C 1.517 -0.307 0 CA-C-O 121.793 0.806 . . . . 0.0 112.092 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' O ' HD13 ' A' ' 17' ' ' ILE . 31.3 Cg_exo -63.33 -42.09 23.89 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.047 2.498 . . . . 0.0 111.723 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 16' ' ' PRO . 27.5 mm -139.59 119.16 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.741 HD21 ' HE1' ' A' ' 20' ' ' TYR . 31.1 tp -128.6 142.39 51.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -171.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.16 120.29 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.658 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.741 ' HE1' HD21 ' A' ' 18' ' ' LEU . 8.9 m-85 -98.87 122.1 41.67 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.848 -0.533 . . . . 0.0 111.396 173.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.557 ' O ' ' HE3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -147.84 -155.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.752 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 57.1 tttp -99.31 121.37 40.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.618 -0.676 . . . . 0.0 109.321 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.36 121.51 7.01 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.246 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 37.9 t -125.77 140.65 37.14 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.38 -41.3 79.55 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.167 1.911 . . . . 0.0 111.665 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -74.44 -28.39 61.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.535 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.5 tt -154.66 104.95 2.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.471 ' O ' ' SD ' ' A' ' 21' ' ' MET . 16.8 Cg_exo -72.29 35.47 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 114.476 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.446 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 7.0 p -169.74 49.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.095 0.558 . . . . 0.0 111.187 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.684 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 51.3 t -54.76 -36.65 65.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.15 -137.69 0.17 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.166 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.457 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.1 m-85 -75.95 -18.61 59.27 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 35.8 t -64.75 -12.16 44.27 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.003 -0.436 . . . . 0.0 111.891 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.86 -42.4 26.53 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.648 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -80.24 -41.68 24.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.07 0.462 . . . . 0.0 110.263 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.62 96.65 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.682 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.67 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 13.9 p -56.66 -39.48 63.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.348 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.63 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.8 mm100 -68.91 -46.15 69.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.95 -42.8 94.86 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.294 0.371 . . . . 0.0 111.505 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.497 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -63.15 -55.11 27.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.412 0.625 . . . . 0.0 109.681 -176.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.16 69.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.478 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 -49.13 19.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.506 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.753 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.6 p -74.52 -53.36 9.62 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.457 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.5 -141.0 11.51 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.87 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 69.8 mm-40 -117.87 -152.15 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.832 0.453 . . . . 0.0 111.144 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HE ' ' N ' ' A' ' 46' ' ' ARG . 3.4 mmp_? -65.44 158.23 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.46 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.67 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 17.0 p90 -154.35 159.07 40.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.551 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.86 154.09 17.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.805 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -143.6 153.89 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -174.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.678 HG23 HD11 ' A' ' 18' ' ' LEU . 57.6 t -133.79 130.29 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.504 0.193 . . . . 0.0 110.56 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.509 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 36.5 p-10 -74.49 131.9 41.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.485 0.659 . . . . 0.0 110.924 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.705 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.4 pp -147.85 -35.63 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.861 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -65.35 -11.62 43.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.412 167.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -97.52 -44.94 6.61 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.465 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.9 m-20 -82.25 118.12 70.83 Favored Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 122.192 -0.318 . . . . 0.0 110.437 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.69 -44.09 14.8 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.434 2.089 . . . . 0.0 113.756 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -72.53 -52.71 14.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.078 0.466 . . . . 0.0 111.573 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -62.46 -35.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.268 0.556 . . . . 0.0 110.424 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 62.4 ttp180 -52.89 -32.43 45.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.202 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -88.19 -41.53 12.91 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.576 -166.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.549 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 32.0 tp10 -78.79 -59.67 2.69 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -158.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.711 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.9 pt? -68.11 -31.39 3.25 Favored Pre-proline 0 N--CA 1.474 0.726 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 18.5 Cg_endo -57.82 -43.44 49.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 121.103 1.43 . . . . 0.0 111.138 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.641 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 48.6 mtmt -55.68 -37.88 68.9 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.035 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.696 ' HE2' ' NE2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -65.21 -50.83 64.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.477 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.929 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -73.3 -55.7 6.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.379 -0.929 . . . . 0.0 112.935 -170.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.632 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.8 t30 -175.41 -52.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.211 1.005 . . . . 0.0 110.237 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.632 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -59.75 150.33 68.15 Favored Pre-proline 0 C--O 1.215 -0.743 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.936 -177.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -63.54 -36.76 52.05 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 121.954 1.769 . . . . 0.0 109.912 171.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -141.79 -124.28 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.003 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.923 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 25.7 m-85 -140.72 -165.61 0.1 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.923 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.1 Cg_endo -67.09 153.51 84.62 Favored 'Cis proline' 0 C--N 1.361 1.216 0 CA-C-N 121.691 1.64 . . . . 0.0 113.885 -1.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.593 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 70.6 mt-30 -143.21 135.19 26.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.706 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -100.08 135.17 41.91 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.588 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.61 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 49.4 m95 -121.91 125.77 47.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.242 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.5 t -105.91 119.04 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.557 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.1 t70 56.74 27.95 13.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 123.722 1.725 . . . . 0.0 108.622 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.07 29.3 54.38 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.375 -1.739 . . . . 0.0 113.044 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -124.68 130.97 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.322 . . . . 0.0 110.472 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.929 HD22 ' HB1' ' A' ' 66' ' ' ALA . 40.6 tp -68.95 127.31 32.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.406 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.548 HG12 ' CG2' ' A' ' 86' ' ' ILE . 87.3 t -105.28 -55.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.759 170.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.39 135.23 2.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.29 -65.52 1.52 Allowed Glycine 0 C--O 1.217 -0.943 0 C-N-CA 118.584 -1.77 . . . . 0.0 116.482 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 21.8 p -80.56 -68.05 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.76 1.28 . . . . 0.0 113.231 -171.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.26 -46.82 63.62 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.939 0.399 . . . . 0.0 111.244 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 81' ' ' VAL . 46.1 mm -59.99 -44.79 95.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.013 -172.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 82' ' ' GLY . 56.0 t -58.27 -49.03 83.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.289 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.478 ' O ' ' HD2' ' A' ' 91' ' ' TYR . 39.4 mm -58.1 -53.21 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.41 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 87.8 tt0 -65.97 -47.43 74.64 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.882 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.767 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.2 mmt -58.62 -36.55 74.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.633 0.254 . . . . 0.0 111.057 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.601 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -58.03 -48.81 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 172.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.538 ' HG2' ' CD2' ' A' ' 91' ' ' TYR . 15.2 mm-40 -62.58 -43.75 98.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.013 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 44.4 mmm-85 -62.93 -33.99 76.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.777 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 96.13 -25.29 26.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.747 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.5 mt-10 -55.54 -35.53 65.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.767 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 63.6 tp -62.37 -54.66 37.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.753 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -63.49 -26.78 68.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.024 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.6 mm-40 -64.0 -46.63 83.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.132 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 46.4 mt -67.6 -44.75 77.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.903 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.0 mm -60.62 -46.26 96.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.482 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 113' ' ' ASP . 39.4 ttpt -59.06 -52.86 63.91 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.3 -43.14 82.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.259 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.557 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 46.7 m -72.07 -50.17 30.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.076 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.05 92.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.565 -177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.31 72.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.77 -29.58 51.03 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.959 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.562 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 62.9 m-85 -86.83 -49.54 7.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.005 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.813 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -96.03 119.82 35.21 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.148 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -54.32 117.04 2.96 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 52.07 37.49 21.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.245 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 60.6 mm-40 -80.46 123.65 82.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.634 174.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.1 Cg_endo -83.94 109.41 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.696 2.264 . . . . 0.0 112.45 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.2 m-20 . . . . . 0 C--N 1.321 -0.66 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.394 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.702 ' CG2' HE21 ' A' ' 9' ' ' GLN . 37.5 mt . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 96.1 mt-10 -49.27 -47.55 46.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.545 0.212 . . . . 0.0 111.556 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 19.2 ptpt -61.79 -43.42 98.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.612 0.72 . . . . 0.0 110.116 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.595 HG21 ' HB3' ' A' ' 62' ' ' LEU . 72.2 mt -66.26 -46.84 86.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.936 -174.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.702 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.1 mt-30 -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.549 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.0 mmp_? -59.89 -37.55 79.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.851 0.358 . . . . 0.0 110.361 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 51.7 tt0 -71.03 -49.21 47.41 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.15 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.829 HG22 ' HA2' ' A' ' 78' ' ' GLY . 17.3 mt -65.88 -39.52 84.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.667 0.746 . . . . 0.0 110.835 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.12 81.94 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.637 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 24.0 pt-20 -72.81 -39.24 66.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.672 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -76.58 134.18 69.8 Favored Pre-proline 0 CA--C 1.515 -0.384 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -176.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' HD13 ' A' ' 17' ' ' ILE . 20.1 Cg_endo -61.94 -40.84 40.89 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.158 2.572 . . . . 0.0 112.056 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 16' ' ' PRO . 26.7 mm -139.27 120.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.672 HD22 ' OD1' ' A' ' 15' ' ' ASN . 28.1 tp -132.02 143.14 49.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.376 0.608 . . . . 0.0 111.414 -173.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 16.1 tp -138.95 120.6 15.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.362 -176.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.666 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -96.66 124.5 40.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.752 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 8.0 ptp -145.26 -171.09 3.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.524 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.817 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.3 tttm -95.97 140.62 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -138.67 129.5 4.52 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 118.941 -1.6 . . . . 0.0 113.696 -165.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -150.43 142.72 15.82 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.0 -38.99 60.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.598 2.199 . . . . 0.0 112.025 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -62.99 -33.08 74.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.325 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tt -160.02 108.7 1.42 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.85 19.97 0.18 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.239 1.959 . . . . 0.0 114.34 -174.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.817 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 13.5 p -164.22 49.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.287 0.565 . . . . 0.0 111.532 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.757 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 3.6 p -65.83 54.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.65 -137.58 2.24 Favored Glycine 0 C--N 1.321 -0.267 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.8 -39.67 61.57 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.761 0.791 . . . . 0.0 108.952 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 20.6 p -48.1 -24.14 1.03 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.695 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -51.52 -41.76 61.25 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.286 0.366 . . . . 0.0 111.652 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -33.24 43.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.352 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.17 66.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.132 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.661 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.5 p -52.25 -38.12 24.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.7 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.592 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.1 mm100 -62.25 -46.94 86.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.819 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -60.61 -43.84 97.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.087 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.5 tt -61.85 -55.15 32.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -176.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.36 76.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.441 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -49.59 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.37 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.898 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.5 m -72.84 -56.02 5.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.49 -134.85 8.63 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.153 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.4 mm-40 -140.88 -152.17 0.4 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.822 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 28.8 mmm180 -58.15 143.67 43.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.823 0.82 . . . . 0.0 112.636 -169.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.661 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 16.6 p90 -152.93 156.42 38.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.878 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.45 146.87 25.31 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.1 p90 -136.83 150.21 48.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.576 HG23 HD11 ' A' ' 18' ' ' LEU . 48.3 t -127.6 127.66 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.8 p30 -77.9 133.9 38.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.293 0.568 . . . . 0.0 109.83 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 53' ' ' LEU . 1.1 pp -148.1 -32.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.264 -171.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.762 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -66.54 -11.09 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.098 167.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.423 ' HB3' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -94.38 -43.27 8.46 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.07 178.174 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -77.63 123.99 86.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 121.026 0.441 . . . . 0.0 110.925 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.32 -42.94 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.373 2.049 . . . . 0.0 113.523 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -82.94 -50.89 8.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.672 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 mt -56.8 -37.11 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.249 0.547 . . . . 0.0 110.635 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.637 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 58.7 ttp180 -53.16 -31.24 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.158 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.35 -35.98 19.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -78.27 -61.14 2.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -162.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.709 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.9 pt? -76.8 -31.88 0.96 Allowed Pre-proline 0 N--CA 1.472 0.626 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.81 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 11.7 Cg_endo -55.21 -39.7 89.59 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 CA-C-N 120.917 1.363 . . . . 0.0 110.53 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -53.91 -41.36 67.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.543 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.698 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -68.56 -41.9 79.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.461 -178.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.947 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -73.49 -58.32 3.39 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.988 -176.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.458 ' HB2' ' CE3' ' A' ' 68' ' ' TRP . 24.4 m-20 -173.27 -57.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.052 0.93 . . . . 0.0 109.539 168.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.567 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -53.88 147.8 22.62 Favored Pre-proline 0 C--O 1.215 -0.713 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.381 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.7 -36.21 53.47 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.289 1.993 . . . . 0.0 110.096 171.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.476 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -142.04 -127.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.372 -1.286 . . . . 0.0 109.698 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 1.004 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 36.0 m-85 -142.78 -170.63 0.24 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.004 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 38.4 Cg_endo -68.34 157.76 87.22 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 120.981 1.386 . . . . 0.0 114.525 -1.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.916 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.7 pt20 -148.57 133.72 18.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.741 174.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.38 138.37 33.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.999 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.772 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 56.1 m95 -127.07 126.93 43.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.497 0.665 . . . . 0.0 110.894 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.952 HG21 HD13 ' A' ' 99' ' ' LEU . 50.2 t -106.28 114.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.483 -0.781 . . . . 0.0 108.919 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' HB2' HG21 ' A' ' 103' ' ' THR . 25.1 t70 54.42 32.08 15.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 123.108 1.432 . . . . 0.0 110.364 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.829 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 79.7 28.74 50.41 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 113.789 -1.551 . . . . 0.0 113.565 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -127.29 131.3 50.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.904 173.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.947 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.5 tp -68.95 130.2 42.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.607 -174.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.579 HG12 ' CG2' ' A' ' 86' ' ' ILE . 91.7 t -107.09 -54.11 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.447 168.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.88 132.82 2.55 Favored Glycine 0 C--O 1.22 -0.761 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.566 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.13 -62.43 1.66 Allowed Glycine 0 C--O 1.221 -0.678 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.863 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.2 p -77.18 -67.6 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.798 -0.825 . . . . 0.0 112.557 -171.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -73.6 -48.77 30.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.579 ' CG2' HG12 ' A' ' 81' ' ' VAL . 43.1 mm -61.92 -42.27 94.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.382 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 82' ' ' GLY . 65.6 t -58.74 -48.22 86.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.792 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.555 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.0 mm -60.9 -47.31 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.595 0.236 . . . . 0.0 110.831 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.9 tt0 -59.79 -55.21 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.651 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.592 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -60.07 -35.67 75.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.35 0.26 . . . . 0.0 111.276 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.898 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 17.7 t80 -56.79 -50.96 70.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.848 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -63.76 -40.68 97.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.1 mmm-85 -63.63 -33.94 76.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.604 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.15 -24.39 25.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.169 -171.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.7 mt-10 -58.22 -27.23 63.74 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.592 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 6.2 tt -60.44 -58.95 6.33 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.5 pt20 -60.27 -27.04 66.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.35 176.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.2 mm100 -65.07 -55.66 17.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.952 HD13 HG21 ' A' ' 76' ' ' VAL . 2.5 pp -70.76 -32.34 69.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.665 177.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 99' ' ' LEU . 34.3 mm -64.57 -48.23 85.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.254 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -56.81 -52.05 66.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.369 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.91 -44.58 78.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.542 HG21 ' HB2' ' A' ' 77' ' ' ASP . 32.6 m -71.0 -50.55 32.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.613 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.48 93.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.537 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.72 93.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -73.46 -26.86 61.11 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.985 -178.33 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.497 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 43.0 m-85 -87.68 -47.21 8.84 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.092 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.625 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -75.71 -158.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -76.18 -167.36 0.74 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.674 165.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.71 57.34 0.13 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 53.9 mm-40 -73.12 124.63 90.84 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.359 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 93.0 Cg_endo -96.44 53.03 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.962 3.108 . . . . 0.0 113.991 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 28.6 m-20 . . . . . 0 C--N 1.313 -1.007 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -171.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.679 ' CG2' HE21 ' A' ' 9' ' ' GLN . 44.4 mt . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 54.3 mt-10 -55.55 -47.42 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.582 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -62.68 -43.51 98.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 110.648 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.73 HG21 ' HB3' ' A' ' 62' ' ' LEU . 75.5 mt -60.95 -45.77 97.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.929 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.679 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.6 mt-30 -64.92 -33.26 75.6 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.365 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.644 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 4.3 mmp_? -55.94 -42.26 75.9 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -69.14 -44.35 72.51 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.953 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.627 HG23 HD23 ' A' ' 18' ' ' LEU . 19.9 mt -65.56 -43.34 94.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.442 0.639 . . . . 0.0 110.171 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.47 68.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.481 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.644 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 32.0 mt-10 -62.18 -46.65 87.99 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.077 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -78.45 125.17 85.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.231 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 37.3 Cg_endo -66.25 -42.0 11.39 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.467 2.111 . . . . 0.0 112.21 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.61 HD12 HG23 ' A' ' 100' ' ' ILE . 27.5 mm -127.12 119.82 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.679 HD11 HG23 ' A' ' 50' ' ' VAL . 21.5 tp -133.59 141.34 47.63 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.98 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.3 tp -138.27 120.1 15.32 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.306 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.631 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.8 m-85 -97.28 120.53 37.81 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.582 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.502 ' SD ' ' HB2' ' A' ' 29' ' ' SER . 20.0 ptt? -146.6 -163.77 1.83 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 29.2 tptp -96.73 127.63 42.91 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.144 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.37 125.46 8.38 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.618 -1.753 . . . . 0.0 111.74 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 46.4 t -138.5 141.22 30.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -54.01 -41.09 78.14 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.246 1.964 . . . . 0.0 111.453 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -71.71 -28.48 63.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.894 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.52 HD23 ' HD2' ' A' ' 28' ' ' PRO . 2.2 tt -161.5 121.72 1.55 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.52 ' HD2' HD23 ' A' ' 27' ' ' LEU . 50.1 Cg_endo -71.71 29.38 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.277 1.984 . . . . 0.0 113.307 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.613 ' OG ' ' HB3' ' A' ' 33' ' ' SER . 11.8 t -165.78 54.69 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.584 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 42.7 t -55.59 -36.88 67.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.698 -173.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.665 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -73.42 -138.68 0.37 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 36.4 m-85 -77.58 -20.87 53.31 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 32.8 t -69.02 -10.21 56.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.423 -0.798 . . . . 0.0 111.083 -174.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.26 -40.84 17.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.62 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.94 -38.04 38.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 178.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.86 91.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.931 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -56.19 -36.47 45.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.887 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.615 ' HA ' HE21 ' A' ' 38' ' ' GLN . 2.1 mm100 -67.73 -42.07 82.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.719 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -57.27 -48.08 79.81 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.07 0.231 . . . . 0.0 111.183 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD12 HD22 ' A' ' 19' ' ' LEU . 9.9 mt -58.97 -62.29 1.99 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.952 0.882 . . . . 0.0 112.567 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.19 -28.51 58.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.134 -176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.51 -56.32 4.96 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.319 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.956 ' SG ' ' HB3' ' A' ' 97' ' ' GLN . 42.6 t -72.21 -59.13 2.89 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.815 -167.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -103.12 -125.59 5.68 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.354 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 44.6 mt-10 -142.11 -148.34 0.24 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.483 -0.859 . . . . 0.0 111.49 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.417 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 33.3 mmt180 -61.46 143.24 56.21 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.992 0.901 . . . . 0.0 112.119 -165.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.21 152.45 30.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.963 -1.472 . . . . 0.0 109.039 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.59 149.66 23.04 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.372 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -134.34 151.12 51.05 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.679 HG23 HD11 ' A' ' 18' ' ' LEU . 61.9 t -127.16 128.19 70.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.869 0.366 . . . . 0.0 110.099 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.1 p30 -75.65 130.61 39.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.739 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.689 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -146.1 -34.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.751 -173.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.689 ' H ' HD12 ' A' ' 52' ' ' ILE . 1.3 mm? -63.05 -14.5 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.906 167.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -95.15 -42.9 8.35 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.778 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.6 m-20 -79.2 122.34 84.12 Favored Pre-proline 0 N--CA 1.472 0.635 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.91 -44.72 9.5 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.147 1.898 . . . . 0.0 113.118 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -75.74 -47.68 24.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.2 -38.25 81.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.176 0.512 . . . . 0.0 110.487 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.603 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 77.4 ttt180 -50.88 -36.3 37.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.212 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.558 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -83.84 -42.19 16.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 50.3 mm-40 -78.0 -59.31 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -161.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.73 ' HB3' HG21 ' A' ' 8' ' ' ILE . 2.2 pt? -70.45 -32.59 2.74 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.3 Cg_endo -53.68 -42.25 67.61 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.324 1.349 . . . . 0.0 111.415 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 46.2 mtmt -54.57 -38.87 67.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.709 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.596 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.26 -41.09 77.37 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.144 -179.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.858 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -78.74 -57.35 3.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.583 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.68 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.6 t30 -175.0 -53.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 0.0 110.084 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.68 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -59.62 150.48 66.32 Favored Pre-proline 0 C--O 1.215 -0.746 0 CA-C-N 113.347 -1.752 . . . . 0.0 113.058 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.77 -33.81 42.62 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 121.828 1.685 . . . . 0.0 110.235 171.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 50.7 p -142.47 -124.2 0.09 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.083 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 1.006 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 55.0 m-85 -141.8 -167.51 0.15 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.006 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 56.9 Cg_endo -68.77 153.42 90.27 Favored 'Cis proline' 0 C--N 1.36 1.179 0 CA-C-N 121.631 1.618 . . . . 0.0 114.107 -1.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.655 HE22 ' HA ' ' A' ' 63' ' ' PRO . 58.2 mt-30 -145.27 133.32 21.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.2 tm? -95.56 137.46 34.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.806 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.605 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 61.2 m95 -122.4 127.42 49.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.572 HG22 HD13 ' A' ' 100' ' ' ILE . 46.4 t -106.02 115.2 47.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.603 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 28.5 t70 55.9 32.65 20.14 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 123.251 1.5 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.69 28.54 60.97 Favored Glycine 0 C--N 1.308 -0.988 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.989 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -124.69 129.75 51.1 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.175 0.19 . . . . 0.0 110.778 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.858 HD22 ' HB1' ' A' ' 66' ' ' ALA . 51.8 tp -69.94 136.59 50.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.596 HG12 ' CG2' ' A' ' 86' ' ' ILE . 92.5 t -119.31 -53.8 3.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.94 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.12 137.0 2.91 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.62 -65.82 1.49 Allowed Glycine 0 C--O 1.216 -0.98 0 C-N-CA 118.929 -1.605 . . . . 0.0 116.338 -168.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 1.9 p -79.33 -69.29 0.59 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.744 1.272 . . . . 0.0 113.388 -173.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.56 -48.4 64.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.415 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.596 ' CG2' HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.81 -46.8 93.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.642 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -58.23 -50.48 78.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.082 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.613 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 39.0 mm -56.04 -51.24 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.221 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.2 tt0 -62.59 -49.79 73.83 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.317 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.913 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 96.3 mmm -59.86 -38.36 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.63 ' HD1' ' HB2' ' A' ' 43' ' ' CYS . 3.0 t80 -60.05 -46.35 89.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.158 0.583 . . . . 0.0 110.475 173.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.613 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.2 mt-30 -64.59 -40.16 95.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.779 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 29.0 mmm180 -59.01 -33.87 71.21 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.053 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.25 20.16 79.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.313 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.631 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 53.7 mt-10 -98.8 -24.58 14.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.106 0.479 . . . . 0.0 111.28 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 23.5 tp -75.2 -43.23 53.17 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.956 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 5.2 pt20 -57.99 -26.9 62.97 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.266 170.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 3.3 mm100 -72.95 -48.03 40.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 39.7 mt -66.33 -48.0 71.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.741 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.61 HG23 HD12 ' A' ' 17' ' ' ILE . 26.5 mm -62.04 -47.14 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.162 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -55.67 -47.25 77.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 123.253 0.345 . . . . 0.0 111.795 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.07 -46.81 78.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.008 0.432 . . . . 0.0 109.922 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.603 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 89.7 m -68.45 -54.69 15.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.164 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.577 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.66 -49.93 74.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.992 -174.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.86 -41.24 82.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.43 -24.5 61.23 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.423 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.533 ' HE2' HG23 ' A' ' 103' ' ' THR . 35.5 m-85 -88.53 -41.7 12.55 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.688 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 108' ' ' LYS . 9.5 mmpt? -72.99 -156.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.56 0.695 . . . . 0.0 109.849 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.7 t -82.22 -146.27 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.722 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -79.93 44.68 0.67 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.33 0.586 . . . . 0.0 109.467 169.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.489 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 50.5 mm-40 -73.63 135.02 78.49 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.311 -172.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.95 42.86 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.69 2.927 . . . . 0.0 114.188 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 123.672 0.789 . . . . 0.0 112.935 179.465 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 m -62.63 123.74 19.16 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.6 t -72.97 46.4 0.17 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.44 0.638 . . . . 0.0 111.918 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 8' ' ' ILE . 10.2 t -168.03 -46.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.855 -0.528 . . . . 0.0 111.088 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.702 ' CG2' HE21 ' A' ' 9' ' ' GLN . 48.2 mt -58.02 -40.27 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 118.005 0.366 . . . . 0.0 111.647 176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.37 -44.3 84.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.27 -47.34 77.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.162 174.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.743 HD13 HD22 ' A' ' 62' ' ' LEU . 84.4 mt -57.8 -44.63 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.249 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.702 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.9 mt-30 -61.87 -40.38 95.16 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.594 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.2 mmp_? -60.86 -36.47 79.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 73.5 mt-30 -71.79 -45.12 62.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.415 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.817 HG22 ' HA2' ' A' ' 78' ' ' GLY . 27.2 mt -63.4 -44.28 98.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.095 0.474 . . . . 0.0 110.107 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.14 96.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 11.9 pt-20 -69.23 -37.48 78.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.694 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.33 126.42 86.45 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 121.315 0.579 . . . . 0.0 110.615 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.531 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.5 Cg_exo -62.1 -42.22 31.0 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 C-N-CA 123.262 2.641 . . . . 0.0 112.82 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.3 mm -136.75 119.48 20.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 12' ' ' ILE . 18.0 tp -132.8 139.95 47.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.345 -170.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.4 tp -136.39 122.98 20.95 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.02 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.744 ' CE2' HD21 ' A' ' 62' ' ' LEU . 6.0 m-85 -98.95 118.06 34.87 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.491 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.9 ptt? -145.99 -166.18 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.662 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.056 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.9 tttt -99.61 118.48 36.24 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.467 -0.771 . . . . 0.0 110.079 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.93 68.46 1.02 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.096 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.4 m -77.71 139.24 62.47 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -53.68 -41.28 75.32 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.086 1.857 . . . . 0.0 111.724 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.87 -35.67 81.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.881 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -154.93 111.38 2.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.463 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 39.0 Cg_endo -74.41 32.29 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.654 2.236 . . . . 0.0 113.868 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -165.07 46.52 0.09 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.163 0.506 . . . . 0.0 110.132 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.759 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 37.5 t -71.65 66.97 0.54 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.158 -173.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.91 -140.81 3.08 Favored Glycine 0 C--N 1.312 -0.799 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -76.91 -33.79 57.75 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.145 0.498 . . . . 0.0 110.699 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.856 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 15.1 p -49.88 -21.06 1.03 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.592 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.18 -42.73 30.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 36' ' ' ALA . 1.7 pm0 -80.47 -34.94 35.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.233 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB2' HE21 ' A' ' 35' ' ' GLN . . . -69.46 -43.08 73.98 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.489 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 7.9 p -53.38 -37.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.108 0.48 . . . . 0.0 110.729 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.582 ' HA ' HE21 ' A' ' 38' ' ' GLN . 0.9 OUTLIER -63.13 -46.18 88.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.842 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.9 -44.41 97.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.876 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -60.65 -55.48 32.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 109.675 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.75 70.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.476 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.93 -48.34 46.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.727 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.3 m -68.62 -57.42 5.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.83 -147.59 20.09 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.452 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.0 mm-40 -100.36 -153.58 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.53 0.681 . . . . 0.0 111.184 174.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.487 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.05 154.16 42.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.872 177.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 19' ' ' LEU . 17.4 p90 -145.97 158.89 43.86 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.006 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.57 146.34 25.37 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -137.72 149.16 46.26 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.501 HG23 HD11 ' A' ' 18' ' ' LEU . 52.9 t -122.63 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' MET . 10.5 p-10 -74.11 130.33 39.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.081 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.641 HG12 ' HB3' ' A' ' 20' ' ' TYR . 1.3 pp -146.68 -34.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.651 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.056 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -63.4 -13.2 37.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.518 171.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -96.47 -45.44 6.76 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.347 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -76.31 116.02 52.38 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.953 0.342 . . . . 0.0 110.742 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 50.1 Cg_exo -59.74 -45.18 26.4 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.0 2.467 . . . . 0.0 113.608 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.41 -54.33 14.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.507 0.67 . . . . 0.0 111.126 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.569 HG22 HD23 ' A' ' 62' ' ' LEU . 36.2 mt -63.6 -35.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.2 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.721 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 61.9 ttt-85 -57.61 -33.36 68.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.095 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -90.62 -52.68 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.62 -54.63 5.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -168.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.754 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -55.22 -44.39 99.6 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.721 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 22.1 Cg_endo -58.13 -41.74 64.4 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 121.465 1.444 . . . . 0.0 111.447 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.6 mtmp? -61.1 -32.37 72.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.751 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.544 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -63.15 -43.2 99.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.818 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -78.16 -57.66 3.67 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.404 -0.918 . . . . 0.0 112.389 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.507 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 41.5 t30 -174.73 -54.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.784 0.802 . . . . 0.0 110.323 168.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -55.6 148.58 34.3 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.835 -1.53 . . . . 0.0 113.274 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -61.62 -38.96 57.84 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.461 2.107 . . . . 0.0 110.459 172.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -143.06 -127.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.253 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.967 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 47.8 m-85 -138.15 -170.99 0.25 Allowed Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.967 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.6 Cg_endo -67.17 155.57 84.83 Favored 'Cis proline' 0 C--N 1.352 0.757 0 CA-C-N 121.132 1.44 . . . . 0.0 114.613 -0.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.487 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 59.3 mt-30 -147.51 132.66 18.33 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.429 173.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.85 138.56 33.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.987 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.526 ' N ' HD13 ' A' ' 74' ' ' LEU . 55.9 m95 -125.06 127.47 46.99 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.18 0.514 . . . . 0.0 110.73 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 100' ' ' ILE . 65.4 t -111.61 121.16 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 176.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 57.15 29.12 16.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.507 1.622 . . . . 0.0 108.691 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.817 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.41 29.11 64.52 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 113.6 -1.637 . . . . 0.0 113.152 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.57 132.15 51.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 110.807 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.818 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.0 tp -65.71 132.42 48.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.801 -172.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.489 ' O ' HG21 ' A' ' 86' ' ' ILE . 78.1 t -110.49 -53.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.199 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 142.19 135.11 3.05 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.36 -62.25 1.66 Allowed Glycine 0 C--O 1.223 -0.584 0 C-N-CA 119.525 -1.322 . . . . 0.0 116.232 -168.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -78.01 -70.76 0.46 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -168.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -80.19 -40.59 26.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.489 HG21 ' O ' ' A' ' 81' ' ' VAL . 48.3 mm -55.9 -45.64 79.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.265 -174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.495 HG13 HD11 ' A' ' 96' ' ' LEU . 86.0 t -59.26 -49.24 84.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.206 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 39' ' ' ALA . 39.6 mm -60.28 -48.79 86.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.456 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.751 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 40.0 tt0 -61.63 -53.28 58.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.69 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.579 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 80.8 mtp -62.64 -30.61 71.49 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.787 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 14.1 t80 -57.34 -52.24 66.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.69 170.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -63.55 -40.59 97.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.101 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 46.3 mmm-85 -59.62 -33.95 72.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.363 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 90.28 -24.66 15.31 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.286 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 91.0 mt-10 -60.07 -29.78 68.79 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 6.5 tt -61.74 -54.5 41.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.071 0.463 . . . . 0.0 110.208 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.864 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.1 pt20 -63.86 -26.58 68.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.775 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 90.9 mm-40 -62.9 -44.82 95.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 24.5 mt -69.9 -46.83 64.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.178 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.523 HG22 ' OD2' ' A' ' 113' ' ' ASP . 47.7 mm -60.62 -46.31 95.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.679 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.923 ' HD3' ' H ' ' A' ' 115' ' ' GLU . 38.7 ttpt -55.54 -53.59 54.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.193 0.308 . . . . 0.0 111.424 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 37.8 tt0 -63.85 -44.48 93.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.119 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.449 ' O ' ' HD2' ' A' ' 107' ' ' TYR . 61.9 m -63.29 -47.14 83.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.645 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.639 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.11 -45.15 94.74 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.389 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.2 95.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.551 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -70.31 -33.19 71.23 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.841 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.457 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 58.0 m-85 -78.68 -47.29 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.639 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -100.38 -147.32 0.35 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 51.6 p -74.45 -155.62 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.969 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.3 57.16 0.87 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.809 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.31 114.18 6.77 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.158 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -95.59 47.31 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 122.699 2.266 . . . . 0.0 112.919 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.523 ' OD2' HG22 ' A' ' 100' ' ' ILE . 7.6 m-20 -52.35 -66.64 0.35 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.143 -168.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.686 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -77.97 -52.19 9.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.305 0.574 . . . . 0.0 110.682 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.923 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 39.6 tt0 . . . . . 0 C--O 1.253 1.289 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.971 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtm . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p -168.01 138.37 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.945 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -72.4 125.05 26.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.808 ' HB ' ' HG2' ' A' ' 6' ' ' GLU . 41.0 p -73.3 131.0 41.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.068 0.461 . . . . 0.0 111.134 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.709 ' CG2' HE21 ' A' ' 9' ' ' GLN . 33.5 mt -60.11 -32.16 49.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.249 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.808 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 10.8 pt-20 -53.3 -44.51 68.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.336 176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.1 ptmt -76.05 -38.41 57.17 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.659 HD13 ' HB3' ' A' ' 62' ' ' LEU . 75.1 mt -58.63 -46.9 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.914 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.709 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.0 mt-30 -62.3 -40.48 96.44 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.76 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -60.39 -35.56 76.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.79 0.329 . . . . 0.0 110.668 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.94 -44.35 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.774 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.774 HG23 HD23 ' A' ' 18' ' ' LEU . 28.9 mt -67.23 -47.34 81.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -59.42 -39.35 83.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.85 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.79 -30.63 70.12 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.946 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 76.5 m-20 -76.31 126.77 86.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.069 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.608 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.7 Cg_exo -61.92 -42.95 27.68 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.849 2.366 . . . . 0.0 112.431 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 16' ' ' PRO . 27.2 mm -137.37 121.1 22.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.774 HD23 HG23 ' A' ' 12' ' ' ILE . 24.5 tp -133.04 141.21 48.12 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.64 -170.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.8 tp -137.39 119.0 14.93 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.986 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.607 ' CE2' HD11 ' A' ' 62' ' ' LEU . 6.8 m-85 -96.51 119.6 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.036 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.685 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 23.2 ptt? -145.92 -166.99 2.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.417 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 86.9 tttt -95.76 90.04 5.52 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -91.84 67.69 2.1 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.463 -170.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -77.87 146.55 72.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.366 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.76 -39.78 89.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.995 1.797 . . . . 0.0 111.066 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.57 -34.36 77.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.617 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 30' ' ' CYS . 1.8 tt -161.42 112.59 1.24 Allowed Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.522 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -69.56 14.3 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.807 2.338 . . . . 0.0 114.11 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.685 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 24.8 p -163.21 47.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.31 0.576 . . . . 0.0 110.613 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.677 ' HA ' HD13 ' A' ' 27' ' ' LEU . 48.0 t -56.46 -40.63 75.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.658 -173.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.644 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.33 -134.48 0.13 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.237 -0.506 . . . . 0.0 114.275 -175.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 41.6 m-85 -74.23 -18.01 60.81 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 121.057 0.456 . . . . 0.0 111.872 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 21' ' ' MET . 8.4 p -63.78 -19.5 65.04 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.9 -42.84 13.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.656 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.85 -38.88 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.299 0.571 . . . . 0.0 110.198 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.03 88.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.909 -175.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 9.3 p -55.23 -39.18 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.523 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.591 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.7 mm100 -67.02 -48.71 67.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -58.29 -45.12 88.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.89 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.3 tt -61.18 -55.38 32.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.232 0.539 . . . . 0.0 110.197 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.02 -32.35 71.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.175 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.62 -47.52 59.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.664 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.3 p -77.16 -51.44 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.846 0.355 . . . . 0.0 111.098 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.78 -134.68 8.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.831 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.25 -152.12 0.51 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.561 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' ARG . 36.8 mmt180 -64.8 150.42 47.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.543 0.687 . . . . 0.0 112.777 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.502 ' CD2' HD13 ' A' ' 40' ' ' LEU . 16.5 p90 -149.4 157.35 43.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.732 -172.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.25 146.94 25.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -137.7 153.36 49.79 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.543 HG23 HD11 ' A' ' 18' ' ' LEU . 52.4 t -130.18 129.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.533 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -74.62 135.2 42.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.401 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.662 HD12 HD22 ' A' ' 53' ' ' LEU . 1.1 pp -151.63 -37.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.522 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -64.39 -11.44 32.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.726 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.57 -41.77 8.76 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.504 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.568 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 74.7 m-20 -76.76 131.64 73.32 Favored Pre-proline 0 N--CA 1.473 0.712 0 O-C-N 122.241 -0.287 . . . . 0.0 110.376 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 16.6 Cg_exo -68.3 -44.45 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.468 2.112 . . . . 0.0 112.421 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.589 ' OD1' HG13 ' A' ' 58' ' ' ILE . 1.3 p30 -77.78 -56.0 4.87 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.589 HG13 ' OD1' ' A' ' 57' ' ' ASP . 48.7 mt -60.42 -32.88 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.45 -176.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.572 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 80.0 ttt180 -51.63 -36.25 45.17 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.222 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.39 -44.64 11.89 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -77.32 -60.23 2.45 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -160.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.733 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.0 pt? -69.14 -31.81 2.95 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 14.1 Cg_endo -54.93 -41.36 79.37 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.533 1.489 . . . . 0.0 110.509 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.64 -39.4 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.494 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.564 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.83 -42.48 70.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.038 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.827 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.69 -57.99 3.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.484 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.715 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.9 t-20 -175.89 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 122.102 0.953 . . . . 0.0 109.407 169.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.715 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -57.32 148.53 52.95 Favored Pre-proline 0 C--O 1.22 -0.449 0 CA-C-N 113.209 -1.814 . . . . 0.0 113.328 -176.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -62.85 -35.98 64.27 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.279 1.986 . . . . 0.0 110.314 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.5 p -143.19 -128.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.036 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.97 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.8 m-85 -139.09 -167.85 0.17 Allowed Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.97 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 48.4 Cg_endo -67.42 151.12 84.17 Favored 'Cis proline' 0 C--N 1.359 1.091 0 CA-C-N 121.318 1.507 . . . . 0.0 114.006 -1.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 19.3 mt-30 -139.15 132.57 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.188 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -95.75 137.23 35.11 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 67.9 m95 -122.99 132.48 54.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 110.92 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.904 HG21 HD13 ' A' ' 99' ' ' LEU . 58.0 t -118.54 119.73 62.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.483 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.534 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 33.3 t70 56.68 25.53 10.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.857 1.313 . . . . 0.0 110.02 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.614 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.49 28.4 47.99 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.135 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.11 135.58 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.996 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.827 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.1 tp -70.97 129.16 38.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.261 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.568 HG12 ' CG2' ' A' ' 86' ' ' ILE . 98.5 t -105.62 -54.74 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.824 170.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 141.01 133.4 2.93 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -86.11 -64.84 1.45 Allowed Glycine 0 C--O 1.217 -0.907 0 C-N-CA 119.046 -1.549 . . . . 0.0 116.436 -167.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.4 p -78.94 -59.61 2.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.21 1.005 . . . . 0.0 113.031 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.3 -46.11 21.0 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 120.886 0.374 . . . . 0.0 111.0 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.568 ' CG2' HG12 ' A' ' 81' ' ' VAL . 46.0 mm -63.4 -42.69 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.73 -171.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.6 t -59.5 -48.35 87.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.141 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.5 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.1 mm -59.03 -49.01 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.759 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 39.7 tt0 -61.61 -54.49 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.679 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.617 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -56.21 -36.27 68.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.536 0.208 . . . . 0.0 111.412 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.579 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.0 t80 -59.6 -50.85 72.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.062 174.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.6 mt-30 -66.01 -44.02 85.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.9 mmm-85 -58.93 -33.71 70.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.695 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.23 21.67 64.54 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.567 -1.197 . . . . 0.0 112.152 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.3 mt-10 -88.35 -29.4 20.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.379 0.609 . . . . 0.0 110.851 173.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 60.3 tp -62.16 -55.0 33.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.048 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.999 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 16.3 pt20 -59.22 -26.26 64.71 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.632 174.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.695 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.1 mm-40 -68.81 -55.14 12.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.801 0.334 . . . . 0.0 111.404 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.904 HD13 HG21 ' A' ' 76' ' ' VAL . 2.3 pp -71.19 -36.09 71.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.044 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 99' ' ' LEU . 46.2 mm -62.31 -44.67 99.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 113' ' ' ASP . 21.9 ttmt -49.29 -57.6 6.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.51 0.672 . . . . 0.0 111.793 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 88.2 tt0 -62.15 -46.09 90.55 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.528 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 86.6 m -67.22 -49.73 63.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.97 89.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.581 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.73 91.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -67.3 -26.79 66.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.79 -177.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.526 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 37.8 m-85 -79.19 -46.61 17.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.204 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.418 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 48.0 mtmt -91.94 -158.27 0.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.308 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 p -84.84 55.25 3.37 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.353 1.073 . . . . 0.0 112.015 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 53.86 47.23 24.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.319 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 40.0 mm-40 -62.44 136.34 95.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.585 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.39 132.25 20.41 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.084 2.523 . . . . 0.0 112.401 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 10.9 t70 -120.69 -104.96 0.39 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.672 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.999 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -64.25 -33.03 74.87 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.481 0.658 . . . . 0.0 110.182 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.861 -172.798 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ppp? . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 p -79.12 -125.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.614 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.0 m 74.17 -24.18 0.21 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.772 0.429 . . . . 0.0 112.062 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 8' ' ' ILE . 31.7 m -51.57 -49.6 61.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.542 0.337 . . . . 0.0 111.32 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.732 ' CG2' HE21 ' A' ' 9' ' ' GLN . 65.1 mt -60.43 -37.46 74.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 52.6 mm-40 -53.96 -47.62 71.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.437 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -67.12 -43.93 81.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.283 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.694 HG21 HD13 ' A' ' 62' ' ' LEU . 81.4 mt -59.23 -44.48 92.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.732 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.3 mt-30 -61.34 -43.46 98.83 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.486 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 2.3 mmp_? -61.15 -35.84 78.17 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -68.08 -45.75 72.92 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.655 HG23 HD23 ' A' ' 18' ' ' LEU . 41.3 mt -63.55 -41.14 91.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.918 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -34.27 71.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.347 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 72.8 mt-10 -59.84 -50.42 73.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.898 0.38 . . . . 0.0 111.07 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -79.33 128.81 74.3 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.111 -171.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' O ' HD13 ' A' ' 17' ' ' ILE . 50.8 Cg_exo -59.05 -42.6 49.86 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 123.144 2.563 . . . . 0.0 112.03 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.6 mm -133.88 122.64 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.655 HD23 HG23 ' A' ' 12' ' ' ILE . 20.8 tp -133.87 141.7 47.49 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.2 -171.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.4 tp -136.61 119.87 16.75 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.096 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.702 ' CE2' HD21 ' A' ' 62' ' ' LEU . 6.2 m-85 -98.26 119.33 36.74 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.795 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 23.0 ptt? -146.19 -166.81 2.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.206 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 84.4 tttt -96.57 144.74 26.35 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.66 121.2 3.55 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.508 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.579 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 41.5 t -132.93 144.87 54.66 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.59 -39.89 86.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.475 2.117 . . . . 0.0 111.277 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -68.43 -34.34 75.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.496 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.09 117.56 1.87 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -74.99 26.3 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.5 2.134 . . . . 0.0 114.434 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.1 p -164.33 49.86 0.12 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.529 0.681 . . . . 0.0 111.448 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.653 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 1.6 p -67.06 61.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.426 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.81 -138.69 2.57 Favored Glycine 0 C--N 1.32 -0.336 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.516 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 42.9 m-85 -76.9 -19.86 56.92 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 25.8 p -69.52 -15.2 63.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -46.95 -42.12 17.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -174.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.663 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.74 -40.87 32.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.085 0.469 . . . . 0.0 110.438 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.84 97.99 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.922 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.4 p -55.8 -38.49 51.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.583 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.598 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.7 mm100 -68.13 -46.01 72.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.367 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.36 -45.41 88.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -63.42 -55.43 24.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.164 0.507 . . . . 0.0 110.364 -175.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.2 -33.34 70.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.05 -48.63 57.07 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.312 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.759 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -73.3 -58.17 3.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.05 -143.31 13.79 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.465 -0.874 . . . . 0.0 114.164 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.673 ' OE2' ' HB3' ' A' ' 111' ' ' GLU . 51.8 mt-10 -97.37 -154.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.437 0.637 . . . . 0.0 111.337 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -66.88 153.3 43.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.164 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 24.4 p90 -147.67 153.43 39.32 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.3 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.21 144.85 27.22 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -132.67 153.27 51.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG23 HD11 ' A' ' 18' ' ' LEU . 58.3 t -128.35 129.73 69.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' MET . 43.2 p-10 -75.34 135.64 40.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.63 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.773 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 1.1 pp -149.68 -37.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.76 -11.05 23.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.613 170.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 -40.56 9.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.073 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.773 ' ND2' ' HA ' ' A' ' 52' ' ' ILE . 19.8 p30 -80.23 140.85 53.14 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 121.389 0.614 . . . . 0.0 111.428 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.23 -41.79 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.995 1.797 . . . . 0.0 112.524 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -78.74 -55.84 4.86 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -170.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.552 HG22 HD23 ' A' ' 62' ' ' LEU . 51.3 mt -62.9 -39.1 83.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.392 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.1 ttt180 -53.93 -34.72 60.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.048 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.17 -54.16 5.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 64' ' ' LYS . 42.1 mt-10 -79.84 -51.36 9.24 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.802 ' HG ' ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -58.07 -43.29 98.29 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -171.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.594 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 21.2 Cg_endo -57.76 -38.71 92.0 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 121.631 1.554 . . . . 0.0 111.197 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 61' ' ' GLU . 5.0 mtpm? -55.09 -39.48 69.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.04 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.563 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.79 -41.62 91.76 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.133 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.77 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -80.72 -56.93 3.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.97 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.73 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -174.99 -55.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.319 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.73 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.27 151.36 58.89 Favored Pre-proline 0 C--O 1.222 -0.365 0 CA-C-N 113.646 -1.615 . . . . 0.0 113.72 -175.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.21 -39.21 39.84 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.318 2.012 . . . . 0.0 110.336 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.552 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 67.9 p -142.44 -124.38 0.09 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.66 172.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.984 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 24.1 m-85 -138.67 -168.26 0.18 Allowed Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.984 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 41.6 Cg_endo -67.4 155.34 85.75 Favored 'Cis proline' 0 C--N 1.361 1.228 0 CA-C-N 121.235 1.477 . . . . 0.0 114.466 -1.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.726 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 18.8 mt-30 -143.6 133.07 23.44 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.507 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.8 137.42 34.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.998 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.524 ' N ' HD13 ' A' ' 74' ' ' LEU . 61.4 m95 -122.66 129.3 51.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.283 0.563 . . . . 0.0 110.805 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.914 HG21 HD13 ' A' ' 99' ' ' LEU . 48.7 t -115.16 119.96 63.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.3 t70 56.22 30.33 16.39 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 123.563 1.649 . . . . 0.0 108.812 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.605 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 74.53 29.06 62.28 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.381 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 49.5 mt-10 -125.37 133.71 52.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.383 . . . . 0.0 110.782 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.77 HD22 ' HB1' ' A' ' 66' ' ' ALA . 55.4 tp -71.05 130.95 42.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.609 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.534 HG12 ' CG2' ' A' ' 86' ' ' ILE . 99.3 t -110.37 -52.05 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.199 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 145.64 134.92 2.75 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.484 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.47 -64.63 1.56 Allowed Glycine 0 C--O 1.218 -0.897 0 C-N-CA 118.751 -1.69 . . . . 0.0 116.526 -166.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.516 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 25.1 p -80.62 -69.04 0.63 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.285 1.042 . . . . 0.0 112.824 -170.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 40.5 m-20 -74.42 -43.7 55.12 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.263 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 81' ' ' VAL . 50.7 mm -58.54 -45.31 90.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.937 -174.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 39' ' ' ALA . 74.5 t -57.44 -48.01 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.185 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 39' ' ' ALA . 44.0 mm -60.29 -51.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.973 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.7 tt0 -62.19 -50.17 72.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.795 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.4 mmt -57.81 -39.73 78.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.843 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 13.3 t80 -60.15 -49.14 78.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.805 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.3 mt-30 -65.5 -40.09 92.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.83 0.348 . . . . 0.0 110.168 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.7 mmm-85 -57.82 -33.24 68.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.143 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 80.22 21.64 64.62 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.602 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 93.0 mt-10 -99.06 -13.85 19.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 0.0 111.543 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.661 HD12 HD11 ' A' ' 99' ' ' LEU . 55.7 tp -72.12 -53.06 13.89 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 4.2 pm0 -56.31 -25.66 49.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.703 170.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 11.7 mm-40 -71.17 -50.52 32.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.845 0.355 . . . . 0.0 111.58 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.914 HD13 HG21 ' A' ' 76' ' ' VAL . 2.6 pp -74.59 -36.22 63.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.366 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 99' ' ' LEU . 42.6 mm -63.63 -42.11 94.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 173.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 21.8 ttmm -52.42 -56.24 16.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.303 0.573 . . . . 0.0 111.25 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -57.3 -48.61 78.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.924 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.8 m -69.4 -47.95 62.58 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.615 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -61.22 -47.93 83.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.005 0.431 . . . . 0.0 110.307 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.69 95.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -68.92 -29.76 68.09 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.11 -0.369 . . . . 0.0 111.863 -178.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.523 ' HE2' HG23 ' A' ' 103' ' ' THR . 52.8 m-85 -78.78 -46.6 18.46 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.245 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.615 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.68 -160.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.681 174.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.7 p -84.73 -140.1 0.07 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.953 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.77 45.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.959 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.673 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . 5.0 mm-40 -70.81 130.58 88.4 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.996 0.427 . . . . 0.0 111.373 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 1.5 Cg_endo -82.98 116.42 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.837 2.358 . . . . 0.0 112.318 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD2' HG22 ' A' ' 100' ' ' ILE . 12.9 t70 -84.01 -124.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.856 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -61.18 -42.7 99.04 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.362 0.601 . . . . 0.0 110.299 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 117.539 -1.22 . . . . 0.0 108.046 175.738 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.176 0.036 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 m 70.82 -41.42 0.5 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.565 0.746 . . . . 0.0 112.042 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.9 p -57.09 135.73 56.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.341 0.591 . . . . 0.0 112.456 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.4 m -62.48 -25.55 68.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.212 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.975 HG22 ' HG3' ' A' ' 9' ' ' GLN . 22.4 mm -53.88 -34.77 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.878 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 70.6 mm-40 -44.69 -45.79 9.94 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -62.16 -43.76 98.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.074 0.464 . . . . 0.0 110.93 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 62' ' ' LEU . 73.0 mt -68.3 -40.55 82.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.626 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.975 ' HG3' HG22 ' A' ' 5' ' ' ILE . 62.7 mt-30 -58.54 -44.2 89.51 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -55.54 -34.73 64.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.268 175.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.645 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 38.6 tt0 -68.44 -48.41 64.66 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.431 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.551 HG22 ' HA2' ' A' ' 78' ' ' GLY . 21.0 mt -68.32 -39.24 80.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.77 0.795 . . . . 0.0 110.472 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.46 81.0 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.839 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.1 pt-20 -70.03 -39.28 75.86 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -173.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 2.7 p30 -79.22 134.96 58.35 Favored Pre-proline 0 CA--C 1.518 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 112.737 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.524 ' O ' HD13 ' A' ' 17' ' ' ILE . 32.7 Cg_exo -64.24 -41.73 20.5 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 123.165 2.576 . . . . 0.0 111.648 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 16' ' ' PRO . 24.1 mm -138.52 121.8 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.757 HD11 HG23 ' A' ' 50' ' ' VAL . 25.6 tp -132.43 141.25 48.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.232 0.539 . . . . 0.0 111.959 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.5 tp -132.34 120.67 22.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.791 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.793 ' CE2' HD21 ' A' ' 62' ' ' LEU . 7.5 m-85 -99.53 120.99 40.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.703 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.527 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -148.1 -154.05 0.53 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.755 ' HD3' ' HB3' ' A' ' 30' ' ' CYS . 64.6 tttm -100.7 112.01 24.34 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.43 69.5 1.06 Allowed Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.674 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -78.85 143.97 63.26 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.198 . . . . 0.0 111.068 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.04 -40.23 85.38 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.119 1.879 . . . . 0.0 110.94 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -65.27 -33.09 75.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.765 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -160.46 116.67 1.44 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.511 ' O ' ' SD ' ' A' ' 21' ' ' MET . 9.3 Cg_exo -72.94 31.43 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.738 2.292 . . . . 0.0 113.984 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -169.61 51.82 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.454 0.702 . . . . 0.0 110.241 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.755 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.8 t -56.37 -37.07 69.57 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.554 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -70.5 -135.82 0.11 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 -177.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.5 -36.4 57.81 Favored 'General case' 0 C--O 1.219 -0.529 0 O-C-N 122.353 -0.498 . . . . 0.0 111.943 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.486 ' CB ' ' HB3' ' A' ' 21' ' ' MET . 34.6 t -54.01 -10.39 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.41 -42.32 42.2 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.083 0.24 . . . . 0.0 111.325 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' ' 36' ' ' ALA . 1.5 pm0 -80.56 -34.85 35.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.234 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB2' HE21 ' A' ' 35' ' ' GLN . . . -67.26 -42.75 83.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.304 -175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.527 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.54 -37.41 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.305 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.619 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.8 mm100 -64.81 -46.08 83.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.306 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.65 -43.95 93.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.618 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -64.12 -57.88 8.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.618 -174.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.41 ' HB2' ' HE2' ' A' ' 47' ' ' PHE . . . -59.56 -34.41 72.65 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.271 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.52 -48.84 59.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.681 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.5 p -72.81 -54.25 9.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.795 -173.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.774 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.38 -142.45 12.75 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.451 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 46' ' ' ARG . 17.1 pt-20 -99.95 -154.68 0.48 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.52 . . . . 0.0 111.082 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -68.79 158.68 33.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.991 170.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.527 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 15.5 p90 -152.96 159.73 42.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.297 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.54 151.98 19.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.475 ' HD1' ' HE2' ' A' ' 21' ' ' MET . 2.0 p90 -138.05 151.59 48.0 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.757 HG23 HD11 ' A' ' 18' ' ' LEU . 46.2 t -132.3 126.78 56.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.61 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.8 p30 -76.59 131.39 38.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.277 0.56 . . . . 0.0 110.73 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.681 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -143.5 -33.93 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.709 -174.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 52' ' ' ILE . 1.6 mm? -65.74 -9.47 28.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.142 166.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -46.82 6.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.236 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -83.44 116.57 65.16 Favored Pre-proline 0 N--CA 1.476 0.842 0 O-C-N 122.059 -0.401 . . . . 0.0 111.025 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.93 -44.81 18.78 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.792 2.328 . . . . 0.0 113.248 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -61.5 -55.07 35.16 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.443 0.64 . . . . 0.0 111.341 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.457 HG22 HD23 ' A' ' 62' ' ' LEU . 41.9 mt -67.34 -36.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.365 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 79.3 ttt180 -56.98 -33.68 67.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.72 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.51 7.33 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.749 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 55.3 mm-40 -84.7 -51.05 7.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -167.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.793 HD21 ' CE2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -60.09 -41.67 85.9 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -172.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.626 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 32.4 Cg_endo -59.52 -39.28 76.95 Favored 'Trans proline' 0 CA--C 1.513 -0.545 0 C-N-CA 121.282 1.321 . . . . 0.0 111.168 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 37.9 mtmt -55.55 -41.75 73.68 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.219 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.666 ' HD2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -63.32 -44.89 93.64 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.111 -176.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.816 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.1 -56.11 5.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.462 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.738 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.5 t-20 -174.82 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.188 0.994 . . . . 0.0 110.006 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.738 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.12 148.25 62.31 Favored Pre-proline 0 C--O 1.219 -0.542 0 CA-C-N 113.236 -1.802 . . . . 0.0 113.365 -175.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.77 -37.36 68.1 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 121.912 1.741 . . . . 0.0 110.437 171.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 37.2 p -143.07 -128.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.58 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 31.6 m-85 -137.11 -169.7 0.22 Allowed Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.968 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.55 153.39 82.59 Favored 'Cis proline' 0 C--N 1.361 1.22 0 CA-C-N 121.374 1.527 . . . . 0.0 114.14 -0.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.688 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.6 mt-30 -142.28 135.45 28.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.298 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.2 tm? -99.3 133.71 43.2 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 59.4 m95 -116.9 131.33 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.314 0.578 . . . . 0.0 110.863 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.827 HG21 HD13 ' A' ' 99' ' ' LEU . 86.4 t -121.67 122.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' HB2' HG23 ' A' ' 103' ' ' THR . 37.3 t70 58.22 30.12 18.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.811 1.291 . . . . 0.0 109.332 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.68 28.77 66.62 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.16 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -137.04 137.56 39.49 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 111.479 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.816 HD22 ' HB1' ' A' ' 66' ' ' ALA . 46.3 tp -66.96 132.48 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.229 -172.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.572 HG12 ' CG2' ' A' ' 86' ' ' ILE . 76.1 t -110.32 -54.65 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.921 171.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.63 134.49 2.7 Favored Glycine 0 C--O 1.222 -0.648 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.87 -62.39 1.69 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -168.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.1 p -78.67 -68.12 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.701 -0.882 . . . . 0.0 112.992 -170.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.94 -47.65 43.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.031 0.444 . . . . 0.0 111.008 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.572 ' CG2' HG12 ' A' ' 81' ' ' VAL . 44.4 mm -59.95 -46.82 93.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.754 -170.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -56.11 -50.33 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.361 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 39' ' ' ALA . 36.7 mm -61.94 -50.66 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.631 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.781 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.3 tt0 -63.25 -50.48 70.02 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.422 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.463 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.3 mmt -57.54 -38.02 74.02 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.0 t80 -58.02 -51.64 68.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.149 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.0 mt-30 -63.93 -39.85 95.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.649 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.781 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 25.9 mmm180 -63.6 -33.89 76.6 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.821 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 99.59 -24.09 33.58 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.34 -170.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 5.1 mm-40 -52.14 -36.14 50.52 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.61 HD12 HD11 ' A' ' 99' ' ' LEU . 53.3 tp -64.77 -54.99 22.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.68 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.5 pt20 -61.18 -26.47 67.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.405 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 10.4 mm100 -66.81 -54.54 21.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.633 0.254 . . . . 0.0 111.407 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 HG21 ' A' ' 76' ' ' VAL . 3.0 pp -70.28 -35.26 73.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.558 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 99' ' ' LEU . 35.7 mm -62.97 -48.6 87.22 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -55.62 -52.22 64.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 111.753 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -57.1 -45.32 83.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.949 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 77' ' ' ASP . 91.1 m -68.0 -47.97 67.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.417 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.06 99.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.025 0.441 . . . . 0.0 110.06 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.65 99.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -72.14 -33.6 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.643 -178.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.465 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 80.0 m-85 -79.57 -46.69 16.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.767 173.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.636 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -89.58 -149.91 0.2 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.184 -177.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 25.3 t -82.84 -148.36 0.08 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.331 170.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -75.11 54.3 0.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.877 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 38.5 mm-40 -66.11 117.56 44.07 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 121.178 0.514 . . . . 0.0 110.398 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -99.7 49.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.598 2.865 . . . . 0.0 113.233 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.774 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 36.4 m-20 -50.31 -61.23 2.29 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.62 -53.62 6.67 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.016 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.855 -1.069 . . . . 0.0 109.136 -175.236 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 111.482 0.178 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -59.31 136.65 58.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.101 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 4' ' ' THR . 68.5 p 53.09 -121.48 1.88 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.166 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 3' ' ' THR . 58.5 m 75.18 132.5 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.4 0.619 . . . . 0.0 110.82 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.822 HG22 HE21 ' A' ' 9' ' ' GLN . 73.3 mt -53.75 -37.48 32.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.6 -175.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -53.38 -47.29 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.982 0.42 . . . . 0.0 110.725 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.951 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -68.43 -45.35 72.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.56 175.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.63 HG21 HD22 ' A' ' 62' ' ' LEU . 82.6 mt -56.69 -44.2 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.822 HE21 HG22 ' A' ' 5' ' ' ILE . 71.7 mt-30 -60.35 -35.84 76.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.831 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -60.23 -35.68 76.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.494 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -72.36 -42.11 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.542 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.649 HG23 HD23 ' A' ' 18' ' ' LEU . 19.6 mt -68.39 -45.66 81.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.119 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -37.81 78.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.169 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.2 pt-20 -68.57 -34.8 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -78.55 127.57 80.15 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-O 120.901 0.381 . . . . 0.0 111.273 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.611 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 50.7 Cg_exo -61.8 -42.84 29.05 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.019 2.48 . . . . 0.0 112.333 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 16' ' ' PRO . 32.1 mm -137.47 120.95 21.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD23 HG23 ' A' ' 12' ' ' ILE . 21.5 tp -133.41 142.43 48.34 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.466 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.3 tp -136.32 120.28 17.55 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.12 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.769 ' CE2' HD21 ' A' ' 62' ' ' LEU . 5.5 m-85 -97.35 117.92 32.66 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.848 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.532 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 21.6 ptt? -146.84 -164.89 2.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.4 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.948 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 61.9 tttm -98.34 103.16 15.08 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.24 67.0 1.76 Allowed Glycine 0 C--N 1.309 -0.926 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.437 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 t -76.07 141.3 70.85 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.6 -41.42 45.11 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.253 1.969 . . . . 0.0 112.188 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -65.14 -35.62 81.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.844 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -158.57 118.99 1.84 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -172.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.552 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.1 Cg_exo -71.99 20.37 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.798 2.332 . . . . 0.0 114.303 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.7 p -161.97 52.35 0.23 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.517 0.675 . . . . 0.0 111.037 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 43.4 t -71.54 56.24 0.25 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.126 -177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.23 -136.53 2.02 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.695 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 28.2 m-85 -76.25 -38.28 56.48 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 117.481 0.64 . . . . 0.0 109.518 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 35.1 p -46.4 -24.58 0.52 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.195 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.99 -42.2 48.6 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.555 0.216 . . . . 0.0 111.097 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' O ' ' A' ' 32' ' ' PHE . 1.8 pp0? -77.41 -37.94 50.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 10.6 p -57.53 -38.98 66.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 1.8 mm100 -65.42 -41.92 93.07 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.924 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -60.1 -43.33 95.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.604 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.08 -56.0 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.121 0.486 . . . . 0.0 109.908 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.35 72.24 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.885 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.6 m -70.41 -60.36 2.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.33 -138.91 9.57 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -115.09 -151.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.351 -0.925 . . . . 0.0 110.621 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -59.38 152.68 20.73 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.628 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.51 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 26.1 p90 -155.64 154.16 31.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.057 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 151.71 20.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.947 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.3 p90 -135.72 153.91 51.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.648 HG23 HD11 ' A' ' 18' ' ' LEU . 61.6 t -131.43 134.51 60.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.651 ' OD1' ' HB3' ' A' ' 54' ' ' GLN . 7.9 t70 -73.13 138.89 46.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.185 175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.1 pp -152.0 -35.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.387 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.948 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -65.25 -18.0 64.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.387 174.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.651 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -94.94 -43.23 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.616 176.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -71.51 118.55 67.27 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 117.797 0.271 . . . . 0.0 110.503 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.81 -43.98 8.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.313 2.009 . . . . 0.0 113.029 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -69.25 -52.79 24.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.85 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.568 HG22 HD23 ' A' ' 62' ' ' LEU . 19.8 mt -65.12 -36.53 78.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.391 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.2 tmm_? -56.32 -37.93 70.61 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.73 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.609 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -80.43 -50.99 9.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.596 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 4.9 mm-40 -79.18 -53.51 6.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -167.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -62.53 -40.69 67.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -169.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.63 ' HD3' ' CE1' ' A' ' 71' ' ' PHE . 27.5 Cg_endo -59.44 -40.74 64.25 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 C-N-CA 121.378 1.385 . . . . 0.0 111.468 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 51.6 mtmt -56.28 -36.06 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.556 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.557 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.81 -43.23 80.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.534 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.781 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.81 -56.26 4.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.434 -174.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.765 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 26.3 t-20 -175.47 -53.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.253 1.025 . . . . 0.0 109.362 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.765 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -58.73 150.64 57.18 Favored Pre-proline 0 C--O 1.218 -0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 113.484 -176.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 68' ' ' TRP . 10.3 Cg_exo -64.1 -39.12 32.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.211 1.941 . . . . 0.0 110.113 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.5 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 47.6 p -143.12 -129.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.728 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 1.011 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.4 m-85 -137.86 -171.85 0.29 Allowed Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.528 -0.733 . . . . 0.0 109.141 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.011 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.57 156.07 82.31 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 120.933 1.369 . . . . 0.0 114.469 -0.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.678 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.9 mt-30 -142.08 133.58 26.67 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.264 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -94.06 138.13 32.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 58.9 m95 -124.28 128.03 48.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.257 0.551 . . . . 0.0 110.828 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.54 120.96 62.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.587 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 32.6 t70 56.39 27.44 12.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.917 1.341 . . . . 0.0 110.01 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.646 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 77.38 29.34 56.15 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.905 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -125.83 132.62 52.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.781 HD22 ' HB1' ' A' ' 66' ' ' ALA . 56.3 tp -69.81 130.29 41.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.472 HG12 ' CG2' ' A' ' 86' ' ' ILE . 88.3 t -108.35 -55.75 5.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.346 172.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.29 131.41 2.43 Favored Glycine 0 C--O 1.22 -0.768 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.468 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.36 -62.33 1.65 Allowed Glycine 0 C--O 1.222 -0.641 0 C-N-CA 119.593 -1.289 . . . . 0.0 116.1 -168.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 p -77.52 -67.85 0.68 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.759 -0.848 . . . . 0.0 112.934 -170.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -79.04 -45.0 21.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.023 -173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG13 ' HA3' ' A' ' 82' ' ' GLY . 48.0 mm -58.01 -47.01 87.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 82' ' ' GLY . 60.5 t -57.29 -51.86 64.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.568 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.519 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 45.6 mm -59.83 -50.39 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 42.7 tt0 -61.04 -51.51 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.694 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.683 ' HG2' ' N ' ' A' ' 96' ' ' LEU . 46.5 ttm -63.88 -32.59 74.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.098 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.885 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 7.8 t80 -57.35 -52.05 66.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.657 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.1 mt-30 -62.83 -38.28 90.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.14 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -59.12 -32.84 70.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.062 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.04 17.64 79.54 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.571 -171.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.666 ' HA ' ' HB3' ' A' ' 98' ' ' GLN . 88.9 mt-10 -90.87 -27.17 18.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.525 177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.683 ' N ' ' HG2' ' A' ' 90' ' ' MET . 61.7 tp -60.1 -53.66 55.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.579 0.704 . . . . 0.0 109.462 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 1.078 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 14.1 pt20 -64.31 -26.62 68.57 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.28 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -64.59 -44.16 91.52 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.175 0.512 . . . . 0.0 109.713 175.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 25.4 mt -69.95 -46.46 65.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.57 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.08 -45.23 98.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.148 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' A' ' 113' ' ' ASP . 36.4 ttpt -55.96 -48.78 75.18 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.49 -44.03 96.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.13 0.49 . . . . 0.0 110.373 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.587 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 42.1 m -75.33 -52.2 11.39 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.58 94.12 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.261 -0.274 . . . . 0.0 111.154 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.3 80.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.635 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -75.04 -27.03 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.153 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.611 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 44.4 m-85 -80.73 -45.77 16.54 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.063 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -76.64 -156.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.4 p -82.45 -147.75 0.08 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -76.81 46.51 0.46 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.916 0.389 . . . . 0.0 110.925 171.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -68.34 129.06 93.02 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.894 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.15 111.38 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.399 2.066 . . . . 0.0 112.721 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 101' ' ' LYS . 31.1 t70 -88.09 -117.59 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 172.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.078 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -69.7 39.3 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.232 -0.889 . . . . 0.0 109.5 178.371 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtm . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.6 p 50.91 -117.01 1.03 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.024 0.53 . . . . 0.0 111.569 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 4' ' ' THR . 23.7 m -151.94 -130.74 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.626 ' H ' HG22 ' A' ' 3' ' ' THR . 60.3 p -146.83 -147.53 0.22 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.851 0.75 . . . . 0.0 111.121 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.71 ' CG2' HE21 ' A' ' 9' ' ' GLN . 91.5 mt -57.45 -37.51 58.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.981 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 33.8 mm-40 -51.28 -53.71 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 111.429 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.78 -40.19 88.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.304 0.573 . . . . 0.0 110.674 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.918 HG21 ' HG ' ' A' ' 62' ' ' LEU . 83.4 mt -59.76 -46.14 93.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.616 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.71 HE21 ' CG2' ' A' ' 5' ' ' ILE . 69.3 mt-30 -61.77 -35.24 77.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.662 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -60.82 -38.54 85.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.172 175.086 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 8' ' ' ILE . 17.2 pt20 -79.68 -39.81 30.47 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.009 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.643 HG22 ' HA2' ' A' ' 78' ' ' GLY . 22.3 mt -61.88 -45.22 99.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.218 0.533 . . . . 0.0 110.429 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.6 91.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.1 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.0 pt-20 -70.43 -30.15 66.93 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.828 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.9 m-20 -76.74 126.87 85.32 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.275 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.632 ' O ' HD13 ' A' ' 17' ' ' ILE . 51.0 Cg_exo -60.29 -43.56 33.93 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.911 2.407 . . . . 0.0 112.56 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 16' ' ' PRO . 26.2 mm -139.92 120.61 14.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD23 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -133.76 142.26 47.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.375 -169.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 14.5 tp -137.52 116.62 12.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.17 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 6.6 m-85 -96.35 118.83 33.69 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.305 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.848 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 24.2 ptt? -147.44 -167.44 2.79 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 65.9 tttm -97.11 108.68 21.46 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -94.63 71.15 1.13 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.328 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.9 m -78.67 146.71 69.73 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.92 -41.69 74.62 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.479 2.119 . . . . 0.0 112.288 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.88 -31.45 71.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 tt -157.58 115.22 1.88 Allowed Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 40.2 Cg_endo -71.84 22.12 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.674 2.25 . . . . 0.0 113.713 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.848 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 15.7 p -163.14 50.48 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.014 0.526 . . . . 0.0 109.903 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.63 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 37.6 t -71.93 53.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.288 -176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.12 -134.38 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.152 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 1.037 ' HB3' ' HB2' ' A' ' 84' ' ' CYS . 63.3 m-85 -76.43 -23.16 53.95 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.405 ' N ' ' HG2' ' A' ' 72' ' ' PRO . 23.3 t -74.82 -11.54 60.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.664 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -50.76 -43.4 58.29 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.622 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -77.42 -39.13 48.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.068 0.461 . . . . 0.0 110.107 176.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.34 89.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.102 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -56.8 -39.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.321 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.598 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.7 mm100 -66.89 -47.35 72.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.858 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.36 -42.86 92.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.984 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -62.37 -57.08 12.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 110.036 -175.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.03 69.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.204 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.82 -50.62 23.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.557 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.9 p -76.5 -52.99 8.73 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.246 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.64 -135.59 8.99 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.486 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 26.3 mt-10 -141.95 -147.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.101 -0.549 . . . . 0.0 111.348 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 34.3 mmt-85 -48.02 146.96 2.28 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.359 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' HD13 ' A' ' 40' ' ' LEU . 21.6 p90 -159.38 150.86 20.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.876 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -98.99 144.06 28.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.557 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 p90 -130.78 149.74 52.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.485 HG23 HD11 ' A' ' 18' ' ' LEU . 44.0 t -124.31 128.04 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.535 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.0 p30 -78.46 132.2 37.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.393 0.616 . . . . 0.0 110.166 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.664 HD12 HD22 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -142.53 -34.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.342 -173.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.664 HD22 HD12 ' A' ' 52' ' ' ILE . 1.8 mm? -67.19 -8.68 33.2 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.116 167.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.25 -47.12 5.86 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.698 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.674 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.1 m-20 -73.78 131.35 81.96 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 121.958 -0.464 . . . . 0.0 111.419 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.76 -43.63 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.364 2.043 . . . . 0.0 112.924 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -76.1 -55.5 5.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.78 -33.38 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.674 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 28.1 ttm180 -49.73 -40.4 40.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.612 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.39 18.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 56.7 mm-40 -78.86 -60.08 2.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -161.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.918 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.92 -25.18 0.49 Allowed Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -170.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.687 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 14.1 Cg_endo -55.24 -41.82 74.66 Favored 'Trans proline' 0 C--N 1.359 1.094 0 CA-C-N 121.682 1.637 . . . . 0.0 110.682 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -48.38 -41.93 30.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.777 175.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.639 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -71.97 -41.7 67.39 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.149 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.824 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -72.53 -57.56 4.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.64 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.689 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 50.3 t30 -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.256 1.027 . . . . 0.0 109.861 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.689 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -60.78 148.07 83.39 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 113.12 -1.854 . . . . 0.0 112.738 -176.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -61.95 -33.94 82.45 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.194 1.93 . . . . 0.0 110.145 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -143.0 -126.64 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.917 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.966 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.3 m-85 -142.28 -164.49 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.966 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 2.1 Cg_endo -74.32 154.9 99.88 Favored 'Cis proline' 0 C--N 1.362 1.278 0 CA-C-N 121.503 1.572 . . . . 0.0 113.282 -2.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.618 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 61.8 mt-30 -144.02 135.4 25.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.704 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -93.55 137.04 33.23 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 59.1 m95 -121.26 132.56 54.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.236 0.541 . . . . 0.0 111.083 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.06 120.88 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.591 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 30.6 t70 56.38 28.35 13.38 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.799 1.285 . . . . 0.0 110.43 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.51 28.21 55.77 Favored Glycine 0 C--N 1.311 -0.821 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.887 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -127.76 133.84 49.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.909 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.824 HD22 ' HB1' ' A' ' 66' ' ' ALA . 52.0 tp -69.44 130.25 41.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.771 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' CG2' ' A' ' 86' ' ' ILE . 81.6 t -107.35 -54.4 5.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.902 173.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.59 140.78 3.64 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.16 -67.66 1.4 Allowed Glycine 0 C--O 1.217 -0.951 0 C-N-CA 118.549 -1.786 . . . . 0.0 116.1 -167.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 1.037 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 42.0 t -81.76 -68.03 0.73 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.767 1.283 . . . . 0.0 112.657 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 86' ' ' ILE . 1.5 m-20 -65.53 -49.62 68.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.6 -169.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.6 mp -63.58 -43.15 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.992 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 HD11 ' A' ' 96' ' ' LEU . 53.1 t -59.84 -51.39 73.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.441 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.1 mm -59.02 -48.77 85.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.928 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.736 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.2 tt0 -62.28 -52.11 64.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.096 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.685 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.9 mmt -60.43 -34.78 74.47 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.611 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 7.6 t80 -58.2 -50.04 74.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.772 172.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 81.4 mt-30 -64.31 -40.81 96.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.11 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.7 mmm180 -61.96 -34.53 76.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.584 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.77 -23.53 32.33 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.824 -171.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.755 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 4.7 mm-40 -56.4 -39.69 73.41 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.824 0.45 . . . . 0.0 112.179 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.8 tt -60.31 -52.7 64.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.186 -176.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.708 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -64.68 -26.75 68.51 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -68.61 -46.83 68.23 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.108 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 53.5 mt -63.44 -46.19 87.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.06 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 96' ' ' LEU . 48.8 mm -62.1 -45.17 99.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.145 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.685 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 26.0 ttpp -53.03 -52.7 57.61 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.234 0.54 . . . . 0.0 111.375 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 87.7 tt0 -65.2 -46.6 80.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.547 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.951 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 91.4 m -66.87 -46.99 73.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.368 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.49 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.93 -42.29 99.75 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.58 78.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.951 ' HE2' ' HA ' ' A' ' 103' ' ' THR 0.255 0.0 OUTLIER -77.79 -26.97 50.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.349 178.631 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.692 ' CE2' ' HE3' ' A' ' 106' ' ' LYS . 93.8 m-85 -87.95 -49.55 6.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.521 171.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -101.82 135.9 42.57 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 p -58.17 115.84 3.18 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 49.47 43.23 23.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.396 -1.729 . . . . 0.0 114.143 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -78.33 117.69 67.73 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.38 171.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.18 59.03 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.697 2.931 . . . . 0.0 114.431 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.529 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 55.1 m-20 -53.84 -63.68 1.07 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.685 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -73.57 -41.75 62.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.998 0.428 . . . . 0.0 110.972 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.448 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 38.8 tt0 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 117.781 -1.104 . . . . 0.0 108.426 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.838 0.352 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 t -66.69 -46.59 75.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.168 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.3 p -149.96 131.48 14.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.255 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.456 HG21 ' OE1' ' A' ' 61' ' ' GLU . 22.9 m -158.25 -46.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.731 ' CG2' HE21 ' A' ' 9' ' ' GLN . 62.2 mt -54.4 -36.85 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.127 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -54.42 -45.67 73.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.002 0.43 . . . . 0.0 110.331 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -71.64 -40.19 69.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.051 174.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.695 HD13 HD22 ' A' ' 62' ' ' LEU . 72.3 mt -57.51 -43.66 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.56 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.731 HE21 ' CG2' ' A' ' 5' ' ' ILE . 73.1 mt-30 -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 7' ' ' LYS . 5.7 tpm_? -60.01 -38.24 82.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.383 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 53.0 tt0 -68.0 -45.8 73.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.124 0.487 . . . . 0.0 110.948 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.785 HG22 ' HA2' ' A' ' 78' ' ' GLY . 29.3 mt -66.56 -46.64 85.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.009 0.433 . . . . 0.0 110.722 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.69 88.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.4 pt-20 -66.93 -34.39 77.68 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.353 -176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 70.2 m-80 -77.34 128.38 80.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.607 ' O ' HD13 ' A' ' 17' ' ' ILE . 50.4 Cg_exo -60.22 -42.93 38.54 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 123.063 2.509 . . . . 0.0 112.075 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 16' ' ' PRO . 36.0 mm -139.4 125.98 23.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.685 HD11 HG23 ' A' ' 50' ' ' VAL . 27.5 tp -133.44 141.21 47.72 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.386 -170.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.3 tp -136.43 119.06 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.601 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -96.98 119.36 35.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.972 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 20.4 ptt? -146.19 -169.38 3.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.299 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.022 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.8 tttt -97.68 115.04 27.16 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.665 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.62 70.21 1.0 Allowed Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.399 -175.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 30' ' ' CYS . 80.4 p -79.05 143.37 61.21 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.777 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.3 -41.51 65.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.389 2.059 . . . . 0.0 112.278 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -65.0 -32.29 73.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.418 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 29' ' ' SER . 51.3 tp -158.72 116.92 1.72 Allowed Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.594 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 11.3 Cg_exo -71.86 27.97 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.3 2.0 . . . . 0.0 112.736 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 40.6 p -162.84 51.56 0.18 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.179 0.514 . . . . 0.0 111.889 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.598 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 40.4 t -72.84 59.19 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.225 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.07 -139.81 2.97 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.82 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 55.1 m-85 -74.88 -17.7 60.54 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 120.994 0.426 . . . . 0.0 111.632 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 30.2 p -69.92 -18.45 63.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -48.65 -42.23 33.81 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.663 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.71 -38.97 58.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.141 0.496 . . . . 0.0 109.853 178.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.49 92.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.048 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.98 -39.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.028 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 1.8 mm100 -67.11 -44.28 80.33 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.91 -47.35 85.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.991 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -61.37 -51.83 67.15 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.9 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.75 67.98 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.883 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 44' ' ' GLY . . . -71.65 -48.66 46.22 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.15 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.961 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -70.45 -9.18 55.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.811 170.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -10.59 120.48 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.967 0 CA-C-N 110.684 -2.962 . . . . 0.0 119.056 -160.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.779 ' OE2' ' HA ' ' A' ' 97' ' ' GLN . 3.6 mp0 -133.43 138.19 46.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 109.95 -3.125 . . . . 0.0 103.887 164.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -56.39 129.41 40.45 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.643 -170.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 14.7 p90 -140.47 148.08 40.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.04 -166.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.36 152.94 21.0 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.929 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.5 p90 -136.38 153.18 51.18 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.685 HG23 HD11 ' A' ' 18' ' ' LEU . 61.4 t -128.95 131.45 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.5 p30 -76.51 132.37 39.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 110.368 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.626 HD12 HD22 ' A' ' 53' ' ' LEU . 1.2 pp -147.64 -37.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.022 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -65.56 -7.66 15.86 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.22 173.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HB3' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.22 -42.84 7.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.433 177.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.4 m-20 -77.09 123.26 87.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.5 -45.23 11.99 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.121 1.881 . . . . 0.0 112.763 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.04 -56.72 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.993 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.73 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.473 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.619 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 78.9 ttt180 -52.8 -31.93 41.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.7 -47.36 8.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.456 ' OE1' HG21 ' A' ' 4' ' ' THR . 50.1 mt-10 -76.4 -60.61 2.26 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -163.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.695 HD22 HD13 ' A' ' 8' ' ' ILE . 1.8 pt? -68.36 -33.49 4.78 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.694 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.5 Cg_endo -53.94 -42.11 69.4 Favored 'Trans proline' 0 C--N 1.353 0.81 0 CA-C-N 120.939 1.371 . . . . 0.0 110.785 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.13 -40.53 61.49 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.28 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.509 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.3 -43.98 76.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.779 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -76.6 -57.59 3.77 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.816 -174.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.3 t-20 -174.99 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.109 0.957 . . . . 0.0 109.972 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -57.67 149.18 53.44 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 113.303 -1.772 . . . . 0.0 113.351 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -62.18 -37.11 65.17 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.426 2.084 . . . . 0.0 110.194 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 57.8 p -141.86 -124.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.278 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.998 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 46.0 m-85 -141.43 -170.58 0.24 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.998 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 58.5 Cg_endo -69.71 154.2 93.06 Favored 'Cis proline' 0 C--N 1.357 1.004 0 CA-C-N 121.27 1.489 . . . . 0.0 114.349 -1.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.617 HE22 ' HA ' ' A' ' 63' ' ' PRO . 61.2 mt-30 -144.96 134.92 23.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.655 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -98.63 137.52 37.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.029 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.535 ' N ' HD13 ' A' ' 74' ' ' LEU . 60.3 m95 -123.81 132.19 53.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.276 0.56 . . . . 0.0 111.222 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 99' ' ' LEU . 38.9 t -114.31 118.05 57.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.536 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.2 t70 55.61 26.9 9.74 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.388 1.566 . . . . 0.0 108.72 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.785 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 80.82 28.54 46.02 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.607 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.47 133.33 47.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.973 0.416 . . . . 0.0 111.077 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.779 HD22 ' HB1' ' A' ' 66' ' ' ALA . 55.5 tp -68.81 133.44 48.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.556 HG12 ' CG2' ' A' ' 86' ' ' ILE . 90.1 t -110.41 -54.42 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.069 170.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.48 135.03 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.475 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -85.1 -63.56 1.58 Allowed Glycine 0 C--O 1.219 -0.803 0 C-N-CA 119.291 -1.433 . . . . 0.0 116.589 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 18.9 p -78.89 -67.6 0.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.427 -1.043 . . . . 0.0 113.373 -168.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.21 -43.34 28.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.556 ' CG2' HG12 ' A' ' 81' ' ' VAL . 48.4 mm -57.18 -45.61 84.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.157 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.8 t -58.67 -48.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.44 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.844 HD13 ' HB2' ' A' ' 39' ' ' ALA . 36.9 mm -58.59 -53.42 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.09 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.4 tt0 -63.2 -49.36 74.53 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.246 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.816 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -61.09 -37.64 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 2.3 t80 -57.86 -49.39 76.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.553 173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 83.5 mt-30 -64.16 -39.64 94.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 27.1 mmm180 -57.49 -33.55 68.13 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.639 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.541 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 89.82 -24.05 17.16 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.211 -170.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.511 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.1 mt-10 -60.92 -26.44 67.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 7.9 tt -73.08 -53.96 9.74 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.961 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 17.5 pt20 -57.89 -25.92 61.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.181 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.3 mm100 -69.23 -53.27 20.75 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.667 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.802 HD13 HG21 ' A' ' 76' ' ' VAL . 2.8 pp -71.58 -35.39 70.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.713 ' HB ' ' OE2' ' A' ' 45' ' ' GLU . 29.4 mm -66.1 -48.38 81.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.173 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.618 ' HD3' ' H ' ' A' ' 115' ' ' GLU . 38.9 ttpt -56.31 -51.07 69.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.683 0.278 . . . . 0.0 110.953 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 85.9 tt0 -55.96 -48.02 76.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.876 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 63.7 m -63.15 -48.31 78.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.512 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.677 ' HB1' ' NZ ' ' A' ' 108' ' ' LYS . . . -60.15 -46.44 89.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.94 88.48 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.132 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -72.77 -20.8 61.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.771 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 33.0 m-85 -81.83 -46.77 13.7 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.677 ' NZ ' ' HB1' ' A' ' 104' ' ' ALA . 1.0 OUTLIER -87.09 -151.65 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.311 170.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 m -86.55 -153.82 0.21 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.7 51.43 0.11 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.471 0.309 . . . . 0.0 111.771 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.476 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 56.7 mm-40 -70.58 122.81 87.72 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.152 0.501 . . . . 0.0 112.021 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.67 65.35 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.337 2.692 . . . . 0.0 113.271 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' HB3' ' CG ' ' A' ' 45' ' ' GLU . 31.4 m-20 -61.49 -109.21 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.482 -178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.932 ' HB1' ' HB2' ' A' ' 97' ' ' GLN . . . -50.69 -45.18 58.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -170.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.618 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 41.9 tt0 . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.161 -0.923 . . . . 0.0 109.131 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 119.904 -0.093 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 m 50.44 47.79 23.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.033 0.444 . . . . 0.0 111.504 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.6 t -68.41 139.32 55.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.567 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.504 HG21 ' OE1' ' A' ' 61' ' ' GLU . 60.1 m -155.3 -50.69 0.09 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.091 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.673 ' CG2' HE21 ' A' ' 9' ' ' GLN . 63.7 mt -62.12 -37.89 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -54.73 -44.12 73.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.636 0.255 . . . . 0.0 110.787 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.4 -45.11 73.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.667 HG21 HD13 ' A' ' 62' ' ' LEU . 69.0 mt -59.53 -45.06 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.673 HE21 ' CG2' ' A' ' 5' ' ' ILE . 69.9 mt-30 -64.3 -38.36 90.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.474 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 13.3 mmp_? -62.61 -37.01 84.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 109.868 172.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.69 -46.0 70.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.6 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.805 HG22 ' HA2' ' A' ' 78' ' ' GLY . 35.7 mt -65.72 -44.43 93.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.094 0.473 . . . . 0.0 110.53 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.01 95.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.089 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 23.5 pt-20 -66.55 -32.75 74.29 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.33 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.471 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -77.16 127.24 83.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.595 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' O ' HD13 ' A' ' 17' ' ' ILE . 52.1 Cg_exo -59.68 -43.44 38.57 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.752 2.301 . . . . 0.0 112.576 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 16' ' ' PRO . 31.6 mm -140.27 124.2 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.701 HD23 HG23 ' A' ' 12' ' ' ILE . 20.0 tp -134.32 142.15 47.16 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.625 -169.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.5 tp -135.15 116.95 15.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.64 ' CE2' HD11 ' A' ' 62' ' ' LEU . 10.8 m-85 -96.83 117.94 32.18 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.795 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.566 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -147.12 -158.15 0.88 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.737 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 64.9 tttm -98.85 107.95 20.51 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 121.648 -0.657 . . . . 0.0 109.756 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.65 126.19 8.68 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.062 -1.065 . . . . 0.0 111.79 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.441 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 37.2 t -146.4 145.16 22.81 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -41.13 79.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.204 1.936 . . . . 0.0 111.18 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.4 pttt -65.72 -32.36 73.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.667 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.467 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -160.49 119.98 1.59 Allowed Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HD2' HD13 ' A' ' 27' ' ' LEU . 44.0 Cg_endo -73.34 20.69 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.382 0 C-N-CA 122.41 2.073 . . . . 0.0 114.121 -178.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 22.1 p -169.51 52.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 52.9 t -55.8 -37.7 68.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -168.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -68.83 -135.65 0.07 OUTLIER Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.924 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -74.18 -32.61 63.15 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 122.204 -0.586 . . . . 0.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.7 p -46.54 -22.09 0.24 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.271 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.96 32.14 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.231 0.332 . . . . 0.0 111.867 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.461 HE21 ' HB2' ' A' ' 36' ' ' ALA . 1.3 pm0 -80.69 -35.5 33.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.266 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB2' HE21 ' A' ' 35' ' ' GLN . . . -68.97 -44.3 73.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.539 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.0 p -53.4 -38.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.484 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.559 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.2 mm100 -63.74 -46.82 83.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.077 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.15 -42.04 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.839 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.459 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -61.95 -56.23 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.511 . . . . 0.0 109.895 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.31 71.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.294 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.39 -47.43 56.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.805 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 1.6 m -72.23 -57.98 3.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -103.87 -148.62 19.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.314 -0.946 . . . . 0.0 114.421 -175.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.8 mm-40 -105.98 -154.4 0.52 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 37.1 mmt-85 -62.2 152.7 32.53 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.558 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 24.4 p90 -151.87 156.14 39.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.142 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.51 149.67 22.49 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.2 p90 -136.63 151.74 49.65 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG23 HD11 ' A' ' 18' ' ' LEU . 54.0 t -130.98 129.5 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.745 0.307 . . . . 0.0 110.377 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 2.7 p30 -75.01 134.19 41.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.503 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.677 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -149.28 -34.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.677 HD22 HD12 ' A' ' 52' ' ' ILE . 1.6 mm? -67.87 -7.57 29.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.583 169.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.425 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.59 -38.42 10.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.861 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.2 m-20 -79.39 128.03 76.71 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-O 120.642 0.258 . . . . 0.0 111.009 174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.86 -45.0 6.86 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.333 2.022 . . . . 0.0 112.928 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -84.52 -49.73 8.35 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.529 HG22 HG22 ' A' ' 52' ' ' ILE . 40.9 mt -58.39 -33.32 47.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.35 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.697 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -50.53 -38.7 46.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.976 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.654 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -91.42 -35.34 14.42 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.674 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 51.7 mt-10 -76.18 -61.62 1.88 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -162.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.0 pt? -70.71 -32.49 2.57 Favored Pre-proline 0 N--CA 1.468 0.433 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.697 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 18.9 Cg_endo -56.09 -40.04 87.43 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 120.925 1.366 . . . . 0.0 110.85 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.674 ' NZ ' ' HA ' ' A' ' 61' ' ' GLU . 31.6 mtmm -56.25 -38.34 70.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.519 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -66.48 -43.12 86.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.136 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.93 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.4 -57.1 4.1 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.104 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.679 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.2 t30 -175.87 -53.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 122.167 0.984 . . . . 0.0 109.47 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.679 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -54.9 149.24 24.1 Favored Pre-proline 0 C--O 1.217 -0.623 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.388 -176.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -62.77 -37.75 53.8 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.242 1.961 . . . . 0.0 110.191 171.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.9 p -142.01 -130.43 0.1 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.635 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.922 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 17.1 m-85 -137.67 -166.15 0.11 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.922 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.1 Cg_endo -65.87 153.28 80.0 Favored 'Cis proline' 0 C--N 1.362 1.274 0 CA-C-N 121.586 1.602 . . . . 0.0 113.744 -1.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.608 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.1 mt-30 -141.74 133.11 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.53 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -93.96 138.4 32.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 59.6 m95 -126.77 130.19 49.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.799 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' CG2' HD13 ' A' ' 100' ' ' ILE . 2.4 p -125.63 123.79 65.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.5 t70 61.28 28.25 17.81 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.468 1.604 . . . . 0.0 108.091 -171.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.805 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 68.2 25.67 74.46 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 113.029 -1.896 . . . . 0.0 112.95 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 37.0 mm-40 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.805 0.442 . . . . 0.0 110.559 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.93 HD22 ' HB1' ' A' ' 66' ' ' ALA . 44.6 tp -71.93 125.13 26.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.764 0.316 . . . . 0.0 111.567 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.578 HG12 ' CG2' ' A' ' 86' ' ' ILE . 71.8 t -106.27 -53.04 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.934 172.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.564 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 141.46 134.45 3.02 Favored Glycine 0 C--O 1.221 -0.693 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.462 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -85.23 -62.63 1.64 Allowed Glycine 0 C--O 1.22 -0.742 0 C-N-CA 119.498 -1.334 . . . . 0.0 116.292 -168.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.4 p -77.24 -68.25 0.63 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.683 -0.892 . . . . 0.0 112.903 -170.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.4 -44.59 28.69 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 111.289 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.578 ' CG2' HG12 ' A' ' 81' ' ' VAL . 45.0 mm -59.33 -44.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.258 -172.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 82' ' ' GLY . 69.1 t -58.02 -49.51 81.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.9 mm -60.58 -48.56 88.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.497 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.823 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -62.24 -52.88 61.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.593 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.579 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 25.4 mmt -57.35 -36.52 71.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.581 0.229 . . . . 0.0 111.35 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.794 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 19.6 t80 -56.23 -51.27 68.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.995 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -65.59 -44.85 85.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.691 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 2.1 mmp_? -60.64 -33.94 73.53 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.978 0.418 . . . . 0.0 111.281 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.641 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 98.6 -25.24 28.74 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.72 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.2 mt-10 -56.0 -32.33 63.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 61.7 tp -57.41 -55.71 31.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.181 0.515 . . . . 0.0 110.703 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.805 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.3 pt20 -65.61 -26.22 67.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.627 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.8 mm100 -63.83 -46.42 85.12 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.0 mt -67.76 -46.49 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.149 177.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 96' ' ' LEU . 32.8 mm -63.7 -42.47 96.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.847 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.632 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 28.2 ttpt -54.72 -56.09 22.96 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.505 0.669 . . . . 0.0 110.863 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 15.6 tp10 -58.75 -45.95 88.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.567 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 88.5 m -69.85 -49.07 56.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.26 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.36 92.45 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.267 -0.271 . . . . 0.0 110.314 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.48 93.68 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.598 0.561 . . . . 0.0 111.798 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HG3' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -71.57 -18.57 62.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.475 ' HE2' HG23 ' A' ' 103' ' ' THR . 57.1 m-85 -92.08 -47.52 7.21 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.261 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 46.2 mtmt -101.03 -147.18 0.35 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.952 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -64.92 155.53 34.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.884 164.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.49 55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -174.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -65.08 121.26 73.21 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.23 60.21 1.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.697 2.932 . . . . 0.0 113.434 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.425 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.2 m-20 -44.55 -51.68 8.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 0.0 112.01 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.632 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -105.95 -120.87 0.23 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.059 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.117 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.3 m 58.06 43.59 20.69 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.422 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t 178.92 -41.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.186 0.517 . . . . 0.0 109.899 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 8' ' ' ILE . 35.6 p -63.37 -52.1 63.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.039 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.692 ' CG2' HE21 ' A' ' 9' ' ' GLN . 52.9 mt -59.22 -36.4 63.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.513 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 65.0 mm-40 -57.02 -47.0 81.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -67.16 -43.89 81.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.805 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.664 HG21 HD13 ' A' ' 62' ' ' LEU . 69.7 mt -59.6 -48.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.692 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.1 mt-30 -61.55 -39.74 92.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.396 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.775 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 3.7 mmp_? -59.49 -40.4 86.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -71.92 -43.13 65.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.717 HG22 ' HA2' ' A' ' 78' ' ' GLY . 39.8 mt -60.08 -42.09 88.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.208 0.528 . . . . 0.0 109.577 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -36.68 78.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.718 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.775 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 83.0 mt-10 -58.68 -46.46 87.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.977 0.418 . . . . 0.0 110.598 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 74.0 m-80 -79.31 124.27 84.28 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.254 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.492 ' O ' HD13 ' A' ' 17' ' ' ILE . 32.1 Cg_exo -62.9 -43.45 19.92 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 C-N-CA 122.355 2.037 . . . . 0.0 111.77 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 16' ' ' PRO . 23.0 mm -128.9 120.89 53.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.645 HD23 HG23 ' A' ' 12' ' ' ILE . 20.8 tp -133.54 140.56 47.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.452 -169.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD21 HG12 ' A' ' 37' ' ' VAL . 11.6 tp -134.69 116.93 15.48 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.351 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.635 ' HB3' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -97.93 115.94 29.15 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.011 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HE3' ' HB2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -148.72 -154.36 0.55 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.943 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 2.2 tmtp? -98.04 97.1 8.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -170.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.675 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.23 71.73 1.39 Allowed Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.499 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.509 ' HB2' ' HE2' ' A' ' 22' ' ' LYS . 38.5 t -78.59 145.14 66.64 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.95 -40.07 87.5 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.058 1.838 . . . . 0.0 111.475 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -70.01 -30.74 68.12 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.605 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 28' ' ' PRO . 54.2 tp -157.88 118.38 1.94 Allowed Pre-proline 0 C--O 1.235 0.292 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' A' ' 27' ' ' LEU . 36.4 Cg_endo -70.73 22.28 0.2 Allowed 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.509 2.139 . . . . 0.0 113.647 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -164.95 48.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 110.883 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.943 ' HB3' ' HD2' ' A' ' 22' ' ' LYS . 42.6 t -70.42 58.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.442 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.25 -139.4 2.63 Favored Glycine 0 C--N 1.314 -0.683 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -78.05 -45.73 22.79 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 117.63 0.715 . . . . 0.0 111.582 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' HG13 ' A' ' 37' ' ' VAL . 35.5 t -52.21 -10.26 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -49.52 -41.87 42.25 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 119.265 -0.397 . . . . 0.0 110.401 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.586 HE21 ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -81.29 -30.48 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 172.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.586 ' N ' HE21 ' A' ' 35' ' ' GLN . . . -67.27 -42.69 83.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 33' ' ' SER . 26.9 m -54.67 -41.59 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.96 ' H ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -56.92 -47.9 79.53 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 122.443 0.297 . . . . 0.0 110.29 178.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.675 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.3 -45.4 88.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.859 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.48 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -64.55 -55.09 22.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -177.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.32 74.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.959 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.51 -45.5 68.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.649 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 27.2 p -76.81 -56.11 4.89 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -173.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -100.16 -144.85 16.66 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.066 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.686 ' OE2' ' HB1' ' A' ' 104' ' ' ALA . 13.1 pt-20 -100.29 -153.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 155.39 40.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.627 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' CD2' HD13 ' A' ' 40' ' ' LEU . 17.6 p90 -145.01 158.41 43.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 -169.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 152.05 19.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.466 ' HB2' ' HE3' ' A' ' 21' ' ' MET . 1.5 p90 -138.67 154.41 48.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG23 HD11 ' A' ' 18' ' ' LEU . 48.4 t -131.45 129.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.675 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.2 p30 -78.97 133.33 36.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 110.523 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.721 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -147.47 -35.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 -173.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.721 ' H ' HD12 ' A' ' 52' ' ' ILE . 1.4 mm? -66.21 -9.6 33.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.304 169.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 -42.94 8.02 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.674 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.4 m-20 -78.84 123.26 85.27 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.322 -0.237 . . . . 0.0 110.707 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.81 -45.06 9.05 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.099 1.866 . . . . 0.0 112.802 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.17 -52.95 12.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.436 HG22 HG22 ' A' ' 52' ' ' ILE . 37.6 mt -61.77 -36.97 76.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.522 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 54.6 ttp85 -51.24 -35.19 35.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.46 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . -85.0 -47.12 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -170.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -78.87 -59.52 2.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -161.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.665 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 2.2 pt? -67.48 -33.37 5.43 Favored Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -173.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 12.3 Cg_endo -55.1 -41.15 81.48 Favored 'Trans proline' 0 C--N 1.352 0.714 0 CA-C-N 121.167 1.452 . . . . 0.0 111.125 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 60' ' ' ALA . 10.1 mtmp? -58.58 -34.01 70.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.682 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -66.6 -44.17 82.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.935 176.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.799 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.66 -57.33 3.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.592 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.726 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.1 t-20 -175.67 -56.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.158 0.98 . . . . 0.0 109.636 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.728 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.58 151.27 31.0 Favored Pre-proline 0 C--O 1.22 -0.458 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.257 -176.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -64.13 -36.96 44.62 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.312 2.008 . . . . 0.0 110.024 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.3 p -142.1 -125.09 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.765 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.942 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 22.0 m-85 -141.53 -164.8 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.942 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.4 Cg_endo -66.44 153.46 82.21 Favored 'Cis proline' 0 C--N 1.363 1.337 0 CA-C-N 121.849 1.696 . . . . 0.0 113.699 -1.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 20.2 mt-30 -142.5 132.04 23.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.495 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.48 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -94.81 135.11 36.7 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 62.2 m95 -119.02 128.87 54.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.43 0.634 . . . . 0.0 110.789 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 99' ' ' LEU . 92.5 t -115.53 120.49 64.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.222 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' H ' HG21 ' A' ' 103' ' ' THR . 32.4 t70 57.73 28.55 16.02 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.034 1.397 . . . . 0.0 109.889 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.717 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 76.01 28.29 60.81 Favored Glycine 0 C--N 1.312 -0.781 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.047 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.4 135.09 46.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.498 . . . . 0.0 111.305 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.799 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.9 tp -69.22 131.13 44.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.377 -174.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.537 HG12 ' CG2' ' A' ' 86' ' ' ILE . 96.8 t -110.57 -51.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.028 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.495 ' HA3' HG13 ' A' ' 86' ' ' ILE . . . 144.64 133.6 2.67 Favored Glycine 0 C--O 1.222 -0.615 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.447 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.56 -62.44 1.71 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.492 -1.337 . . . . 0.0 116.064 -168.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.413 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 20.5 p -78.99 -67.55 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.689 -0.889 . . . . 0.0 112.955 -170.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -78.59 -43.8 25.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.66 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.537 ' CG2' HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.86 -44.51 94.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.772 -173.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 39' ' ' ALA . 96.0 t -57.69 -48.91 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.675 HD13 ' HB2' ' A' ' 39' ' ' ALA . 35.6 mm -60.11 -51.59 71.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.758 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 84.2 tt0 -59.37 -54.74 43.23 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.38 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.828 ' HB2' HD23 ' A' ' 96' ' ' LEU . 26.4 mmt -58.15 -37.95 75.64 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.534 0.207 . . . . 0.0 110.743 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.504 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.0 t80 -57.16 -49.81 74.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.391 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.652 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 78.5 mt-30 -64.79 -38.56 91.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.113 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 1.2 mmm180 -62.34 -32.0 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.767 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 21.24 58.45 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.555 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.731 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.9 mm-40 -90.39 -32.41 16.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.404 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -60.47 -53.43 57.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.54 -172.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.768 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 4.0 pm0 -62.57 -28.88 70.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.58 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.415 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.0 mm100 -66.12 -45.98 79.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 33.4 mt -67.4 -45.14 77.05 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.03 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 96' ' ' LEU . 51.0 mm -64.97 -42.5 94.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.465 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.766 ' HE3' ' HB3' ' A' ' 114' ' ' ALA . 31.9 ttmt -52.0 -56.66 12.91 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.453 0.644 . . . . 0.0 111.225 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.58 -43.99 89.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.255 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.598 ' O ' ' HD2' ' A' ' 107' ' ' TYR . 73.1 m -72.41 -44.05 63.01 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.783 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB1' ' OE2' ' A' ' 45' ' ' GLU . . . -65.98 -44.11 85.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.481 -0.762 . . . . 0.0 110.167 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.11 95.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.808 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 107' ' ' TYR . 17.1 ptpt -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.014 -0.429 . . . . 0.0 110.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.598 ' HD2' ' O ' ' A' ' 103' ' ' THR . 81.1 m-85 -77.99 -45.73 23.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -97.55 -150.33 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.733 177.485 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 111' ' ' GLU . 11.1 p -67.93 169.66 9.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 166.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.72 60.39 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 65.8 mm-40 -58.44 126.36 78.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.778 0.799 . . . . 0.0 111.73 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 73.9 Cg_endo -94.15 56.75 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 123.416 2.744 . . . . 0.0 113.039 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.685 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 1.5 m-20 -50.56 -56.6 10.97 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.05 -169.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.766 ' HB3' ' HE3' ' A' ' 101' ' ' LYS . . . -88.86 -40.53 13.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.993 0.425 . . . . 0.0 110.97 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.501 ' H ' ' HE2' ' A' ' 101' ' ' LYS . 66.3 mm-40 . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.206 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttp . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 3' ' ' THR . 55.0 p -84.11 132.23 34.72 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 170.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 2' ' ' SER . 89.8 m 72.72 131.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 109.927 -171.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.917 HG22 ' H ' ' A' ' 5' ' ' ILE . 10.2 m -156.78 -148.62 0.22 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.917 ' H ' HG22 ' A' ' 4' ' ' THR . 95.1 mt -53.44 -40.54 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 123.11 0.564 . . . . 0.0 112.466 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.73 -49.33 68.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.7 mptt -72.54 -39.62 67.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.034 175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.864 HG21 ' HG ' ' A' ' 62' ' ' LEU . 71.8 mt -58.21 -47.65 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.011 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.673 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.9 mt-30 -61.03 -32.79 72.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.483 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 17.2 mmt180 -60.06 -37.54 80.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.419 . . . . 0.0 110.51 173.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 45.4 tt0 -72.97 -45.46 57.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.378 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.661 ' HA ' ' CD2' ' A' ' 18' ' ' LEU . 21.8 mt -63.78 -42.8 97.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.228 0.537 . . . . 0.0 110.111 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.28 98.3 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.788 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 25.4 pt-20 -65.07 -38.56 91.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.264 -175.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -78.74 127.15 81.1 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HB3' ' CG ' ' A' ' 107' ' ' TYR . 31.8 Cg_endo -64.25 -41.24 22.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.011 2.474 . . . . 0.0 112.384 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 16' ' ' PRO . 34.2 mm -132.87 123.59 48.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.684 HD11 HG23 ' A' ' 50' ' ' VAL . 33.2 tp -133.8 143.45 48.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.436 -170.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.43 118.5 15.39 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.345 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.604 ' HE1' HD21 ' A' ' 18' ' ' LEU . 7.6 m-85 -96.46 119.13 34.38 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.273 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.598 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 22.8 ptt? -146.5 -168.08 2.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.896 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.074 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 40.1 ttmt -96.75 138.15 34.75 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 28' ' ' PRO . . . -140.49 135.15 6.86 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 118.287 -1.911 . . . . 0.0 112.975 174.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 t -121.29 150.61 54.47 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.626 -1.287 . . . . 0.0 108.466 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.03 -38.14 58.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.023 1.815 . . . . 0.0 111.664 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -70.49 -35.09 73.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.773 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.0 tp -159.43 114.62 1.55 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.426 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 52.2 Cg_endo -73.38 32.51 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.081 2.521 . . . . 0.0 113.891 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 11.3 p -165.47 47.3 0.09 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.01 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.608 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 49.1 t -74.39 53.07 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.885 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.31 -141.22 3.14 Favored Glycine 0 C--N 1.315 -0.586 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -76.4 -36.04 58.29 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.299 0.571 . . . . 0.0 109.847 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.598 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 48.7 p -52.35 -22.87 5.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.748 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.75 -44.43 28.14 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.473 0.483 . . . . 0.0 111.656 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.617 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -80.92 -35.34 32.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.582 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 11.6 p -54.47 -37.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.586 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.1 mm100 -65.76 -45.4 82.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.77 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -57.69 -44.73 86.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.509 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.24 -57.13 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.481 . . . . 0.0 110.362 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.49 71.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.123 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.21 -49.53 42.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.629 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.7 p -76.4 -49.97 15.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.344 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.47 -131.47 7.39 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.064 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 4.6 mm-40 -140.39 -152.56 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.149 0.579 . . . . 0.0 111.04 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.489 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 42.2 mmm-85 -55.68 148.02 17.18 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.832 0.825 . . . . 0.0 112.387 -173.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 21.9 p90 -156.65 155.36 31.65 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.292 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.01 159.25 15.09 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.687 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.4 p90 -143.7 154.32 43.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.684 HG23 HD11 ' A' ' 18' ' ' LEU . 47.1 t -133.43 127.81 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' MET . 12.1 p-10 -81.25 131.5 35.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.573 . . . . 0.0 110.585 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.626 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -146.69 -32.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.287 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.074 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -67.32 -8.49 32.77 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.545 171.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -97.42 -48.55 5.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.33 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.3 m-20 -79.66 116.03 57.89 Favored Pre-proline 0 N--CA 1.472 0.647 0 O-C-N 122.118 -0.364 . . . . 0.0 110.784 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 24.7 Cg_exo -64.14 -44.34 12.63 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.981 2.454 . . . . 0.0 113.402 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -66.42 -54.64 21.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -62.28 -34.76 65.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 29.2 ttm180 -53.16 -40.91 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.031 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.466 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -79.61 -38.6 33.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -167.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.533 ' CD ' HG23 ' A' ' 4' ' ' THR . 47.9 mt-10 -77.88 -59.21 2.87 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -161.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.864 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.17 -26.94 0.57 Allowed Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -170.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.744 ' HD3' HD13 ' A' ' 62' ' ' LEU . 18.4 Cg_endo -57.08 -41.61 72.76 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.603 1.608 . . . . 0.0 111.521 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 53.6 mtmt -59.58 -34.24 72.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.701 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.504 ' CD2' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -66.15 -42.2 89.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.807 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.95 -56.86 4.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.446 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.699 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 22.6 t-20 -175.71 -55.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 122.159 0.981 . . . . 0.0 109.613 170.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.699 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 0.8 OUTLIER -56.82 150.37 38.04 Favored Pre-proline 0 C--O 1.222 -0.384 0 CA-C-N 113.178 -1.828 . . . . 0.0 113.645 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -63.79 -38.83 37.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.419 2.079 . . . . 0.0 110.283 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.9 p -141.4 -125.97 0.1 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.388 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.863 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 14.4 m-85 -141.13 -166.1 0.11 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.863 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 39.1 Cg_endo -65.65 156.7 78.42 Favored 'Cis proline' 0 C--N 1.362 1.244 0 CA-C-N 121.597 1.606 . . . . 0.0 113.836 -2.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.667 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 70.9 mt-30 -146.52 131.39 18.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.805 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 18' ' ' LEU . 61.1 tp -91.32 137.84 32.05 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.625 174.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 58.2 m95 -121.9 125.21 45.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.284 0.564 . . . . 0.0 109.921 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.4 t -110.04 119.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.197 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.57 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.2 t70 58.24 28.85 17.17 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 123.403 1.573 . . . . 0.0 108.589 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.62 29.8 59.07 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.726 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 48.9 mt-10 -126.97 131.0 51.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.661 0.267 . . . . 0.0 110.359 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.807 HD22 ' HB1' ' A' ' 66' ' ' ALA . 47.6 tp -67.66 130.9 44.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -173.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.622 HG12 ' CG2' ' A' ' 86' ' ' ILE . 94.4 t -112.29 -52.52 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.123 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 145.85 136.0 2.88 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.518 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -86.88 -64.09 1.43 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 119.377 -1.392 . . . . 0.0 116.471 -169.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.0 p -80.13 -66.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.692 -0.887 . . . . 0.0 112.831 -171.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -74.03 -46.36 43.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.026 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.622 ' CG2' HG12 ' A' ' 81' ' ' VAL . 2.0 mp -60.98 -46.79 95.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.21 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 82' ' ' GLY . 70.9 t -55.76 -49.4 74.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.258 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 35' ' ' GLN . 36.9 mm -62.12 -50.71 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.947 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.737 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.6 tt0 -62.46 -51.93 65.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.679 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.62 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -58.95 -33.63 70.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.308 0.243 . . . . 0.0 111.543 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.688 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.2 t80 -59.06 -52.48 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.129 172.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.0 mt-30 -62.88 -42.88 99.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.418 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.737 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 38.5 mmm-85 -62.58 -34.55 77.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.248 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 102.58 -23.79 32.91 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.945 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.783 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 51.3 mt-10 -56.11 -33.27 64.95 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.693 HD22 ' SG ' ' A' ' 43' ' ' CYS . 5.6 tt -69.77 -50.04 47.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.184 0.516 . . . . 0.0 109.669 -174.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.2 pt20 -61.55 -25.22 67.16 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.058 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.5 mm100 -69.79 -48.08 60.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.53 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 54.1 mt -63.9 -46.11 86.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.201 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.539 HG22 ' OD2' ' A' ' 113' ' ' ASP . 50.5 mm -64.43 -44.48 97.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.818 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' CE ' ' HB3' ' A' ' 114' ' ' ALA . 37.4 ttmt -48.74 -52.14 25.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.352 0.596 . . . . 0.0 111.144 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -62.24 -50.82 70.22 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.432 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.57 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 95.3 m -71.18 -48.94 48.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.489 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . . . -61.67 -46.37 90.0 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 122.141 -0.349 . . . . 0.0 110.55 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 110' ' ' GLU . . . -61.77 -32.85 73.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.911 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.603 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -80.44 -17.86 50.51 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.654 179.009 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.597 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 53.9 m-85 -90.5 -50.52 5.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.858 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.599 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 2.1 mppt? -103.06 121.23 42.15 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 165.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 p -46.26 113.19 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.561 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 53.5 mt-10 49.66 44.56 24.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 113.317 -1.765 . . . . 0.0 113.355 172.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.599 ' OE1' ' HB2' ' A' ' 108' ' ' LYS . 8.9 pt-20 -75.67 130.16 79.8 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.521 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 3.7 Cg_exo -79.56 121.62 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.743 2.295 . . . . 0.0 111.611 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.613 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 43.7 m-20 -109.13 -63.23 1.38 Allowed 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -78.11 -38.4 44.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.243 173.676 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' HG23 ' A' ' 3' ' ' THR . 49.2 tpp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.606 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 57.4 p -163.7 51.87 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.913 -172.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.447 HG23 ' SD ' ' A' ' 1' ' ' MET . 61.5 p -70.99 -136.35 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.538 HG22 HG13 ' A' ' 8' ' ' ILE . 26.9 m -60.38 -31.79 70.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.864 -175.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.73 ' CG2' HE21 ' A' ' 9' ' ' GLN . 59.9 mt -51.1 -38.78 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 2' ' ' SER . 3.7 mm-40 -59.92 -43.54 94.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 0.0 110.065 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -63.75 -45.22 90.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.038 172.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.721 HD13 HD22 ' A' ' 62' ' ' LEU . 74.4 mt -60.94 -43.86 96.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.659 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.73 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.8 mt-30 -63.24 -38.71 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.299 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -60.75 -37.01 80.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.32 0.581 . . . . 0.0 109.766 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 38.2 tt0 -68.09 -45.45 73.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.001 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.712 HG23 HD23 ' A' ' 18' ' ' LEU . 36.4 mt -70.43 -44.59 77.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 110.661 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.26 77.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.2 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.34 -34.04 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.829 -176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 76.9 m-20 -77.61 128.63 79.26 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-O 121.166 0.508 . . . . 0.0 111.112 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.553 ' O ' HD13 ' A' ' 17' ' ' ILE . 44.5 Cg_exo -61.78 -42.92 28.68 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 123.008 2.472 . . . . 0.0 112.679 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.2 mm -139.61 122.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.712 HD23 HG23 ' A' ' 12' ' ' ILE . 23.2 tp -134.15 141.34 47.06 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.505 -169.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' A' ' 21' ' ' MET . 12.1 tp -135.45 117.21 15.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.525 -176.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE2' HD11 ' A' ' 62' ' ' LEU . 8.7 m-85 -97.33 117.99 32.8 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.938 174.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.731 ' HE3' ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -148.09 -159.48 1.04 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.727 177.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.044 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 34.7 ttpt -99.65 117.75 34.68 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.374 -0.829 . . . . 0.0 110.562 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.599 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -95.84 70.6 0.95 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.512 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -78.21 140.68 61.41 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.45 -41.3 74.29 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.054 1.836 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -69.46 -30.35 68.23 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.041 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tt -156.57 105.91 2.0 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.44 ' O ' ' SD ' ' A' ' 21' ' ' MET . 15.0 Cg_exo -73.66 28.57 0.31 Allowed 'Trans proline' 0 C--O 1.223 -0.225 0 C-N-CA 122.642 2.228 . . . . 0.0 114.052 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -166.09 52.23 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.836 0.351 . . . . 0.0 111.484 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 22' ' ' LYS . 46.3 t -71.32 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 61.08 -139.29 47.8 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.203 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.48 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 37.9 m-85 -79.29 -20.88 46.92 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 21' ' ' MET . 30.6 p -70.2 -11.71 61.08 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -170.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.24 -43.89 22.32 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.352 0.407 . . . . 0.0 111.864 -175.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.645 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.02 -40.02 40.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.617 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.16 -44.96 90.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.154 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p -55.75 -38.8 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.559 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.578 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -67.24 -46.66 73.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.891 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.87 -42.31 93.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.862 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -62.09 -56.74 15.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.374 0.607 . . . . 0.0 109.704 -175.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.06 72.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.486 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.45 -46.34 64.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.82 ' SG ' ' HD1' ' A' ' 91' ' ' TYR . 1.4 m -71.91 -59.36 2.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.04 -145.01 13.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.371 -0.918 . . . . 0.0 114.499 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.849 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 32.2 mm-40 -120.37 -150.41 0.45 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.857 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 43.2 mmm-85 -55.54 144.98 24.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.058 0.933 . . . . 0.0 113.262 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 40' ' ' LEU . 26.3 p90 -150.83 152.56 33.93 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.386 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.7 152.71 19.35 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.479 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.9 p90 -137.36 150.58 47.81 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.561 HG23 HD11 ' A' ' 18' ' ' LEU . 46.5 t -129.56 126.56 63.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.599 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 1.4 p30 -76.23 129.55 36.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.88 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -145.59 -36.41 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.044 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -63.99 -11.58 30.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.423 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.51 -41.78 8.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.405 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -87.93 116.14 65.26 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 122.198 -0.313 . . . . 0.0 110.667 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.16 -43.83 13.94 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.167 1.912 . . . . 0.0 113.28 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.16 -50.67 67.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.029 0.443 . . . . 0.0 111.8 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.0 -40.67 81.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 78.9 ttt180 -52.1 -37.69 54.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.89 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.41 -49.16 44.63 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.2 -59.17 2.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -163.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 8' ' ' ILE . 2.1 pt? -66.1 -33.21 6.58 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -168.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.706 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 12.8 Cg_endo -55.16 -40.13 87.38 Favored 'Trans proline' 0 C--N 1.348 0.501 0 CA-C-N 121.182 1.458 . . . . 0.0 110.573 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -51.71 -41.02 61.16 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.759 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.536 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.68 -42.94 70.07 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.446 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.843 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.79 -59.92 2.54 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.703 -174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.741 ' HB2' ' HE3' ' A' ' 68' ' ' TRP . 8.4 m120 -168.61 -59.42 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.971 0.908 . . . . 0.0 109.172 168.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.741 ' HE3' ' HB2' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -53.46 149.84 13.83 Favored Pre-proline 0 C--O 1.217 -0.61 0 CA-C-N 113.118 -1.855 . . . . 0.0 113.697 -174.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.99 -37.36 43.83 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 121.873 1.716 . . . . 0.0 110.229 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 74.5 p -142.12 -123.41 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.279 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.958 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 27.6 m-85 -141.03 -168.04 0.17 Allowed Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.958 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.3 Cg_endo -67.8 153.41 87.0 Favored 'Cis proline' 0 C--N 1.362 1.261 0 CA-C-N 121.309 1.503 . . . . 0.0 114.286 -1.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.614 ' NE2' ' HB2' ' A' ' 68' ' ' TRP . 71.7 mt-30 -141.41 134.77 29.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.661 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -99.22 135.17 41.02 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -119.63 131.11 55.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.795 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.2 t -116.66 120.6 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t0 54.8 37.74 29.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 123.242 1.496 . . . . 0.0 108.595 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.634 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 67.19 29.09 73.97 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 113.746 -1.57 . . . . 0.0 113.957 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -132.5 134.85 45.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.382 0.611 . . . . 0.0 111.366 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.843 HD22 ' HB1' ' A' ' 66' ' ' ALA . 60.8 tp -67.36 130.35 42.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.818 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.51 HG12 ' CG2' ' A' ' 86' ' ' ILE . 99.3 t -106.03 -54.28 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.772 170.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.32 134.16 2.59 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.71 -63.98 1.58 Allowed Glycine 0 C--O 1.219 -0.829 0 C-N-CA 119.047 -1.549 . . . . 0.0 116.316 -167.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 32' ' ' PHE . 22.4 p -80.21 -67.45 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.429 1.115 . . . . 0.0 112.956 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.33 -45.29 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.316 -174.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.51 ' CG2' HG12 ' A' ' 81' ' ' VAL . 50.4 mm -57.8 -44.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.338 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 82' ' ' GLY . 79.4 t -58.02 -48.51 84.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.99 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.504 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 38.1 mm -59.78 -49.91 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.388 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.765 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 35.5 tt0 -60.79 -52.95 62.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.291 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.532 ' HG3' ' CA ' ' A' ' 96' ' ' LEU . 41.7 tpp -60.88 -34.81 75.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.82 ' HD1' ' SG ' ' A' ' 43' ' ' CYS . 16.8 t80 -58.81 -51.45 69.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.014 171.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.6 mt-30 -62.38 -39.29 92.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.991 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 45.6 mmm-85 -60.75 -30.72 70.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.73 175.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.02 -23.69 10.45 Favored Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.726 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 45.9 mt-10 -62.51 -21.32 65.42 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' MET . 62.5 tp -61.35 -54.86 38.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.343 0.592 . . . . 0.0 110.669 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.81 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 11.8 pt20 -64.03 -25.53 68.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.374 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 13.3 mm100 -64.2 -48.08 77.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.272 0.558 . . . . 0.0 109.599 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 38.5 mt -65.74 -45.88 80.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.155 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.8 mm -63.82 -44.35 98.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.144 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.557 ' HE3' ' HB3' ' A' ' 114' ' ' ALA . 28.7 ttmt -51.89 -57.69 8.66 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 111.2 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.5 -45.79 92.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.165 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 80.7 m -68.99 -46.85 67.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.455 ' HA ' ' HZ3' ' A' ' 108' ' ' LYS . . . -60.75 -45.93 92.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.37 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.09 82.01 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.754 0.659 . . . . 0.0 112.323 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.503 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -74.06 -33.39 63.66 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.747 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.503 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 80.1 m-85 -80.19 -51.55 8.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.641 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HZ3' ' HA ' ' A' ' 104' ' ' ALA . 1.1 mppt? -106.29 131.34 53.63 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m -51.82 125.44 15.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.471 0.653 . . . . 0.0 112.267 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 35.13 52.0 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.293 -1.776 . . . . 0.0 114.969 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 27.4 tt0 -77.37 120.49 81.73 Favored Pre-proline 0 N--CA 1.427 -1.592 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 6.1 Cg_exo -86.73 60.75 4.27 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.55 2.833 . . . . 0.0 114.563 -170.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.849 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 1.8 m-20 -50.95 -70.48 0.08 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -83.81 -48.44 10.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.263 0.554 . . . . 0.0 110.966 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.466 ' H ' ' HE2' ' A' ' 101' ' ' LYS . 34.4 tt0 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.161 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.9 mtp . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -66.41 -43.61 85.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.844 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 4' ' ' THR . 74.7 p 56.19 115.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.3 1.04 . . . . 0.0 112.401 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 3' ' ' THR . 11.8 p -163.0 144.15 9.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.955 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.682 ' CG2' HE21 ' A' ' 9' ' ' GLN . 41.2 mt -54.61 -34.05 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.22 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.62 -51.15 64.01 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 20.4 ptmt -67.53 -40.37 85.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.44 0.638 . . . . 0.0 109.599 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG21 ' HG ' ' A' ' 62' ' ' LEU . 73.9 mt -57.54 -49.09 81.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.941 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.682 HE21 ' CG2' ' A' ' 5' ' ' ILE . 68.3 mt-30 -61.71 -40.75 96.15 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.597 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -57.75 -37.07 72.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.296 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 -68.01 -47.19 69.13 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.122 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.794 HG22 ' HA2' ' A' ' 78' ' ' GLY . 22.2 mt -67.52 -39.15 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.789 0.804 . . . . 0.0 110.601 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.71 88.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.512 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 11.6 pt-20 -70.33 -38.49 74.88 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.554 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 1.6 p30 -77.17 135.44 66.38 Favored Pre-proline 0 CA--C 1.512 -0.514 0 CA-C-O 121.652 0.739 . . . . 0.0 111.877 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.609 ' O ' HD13 ' A' ' 17' ' ' ILE . 33.7 Cg_exo -62.75 -42.17 26.91 Favored 'Trans proline' 0 CA--C 1.508 -0.788 0 C-N-CA 122.801 2.334 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 16' ' ' PRO . 25.5 mm -139.38 120.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.726 HD11 HG23 ' A' ' 50' ' ' VAL . 27.7 tp -131.66 142.89 49.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.483 0.659 . . . . 0.0 111.855 -171.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 11.9 tp -136.94 123.85 21.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.442 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.601 ' HE1' ' CD2' ' A' ' 18' ' ' LEU . 7.2 m-85 -98.86 119.99 38.55 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.801 -0.562 . . . . 0.0 111.702 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 18.5 ptt? -146.23 -165.77 2.3 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 63.8 tttm -99.08 121.45 41.01 Favored 'General case' 0 C--O 1.208 -1.122 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -95.69 69.19 1.03 Allowed Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.332 -175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -79.94 148.54 68.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.818 -0.225 . . . . 0.0 111.233 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.85 -41.5 68.67 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.19 1.927 . . . . 0.0 111.121 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.615 ' HE3' ' SG ' ' A' ' 30' ' ' CYS . 60.8 pttt -66.7 -31.31 71.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.66 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 49.6 tp -160.43 122.84 1.82 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 2.8 Cg_exo -73.9 29.36 0.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.432 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 8.3 t -165.35 47.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.48 173.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.615 ' SG ' ' HE3' ' A' ' 26' ' ' LYS . 34.6 t -71.24 57.08 0.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.86 -136.4 2.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -76.71 -38.65 53.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 117.607 0.703 . . . . 0.0 110.992 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.876 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 33.1 t -55.13 -10.15 0.5 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -176.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.54 -40.74 60.26 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.194 0.198 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.424 ' O ' HD11 ' A' ' 88' ' ' ILE . 1.2 pm0 -80.49 -35.72 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.922 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 87' ' ' VAL . . . -64.24 -43.64 94.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.142 0.577 . . . . 0.0 112.518 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.23 -36.13 44.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.337 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.576 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.3 mm100 -66.12 -43.8 86.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.102 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.716 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -57.08 -45.21 83.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.456 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 74' ' ' LEU . 1.8 mt -61.84 -59.41 5.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.01 67.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.38 -49.13 28.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.402 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.841 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 28.1 p -75.55 -57.23 4.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.199 -171.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.25 -142.15 12.21 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.439 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 90.7 mt-10 -100.2 -151.46 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.943 0.878 . . . . 0.0 111.248 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.94 158.29 35.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.57 174.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CG ' HD13 ' A' ' 40' ' ' LEU . 13.5 p90 -151.82 160.83 43.42 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.688 -171.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.19 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.6 p90 -140.3 152.56 45.97 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 18' ' ' LEU . 51.5 t -129.37 132.19 66.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.804 0.335 . . . . 0.0 110.339 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' MET . 32.3 p-10 -76.64 129.32 36.22 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.543 0.687 . . . . 0.0 110.686 173.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.704 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -144.4 -36.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.903 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.84 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -65.6 -10.42 35.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.814 168.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -43.8 7.51 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.603 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -83.86 113.94 50.81 Favored Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 122.137 -0.352 . . . . 0.0 110.838 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.9 -45.54 28.12 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.966 2.444 . . . . 0.0 113.381 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.504 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.89 -38.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.138 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.665 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 58.3 ttt-85 -49.81 -35.78 24.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.425 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -86.77 -41.28 14.24 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -174.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -79.57 -60.94 2.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -162.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.766 HD13 ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -73.09 -27.66 0.88 Allowed Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -172.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.766 ' HD3' HD13 ' A' ' 62' ' ' LEU . 17.9 Cg_endo -57.2 -41.17 76.7 Favored 'Trans proline' 0 C--N 1.357 1.006 0 CA-C-N 121.368 1.524 . . . . 0.0 110.853 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 39.1 mtmt -54.86 -39.37 68.56 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.733 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.611 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -68.43 -41.52 80.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.871 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.797 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -74.91 -57.7 3.74 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.562 -176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.644 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 48.6 t30 -175.0 -53.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.947 0.88 . . . . 0.0 109.987 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.644 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -59.93 146.62 81.65 Favored Pre-proline 0 C--O 1.218 -0.6 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.208 -176.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.01 -35.99 84.81 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.127 1.885 . . . . 0.0 110.667 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.1 p -141.79 -128.58 0.1 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.568 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.963 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 30.5 m-85 -142.23 -173.75 0.38 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.963 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 47.6 Cg_endo -66.99 160.16 78.87 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 120.848 1.339 . . . . 0.0 114.36 -0.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.634 ' HA ' ' CA ' ' A' ' 83' ' ' GLY . 56.0 mt-30 -150.78 129.45 12.3 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.179 172.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.475 ' CD2' HD11 ' A' ' 40' ' ' LEU . 3.1 tm? -89.58 137.38 32.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.024 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 66' ' ' ALA . 58.6 m95 -121.64 131.34 54.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.206 0.526 . . . . 0.0 110.87 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 100' ' ' ILE . 67.2 t -116.6 119.52 62.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.608 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.9 t70 54.75 41.5 31.87 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 122.993 1.378 . . . . 0.0 108.933 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.794 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 62.76 28.28 71.41 Favored Glycine 0 C--N 1.31 -0.897 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.696 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -129.04 134.8 48.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 111.107 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD22 ' HB1' ' A' ' 66' ' ' ALA . 54.3 tp -66.64 136.96 56.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.618 -173.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' HG21 ' A' ' 86' ' ' ILE . 96.2 t -115.08 -56.26 4.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.813 170.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.763 ' HA3' ' HB ' ' A' ' 86' ' ' ILE . . . 155.73 133.74 1.73 Allowed Glycine 0 C--O 1.225 -0.431 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 72' ' ' PRO . . . -85.67 -61.37 1.7 Allowed Glycine 0 C--O 1.218 -0.886 0 C-N-CA 119.999 -1.096 . . . . 0.0 115.625 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.58 -67.9 0.73 Allowed 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.705 -0.88 . . . . 0.0 112.262 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -80.72 -51.32 8.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.9 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.763 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 50.1 mm -55.8 -53.5 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.459 -171.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 96' ' ' LEU . 10.4 p -59.8 -43.12 91.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.34 -173.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.716 HD13 ' HB2' ' A' ' 39' ' ' ALA . 34.8 mm -59.14 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.489 175.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.726 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.9 tt0 -62.54 -48.94 77.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.483 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.404 ' C ' ' HB2' ' A' ' 96' ' ' LEU . 25.6 mmt -54.62 -39.79 68.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.922 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.573 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.8 t80 -59.01 -52.68 64.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 174.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.1 -38.66 91.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.742 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 23.1 mmm180 -61.64 -32.07 72.2 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.402 0.62 . . . . 0.0 109.824 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 83.61 21.43 58.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.611 -174.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.635 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 62.8 mm-40 -90.34 -31.36 16.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 110.737 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.598 HD11 HG22 ' A' ' 87' ' ' VAL . 1.4 tt -57.77 -54.75 43.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.204 -175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.841 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 14.1 pt20 -62.18 -27.43 68.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.394 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 9.4 mm-40 -68.83 -44.26 73.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.295 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 40.6 mt -65.84 -48.08 72.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.686 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 17' ' ' ILE . 42.5 mm -60.86 -48.28 89.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.102 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.694 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 39.7 ttpt -58.17 -47.26 83.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.643 0.259 . . . . 0.0 111.676 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -59.49 -48.32 82.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.018 0.437 . . . . 0.0 110.046 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.608 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 60.2 m -69.74 -46.25 66.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.372 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.844 ' HB1' ' HE2' ' A' ' 108' ' ' LYS . . . -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.56 86.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.8 -26.57 64.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.877 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.537 ' CE2' ' HD2' ' A' ' 106' ' ' LYS . 92.3 m-85 -91.48 -48.9 6.61 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.531 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.844 ' HE2' ' HB1' ' A' ' 104' ' ' ALA . 39.4 mtmt -91.72 110.22 21.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -61.64 125.76 24.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.098 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' C ' ' HD3' ' A' ' 112' ' ' PRO . 48.2 mt-10 55.87 45.28 24.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.371 175.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 5.5 mm-40 -121.87 67.13 22.36 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.214 176.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 110' ' ' GLU . 26.9 Cg_exo -64.08 115.98 3.44 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.797 1.665 . . . . 0.0 112.431 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -77.21 -59.19 2.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.694 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -68.7 -58.04 4.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.058 0.456 . . . . 0.0 111.797 -172.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.518 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 9.7 tm-20 . . . . . 0 C--O 1.248 0.98 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.49 0.186 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 t 59.83 -129.62 1.05 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.201 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.557 HG21 HG12 ' A' ' 58' ' ' ILE . 26.8 m -148.03 53.62 1.03 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.999 0.905 . . . . 0.0 108.765 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.7 p -66.63 149.45 50.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.41 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.703 ' CG2' HE21 ' A' ' 9' ' ' GLN . 57.7 mt -52.24 -35.8 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.832 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 97.3 mt-10 -56.55 -46.01 80.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.817 0.342 . . . . 0.0 110.43 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.55 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 3.7 mmmp? -65.21 -44.09 89.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 172.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.824 HD13 ' HB3' ' A' ' 62' ' ' LEU . 91.1 mt -60.31 -46.96 94.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.599 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.703 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.6 mt-30 -62.55 -43.6 98.41 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.803 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -59.09 -33.9 71.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.591 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.4 tt0 -72.35 -44.77 62.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.077 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.785 HG22 ' HA2' ' A' ' 78' ' ' GLY . 38.1 mt -67.31 -43.11 88.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.173 0.511 . . . . 0.0 110.184 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.41 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.211 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -66.8 -32.71 74.17 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.613 -175.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -78.43 127.04 82.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.84 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' O ' HD13 ' A' ' 17' ' ' ILE . 69.3 Cg_exo -58.47 -42.61 53.36 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 122.992 2.462 . . . . 0.0 111.973 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 16' ' ' PRO . 24.3 mm -138.28 123.23 22.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.72 HD23 HG23 ' A' ' 12' ' ' ILE . 21.2 tp -133.92 141.24 47.25 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -171.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.5 tp -138.98 118.87 13.24 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.749 -173.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.637 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 m-85 -97.69 124.75 42.14 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.332 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.782 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 13.3 ptp -145.03 -168.21 2.88 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.241 -177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.89 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 64.2 tttm -97.68 111.87 23.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.57 127.78 9.31 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 119.619 -1.276 . . . . 0.0 112.628 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.7 m -142.73 141.54 20.49 Favored Pre-proline 0 N--CA 1.442 -0.844 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -52.98 -41.16 73.42 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.331 2.021 . . . . 0.0 111.981 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.14 -27.24 62.48 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.164 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.471 HD22 ' H ' ' A' ' 29' ' ' SER . 1.4 tt -158.71 113.22 1.65 Allowed Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' O ' ' SD ' ' A' ' 21' ' ' MET . 39.3 Cg_endo -71.63 15.86 0.35 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.566 2.178 . . . . 0.0 114.156 -176.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.782 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 21.8 p -161.69 51.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 39.0 t -68.71 51.58 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.465 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -161.0 -137.02 2.11 Favored Glycine 0 C--N 1.316 -0.564 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.176 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.27 -39.79 53.46 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 117.11 0.455 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.823 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 19.2 t -57.64 -11.21 1.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.455 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 37' ' ' VAL . . . -53.31 -43.67 67.76 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.35 0.406 . . . . 0.0 111.521 176.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HG2' HD11 ' A' ' 88' ' ' ILE . 1.2 pm0 -80.25 -31.94 38.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.746 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.58 85.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.216 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 34' ' ' ALA . 9.5 p -54.46 -37.09 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.219 0.533 . . . . 0.0 110.447 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.577 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -64.56 -46.3 83.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.62 -44.08 89.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.577 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.487 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -62.73 -55.83 23.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.437 . . . . 0.0 110.376 -175.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 47' ' ' PHE . . . -59.35 -32.88 70.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.182 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.97 -48.6 43.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.509 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.7 p -75.69 -50.54 15.07 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.43 -130.51 7.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.092 -0.575 . . . . 0.0 114.419 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.657 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 2.4 pp20? -128.89 -152.74 0.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.457 -0.872 . . . . 0.0 109.65 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 -64.17 152.96 39.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.608 0.718 . . . . 0.0 111.421 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.487 ' CG ' HD13 ' A' ' 40' ' ' LEU . 20.8 p90 -158.78 150.01 20.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.866 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.05 144.24 28.42 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.193 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.2 p90 -124.87 154.61 40.79 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.436 HG23 HD11 ' A' ' 18' ' ' LEU . 48.4 t -130.66 130.14 64.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' MET . 11.3 p-10 -74.94 132.29 41.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.228 175.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.695 HD12 HD22 ' A' ' 53' ' ' LEU . 1.3 pp -149.21 -31.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.965 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.89 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -68.34 -9.34 47.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.269 167.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -95.82 -47.68 6.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.984 176.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.669 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.4 m-20 -73.8 126.27 89.7 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 120.502 0.191 . . . . 0.0 110.653 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.98 -42.89 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.246 1.964 . . . . 0.0 113.16 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.86 -53.31 8.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.945 0.402 . . . . 0.0 112.021 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.557 HG12 HG21 ' A' ' 3' ' ' THR . 37.3 mt -60.8 -32.34 51.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.49 0.662 . . . . 0.0 110.33 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.727 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 29.8 ttm180 -53.16 -34.91 58.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.167 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.4 6.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.64 -55.0 5.9 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -163.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.824 ' HB3' HD13 ' A' ' 8' ' ' ILE . 3.6 pp -68.39 -35.89 7.78 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.727 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 25.6 Cg_endo -58.21 -42.43 56.76 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.393 1.396 . . . . 0.0 111.394 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -58.31 -34.17 70.29 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.073 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.521 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -65.65 -39.99 91.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.937 177.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -72.58 -53.53 11.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.575 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.859 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 21.5 t-20 -171.55 -47.83 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.022 174.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.859 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 33.5 p90 -124.8 146.33 52.68 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -40.19 -36.8 1.64 Allowed 'Trans proline' 0 C--N 1.352 0.715 1 C-N-CA 125.4 4.067 . . . . 0.0 117.152 -169.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 p -140.5 -135.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 119.076 0.853 . . . . 0.0 111.951 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.975 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 49.2 m-85 -145.15 -172.43 0.31 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.975 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 21.1 Cg_endo -62.91 154.53 69.04 Favored 'Cis proline' 0 C--N 1.36 1.184 0 CA-C-N 120.6 1.25 . . . . 0.0 114.33 -0.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.711 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 25.2 mt-30 -139.97 131.7 27.39 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.352 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -95.94 139.35 32.26 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.339 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.675 ' N ' HD13 ' A' ' 74' ' ' LEU . 57.7 m95 -127.73 127.79 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.384 0.611 . . . . 0.0 110.739 177.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 99' ' ' LEU . 57.3 t -113.2 118.33 57.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.273 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.6 t70 57.03 32.26 21.37 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 123.757 1.741 . . . . 0.0 108.711 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.785 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 72.33 28.43 67.96 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 113.488 -1.687 . . . . 0.0 113.04 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 40.5 mt-10 -119.44 133.37 55.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.786 HD21 ' HZ3' ' A' ' 68' ' ' TRP . 18.9 tp -65.57 131.44 46.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.781 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 86' ' ' ILE . 84.6 t -117.76 -52.84 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.931 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.82 ' HA3' HD12 ' A' ' 86' ' ' ILE . . . 134.08 133.24 3.3 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.37 -60.82 1.87 Allowed Glycine 0 C--O 1.222 -0.634 0 N-CA-C 116.367 1.307 . . . . 0.0 116.367 -166.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -75.24 -68.95 0.51 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.439 -1.036 . . . . 0.0 113.378 -167.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -78.71 -43.9 24.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.443 0.639 . . . . 0.0 110.629 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.82 HD12 ' HA3' ' A' ' 82' ' ' GLY . 43.7 mt -60.34 -42.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.456 -171.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -59.93 -50.38 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.055 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.567 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.7 mm -60.73 -49.04 86.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.447 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.78 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.9 tt0 -61.89 -54.35 43.24 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.918 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.408 ' HA ' ' HB2' ' A' ' 93' ' ' ARG . 55.1 mtt -58.43 -32.46 68.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.605 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 12.2 t80 -58.57 -53.19 61.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.73 171.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.1 mt-30 -65.12 -39.45 93.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.48 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.78 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.0 mmt180 -59.37 -33.6 71.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.657 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.623 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 94.8 -24.37 28.51 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -169.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.673 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.8 mt-10 -57.57 -31.22 65.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 99' ' ' LEU . 56.3 tp -68.91 -55.42 11.08 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.585 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 1.019 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 10.2 pt20 -57.56 -24.71 57.66 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.15 171.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.3 mm100 -71.01 -56.75 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 76' ' ' VAL . 2.2 pp -70.67 -34.72 72.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.746 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 99' ' ' LEU . 38.1 mm -62.03 -42.32 94.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 39.5 ttmt -52.32 -56.8 12.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.183 0.516 . . . . 0.0 112.072 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.38 -45.9 90.17 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.582 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 58.8 m -66.45 -51.09 60.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.351 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 45' ' ' GLU . . . -60.94 -51.66 68.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.87 -175.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.61 73.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.515 -176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.57 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.58 -25.73 50.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.042 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.472 ' HE2' HG23 ' A' ' 103' ' ' THR . 54.4 m-85 -84.93 -48.59 9.14 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.09 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -102.66 108.41 19.67 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 163.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 m -53.46 122.76 10.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.416 0.627 . . . . 0.0 110.787 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 49.31 38.98 14.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.736 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.415 ' OE2' ' HB2' ' A' ' 45' ' ' GLU . 38.7 tt0 -77.49 133.32 67.52 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.05 128.26 23.61 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.865 1.71 . . . . 0.0 112.65 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -98.6 -129.49 0.19 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.694 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.019 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -82.01 -46.64 13.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.901 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.596 -1.192 . . . . 0.0 108.558 -171.061 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.783 0.325 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 p -177.59 142.65 0.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.555 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -71.52 -127.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.122 0.264 . . . . 0.0 110.861 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG13 ' A' ' 8' ' ' ILE . 44.6 p -143.47 -134.66 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 0.0 111.2 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.701 ' CG2' HE21 ' A' ' 9' ' ' GLN . 77.8 mt -51.19 -37.08 17.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.478 0.711 . . . . 0.0 112.607 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.97 -44.03 82.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.144 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.69 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -70.79 -45.45 64.66 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.956 0.408 . . . . 0.0 110.175 171.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.62 HD13 HD22 ' A' ' 62' ' ' LEU . 79.4 mt -54.35 -47.09 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.701 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.7 mt-30 -63.62 -39.74 95.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.606 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 12.1 mmp_? -61.09 -34.22 74.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.343 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.529 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -74.63 -41.27 60.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.469 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.843 HG22 ' HA2' ' A' ' 78' ' ' GLY . 30.5 mt -66.5 -46.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.712 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -62.13 -39.96 94.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.862 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 11' ' ' GLN . 16.6 pt-20 -65.5 -32.5 74.13 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.113 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -76.68 125.44 87.25 Favored Pre-proline 0 CA--C 1.517 -0.312 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.846 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HA ' ' CE2' ' A' ' 107' ' ' TYR . 45.7 Cg_exo -62.26 -42.91 25.84 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 122.462 2.108 . . . . 0.0 112.225 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 16' ' ' PRO . 28.7 mm -136.27 121.71 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.648 HD23 HG23 ' A' ' 12' ' ' ILE . 22.0 tp -133.05 142.08 48.58 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.327 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.1 tp -137.21 119.9 16.16 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.151 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.653 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.1 m-85 -97.36 120.03 36.99 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.986 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.699 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 21.1 ptt? -146.29 -170.92 3.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.126 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.008 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.2 119.87 35.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 121.387 -0.821 . . . . 0.0 109.576 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -93.77 71.62 1.29 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.077 -174.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 36.6 t -78.54 142.56 62.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.85 -40.9 82.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.019 1.812 . . . . 0.0 111.459 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 60.7 pttt -67.99 -30.36 69.61 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.805 177.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 29' ' ' SER . 49.1 tp -160.62 115.97 1.4 Allowed Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 12.2 Cg_exo -71.19 29.73 0.22 Allowed 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 123.145 2.563 . . . . 0.0 112.985 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.699 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 11.9 p -162.58 46.61 0.15 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.347 0.594 . . . . 0.0 111.057 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.615 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 42.6 t -64.64 147.57 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.678 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.55 -141.35 15.27 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.799 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -78.2 -38.27 43.69 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 20.0 p -46.77 -19.61 0.1 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -50.35 -42.99 53.94 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.985 0.178 . . . . 0.0 111.095 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.638 HE21 ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.35 -37.11 38.26 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.638 ' N ' HE21 ' A' ' 35' ' ' GLN . . . -66.6 -45.79 78.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG13 HE21 ' A' ' 38' ' ' GLN . 13.1 p -56.36 -36.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.73 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.656 HE21 HG13 ' A' ' 37' ' ' VAL . 32.3 mm-40 -66.78 -46.85 73.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.285 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.584 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -59.05 -40.09 84.02 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.15 0.281 . . . . 0.0 111.609 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.3 tt -62.43 -57.26 11.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.938 -175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 -35.19 79.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.386 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.12 -47.67 76.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.016 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.895 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.3 m -73.08 -55.57 6.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.2 -133.14 8.01 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.308 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 113' ' ' ASP . 64.5 mm-40 -137.36 -150.64 0.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.708 -0.746 . . . . 0.0 110.241 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -60.07 150.72 28.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.476 0.655 . . . . 0.0 112.487 -172.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.465 ' CD2' HD13 ' A' ' 40' ' ' LEU . 20.3 p90 -157.93 156.72 31.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.359 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.34 152.94 18.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.621 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.5 p90 -138.1 152.63 48.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.611 HG23 HD11 ' A' ' 18' ' ' LEU . 58.6 t -129.66 130.91 67.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 110.27 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' MET . 9.5 p-10 -76.53 128.12 34.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.58 175.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.3 pp -145.22 -38.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.008 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.1 mm? -60.46 -17.81 47.2 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.003 0.82 . . . . 0.0 110.822 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.724 HE22 ' ND2' ' A' ' 55' ' ' ASN . 3.1 pp0? -95.34 -33.97 12.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.724 ' ND2' HE22 ' A' ' 54' ' ' GLN . 77.9 m-20 -74.72 131.22 79.91 Favored Pre-proline 0 N--CA 1.477 0.88 0 O-C-N 122.178 -0.326 . . . . 0.0 110.709 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.79 -43.99 4.68 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.467 2.111 . . . . 0.0 112.943 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.58 -57.95 3.56 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -173.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.71 -35.28 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.688 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.591 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 79.1 ttt180 -55.72 -27.99 53.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.95 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -89.14 -48.08 7.64 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -171.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 52.7 mt-10 -78.93 -60.05 2.53 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.294 1.591 . . . . 0.0 115.294 -162.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.687 ' N ' ' HD2' ' A' ' 63' ' ' PRO . 1.8 pt? -67.47 -34.64 7.05 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 19.1 Cg_endo -56.11 -38.22 95.2 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 121.405 1.403 . . . . 0.0 110.997 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 61' ' ' GLU . 42.8 mtmt -55.23 -41.99 72.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.439 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.591 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.63 -38.86 84.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.093 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB1' HD13 ' A' ' 80' ' ' LEU . . . -68.75 -53.54 21.34 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.158 -175.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.949 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 25.6 t-20 -172.35 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.658 171.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.949 ' HE3' ' HB3' ' A' ' 67' ' ' ASN . 31.2 p90 -126.49 149.42 67.68 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.736 -167.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.62 -37.48 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 125.256 3.971 . . . . 0.0 117.05 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.9 p -140.78 -137.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.202 0.91 . . . . 0.0 111.961 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 42.6 m-85 -140.57 -170.71 0.25 Allowed Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -173.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.968 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 37.0 Cg_endo -64.41 148.62 70.15 Favored 'Cis proline' 0 C--N 1.36 1.149 0 CA-C-N 120.864 1.344 . . . . 0.0 113.495 -2.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.623 ' HG2' ' CZ2' ' A' ' 68' ' ' TRP . 68.2 mt-30 -133.5 130.59 38.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.758 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.3 tm? -92.31 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.572 ' N ' HD13 ' A' ' 74' ' ' LEU . 67.3 m95 -125.03 129.4 50.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.69 0.757 . . . . 0.0 111.323 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.499 HG11 ' HB3' ' A' ' 99' ' ' LEU . 86.5 t -115.91 120.08 63.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.1 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.462 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 10.1 t70 56.93 32.08 20.9 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 123.078 1.418 . . . . 0.0 109.145 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.843 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.17 28.19 70.59 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 114.044 -1.435 . . . . 0.0 113.264 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -127.95 135.14 49.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 111.126 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.873 HD21 ' HZ3' ' A' ' 68' ' ' TRP . 19.4 tp -64.65 136.13 56.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.67 -172.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.539 ' O ' HG21 ' A' ' 86' ' ' ILE . 91.3 t -120.8 -53.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.358 170.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.9 ' HA2' ' HH2' ' A' ' 68' ' ' TRP . . . 129.7 133.32 3.58 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.73 -61.37 1.7 Allowed Glycine 0 C--O 1.221 -0.69 0 N-CA-C 116.236 1.254 . . . . 0.0 116.236 -167.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.9 p -69.18 -68.91 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.632 -0.922 . . . . 0.0 113.431 -166.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -80.72 -41.91 22.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.077 0.465 . . . . 0.0 110.469 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.628 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.5 mp -60.41 -45.7 96.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.58 -171.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 82' ' ' GLY . 71.0 t -58.83 -47.67 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.715 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 39' ' ' ALA . 32.8 mm -60.15 -46.61 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.02 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.728 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 85.2 tt0 -61.11 -54.66 41.82 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.932 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.587 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.3 mmt -57.97 -36.32 72.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.712 0.292 . . . . 0.0 111.512 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.895 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 18.7 t80 -56.36 -51.43 68.3 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.781 172.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 77.2 mt-30 -65.32 -38.46 90.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.9 mmm180 -58.94 -34.37 71.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.072 176.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 86.88 -23.93 9.78 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -168.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.782 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 52.6 mt-10 -58.01 -29.39 65.27 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.588 ' O ' HG12 ' A' ' 100' ' ' ILE . 63.7 tp -60.14 -56.63 19.19 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.201 0.524 . . . . 0.0 111.063 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.738 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.2 pt20 -63.12 -28.99 70.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.917 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.6 mm100 -62.27 -47.15 85.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.038 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 37.0 mt -66.19 -45.36 81.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 96' ' ' LEU . 49.5 mm -61.38 -47.88 91.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.721 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.884 ' HD3' ' H ' ' A' ' 115' ' ' GLU . 39.7 ttpt -62.01 -49.46 75.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.553 0.216 . . . . 0.0 111.339 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -55.42 -44.95 76.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.614 0.721 . . . . 0.0 109.957 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.489 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 92.9 m -70.53 -45.86 64.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.472 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.407 ' O ' ' HE2' ' A' ' 108' ' ' LYS . . . -59.65 -44.23 93.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 109' ' ' SER . . . -61.01 -41.84 97.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.478 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -72.87 -31.78 64.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.333 -178.494 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' A' ' 16' ' ' PRO . 60.0 m-85 -78.47 -47.09 18.15 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.55 ' CE ' ' HG3' ' A' ' 111' ' ' GLU . 3.1 mppt? -98.82 -145.47 0.32 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.496 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 105' ' ' ALA . 50.4 m -83.57 -155.94 0.19 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -70.08 59.91 0.18 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.55 ' HG3' ' CE ' ' A' ' 108' ' ' LYS . 58.5 mm-40 -59.48 121.94 60.61 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 72.4 Cg_endo -92.7 48.14 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.656 2.237 . . . . 0.0 113.924 -173.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.1 m-20 -51.27 -51.27 55.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.113 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.758 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -88.63 -48.04 7.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.043 0.449 . . . . 0.0 111.304 176.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.884 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 3.5 tm-20 . . . . . 0 C--O 1.244 0.793 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.872 0.368 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 p -168.84 -42.89 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.369 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.6 p -74.29 46.24 0.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.902 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 p -69.63 137.59 52.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.944 0.402 . . . . 0.0 110.558 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.692 ' CG2' HE21 ' A' ' 9' ' ' GLN . 61.1 mt -58.23 -31.28 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.681 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -55.61 -47.1 77.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.21 -43.5 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.48 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.86 HD13 ' HB2' ' A' ' 62' ' ' LEU . 85.2 mt -62.32 -47.83 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.435 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.692 HE21 ' CG2' ' A' ' 5' ' ' ILE . 73.0 mt-30 -62.91 -39.35 94.28 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.224 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -58.86 -34.5 71.66 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 8.2 tt0 -73.14 -50.35 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.784 HG22 ' HA2' ' A' ' 78' ' ' GLY . 26.5 mt -63.4 -38.13 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.873 0.845 . . . . 0.0 111.042 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.4 83.8 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.269 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -73.78 -35.82 65.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.861 -171.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.712 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -77.21 131.28 72.69 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 121.494 0.664 . . . . 0.0 111.323 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 50.2 Cg_exo -59.44 -42.06 52.05 Favored 'Trans proline' 0 CA--C 1.509 -0.739 0 C-N-CA 123.24 2.626 . . . . 0.0 112.492 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.9 mm -141.9 121.33 10.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.712 HD22 ' OD1' ' A' ' 15' ' ' ASN . 22.8 tp -131.83 142.67 49.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 0.0 111.313 -170.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 21' ' ' MET . 11.8 tp -137.22 121.45 18.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.359 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.818 ' CE2' HD21 ' A' ' 62' ' ' LEU . 8.0 m-85 -97.92 115.69 28.62 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.808 ' HE3' ' HB3' ' A' ' 33' ' ' SER . 14.2 ptm -148.06 -157.18 0.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.016 173.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.671 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 tttt -98.28 125.98 43.59 Favored 'General case' 0 C--O 1.213 -0.857 0 O-C-N 121.232 -0.917 . . . . 0.0 112.154 -169.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 67.91 0.94 Allowed Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.442 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 p -77.09 145.04 72.75 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -51.62 -41.48 60.97 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.616 2.211 . . . . 0.0 112.127 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.75 -29.08 68.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.131 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tt -159.96 118.0 1.57 Allowed Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.66 17.84 0.13 Allowed 'Trans proline' 0 N--CA 1.47 0.141 0 C-N-CA 122.801 2.334 . . . . 0.0 114.471 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.76 ' HB2' ' CE ' ' A' ' 21' ' ' MET . 11.2 p -164.12 61.11 0.15 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.42 0.629 . . . . 0.0 112.605 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.547 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 39.1 t -80.67 -143.3 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.946 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . 65.42 -152.89 51.27 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 122.409 -0.182 . . . . 0.0 113.432 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 17.6 m-85 -78.19 -35.95 48.0 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.808 ' HB3' ' HE3' ' A' ' 21' ' ' MET . 32.4 t -59.72 -7.3 1.51 Allowed 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.036 -0.415 . . . . 0.0 112.091 -172.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -45.28 -42.05 9.27 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.612 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.01 -38.86 61.43 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.244 0.545 . . . . 0.0 109.708 177.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.72 -43.97 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.383 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 34' ' ' ALA . 11.1 p -55.87 -37.6 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.449 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.597 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.5 mm100 -67.78 -45.44 74.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.783 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -58.0 -44.69 87.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.644 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.419 HD13 ' CG ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -61.25 -57.49 12.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.955 0.407 . . . . 0.0 110.271 -175.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.05 -32.17 70.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.567 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.35 -48.6 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.2 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.755 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 29.3 p -74.47 -54.58 7.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.18 -130.2 6.93 Favored Glycine 0 N--CA 1.454 -0.151 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.933 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.669 ' HG3' ' HA ' ' A' ' 113' ' ' ASP . 49.5 mt-10 -140.84 -149.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.168 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 40.3 mmt180 -48.1 146.64 2.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.421 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 20.0 p90 -158.5 153.15 24.66 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.35 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.61 152.77 19.24 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.682 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -132.12 148.44 52.48 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.656 HG23 HD11 ' A' ' 18' ' ' LEU . 43.3 t -123.2 131.12 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.6 p30 -81.63 131.23 35.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.365 0.602 . . . . 0.0 109.957 176.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 53' ' ' LEU . 1.2 pp -147.49 -28.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.741 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.734 HD22 HD12 ' A' ' 52' ' ' ILE . 1.9 mm? -65.87 -14.5 61.58 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 165.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 -46.12 6.58 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.858 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.8 m-20 -77.28 121.33 84.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.615 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 55' ' ' ASN . 18.5 Cg_exo -66.89 -43.66 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.974 2.449 . . . . 0.0 112.939 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.78 -51.08 29.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 62' ' ' LEU . 33.1 mt -63.52 -34.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.172 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.64 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 47.9 ttt85 -50.88 -35.32 32.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.195 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.611 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -90.89 -51.87 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.495 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 56.6 mm-40 -76.93 -55.46 5.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -167.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.86 ' HB2' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -61.55 -43.57 89.12 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -172.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 20.4 Cg_endo -57.81 -41.54 68.62 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 121.334 1.356 . . . . 0.0 111.217 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 52.4 mtmt -57.04 -35.27 69.1 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.766 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.606 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -67.0 -43.22 83.48 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.943 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.811 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -75.08 -56.88 4.29 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.799 -175.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.707 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 25.8 t-20 -174.85 -55.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.34 1.067 . . . . 0.0 109.507 172.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.707 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.3 m-90 -58.79 147.28 72.58 Favored Pre-proline 0 C--O 1.216 -0.687 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.339 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -60.71 -38.27 72.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.345 2.03 . . . . 0.0 110.306 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.9 p -142.66 -124.73 0.09 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.462 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.97 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 53.6 m-85 -139.61 -172.27 0.31 Allowed Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.97 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 64.3 Cg_endo -71.37 165.05 81.99 Favored 'Cis proline' 0 C--N 1.357 1.014 0 CA-C-N 120.777 1.313 . . . . 0.0 114.611 -1.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.777 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.6 pt20 -156.74 133.67 10.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.038 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 87' ' ' VAL . 61.4 tp -90.72 141.91 28.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.734 178.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.655 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 52.1 m95 -129.16 125.13 36.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 110.329 175.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.04 117.37 51.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.654 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 60.6 t0 57.09 33.99 24.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 123.117 1.437 . . . . 0.0 109.465 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.784 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 71.41 29.24 68.42 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.071 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -127.31 129.04 46.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.312 . . . . 0.0 110.492 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.811 HD22 ' HB1' ' A' ' 66' ' ' ALA . 59.2 tp -67.95 135.56 52.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.806 -170.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.597 ' O ' HG21 ' A' ' 86' ' ' ILE . 97.9 t -117.48 -53.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.194 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 146.54 140.03 3.4 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.02 -67.35 1.41 Allowed Glycine 0 C--O 1.216 -0.994 0 C-N-CA 118.226 -1.94 . . . . 0.0 116.258 -167.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 41.8 t -81.61 -68.72 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.728 1.264 . . . . 0.0 113.088 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.88 -47.13 60.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.404 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.597 HG21 ' O ' ' A' ' 81' ' ' VAL . 45.7 mm -58.36 -43.78 87.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.388 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.647 HG13 HD11 ' A' ' 96' ' ' LEU . 69.3 t -59.46 -49.23 84.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.974 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 37.3 mm -58.22 -49.68 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.36 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.729 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 88.2 tt0 -61.25 -54.28 46.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.693 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 24.9 mmt -58.58 -35.03 71.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.599 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 6.5 t80 -58.62 -50.63 73.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.767 173.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.2 mt-30 -62.69 -41.32 99.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 28.8 mmm180 -58.74 -33.88 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.699 178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.9 17.37 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.65 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.813 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 41.0 mt-10 -57.49 -36.92 72.12 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 122.96 0.504 . . . . 0.0 111.728 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 5.9 tt -61.29 -54.63 41.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.128 0.49 . . . . 0.0 109.92 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 18.9 pt20 -64.91 -28.96 69.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.889 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 95' ' ' GLU . 2.0 tp-100 -63.93 -44.13 93.81 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.239 0.616 . . . . 0.0 110.032 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.813 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 43.0 mt -68.78 -47.53 65.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.907 174.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 96' ' ' LEU . 46.3 mm -57.56 -47.65 84.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.432 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 113' ' ' ASP . 26.7 ttpp -55.26 -50.73 68.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.664 0.269 . . . . 0.0 111.692 -177.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.57 -48.77 80.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.654 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 94.0 m -65.17 -53.24 47.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.399 0.619 . . . . 0.0 111.694 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.657 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -62.71 -44.14 97.0 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.822 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.62 75.92 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.399 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -69.46 -29.34 67.0 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.131 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.571 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 46.9 m-85 -79.56 -46.06 18.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -77.77 -163.73 0.43 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.097 0.475 . . . . 0.0 110.395 170.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 p -87.45 59.63 5.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.156 0.979 . . . . 0.0 111.964 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 57.07 47.47 17.35 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.777 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.625 ' HG2' ' HB3' ' A' ' 108' ' ' LYS . 43.1 mm-40 -67.78 135.89 92.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.858 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.8 Cg_exo -80.43 51.37 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 124.589 3.526 . . . . 0.0 113.017 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.674 ' HB2' ' HA ' ' A' ' 101' ' ' LYS . 1.4 m-20 -44.98 -59.16 2.72 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 97' ' ' GLN . . . -87.15 -34.43 19.06 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--O 1.247 0.933 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.089 -167.64 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.881 ' HA ' HD11 ' A' ' 58' ' ' ILE . 20.9 ptp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.705 0.288 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t -70.79 126.23 29.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.051 0.453 . . . . 0.0 110.791 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.5 p -86.05 -40.54 15.66 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.785 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.504 ' HB ' ' HG2' ' A' ' 6' ' ' GLU . 41.7 p -59.96 126.16 26.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.981 -175.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.714 ' CG2' HE21 ' A' ' 9' ' ' GLN . 74.7 mt -59.53 -39.17 78.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.716 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 9.7 pt-20 -52.06 -46.57 65.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.023 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 47.5 mmtm -73.54 -43.69 59.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.015 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.698 HD13 HD22 ' A' ' 62' ' ' LEU . 66.9 mt -53.23 -44.45 53.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.714 HE21 ' CG2' ' A' ' 5' ' ' ILE . 71.1 mt-30 -63.14 -33.57 75.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.937 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -58.08 -40.26 80.63 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.359 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.695 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.8 mp0 -73.69 -46.41 46.46 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' OH ' ' A' ' 65' ' ' TYR . 18.4 mt -59.94 -44.61 94.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.39 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 78' ' ' GLY . . . -65.01 -40.58 95.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.955 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.695 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 12.4 pt-20 -66.44 -31.38 72.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.269 -176.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 73.5 m-80 -76.63 125.87 86.75 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.927 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' HD13 ' A' ' 17' ' ' ILE . 51.5 Cg_exo -60.38 -42.98 37.01 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 123.058 2.505 . . . . 0.0 112.437 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 16' ' ' PRO . 33.8 mm -141.13 123.26 14.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 50' ' ' VAL . 20.0 tp -133.51 142.09 48.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.16 -167.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.2 tp -136.37 117.99 14.94 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.326 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.774 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.9 m-85 -97.25 121.76 39.51 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.993 -0.442 . . . . 0.0 112.012 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.982 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 45.3 mmm -147.16 -158.49 0.92 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.011 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 65.6 tttm -96.93 112.82 24.41 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.788 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -93.9 68.04 1.5 Allowed Glycine 0 C--N 1.306 -1.118 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.095 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 p -77.71 144.57 69.3 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -52.74 -40.25 74.58 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.267 1.978 . . . . 0.0 111.529 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -66.7 -32.56 73.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.153 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.17 115.91 2.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.34 15.6 0.2 Allowed 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.895 2.397 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.4 p -164.83 47.08 0.1 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.141 0.496 . . . . 0.0 111.177 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.674 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 45.2 t -65.81 124.12 21.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.306 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.84 -134.71 6.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.424 -175.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.32 -42.14 31.58 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.68 ' CB ' ' HG3' ' A' ' 21' ' ' MET . 29.6 t -55.0 -10.12 0.46 Allowed 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.61 11.29 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.653 0.206 . . . . 0.0 110.893 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.519 ' O ' HD11 ' A' ' 88' ' ' ILE . 1.6 pm0 -81.53 -36.99 28.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.008 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.48 ' HB2' HE21 ' A' ' 35' ' ' GLN . . . -67.36 -44.74 78.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.581 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.8 p -54.38 -37.95 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.716 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.584 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.3 mm100 -62.29 -45.1 94.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.113 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -60.3 -45.9 91.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.42 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.77 -56.59 16.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.526 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.49 -32.14 69.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.24 -48.56 50.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.042 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.877 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 31.7 p -71.73 -56.29 6.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.327 -171.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -102.51 -146.09 17.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.456 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 92.5 mt-10 -102.39 -153.55 0.47 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.283 -0.458 . . . . 0.0 111.337 174.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HD2' ' C ' ' A' ' 46' ' ' ARG . 6.5 ppt_? -71.56 150.35 44.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.014 -176.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 12.9 p90 -141.35 156.31 45.84 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.541 -170.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -97.43 152.47 18.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.888 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.9 p90 -136.77 153.97 50.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.744 HG23 HD11 ' A' ' 18' ' ' LEU . 47.3 t -131.71 130.57 62.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.788 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 2.1 p30 -78.64 134.9 37.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.48 0.657 . . . . 0.0 110.907 175.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.774 HG12 ' HD2' ' A' ' 20' ' ' TYR . 1.3 pp -153.08 -34.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.616 -174.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.011 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.2 mm? -69.8 -5.84 28.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.368 168.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.85 -43.21 7.59 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.256 176.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 75.2 m-80 -82.21 124.9 78.05 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.029 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.18 -44.22 9.79 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 121.992 1.795 . . . . 0.0 112.524 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -56.3 6.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.036 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.881 HD11 ' HA ' ' A' ' 1' ' ' MET . 28.9 mt -61.72 -33.92 59.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.39 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.628 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 59.8 ttp180 -51.93 -34.0 39.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.982 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.499 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -87.15 -41.59 13.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.62 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -77.96 -61.65 1.93 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -164.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 20' ' ' TYR . 2.2 pt? -71.46 -34.0 2.99 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -171.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.729 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 19.8 Cg_endo -56.04 -38.72 94.34 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.348 1.365 . . . . 0.0 110.772 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.62 ' HE3' ' HA ' ' A' ' 61' ' ' GLU . 8.8 mtmp? -54.11 -39.1 66.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.776 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.639 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.6 -38.28 73.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.643 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -70.76 -54.31 12.21 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.562 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.824 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 24.5 t-20 -171.94 -54.22 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.347 169.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.862 ' CH2' HD11 ' A' ' 80' ' ' LEU . 32.8 p90 -105.55 144.71 29.38 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.096 -1.411 . . . . 0.0 114.511 -167.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -40.84 -37.0 2.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 125.07 3.847 . . . . 0.0 115.919 -172.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -140.41 -133.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.223 0.465 . . . . 0.0 111.409 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.964 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 45.5 m-85 -141.81 -174.17 0.4 Allowed Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -170.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.982 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 42.6 Cg_endo -65.99 172.58 32.22 Favored 'Cis proline' 0 C--N 1.357 0.989 0 CA-C-N 120.1 1.072 . . . . 0.0 114.032 -0.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.862 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.9 pt20 -160.58 132.43 5.95 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.395 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -96.6 137.68 35.31 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.217 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.678 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 55.5 m95 -126.36 125.8 42.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.438 0.637 . . . . 0.0 110.637 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 99' ' ' LEU . 64.8 t -106.77 119.72 56.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.907 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB2' HG23 ' A' ' 103' ' ' THR . 35.1 t70 55.79 28.72 12.73 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.764 1.269 . . . . 0.0 110.268 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.633 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 77.82 29.89 53.54 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.048 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 46.9 mt-10 -126.33 133.83 51.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.706 0.289 . . . . 0.0 111.172 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.862 HD11 ' CH2' ' A' ' 68' ' ' TRP . 24.6 tp -63.76 135.6 56.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.193 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.566 ' O ' HG21 ' A' ' 86' ' ' ILE . 98.4 t -124.33 -51.95 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.765 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.723 ' HA2' ' CH2' ' A' ' 68' ' ' TRP . . . 135.29 135.88 3.53 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -84.35 -61.8 1.78 Allowed Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.682 -1.247 . . . . 0.0 116.208 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 17.6 p -79.86 -67.83 0.73 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 -44.92 30.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.673 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.566 HG21 ' O ' ' A' ' 81' ' ' VAL . 50.8 mm -56.27 -45.94 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.045 -174.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.5 t -58.34 -49.1 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 39' ' ' ALA . 37.6 mm -60.7 -50.64 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.606 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.4 tt0 -61.19 -52.36 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.071 -178.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 59.9 mtt -61.7 -31.14 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 8.9 t80 -58.35 -51.86 68.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 171.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.1 mt-30 -64.96 -40.3 94.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.231 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 42.7 mmm-85 -57.81 -33.29 68.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.464 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.706 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.38 -25.81 18.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.903 -173.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.775 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 55.6 mt-10 -53.57 -37.27 62.75 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.9 tp -59.68 -54.69 43.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 110.575 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.877 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 12.3 pt20 -65.32 -26.01 67.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.663 175.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 97.3 mm-40 -65.71 -44.57 85.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.266 0.555 . . . . 0.0 109.611 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 44.1 mt -69.65 -47.14 64.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.144 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.703 HG22 ' OD2' ' A' ' 113' ' ' ASP . 45.7 mm -61.98 -42.26 94.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.789 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.586 ' HE3' ' HB3' ' A' ' 114' ' ' ALA . 29.7 ttmt -51.34 -59.14 4.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.37 0.605 . . . . 0.0 111.584 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -62.41 -42.74 99.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.484 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 77' ' ' ASP . 74.8 m -69.03 -48.58 62.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.752 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.664 ' O ' ' HE3' ' A' ' 108' ' ' LYS . . . -60.39 -45.96 91.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.601 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.42 81.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.755 0.312 . . . . 0.0 111.53 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 103' ' ' THR . 0.0 OUTLIER -73.59 -26.38 60.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.242 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.509 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 54.3 m-85 -83.68 -47.23 11.43 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.664 ' HE3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -83.41 -154.81 0.15 Allowed 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 108' ' ' LYS . 36.6 m -75.37 -153.61 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 169.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.78 46.93 0.23 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.868 0.366 . . . . 0.0 111.774 174.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -76.86 110.17 11.06 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.347 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.597 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 9.3 Cg_endo -90.8 120.93 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.432 . . . . 0.0 111.81 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.834 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 21.0 m-20 -82.96 -72.15 0.46 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.019 0.437 . . . . 0.0 111.627 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -81.28 48.47 1.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.165 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 112' ' ' PRO . 42.3 tp10 . . . . . 0 C--O 1.246 0.892 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -170.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.41 0.148 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p -171.59 -46.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.692 0.282 . . . . 0.0 111.463 177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.698 ' HA ' ' OE2' ' A' ' 6' ' ' GLU . 12.5 t -69.39 141.02 54.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.793 0.33 . . . . 0.0 110.406 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t -161.2 -134.46 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.816 -173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.983 HG22 ' HG3' ' A' ' 9' ' ' GLN . 30.2 mm -53.68 -31.43 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 118.053 0.388 . . . . 0.0 111.598 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.698 ' OE2' ' HA ' ' A' ' 3' ' ' THR . 13.6 pt-20 -40.68 -48.32 2.93 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.529 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 75.3 mmtt -62.76 -43.8 97.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 110.303 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.765 HG21 ' HG ' ' A' ' 62' ' ' LEU . 71.9 mt -65.53 -50.05 74.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.631 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.983 ' HG3' HG22 ' A' ' 5' ' ' ILE . 64.9 mt-30 -56.01 -40.48 73.44 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.9 mmp_? -60.93 -33.88 73.84 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.977 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.499 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.4 tt0 -72.21 -42.98 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.439 174.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.749 HG22 ' HA2' ' A' ' 78' ' ' GLY . 18.8 mt -64.16 -45.27 96.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.04 0.448 . . . . 0.0 110.376 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -41.01 96.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.936 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 11' ' ' GLN . 14.0 pt-20 -64.26 -37.42 87.43 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.64 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' CB ' ' HG ' ' A' ' 18' ' ' LEU . 77.5 m-20 -77.2 120.56 82.09 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' O ' HD13 ' A' ' 17' ' ' ILE . 49.2 Cg_exo -62.17 -42.05 31.56 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.541 2.161 . . . . 0.0 111.829 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.595 HG23 HD12 ' A' ' 100' ' ' ILE . 31.4 mm -131.93 125.32 54.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.777 HD13 ' HE1' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -131.69 143.4 50.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.276 -169.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 17.0 tp -136.67 113.24 10.12 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.394 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.777 ' HE1' HD13 ' A' ' 18' ' ' LEU . 8.0 m-85 -96.01 115.06 26.85 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.815 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.605 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 24.5 ptt? -145.97 -157.31 0.79 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.113 -176.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.741 ' HD3' ' O ' ' A' ' 30' ' ' CYS . 79.6 tttt -98.42 143.38 28.92 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -142.75 130.18 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.582 -1.294 . . . . 0.0 113.204 -171.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.444 ' OG ' ' HG2' ' A' ' 26' ' ' LYS . 27.9 t -146.56 143.68 19.29 Favored Pre-proline 0 C--N 1.312 -1.029 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.71 -36.54 82.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.143 1.895 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HG2' ' OG ' ' A' ' 24' ' ' SER . 18.4 ptpt -64.65 -35.15 80.08 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.178 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 tt -159.52 113.27 1.52 Allowed Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.85 19.63 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 114.649 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 15.3 p -164.14 49.69 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.468 0.651 . . . . 0.0 111.295 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.741 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 2.2 p -69.44 49.67 0.09 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.32 -136.15 2.15 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.704 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.636 ' HB3' ' SG ' ' A' ' 84' ' ' CYS . 4.2 m-85 -74.63 -40.31 61.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.869 0.843 . . . . 0.0 109.466 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.605 ' OG ' ' HB2' ' A' ' 21' ' ' MET . 51.2 p -54.17 -18.07 3.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.253 -1.339 . . . . 0.0 113.548 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -49.65 -39.47 36.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 110.401 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.631 ' HG2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -79.89 -38.88 31.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 175.637 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.28 77.91 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -54.38 -39.38 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.119 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.594 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.6 mm100 -64.42 -43.87 92.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.329 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.504 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -58.38 -42.09 86.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.743 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -55.97 20.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.146 0.498 . . . . 0.0 110.023 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.08 70.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.468 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 -46.26 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.47 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.701 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 26.8 p -77.71 -55.25 5.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.52 -135.33 8.82 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.064 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 30.8 mt-10 -134.9 -148.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.957 0.503 . . . . 0.0 110.909 177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 26.0 mmm180 -50.6 146.42 5.62 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.498 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.424 ' HA ' ' HB ' ' A' ' 17' ' ' ILE . 26.6 p90 -158.22 153.77 26.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.962 -175.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' LEU . . . -99.38 143.5 29.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.3 p90 -124.86 148.36 48.29 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG23 HD21 ' A' ' 18' ' ' LEU . 57.7 t -124.81 130.8 73.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.198 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.42 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . 41.6 p-10 -78.27 132.07 37.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.604 0.716 . . . . 0.0 110.22 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.966 HD12 ' HG ' ' A' ' 53' ' ' LEU . 1.4 pp -148.68 -34.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.124 -172.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.966 ' HG ' HD12 ' A' ' 52' ' ' ILE . 36.4 mt -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.779 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -46.21 6.25 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.5 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 m-20 -76.42 120.36 81.32 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 120.579 0.228 . . . . 0.0 110.729 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.19 -44.77 11.36 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.261 1.974 . . . . 0.0 113.039 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.05 -54.13 14.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.0 -36.02 71.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 110.279 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.65 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 60.5 ttp180 -51.5 -32.44 27.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.801 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -90.7 -39.14 12.61 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -169.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.456 ' C ' ' HD2' ' A' ' 63' ' ' PRO . 14.8 tp10 -79.64 -62.09 1.8 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -163.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.765 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -74.28 -26.36 0.69 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -173.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.732 ' HD3' HD13 ' A' ' 62' ' ' LEU . 31.9 Cg_endo -59.73 -40.76 61.36 Favored 'Trans proline' 0 C--N 1.358 1.069 0 CA-C-N 121.352 1.519 . . . . 0.0 110.683 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 8.6 mtmp? -56.54 -39.25 73.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.352 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.563 ' HD2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -64.38 -44.03 92.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.874 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -77.88 -57.23 3.91 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.504 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.655 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.3 t30 -174.68 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.026 0.917 . . . . 0.0 110.45 169.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.681 ' HB2' ' OE1' ' A' ' 73' ' ' GLN . 0.9 OUTLIER -56.49 147.11 51.22 Favored Pre-proline 0 C--O 1.222 -0.38 0 CA-C-N 113.358 -1.747 . . . . 0.0 113.311 -174.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.5 -36.52 76.52 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.232 1.955 . . . . 0.0 110.045 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -142.69 -126.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.181 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.868 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 10.9 m-85 -143.47 -164.26 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.868 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.2 Cg_endo -67.09 154.92 84.86 Favored 'Cis proline' 0 C--N 1.364 1.385 0 CA-C-N 121.993 1.747 . . . . 0.0 114.057 -1.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.681 ' OE1' ' HB2' ' A' ' 68' ' ' TRP . 21.0 mt-30 -142.62 134.13 26.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.641 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.0 tm? -91.09 137.91 32.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.623 ' N ' HD13 ' A' ' 74' ' ' LEU . 69.5 m95 -125.19 128.7 48.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 0.0 110.935 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 99' ' ' LEU . 96.4 t -112.9 115.23 49.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 11.7 t70 57.58 30.56 18.96 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.633 1.682 . . . . 0.0 108.809 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.749 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.14 29.01 65.23 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 113.485 -1.688 . . . . 0.0 113.05 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 91.4 mt-10 -115.94 130.57 56.88 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.874 HD22 ' HB1' ' A' ' 66' ' ' ALA . 47.0 tp -69.32 134.56 49.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 111.756 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.586 HG12 ' CG2' ' A' ' 86' ' ' ILE . 93.9 t -119.32 -50.33 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.145 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.28 132.88 2.91 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.489 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.77 -64.12 1.57 Allowed Glycine 0 C--O 1.222 -0.631 0 C-N-CA 118.895 -1.621 . . . . 0.0 116.644 -166.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 32' ' ' PHE . 42.2 t -80.3 -68.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.428 1.114 . . . . 0.0 112.3 -170.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -71.22 -43.98 66.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.498 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.586 ' CG2' HG12 ' A' ' 81' ' ' VAL . 2.4 mp -62.16 -44.1 98.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.151 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.463 HG13 HD21 ' A' ' 96' ' ' LEU . 73.4 t -57.21 -49.2 80.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.244 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.631 HD11 ' HG2' ' A' ' 35' ' ' GLN . 35.7 mm -60.1 -49.92 82.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.043 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.735 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 38.2 tt0 -62.16 -51.62 67.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.845 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.586 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 26.0 mmt -58.77 -35.12 72.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.505 0.193 . . . . 0.0 111.307 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.568 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t80 -58.58 -51.23 70.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.205 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 82.0 mt-30 -64.77 -41.01 96.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.089 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 37.3 mmm-85 -60.43 -34.66 74.3 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.654 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.686 ' O ' ' HG3' ' A' ' 98' ' ' GLN . . . 95.36 -24.79 27.51 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.27 -174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.707 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 47.6 mt-10 -58.7 -30.03 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 100' ' ' ILE . 62.3 tp -59.3 -54.57 45.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.645 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.701 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 15.9 pt20 -63.45 -28.08 69.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.002 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 94' ' ' GLY . 75.2 mt-30 -62.79 -46.04 89.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 49.1 mt -65.39 -44.58 87.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.856 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.635 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.4 mm -61.27 -46.77 95.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.492 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.803 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 38.7 ttpt -59.17 -50.73 72.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.882 0.373 . . . . 0.0 110.989 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -52.15 -45.53 65.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.32 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 86.0 m -77.06 -48.6 17.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.971 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 108' ' ' LYS . . . -59.54 -43.69 93.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.37 96.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.549 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.06 -32.34 64.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.281 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.505 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 65.7 m-85 -79.1 -47.47 16.06 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -87.72 -150.73 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 p -88.15 -150.54 0.18 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.935 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -70.6 54.47 0.16 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 108' ' ' LYS . 31.3 mm-40 -69.44 114.9 27.44 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-O 120.955 0.407 . . . . 0.0 110.411 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -93.2 52.59 0.42 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.335 2.69 . . . . 0.0 113.795 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.3 m-20 -50.15 -57.85 6.84 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -172.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.803 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -75.51 -47.11 28.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 111.727 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.509 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 38.8 tt0 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.769 -1.11 . . . . 0.0 109.651 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.484 0.183 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 t 69.67 121.92 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 124.15 0.906 . . . . 0.0 111.358 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 32.3 p -95.98 55.34 1.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.368 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.6 p -57.37 -43.58 83.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.53 HG12 ' CB ' ' A' ' 65' ' ' TYR . 2.0 mp -65.73 -42.94 93.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 3' ' ' THR . 24.8 pt-20 -55.25 -40.4 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.607 0.639 . . . . 0.0 110.246 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.32 -43.38 88.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.521 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.693 HD13 ' HB3' ' A' ' 62' ' ' LEU . 77.9 mt -65.71 -47.47 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.876 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.696 ' NE2' ' HE2' ' A' ' 65' ' ' TYR . 59.5 mm-40 -62.16 -25.97 68.07 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.278 -173.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 3.4 mmp_? -50.85 -41.28 57.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 94.4 mm-40 -75.06 -49.35 20.01 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.296 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.627 HG23 HD23 ' A' ' 18' ' ' LEU . 4.6 mt -61.44 -43.11 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.601 0.715 . . . . 0.0 111.016 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.83 79.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.759 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 10.5 pt-20 -73.33 -36.26 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -173.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.64 ' OD1' ' HB2' ' A' ' 18' ' ' LEU . 3.6 p30 -77.63 134.12 65.96 Favored Pre-proline 0 CA--C 1.517 -0.307 0 CA-C-O 121.793 0.806 . . . . 0.0 112.092 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' O ' HD13 ' A' ' 17' ' ' ILE . 31.3 Cg_exo -63.33 -42.09 23.89 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.047 2.498 . . . . 0.0 111.723 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 16' ' ' PRO . 27.5 mm -139.59 119.16 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.741 HD21 ' HE1' ' A' ' 20' ' ' TYR . 31.1 tp -128.6 142.39 51.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -171.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 12.9 tp -136.16 120.29 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.658 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.741 ' HE1' HD21 ' A' ' 18' ' ' LEU . 8.9 m-85 -98.87 122.1 41.67 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.848 -0.533 . . . . 0.0 111.396 173.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.557 ' O ' ' HE3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -147.84 -155.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.752 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 57.1 tttp -99.31 121.37 40.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.618 -0.676 . . . . 0.0 109.321 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.36 121.51 7.01 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.246 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 37.9 t -125.77 140.65 37.14 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.38 -41.3 79.55 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.167 1.911 . . . . 0.0 111.665 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -74.44 -28.39 61.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.535 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.5 tt -154.66 104.95 2.34 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' O ' ' SD ' ' A' ' 21' ' ' MET . 16.8 Cg_exo -72.29 35.47 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 114.476 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.446 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 7.0 p -169.74 49.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.095 0.558 . . . . 0.0 111.187 173.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.684 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 51.3 t -54.76 -36.65 65.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -71.15 -137.69 0.17 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.166 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.457 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.1 m-85 -75.95 -18.61 59.27 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 35.8 t -64.75 -12.16 44.27 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.003 -0.436 . . . . 0.0 111.891 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.86 -42.4 26.53 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.648 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -80.24 -41.68 24.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.07 0.462 . . . . 0.0 110.263 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.62 96.65 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.682 -175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.67 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 13.9 p -56.66 -39.48 63.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.348 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.63 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.8 mm100 -68.91 -46.15 69.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -59.95 -42.8 94.86 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.294 0.371 . . . . 0.0 111.505 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.497 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -63.15 -55.11 27.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.412 0.625 . . . . 0.0 109.681 -176.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.16 69.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.478 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 -49.13 19.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.506 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.753 ' HB2' ' HB3' ' A' ' 97' ' ' GLN . 25.6 p -74.52 -53.36 9.62 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.457 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.5 -141.0 11.51 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.87 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 69.8 mm-40 -117.87 -152.15 0.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.832 0.453 . . . . 0.0 111.144 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HE ' ' N ' ' A' ' 46' ' ' ARG . 3.4 mmp_? -65.44 158.23 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.46 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.67 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 17.0 p90 -154.35 159.07 40.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.551 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.86 154.09 17.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.805 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 p90 -143.6 153.89 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -174.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.678 HG23 HD11 ' A' ' 18' ' ' LEU . 57.6 t -133.79 130.29 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.504 0.193 . . . . 0.0 110.56 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.509 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 36.5 p-10 -74.49 131.9 41.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.485 0.659 . . . . 0.0 110.924 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.705 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.4 pp -147.85 -35.63 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.861 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.3 mm? -65.35 -11.62 43.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.412 167.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -97.52 -44.94 6.61 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.465 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.9 m-20 -82.25 118.12 70.83 Favored Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 122.192 -0.318 . . . . 0.0 110.437 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.69 -44.09 14.8 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.434 2.089 . . . . 0.0 113.756 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -72.53 -52.71 14.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.078 0.466 . . . . 0.0 111.573 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -62.46 -35.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.268 0.556 . . . . 0.0 110.424 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 62.4 ttp180 -52.89 -32.43 45.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.202 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -88.19 -41.53 12.91 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.576 -166.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.549 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 32.0 tp10 -78.79 -59.67 2.69 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -158.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.711 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.9 pt? -68.11 -31.39 3.25 Favored Pre-proline 0 N--CA 1.474 0.726 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 18.5 Cg_endo -57.82 -43.44 49.43 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 121.103 1.43 . . . . 0.0 111.138 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.641 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 48.6 mtmt -55.68 -37.88 68.9 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.035 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.696 ' HE2' ' NE2' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -65.21 -50.83 64.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.477 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.929 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -73.3 -55.7 6.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.379 -0.929 . . . . 0.0 112.935 -170.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.632 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.8 t30 -175.41 -52.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.211 1.005 . . . . 0.0 110.237 169.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.632 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -59.75 150.33 68.15 Favored Pre-proline 0 C--O 1.215 -0.743 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.936 -177.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -63.54 -36.76 52.05 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 121.954 1.769 . . . . 0.0 109.912 171.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -141.79 -124.28 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.003 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.923 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 25.7 m-85 -140.72 -165.61 0.1 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.923 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 54.1 Cg_endo -67.09 153.51 84.62 Favored 'Cis proline' 0 C--N 1.361 1.216 0 CA-C-N 121.691 1.64 . . . . 0.0 113.885 -1.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.593 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 70.6 mt-30 -143.21 135.19 26.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.706 175.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -100.08 135.17 41.91 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.588 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.61 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 49.4 m95 -121.91 125.77 47.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.242 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.5 t -105.91 119.04 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.557 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 9.1 t70 56.74 27.95 13.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 123.722 1.725 . . . . 0.0 108.622 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 78.07 29.3 54.38 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.375 -1.739 . . . . 0.0 113.044 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -124.68 130.97 53.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.322 . . . . 0.0 110.472 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.929 HD22 ' HB1' ' A' ' 66' ' ' ALA . 40.6 tp -68.95 127.31 32.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.406 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.548 HG12 ' CG2' ' A' ' 86' ' ' ILE . 87.3 t -105.28 -55.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.759 170.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.39 135.23 2.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.29 -65.52 1.52 Allowed Glycine 0 C--O 1.217 -0.943 0 C-N-CA 118.584 -1.77 . . . . 0.0 116.482 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 21.8 p -80.56 -68.05 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.76 1.28 . . . . 0.0 113.231 -171.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.26 -46.82 63.62 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.939 0.399 . . . . 0.0 111.244 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 81' ' ' VAL . 46.1 mm -59.99 -44.79 95.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.013 -172.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 82' ' ' GLY . 56.0 t -58.27 -49.03 83.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.289 175.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.478 ' O ' ' HD2' ' A' ' 91' ' ' TYR . 39.4 mm -58.1 -53.21 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.41 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 87.8 tt0 -65.97 -47.43 74.64 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.882 -176.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.767 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 25.2 mmt -58.62 -36.55 74.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.633 0.254 . . . . 0.0 111.057 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.601 ' HD1' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -58.03 -48.81 78.96 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 172.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.538 ' HG2' ' CD2' ' A' ' 91' ' ' TYR . 15.2 mm-40 -62.58 -43.75 98.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.013 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.732 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 44.4 mmm-85 -62.93 -33.99 76.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.777 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 96.13 -25.29 26.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.747 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.5 mt-10 -55.54 -35.53 65.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.767 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 63.6 tp -62.37 -54.66 37.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.753 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 19.1 pt20 -63.49 -26.78 68.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.024 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 92.6 mm-40 -64.0 -46.63 83.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.132 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 46.4 mt -67.6 -44.75 77.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.903 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 96' ' ' LEU . 50.0 mm -60.62 -46.26 96.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.482 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 113' ' ' ASP . 39.4 ttpt -59.06 -52.86 63.91 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.551 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.3 -43.14 82.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.259 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.557 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 46.7 m -72.07 -50.17 30.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.076 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.05 92.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.565 -177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.31 72.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -77.77 -29.58 51.03 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.959 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.562 ' CD2' ' HB3' ' A' ' 16' ' ' PRO . 62.9 m-85 -86.83 -49.54 7.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.005 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.813 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -96.03 119.82 35.21 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.148 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -54.32 117.04 2.96 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 52.07 37.49 21.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.596 -1.638 . . . . 0.0 113.245 170.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 60.6 mm-40 -80.46 123.65 82.75 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.634 174.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 2.1 Cg_endo -83.94 109.41 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.696 2.264 . . . . 0.0 112.45 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 1.2 m-20 -91.34 -93.22 0.14 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.394 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 97' ' ' GLN . . . -67.47 -48.16 67.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -171.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.427 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 46.5 tp10 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.699 -1.143 . . . . 0.0 109.698 -170.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 120.648 0.261 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.3 p -70.24 -119.4 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 4' ' ' THR . 42.3 p -81.06 -150.37 0.08 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.941 0.4 . . . . 0.0 111.717 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.639 ' O ' ' HG2' ' A' ' 7' ' ' LYS . 9.0 t 171.76 -38.59 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.962 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.702 ' CG2' HE21 ' A' ' 9' ' ' GLN . 37.5 mt -55.11 -25.47 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.036 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 96.1 mt-10 -49.27 -47.55 46.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.545 0.212 . . . . 0.0 111.556 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.2 ptpt -61.79 -43.42 98.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.612 0.72 . . . . 0.0 110.116 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.595 HG21 ' HB3' ' A' ' 62' ' ' LEU . 72.2 mt -66.26 -46.84 86.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.936 -174.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.702 HE21 ' CG2' ' A' ' 5' ' ' ILE . 72.1 mt-30 -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.549 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 4.0 mmp_? -59.89 -37.55 79.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.851 0.358 . . . . 0.0 110.361 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 51.7 tt0 -71.03 -49.21 47.41 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.15 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.829 HG22 ' HA2' ' A' ' 78' ' ' GLY . 17.3 mt -65.88 -39.52 84.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.667 0.746 . . . . 0.0 110.835 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.12 81.94 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.637 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 24.0 pt-20 -72.81 -39.24 66.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.672 ' OD1' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -76.58 134.18 69.8 Favored Pre-proline 0 CA--C 1.515 -0.384 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -176.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' HD13 ' A' ' 17' ' ' ILE . 20.1 Cg_endo -61.94 -40.84 40.89 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.158 2.572 . . . . 0.0 112.056 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 16' ' ' PRO . 26.7 mm -139.27 120.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.672 HD22 ' OD1' ' A' ' 15' ' ' ASN . 28.1 tp -132.02 143.14 49.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.376 0.608 . . . . 0.0 111.414 -173.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 16.1 tp -138.95 120.6 15.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.362 -176.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.666 ' HD2' HG12 ' A' ' 52' ' ' ILE . 9.5 m-85 -96.66 124.5 40.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.752 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' HB3' ' A' ' 29' ' ' SER . 8.0 ptp -145.26 -171.09 3.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.524 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.817 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.3 tttm -95.97 140.62 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 51' ' ' ASP . . . -138.67 129.5 4.52 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 118.941 -1.6 . . . . 0.0 113.696 -165.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -150.43 142.72 15.82 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.0 -38.99 60.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.598 2.199 . . . . 0.0 112.025 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -62.99 -33.08 74.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.325 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tt -160.02 108.7 1.42 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.85 19.97 0.18 Allowed 'Trans proline' 0 C--O 1.22 -0.376 0 C-N-CA 122.239 1.959 . . . . 0.0 114.34 -174.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.817 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 13.5 p -164.22 49.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.287 0.565 . . . . 0.0 111.532 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.757 ' SG ' ' HG2' ' A' ' 22' ' ' LYS . 3.6 p -65.83 54.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.65 -137.58 2.24 Favored Glycine 0 C--N 1.321 -0.267 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.8 -39.67 61.57 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.761 0.791 . . . . 0.0 108.952 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 72' ' ' PRO . 20.6 p -48.1 -24.14 1.03 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.695 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -51.52 -41.76 61.25 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.286 0.366 . . . . 0.0 111.652 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -33.24 43.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.352 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.17 66.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.132 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.661 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 8.5 p -52.25 -38.12 24.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.7 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.592 ' HA ' HE21 ' A' ' 38' ' ' GLN . 1.1 mm100 -62.25 -46.94 86.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.819 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 88' ' ' ILE . . . -60.61 -43.84 97.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.087 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 47' ' ' PHE . 1.5 tt -61.85 -55.15 32.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -176.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.36 76.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.441 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -49.59 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.37 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.898 ' HG ' ' HD1' ' A' ' 91' ' ' TYR . 1.5 m -72.84 -56.02 5.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 113' ' ' ASP . . . -101.49 -134.85 8.63 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.153 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 50.4 mm-40 -140.88 -152.17 0.4 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.822 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 28.8 mmm180 -58.15 143.67 43.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.823 0.82 . . . . 0.0 112.636 -169.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.661 ' HZ ' HG23 ' A' ' 37' ' ' VAL . 16.6 p90 -152.93 156.42 38.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.878 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.45 146.87 25.31 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.1 p90 -136.83 150.21 48.17 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG23 HD11 ' A' ' 18' ' ' LEU . 48.3 t -127.6 127.66 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.8 p30 -77.9 133.9 38.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.293 0.568 . . . . 0.0 109.83 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.734 HD12 HD22 ' A' ' 53' ' ' LEU . 1.1 pp -148.1 -32.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.264 -171.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.762 ' HB2' ' HB2' ' A' ' 22' ' ' LYS . 1.8 mm? -66.54 -11.09 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.098 167.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.423 ' HB3' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -94.38 -43.27 8.46 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.07 178.174 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -77.63 123.99 86.59 Favored Pre-proline 0 N--CA 1.469 0.502 0 CA-C-O 121.026 0.441 . . . . 0.0 110.925 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.32 -42.94 11.91 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.373 2.049 . . . . 0.0 113.523 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -82.94 -50.89 8.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.672 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 mt -56.8 -37.11 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.249 0.547 . . . . 0.0 110.635 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.637 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 58.7 ttp180 -53.16 -31.24 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.158 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.35 -35.98 19.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -78.27 -61.14 2.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -162.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.709 ' H ' HD23 ' A' ' 62' ' ' LEU . 1.9 pt? -76.8 -31.88 0.96 Allowed Pre-proline 0 N--CA 1.472 0.626 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.81 ' HD3' ' CZ ' ' A' ' 71' ' ' PHE . 11.7 Cg_endo -55.21 -39.7 89.59 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 CA-C-N 120.917 1.363 . . . . 0.0 110.53 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -53.91 -41.36 67.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.543 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.698 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -68.56 -41.9 79.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.461 -178.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.947 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -73.49 -58.32 3.39 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.988 -176.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.458 ' HB2' ' CE3' ' A' ' 68' ' ' TRP . 24.4 m-20 -173.27 -57.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.052 0.93 . . . . 0.0 109.539 168.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.567 ' CZ3' HD21 ' A' ' 80' ' ' LEU . 1.2 m-90 -53.88 147.8 22.62 Favored Pre-proline 0 C--O 1.215 -0.713 0 CA-C-N 113.079 -1.873 . . . . 0.0 113.381 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.7 -36.21 53.47 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.289 1.993 . . . . 0.0 110.096 171.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.476 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 40.9 p -142.04 -127.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.372 -1.286 . . . . 0.0 109.698 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 1.004 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 36.0 m-85 -142.78 -170.63 0.24 Allowed Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.004 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 38.4 Cg_endo -68.34 157.76 87.22 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 120.981 1.386 . . . . 0.0 114.525 -1.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.916 ' HG2' ' HD2' ' A' ' 71' ' ' PHE . 3.7 pt20 -148.57 133.72 18.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.741 174.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.4 tm? -95.38 138.37 33.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.999 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.772 ' HE1' ' HG3' ' A' ' 73' ' ' GLN . 56.1 m95 -127.07 126.93 43.88 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.497 0.665 . . . . 0.0 110.894 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.952 HG21 HD13 ' A' ' 99' ' ' LEU . 50.2 t -106.28 114.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.483 -0.781 . . . . 0.0 108.919 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' HB2' HG21 ' A' ' 103' ' ' THR . 25.1 t70 54.42 32.08 15.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 123.108 1.432 . . . . 0.0 110.364 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.829 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 79.7 28.74 50.41 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 113.789 -1.551 . . . . 0.0 113.565 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' TRP . 51.9 mt-10 -127.29 131.3 50.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.904 173.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.947 HD22 ' HB1' ' A' ' 66' ' ' ALA . 53.5 tp -68.95 130.2 42.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.607 -174.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.579 HG12 ' CG2' ' A' ' 86' ' ' ILE . 91.7 t -107.09 -54.11 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.447 168.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 144.88 132.82 2.55 Favored Glycine 0 C--O 1.22 -0.761 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.566 ' N ' ' HA ' ' A' ' 73' ' ' GLN . . . -85.13 -62.43 1.66 Allowed Glycine 0 C--O 1.221 -0.678 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.863 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.2 p -77.18 -67.6 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.798 -0.825 . . . . 0.0 112.557 -171.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -73.6 -48.77 30.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.677 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.579 ' CG2' HG12 ' A' ' 81' ' ' VAL . 43.1 mm -61.92 -42.27 94.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.382 -171.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 82' ' ' GLY . 65.6 t -58.74 -48.22 86.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.792 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.555 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 36.0 mm -60.9 -47.31 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.595 0.236 . . . . 0.0 110.831 176.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.9 tt0 -59.79 -55.21 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.651 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.592 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 26.2 mmt -60.07 -35.67 75.68 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.35 0.26 . . . . 0.0 111.276 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.898 ' HD1' ' HG ' ' A' ' 43' ' ' CYS . 17.7 t80 -56.79 -50.96 70.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.848 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 80.8 mt-30 -63.76 -40.68 97.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.409 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 41.1 mmm-85 -63.63 -33.94 76.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.604 ' O ' ' HG2' ' A' ' 98' ' ' GLN . . . 93.15 -24.39 25.14 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.169 -171.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 49.7 mt-10 -58.22 -27.23 63.74 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.592 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 6.2 tt -60.44 -58.95 6.33 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 15.5 pt20 -60.27 -27.04 66.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.35 176.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 94' ' ' GLY . 3.2 mm100 -65.07 -55.66 17.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.952 HD13 HG21 ' A' ' 76' ' ' VAL . 2.5 pp -70.76 -32.34 69.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.665 177.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 99' ' ' LEU . 34.3 mm -64.57 -48.23 85.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.254 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.574 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 39.1 ttpt -56.81 -52.05 66.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.369 -176.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.91 -44.58 78.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.393 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.542 HG21 ' HB2' ' A' ' 77' ' ' ASP . 32.6 m -71.0 -50.55 32.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.613 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.48 93.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.537 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.72 93.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -73.46 -26.86 61.11 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.985 -178.33 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.497 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 43.0 m-85 -87.68 -47.21 8.84 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.092 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.625 ' HE2' ' N ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -75.71 -158.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -76.18 -167.36 0.74 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.674 165.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.71 57.34 0.13 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 53.9 mm-40 -73.12 124.63 90.84 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.359 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 93.0 Cg_endo -96.44 53.03 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.962 3.108 . . . . 0.0 113.991 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 28.6 m-20 -51.12 -61.23 2.36 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.574 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -73.94 -45.93 47.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 0.0 111.871 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.445 ' H ' ' HD3' ' A' ' 101' ' ' LYS . 5.4 tm-20 . . . . . 0 C--N 1.319 -0.756 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -173.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.411 ' N ' ' SD ' ' A' ' 1' ' ' MET . 61.4 p -78.18 60.91 2.57 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.604 0.362 . . . . 0.0 111.089 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.509 HG22 ' H ' ' A' ' 4' ' ' THR . 5.0 m -70.1 -132.25 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.591 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.509 ' H ' HG22 ' A' ' 3' ' ' THR . 37.9 p -76.03 37.77 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -175.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.679 ' CG2' HE21 ' A' ' 9' ' ' GLN . 44.4 mt -63.72 -38.09 81.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 176.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 54.3 mt-10 -55.55 -47.42 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.582 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -62.68 -43.51 98.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 110.648 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.73 HG21 ' HB3' ' A' ' 62' ' ' LEU . 75.5 mt -60.95 -45.77 97.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.929 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.679 HE21 ' CG2' ' A' ' 5' ' ' ILE . 70.6 mt-30 -64.92 -33.26 75.6 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.365 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.644 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 4.3 mmp_? -55.94 -42.26 75.9 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -69.14 -44.35 72.51 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.953 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.627 HG23 HD23 ' A' ' 18' ' ' LEU . 19.9 mt -65.56 -43.34 94.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.442 0.639 . . . . 0.0 110.171 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.47 68.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.481 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.644 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 32.0 mt-10 -62.18 -46.65 87.99 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.077 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -78.45 125.17 85.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.231 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HB3' ' CD2' ' A' ' 107' ' ' TYR . 37.3 Cg_endo -66.25 -42.0 11.39 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.467 2.111 . . . . 0.0 112.21 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.61 HD12 HG23 ' A' ' 100' ' ' ILE . 27.5 mm -127.12 119.82 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.679 HD11 HG23 ' A' ' 50' ' ' VAL . 21.5 tp -133.59 141.34 47.63 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.98 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 13.3 tp -138.27 120.1 15.32 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.306 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.631 ' HB3' HG12 ' A' ' 52' ' ' ILE . 7.8 m-85 -97.28 120.53 37.81 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.582 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.502 ' SD ' ' HB2' ' A' ' 29' ' ' SER . 20.0 ptt? -146.6 -163.77 1.83 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HB3' ' H ' ' A' ' 31' ' ' GLY . 29.2 tptp -96.73 127.63 42.91 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.144 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.37 125.46 8.38 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.618 -1.753 . . . . 0.0 111.74 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 46.4 t -138.5 141.22 30.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -54.01 -41.09 78.14 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.246 1.964 . . . . 0.0 111.453 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -71.71 -28.48 63.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.894 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.52 HD23 ' HD2' ' A' ' 28' ' ' PRO . 2.2 tt -161.5 121.72 1.55 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.52 ' HD2' HD23 ' A' ' 27' ' ' LEU . 50.1 Cg_endo -71.71 29.38 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.277 1.984 . . . . 0.0 113.307 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.613 ' OG ' ' HB3' ' A' ' 33' ' ' SER . 11.8 t -165.78 54.69 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.584 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . 42.7 t -55.59 -36.88 67.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.698 -173.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.665 ' H ' ' HB3' ' A' ' 22' ' ' LYS . . . -73.42 -138.68 0.37 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 114.556 0.582 . . . . 0.0 114.556 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.567 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 36.4 m-85 -77.58 -20.87 53.31 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 72' ' ' PRO . 32.8 t -69.02 -10.21 56.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.423 -0.798 . . . . 0.0 111.083 -174.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 38' ' ' GLN . . . -47.26 -40.84 17.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.62 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -78.94 -38.04 38.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 178.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.86 91.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.931 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -56.19 -36.47 45.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.887 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.615 ' HA ' HE21 ' A' ' 38' ' ' GLN . 2.1 mm100 -67.73 -42.07 82.47 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.719 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HB1' ' CG ' ' A' ' 91' ' ' TYR . . . -57.27 -48.08 79.81 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.07 0.231 . . . . 0.0 111.183 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.847 HD23 ' HG2' ' A' ' 115' ' ' GLU . 9.9 mt -58.97 -62.29 1.99 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.952 0.882 . . . . 0.0 112.567 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.19 -28.51 58.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.134 -176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.51 -56.32 4.96 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.319 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.956 ' SG ' ' HB3' ' A' ' 97' ' ' GLN . 42.6 t -72.21 -59.13 2.89 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.815 -167.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.616 ' HA3' ' C ' ' A' ' 115' ' ' GLU . . . -103.12 -125.59 5.68 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.354 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 46' ' ' ARG . 44.6 mt-10 -142.11 -148.34 0.24 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.483 -0.859 . . . . 0.0 111.49 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 33.3 mmt180 -61.46 143.24 56.21 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.992 0.901 . . . . 0.0 112.119 -165.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.21 152.45 30.36 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.963 -1.472 . . . . 0.0 109.039 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.59 149.66 23.04 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.372 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.4 p90 -134.34 151.12 51.05 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.679 HG23 HD11 ' A' ' 18' ' ' LEU . 61.9 t -127.16 128.19 70.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.869 0.366 . . . . 0.0 110.099 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' MET . 2.1 p30 -75.65 130.61 39.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.739 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.689 HD12 ' H ' ' A' ' 53' ' ' LEU . 1.2 pp -146.1 -34.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.751 -173.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.689 ' H ' HD12 ' A' ' 52' ' ' ILE . 1.3 mm? -63.05 -14.5 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.906 167.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -95.15 -42.9 8.35 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.778 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 76.6 m-20 -79.2 122.34 84.12 Favored Pre-proline 0 N--CA 1.472 0.635 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.91 -44.72 9.5 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.147 1.898 . . . . 0.0 113.118 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -75.74 -47.68 24.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.2 -38.25 81.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.176 0.512 . . . . 0.0 110.487 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.603 ' O ' ' HG3' ' A' ' 63' ' ' PRO . 77.4 ttt180 -50.88 -36.3 37.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.212 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.558 ' O ' ' HE2' ' A' ' 64' ' ' LYS . . . -83.84 -42.19 16.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 50.3 mm-40 -78.0 -59.31 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -161.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.73 ' HB3' HG21 ' A' ' 8' ' ' ILE . 2.2 pt? -70.45 -32.59 2.74 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 62' ' ' LEU . 11.3 Cg_endo -53.68 -42.25 67.61 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.324 1.349 . . . . 0.0 111.415 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 60' ' ' ALA . 46.2 mtmt -54.57 -38.87 67.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.709 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.596 ' OH ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.26 -41.09 77.37 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.144 -179.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.858 ' HB1' HD22 ' A' ' 80' ' ' LEU . . . -78.74 -57.35 3.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.583 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.68 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 46.6 t30 -175.0 -53.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 0.0 110.084 170.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.68 ' CE3' ' HB3' ' A' ' 67' ' ' ASN . 1.1 m-90 -59.62 150.48 66.32 Favored Pre-proline 0 C--O 1.215 -0.746 0 CA-C-N 113.347 -1.752 . . . . 0.0 113.058 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.77 -33.81 42.62 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 121.828 1.685 . . . . 0.0 110.235 171.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 50.7 p -142.47 -124.2 0.09 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.083 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 1.006 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 55.0 m-85 -141.8 -167.51 0.15 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.006 ' HA ' ' HB3' ' A' ' 71' ' ' PHE . 56.9 Cg_endo -68.77 153.42 90.27 Favored 'Cis proline' 0 C--N 1.36 1.179 0 CA-C-N 121.631 1.618 . . . . 0.0 114.107 -1.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.655 HE22 ' HA ' ' A' ' 63' ' ' PRO . 58.2 mt-30 -145.27 133.32 21.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 75' ' ' TRP . 3.2 tm? -95.56 137.46 34.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.806 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.605 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 61.2 m95 -122.4 127.42 49.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 178.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG22 HD13 ' A' ' 100' ' ' ILE . 46.4 t -106.02 115.2 47.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.603 ' HB2' ' CG2' ' A' ' 103' ' ' THR . 28.5 t70 55.9 32.65 20.14 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 123.251 1.5 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 75.69 28.54 60.97 Favored Glycine 0 C--N 1.308 -0.988 0 CA-C-N 113.378 -1.737 . . . . 0.0 112.989 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -124.69 129.75 51.1 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 122.175 0.19 . . . . 0.0 110.778 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.858 HD22 ' HB1' ' A' ' 66' ' ' ALA . 51.8 tp -69.94 136.59 50.71 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.596 HG12 ' CG2' ' A' ' 86' ' ' ILE . 92.5 t -119.31 -53.8 3.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.94 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 147.12 137.0 2.91 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' HA3' ' C ' ' A' ' 72' ' ' PRO . . . -84.62 -65.82 1.49 Allowed Glycine 0 C--O 1.216 -0.98 0 C-N-CA 118.929 -1.605 . . . . 0.0 116.338 -168.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 1.9 p -79.33 -69.29 0.59 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.744 1.272 . . . . 0.0 113.388 -173.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.56 -48.4 64.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.415 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.596 ' CG2' HG12 ' A' ' 81' ' ' VAL . 49.9 mm -59.81 -46.8 93.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.642 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 82' ' ' GLY . 77.3 t -58.23 -50.48 78.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.082 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.613 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 39.0 mm -56.04 -51.24 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.221 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 36.2 tt0 -62.59 -49.79 73.83 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.317 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.913 ' HB3' ' HB2' ' A' ' 96' ' ' LEU . 96.3 mmm -59.86 -38.36 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.63 ' HD1' ' HB2' ' A' ' 43' ' ' CYS . 3.0 t80 -60.05 -46.35 89.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.158 0.583 . . . . 0.0 110.475 173.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.613 ' HG3' ' O ' ' A' ' 88' ' ' ILE . 79.2 mt-30 -64.59 -40.16 95.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.779 176.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 29.0 mmm180 -59.01 -33.87 71.21 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.053 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.25 20.16 79.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.313 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.631 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 53.7 mt-10 -98.8 -24.58 14.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.106 0.479 . . . . 0.0 111.28 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 23.5 tp -75.2 -43.23 53.17 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.956 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 5.2 pt20 -57.99 -26.9 62.97 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.266 170.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 95' ' ' GLU . 3.3 mm100 -72.95 -48.03 40.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 175.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 39.7 mt -66.33 -48.0 71.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.741 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' A' ' 115' ' ' GLU . 26.5 mm -62.04 -47.14 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.162 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 114' ' ' ALA . 35.6 ttpt -55.67 -47.25 77.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 123.253 0.345 . . . . 0.0 111.795 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.07 -46.81 78.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.008 0.432 . . . . 0.0 109.922 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.603 ' CG2' ' HB2' ' A' ' 77' ' ' ASP . 89.7 m -68.45 -54.69 15.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.164 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.577 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.66 -49.93 74.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.992 -174.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.86 -41.24 82.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -72.43 -24.5 61.23 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.423 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.533 ' HE2' HG23 ' A' ' 103' ' ' THR . 35.5 m-85 -88.53 -41.7 12.55 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.688 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 108' ' ' LYS . 9.5 mmpt? -72.99 -156.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.56 0.695 . . . . 0.0 109.849 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.7 t -82.22 -146.27 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.722 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -79.93 44.68 0.67 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.33 0.586 . . . . 0.0 109.467 169.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.489 ' HG3' ' HB3' ' A' ' 108' ' ' LYS . 50.5 mm-40 -73.63 135.02 78.49 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.311 -172.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.95 42.86 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.69 2.927 . . . . 0.0 114.188 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.63 152.52 18.38 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.672 0.789 . . . . 0.0 112.935 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.778 ' HB1' ' HB2' ' A' ' 97' ' ' GLN . . . -122.85 -116.57 0.3 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 111.882 -2.417 . . . . 0.0 106.621 160.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.847 ' HG2' HD23 ' A' ' 40' ' ' LEU . 75.5 tt0 . . . . . 0 C--N 1.317 -0.831 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.944 172.13 . . . . . . . . 1 1 . 1 stop_ save_